1	Articles	NNPS	O	Articles	_	0	SENT_1	[p1l101t169r251b205],

1	3	CD	NUMBER	3	_	0	SENT_2	[p1l73t360r149b425],
2	@	SYM	O	@	dep	4	SENT_2	[p1l171t360r235b434],
3	+5	CD	NUMBER	+5	num	4	SENT_2	[p1l256t345r316b430],
4	Effect	NN	O	effect	dep	11	SENT_2	[p1l356t363r524b418],
5	of	IN	O	of	_	0	SENT_2	[p1l541t363r605b418],
6	CYP2C19	NN	O	cyp2c19	prep_of	4	SENT_2	[p1l619t367r881b426],
7	and	CC	O	and	_	0	SENT_2	[p1l899t363r1011b418],
8	ABCB1	NN	O	abcb1	prep_of	4	SENT_2	[p1l1025t367r1220b418],
9	single	JJ	O	single	amod	11	SENT_2	[p1l1240t363r1415b435],
10	nucleotide	NN	O	nucleotide	nn	11	SENT_2	[p1l1436t363r1750b418],
11	polymorphisms	NNS	O	polymorphism	dep	1	SENT_2	[p1l352t454r825b525],
12	on	IN	O	on	_	0	SENT_2	[p1l842t472r916b509],
13	outcomes	NNS	O	outcome	prep_on	11	SENT_2	[p1l935t463r1231b509],
14	of	IN	O	of	_	0	SENT_2	[p1l1248t454r1312b509],
15	treatment	NN	O	treatment	prep_of	13	SENT_2	[p1l1322t463r1635b509],
16	with	IN	O	with	_	0	SENT_2	[p1l1649t454r1787b508],
17	ticagrelor	NN	O	ticagrelor	prep_with	15	SENT_2	[p1l1803t454r2094b526],
18	versus	CC	O	versus	prep	17	SENT_2	[p1l351t563r541b600],
19	clopidogrel	NN	O	clopidogrel	dep	18	SENT_2	[p1l559t545r893b617],
20	for	IN	O	for	_	0	SENT_2	[p1l911t545r999b600],
21	acute	JJ	O	acute	amod	23	SENT_2	[p1l1015t554r1177b600],
22	coronary	JJ	O	coronary	amod	23	SENT_2	[p1l1195t563r1461b616],
23	syndromes	NNS	O	syndrome	prep_for	19	SENT_2	[p1l1477t545r1823b616],
24	:	:	O	:	_	0	SENT_2	[p1l1477t545r1823b616],
25	a	DT	O	a	det	27	SENT_2	[p1l1843t563r1874b600],
26	genetic	JJ	O	genetic	amod	27	SENT_2	[p1l1891t548r2113b617],
27	substudy	NN	O	substudy	dep	1	SENT_2	[p1l353t637r630b708],
28	of	IN	O	of	_	0	SENT_2	[p1l646t636r709b691],
29	the	DT	O	the	det	31	SENT_2	[p1l719t637r819b691],
30	PLATO	NNP	O	PLATO	nn	31	SENT_2	[p1l840t641r1033b691],
31	trial	NN	O	trial	prep_of	27	SENT_2	[p1l1047t637r1167b691],

1	Lars	NNP	PERSON	Lars	nn	2	SENT_3	[p1l352t759r402b782],
2	Wallentin	NNP	PERSON	Wallentin	_	0	SENT_3	[p1l410t756r537b787],
3	,	,	O	,	_	0	SENT_3	[p1l410t756r537b787],
4	Stefan	NNP	PERSON	Stefan	nn	5	SENT_3	[p1l546t756r627b790],
5	james	NNS	O	jame	appos	2	SENT_3	[p1l631t758r716b788],
6	,	,	O	,	_	0	SENT_3	[p1l631t758r716b788],
7	Robert	NNP	PERSON	Robert	nn	9	SENT_3	[p1l726t756r808b782],
8	F	NN	PERSON	f	nn	9	SENT_3	[p1l815t759r829b782],
9	Storey	NNP	PERSON	Storey	appos	2	SENT_3	[p1l835t758r920b790],
10	,	,	O	,	_	0	SENT_3	[p1l835t758r920b790],
11	Martin	NNP	PERSON	Martin	nn	12	SENT_3	[p1l929t759r1015b782],
12	Armstrong	NNP	PERSON	Armstrong	appos	2	SENT_3	[p1l1022t759r1166b790],
13	,	,	O	,	_	0	SENT_3	[p1l1022t759r1166b790],
14	Bryan	NNP	PERSON	Bryan	nn	16	SENT_3	[p1l1176t759r1247b790],
15	J	NNP	PERSON	J	nn	16	SENT_3	[p1l1252t759r1262b788],
16	Barratt	NNP	PERSON	Barratt	appos	2	SENT_3	[p1l1271t759r1366b787],
17	,	,	O	,	_	0	SENT_3	[p1l1271t759r1366b787],
18	jay	NNP	PERSON	jay	nn	19	SENT_3	[p1l1371t759r1413b790],
19	Horrow	NNP	PERSON	Horrow	appos	2	SENT_3	[p1l1421t758r1519b787],
20	,	,	O	,	_	0	SENT_3	[p1l1421t758r1519b787],
21	Steen	NNP	PERSON	Steen	nn	22	SENT_3	[p1l1528t758r1597b782],
22	Husted	NNP	PERSON	Husted	appos	2	SENT_3	[p1l1606t756r1701b787],
23	,	,	O	,	_	0	SENT_3	[p1l1606t756r1701b787],
24	Hugo	NNP	PERSON	Hugo	nn	25	SENT_3	[p1l1710t759r1777b790],
25	Katus	NNP	PERSON	Katus	appos	2	SENT_3	[p1l1785t759r1862b787],
26	,	,	O	,	_	0	SENT_3	[p1l1785t759r1862b787],
27	P	NN	O	p	nn	29	SENT_3	[p1l1871t759r1887b782],
28	Gabriel	NNP	PERSON	Gabriel	nn	29	SENT_3	[p1l1894t756r1981b782],
29	Steg	NNP	PERSON	Steg	appos	2	SENT_3	[p1l1988t758r2049b790],
30	,	,	O	,	_	0	SENT_3	[p1l1988t758r2049b790],
31	Svati	NNP	PERSON	Svati	nn	33	SENT_3	[p1l351t802r415b826],
32	H	NNP	PERSON	H	nn	33	SENT_3	[p1l423t802r441b826],
33	Shah	NNP	PERSON	Shah	appos	2	SENT_3	[p1l448t800r518b830],
34	,	,	O	,	_	0	SENT_3	[p1l448t800r518b830],
35	Richard	NNP	PERSON	Richard	nn	37	SENT_3	[p1l528t800r621b826],
36	C	NNP	PERSON	C	nn	37	SENT_3	[p1l629t802r645b826],
37	Becker	NNP	PERSON	Becker	appos	2	SENT_3	[p1l652t800r737b830],
38	,	,	O	,	_	0	SENT_3	[p1l652t800r737b830],
39	for	IN	O	for	_	0	SENT_3	[p1l746t800r781b834],
40	the	DT	O	the	det	41	SENT_3	[p1l787t800r828b826],
41	PLATO	NNP	O	PLATO	prep_for	2	SENT_3	[p1l836t802r921b826],
42	investigators	NNS	O	investigator	dep	2	SENT_3	[p1l929t802r1091b834],

1	Summary	NNP	O	Summary	nn	2	SENT_4	[p1l6t887r184b928],
2	Lancet	NNP	O	Lancet	_	0	SENT_4	[p1l55t944r124b963],
3	2010	CD	DATE	2010	dep	2	SENT_4	[p1l130t945r191b966],
4	;	:	O	;	_	0	SENT_4	[p1l130t945r191b966],
5	376	CD	NUMBER	376	dep	3	SENT_4	[p1l204t942r251b966],
6	:	:	O	:	_	0	SENT_4	[p1l204t942r251b966],
7	1320-28	CD	NUMBER	1320-28	num	8	SENT_4	[p1l265t942r357b966],
8	Background	NN	O	background	dep	2	SENT_4	[p1l403t935r582b972],
9	In	IN	O	in	dep	8	SENT_4	[p1l601t937r635b963],
10	the	DT	O	the	det	12	SENT_4	[p1l652t934r701b963],
11	PLATO	NNP	O	PLATO	nn	12	SENT_4	[p1l720t936r832b963],
12	trial	NN	O	trial	pobj	9	SENT_4	[p1l850t934r913b963],
13	of	IN	O	of	_	0	SENT_4	[p1l930t934r966b963],
14	ticagrelor	NN	O	ticagrelor	prep_of	12	SENT_4	[p1l971t934r1119b972],
15	versus	CC	O	versus	dep	8	SENT_4	[p1l1135t944r1235b963],
16	clopidogrel	NN	O	clopidogrel	dep	15	SENT_4	[p1l1254t934r1428b972],
17	for	IN	O	for	_	0	SENT_4	[p1l1446t934r1491b963],
18	treatment	NN	O	treatment	prep_for	16	SENT_4	[p1l1507t940r1661b963],
19	of	IN	O	of	_	0	SENT_4	[p1l1678t934r1714b963],
20	acute	JJ	O	acute	amod	22	SENT_4	[p1l1719t940r1801b963],
21	coronary	JJ	O	coronary	amod	22	SENT_4	[p1l1819t944r1957b972],
22	syndromes	NNS	O	syndrome	prep_of	18	SENT_4	[p1l1974t934r2154b972],
23	,	,	O	,	_	0	SENT_4	[p1l1974t934r2154b972],
24	ticagrelor	NN	O	ticagrelor	appos	22	SENT_4	[p1l6t980r155b1018],

1	Published	VBN	O	publish	amod	2	SENT_5	[p1l169t1037r267b1057],
2	Online	NN	O	online	nsubj	18	SENT_5	[p1l281t1037r351b1057],
3	reduced	VBD	O	reduce	_	0	SENT_5	[p1l395t1026r520b1055],
4	the	DT	O	the	det	6	SENT_5	[p1l539t1026r589b1055],
5	composite	JJ	O	composite	amod	6	SENT_5	[p1l609t1027r770b1064],
6	outcome	NN	O	outcome	dobj	3	SENT_5	[p1l790t1032r926b1055],
7	of	IN	O	of	_	0	SENT_5	[p1l946t1026r981b1055],
8	cardiovascular	JJ	O	cardiovascular	amod	9	SENT_5	[p1l996t1026r1221b1055],
9	death	NN	O	death	prep_of	6	SENT_5	[p1l1240t1026r1334b1059],
10	,	,	O	,	_	0	SENT_5	[p1l1240t1026r1334b1059],
11	myocardial	JJ	O	myocardial	amod	12	SENT_5	[p1l1355t1026r1528b1064],
12	infarction	NN	O	infarction	prep_of	6	SENT_5	[p1l1548t1026r1709b1059],
13	,	,	O	,	_	0	SENT_5	[p1l1548t1026r1709b1059],
14	and	CC	O	and	_	0	SENT_5	[p1l1731t1026r1789b1055],
15	stroke	NN	O	stroke	prep_of	6	SENT_5	[p1l1809t1026r1912b1059],
16	,	,	O	,	_	0	SENT_5	[p1l1809t1026r1912b1059],
17	but	CC	O	but	_	0	SENT_5	[p1l1933t1026r1985b1055],
18	increased	VBD	O	increase	conj_but	3	SENT_5	[p1l2005t1026r2154b1055],
19	events	NNS	O	event	dobj	18	SENT_5	[p1l6t1078r104b1101],
20	of	IN	O	of	prep	18	SENT_5	[p1l118t1072r153b1101],

1	August	NNP	DATE	August	_	0	SENT_6	[p1l169t1112r241b1135],
2	29,2010	CD	NUMBER	29,2010	num	1	SENT_6	[p1l247t1113r335b1133],
3	major	JJ	O	major	amod	4	SENT_6	[p1l371t1110r462b1145],
4	bleeding	NN	O	bleeding	dep	1	SENT_6	[p1l474t1109r606b1145],
5	related	JJ	O	related	amod	13	SENT_6	[p1l619t1109r722b1137],
6	to	TO	O	to	_	0	SENT_6	[p1l735t1114r763b1136],
7	non-coronary	JJ	O	non-coronary	amod	10	SENT_6	[p1l777t1119r981b1145],
8	artery	NN	O	artery	nn	10	SENT_6	[p1l994t1114r1082b1145],
9	bypass	NN	O	bypass	nn	10	SENT_6	[p1l1094t1109r1195b1145],
10	graft	NN	O	graft	prep_to	5	SENT_6	[p1l1209t1109r1280b1145],
11	(	CD	NUMBER	(	tmod	5	SENT_6	[p1l1294t1111r1421b1145],
12	CABG	NN	ORGANIZATION	cabg	nn	13	SENT_6	[p1l1294t1111r1421b1145],
13	)	NN	O	)	dep	4	SENT_6	[p1l1294t1111r1421b1145],
14	.	.	O	.	_	0	SENT_6	[p1l1294t1111r1421b1145],

1	C	NN	O	c	nn	2	SENT_7	[p1l1438t1111r1460b1137],
2	YPZCI9	NN	O	ypzci9	nsubjpass	7	SENT_7	[p1l1463t1111r1580b1137],
3	and	CC	O	and	_	0	SENT_7	[p1l1591t1109r1648b1136],
4	ABCB1	NN	O	abcb1	nn	5	SENT_7	[p1l1660t1111r1770b1137],
5	genotypes	NNS	O	genotype	conj_and	2	SENT_7	[p1l1783t1114r1935b1145],
6	are	VBP	O	be	auxpass	7	SENT_7	[p1l1949t1119r1995b1137],
7	known	VBN	O	know	_	0	SENT_7	[p1l2008t1109r2113b1137],
8	to	TO	O	to	_	0	SENT_7	[p1l2125t1114r2154b1137],
9	D	NNP	O	D	prep_to	7	SENT_7	[p1l128t1145r335b1167],
10	°	CD	NUMBER	°	num	9	SENT_7	[p1l128t1145r335b1167],
11	"	``	O	"	punct	9	SENT_7	[p1l128t1145r335b1167],
12	1	CD	NUMBER	1	number	13	SENT_7	[p1l128t1145r335b1167],
13	°	CD	NUMBER	°	num	14	SENT_7	[p1l128t1145r335b1167],
14	‘	NN	O	‘	dep	9	SENT_7	[p1l128t1145r335b1167],
15	1	CD	NUMBER	1	number	16	SENT_7	[p1l128t1145r335b1167],
16	°	CD	NUMBER	°	num	17	SENT_7	[p1l128t1145r335b1167],
17	16/50140	CD	NUMBER	16/50140	dep	14	SENT_7	[p1l128t1145r335b1167],
18	"	``	O	"	punct	17	SENT_7	[p1l128t1145r335b1167],
19	inﬂuence	NN	O	inﬂuence	dep	17	SENT_7	[p1l371t1153r514b1181],
20	the	DT	O	the	det	21	SENT_7	[p1l528t1153r576b1181],
21	elfects	NNS	O	elfect	dep	19	SENT_7	[p1l591t1153r688b1181],
22	of	IN	O	of	_	0	SENT_7	[p1l703t1153r738b1181],
23	clopidogrel	NN	O	clopidogrel	prep_of	21	SENT_7	[p1l747t1153r925b1190],
24	.	.	O	.	_	0	SENT_7	[p1l747t1153r925b1190],

1	In	IN	O	in	_	0	SENT_8	[p1l942t1156r975b1181],
2	this	DT	O	this	det	3	SENT_8	[p1l989t1153r1045b1181],
3	substudy	NN	O	substudy	prep_in	6	SENT_8	[p1l1061t1153r1203b1190],
4	,	,	O	,	_	0	SENT_8	[p1l1061t1153r1203b1190],
5	we	PRP	O	we	nsubj	6	SENT_8	[p1l1218t1163r1260b1181],
6	investigated	VBD	O	investigate	_	0	SENT_8	[p1l1275t1153r1458b1190],
7	the	DT	O	the	det	8	SENT_8	[p1l1472t1153r1520b1181],
8	effects	NNS	O	effect	dobj	6	SENT_8	[p1l1535t1153r1631b1181],
9	of	IN	O	of	_	0	SENT_8	[p1l1647t1153r1681b1181],
10	these	DT	O	these	det	11	SENT_8	[p1l1690t1153r1770b1181],
11	genotypes	NNS	O	genotype	prep_of	8	SENT_8	[p1l1785t1159r1937b1190],
12	on	IN	O	on	_	0	SENT_8	[p1l1953t1163r1992b1181],
13	outcomes	NNS	O	outcome	prep_on	6	SENT_8	[p1l2006t1159r2153b1181],
14	6736	CD	NUMBER	6736	num	13	SENT_8	[p1l156t1181r335b1205],
15	(	CD	NUMBER	(	number	16	SENT_8	[p1l156t1181r335b1205],
16	10	CD	NUMBER	10	dep	13	SENT_8	[p1l156t1181r335b1205],
17	)	NN	O	)	dep	16	SENT_8	[p1l156t1181r335b1205],
18	61274-3	CD	NUMBER	61274-3	num	17	SENT_8	[p1l156t1181r335b1205],
19	.	.	O	.	_	0	SENT_8	[p1l602t1199r608b1205],

1	.	.	O	.	_	0	SENT_9	[p1l644t1199r650b1205],

1	between	IN	O	between	_	0	SENT_10	[p1l370t1198r498b1226],
2	and	CC	O	and	_	0	SENT_10	[p1l508t1198r565b1226],
3	within	IN	O	within	conj_and	1	SENT_10	[p1l574t1198r673b1226],
4	treatment	NN	O	treatment	nn	5	SENT_10	[p1l683t1203r833b1226],
5	groups	NNS	O	group	pobj	1	SENT_10	[p1l843t1208r956b1235],
6	.	.	O	.	_	0	SENT_10	[p1l843t1208r956b1235],

1	See	VB	O	see	_	0	SENT_11	[p1l80t1229r113b1247],
2	Comment	NN	O	comment	nn	3	SENT_11	[p1l120t1229r225b1247],
3	page	NN	O	page	dobj	1	SENT_11	[p1l231t1234r279b1253],
4	1278	CD	DATE	1278	num	3	SENT_11	[p1l286t1228r335b1250],
5	See	VB	O	see	dep	1	SENT_11	[p1l111t1262r146b1280],
6	Articles	NNPS	O	Articles	dobj	5	SENT_11	[p1l152t1260r233b1280],
7	page	NN	O	page	dep	5	SENT_11	[p1l239t1267r288b1286],
8	1312	CD	DATE	1312	num	12	SENT_11	[p1l295t1263r344b1283],
9	Uppsala	NNP	LOCATION	Uppsala	nn	12	SENT_11	[p1l75t1308r161b1334],
10	Clinical	JJ	O	clinical	amod	12	SENT_11	[p1l167t1308r243b1328],
11	Research	NNP	O	Research	nn	12	SENT_11	[p1l251t1308r344b1328],
12	Centre	NNP	O	Centre	dep	7	SENT_11	[p1l51t1346r128b1368],
13	,	,	O	,	_	0	SENT_11	[p1l51t1346r128b1368],
14	Uppsala	NNP	ORGANIZATION	Uppsala	nn	15	SENT_11	[p1l135t1345r221b1371],
15	University	NNP	ORGANIZATION	University	appos	12	SENT_11	[p1l227t1346r344b1371],
16	,	,	O	,	_	0	SENT_11	[p1l227t1346r344b1371],
17	Uppsala	NNP	LOCATION	Uppsala	appos	12	SENT_11	[p1l161t1381r252b1407],
18	,	,	O	,	_	0	SENT_11	[p1l161t1381r252b1407],
19	Sweden	NNP	LOCATION	Sweden	appos	12	SENT_11	[p1l259t1381r344b1401],

1	Methods	NNS	O	method	nn	3	SENT_12	[p1l7t1483r140b1511],
2	DNA	NN	O	dna	nn	3	SENT_12	[p1l157t1484r237b1511],
3	samples	NNS	O	sample	nsubjpass	12	SENT_12	[p1l253t1482r379b1519],
4	obtained	VBN	O	obtain	partmod	3	SENT_12	[p1l396t1482r532b1511],
5	from	IN	O	from	_	0	SENT_12	[p1l548t1482r625b1511],
6	patients	NNS	O	patient	prep_from	4	SENT_12	[p1l641t1483r764b1519],
7	in	IN	O	in	_	0	SENT_12	[p1l781t1483r813b1510],
8	the	DT	O	the	det	10	SENT_12	[p1l828t1482r877b1511],
9	PLATO	NNP	O	PLATO	nn	10	SENT_12	[p1l894t1484r1007b1511],
10	trial	NN	O	trial	prep_in	6	SENT_12	[p1l1023t1482r1086b1511],
11	were	VBD	O	be	auxpass	12	SENT_12	[p1l1101t1492r1176b1511],
12	genotyped	VBN	O	genotype	_	0	SENT_12	[p1l1192t1482r1353b1520],
13	for	IN	O	for	mark	17	SENT_12	[p1l1369t1482r1414b1511],
14	CYPZCI9	NN	O	cypzci9	nn	16	SENT_12	[p1l1432t1484r1578b1511],
15	loss-of-function	NN	O	loss-of-function	nn	16	SENT_12	[p1l1591t1482r1836b1511],
16	alleles	NNS	O	allele	nsubj	17	SENT_12	[p1l6t1528r102b1557],
17	(	VBP	O	(	advcl	66	SENT_12	[p1l119t1530r173b1566],
18	*	NN	O	*	nsubj	57	SENT_12	[p1l119t1530r173b1566],
19	2	CD	NUMBER	2	num	18	SENT_12	[p1l119t1530r173b1566],
20	,	,	O	,	_	0	SENT_12	[p1l119t1530r173b1566],
21	*	CD	NUMBER	*	number	22	SENT_12	[p1l190t1530r234b1561],
22	3	CD	NUMBER	3	appos	18	SENT_12	[p1l190t1530r234b1561],
23	,	,	O	,	_	0	SENT_12	[p1l190t1530r234b1561],
24	*	CD	NUMBER	*	num	25	SENT_12	[p1l250t1530r295b1561],
25	4	CD	NUMBER	4	conj_and	18	SENT_12	[p1l250t1530r295b1561],
26	,	,	O	,	_	0	SENT_12	[p1l250t1530r295b1561],
27	*	CD	NUMBER	*	number	28	SENT_12	[p1l311t1529r355b1561],
28	5	CD	NUMBER	5	appos	25	SENT_12	[p1l311t1529r355b1561],
29	,	,	O	,	_	0	SENT_12	[p1l311t1529r355b1561],
30	*	CD	NUMBER	*	number	31	SENT_12	[p1l372t1530r416b1561],
31	‘	CD	NUMBER	‘	conj_and	18	SENT_12	[p1l372t1530r416b1561],
32	6	CD	NUMBER	6	dep	31	SENT_12	[p1l372t1530r416b1561],
33	,	,	O	,	_	0	SENT_12	[p1l372t1530r416b1561],
34	*	CD	NUMBER	*	number	35	SENT_12	[p1l432t1530r476b1561],
35	7	CD	NUMBER	7	conj_and	18	SENT_12	[p1l432t1530r476b1561],
36	,	,	O	,	_	0	SENT_12	[p1l432t1530r476b1561],
37	and	CC	O	and	_	0	SENT_12	[p1l493t1528r551b1557],
38	*	NN	O	*	conj_and	18	SENT_12	[p1l565t1530r621b1566],
39	8	CD	NUMBER	8	num	40	SENT_12	[p1l565t1530r621b1566],
40	)	NN	O	)	dep	38	SENT_12	[p1l565t1530r621b1566],
41	,	,	O	,	_	0	SENT_12	[p1l565t1530r621b1566],
42	the	DT	O	the	det	45	SENT_12	[p1l637t1528r686b1557],
43	CYPZCI9	NN	O	cypzci9	nn	45	SENT_12	[p1l704t1530r850b1557],
44	gain-of-function	NN	O	gain-of-function	nn	45	SENT_12	[p1l863t1528r1115b1566],
45	allele	NN	O	allele	conj_and	18	SENT_12	[p1l1130t1528r1210b1557],
46	*	CD	NUMBER	*	number	47	SENT_12	[p1l1225t1530r1286b1561],
47	17	CD	NUMBER	17	dep	45	SENT_12	[p1l1225t1530r1286b1561],
48	,	,	O	,	_	0	SENT_12	[p1l1225t1530r1286b1561],
49	and	CC	O	and	_	0	SENT_12	[p1l1302t1528r1360b1557],
50	the	DT	O	the	det	51	SENT_12	[p1l1374t1528r1423b1557],
51	ABCB1	NN	O	abcb1	conj_and	18	SENT_12	[p1l1437t1530r1550b1557],
52	single	JJ	O	single	amod	54	SENT_12	[p1l1565t1528r1658b1566],
53	nucleotide	NN	O	nucleotide	nn	54	SENT_12	[p1l1673t1528r1836b1557],
54	polymorphism	NN	O	polymorphism	dep	51	SENT_12	[p1l6t1574r238b1612],
55	3435C	NN	O	3435c	npadvmod	57	SENT_12	[p1l249t1575r411b1603],
56	—	CD	NUMBER	—	num	55	SENT_12	[p1l249t1575r411b1603],
57	>	JJR	O	>	xcomp	17	SENT_12	[p1l249t1575r411b1603],
58	T.	FW	O	t.	dep	57	SENT_12	[p1l249t1575r411b1603],
59	For	IN	O	for	dep	57	SENT_12	[p1l424t1576r475b1603],
60	the	DT	O	the	det	62	SENT_12	[p1l484t1574r534b1603],
61	CYPZCI9	NN	O	cypzci9	nn	62	SENT_12	[p1l547t1576r693b1603],
62	genotype	NN	O	genotype	pobj	59	SENT_12	[p1l701t1580r851b1612],
63	,	,	O	,	_	0	SENT_12	[p1l701t1580r851b1612],
64	patients	NNS	O	patient	nsubjpass	66	SENT_12	[p1l862t1575r986b1611],
65	were	VBD	O	be	auxpass	66	SENT_12	[p1l996t1584r1071b1603],
66	stratiﬁed	VBN	O	stratiﬁed	ccomp	12	SENT_12	[p1l1082t1574r1220b1603],
67	by	IN	O	by	_	0	SENT_12	[p1l1229t1574r1266b1612],
68	the	DT	O	the	det	69	SENT_12	[p1l1275t1574r1324b1603],
69	presence	NN	O	presence	agent	66	SENT_12	[p1l1335t1584r1474b1611],
70	or	CC	O	or	_	0	SENT_12	[p1l1484t1584r1517b1603],
71	absence	NN	O	absence	conj_or	69	SENT_12	[p1l1526t1574r1651b1603],
72	of	IN	O	of	_	0	SENT_12	[p1l1661t1574r1697b1603],
73	any	DT	O	any	det	78	SENT_12	[p1l1701t1584r1757b1612],
74	loss	NN	O	loss	nn	78	SENT_12	[p1l1766t1574r1836b1603, p1l126t1623r296b1648],
75	(	NN	O	(	nn	78	SENT_12	[p1l1766t1574r1836b1603, p1l126t1623r296b1648],
76	ProfLWa	NNP	O	ProfLWa	nn	78	SENT_12	[p1l1766t1574r1836b1603, p1l126t1623r296b1648],
77	|	NNP	O	|	nn	78	SENT_12	[p1l1766t1574r1836b1603, p1l126t1623r296b1648],
78	lentin	NN	O	lentin	prep_of	69	SENT_12	[p1l1766t1574r1836b1603, p1l126t1623r296b1648],

1	MD	NN	O	md	nn	4	SENT_13	[p1l307t1625r347b1647],
2	,	,	O	,	_	0	SENT_13	[p1l307t1625r347b1647],
3	of-function	JJ	O	of-function	amod	4	SENT_13	[p1l388t1615r562b1644],
4	allele	NN	O	allele	_	0	SENT_13	[p1l587t1615r675b1649],
5	,	,	O	,	_	0	SENT_13	[p1l587t1615r675b1649],
6	and	CC	O	and	_	0	SENT_13	[p1l702t1615r761b1644],
7	for	IN	O	for	mark	14	SENT_13	[p1l786t1615r831b1644],
8	the	DT	O	the	det	10	SENT_13	[p1l855t1615r904b1644],
9	ABCB1	NN	O	abcb1	nn	10	SENT_13	[p1l929t1617r1042b1644],
10	genotype	NN	O	genotype	nsubjpass	14	SENT_13	[p1l1066t1621r1216b1653],
11	,	,	O	,	_	0	SENT_13	[p1l1066t1621r1216b1653],
12	patients	NNS	O	patient	appos	10	SENT_13	[p1l1243t1616r1366b1653],
13	were	VBD	O	be	auxpass	14	SENT_13	[p1l1392t1625r1467b1644],
14	stratiﬁed	VBN	O	stratiﬁed	conj_and	4	SENT_13	[p1l1492t1615r1630b1644],
15	by	IN	O	by	_	0	SENT_13	[p1l1654t1615r1691b1653],
16	predicted	VBN	O	predict	amod	18	SENT_13	[p1l1716t1615r1862b1653],
17	gene	NN	O	gene	nn	18	SENT_13	[p1l1887t1625r1961b1653],
18	expression	NN	O	expression	agent	14	SENT_13	[p1l1987t1616r2154b1653],

1	(	RB	O	(	advmod	2	SENT_14	[p1l6t1661r95b1699],
2	high	JJ	O	high	dep	6	SENT_14	[p1l6t1661r95b1699],
3	,	,	O	,	_	0	SENT_14	[p1l6t1661r95b1699],
4	Slames	NNP	O	Slames	nn	6	SENT_14	[p1l42t1707r120b1730],
5	MP	NNP	O	MP	nn	6	SENT_14	[p1l134t1706r184b1747],
6	)	NNP	O	)	_	0	SENT_14	[p1l134t1706r184b1747],
7	?	.	O	?	_	0	SENT_14	[p1l134t1706r184b1747],

1	°	JJ	O	°	amod	2	SENT_15	[p1l199t1707r331b1747],
2	eP	NN	O	ep	_	0	SENT_15	[p1l199t1707r331b1747],
3	“	NN	O	“	dep	2	SENT_15	[p1l199t1707r331b1747],
4	'	''	O	'	_	0	SENT_15	[p1l199t1707r331b1747],
5	t	NN	O	t	dep	3	SENT_15	[p1l199t1707r331b1747],
6	"	''	O	"	punct	5	SENT_15	[p1l199t1707r331b1747],
7	'	''	O	'	_	0	SENT_15	[p1l199t1707r331b1747],
8	[	CD	NUMBER	[	dep	5	SENT_15	[p1l199t1707r331b1747],
9	°	CD	NUMBER	°	dep	2	SENT_15	[p1l199t1707r331b1747],
10	"	``	O	"	punct	13	SENT_15	[p1l199t1707r331b1747],
11	‘	FW	O	‘	nn	13	SENT_15	[p1l199t1707r331b1747],
12	°	FW	O	°	nn	13	SENT_15	[p1l337t1705r360b1725],
13	f	FW	O	f	dep	9	SENT_15	[p1l337t1705r360b1725],
14	intermediate	JJ	O	intermediate	amod	18	SENT_15	[p1l404t1707r612b1740],
15	,	,	O	,	_	0	SENT_15	[p1l404t1707r612b1740],
16	or	CC	O	or	_	0	SENT_15	[p1l629t1717r662b1736],
17	low	JJ	O	low	conj_or	14	SENT_15	[p1l677t1707r751b1745],
18	)	NN	O	)	dep	13	SENT_15	[p1l677t1707r751b1745],
19	.	.	O	.	_	0	SENT_15	[p1l677t1707r751b1745],

1	The	DT	O	the	det	4	SENT_16	[p1l769t1707r829b1736],
2	primary	JJ	O	primary	amod	4	SENT_16	[p1l845t1708r971b1745],
3	eﬂicacy	NN	O	eﬂicacy	nn	4	SENT_16	[p1l986t1707r1102b1745],
4	endpoint	NN	O	endpoint	nsubj	7	SENT_16	[p1l1118t1707r1259b1745],
5	was	VBD	O	be	cop	7	SENT_16	[p1l1273t1717r1332b1736],
6	the	DT	O	the	det	7	SENT_16	[p1l1348t1707r1397b1736],
7	composite	NN	O	composite	_	0	SENT_16	[p1l1414t1708r1575b1745],
8	of	IN	O	of	_	0	SENT_16	[p1l1591t1707r1626b1736],
9	cardiovascular	JJ	O	cardiovascular	amod	10	SENT_16	[p1l1629t1707r1854b1736],
10	death	NN	O	death	prep_of	7	SENT_16	[p1l1870t1707r1963b1740],
11	,	,	O	,	_	0	SENT_16	[p1l1870t1707r1963b1740],
12	myocardial	JJ	O	myocardial	amod	14	SENT_16	[p1l1981t1707r2154b1745],
13	infarcvgiiglltlfilascular	JJ	O	infarcvgiiglltlfilascular	amod	14	SENT_16	[p1l6t1753r253b1800],
14	Science	NN	O	science	appos	10	SENT_16	[p1l258t1786r337b1800],

1	University	NNP	ORGANIZATION	University	_	0	SENT_17	[p1l98t1818r209b1843],
2	of	IN	ORGANIZATION	of	_	0	SENT_17	[p1l215t1817r238b1837],
3	Shefﬁeldl	NNP	ORGANIZATION	Shefﬁeldl	prep_of	1	SENT_17	[p1l243t1817r343b1840],
4	or	CC	O	or	_	0	SENT_17	[p1l381t1802r413b1820],
5	stroke	NN	O	stroke	prep_of	1	SENT_17	[p1l424t1791r518b1820],
6	after	IN	O	after	_	0	SENT_17	[p1l529t1791r600b1820],
7	up	RB	DURATION	up	advmod	11	SENT_17	[p1l609t1802r650b1829],
8	to	TO	DURATION	to	_	0	SENT_17	[p1l660t1797r690b1820],
9	12	CD	DURATION	12	num	10	SENT_17	[p1l701t1794r734b1820],
10	months	NNS	NUMBER	month	prep_to	7	SENT_17	[p1l744t1791r864b1820],
11	treatment	NN	O	treatment	prep_after	1	SENT_17	[p1l882t1797r1037b1820],
12	with	IN	O	with	_	0	SENT_17	[p1l1046t1791r1115b1820],
13	ticagrelor	NN	O	ticagrelor	prep_with	11	SENT_17	[p1l1125t1791r1274b1829],
14	or	CC	O	or	_	0	SENT_17	[p1l1283t1802r1316b1820],
15	clopidogrel	NN	O	clopidogrel	prep_with	11	SENT_17	[p1l1326t1791r1508b1829],
16	.	.	O	.	_	0	SENT_17	[p1l1326t1791r1508b1829],

1	Shefﬁelcl	NNP	O	Shefﬁelcl	nn	3	SENT_18	[p1l33t1853r134b1876],
2	,	,	O	,	_	0	SENT_18	[p1l33t1853r134b1876],
3	UK	NNP	LOCATION	UK	nsubj	18	SENT_18	[p1l141t1855r171b1873],
4	(	CD	NUMBER	(	num	3	SENT_18	[p1l178t1854r198b1878],
5	R	NN	O	r	nn	8	SENT_18	[p1l178t1854r198b1878],
6	F	NN	O	f	nn	8	SENT_18	[p1l206t1855r215b1873],
7	Storey	NNP	PERSON	Storey	nn	8	SENT_18	[p1l222t1855r288b1879],
8	MD	NNP	O	MD	dep	3	SENT_18	[p1l294t1854r344b1878],
9	)	NN	O	)	dep	3	SENT_18	[p1l294t1854r344b1878],
10	;	:	O	;	_	0	SENT_18	[p1l294t1854r344b1878],
11	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	nn	12	SENT_18	[p1l63t1899r197b1918],
12	Research	NNP	ORGANIZATION	Research	dep	9	SENT_18	[p1l205t1897r298b1918],
13	and	CC	O	and	_	0	SENT_18	[p1l305t1897r346b1918],
14	Findings	NNS	O	finding	dep	9	SENT_18	[p1l386t1892r513b1928],
15	10	CD	NUMBER	10	number	16	SENT_18	[p1l535t1894r567b1920],
16	285	CD	NUMBER	285	num	17	SENT_18	[p1l577t1892r629b1920],
17	patients	NNS	O	patient	dep	14	SENT_18	[p1l652t1892r775b1929],
18	provided	VBD	O	provide	_	0	SENT_18	[p1l797t1891r934b1929],
19	samples	NNS	O	sample	dobj	18	SENT_18	[p1l955t1891r1081b1929],
20	for	IN	O	for	_	0	SENT_18	[p1l1103t1891r1148b1920],
21	genetic	JJ	O	genetic	amod	22	SENT_18	[p1l1168t1892r1280b1929],
22	analysis	NN	O	analysis	prep_for	18	SENT_18	[p1l1300t1891r1432b1929],
23	.	.	O	.	_	0	SENT_18	[p1l1300t1891r1432b1929],

1	The	DT	O	the	det	3	SENT_19	[p1l1454t1891r1515b1920],
2	primary	JJ	O	primary	amod	3	SENT_19	[p1l1535t1892r1661b1929],
3	outcome	NN	O	outcome	nsubj	4	SENT_19	[p1l1681t1897r1817b1920],
4	occurred	VBD	O	occur	_	0	SENT_19	[p1l1838t1891r1975b1920],
5	less	RBR	O	less	advmod	6	SENT_19	[p1l1995t1891r2053b1920],
6	often	RB	O	often	advmod	4	SENT_19	[p1l2074t1891r2154b1920],
7	with	IN	O	with	_	0	SENT_19	[p1l6t1939r75b1968],
8	Development	NNP	O	Development	prep_with	4	SENT_19	[p1l17t1973r170b1999],
9	,	,	O	,	_	0	SENT_19	[p1l17t1973r170b1999],
10	Alderley	NNP	O	Alderley	nn	11	SENT_19	[p1l176t1973r266b1999],
11	Park	NNP	O	Park	prep_with	4	SENT_19	[p1l272t1973r324b1996],
12	,	,	O	,	_	0	SENT_19	[p1l272t1973r324b1996],
13	UK	NNP	LOCATION	UK	prep_with	4	SENT_19	[p1l6t2011r42b2033],
14	,	,	O	,	_	0	SENT_19	[p1l6t2011r42b2033],
15	and	CC	O	and	_	0	SENT_19	[p1l49t2009r89b2029],
16	Wilmington	NNP	LOCATION	Wilmington	conj_and	8	SENT_19	[p1l94t2009r232b2035],
17	,	,	O	,	_	0	SENT_19	[p1l94t2009r232b2035],
18	DE	NN	O	de	appos	16	SENT_19	[p1l240t2011r273b2033],
19	,	,	O	,	_	0	SENT_19	[p1l240t2011r273b2033],
20	USA	NNP	LOCATION	USA	nn	22	SENT_19	[p1l281t2011r325b2029],
21	(	CD	NUMBER	(	num	22	SENT_19	[p1l126t2047r152b2071],
22	M	NN	O	m	appos	16	SENT_19	[p1l126t2047r152b2071],
23	Armstrong	NNP	ORGANIZATION	Armstrong	nn	24	SENT_19	[p1l159t2047r270b2072],
24	PhD	NNP	O	PhD	dep	22	SENT_19	[p1l279t2046r324b2069],
25	,	,	O	,	_	0	SENT_19	[p1l279t2046r324b2069],
26	Bl	NNP	O	Bl	nn	28	SENT_19	[p1l17t2084r39b2107],
27	Barratt	NNP	O	Barratt	nn	28	SENT_19	[p1l48t2084r118b2102],
28	PhD	NNP	O	PhD	appos	16	SENT_19	[p1l126t2082r182b2107],
29	,	,	O	,	_	0	SENT_19	[p1l126t2082r182b2107],
30	J	NNP	O	J	nn	33	SENT_19	[p1l126t2082r182b2107],
31	Horrow	NNP	PERSON	Horrow	nn	33	SENT_19	[p1l191t2084r268b2102],
32	MD	NNP	O	MD	nn	33	SENT_19	[p1l275t2083r325b2107],
33	)	NN	O	)	appos	28	SENT_19	[p1l275t2083r325b2107],
34	;	:	O	;	_	0	SENT_19	[p1l275t2083r325b2107],

1	ticagrelor	NN	O	ticagrelor	dep	17	SENT_20	[p1l6t2182r155b2219],
2	versus	CC	O	versus	prep	1	SENT_20	[p1l170t2192r269b2210],
3	clopidogrel	NN	O	clopidogrel	dep	2	SENT_20	[p1l287t2182r469b2219],
4	,	,	O	,	_	0	SENT_20	[p1l287t2182r469b2219],
5	irrespective	RB	O	irrespective	_	0	SENT_20	[p1l486t2183r667b2219],
6	of	IN	O	of	_	0	SENT_20	[p1l683t2182r719b2210],
7	CYPZC19	NN	O	cypzc19	nn	8	SENT_20	[p1l732t2184r878b2210],
8	genotype	NN	O	genotype	prep_irrespective_of	3	SENT_20	[p1l892t2187r1041b2219],
9	:	:	O	:	_	0	SENT_20	[p1l892t2187r1041b2219],
10	8-6	CD	PERCENT	8-6	num	11	SENT_20	[p1l1060t2184r1145b2212],
11	%	NN	PERCENT	%	dep	3	SENT_20	[p1l1060t2184r1145b2212],
12	versus	CC	O	versus	prep	11	SENT_20	[p1l1161t2192r1261b2210],
13	11-2	CD	PERCENT	11-2	num	14	SENT_20	[p1l1279t2184r1377b2212],
14	%	NN	PERCENT	%	dep	12	SENT_20	[p1l1279t2184r1377b2212],
15	(	CD	NUMBER	(	num	16	SENT_20	[p1l1395t2182r1512b2219],
16	hazard	NN	O	hazard	dep	17	SENT_20	[p1l1395t2182r1512b2219],
17	ratio	NN	O	ratio	dep	77	SENT_20	[p1l1528t2183r1599b2210],
18	0-77	CD	NUMBER	0-77	num	17	SENT_20	[p1l1615t2183r1696b2215],
19	,	,	O	,	_	0	SENT_20	[p1l1615t2183r1696b2215],
20	95	CD	PERCENT	95	number	21	SENT_20	[p1l1714t2183r1781b2212],
21	%	NN	PERCENT	%	amod	23	SENT_20	[p1l1714t2183r1781b2212],
22	CI	NN	O	ci	nn	23	SENT_20	[p1l1799t2184r1835b2210],
23	o	NN	O	o	appos	17	SENT_20	[p1l7t2230r36b2256],
24	-	:	O	-	_	0	SENT_20	[p1l7t2230r36b2256],
25	60-0	CD	NUMBER	60-0	num	27	SENT_20	[p1l44t2230r117b2256],
26	-	:	O	-	_	0	SENT_20	[p1l124t2244r129b2249],
27	99	CD	DATE	99	dep	17	SENT_20	[p1l137t2230r180b2261],
28	,	,	O	,	_	0	SENT_20	[p1l137t2230r180b2261],
29	p	NN	O	p	nn	31	SENT_20	[p1l189t2230r247b2265],
30	=	JJ	O	=	amod	31	SENT_20	[p1l189t2230r247b2265],
31	o	NN	O	o	appos	27	SENT_20	[p1l189t2230r247b2265],
32	-	:	O	-	_	0	SENT_20	[p1l254t2244r260b2249],
33	0380	CD	DATE	0380	number	34	SENT_20	[p1l267t2230r350b2265],
34	)	CD	NUMBER	)	dep	17	SENT_20	[p1l267t2230r350b2265],
35	in	IN	O	in	_	0	SENT_20	[p1l360t2229r391b2256],
36	patients	NNS	O	patient	prep_in	34	SENT_20	[p1l399t2229r522b2265],
37	with	IN	O	with	_	0	SENT_20	[p1l530t2228r599b2256],
38	any	DT	O	any	det	40	SENT_20	[p1l606t2238r662b2265],
39	loss-of-function	JJ	O	loss-of-function	amod	40	SENT_20	[p1l668t2227r913b2256],
40	allele	NN	O	allele	prep_with	36	SENT_20	[p1l920t2228r1009b2261],
41	;	:	O	;	_	0	SENT_20	[p1l920t2228r1009b2261],
42	and	CC	O	and	cc	43	SENT_20	[p1l1018t2228r1076b2256],
43	8	CD	NUMBER	8	dep	17	SENT_20	[p1l1085t2230r1100b2256],
44	-	:	O	-	_	0	SENT_20	[p1l1108t2244r1113b2249],
45	8	CD	PERCENT	8	num	46	SENT_20	[p1l1121t2229r1169b2257],
46	%	NN	PERCENT	%	dep	43	SENT_20	[p1l1121t2229r1169b2257],
47	versus	CC	O	versus	prep	46	SENT_20	[p1l1177t2238r1276b2256],
48	10	CD	NUMBER	10	dep	47	SENT_20	[p1l1286t2230r1318b2256],
49	-	:	O	-	_	0	SENT_20	[p1l1325t2244r1331b2249],
50	o	NN	PERCENT	o	nn	51	SENT_20	[p1l1338t2229r1386b2257],
51	%	NN	PERCENT	%	dep	17	SENT_20	[p1l1338t2229r1386b2257],
52	(	CD	NUMBER	(	num	53	SENT_20	[p1l1396t2230r1423b2265],
53	o	NN	O	o	dep	51	SENT_20	[p1l1396t2230r1423b2265],
54	-	:	O	-	_	0	SENT_20	[p1l1431t2244r1436b2249],
55	86	CD	DATE	86	dep	17	SENT_20	[p1l1444t2230r1487b2260],
56	,	,	O	,	_	0	SENT_20	[p1l1444t2230r1487b2260],
57	o	NN	O	o	appos	55	SENT_20	[p1l1497t2230r1513b2256],
58	-	:	O	-	_	0	SENT_20	[p1l1521t2244r1526b2249],
59	74-1-01	CD	NUMBER	74-1-01	dep	17	SENT_20	[p1l1534t2229r1664b2261],
60	,	,	O	,	_	0	SENT_20	[p1l1534t2229r1664b2261],
61	p	NN	O	p	nn	63	SENT_20	[p1l1673t2230r1731b2265],
62	=	JJ	O	=	amod	63	SENT_20	[p1l1673t2230r1731b2265],
63	o	NN	O	o	appos	59	SENT_20	[p1l1673t2230r1731b2265],
64	-	:	O	-	_	0	SENT_20	[p1l1739t2244r1744b2249],
65	0608	CD	DATE	0608	number	66	SENT_20	[p1l1751t2230r1834b2265],
66	)	CD	NUMBER	)	dep	17	SENT_20	[p1l1751t2230r1834b2265],
67	in	IN	O	in	_	0	SENT_20	[p1l7t2275r38b2302],
68	those	DT	O	those	prep_in	66	SENT_20	[p1l48t2273r131b2302],
69	without	IN	O	without	_	0	SENT_20	[p1l141t2273r262b2302],
70	any	DT	O	any	det	75	SENT_20	[p1l271t2284r327b2311],
71	loss-of-function	JJ	O	loss-of-function	amod	75	SENT_20	[p1l336t2273r580b2302],
72	allele	NN	O	allele	nn	75	SENT_20	[p1l590t2273r671b2302],
73	(	NN	O	(	nn	75	SENT_20	[p1l683t2275r863b2311],
74	interaction	NN	O	interaction	nn	75	SENT_20	[p1l683t2275r863b2311],
75	p	NN	O	p	prep_without	17	SENT_20	[p1l872t2276r931b2311],
76	=	JJ	O	=	amod	77	SENT_20	[p1l872t2276r931b2311],
77	o	NN	O	o	dep	80	SENT_20	[p1l872t2276r931b2311],
78	-	:	O	-	_	0	SENT_20	[p1l938t2290r943b2295],
79	46	CD	NUMBER	46	num	80	SENT_20	[p1l950t2276r1006b2311],
80	)	NN	O	)	_	0	SENT_20	[p1l950t2276r1006b2311],
81	.	.	O	.	_	0	SENT_20	[p1l950t2276r1006b2311],

1	For	IN	O	for	dep	7	SENT_21	[p1l1018t2275r1070b2302],
2	the	DT	O	the	det	4	SENT_21	[p1l1079t2273r1128b2302],
3	ABCB1	NN	O	abcb1	nn	4	SENT_21	[p1l1138t2276r1250b2302],
4	genotype	NN	O	genotype	pobj	1	SENT_21	[p1l1260t2279r1409b2311],
5	,	,	O	,	_	0	SENT_21	[p1l1260t2279r1409b2311],
6	event	NN	O	event	nn	7	SENT_21	[p1l1421t2279r1504b2302],
7	rates	NNS	O	rate	_	0	SENT_21	[p1l1514t2279r1587b2302],
8	for	IN	O	for	_	0	SENT_21	[p1l1598t2273r1643b2302],
9	the	DT	O	the	det	11	SENT_21	[p1l1652t2273r1701b2302],
10	primary	JJ	O	primary	amod	11	SENT_21	[p1l1711t2275r1837b2311],
11	Department	NNP	ORGANIZATION	Department	prep_for	7	SENT_21	[p1l54t2324r183b2347],
12	of	IN	ORGANIZATION	of	_	0	SENT_21	[p1l189t2322r212b2342],
13	Cardiology	NNP	ORGANIZATION	Cardiology	prep_of	7	SENT_21	[p1l216t2322r335b2348],
14	.	.	O	.	_	0	SENT_21	[p1l216t2322r335b2348],

1	outcome	NN	O	outcome	nsubj	5	SENT_22	[p1l371t2322r504b2345],
2	were	VBD	O	be	cop	5	SENT_22	[p1l510t2327r583b2345],
3	also	RB	O	also	advmod	5	SENT_22	[p1l591t2317r650b2345],
4	consistently	RB	O	consistently	advmod	5	SENT_22	[p1l658t2317r840b2353],
5	lower	JJR	O	lower	_	0	SENT_22	[p1l846t2317r931b2345],
6	in	IN	O	in	_	0	SENT_22	[p1l938t2318r968b2344],
7	the	DT	O	the	det	8	SENT_22	[p1l975t2317r1023b2345],
8	ticagrelor	NN	O	ticagrelor	prep_in	5	SENT_22	[p1l1030t2317r1175b2354],
9	than	IN	O	than	rcmod	8	SENT_22	[p1l1182t2317r1250b2345],
10	in	IN	O	in	_	0	SENT_22	[p1l1258t2318r1289b2344],
11	the	DT	O	the	det	13	SENT_22	[p1l1296t2317r1344b2345],
12	clopidogrel	NN	O	clopidogrel	nn	13	SENT_22	[p1l1351t2317r1521b2354],
13	group	NN	O	group	prep_in	9	SENT_22	[p1l1528t2327r1618b2354],
14	for	IN	O	for	dep	9	SENT_22	[p1l1626t2317r1670b2345],
15	all	DT	O	all	det	16	SENT_22	[p1l1677t2317r1712b2345],
16	genotype	NN	O	genotype	pobj	14	SENT_22	[p1l1719t2322r1857b2354],
17	groups	NNS	O	group	nsubj	18	SENT_22	[p1l1865t2327r1969b2354],
18	(	VBP	O	(	rcmod	16	SENT_22	[p1l1979t2318r2154b2354],
19	interaction	NN	O	interaction	dobj	18	SENT_22	[p1l1979t2318r2154b2354],
20	ArhUﬁ	NN	O	arhuﬁ	rcmod	19	SENT_22	[p1l6t2354r335b2418],
21	'	''	O	'	_	0	SENT_22	[p1l6t2354r335b2418],
22	3	CD	NUMBER	3	dep	20	SENT_22	[p1l6t2354r335b2418],
23	:	:	O	:	_	0	SENT_22	[p1l6t2354r335b2418],
24	:	:	O	:	_	0	SENT_22	[p1l6t2354r335b2418],
25	:1	CD	NUMBER	:1	dep	19	SENT_22	[p1l6t2354r335b2418],
26	:	:	O	:	_	0	SENT_22	[p1l6t2354r335b2418],
27	:	:	O	:	_	0	SENT_22	[p1l6t2354r335b2418],
28	‘	CD	NUMBER	‘	num	29	SENT_22	[p1l6t2354r335b2418],
29	|	CD	NUMBER	|	dep	19	SENT_22	[p1l6t2354r335b2418],
30	:	:	O	:	_	0	SENT_22	[p1l6t2354r335b2418],
31	“	CD	NUMBER	“	number	32	SENT_22	[p1l6t2354r335b2418],
32	(	CD	NUMBER	(	dep	29	SENT_22	[p1l6t2354r335b2418],
33	:	:	O	:	_	0	SENT_22	[p1l6t2354r335b2418],
34	i	FW	O	i	dep	32	SENT_22	[p1l6t2354r335b2418],
35	$	$	MONEY	$	dep	37	SENT_22	[p1l6t2354r335b2418],
36	’	CD	MONEY	’	num	37	SENT_22	[p1l6t2354r335b2418],
37	J	NN	O	j	dep	34	SENT_22	[p1l6t2354r335b2418],
38	:	:	O	:	_	0	SENT_22	[p1l6t2354r335b2418],
39	:	:	O	:	_	0	SENT_22	[p1l6t2354r335b2418],
40	:	:	O	:	_	0	SENT_22	[p1l6t2354r335b2418],
41	l	NN	O	l	dep	16	SENT_22	[p1l6t2354r335b2418],
42	;	:	O	;	_	0	SENT_22	[p1l6t2354r335b2418],
43	;	:	O	;	_	0	SENT_22	[p1l6t2354r335b2418],
44	‘	NN	O	‘	dep	8	SENT_22	[p1l6t2354r335b2418],
45	;	:	O	;	_	0	SENT_22	[p1l6t2354r335b2418],
46	;	:	O	;	_	0	SENT_22	[p1l6t2354r335b2418],
47	:	:	O	:	_	0	SENT_22	[p1l6t2354r335b2418],
48	p	NN	O	p	nn	50	SENT_22	[p1l371t2364r428b2398],
49	=	JJ	O	=	amod	50	SENT_22	[p1l371t2364r428b2398],
50	o	NN	O	o	dep	8	SENT_22	[p1l371t2364r428b2398],
51	~	NN	O	~	dep	50	SENT_22	[p1l435t2377r440b2383],
52	39	CD	NUMBER	39	num	51	SENT_22	[p1l447t2364r490b2394],
53	;	:	O	;	_	0	SENT_22	[p1l447t2364r490b2394],
54	8	CD	NUMBER	8	dep	50	SENT_22	[p1l503t2364r531b2389],
55	-	:	O	-	_	0	SENT_22	[p1l503t2364r531b2389],
56	8	CD	PERCENT	8	num	57	SENT_22	[p1l539t2363r586b2391],
57	%	NN	PERCENT	%	dep	54	SENT_22	[p1l539t2363r586b2391],
58	vs	CC	O	vs	_	0	SENT_22	[p1l597t2372r625b2389],
59	11	CD	NUMBER	11	conj_vs	57	SENT_22	[p1l636t2364r665b2389],
60	-	:	O	-	_	0	SENT_22	[p1l672t2377r677b2383],
61	9	CD	PERCENT	9	number	62	SENT_22	[p1l684t2363r740b2394],
62	%	NN	PERCENT	%	amod	54	SENT_22	[p1l684t2363r740b2394],
63	;	:	O	;	_	0	SENT_22	[p1l684t2363r740b2394],
64	o	NN	O	o	dep	50	SENT_22	[p1l753t2364r781b2389],
65	-	:	O	-	_	0	SENT_22	[p1l753t2364r781b2389],
66	71	CD	DATE	71	dep	64	SENT_22	[p1l789t2363r828b2394],
67	,	,	O	,	_	0	SENT_22	[p1l789t2363r828b2394],
68	o	NN	O	o	appos	50	SENT_22	[p1l841t2364r858b2389],
69	-	:	O	-	_	0	SENT_22	[p1l865t2377r870b2383],
70	55-0	CD	NUMBER	55-0	num	72	SENT_22	[p1l878t2363r948b2389],
71	-	:	O	-	_	0	SENT_22	[p1l955t2377r960b2383],
72	92	CD	DATE	92	dep	68	SENT_22	[p1l968t2364r1002b2389],
73	for	IN	O	for	_	0	SENT_22	[p1l1014t2361r1058b2389],
74	the	DT	O	the	det	77	SENT_22	[p1l1068t2361r1116b2389],
75	high-expression	JJ	O	high-expression	amod	77	SENT_22	[p1l1126t2361r1370b2398],
76	genotype	NN	O	genotype	nn	77	SENT_22	[p1l1381t2364r1538b2398],
77	)	NN	O	)	prep_for	72	SENT_22	[p1l1381t2364r1538b2398],
78	.	.	O	.	_	0	SENT_22	[p1l1381t2364r1538b2398],

1	In	IN	O	in	_	0	SENT_23	[p1l1552t2364r1585b2389],
2	the	DT	O	the	det	4	SENT_23	[p1l1595t2361r1643b2389],
3	clopidogrel	NN	O	clopidogrel	nn	4	SENT_23	[p1l1655t2361r1824b2398],
4	group	NN	O	group	prep_in	17	SENT_23	[p1l1835t2371r1933b2398],
5	,	,	O	,	_	0	SENT_23	[p1l1835t2371r1933b2398],
6	the	DT	O	the	det	8	SENT_23	[p1l1946t2361r1994b2389],
7	event	NN	O	event	nn	8	SENT_23	[p1l2005t2367r2086b2389],
8	rate	NN	O	rate	appos	4	SENT_23	[p1l2097t2367r2154b2389],
9	'	''	O	'	_	0	SENT_23	[p1l69t2409r74b2416],
10	Medizinische	NNP	MISC	Medizinische	nn	11	SENT_23	[p1l126t2429r263b2448],
11	Knnik	NNP	MISC	Knnik	dep	8	SENT_23	[p1l270t2409r335b2452],
12	:	:	O	:	_	0	SENT_23	[p1l270t2409r335b2452],
13	at	IN	O	at	advmod	4	SENT_23	[p1l371t2412r398b2434],
14	30	CD	DURATION	30	num	15	SENT_23	[p1l412t2409r446b2434],
15	days	NNS	NUMBER	day	pobj	13	SENT_23	[p1l460t2406r526b2443],
16	was	VBD	O	be	cop	17	SENT_23	[p1l539t2416r596b2434],
17	higher	JJR	O	higher	dep	33	SENT_23	[p1l609t2406r711b2443],
18	in	IN	O	in	_	0	SENT_23	[p1l723t2407r754b2434],
19	patients	NNS	O	patient	prep_in	17	SENT_23	[p1l767t2407r887b2443],
20	with	IN	O	with	_	0	SENT_23	[p1l900t2406r968b2434],
21	than	IN	O	than	mark	29	SENT_23	[p1l981t2406r1050b2434],
22	in	IN	O	in	_	0	SENT_23	[p1l1063t2407r1094b2434],
23	those	DT	O	those	prep_in	29	SENT_23	[p1l1106t2406r1188b2434],
24	without	IN	O	without	_	0	SENT_23	[p1l1201t2406r1319b2434],
25	any	DT	O	any	det	26	SENT_23	[p1l1332t2416r1386b2443],
26	loss-of-ﬁmction	NN	O	loss-of-ﬁmction	prep_without	23	SENT_23	[p1l1398t2406r1636b2434],
27	CYPZCI9	NN	O	cypzci9	nn	28	SENT_23	[p1l1652t2408r1794b2434],
28	alleles	NNS	O	allele	nsubj	29	SENT_23	[p1l1806t2406r1899b2434],
29	(	VBP	O	(	prepc_with	17	SENT_23	[p1l1915t2408r1940b2443],
30	5	LS	NUMBER	5	acomp	29	SENT_23	[p1l1915t2408r1940b2443],
31	-	:	O	-	_	0	SENT_23	[p1l1948t2422r1953b2427],
32	7	CD	PERCENT	7	num	33	SENT_23	[p1l1961t2408r2008b2435],
33	%	NN	PERCENT	%	_	0	SENT_23	[p1l1961t2408r2008b2435],
34	vs	CC	O	vs	_	0	SENT_23	[p1l2021t2416r2049b2434],
35	3	LS	NUMBER	3	conj_vs	33	SENT_23	[p1l2062t2409r2077b2434],
36	-	:	O	-	_	0	SENT_23	[p1l2085t2422r2090b2427],
37	8	CD	PERCENT	8	num	38	SENT_23	[p1l2098t2408r2153b2439],
38	%	NN	PERCENT	%	dep	33	SENT_23	[p1l2098t2408r2153b2439],
39	,	,	O	,	_	0	SENT_23	[p1l2098t2408r2153b2439],
40	Unive,-5it31	NN	O	unive,-5it31	appos	38	SENT_23	[p1l112t2464r335b2484],
41	;	:	O	;	_	0	SENT_23	[p1l112t2464r335b2484],
42	5k	NN	O	5k	nn	45	SENT_23	[p1l112t2464r335b2484],
43	|	NN	O	|	nn	45	SENT_23	[p1l112t2464r335b2484],
44	inikum	NN	O	inikum	nn	45	SENT_23	[p1l112t2464r335b2484],
45	p	NN	O	p	dep	33	SENT_23	[p1l371t2454r519b2488],
46	=	JJ	O	=	amod	48	SENT_23	[p1l371t2454r519b2488],
47	0-028	CD	NUMBER	0-028	tmod	46	SENT_23	[p1l371t2454r519b2488],
48	)	NN	O	)	dep	45	SENT_23	[p1l371t2454r519b2488],
49	,	,	O	,	_	0	SENT_23	[p1l371t2454r519b2488],
50	leading	VBG	O	lead	appos	33	SENT_23	[p1l536t2451r648b2488],
51	to	TO	O	to	_	0	SENT_23	[p1l663t2457r692b2479],
52	earlier	JJR	O	earlier	amod	53	SENT_23	[p1l707t2451r805b2479],
53	separation	NN	O	separation	prep_to	50	SENT_23	[p1l820t2452r979b2487],
54	of	IN	O	of	_	0	SENT_23	[p1l994t2451r1029b2479],
55	event	NN	O	event	nn	56	SENT_23	[p1l1039t2457r1120b2479],
56	rates	NNS	O	rate	prep_of	53	SENT_23	[p1l1135t2457r1207b2479],
57	between	IN	O	between	_	0	SENT_23	[p1l1223t2451r1350b2479],
58	treatment	NN	O	treatment	nn	59	SENT_23	[p1l1365t2457r1516b2479],
59	groups	NNS	O	group	prep_between	50	SENT_23	[p1l1530t2461r1635b2488],
60	in	IN	O	in	_	0	SENT_23	[p1l1652t2452r1682b2479],
61	patients	NNS	O	patient	prep_in	50	SENT_23	[p1l1697t2452r1818b2487],
62	with	IN	O	with	_	0	SENT_23	[p1l1833t2451r1901b2479],
63	loss-of-ﬁinction	JJ	O	loss-of-ﬁinction	amod	64	SENT_23	[p1l1916t2451r2154b2479],
64	Heidelberg	NNP	LOCATION	Heidelberg	prep_with	61	SENT_23	[p1l90t2500r213b2527],
65	.	.	O	.	_	0	SENT_23	[p1l90t2500r213b2527],

1	Heidelberg	NNP	LOCATION	Heidelberg	_	0	SENT_24	[p1l226t2501r349b2527],
2	.	.	O	.	_	0	SENT_24	[p1l226t2501r349b2527],

1	alleles	NNS	O	allele	_	0	SENT_25	[p1l391t2496r495b2525],
2	.	.	O	.	_	0	SENT_25	[p1l391t2496r495b2525],

1	Patients	NNS	O	patient	nsubj	10	SENT_26	[p1l512t2497r636b2525],
2	on	IN	O	on	_	0	SENT_26	[p1l651t2506r690b2525],
3	clopidogrel	NN	O	clopidogrel	prep_on	1	SENT_26	[p1l704t2496r878b2534],
4	who	WP	O	who	nsubj	5	SENT_26	[p1l892t2496r958b2525],
5	had	VBD	O	have	rcmod	3	SENT_26	[p1l972t2496r1030b2525],
6	any	DT	O	any	det	9	SENT_26	[p1l1044t2506r1099b2534],
7	gain-of-function	NN	O	gain-of-function	nn	9	SENT_26	[p1l1112t2496r1364b2534],
8	CYPZC19	NN	O	cypzc19	nn	9	SENT_26	[p1l1381t2498r1527b2525],
9	allele	NN	O	allele	dobj	5	SENT_26	[p1l1539t2496r1620b2525],
10	had	VBD	O	have	_	0	SENT_26	[p1l1634t2496r1692b2525],
11	a	DT	O	a	det	13	SENT_26	[p1l1705t2506r1721b2525],
12	higher	JJR	O	higher	amod	13	SENT_26	[p1l1735t2496r1839b2534],
13	frequency	NN	O	frequency	dobj	10	SENT_26	[p1l1852t2496r2009b2534],
14	of	IN	O	of	_	0	SENT_26	[p1l2022t2496r2058b2525],
15	major	JJ	O	major	amod	23	SENT_26	[p1l2061t2497r2154b2534],
16	bleeding	JJ	O	bleeding	amod	23	SENT_26	[p1l6t2542r142b2580],
17	Germany	NNP	LOCATION	Germany	nn	23	SENT_26	[p1l47t2584r146b2609],
18	(	CD	NUMBER	(	num	23	SENT_26	[p1l153t2583r204b2608],
19	Prof	NNP	O	Prof	nn	23	SENT_26	[p1l153t2583r204b2608],
20	H	NNP	O	H	nn	23	SENT_26	[p1l210t2585r223b2603],
21	Katus	NNP	O	Katus	nn	23	SENT_26	[p1l231t2585r287b2603],
22	MD	NN	O	md	nn	23	SENT_26	[p1l294t2584r344b2608],
23	)	NN	O	)	prep_of	13	SENT_26	[p1l294t2584r344b2608],
24	;	:	O	;	_	0	SENT_26	[p1l294t2584r344b2608],
25	INSERM	NNP	ORGANIZATION	INSERM	nn	32	SENT_26	[p1l36t2621r120b2639],
26	U-698	NNP	O	U-698	nn	32	SENT_26	[p1l128t2619r203b2643],
27	,	,	O	,	_	0	SENT_26	[p1l128t2619r203b2643],
28	Paris	NNP	LOCATION	Paris	appos	32	SENT_26	[p1l211t2620r267b2643],
29	,	,	O	,	_	0	SENT_26	[p1l211t2620r267b2643],
30	France	NNP	LOCATION	France	appos	32	SENT_26	[p1l275t2621r344b2639],
31	(	CD	NUMBER	(	num	32	SENT_26	[p1l32t2656r83b2681],
32	Prof	NNP	PERSON	Prof	dep	23	SENT_26	[p1l32t2656r83b2681],
33	P	NN	PERSON	p	nn	36	SENT_26	[p1l89t2658r100b2675],
34	G	NN	PERSON	g	nn	36	SENT_26	[p1l106t2657r119b2676],
35	Steg	NNP	PERSON	Steg	nn	36	SENT_26	[p1l127t2657r171b2682],
36	MD	NNP	O	MD	dep	32	SENT_26	[p1l179t2657r344b2681],
37	)	NN	O	)	dep	32	SENT_26	[p1l179t2657r344b2681],
38	;	:	O	;	_	0	SENT_26	[p1l179t2657r344b2681],
39	Université	NNP	O	Université	dep	23	SENT_26	[p1l179t2657r344b2681],

1	(	NN	O	(	nsubj	6	SENT_27	[p1l8t2714r127b2750],
2	11-9	CD	PERCENT	11-9	num	3	SENT_27	[p1l8t2714r127b2750],
3	%	NN	PERCENT	%	dep	1	SENT_27	[p1l8t2714r127b2750],
4	)	CD	NUMBER	)	npadvmod	5	SENT_27	[p1l8t2714r127b2750],
5	than	IN	O	than	advmod	6	SENT_27	[p1l146t2712r217b2740],
6	did	VBD	O	do	_	0	SENT_27	[p1l234t2712r283b2740],
7	those	DT	O	those	nsubj	14	SENT_27	[p1l300t2712r384b2740],
8	without	IN	O	without	_	0	SENT_27	[p1l400t2712r522b2740],
9	any	DT	O	any	det	10	SENT_27	[p1l538t2722r593b2749],
10	gain-of-function	NN	O	gain-of-function	prep_without	7	SENT_27	[p1l610t2712r862b2749],
11	or	CC	O	or	_	0	SENT_27	[p1l879t2722r912b2740],
12	loss-of-function	JJ	O	loss-of-function	amod	13	SENT_27	[p1l928t2712r1173b2740],
13	alleles	NNS	O	allele	conj_or	10	SENT_27	[p1l1190t2712r1285b2740],
14	(	VBP	O	(	ccomp	6	SENT_27	[p1l1305t2713r1409b2750],
15	9-5	CD	PERCENT	9-5	num	16	SENT_27	[p1l1305t2713r1409b2750],
16	%	NN	PERCENT	%	dobj	14	SENT_27	[p1l1305t2713r1409b2750],
17	;	:	O	;	_	0	SENT_27	[p1l1305t2713r1409b2750],
18	p	NN	O	p	dep	16	SENT_27	[p1l1427t2714r1580b2750],
19	=	JJ	O	=	amod	21	SENT_27	[p1l1427t2714r1580b2750],
20	0-022	CD	NUMBER	0-022	tmod	19	SENT_27	[p1l1427t2714r1580b2750],
21	)	NN	O	)	dep	18	SENT_27	[p1l1427t2714r1580b2750],
22	,	,	O	,	_	0	SENT_27	[p1l1427t2714r1580b2750],
23	but	CC	O	but	_	0	SENT_27	[p1l1597t2712r1650b2740],
24	interaction	NN	O	interaction	nsubj	32	SENT_27	[p1l1667t2713r1836b2740],
25	between	IN	O	between	_	0	SENT_27	[p1l6t2758r137b2786],
26	treatment	NN	O	treatment	nn	29	SENT_27	[p1l147t2763r301b2786],
27	and	CC	O	and	_	0	SENT_27	[p1l311t2758r369b2786],
28	genotype	NN	O	genotype	nn	29	SENT_27	[p1l379t2763r520b2795],
29	groups	NNS	O	group	prep_between	24	SENT_27	[p1l531t2768r638b2795],
30	was	VBD	O	be	cop	32	SENT_27	[p1l649t2768r707b2786],
31	not	RB	O	not	neg	32	SENT_27	[p1l718t2763r770b2786],
32	signiﬁcant	JJ	O	signiﬁcant	conj_but	6	SENT_27	[p1l780t2758r945b2795],
33	for	IN	O	for	_	0	SENT_27	[p1l954t2758r1000b2786],
34	any	DT	O	any	det	35	SENT_27	[p1l1009t2768r1064b2795],
35	type	NN	O	type	prep_for	32	SENT_27	[p1l1074t2763r1138b2795],
36	of	IN	O	of	_	0	SENT_27	[p1l1149t2758r1184b2786],
37	major	JJ	O	major	amod	38	SENT_27	[p1l1189t2759r1283b2795],
38	bleeding	NN	O	bleeding	prep_of	35	SENT_27	[p1l1292t2758r1435b2795],
39	.	.	O	.	_	0	SENT_27	[p1l1292t2758r1435b2795],

1	Paris	NNP	LOCATION	Paris	_	0	SENT_28	[p1l131t2806r181b2825],
2	7	CD	NUMBER	7	num	1	SENT_28	[p1l187t2808r203b2828],
3	,	,	O	,	_	0	SENT_28	[p1l187t2808r203b2828],
4	Paris	NNP	LOCATION	Paris	nn	6	SENT_28	[p1l211t2806r267b2828],
5	,	,	O	,	_	0	SENT_28	[p1l211t2806r267b2828],
6	France	NNP	LOCATION	France	appos	1	SENT_28	[p1l275t2807r344b2825],

1	(	NN	O	(	nn	3	SENT_29	[p1l6t2846r94b2872],
2	ProfPG	NNP	O	ProfPG	nn	3	SENT_29	[p1l6t2846r94b2872],
3	Steg	NNP	PERSON	Steg	_	0	SENT_29	[p1l110t2848r169b2873],
4	)	NN	O	)	dep	3	SENT_29	[p1l110t2848r169b2873],
5	;	:	O	;	_	0	SENT_29	[p1l110t2848r169b2873],
6	Hﬁpital	NNP	PERSON	Hﬁpital	nn	7	SENT_29	[p1l186t2846r265b2873],
7	Bichat	NNP	PERSON	Bichat	dep	3	SENT_29	[p1l281t2846r354b2870],
8	.	.	O	.	_	0	SENT_29	[p1l281t2846r354b2870],

1	Interpretation	NN	O	interpretation	nn	2	SENT_30	[p1l402t2845r616b2880],
2	Ticagrelor	NN	O	ticagrelor	nsubj	7	SENT_30	[p1l633t2843r792b2881],
3	is	VBZ	O	be	cop	7	SENT_30	[p1l809t2844r833b2872],
4	a	DT	O	a	det	7	SENT_30	[p1l851t2853r867b2872],
5	more	RBR	O	more	advmod	6	SENT_30	[p1l885t2853r967b2872],
6	efficacious	JJ	O	efficacious	amod	7	SENT_30	[p1l984t2843r1148b2872],
7	treatment	NN	O	treatment	_	0	SENT_30	[p1l1166t2849r1321b2872],
8	for	IN	O	for	_	0	SENT_30	[p1l1337t2843r1382b2872],
9	acute	JJ	O	acute	amod	11	SENT_30	[p1l1399t2849r1481b2872],
10	coronary	JJ	O	coronary	amod	11	SENT_30	[p1l1498t2853r1635b2881],
11	syndromes	NNS	O	syndrome	prep_for	7	SENT_30	[p1l1653t2843r1824b2881],
12	than	IN	O	than	mark	14	SENT_30	[p1l1841t2843r1912b2872],
13	is	VBZ	O	be	cop	14	SENT_30	[p1l1929t2844r1954b2872],
14	clopidogrel	NN	O	clopidogrel	dep	11	SENT_30	[p1l1972t2843r2154b2881],
15	,	,	O	,	_	0	SENT_30	[p1l1972t2843r2154b2881],
16	irrespective	JJ	O	irrespective	amod	18	SENT_30	[p1l6t2891r186b2927],
17	Assistance	NN	O	assistance	nn	18	SENT_30	[p1l6t2930r120b2949],
18	Publique-Hopitaux	NN	O	publique-hopitaux	appos	14	SENT_30	[p1l127t2929r333b2955],
19	de	IN	O	de	amod	14	SENT_30	[p1l103t2965r128b2985],
20	Paris	NNP	LOCATION	Paris	nn	26	SENT_30	[p1l135t2966r192b2989],
21	,	,	O	,	_	0	SENT_30	[p1l135t2966r192b2989],
22	Paris	NNP	LOCATION	Paris	appos	26	SENT_30	[p1l199t2966r256b2989],
23	,	,	O	,	_	0	SENT_30	[p1l199t2966r256b2989],
24	France	NNP	LOCATION	France	appos	26	SENT_30	[p1l263t2967r332b2985],
25	(	CD	NUMBER	(	num	26	SENT_30	[p1l70t3002r121b3027],
26	Prof	NNP	PERSON	Prof	dep	14	SENT_30	[p1l70t3002r121b3027],
27	P	NN	PERSON	p	nn	28	SENT_30	[p1l127t3004r138b3022],
28	G	NN	PERSON	g	dep	26	SENT_30	[p1l144t3004r157b3022],
29	Steg	NNP	PERSON	Steg	dep	26	SENT_30	[p1l165t3003r224b3028],
30	)	CD	NUMBER	)	num	29	SENT_30	[p1l165t3003r224b3028],
31	;	:	O	;	_	0	SENT_30	[p1l165t3003r224b3028],
32	and	CC	O	and	_	0	SENT_30	[p1l231t3002r272b3022],
33	Duke	NNP	PERSON	Duke	conj_and	7	SENT_30	[p1l279t3002r332b3022],
34	of	IN	O	of	_	0	SENT_30	[p1l6t3068r48b3101],
35	C	NNP	O	C	nn	36	SENT_30	[p1l60t3070r87b3101],
36	YP2C19	NN	O	yp2c19	prep_of	33	SENT_30	[p1l90t3070r231b3101],
37	and	CC	O	and	_	0	SENT_30	[p1l244t3068r313b3101],
38	ABCB1	NN	O	abcb1	nn	39	SENT_30	[p1l327t3070r459b3101],
39	polymorphisms	NNS	O	polymorphism	prep_of	33	SENT_30	[p1l473t3068r773b3111],
40	.	.	O	.	_	0	SENT_30	[p1l473t3068r773b3111],

1	Use	NN	O	use	nsubj	7	SENT_31	[p1l792t3071r862b3101],
2	of	IN	O	of	_	0	SENT_31	[p1l878t3068r919b3101],
3	ticagrelor	NN	O	ticagrelor	prep_of	1	SENT_31	[p1l928t3068r1102b3112],
4	instead	RB	O	instead	_	0	SENT_31	[p1l1117t3068r1249b3101],
5	of	IN	O	of	_	0	SENT_31	[p1l1264t3068r1306b3101],
6	clopidogrel	NN	O	clopidogrel	prep_instead_of	3	SENT_31	[p1l1315t3068r1519b3112],
7	eliminates	VBZ	O	eliminate	_	0	SENT_31	[p1l1534t3068r1726b3101],
8	the	DT	O	the	det	9	SENT_31	[p1l1741t3068r1799b3101],
9	need	NN	O	need	dobj	7	SENT_31	[p1l1814t3068r1903b3101],
10	for	IN	O	for	_	0	SENT_31	[p1l1918t3068r1971b3101],
11	presently	RB	O	presently	advmod	7	SENT_31	[p1l1985t3068r2154b3111],
12	recommended	VBN	O	recommend	amod	14	SENT_31	[p1l6t3121r274b3155],
13	genetic	JJ	O	genetic	amod	14	SENT_31	[p1l286t3123r418b3165],
14	testing	NN	O	testing	prep_for	7	SENT_31	[p1l429t3123r555b3165],
15	before	IN	O	before	_	0	SENT_31	[p1l565t3121r682b3155],
16	dual	JJ	O	dual	amod	18	SENT_31	[p1l694t3121r773b3155],
17	antiplatelet	JJ	O	antiplatelet	amod	18	SENT_31	[p1l785t3121r990b3165],
18	treatment	NN	O	treatment	prep_before	14	SENT_31	[p1l1001t3128r1191b3155],
19	.	.	O	.	_	0	SENT_31	[p1l1001t3128r1191b3155],

1	Clinical	JJ	ORGANIZATION	clinical	_	0	SENT_32	[p1l100t3183r228b3216],
2	Research	NNP	ORGANIZATION	Research	nn	3	SENT_32	[p1l242t3183r399b3216],
3	Institute	NNP	ORGANIZATION	Institute	dep	1	SENT_32	[p1l413t3184r582b3222],
4	,	,	O	,	_	0	SENT_32	[p1l413t3184r582b3222],

1	Durham	NNP	LOCATION	Durham	nn	5	SENT_33	[p1l7t3244r164b3283],
2	,	,	O	,	_	0	SENT_33	[p1l7t3244r164b3283],
3	NC	NNP	O	NC	appos	5	SENT_33	[p1l178t3247r238b3283],
4	,	,	O	,	_	0	SENT_33	[p1l178t3247r238b3283],
5	USA	NNP	LOCATION	USA	_	0	SENT_33	[p1l250t3247r326b3277],
6	(	CD	NUMBER	(	num	5	SENT_33	[p1l338t3246r369b3286],
7	S	NN	O	s	nn	10	SENT_33	[p1l338t3246r369b3286],
8	H	NN	O	h	nn	10	SENT_33	[p1l382t3247r404b3277],
9	Shah	NNP	PERSON	Shah	nn	10	SENT_33	[p1l417t3244r500b3277],
10	MD	NNP	O	MD	dep	5	SENT_33	[p1l514t3247r581b3283],
11	,	,	O	,	_	0	SENT_33	[p1l514t3247r581b3283],
12	Funding	NNP	O	Funding	nn	13	SENT_33	[p1l648t3242r854b3302],
13	AStfaZeneca	NNP	O	AStfaZeneca	appos	10	SENT_33	[p1l873t3243r1219b3288],
14	_	IN	O	_	amod	13	SENT_33	[p1l873t3243r1219b3288],

1	Prof	NNP	O	Prof	nn	6	SENT_34	[p1l241t3305r313b3339],
2	R	NNP	O	R	nn	6	SENT_34	[p1l323t3308r342b3338],
3	C	NNP	O	C	nn	6	SENT_34	[p1l352t3308r373b3339],
4	Becker	NNP	PERSON	Becker	nn	6	SENT_34	[p1l386t3305r498b3339],
5	MD	NN	O	md	nn	6	SENT_34	[p1l509t3307r581b3347],
6	)	NN	O	)	_	0	SENT_34	[p1l509t3307r581b3347],

1	Correspondence	NN	O	correspondence	_	0	SENT_35	[p2l245t26r526b69],
2	to	TO	O	to	prep	1	SENT_35	[p2l535t32r581b59],
3	:	:	O	:	_	0	SENT_35	[p2l535t32r581b59],
4	Introduction	NN	O	introduction	dep	1	SENT_35	[p2l649t26r1041b82],

1	Prof	NNP	O	Prof	nn	3	SENT_36	[p2l102t87r174b121],
2	Lars	NNP	PERSON	Lars	nn	3	SENT_36	[p2l184t91r250b121],
3	Wa	NNP	PERSON	Wa	nsubj	4	SENT_36	[p2l258t88r434b127],
4	|	VBD	O	|	_	0	SENT_36	[p2l258t88r434b127],
5	|	CD	NUMBER	|	dobj	4	SENT_36	[p2l258t88r434b127],
6	ent	NN	O	ent	nn	8	SENT_36	[p2l258t88r434b127],
7	'	''	O	'	_	0	SENT_36	[p2l258t88r434b127],
8	n	NN	O	n	tmod	4	SENT_36	[p2l258t88r434b127],
9	,	,	O	,	_	0	SENT_36	[p2l258t88r434b127],
10	U	NNP	O	U	nn	12	SENT_36	[p2l447t91r469b121],
11	sala	NNP	O	sala	nn	12	SENT_36	[p2l518t88r583b121],
12	. . . .	NNP	O	. . . .	appos	8	SENT_36	[p2l1846t115r1853b122],[p2l928t115r935b122],

1	.	.	O	.	_	0	SENT_37	[p2l51t152r56b157],

1	.	.	O	.	_	0	SENT_38	[p2l85t152r90b157],
2	'	''	O	'	_	0	SENT_38	[p2l395t100r400b121],

1	pp	NN	O	pp	nn	4	SENT_39	[p2l473t99r516b131],
2	Dual	JJ	O	dual	amod	4	SENT_39	[p2l648t111r772b159],
3	antiplatelet	JJ	O	antiplatelet	amod	4	SENT_39	[p2l840t111r1134b174],
4	treatment	NN	O	treatment	nsubj	23	SENT_39	[p2l1199t121r1461b159],
5	with	IN	O	with	_	0	SENT_39	[p2l1525t111r1642b159],
6	aspirin	NN	O	aspirin	prep_with	4	SENT_39	[p2l1710t128r1894b174],
7	and	CC	O	and	_	0	SENT_39	[p2l1962t111r2059b159],
8	a	DT	O	a	det	11	SENT_39	[p2l2126t129r2153b159],
9	Clinical	JJ	O	clinical	amod	11	SENT_39	[p2l17t149r137b183],
10	Research	NN	O	research	nn	11	SENT_39	[p2l151t149r300b183],
11	Centre	NNP	O	Centre	nsubj	23	SENT_39	[p2l312t152r434b189],
12	,	,	O	,	_	0	SENT_39	[p2l312t152r434b189],
13	Uppsala	NNP	LOCATION	Uppsala	nn	14	SENT_39	[p2l447t149r583b193],
14	university	NN	O	university	appos	11	SENT_39	[p2l57t214r238b255],
15	,	,	O	,	_	0	SENT_39	[p2l57t214r238b255],
16	55-751	CD	NUMBER	55-751	num	18	SENT_39	[p2l251t214r369b250],
17	35	CD	NUMBER	35	num	18	SENT_39	[p2l382t211r424b250],
18	uppsara	NN	O	uppsara	appos	11	SENT_39	[p2l437t211r581b255],
19	,	,	O	,	_	0	SENT_39	[p2l437t211r581b255],
20	thienopyridine	NN	O	thienopyridine	appos	11	SENT_39	[p2l644t189r1035b252],
21	is	VBZ	O	be	cop	23	SENT_39	[p2l1079t192r1120b237],
22	recommended	VBN	O	recommend	amod	23	SENT_39	[p2l1165t189r1551b237],
23	treatment	NN	O	treatment	_	0	SENT_39	[p2l1593t199r1854b237],
24	for	IN	O	for	_	0	SENT_39	[p2l1896t189r1972b237],
25	acute	JJ	O	acute	amod	28	SENT_39	[p2l2015t199r2152b237],
26	Sweden	NNP	LOCATION	Sweden	nn	28	SENT_39	[p2l447t273r581b307],
27	coronary	JJ	O	coronary	amod	28	SENT_39	[p2l645t284r877b331],
28	syndromes	NNS	O	syndrome	prep_for	23	SENT_39	[p2l918t267r1205b331],
29	to	TO	O	to	aux	30	SENT_39	[p2l1246t277r1295b316],
30	reduce	VB	O	reduce	infmod	23	SENT_39	[p2l1336t267r1513b316],
31	the	DT	O	the	det	32	SENT_39	[p2l1553t267r1635b316],
32	rate	NN	O	rate	dobj	30	SENT_39	[p2l1675t277r1774b316],
33	of	IN	O	of	_	0	SENT_39	[p2l1815t267r1874b316],
34	recurrent	JJ	O	recurrent	prep_of	32	SENT_39	[p2l1905t277r2153b316],
35	'	''	O	'	_	0	SENT_39	[p2l133t334r582b373],
36	a	DT	O	a	dep	39	SENT_39	[p2l133t334r582b373],
37	"	``	O	"	punct	39	SENT_39	[p2l133t334r582b373],
38	"	``	O	"	punct	39	SENT_39	[p2l133t334r582b373],
39	”	CD	NUMBER	”	rcmod	32	SENT_39	[p2l133t334r582b373],
40	"	``	O	"	punct	39	SENT_39	[p2l133t334r582b373],
41	"	``	O	"	dep	39	SENT_39	[p2l133t334r582b373],
42	'	''	O	'	_	0	SENT_39	[p2l133t334r582b373],
43	°	CD	NUMBER	°	dep	39	SENT_39	[p2l133t334r582b373],
44	"	``	O	"	punct	43	SENT_39	[p2l133t334r582b373],
45	“	CD	NUMBER	“	dep	43	SENT_39	[p2l133t334r582b373],
46	"	``	O	"	punct	30	SENT_39	[p2l133t334r582b373],
47	@	SYM	O	@	dep	51	SENT_39	[p2l133t334r582b373],
48	"	``	O	"	punct	51	SENT_39	[p2l133t334r582b373],
49	"	``	O	"	punct	51	SENT_39	[p2l133t334r582b373],
50	'	''	O	'	_	0	SENT_39	[p2l133t334r582b373],
51	”	JJ	O	”	dep	30	SENT_39	[p2l133t334r582b373],
52	"	``	O	"	punct	55	SENT_39	[p2l133t334r582b373],
53	°	FW	O	°	nn	55	SENT_39	[p2l133t334r582b373],
54	‘	FW	O	‘	nn	55	SENT_39	[p2l133t334r582b373],
55	°	FW	O	°	dep	51	SENT_39	[p2l133t334r582b373],
56	ischaemic	JJ	O	ischaemic	amod	57	SENT_39	[p2l645t344r910b392],
57	events	NNS	O	event	dep	55	SENT_39	[p2l921t353r1085b392],
58	and	CC	O	and	_	0	SENT_39	[p2l1098t344r1196b392],
59	stent	JJ	O	stent	amod	60	SENT_39	[p2l1206t353r1334b392],
60	thrombosis	NN	O	thrombosis	dep	30	SENT_39	[p2l1343t344r1705b392],
61	.	.	O	.	_	0	SENT_39	[p2l1343t344r1705b392],

1	”	NN	O	”	nn	2	SENT_40	[p2l1343t344r1705b392],
2	Thienopyridines	NNS	O	thienopyridine	nsubj	3	SENT_40	[p2l1715t344r2151b407],
3	(	VBP	O	(	_	0	SENT_40	[p2l649t421r959b485],
4	clopidogrel	NN	O	clopidogrel	nn	7	SENT_40	[p2l649t421r959b485],
5	and	CC	O	and	_	0	SENT_40	[p2l976t421r1073b470],
6	prasugrel	NN	O	prasugrel	nn	7	SENT_40	[p2l1088t421r1354b485],
7	)	NN	O	)	nsubj	10	SENT_40	[p2l1088t421r1354b485],
8	are	VBP	O	be	cop	10	SENT_40	[p2l1375t439r1454b470],
9	oral	JJ	O	oral	amod	10	SENT_40	[p2l1471t421r1571b470],
10	prodrugs	NNS	O	prodrug	ccomp	3	SENT_40	[p2l1586t421r1826b485],
11	that	WDT	O	that	nsubj	12	SENT_40	[p2l1843t421r1945b470],
12	need	VBP	O	need	rcmod	10	SENT_40	[p2l1961t421r2088b470],
13	to	TO	O	to	aux	15	SENT_40	[p2l2103t431r2152b470],
14	be	VB	O	be	auxpass	15	SENT_40	[p2l643t499r705b548],
15	converted	VBN	O	convert	xcomp	12	SENT_40	[p2l727t499r985b548],
16	to	TO	O	to	_	0	SENT_40	[p2l1005t509r1053b548],
17	active	JJ	O	active	amod	18	SENT_40	[p2l1076t502r1224b548],
18	metabolites	NNS	O	metabolite	prep_to	15	SENT_40	[p2l1245t499r1550b548],
19	to	TO	O	to	aux	21	SENT_40	[p2l1573t509r1622b548],
20	irreversibly	RB	O	irreversibly	advmod	21	SENT_40	[p2l1644t499r1942b563],
21	bind	VB	O	bind	xcomp	15	SENT_40	[p2l1961t499r2083b548],
22	to	TO	O	to	_	0	SENT_40	[p2l2103t509r2152b548],
23	the	DT	O	the	det	24	SENT_40	[p2l644t577r726b625],
24	P2Y	NN	O	p2y	prep_to	21	SENT_40	[p2l744t581r876b637],
25	,	,	O	,	_	0	SENT_40	[p2l744t581r876b637],
26	,	,	O	,	_	0	SENT_40	[p2l744t581r876b637],
27	receptor	NN	O	receptor	dep	21	SENT_40	[p2l891t586r1115b640],
28	.	.	O	.	_	0	SENT_40	[p2l891t586r1115b640],

1	About	IN	O	about	_	0	SENT_41	[p2l1132t577r1292b625],
2	85	CD	PERCENT	85	num	3	SENT_41	[p2l1306t580r1420b627],
3	%	NN	PERCENT	%	prep_about	7	SENT_41	[p2l1306t580r1420b627],
4	of	IN	O	of	_	0	SENT_41	[p2l1436t577r1495b625],
5	clopidogrel	NN	O	clopidogrel	prep_of	3	SENT_41	[p2l1501t577r1795b641],
6	is	VBZ	O	be	auxpass	7	SENT_41	[p2l1809t580r1850b625],
7	hydrolysed	VBN	O	hydrolyse	_	0	SENT_41	[p2l1865t577r2153b640],
8	to	TO	O	to	_	0	SENT_41	[p2l644t663r693b701],
9	an	DT	O	a	det	11	SENT_41	[p2l718t671r781b701],
10	inactive	JJ	O	inactive	amod	11	SENT_41	[p2l804t656r1007b702],
11	metabolite	NN	O	metabolite	prep_to	7	SENT_41	[p2l1030t653r1324b709],
12	,	,	O	,	_	0	SENT_41	[p2l1030t653r1324b709],
13	with	IN	O	with	mark	16	SENT_41	[p2l1348t653r1465b702],
14	the	DT	O	the	det	15	SENT_41	[p2l1487t653r1570b701],
15	remainder	NN	O	remainder	nsubj	16	SENT_41	[p2l1594t653r1873b701],
16	converted	VBD	O	convert	advcl	7	SENT_41	[p2l1896t653r2153b702],
17	to	TO	O	to	_	0	SENT_41	[p2l644t741r693b780],
18	the	DT	O	the	det	20	SENT_41	[p2l707t731r789b780],
19	active	JJ	O	active	amod	20	SENT_41	[p2l804t734r951b780],
20	metabolite	NN	O	metabolite	prep_to	16	SENT_41	[p2l965t731r1244b780],
21	by	IN	O	by	_	0	SENT_41	[p2l1258t731r1319b795],
22	two	CD	NUMBER	two	num	24	SENT_41	[p2l1331t741r1425b780],
23	sequential	JJ	O	sequential	amod	24	SENT_41	[p2l1441t731r1711b794],
24	steps	NNS	O	step	nn	31	SENT_41	[p2l1727t741r1857b794],
25	dependent	JJ	O	dependent	amod	31	SENT_41	[p2l1873t731r2154b794],
26	on	IN	O	on	_	0	SENT_41	[p2l645t826r712b857],
27	cytochrome	NN	O	cytochrome	nn	28	SENT_41	[p2l733t809r1041b872],
28	P450	NN	O	p450	prep_on	25	SENT_41	[p2l1065t812r1190b857],
29	(	CD	NUMBER	(	num	28	SENT_41	[p2l1215t812r1381b873],
30	CYP	NN	O	cyp	nn	31	SENT_41	[p2l1215t812r1381b873],
31	)	NN	O	)	prep_by	16	SENT_41	[p2l1215t812r1381b873],
32	,	,	O	,	_	0	SENT_41	[p2l1215t812r1381b873],
33	with	IN	O	with	_	0	SENT_41	[p2l1403t809r1520b857],
34	contributions	NNS	O	contribution	prep_with	16	SENT_41	[p2l1542t809r1896b857],
35	from	IN	O	from	_	0	SENT_41	[p2l1919t809r2049b857],
36	the	DT	O	the	det	38	SENT_41	[p2l2070t809r2152b857],
37	isoenzymes	NNS	O	isoenzyme	nn	38	SENT_41	[p2l645t889r954b949],
38	CYPZC19	NN	O	cypzc19	prep_from	34	SENT_41	[p2l993t889r1254b941],
39	,	,	O	,	_	0	SENT_41	[p2l993t889r1254b941],
40	CYP3A4	NN	O	cyp3a4	prep_from	34	SENT_41	[p2l1294t889r1515b934],
41	or	CC	O	or	_	0	SENT_41	[p2l1549t903r1603b934],
42	CYP3A5	NN	O	cyp3a5	prep_from	34	SENT_41	[p2l1640t889r1875b941],
43	,	,	O	,	_	0	SENT_41	[p2l1640t889r1875b941],
44	CYPZC9	NN	O	cypzc9	conj_and	42	SENT_41	[p2l1915t889r2150b941],
45	,	,	O	,	_	0	SENT_41	[p2l1915t889r2150b941],
46	CYP1A2	NN	O	cyp1a2	conj_and	42	SENT_41	[p2l647t966r876b1019],
47	,	,	O	,	_	0	SENT_41	[p2l647t966r876b1019],
48	and	CC	O	and	_	0	SENT_41	[p2l901t963r999b1011],
49	CYP2B6	NN	O	cyp2b6	conj_and	42	SENT_41	[p2l1022t966r1305b1011],
50	.6	CD	NUMBER	.6	number	51	SENT_41	[p2l1022t966r1305b1011],
51	““	CD	NUMBER	““	nsubjpass	7	SENT_41	[p2l1022t966r1305b1011],
52	The	DT	O	the	det	55	SENT_41	[p2l1327t963r1428b1012],
53	C	NN	O	c	nn	55	SENT_41	[p2l1456t967r1494b1012],
54	YPZCI9	NN	O	ypzci9	nn	55	SENT_41	[p2l1499t967r1702b1012],
55	genotype	NN	O	genotype	nsubj	56	SENT_41	[p2l1723t973r1960b1027],
56	affects	VBZ	O	affect	rcmod	51	SENT_41	[p2l1984t963r2151b1012],
57	both	CC	O	both	prep	56	SENT_41	[p2l644t1040r763b1088],
58	metabolic	JJ	O	metabolic	amod	59	SENT_41	[p2l792t1040r1051b1088],
59	steps	NNS	O	step	dep	57	SENT_41	[p2l1081t1049r1211b1103],
60	and	CC	O	and	_	0	SENT_41	[p2l1243t1040r1340b1088],
61	is	VBZ	O	be	cop	65	SENT_41	[p2l1368t1043r1409b1088],
62	the	DT	O	the	det	65	SENT_41	[p2l1438t1040r1521b1088],
63	most	RBS	O	most	advmod	64	SENT_41	[p2l1550t1049r1683b1088],
64	important	JJ	O	important	amod	65	SENT_41	[p2l1711t1043r1977b1103],
65	deter1320	NN	O	deter1320	conj_and	56	SENT_41	[p2l2006t1040r2151b1088, p2l6t1230r102b1266],

1	minant	NN	O	minant	_	0	SENT_42	[p2l7t1451r284b1514],
2	of	IN	O	of	_	0	SENT_42	[p2l325t1446r408b1514],
3	the	DT	O	the	det	7	SENT_42	[p2l435t1446r552b1514],
4	pharmacokinetic	JJ	O	pharmacokinetic	amod	7	SENT_42	[p2l593t1446r1228b1535],
5	and	CC	O	and	_	0	SENT_42	[p2l1269t1446r1408b1514],
6	pharmacodynamic	JJ	O	pharmacodynamic	amod	7	SENT_42	[p2l1448t1446r2151b1536],
7	response	NN	O	response	prep_of	1	SENT_42	[p2l7t1580r343b1645],
8	to	TO	O	to	_	0	SENT_42	[p2l377t1569r446b1623],
9	clopidogrel	NN	O	clopidogrel	prep_to	7	SENT_42	[p2l482t1556r918b1646],
10	,	,	O	,	_	0	SENT_42	[p2l482t1556r918b1646],
11	although	IN	O	although	mark	14	SENT_42	[p2l957t1556r1290b1646],
12	it	PRP	O	it	nsubj	14	SENT_42	[p2l1324t1560r1375b1623],
13	only	RB	O	only	advmod	14	SENT_42	[p2l1408t1556r1568b1645],
14	explains	VBZ	O	explain	dep	7	SENT_42	[p2l1601t1556r1905b1645],
15	about	IN	O	about	_	0	SENT_42	[p2l1942t1556r2152b1624],
16	12	CD	PERCENT	12	num	17	SENT_42	[p2l11t1669r162b1735],
17	%	NN	PERCENT	%	prep_about	14	SENT_42	[p2l11t1669r162b1735],
18	of	IN	O	of	_	0	SENT_42	[p2l211t1664r294b1733],
19	reported	VBN	O	report	amod	20	SENT_42	[p2l328t1664r646b1753],
20	variability	NN	O	variability	prep_of	17	SENT_42	[p2l690t1664r1161b1754],
21	.	.	O	.	_	0	SENT_42	[p2l690t1664r1161b1754],

1	”	NN	O	”	_	0	SENT_43	[p2l690t1664r1161b1754],
2	In	IN	O	in	dep	1	SENT_43	[p2l1212t1671r1291b1731],
3	patients	NNS	O	patient	pobj	2	SENT_43	[p2l1337t1669r1633b1753],
4	treated	VBN	O	treat	partmod	3	SENT_43	[p2l1681t1665r1941b1733],
5	with	IN	O	with	_	0	SENT_43	[p2l1984t1665r2151b1733],
6	clopidogrel	NN	O	clopidogrel	prep_with	4	SENT_43	[p2l8t1773r426b1863],
7	after	IN	O	after	_	0	SENT_43	[p2l468t1773r637b1841],
8	an	DT	O	a	det	12	SENT_43	[p2l678t1798r768b1841],
9	acute	JJ	O	acute	amod	12	SENT_43	[p2l810t1787r1005b1841],
10	coronary	JJ	O	coronary	amod	12	SENT_43	[p2l1048t1798r1377b1863],
11	syndrome	NN	O	syndrome	nn	12	SENT_43	[p2l1419t1773r1792b1863],
12	event	NN	O	event	prep_after	4	SENT_43	[p2l1835t1787r2035b1841],
13	or	CC	O	or	_	0	SENT_43	[p2l2076t1798r2152b1841],
14	stenting	NN	O	stenting	conj_or	12	SENT_43	[p2l10t1887r333b1973],
15	,	,	O	,	_	0	SENT_43	[p2l10t1887r333b1973],
16	or	CC	O	or	dep	1	SENT_43	[p2l382t1907r459b1951],
17	both	DT	O	both	dep	1	SENT_43	[p2l499t1883r688b1961],
18	,	,	O	,	_	0	SENT_43	[p2l499t1883r688b1961],
19	the	DT	O	the	det	20	SENT_43	[p2l734t1883r852b1951],
20	presence	NN	O	presence	dep	27	SENT_43	[p2l896t1907r1229b1972],
21	of	IN	O	of	_	0	SENT_43	[p2l1275t1883r1359b1951],
22	any	DT	O	any	det	24	SENT_43	[p2l1391t1907r1522b1972],
23	loss-of-function	JJ	O	loss-of-function	amod	24	SENT_43	[p2l1563t1883r2151b1951],
24	C	NN	O	c	prep_of	20	SENT_43	[p2l14t1997r69b2060],
25	YPZC	NN	O	ypzc	dep	27	SENT_43	[p2l76t1997r284b2060],
26	19	CD	NUMBER	19	num	25	SENT_43	[p2l289t1998r365b2060],
27	allele	NN	O	allele	dep	54	SENT_43	[p2l382t1991r573b2060],
28	(	CD	NUMBER	(	num	29	SENT_43	[p2l601t1996r729b2081],
29	*	NN	O	*	dep	27	SENT_43	[p2l601t1996r729b2081],
30	2	CD	NUMBER	2	nsubjpass	54	SENT_43	[p2l601t1996r729b2081],
31	,	,	O	,	_	0	SENT_43	[p2l601t1996r729b2081],
32	*	CD	NUMBER	*	num	33	SENT_43	[p2l754t1996r859b2069],
33	3	CD	NUMBER	3	appos	30	SENT_43	[p2l754t1996r859b2069],
34	,	,	O	,	_	0	SENT_43	[p2l754t1996r859b2069],
35	"	``	O	"	punct	36	SENT_43	[p2l884t1996r985b2069],
36	4	CD	NUMBER	4	appos	33	SENT_43	[p2l884t1996r985b2069],
37	,	,	O	,	_	0	SENT_43	[p2l884t1996r985b2069],
38	"	``	O	"	punct	33	SENT_43	[p2l1010t1996r1115b2070],
39	"	``	O	"	punct	40	SENT_43	[p2l1010t1996r1115b2070],
40	5	CD	NUMBER	5	dep	33	SENT_43	[p2l1010t1996r1115b2070],
41	,	,	O	,	_	0	SENT_43	[p2l1010t1996r1115b2070],
42	*	CD	NUMBER	*	number	43	SENT_43	[p2l1140t1996r1246b2070],
43	6	CD	NUMBER	6	appos	40	SENT_43	[p2l1140t1996r1246b2070],
44	,	,	O	,	_	0	SENT_43	[p2l1140t1996r1246b2070],
45	"	``	O	"	punct	54	SENT_43	[p2l1270t1996r1369b2070],
46	"	``	O	"	punct	47	SENT_43	[p2l1270t1996r1369b2070],
47	7	CD	NUMBER	7	nsubjpass	54	SENT_43	[p2l1270t1996r1369b2070],
48	,	,	O	,	_	0	SENT_43	[p2l1270t1996r1369b2070],
49	and	CC	O	and	_	0	SENT_43	[p2l1395t1991r1533b2060],
50	*	NN	O	*	nn	52	SENT_43	[p2l1553t1996r1661b2081],
51	8	CD	NUMBER	8	num	52	SENT_43	[p2l1553t1996r1661b2081],
52	)	NN	O	)	nsubjpass	54	SENT_43	[p2l1553t1996r1661b2081],
53	is	VBZ	O	be	auxpass	54	SENT_43	[p2l1688t1996r1745b2060],
54	associated	VBN	O	associate	dep	17	SENT_43	[p2l1770t1991r2152b2060],
55	with	IN	O	with	_	0	SENT_43	[p2l6t2100r172b2169],
56	an	DT	O	a	det	58	SENT_43	[p2l221t2125r311b2169],
57	increased	VBN	O	increase	amod	58	SENT_43	[p2l358t2100r717b2169],
58	risk	NN	O	risk	prep_with	54	SENT_43	[p2l764t2100r906b2169],
59	of	IN	O	of	_	0	SENT_43	[p2l953t2100r1036b2169],
60	ischaemic	JJ	O	ischaemic	amod	61	SENT_43	[p2l1071t2100r1449b2169],
61	events	NNS	O	event	prep_of	58	SENT_43	[p2l1497t2114r1731b2169],
62	and	CC	O	and	_	0	SENT_43	[p2l1782t2100r1921b2169],
63	stent	NN	O	stent	nn	64	SENT_43	[p2l1971t2114r2152b2169],
64	thrombosis	NN	O	thrombosis	prep_of	58	SENT_43	[p2l6t2211r639b2289],
65	,9	CD	NUMBER	,9	num	66	SENT_43	[p2l6t2211r639b2289],
66	’	NN	O	’	dep	64	SENT_43	[p2l6t2211r639b2289],
67	1	CD	NUMBER	1	number	68	SENT_43	[p2l6t2211r639b2289],
68	°	CD	NUMBER	°	num	69	SENT_43	[p2l6t2211r639b2289],
69	’”	NN	O	’”	dep	66	SENT_43	[p2l6t2211r639b2289],
70	'	''	O	'	_	0	SENT_43	[p2l6t2211r639b2289],
71	”	CD	NUMBER	”	dep	88	SENT_43	[p2l6t2211r639b2289],
72	whereas	IN	O	whereas	dep	88	SENT_43	[p2l679t2211r987b2279],
73	the	DT	O	the	det	74	SENT_43	[p2l1033t2211r1150b2279],
74	presence	NN	O	presence	nsubjpass	88	SENT_43	[p2l1196t2235r1529b2300],
75	of	IN	O	of	_	0	SENT_43	[p2l1576t2211r1659b2278],
76	any	DT	O	any	det	82	SENT_43	[p2l1693t2235r1824b2300],
77	gainoffunction	NN	O	gainoffunction	nn	82	SENT_43	[p2l1869t2211r2149b2301, p2l7t2319r327b2388],
78	C	NN	O	c	nn	82	SENT_43	[p2l363t2325r418b2388],
79	YPZCI9	NN	O	ypzci9	nn	82	SENT_43	[p2l424t2325r713b2388],
80	allele	NN	O	allele	nn	82	SENT_43	[p2l739t2319r931b2388],
81	(	CD	NUMBER	(	num	82	SENT_43	[p2l967t2324r1128b2409],
82	‘	NN	O	‘	prep_of	74	SENT_43	[p2l967t2324r1128b2409],
83	''	''	O	''	_	0	SENT_43	[p2l967t2324r1128b2409],
84	‘	NN	O	‘	nn	86	SENT_43	[p2l967t2324r1128b2409],
85	17	CD	NUMBER	17	num	86	SENT_43	[p2l967t2324r1128b2409],
86	)	NN	O	)	dep	82	SENT_43	[p2l967t2324r1128b2409],
87	is	VBZ	O	be	auxpass	88	SENT_43	[p2l1164t2324r1221b2388],
88	associated	VBN	O	associate	dep	58	SENT_43	[p2l1254t2319r1636b2388],
89	with	IN	O	with	_	0	SENT_43	[p2l1663t2319r1829b2388],
90	a	DT	O	a	det	92	SENT_43	[p2l1859t2344r1896b2388],
91	raised	VBN	O	raise	amod	92	SENT_43	[p2l1925t2319r2152b2388],
92	risk	NN	O	risk	prep_with	88	SENT_43	[p2l7t2428r150b2496],
93	of	IN	O	of	_	0	SENT_43	[p2l202t2428r285b2496],
94	bleeding	NN	O	bleeding	prep_of	92	SENT_43	[p2l324t2428r711b2518],
95	.	.	O	.	_	0	SENT_43	[p2l324t2428r711b2518],

1	“	NN	O	“	nn	2	SENT_44	[p2l324t2428r711b2518],
2	Variations	NNS	O	variation	nsubj	6	SENT_44	[p2l764t2433r1143b2497],
3	in	IN	O	in	_	0	SENT_44	[p2l1198t2433r1273b2495],
4	the	DT	O	the	det	5	SENT_44	[p2l1325t2428r1442b2496],
5	genes	NNS	O	gene	prep_in	2	SENT_44	[p2l1497t2452r1709b2518],
6	regulating	VBG	O	regulate	partmod	29	SENT_44	[p2l1765t2428r2151b2518],
7	clopidogrel	NN	O	clopidogrel	nn	8	SENT_44	[p2l8t2538r426b2628],
8	absorption	NN	O	absorption	dobj	6	SENT_44	[p2l485t2538r886b2627],
9	and	CC	O	and	_	0	SENT_44	[p2l945t2538r1084b2605],
10	efﬂux	NN	O	efﬂux	dobj	6	SENT_44	[p2l1141t2538r1368b2616],
11	,	,	O	,	_	0	SENT_44	[p2l1141t2538r1368b2616],
12	such	JJ	O	such	_	0	SENT_44	[p2l1432t2538r1607b2606],
13	as	IN	O	as	_	0	SENT_44	[p2l1665t2562r1738b2605],
14	the	DT	O	the	det	15	SENT_44	[p2l1797t2538r1914b2605],
15	gene	NN	O	gene	prep_such_as	8	SENT_44	[p2l1974t2562r2150b2628],
16	encoding	VBG	O	encode	partmod	15	SENT_44	[p2l8t2646r355b2736],
17	the	DT	O	the	det	18	SENT_44	[p2l385t2646r502b2715],
18	P-glycoprotein	NN	MISC	p-glycoprotein	dobj	16	SENT_44	[p2l539t2646r1080b2736],
19	multidrug	JJ	O	multidrug	amod	18	SENT_44	[p2l1112t2646r1495b2736],
20	resistant-1	NN	O	resistant-1	nn	22	SENT_44	[p2l1527t2651r1910b2715],
21	eﬂclux	NN	O	eﬂclux	nn	22	SENT_44	[p2l1943t2646r2153b2715],
22	transporter	NN	O	transporter	tmod	19	SENT_44	[p2l6t2769r440b2844],
23	,	,	O	,	_	0	SENT_44	[p2l6t2769r440b2844],
24	ABCB1	NN	O	abcb1	appos	22	SENT_44	[p2l468t2760r802b2833],
25	,	,	O	,	_	0	SENT_44	[p2l468t2760r802b2833],
26	“	NN	O	“	nsubj	29	SENT_44	[p2l468t2760r802b2833],
27	might	MD	O	might	aux	29	SENT_44	[p2l827t2755r1054b2845],
28	also	RB	O	also	advmod	29	SENT_44	[p2l1079t2755r1223b2823],
29	affect	VB	O	affect	_	0	SENT_44	[p2l1251t2756r1454b2823],
30	the	DT	O	the	det	31	SENT_44	[p2l1477t2755r1594b2823],
31	rate	NN	O	rate	dobj	29	SENT_44	[p2l1620t2769r1760b2823],
32	of	IN	O	of	_	0	SENT_44	[p2l1787t2755r1871b2823],
33	clinical	JJ	O	clinical	amod	34	SENT_44	[p2l1885t2755r2151b2823],
34	events	NNS	O	event	prep_of	31	SENT_44	[p2l8t2878r242b2932],
35	during	IN	O	during	_	0	SENT_44	[p2l272t2865r525b2955],
36	treatment	NN	O	treatment	prep_during	29	SENT_44	[p2l549t2868r981b2932],
37	.	.	O	.	_	0	SENT_44	[p2l549t2868r981b2932],

1	”	NN	O	”	_	0	SENT_45	[p2l549t2868r981b2932],

1	Articles	NNPS	O	Articles	_	0	SENT_46	[p2l6t3435r156b3471],
2	I	PRP	O	I	dep	1	SENT_46	[p2l205t3272r252b3471],

1	wvwv	NN	O	wvwv	_	0	SENT_47	[p2l798t3137r1333b3188],
2	.	.	O	.	_	0	SENT_47	[p2l798t3137r1333b3188],

1	the	DT	O	the	det	2	SENT_48	[p2l798t3137r1333b3188],
2	|	NN	O	|	_	0	SENT_48	[p2l798t3137r1333b3188],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_48	[p2l798t3137r1333b3188],
4	Vol	NNP	O	Vol	dep	2	SENT_48	[p2l1376t3137r1464b3188],
5	376	CD	NUMBER	376	num	6	SENT_48	[p2l1484t3136r1588b3195],
6	October	NNP	DATE	October	dep	2	SENT_48	[p2l1634t3137r1859b3188],
7	16,2010	CD	DATE	16,2010	num	6	SENT_48	[p2l1876t3136r2122b3197],

1	Ticagrelor	NNP	O	Ticagrelor	nsubj	21	SENT_49	[p3l77t97r459b186],
2	is	VBZ	O	be	cop	17	SENT_49	[p3l496t101r553b165],
3	an	DT	O	a	det	17	SENT_49	[p3l595t121r685b165],
4	oral	JJ	O	oral	amod	17	SENT_49	[p3l724t97r884b175],
5	,	,	O	,	_	0	SENT_49	[p3l724t97r884b175],
6	reversible	JJ	O	reversible	amod	8	SENT_49	[p3l925t97r1289b165],
7	platelet	NN	O	platelet	nn	8	SENT_49	[p3l1327t97r1602b185],
8	inhibitor	NN	O	inhibitor	dep	17	SENT_49	[p3l1638t97r1970b165],
9	that	WDT	O	that	nsubj	10	SENT_49	[p3l2006t97r2152b165],
10	binds	VBZ	O	bind	rcmod	8	SENT_49	[p3l6t205r213b273],
11	directly	RB	O	directly	advmod	10	SENT_49	[p3l257t205r533b295],
12	to	TO	O	to	_	0	SENT_49	[p3l571t219r640b273],
13	the	DT	O	the	det	14	SENT_49	[p3l681t205r798b273],
14	P2Y	NN	O	p2y	prep_to	10	SENT_49	[p3l842t212r1030b290],
15	,	,	O	,	_	0	SENT_49	[p3l842t212r1030b290],
16	,	,	O	,	_	0	SENT_49	[p3l842t212r1030b290],
17	receptor	NN	O	receptor	_	0	SENT_49	[p3l1071t219r1381b294],
18	and	CC	O	and	_	0	SENT_49	[p3l1420t205r1559b273],
19	does	VBZ	O	do	aux	21	SENT_49	[p3l1599t205r1766b273],
20	not	RB	O	not	neg	21	SENT_49	[p3l1809t219r1932b273],
21	need	VB	O	need	conj_and	17	SENT_49	[p3l1970t205r2152b273],
22	metabolic	JJ	O	metabolic	amod	23	SENT_49	[p3l7t316r376b384],
23	activation	NN	O	activation	dobj	21	SENT_49	[p3l449t320r809b384],
24	for	IN	O	for	_	0	SENT_49	[p3l881t316r987b384],
25	pharmacodynamic	JJ	O	pharmacodynamic	amod	26	SENT_49	[p3l1058t316r1761b405],
26	activity	NN	O	activity	prep_for	21	SENT_49	[p3l1834t320r2151b405],
27	.	.	O	.	_	0	SENT_49	[p3l1834t320r2151b405],

1	“	RB	O	“	advmod	7	SENT_50	[p3l1834t320r2151b405],
2	Compared	VBN	O	compare	_	0	SENT_50	[p3l10t424r402b513],
3	with	IN	O	with	prepc_compared_with	7	SENT_50	[p3l454t424r620b493],
4	clopidogrel	NN	O	clopidogrel	pobj	7	SENT_50	[p3l676t424r1112b514],
5	,	,	O	,	_	0	SENT_50	[p3l676t424r1112b514],
6	ticagrelor	NN	O	ticagrelor	appos	4	SENT_50	[p3l1170t424r1527b514],
7	provides	VBZ	O	provide	_	0	SENT_50	[p3l1580t424r1896b513],
8	more	RBR	O	more	advmod	9	SENT_50	[p3l1953t449r2150b493],
9	pronounced	JJ	O	pronounced	amod	13	SENT_50	[p3l7t534r464b623],
10	and	CC	O	and	_	0	SENT_50	[p3l517t534r656b603],
11	consistent	JJ	O	consistent	amod	13	SENT_50	[p3l709t539r1092b603],
12	platelet	NN	O	platelet	nn	13	SENT_50	[p3l1143t534r1417b623],
13	inhibition	NN	O	inhibition	dobj	7	SENT_50	[p3l1468t534r1843b603],
14	with	IN	O	with	_	0	SENT_50	[p3l1894t534r2060b603],
15	a	DT	O	a	det	17	SENT_50	[p3l2114t559r2151b603],
16	faster	RBR	O	faster	advmod	17	SENT_50	[p3l8t644r217b711],
17	onset	NN	O	onset	prep_with	7	SENT_50	[p3l257t657r459b711],
18	and	CC	O	and	_	0	SENT_50	[p3l499t644r638b711],
19	offset	VBN	O	offset	conj_and	7	SENT_50	[p3l678t644r884b711],
20	of	IN	O	of	_	0	SENT_50	[p3l924t644r1008b711],
21	the	DT	O	the	det	22	SENT_50	[p3l1034t644r1151b711],
22	effect	NN	O	effect	prep_of	19	SENT_50	[p3l1193t644r1396b711],
23	of	IN	O	of	_	0	SENT_50	[p3l1436t644r1520b711],
24	treatment	NN	O	treatment	prep_of	22	SENT_50	[p3l1546t649r2032b711],
25	.	.	O	.	_	0	SENT_50	[p3l1546t649r2032b711],

1	“‘	NN	O	“‘	npadvmod	14	SENT_51	[p3l1546t649r2032b711],
2	’19	CD	NUMBER	’19	num	1	SENT_51	[p3l1546t649r2032b711],
3	At	IN	O	at	_	0	SENT_51	[p3l2070t649r2152b711],
4	present	JJ	DATE	present	prep_at	14	SENT_51	[p3l7t766r307b841],
5	,	,	O	,	_	0	SENT_51	[p3l7t766r307b841],
6	no	DT	O	no	det	8	SENT_51	[p3l381t777r475b821],
7	genetic	JJ	O	genetic	amod	8	SENT_51	[p3l549t757r817b842],
8	determinants	NNS	O	determinant	nsubjpass	14	SENT_51	[p3l890t752r1391b821],
9	of	IN	O	of	_	0	SENT_51	[p3l1467t752r1550b821],
10	the	DT	O	the	det	12	SENT_51	[p3l1607t752r1724b821],
11	ticagrelor	NN	O	ticagrelor	nn	12	SENT_51	[p3l1795t752r2152b842],
12	response	NN	O	response	prep_of	8	SENT_51	[p3l7t885r343b950],
13	are	VBP	O	be	auxpass	14	SENT_51	[p3l410t886r521b929],
14	known	VBN	O	know	_	0	SENT_51	[p3l586t861r863b939],
15	,	,	O	,	_	0	SENT_51	[p3l586t861r863b939],
16	although	IN	O	although	mark	21	SENT_51	[p3l932t861r1265b951],
17	ticagrelor	NN	O	ticagrelor	nn	18	SENT_51	[p3l1328t861r1686b951],
18	absorption	NN	O	absorption	nsubjpass	21	SENT_51	[p3l1750t861r2151b950],
19	might	MD	O	might	aux	21	SENT_51	[p3l7t971r235b1061],
20	be	VB	O	be	auxpass	21	SENT_51	[p3l278t971r365b1038],
21	affected	VBN	O	affect	advcl	14	SENT_51	[p3l414t971r705b1038],
22	by	IN	O	by	_	0	SENT_51	[p3l749t971r837b1060],
23	ABCB1	NN	O	abcb1	nn	24	SENT_51	[p3l880t976r1151b1038],
24	polymorphisms	NNS	O	polymorphism	agent	21	SENT_51	[p3l1195t971r1859b1060],
25	.	.	O	.	_	0	SENT_51	[p3l1195t971r1859b1060],

1	”	NN	O	”	nsubj	9	SENT_52	[p3l1195t971r1859b1060],
2	In	IN	O	in	_	0	SENT_52	[p3l1909t977r1988b1037],
3	the	DT	O	the	det	5	SENT_52	[p3l2033t971r2150b1038],
4	PLATelet	NN	O	platelet	nn	5	SENT_52	[p3l12t1079r342b1148],
5	inhibition	NN	O	inhibition	prep_in	9	SENT_52	[p3l404t1079r779b1148],
6	and	CC	O	and	_	0	SENT_52	[p3l845t1079r983b1148],
7	patient	NN	O	patient	nn	8	SENT_52	[p3l1046t1084r1307b1168],
8	Outcomes	NNS	O	outcome	conj_and	5	SENT_52	[p3l1373t1085r1754b1148],
9	(	VBP	O	(	_	0	SENT_52	[p3l1827t1084r2145b1169],
10	PLATO	NNP	ORGANIZATION	PLATO	nn	12	SENT_52	[p3l1827t1084r2145b1169],
11	)	CD	NUMBER	)	num	12	SENT_52	[p3l1827t1084r2145b1169],
12	trial	NN	O	trial	nsubj	51	SENT_52	[p3l6t1188r220b1266],
13	,	,	O	,	_	0	SENT_52	[p3l6t1188r220b1266],
14	“	NN	O	“	nn	15	SENT_52	[p3l6t1188r220b1266],
15	ticagrelor	NN	O	ticagrelor	appos	12	SENT_52	[p3l242t1188r599b1278],
16	reduced	VBD	O	reduce	ccomp	9	SENT_52	[p3l621t1188r922b1256],
17	events	NNS	O	event	nn	38	SENT_52	[p3l946t1202r1180b1257],
18	of	IN	O	of	_	0	SENT_52	[p3l1207t1188r1290b1256],
19	the	DT	O	the	det	22	SENT_52	[p3l1299t1188r1416b1256],
20	primary	JJ	O	primary	amod	22	SENT_52	[p3l1440t1193r1742b1278],
21	composite	JJ	O	composite	amod	22	SENT_52	[p3l1765t1193r2150b1277],
22	endpoint	NN	O	endpoint	prep_of	17	SENT_52	[p3l8t1299r347b1388],
23	of	IN	O	of	_	0	SENT_52	[p3l379t1299r462b1367],
24	cardiovascular	JJ	O	cardiovascular	amod	25	SENT_52	[p3l482t1299r1022b1367],
25	death	NN	O	death	prep_of	22	SENT_52	[p3l1053t1299r1277b1377],
26	,	,	O	,	_	0	SENT_52	[p3l1053t1299r1277b1377],
27	myocardial	JJ	O	myocardial	amod	28	SENT_52	[p3l1313t1299r1728b1388],
28	infarction	NN	O	infarction	conj_or	25	SENT_52	[p3l1760t1299r2147b1377],
29	,	,	O	,	_	0	SENT_52	[p3l1760t1299r2147b1377],
30	or	CC	O	or	_	0	SENT_52	[p3l8t1432r86b1476],
31	stroke	NN	O	stroke	conj_or	25	SENT_52	[p3l109t1407r335b1476],
32	by	IN	O	by	_	0	SENT_52	[p3l356t1407r444b1497],
33	16	CD	PERCENT	16	num	34	SENT_52	[p3l468t1412r619b1478],
34	%	NN	PERCENT	%	prep_by	31	SENT_52	[p3l468t1412r619b1478],
35	(	CD	PERCENT	(	number	36	SENT_52	[p3l649t1412r833b1497],
36	95	CD	PERCENT	95	dep	37	SENT_52	[p3l649t1412r833b1497],
37	%	NN	PERCENT	%	dep	38	SENT_52	[p3l649t1412r833b1497],
38	CI	NN	O	ci	iobj	16	SENT_52	[p3l860t1413r944b1476],
39	8-21	CD	NUMBER	8-21	num	40	SENT_52	[p3l971t1413r1186b1497],
40	)	NN	O	)	dobj	16	SENT_52	[p3l971t1413r1186b1497],
41	,	,	O	,	_	0	SENT_52	[p3l971t1413r1186b1497],
42	without	IN	O	without	_	0	SENT_52	[p3l1210t1407r1502b1476],
43	any	DT	O	any	det	44	SENT_52	[p3l1524t1432r1656b1497],
44	difference	NN	O	difference	prep_without	16	SENT_52	[p3l1677t1407r2052b1476],
45	in	IN	O	in	_	0	SENT_52	[p3l2076t1412r2151b1474],
46	overall	JJ	O	overall	amod	48	SENT_52	[p3l8t1516r255b1585],
47	major	JJ	O	major	amod	48	SENT_52	[p3l300t1521r524b1606],
48	bleeding	NN	O	bleeding	prep_in	44	SENT_52	[p3l566t1516r910b1606],
49	,	,	O	,	_	0	SENT_52	[p3l566t1516r910b1606],
50	but	CC	O	but	_	0	SENT_52	[p3l957t1516r1082b1584],
51	increased	VBD	O	increase	conj_but	16	SENT_52	[p3l1126t1516r1485b1584],
52	events	NNS	O	event	nn	73	SENT_52	[p3l1531t1530r1764b1584],
53	of	IN	O	of	_	0	SENT_52	[p3l1813t1516r1897b1584],
54	major	JJ	O	major	amod	55	SENT_52	[p3l1929t1521r2152b1606],
55	bleeding	NN	O	bleeding	prep_of	52	SENT_52	[p3l6t1626r331b1716],
56	related	JJ	O	related	amod	73	SENT_52	[p3l390t1626r645b1693],
57	to	TO	O	to	_	0	SENT_52	[p3l703t1639r772b1693],
58	non-coronary	JJ	O	non-coronary	amod	64	SENT_52	[p3l832t1650r1338b1715],
59	artery	NN	O	artery	nn	64	SENT_52	[p3l1396t1639r1612b1715],
60	bypass	NN	O	bypass	nn	64	SENT_52	[p3l1668t1626r1916b1715],
61	graft	NN	O	graft	nn	64	SENT_52	[p3l1980t1626r2152b1716],
62	(	CD	NUMBER	(	num	64	SENT_52	[p3l13t1740r300b1824],
63	CABG	NN	ORGANIZATION	cabg	nn	64	SENT_52	[p3l13t1740r300b1824],
64	)	NN	O	)	prep_to	56	SENT_52	[p3l13t1740r300b1824],
65	by	IN	O	by	_	0	SENT_52	[p3l347t1734r435b1824],
66	19	CD	PERCENT	19	number	67	SENT_52	[p3l479t1739r630b1805],
67	%	NN	PERCENT	%	amod	71	SENT_52	[p3l479t1739r630b1805],
68	(	CD	PERCENT	(	number	69	SENT_52	[p3l680t1739r865b1824],
69	95	CD	PERCENT	95	dep	70	SENT_52	[p3l680t1739r865b1824],
70	%	NN	PERCENT	%	dep	71	SENT_52	[p3l680t1739r865b1824],
71	CI	NN	O	ci	prep_by	64	SENT_52	[p3l912t1740r995b1803],
72	2-38	CD	NUMBER	2-38	tmod	56	SENT_52	[p3l1046t1740r1266b1824],
73	)	NN	O	)	dobj	51	SENT_52	[p3l1046t1740r1266b1824],
74	.	.	O	.	_	0	SENT_52	[p3l1046t1740r1266b1824],

1	In	IN	O	in	_	0	SENT_53	[p3l1318t1741r1396b1801],
2	this	DT	O	this	det	4	SENT_53	[p3l1438t1734r1575b1803],
3	first	JJ	ORDINAL	first	amod	4	SENT_53	[p3l1621t1734r1771b1803],
4	substudy	NN	O	substudy	prep_in	12	SENT_53	[p3l1815t1734r2153b1824],
5	from	IN	O	from	_	0	SENT_53	[p3l7t1843r193b1911],
6	the	DT	O	the	det	9	SENT_53	[p3l247t1843r364b1911],
7	PLATO	NNP	O	PLATO	nn	9	SENT_53	[p3l423t1847r692b1911],
8	genetics	NNS	O	genetics	nn	9	SENT_53	[p3l751t1848r1054b1933],
9	programme	NN	O	programme	prep_from	4	SENT_53	[p3l1112t1867r1578b1933],
10	,	,	O	,	_	0	SENT_53	[p3l1112t1867r1578b1933],
11	we	PRP	O	we	nsubj	12	SENT_53	[p3l1634t1867r1738b1911],
12	aimed	VBD	O	aim	_	0	SENT_53	[p3l1794t1843r2028b1911],
13	to	TO	O	to	aux	14	SENT_53	[p3l2081t1856r2150b1911],
14	investigate	VB	O	investigate	xcomp	12	SENT_53	[p3l7t1957r409b2043],
15	the	DT	O	the	det	16	SENT_53	[p3l517t1953r634b2020],
16	role	NN	O	role	dobj	14	SENT_53	[p3l744t1953r885b2020],
17	of	IN	O	of	_	0	SENT_53	[p3l995t1953r1079b2020],
18	CYPZCI9	NN	O	cypzci9	nn	21	SENT_53	[p3l1182t1958r1531b2021],
19	and	CC	O	and	_	0	SENT_53	[p3l1637t1953r1775b2020],
20	ABCB1	NN	O	abcb1	conj_and	18	SENT_53	[p3l1881t1958r2152b2020],
21	polymorphisms	NNS	O	polymorphism	prep_of	16	SENT_53	[p3l7t2061r601b2151],
22	on	IN	O	on	_	0	SENT_53	[p3l652t2086r746b2130],
23	eﬂicacy	NN	O	eﬂicacy	nn	26	SENT_53	[p3l795t2061r1074b2151],
24	and	CC	O	and	_	0	SENT_53	[p3l1122t2061r1260b2130],
25	safety	NN	O	safety	nn	26	SENT_53	[p3l1310t2061r1523b2151],
26	outcomes	NNS	O	outcome	prep_on	14	SENT_53	[p3l1571t2075r1932b2130],
27	both	CC	O	both	preconj	28	SENT_53	[p3l1981t2061r2151b2130],
28	between	IN	O	between	prep	14	SENT_53	[p3l6t2170r320b2238],
29	and	CC	O	and	_	0	SENT_53	[p3l354t2170r493b2238],
30	within	IN	O	within	conj_and	28	SENT_53	[p3l523t2170r767b2238],
31	the	DT	O	the	det	35	SENT_53	[p3l799t2170r916b2238],
32	ticagrelor	NN	O	ticagrelor	nn	35	SENT_53	[p3l949t2170r1306b2260],
33	and	CC	O	and	_	0	SENT_53	[p3l1339t2170r1477b2238],
34	clopidogrel	NN	O	clopidogrel	conj_and	32	SENT_53	[p3l1510t2170r1928b2260],
35	arms	NNS	O	arm	pobj	30	SENT_53	[p3l1962t2194r2148b2238],
36	of	IN	O	of	_	0	SENT_53	[p3l8t2279r92b2348],
37	the	DT	O	the	det	39	SENT_53	[p3l103t2280r220b2348],
38	PLATO	NNP	ORGANIZATION	PLATO	nn	39	SENT_53	[p3l251t2284r519b2348],
39	study	NN	O	study	prep_of	35	SENT_53	[p3l550t2280r760b2369],
40	.	.	O	.	_	0	SENT_53	[p3l550t2280r760b2369],

1	Methods	NNS	O	method	_	0	SENT_54	[p3l12t2489r402b2568],

1	Study	NNP	O	Study	nn	2	SENT_55	[p3l9t2609r232b2699],
2	design	NN	O	design	nsubjpass	15	SENT_55	[p3l253t2609r501b2699],
3	The	DT	O	the	det	5	SENT_55	[p3l6t2718r151b2787],
4	detailed	JJ	O	detailed	amod	5	SENT_55	[p3l189t2718r483b2787],
5	design	NN	O	design	dep	2	SENT_55	[p3l519t2718r766b2808],
6	and	CC	O	and	_	0	SENT_55	[p3l804t2718r942b2787],
7	outcomes	NNS	O	outcome	nsubjpass	15	SENT_55	[p3l978t2732r1339b2787],
8	of	IN	O	of	_	0	SENT_55	[p3l1379t2718r1462b2787],
9	the	DT	O	the	det	11	SENT_55	[p3l1485t2718r1602b2787],
10	PLATO	NNP	ORGANIZATION	PLATO	nn	11	SENT_55	[p3l1643t2723r1911b2787],
11	study	NN	O	study	prep_of	7	SENT_55	[p3l1952t2718r2153b2808],
12	have	VBP	O	have	aux	15	SENT_55	[p3l6t2827r177b2896],
13	previously	RB	DATE	previously	advmod	15	SENT_55	[p3l208t2827r596b2917],
14	been	VBN	O	be	auxpass	15	SENT_55	[p3l622t2827r803b2895],
15	reported	VBN	O	report	_	0	SENT_55	[p3l833t2827r1270b2916],
16	?	.	O	?	_	0	SENT_55	[p3l833t2827r1270b2916],

1	”	NN	O	”	npadvmod	23	SENT_56	[p3l833t2827r1270b2916],
2	In	IN	O	in	_	0	SENT_56	[p3l1304t2834r1383b2894],
3	brief	NN	O	brief	prep_in	23	SENT_56	[p3l1411t2827r1606b2905],
4	,	,	O	,	_	0	SENT_56	[p3l1411t2827r1606b2905],
5	PLATO	NNP	ORGANIZATION	PLATO	nsubj	23	SENT_56	[p3l1643t2832r1911b2895],
6	was	VBD	O	be	cop	23	SENT_56	[p3l1941t2851r2081b2895],
7	a	DT	O	a	det	23	SENT_56	[p3l2114t2852r2151b2895],
8	prospective	JJ	O	prospective	amod	23	SENT_56	[p3l7t2942r453b3027],
9	,	,	O	,	_	0	SENT_56	[p3l7t2942r453b3027],
10	randomised	JJ	O	randomised	amod	23	SENT_56	[p3l498t2938r968b3016],
11	,	,	O	,	_	0	SENT_56	[p3l498t2938r968b3016],
12	double-blind	JJ	O	double-blind	amod	23	SENT_56	[p3l1016t2938r1511b3016],
13	,	,	O	,	_	0	SENT_56	[p3l1016t2938r1511b3016],
14	double-dummy	JJ	O	double-dummy	amod	23	SENT_56	[p3l1558t2938r2147b3027],
15	,	,	O	,	_	0	SENT_56	[p3l1558t2938r2147b3027],
16	parallel-group	JJ	O	parallel-group	amod	23	SENT_56	[p3l7t3046r553b3136],
17	,	,	O	,	_	0	SENT_56	[p3l7t3046r553b3136],
18	international	JJ	O	international	amod	23	SENT_56	[p3l593t3046r1099b3125],
19	,	,	O	,	_	0	SENT_56	[p3l593t3046r1099b3125],
20	multicentre	JJ	O	multicentre	amod	23	SENT_56	[p3l1139t3046r1578b3115],
21	phase	NN	O	phase	nn	23	SENT_56	[p3l1616t3046r1833b3135],
22	3	CD	NUMBER	3	num	23	SENT_56	[p3l1875t3053r1909b3115],
23	study	NN	O	study	conj_or	23	SENT_56	[p3l1952t3046r2153b3136],
24	of	IN	O	of	_	0	SENT_56	[p3l8t3156r92b3225],
25	18	CD	NUMBER	18	number	26	SENT_56	[p3l135t3162r209b3224],
26	624	CD	NUMBER	624	num	27	SENT_56	[p3l227t3162r356b3225],
27	patients	NNS	O	patient	prep_of	23	SENT_56	[p3l404t3161r701b3245],
28	with	IN	O	with	_	0	SENT_56	[p3l754t3156r921b3225],
29	or	CC	O	or	_	0	SENT_56	[p3l974t3181r1051b3225],
30	without	IN	O	without	_	0	SENT_56	[p3l1100t3156r1392b3225],
31	ST-elevation	NN	O	st-elevation	nn	34	SENT_56	[p3l1449t3156r1901b3225],
32	acute	JJ	O	acute	amod	34	SENT_56	[p3l1955t3170r2150b3225],
33	coronary	JJ	O	coronary	amod	34	SENT_56	[p4l8t42r338b107],
34	syndrome	NN	O	syndrome	prep_with	23	SENT_56	[p4l370t18r762b107],
35	.	.	O	.	_	0	SENT_56	[p4l370t18r762b107],

1	The	DT	O	the	det	2	SENT_57	[p4l795t18r940b86],
2	study	NN	O	study	nsubj	3	SENT_57	[p4l974t18r1175b107],
3	assessed	VBD	O	assess	_	0	SENT_57	[p4l1205t18r1526b86],
4	the	DT	O	the	det	5	SENT_57	[p4l1555t18r1672b86],
5	efficacy	NN	O	efficacy	dobj	3	SENT_57	[p4l1705t18r1983b107],
6	and	CC	O	and	_	0	SENT_57	[p4l2013t18r2152b86],
7	safety	NN	O	safety	dobj	3	SENT_57	[p4l10t126r223b216],
8	of	IN	O	of	_	0	SENT_57	[p4l257t126r341b195],
9	up	RB	DURATION	up	advmod	14	SENT_57	[p4l361t151r458b215],
10	to	TO	DURATION	to	_	0	SENT_57	[p4l492t140r561b195],
11	12	CD	DURATION	12	num	12	SENT_57	[p4l600t132r673b193],
12	months	NNS	NUMBER	month	prep_to	9	SENT_57	[p4l710t126r1015b195],
13	’	JJ	O	’	amod	14	SENT_57	[p4l710t126r1015b195],
14	treatment	NN	O	treatment	prep_of	5	SENT_57	[p4l1052t140r1423b195],
15	with	IN	O	with	_	0	SENT_57	[p4l1454t126r1620b195],
16	either	CC	O	either	preconj	41	SENT_57	[p4l1656t126r1874b195],
17	90	CD	NUMBER	90	num	19	SENT_57	[p4l1909t132r1993b195],
18	mg	NN	O	mg	nn	19	SENT_57	[p4l2029t151r2151b216],
19	ticagrelor	NN	O	ticagrelor	npadvmod	20	SENT_57	[p4l6t235r364b325],
20	twice	RB	O	twice	advmod	41	SENT_57	[p4l404t240r598b303],
21	daily	JJ	SET	daily	amod	41	SENT_57	[p4l643t235r820b324],
22	(	NN	O	(	nn	25	SENT_57	[p4l866t241r1011b325],
23	180	CD	NUMBER	180	num	25	SENT_57	[p4l866t241r1011b325],
24	mg	NN	O	mg	nn	25	SENT_57	[p4l1055t259r1178b325],
25	loading	NN	O	loading	nn	41	SENT_57	[p4l1220t235r1501b325],
26	dose	NN	O	dose	nn	27	SENT_57	[p4l1545t235r1736b325],
27	)	NN	O	)	dep	25	SENT_57	[p4l1545t235r1736b325],
28	or	CC	O	or	_	0	SENT_57	[p4l1786t259r1863b303],
29	75	CD	NUMBER	75	num	31	SENT_57	[p4l1904t239r1981b306],
30	mg	NN	O	mg	nn	31	SENT_57	[p4l2029t259r2151b325],
31	clopidogrel	NN	O	clopidogrel	npadvmod	32	SENT_57	[p4l8t345r426b435],
32	once	RB	DATE	once	advmod	34	SENT_57	[p4l453t369r627b412],
33	daily	JJ	SET	daily	amod	34	SENT_57	[p4l655t345r832b434],
34	(	NN	O	(	nn	41	SENT_57	[p4l862t351r1196b435],
35	300	CD	NUMBER	300	num	36	SENT_57	[p4l862t351r1196b435],
36	—	NN	O	—	dep	34	SENT_57	[p4l862t351r1196b435],
37	600	CD	NUMBER	600	num	40	SENT_57	[p4l862t351r1196b435],
38	mg	NN	O	mg	nn	40	SENT_57	[p4l1223t369r1346b435],
39	loading	NN	O	loading	nn	40	SENT_57	[p4l1371t345r1651b435],
40	dose	NN	O	dose	dep	36	SENT_57	[p4l1679t345r1870b435],
41	)	NN	O	)	prep_with	3	SENT_57	[p4l1679t345r1870b435],
42	for	IN	O	for	_	0	SENT_57	[p4l1902t345r2009b412],
43	the	DT	O	the	det	44	SENT_57	[p4l2033t345r2150b412],
44	prevention	NN	O	prevention	prep_for	41	SENT_57	[p4l7t458r413b542],
45	of	IN	O	of	_	0	SENT_57	[p4l433t453r516b522],
46	cardiovascular	JJ	O	cardiovascular	amod	47	SENT_57	[p4l523t453r1062b522],
47	death	NN	O	death	prep_of	44	SENT_57	[p4l1080t453r1304b532],
48	,	,	O	,	_	0	SENT_57	[p4l1080t453r1304b532],
49	myocardial	JJ	O	myocardial	amod	50	SENT_57	[p4l1326t453r1742b543],
50	infarction	NN	O	infarction	appos	47	SENT_57	[p4l1760t453r2147b532],
51	,	,	O	,	_	0	SENT_57	[p4l1760t453r2147b532],
52	and	CC	O	and	_	0	SENT_57	[p4l8t562r147b631],
53	stroke	NN	O	stroke	conj_and	41	SENT_57	[p4l194t562r438b631],
54	.	.	O	.	_	0	SENT_57	[p4l194t562r438b631],

1	The	DT	O	the	det	3	SENT_58	[p4l486t562r630b631],
2	maximum	NN	O	maximum	nn	3	SENT_58	[p4l676t567r1070b631],
3	duration	NN	O	duration	nsubj	6	SENT_58	[p4l1115t562r1437b631],
4	of	IN	O	of	_	0	SENT_58	[p4l1482t562r1566b631],
5	treatment	NN	O	treatment	prep_of	3	SENT_58	[p4l1597t575r1968b631],
6	was	VBD	O	be	_	0	SENT_58	[p4l2009t586r2148b631],

1	12	CD	DURATION	12	num	2	SENT_59	[p4l11t679r83b739],
2	months	NNS	DURATION	month	_	0	SENT_59	[p4l114t673r424b751],
3	,	,	O	,	_	0	SENT_59	[p4l114t673r424b751],
4	which	WDT	O	which	nsubjpass	6	SENT_59	[p4l453t673r683b740],
5	was	VBD	O	be	auxpass	6	SENT_59	[p4l708t697r847b740],
6	shortened	VBN	O	shorten	rcmod	2	SENT_59	[p4l881t673r1255b740],
7	to	TO	O	to	_	0	SENT_59	[p4l1280t686r1350b740],
8	6	CD	NUMBER	6	num	11	SENT_59	[p4l1381t679r1419b740],
9	or	CC	O	or	_	0	SENT_59	[p4l1450t697r1526b740],
10	9	CD	DURATION	9	num	11	SENT_59	[p4l1555t679r1593b741],
11	months	NNS	NUMBER	month	prep_to	6	SENT_59	[p4l1623t673r1911b740],
12	at	IN	O	at	_	0	SENT_59	[p4l1942t686r2008b740],
13	the	DT	O	the	det	14	SENT_59	[p4l2033t673r2150b740],
14	end	NN	O	end	prep_at	2	SENT_59	[p4l8t781r148b850],
15	of	IN	O	of	_	0	SENT_59	[p4l175t781r259b850],
16	the	DT	O	the	det	17	SENT_59	[p4l273t781r390b850],
17	study	NN	O	study	prep_of	2	SENT_59	[p4l421t781r632b871],
18	,	,	O	,	_	0	SENT_59	[p4l421t781r632b871],
19	providing	VBG	O	provide	partmod	17	SENT_59	[p4l663t781r1025b871],
20	a	DT	O	a	det	23	SENT_59	[p4l1054t806r1092b850],
21	median	JJ	O	median	amod	23	SENT_59	[p4l1119t781r1405b850],
22	treatment	NN	O	treatment	nn	23	SENT_59	[p4l1431t795r1802b850],
23	duration	NN	O	duration	dobj	19	SENT_59	[p4l1830t781r2151b850],
24	of	IN	O	of	_	0	SENT_59	[p4l8t891r92b959],
25	277	CD	DURATION	277	num	26	SENT_59	[p4l107t895r225b962],
26	days	NNS	NUMBER	day	prep_of	23	SENT_59	[p4l251t891r432b980],
27	.	.	O	.	_	0	SENT_59	[p4l251t891r432b980],

1	Participation	NN	O	participation	nsubj	11	SENT_60	[p4l83t1005r559b1089],
2	in	IN	O	in	_	0	SENT_60	[p4l581t1005r656b1067],
3	the	DT	O	the	det	5	SENT_60	[p4l678t1001r795b1069],
4	genetic	JJ	O	genetic	amod	5	SENT_60	[p4l820t1005r1088b1090],
5	substudy	NN	O	substudy	prep_in	1	SENT_60	[p4l1113t1001r1451b1090],
6	of	IN	O	of	_	0	SENT_60	[p4l1473t1000r1556b1069],
7	the	DT	O	the	det	9	SENT_60	[p4l1564t1001r1681b1069],
8	PLATO	NNP	O	PLATO	nn	9	SENT_60	[p4l1709t1005r1977b1069],
9	trial	NN	O	trial	prep_of	5	SENT_60	[p4l2001t1001r2151b1069],
10	was	VBD	O	be	cop	11	SENT_60	[p4l6t1133r145b1177],
11	voluntary	JJ	O	voluntary	_	0	SENT_60	[p4l203t1109r559b1199],
12	for	IN	O	for	_	0	SENT_60	[p4l615t1109r722b1177],
13	sites	NNS	O	site	prep_for	11	SENT_60	[p4l780t1114r941b1177],
14	and	CC	O	and	_	0	SENT_60	[p4l1003t1109r1141b1177],
15	patients	NNS	O	patient	conj_and	13	SENT_60	[p4l1197t1114r1514b1198],
16	.	.	O	.	_	0	SENT_60	[p4l1197t1114r1514b1198],

1	Collection	NN	O	collection	nn	4	SENT_61	[p4l1578t1109r1955b1177],
2	and	CC	O	and	_	0	SENT_61	[p4l2013t1109r2152b1177],
3	genetic	JJ	O	genetic	conj_and	1	SENT_61	[p4l9t1223r278b1308],
4	analysis	NN	O	analysis	nsubj	8	SENT_61	[p4l331t1218r625b1307],
5	of	IN	O	of	_	0	SENT_61	[p4l681t1218r764b1286],
6	samples	NNS	O	sample	prep_of	4	SENT_61	[p4l806t1218r1110b1307],
7	was	VBD	O	be	cop	8	SENT_61	[p4l1163t1242r1302b1286],
8	subject	JJ	O	subject	_	0	SENT_61	[p4l1360t1218r1625b1307],
9	to	TO	O	to	_	0	SENT_61	[p4l1675t1231r1744b1286],
10	informed	VBN	O	inform	amod	11	SENT_61	[p4l1798t1218r2152b1286],
11	consent	NN	O	consent	prep_to	8	SENT_61	[p4l8t1341r319b1406],
12	,	,	O	,	_	0	SENT_61	[p4l8t1341r319b1406],
13	separate	JJ	O	separate	amod	29	SENT_61	[p4l365t1341r672b1416],
14	to	TO	O	to	_	0	SENT_61	[p4l710t1341r780b1396],
15	that	DT	O	that	prep_to	13	SENT_61	[p4l819t1328r965b1396],
16	of	IN	O	of	_	0	SENT_61	[p4l1004t1327r1088b1396],
17	the	DT	O	the	det	19	SENT_61	[p4l1113t1328r1230b1396],
18	PLATO	NNP	ORGANIZATION	PLATO	nn	19	SENT_61	[p4l1274t1332r1542b1396],
19	study	NN	O	study	prep_of	15	SENT_61	[p4l1586t1328r1797b1417],
20	,	,	O	,	_	0	SENT_61	[p4l1586t1328r1797b1417],
21	from	IN	O	from	_	0	SENT_61	[p4l1840t1327r2025b1396],
22	all	DT	O	all	det	23	SENT_61	[p4l2066t1328r2151b1396],
23	patients	NNS	O	patient	prep_from	13	SENT_61	[p4l7t1441r303b1525],
24	and	CC	O	and	_	0	SENT_61	[p4l330t1436r468b1504],
25	approval	NN	O	approval	prep_from	13	SENT_61	[p4l491t1436r810b1525],
26	by	IN	O	by	_	0	SENT_61	[p4l832t1436r920b1526],
27	local	JJ	O	local	amod	28	SENT_61	[p4l939t1436r1111b1504],
28	ethics	NNS	O	ethic	prep_by	23	SENT_61	[p4l1135t1436r1350b1504],
29	committees	NNS	O	committee	appos	11	SENT_61	[p4l1377t1441r1836b1504],
30	.	.	O	.	_	0	SENT_61	[p4l1377t1441r1836b1504],

1	A	DT	O	a	det	3	SENT_62	[p4l1862t1441r1922b1503],
2	blood	NN	O	blood	nn	3	SENT_62	[p4l1942t1436r2152b1504],
3	sample	NN	O	sample	nsubjpass	5	SENT_62	[p4l10t1546r277b1635],
4	was	VBD	O	be	auxpass	5	SENT_62	[p4l312t1570r451b1614],
5	obtained	VBN	O	obtain	_	0	SENT_62	[p4l491t1546r817b1614],
6	from	IN	O	from	_	0	SENT_62	[p4l852t1546r1038b1614],
7	every	DT	O	every	det	8	SENT_62	[p4l1075t1570r1270b1635],
8	participant	NN	O	participant	prep_from	5	SENT_62	[p4l1304t1550r1713b1635],
9	as	IN	O	as	_	0	SENT_62	[p4l1749t1570r1821b1614],
10	close	JJ	O	close	prep_as	8	SENT_62	[p4l1861t1546r2044b1614],
11	to	TO	O	to	_	0	SENT_62	[p4l2080t1559r2150b1614],
12	randomisation	NN	O	randomisation	prep_to	5	SENT_62	[p4l7t1656r561b1724],
13	as	IN	O	as	_	0	SENT_62	[p4l596t1680r668b1724],
14	possible	JJ	O	possible	prep_as	5	SENT_62	[p4l705t1656r1029b1744],
15	.	.	O	.	_	0	SENT_62	[p4l705t1656r1029b1744],

1	Genotyping	VBG	O	genotype	partmod	22	SENT_63	[p4l1070t1660r1508b1745],
2	was	VBD	O	be	auxpass	3	SENT_63	[p4l1540t1680r1679b1724],
3	done	VBN	O	do	ccomp	1	SENT_63	[p4l1717t1656r1900b1724],
4	at	IN	O	at	_	0	SENT_63	[p4l1936t1669r2002b1724],
5	the	DT	O	the	det	7	SENT_63	[p4l2033t1656r2150b1724],
6	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	nn	7	SENT_63	[p4l6t1770r479b1834],
7	Research	NNP	ORGANIZATION	Research	prep_at	3	SENT_63	[p4l528t1765r864b1834],
8	and	CC	ORGANIZATION	and	_	0	SENT_63	[p4l910t1765r1048b1834],
9	Development	NNP	ORGANIZATION	Development	conj_and	7	SENT_63	[p4l1095t1765r1598b1854],
10	and	CC	ORGANIZATION	and	_	0	SENT_63	[p4l1642t1765r1781b1834],
11	Genetics	NNP	ORGANIZATION	Genetics	nn	15	SENT_63	[p4l1827t1770r2148b1834],
12	Laboratory	NNP	ORGANIZATION	Laboratory	nn	15	SENT_63	[p4l12t1875r411b1964],
13	(	NNP	O	(	nn	15	SENT_63	[p4l474t1875r809b1965],
14	Alderley	NNP	O	Alderley	nn	15	SENT_63	[p4l474t1875r809b1965],
15	Park	NNP	O	Park	conj_and	7	SENT_63	[p4l870t1875r1054b1953],
16	,	,	O	,	_	0	SENT_63	[p4l870t1875r1054b1953],
17	UK	NNP	LOCATION	UK	nsubj	22	SENT_63	[p4l1122t1881r1266b1965],
18	)	CD	NUMBER	)	num	17	SENT_63	[p4l1122t1881r1266b1965],
19	with	IN	O	with	_	0	SENT_63	[p4l1329t1875r1495b1943],
20	TaqMan	NN	O	taqman	nn	21	SENT_63	[p4l1553t1879r1858b1964],
21	assays	NNS	O	assay	prep_with	17	SENT_63	[p4l1918t1899r2148b1964],
22	(	VBP	O	(	_	0	SENT_63	[p4l13t1983r326b2073],
23	Applied	NNP	O	Applied	nn	24	SENT_63	[p4l13t1983r326b2073],
24	Biosystems	NNP	O	Biosystems	dobj	22	SENT_63	[p4l358t1988r799b2073],
25	,	,	O	,	_	0	SENT_63	[p4l358t1988r799b2073],
26	Life	NNP	ORGANIZATION	Life	nn	27	SENT_63	[p4l835t1983r971b2052],
27	Technologies	NNPS	ORGANIZATION	Technologies	appos	24	SENT_63	[p4l1000t1983r1512b2073],
28	,	,	O	,	_	0	SENT_63	[p4l1000t1983r1512b2073],
29	Pleasanton	NNP	LOCATION	Pleasanton	nn	33	SENT_63	[p4l1549t1983r1978b2062],
30	,	,	O	,	_	0	SENT_63	[p4l1549t1983r1978b2062],
31	CA	NNP	O	CA	appos	33	SENT_63	[p4l2013t1989r2147b2062],
32	,	,	O	,	_	0	SENT_63	[p4l2013t1989r2147b2062],
33	USA	NNP	LOCATION	USA	appos	27	SENT_63	[p4l12t2097r232b2182],
34	)	CD	NUMBER	)	num	33	SENT_63	[p4l12t2097r232b2182],
35	.	.	O	.	_	0	SENT_63	[p4l12t2097r232b2182],

1	We	PRP	O	we	nsubj	2	SENT_64	[p4l265t2099r383b2161],
2	classiﬁed	VBD	O	classiﬁed	_	0	SENT_64	[p4l415t2092r759b2160],
3	every	DT	O	every	det	6	SENT_64	[p4l789t2117r983b2182],
4	C	NN	O	c	nn	6	SENT_64	[p4l1018t2097r1072b2160],
5	YPZCI9	NN	O	ypzci9	nn	6	SENT_64	[p4l1079t2097r1368b2161],
6	allele	NN	O	allele	dobj	2	SENT_64	[p4l1395t2092r1586b2160],
7	by	IN	O	by	_	0	SENT_64	[p4l1615t2092r1703b2182],
8	established	JJ	O	established	amod	9	SENT_64	[p4l1731t2092r2152b2160],
9	nomenclature	NN	O	nomenclature	prep_by	2	SENT_64	[p4l7t2203r533b2271],
10	and	CC	O	and	_	0	SENT_64	[p4l600t2203r739b2271],
11	its	PRP$	O	its	poss	13	SENT_64	[p4l803t2207r888b2271],
12	reported	JJ	O	reported	amod	13	SENT_64	[p4l955t2203r1273b2292],
13	effect	NN	O	effect	prep_by	2	SENT_64	[p4l1339t2203r1542b2271],
14	on	IN	O	on	_	0	SENT_64	[p4l1606t2227r1701b2271],
15	enzymatic	JJ	O	enzymatic	amod	16	SENT_64	[p4l1766t2207r2151b2292],
16	function	NN	O	function	prep_on	2	SENT_64	[p4l7t2311r327b2380],
17	according	VBG	O	accord	_	0	SENT_64	[p4l366t2311r732b2401],
18	to	TO	O	to	prepc_according_to	2	SENT_64	[p4l769t2325r838b2380],
19	published	VBN	O	publish	amod	20	SENT_64	[p4l877t2311r1251b2400],
20	reports	NNS	O	report	pobj	2	SENT_64	[p4l1287t2325r1550b2400],
21	and	CC	O	and	_	0	SENT_64	[p4l1592t2311r1731b2380],
22	databases	NNS	O	database	pobj	2	SENT_64	[p4l1769t2311r2147b2380],
23	.	.	O	.	_	0	SENT_64	[p4l1769t2311r2147b2380],

1	The	DT	O	the	det	2	SENT_65	[p4l6t2420r151b2488],
2	alleles	NNS	O	allele	nsubj	3	SENT_65	[p4l216t2420r444b2488],
3	genotyped	VBN	O	genotype	ccomp	50	SENT_65	[p4l511t2420r899b2510],
4	in	IN	O	in	xcomp	3	SENT_65	[p4l961t2425r1036b2487],
5	the	DT	O	the	dep	4	SENT_65	[p4l1099t2420r1216b2488],
6	total	JJ	O	total	dep	5	SENT_65	[p4l1279t2420r1442b2488],
7	PLATO	NNP	O	PLATO	dep	8	SENT_65	[p4l1509t2424r1777b2488],
8	genetics	NNS	O	genetics	dep	10	SENT_65	[p4l1845t2425r2148b2510],
9	population	NN	O	population	nsubj	10	SENT_65	[p4l7t2531r414b2620],
10	were	VBD	O	be	dep	12	SENT_65	[p4l437t2555r635b2599],
11	:	:	O	:	_	0	SENT_65	[p4l437t2555r635b2599],
12	C	NN	O	c	dep	5	SENT_65	[p4l670t2536r725b2599],
13	YPZC	NN	O	ypzc	dobj	12	SENT_65	[p4l731t2536r939b2599],
14	19	CD	NUMBER	19	tmod	13	SENT_65	[p4l945t2537r1020b2599],
15	loss-of-function	JJ	O	loss-of-function	prep	13	SENT_65	[p4l1039t2531r1627b2599],
16	alleles	NNS	O	allele	dep	15	SENT_65	[p4l1652t2531r1880b2599],
17	"	``	O	"	punct	13	SENT_65	[p4l1908t2535r2013b2609],
18	"	``	O	"	punct	19	SENT_65	[p4l1908t2535r2013b2609],
19	2	CD	NUMBER	2	dep	13	SENT_65	[p4l1908t2535r2013b2609],
20	,	,	O	,	_	0	SENT_65	[p4l1908t2535r2013b2609],
21	"	``	O	"	punct	22	SENT_65	[p4l2042t2535r2147b2609],
22	3	CD	NUMBER	3	appos	19	SENT_65	[p4l2042t2535r2147b2609],
23	,	,	O	,	_	0	SENT_65	[p4l2042t2535r2147b2609],
24	"	``	O	"	punct	4	SENT_65	[p4l8t2644r109b2717],
25	'	''	O	'	_	0	SENT_65	[p4l8t2644r109b2717],
26	~	FW	O	~	nn	28	SENT_65	[p4l8t2644r109b2717],
27	‘	FW	O	‘	dep	28	SENT_65	[p4l8t2644r109b2717],
28	4	CD	NUMBER	4	advmod	3	SENT_65	[p4l8t2644r109b2717],
29	,	,	O	,	_	0	SENT_65	[p4l8t2644r109b2717],
30	"	``	O	"	punct	32	SENT_65	[p4l153t2644r258b2717],
31	"	``	O	"	punct	32	SENT_65	[p4l153t2644r258b2717],
32	5	CD	NUMBER	5	dobj	3	SENT_65	[p4l153t2644r258b2717],
33	,	,	O	,	_	0	SENT_65	[p4l153t2644r258b2717],
34	*	CD	NUMBER	*	num	35	SENT_65	[p4l302t2644r407b2718],
35	6	CD	NUMBER	6	appos	32	SENT_65	[p4l302t2644r407b2718],
36	,	,	O	,	_	0	SENT_65	[p4l302t2644r407b2718],
37	"	``	O	"	punct	39	SENT_65	[p4l451t2644r550b2718],
38	"	``	O	"	punct	39	SENT_65	[p4l451t2644r550b2718],
39	7	CD	NUMBER	7	nsubj	50	SENT_65	[p4l451t2644r550b2718],
40	,	,	O	,	_	0	SENT_65	[p4l451t2644r550b2718],
41	and	CC	O	and	_	0	SENT_65	[p4l594t2639r732b2708],
42	"	``	O	"	punct	39	SENT_65	[p4l771t2644r876b2717],
43	"	``	O	"	punct	44	SENT_65	[p4l771t2644r876b2717],
44	8	CD	NUMBER	8	conj_and	39	SENT_65	[p4l771t2644r876b2717],
45	;	:	O	;	_	0	SENT_65	[p4l771t2644r876b2717],
46	CYPZCI9	CD	NUMBER	cypzci9	num	47	SENT_65	[p4l926t2645r1276b2708],
47	gain-of-function	NN	O	gain-of-function	dep	44	SENT_65	[p4l1313t2639r1918b2729],
48	allele	NN	O	allele	dep	47	SENT_65	[p4l1958t2639r2150b2708],
49	"	''	O	"	punct	44	SENT_65	[p4l8t2752r143b2826],
50	<	JJR	O	<	_	0	SENT_65	[p4l8t2752r143b2826],
51	17	CD	NUMBER	17	dobj	50	SENT_65	[p4l8t2752r143b2826],
52	;	:	O	;	_	0	SENT_65	[p4l8t2752r143b2826],
53	and	CC	O	and	_	0	SENT_65	[p4l233t2748r372b2816],
54	ABCB1	NN	O	abcb1	conj_and	51	SENT_65	[p4l453t2753r724b2816],
55	single	JJ	O	single	amod	58	SENT_65	[p4l810t2748r1030b2838],
56	nucleotide	NN	O	nucleotide	nn	58	SENT_65	[p4l1116t2748r1508b2816],
57	polymorphism	NN	O	polymorphism	nn	58	SENT_65	[p4l1593t2748r2151b2837],
58	3435C	NN	O	3435c	dep	54	SENT_65	[p4l12t2862r385b2925],
59	—	CD	NUMBER	—	num	61	SENT_65	[p4l12t2862r385b2925],
60	>	JJR	O	>	amod	61	SENT_65	[p4l12t2862r385b2925],
61	T	NN	O	t	dep	54	SENT_65	[p4l12t2862r385b2925],
62	(	CD	NUMBER	(	dep	61	SENT_65	[p4l422t2862r857b2947],
63	rs1045642	NN	O	rs1045642	prep	50	SENT_65	[p4l422t2862r857b2947],
64	)	NN	O	)	dep	63	SENT_65	[p4l422t2862r857b2947],
65	.	.	O	.	_	0	SENT_65	[p4l422t2862r857b2947],

1	Genotyping	VBG	O	genotype	amod	3	SENT_66	[p4l896t2862r1334b2947],
2	success	NN	O	success	nn	3	SENT_66	[p4l1369t2882r1645b2925],
3	rates	NNS	O	rate	nsubj	4	SENT_66	[p4l1680t2871r1856b2925],
4	ranged	VBD	O	range	_	0	SENT_66	[p4l1891t2858r2152b2948],
5	from	IN	O	from	_	0	SENT_66	[p4l7t2966r193b3035],
6	98-8	CD	PERCENT	98-8	num	7	SENT_66	[p4l226t2971r475b3037],
7	%	NN	PERCENT	%	prep_from	4	SENT_66	[p4l226t2971r475b3037],
8	to	TO	O	to	_	0	SENT_66	[p4l506t2980r576b3035],
9	99-5	CD	PERCENT	99-5	num	10	SENT_66	[p4l610t2971r859b3037],
10	%	NN	PERCENT	%	prep_to	4	SENT_66	[p4l610t2971r859b3037],
11	of	IN	O	of	_	0	SENT_66	[p4l893t2966r976b3035],
12	all	DT	O	all	det	13	SENT_66	[p4l996t2966r1082b3035],
13	samples	NNS	O	sample	prep_of	10	SENT_66	[p4l1116t2966r1419b3055],
14	genotyped	VBD	O	genotype	partmod	13	SENT_66	[p4l1454t2966r1859b3056],
15	,	,	O	,	_	0	SENT_66	[p4l1454t2966r1859b3056],
16	and	CC	O	and	_	0	SENT_66	[p4l1895t2966r2034b3035],
17	all	DT	O	all	det	18	SENT_66	[p4l2066t2966r2151b3035],
18	www	NN	O	www	conj_and	13	SENT_66	[p4l6t3238r542b3289],
19	.	.	O	.	_	0	SENT_66	[p4l6t3238r542b3289],

1	the	DT	O	the	det	2	SENT_67	[p4l6t3238r542b3289],
2	|	NN	O	|	_	0	SENT_67	[p4l6t3238r542b3289],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_67	[p4l6t3238r542b3289],
4	Vol	NNP	O	Vol	dep	2	SENT_67	[p4l585t3238r673b3289],
5	376	CD	NUMBER	376	num	6	SENT_67	[p4l692t3237r797b3296],
6	October	NNP	DATE	October	dep	2	SENT_67	[p4l843t3238r1068b3289],
7	16,2010	CD	DATE	16,2010	num	6	SENT_67	[p4l1085t3237r1330b3297],

1	single	JJ	O	single	amod	3	SENT_68	[p5l10t70r166b134],
2	nucleotide	NN	O	nucleotide	nn	3	SENT_68	[p5l193t70r469b118],
3	polymorphisms	NNS	O	polymorphism	nsubj	4	SENT_68	[p5l496t70r914b134],
4	passed	VBD	O	pass	_	0	SENT_68	[p5l942t70r1121b133],
5	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	poss	10	SENT_68	[p5l1146t73r1517b119],
6	’s	POS	O	’s	_	0	SENT_68	[p5l1146t73r1517b119],
7	internal	JJ	O	internal	amod	10	SENT_68	[p5l8t148r216b197],
8	quality	NN	O	quality	nn	10	SENT_68	[p5l264t148r443b212],
9	control	NN	O	control	nn	10	SENT_68	[p5l490t148r675b197],
10	criteria	NNS	O	criterion	dobj	4	SENT_68	[p5l723t151r909b197],
11	for	IN	O	for	_	0	SENT_68	[p5l956t148r1031b197],
12	I-Iardy-Weinberg	NN	O	i-iardy-weinberg	nn	13	SENT_68	[p5l1080t148r1519b212],
13	equilibrium	NN	O	equilibrium	prep_for	4	SENT_68	[p5l9t227r325b290],
14	(	CD	NUMBER	(	num	15	SENT_68	[p5l366t231r474b291],
15	p	NN	O	p	tmod	4	SENT_68	[p5l366t231r474b291],
16	=	JJ	O	=	amod	15	SENT_68	[p5l366t231r474b291],
17	1	CD	NUMBER	1	tmod	16	SENT_68	[p5l366t231r474b291],
18	for	IN	O	for	_	0	SENT_68	[p5l511t227r586b275],
19	seven	CD	TIME	seven	prep_for	4	SENT_68	[p5l623t244r770b275],
20	of	IN	TIME	of	_	0	SENT_68	[p5l807t227r865b275],
21	nine	CD	TIME	nine	num	24	SENT_68	[p5l893t230r1011b275],
22	single	JJ	O	single	amod	24	SENT_68	[p5l1050t227r1205b291],
23	nucleotide	NN	O	nucleotide	nn	24	SENT_68	[p5l1242t227r1519b275],
24	polymorphisms	NNS	O	polymorphism	prep_of	19	SENT_68	[p5l8t304r441b368],
25	,	,	O	,	_	0	SENT_68	[p5l8t304r441b368],
26	p	NN	O	p	nn	28	SENT_68	[p5l495t309r688b367],
27	=	JJ	O	=	amod	28	SENT_68	[p5l495t309r688b367],
28	O-94	NN	O	o-94	appos	24	SENT_68	[p5l495t309r688b367],
29	for	IN	O	for	_	0	SENT_68	[p5l737t304r812b353],
30	the	DT	O	the	det	31	SENT_68	[p5l862t304r945b353],
31	CYP2C19	NN	O	cyp2c19	prep_for	28	SENT_68	[p5l1002t307r1312b353],
32	"	''	O	"	punct	31	SENT_68	[p5l1002t307r1312b353],
33	"	``	O	"	punct	31	SENT_68	[p5l1002t307r1312b353],
34	5	CD	NUMBER	5	num	37	SENT_68	[p5l1002t307r1312b353],
35	single	JJ	O	single	amod	37	SENT_68	[p5l1363t304r1519b368],
36	nucleotide	NN	O	nucleotide	nn	37	SENT_68	[p5l8t382r285b431],
37	polymorphism	NN	O	polymorphism	dep	31	SENT_68	[p5l296t382r702b446],
38	,	,	O	,	_	0	SENT_68	[p5l296t382r702b446],
39	and	CC	O	and	_	0	SENT_68	[p5l717t382r814b431],
40	p	NN	O	p	nn	42	SENT_68	[p5l824t386r923b445],
41	=	JJ	O	=	amod	42	SENT_68	[p5l824t386r923b445],
42	O	NN	O	o	prep_for	4	SENT_68	[p5l824t386r923b445],
43	-	:	O	-	_	0	SENT_68	[p5l936t410r944b418],
44	32	CD	DATE	32	prep_for	4	SENT_68	[p5l959t387r1015b431],
45	for	IN	O	for	_	0	SENT_68	[p5l1028t382r1104b431],
46	the	DT	O	the	det	48	SENT_68	[p5l1113t382r1195b431],
47	C	NN	O	c	nn	48	SENT_68	[p5l1212t386r1250b431],
48	YP2C19	NN	O	yp2c19	prep_for	44	SENT_68	[p5l1255t385r1522b431],
49	"	''	O	"	punct	19	SENT_68	[p5l1255t385r1522b431],
50	"	``	O	"	punct	19	SENT_68	[p5l1255t385r1522b431],
51	2	CD	NUMBER	2	num	53	SENT_68	[p5l1255t385r1522b431],
52	single	JJ	O	single	amod	53	SENT_68	[p5l10t461r166b525],
53	nucleotide	NN	O	nucleotide	conj_and	19	SENT_68	[p5l184t461r461b509],
54	polymorphism	NN	O	polymorphism	nn	55	SENT_68	[p5l479t461r905b525],
55	)	NN	O	)	dep	53	SENT_68	[p5l479t461r905b525],
56	.	.	O	.	_	0	SENT_68	[p5l479t461r905b525],

1	Statistical	JJ	O	statistical	amod	2	SENT_69	[p5l9t615r275b664],
2	analysis	NN	O	analysis	nsubj	18	SENT_69	[p5l293t615r504b679],
3	The	DT	O	the	det	6	SENT_69	[p5l7t694r109b742],
4	statistical	JJ	O	statistical	amod	6	SENT_69	[p5l131t694r376b742],
5	analysis	NN	O	analysis	nn	6	SENT_69	[p5l395t694r603b757],
6	plan	NN	O	plan	nsubjpass	12	SENT_69	[p5l624t694r739b757],
7	for	IN	O	for	_	0	SENT_69	[p5l758t694r834b742],
8	the	DT	O	the	det	10	SENT_69	[p5l851t694r934b742],
9	genetic	JJ	O	genetic	amod	10	SENT_69	[p5l955t697r1144b758],
10	substudy	NN	O	substudy	prep_for	6	SENT_69	[p5l1165t694r1403b757],
11	was	VBD	O	be	auxpass	12	SENT_69	[p5l1419t711r1517b742],
12	prespeciﬁed	VBN	O	prespeciﬁed	rcmod	2	SENT_69	[p5l8t771r330b834],
13	before	IN	O	before	_	0	SENT_69	[p5l361t771r528b820],
14	any	DT	O	any	det	16	SENT_69	[p5l562t789r654b835],
15	genetic	JJ	O	genetic	amod	16	SENT_69	[p5l686t774r876b835],
16	results	NNS	O	result	prep_before	12	SENT_69	[p5l908t771r1083b820],
17	were	VBD	O	be	cop	18	SENT_69	[p5l1116t789r1242b820],
18	available	JJ	O	available	_	0	SENT_69	[p5l1276t771r1516b820],
19	.	.	O	.	_	0	SENT_69	[p5l1276t771r1516b820],

1	The	DT	O	the	det	3	SENT_70	[p5l7t849r109b898],
2	genetic	JJ	O	genetic	amod	3	SENT_70	[p5l141t852r330b913],
3	information	NN	O	information	nsubjpass	5	SENT_70	[p5l360t849r681b898],
4	was	VBD	O	be	auxpass	5	SENT_70	[p5l709t866r807b898],
5	merged	VBN	O	merge	_	0	SENT_70	[p5l839t849r1043b913],
6	with	IN	O	with	_	0	SENT_70	[p5l1071t849r1188b898],
7	the	DT	O	the	det	9	SENT_70	[p5l1218t849r1300b898],
8	clinical	JJ	O	clinical	amod	9	SENT_70	[p5l1331t849r1519b898],
9	database	NN	O	database	prep_with	5	SENT_70	[p5l9t928r235b976],
10	for	IN	O	for	_	0	SENT_70	[p5l258t928r333b976],
11	the	DT	O	the	det	13	SENT_70	[p5l354t928r437b976],
12	genetics	NNS	O	genetics	nn	13	SENT_70	[p5l461t931r675b992],
13	subset	NN	O	subset	prep_for	9	SENT_70	[p5l701t928r869b976],
14	of	IN	O	of	_	0	SENT_70	[p5l892t928r950b976],
15	the	DT	O	the	det	17	SENT_70	[p5l963t928r1045b976],
16	intention-to-treat	JJ	O	intention-to-treat	amod	17	SENT_70	[p5l1068t931r1520b976],
17	population	NN	O	population	prep_of	13	SENT_70	[p5l8t1005r308b1068],
18	.	.	O	.	_	0	SENT_70	[p5l8t1005r308b1068],

1	Genotype	NN	O	genotype	nn	2	SENT_71	[p5l336t1009r586b1069],
2	frequencies	NNS	O	frequency	nsubjpass	4	SENT_71	[p5l610t1005r917b1068],
3	were	VBD	O	be	auxpass	4	SENT_71	[p5l940t1023r1066b1054],
4	assessed	VBN	O	assess	_	0	SENT_71	[p5l1090t1005r1317b1054],
5	for	IN	O	for	_	0	SENT_71	[p5l1339t1005r1415b1054],
6	the	DT	O	the	det	9	SENT_71	[p5l1436t1005r1518b1054],
7	entire	JJ	O	entire	amod	9	SENT_71	[p5l9t1086r162b1131],
8	genetics	NNS	O	genetics	nn	9	SENT_71	[p5l205t1086r419b1147],
9	cohort	NN	O	cohort	prep_for	4	SENT_71	[p5l463t1083r633b1131],
10	to	TO	O	to	aux	11	SENT_71	[p5l672t1093r721b1131],
11	show	VB	O	show	xcomp	4	SENT_71	[p5l766t1083r903b1131],
12	that	IN	O	that	complm	16	SENT_71	[p5l943t1083r1046b1131],
13	the	DT	O	the	det	14	SENT_71	[p5l1085t1083r1168b1131],
14	cohort	NN	O	cohort	nsubj	16	SENT_71	[p5l1211t1083r1380b1131],
15	was	VBD	O	be	cop	16	SENT_71	[p5l1419t1100r1517b1131],
16	representative	NN	O	representative	ccomp	11	SENT_71	[p5l8t1164r382b1224],
17	of	IN	O	of	_	0	SENT_71	[p5l410t1161r469b1209],
18	a	DT	O	a	det	20	SENT_71	[p5l487t1178r514b1209],
19	white	JJ	O	white	amod	20	SENT_71	[p5l539t1161r685b1209],
20	population	NN	O	population	prep_of	16	SENT_71	[p5l712t1161r1000b1224],
21	and	CC	O	and	_	0	SENT_71	[p5l1027t1161r1125b1209],
22	for	IN	O	for	mark	27	SENT_71	[p5l1151t1161r1226b1209],
23	individual	JJ	O	individual	amod	25	SENT_71	[p5l1252t1161r1519b1209],
24	treatment	NN	O	treatment	nn	25	SENT_71	[p5l7t1248r269b1287],
25	groups	NNS	O	group	nsubj	27	SENT_71	[p5l288t1256r468b1302],
26	to	TO	O	to	aux	27	SENT_71	[p5l488t1248r537b1287],
27	ensure	VB	O	ensure	ccomp	11	SENT_71	[p5l557t1256r736b1287],
28	balance	NN	O	balance	dobj	27	SENT_71	[p5l755t1238r955b1287],
29	between	IN	O	between	_	0	SENT_71	[p5l973t1238r1195b1287],
30	groups	NNS	O	group	prep_between	28	SENT_71	[p5l1214t1256r1410b1302],
31	.	.	O	.	_	0	SENT_71	[p5l1214t1256r1410b1302],

1	For	IN	O	for	dep	117	SENT_72	[p5l1434t1241r1520b1287],
2	the	DT	O	the	dep	117	SENT_72	[p5l7t1316r90b1364],
3	CYPZCI9	NN	O	cypzci9	dep	117	SENT_72	[p5l121t1319r368b1365],
4	genotype	NN	O	genotype	dep	117	SENT_72	[p5l392t1326r644b1380],
5	,	,	O	,	_	0	SENT_72	[p5l392t1326r644b1380],
6	patients	NNS	O	patient	dep	117	SENT_72	[p5l672t1319r880b1379],
7	were	VBD	O	be	dep	117	SENT_72	[p5l907t1333r1033b1364],
8	stratified	VBN	O	stratify	dep	117	SENT_72	[p5l1061t1316r1294b1364],
9	into	IN	O	into	dep	117	SENT_72	[p5l1319t1319r1422b1364],
10	six	CD	NUMBER	six	dep	117	SENT_72	[p5l1451t1319r1520b1364],
11	groups	NNS	O	group	dep	117	SENT_72	[p5l9t1411r190b1457],
12	to	TO	O	to	dep	117	SENT_72	[p5l206t1403r256b1442],
13	represent	VB	O	represent	dep	117	SENT_72	[p5l272t1403r524b1457],
14	their	PRP$	O	they	dep	117	SENT_72	[p5l538t1394r664b1442],
15	predicted	VBN	O	predict	dep	117	SENT_72	[p5l678t1394r926b1457],
16	phenotypes	NNS	O	phenotype	dep	117	SENT_72	[p5l941t1394r1258b1457],
17	:	:	O	:	_	0	SENT_72	[p5l941t1394r1258b1457],
18	extensive	JJ	O	extensive	dep	117	SENT_72	[p5l1278t1397r1519b1442],
19	(	JJ	O	(	dep	117	SENT_72	[p5l12t1474r200b1535],
20	"	``	O	"	dep	117	SENT_72	[p5l12t1474r200b1535],
21	'	''	O	'	_	0	SENT_72	[p5l12t1474r200b1535],
22	~	FW	O	~	dep	117	SENT_72	[p5l12t1474r200b1535],
23	‘	FW	O	‘	dep	117	SENT_72	[p5l12t1474r200b1535],
24	1	CD	NUMBER	1	dep	117	SENT_72	[p5l12t1474r200b1535],
25	/	:	O	/	dep	117	SENT_72	[p5l12t1474r200b1535],
26	"	``	O	"	dep	117	SENT_72	[p5l12t1474r200b1535],
27	’	NN	O	’	dep	117	SENT_72	[p5l12t1474r200b1535],
28	1	CD	NUMBER	1	dep	117	SENT_72	[p5l12t1474r200b1535],
29	)	NN	O	)	dep	117	SENT_72	[p5l12t1474r200b1535],
30	,	,	O	,	_	0	SENT_72	[p5l12t1474r200b1535],
31	intermediate	JJ	O	intermediate	dep	117	SENT_72	[p5l243t1471r582b1520],
32	(	CD	NUMBER	(	dep	117	SENT_72	[p5l628t1474r917b1535],
33	"	``	O	"	dep	117	SENT_72	[p5l628t1474r917b1535],
34	"	``	O	"	dep	117	SENT_72	[p5l628t1474r917b1535],
35	‘	NN	O	‘	dep	117	SENT_72	[p5l628t1474r917b1535],
36	1	CD	NUMBER	1	dep	117	SENT_72	[p5l628t1474r917b1535],
37	/	:	O	/	dep	117	SENT_72	[p5l628t1474r917b1535],
38	*	CD	NUMBER	*	dep	117	SENT_72	[p5l628t1474r917b1535],
39	‘	NN	O	‘	dep	117	SENT_72	[p5l628t1474r917b1535],
40	2	CD	NUMBER	2	dep	117	SENT_72	[p5l628t1474r917b1535],
41	—	CD	NUMBER	—	dep	117	SENT_72	[p5l628t1474r917b1535],
42	"	``	O	"	dep	117	SENT_72	[p5l628t1474r917b1535],
43	"	``	O	"	dep	117	SENT_72	[p5l628t1474r917b1535],
44	8	CD	NUMBER	8	dep	117	SENT_72	[p5l628t1474r917b1535],
45	)	NN	O	)	dep	117	SENT_72	[p5l628t1474r917b1535],
46	,	,	O	,	_	0	SENT_72	[p5l628t1474r917b1535],
47	poor	JJ	O	poor	dep	117	SENT_72	[p5l960t1489r1082b1534],
48	(	NN	O	(	dep	117	SENT_72	[p5l1126t1474r1517b1535],
49	*	CD	NUMBER	*	dep	117	SENT_72	[p5l1126t1474r1517b1535],
50	‘	NN	O	‘	dep	117	SENT_72	[p5l1126t1474r1517b1535],
51	2	CD	NUMBER	2	dep	117	SENT_72	[p5l1126t1474r1517b1535],
52	—	CD	NUMBER	—	dep	117	SENT_72	[p5l1126t1474r1517b1535],
53	"	``	O	"	dep	117	SENT_72	[p5l1126t1474r1517b1535],
54	"	``	O	"	dep	117	SENT_72	[p5l1126t1474r1517b1535],
55	‘	NN	O	‘	dep	117	SENT_72	[p5l1126t1474r1517b1535],
56	8	CD	NUMBER	8	dep	117	SENT_72	[p5l1126t1474r1517b1535],
57	/	:	O	/	dep	117	SENT_72	[p5l1126t1474r1517b1535],
58	"	``	O	"	dep	117	SENT_72	[p5l1126t1474r1517b1535],
59	"	``	O	"	dep	117	SENT_72	[p5l1126t1474r1517b1535],
60	‘	NN	O	‘	dep	117	SENT_72	[p5l1126t1474r1517b1535],
61	2	CD	NUMBER	2	dep	117	SENT_72	[p5l1126t1474r1517b1535],
62	—	CD	NUMBER	—	dep	117	SENT_72	[p5l1126t1474r1517b1535],
63	"	``	O	"	dep	117	SENT_72	[p5l1126t1474r1517b1535],
64	"	``	O	"	dep	117	SENT_72	[p5l1126t1474r1517b1535],
65	‘	CD	NUMBER	‘	dep	117	SENT_72	[p5l1126t1474r1517b1535],
66	8	CD	NUMBER	8	dep	117	SENT_72	[p5l1126t1474r1517b1535],
67	)	NN	O	)	dep	117	SENT_72	[p5l1126t1474r1517b1535],
68	,	,	O	,	_	0	SENT_72	[p5l1126t1474r1517b1535],
69	poor	JJ	O	poor	dep	117	SENT_72	[p5l8t1566r129b1612],
70	or	CC	O	or	dep	117	SENT_72	[p5l139t1566r194b1597],
71	rapid	JJ	O	rapid	dep	117	SENT_72	[p5l203t1549r341b1612],
72	heterozygote	NN	O	heterozygote	dep	117	SENT_72	[p5l350t1549r689b1613],
73	(	CD	NUMBER	(	dep	117	SENT_72	[p5l704t1552r875b1613],
74	‘	NN	O	‘	dep	117	SENT_72	[p5l704t1552r875b1613],
75	''	''	O	''	_	0	SENT_72	[p5l704t1552r875b1613],
76	‘	NN	O	‘	dep	117	SENT_72	[p5l704t1552r875b1613],
77	2	CD	NUMBER	2	dep	117	SENT_72	[p5l704t1552r875b1613],
78	—	CD	NUMBER	—	dep	117	SENT_72	[p5l704t1552r875b1613],
79	‘	NN	O	‘	dep	117	SENT_72	[p5l704t1552r875b1613],
80	''	''	O	''	_	0	SENT_72	[p5l704t1552r875b1613],
81	\	IN	O	\	dep	117	SENT_72	[p5l704t1552r875b1613],
82	‘	CD	NUMBER	‘	dep	117	SENT_72	[p5l704t1552r875b1613],
83	8	CD	NUMBER	8	dep	117	SENT_72	[p5l704t1552r875b1613],
84	/	:	O	/	dep	117	SENT_72	[p5l881t1552r1020b1613],
85	’‘	CD	NUMBER	’‘	dep	117	SENT_72	[p5l881t1552r1020b1613],
86	17	CD	NUMBER	17	dep	117	SENT_72	[p5l881t1552r1020b1613],
87	)	NN	O	)	dep	117	SENT_72	[p5l881t1552r1020b1613],
88	,	,	O	,	_	0	SENT_72	[p5l881t1552r1020b1613],
89	rapid	JJ	O	rapid	dep	117	SENT_72	[p5l1033t1549r1171b1612],
90	heterozygote	NN	O	heterozygote	dep	117	SENT_72	[p5l1179t1549r1518b1613],
91	(	CD	NUMBER	(	dep	117	SENT_72	[p5l12t1629r227b1690],
92	"	``	O	"	dep	117	SENT_72	[p5l12t1629r227b1690],
93	'	''	O	'	_	0	SENT_72	[p5l12t1629r227b1690],
94	~	FW	O	~	dep	117	SENT_72	[p5l12t1629r227b1690],
95	‘	FW	O	‘	dep	117	SENT_72	[p5l12t1629r227b1690],
96	1	CD	NUMBER	1	dep	117	SENT_72	[p5l12t1629r227b1690],
97	/	:	O	/	dep	117	SENT_72	[p5l12t1629r227b1690],
98	*	CD	NUMBER	*	dep	117	SENT_72	[p5l12t1629r227b1690],
99	‘	CD	NUMBER	‘	dep	117	SENT_72	[p5l12t1629r227b1690],
100	17	CD	NUMBER	17	dep	117	SENT_72	[p5l12t1629r227b1690],
101	)	NN	O	)	dep	117	SENT_72	[p5l12t1629r227b1690],
102	,	,	O	,	_	0	SENT_72	[p5l12t1629r227b1690],
103	and	CC	O	and	dep	117	SENT_72	[p5l260t1627r358b1675],
104	ultra	NN	O	ultra	dep	117	SENT_72	[p5l386t1627r510b1675],
105	rapid	JJ	O	rapid	dep	117	SENT_72	[p5l540t1627r678b1690],
106	(	CD	NUMBER	(	dep	117	SENT_72	[p5l711t1629r952b1690],
107	"	``	O	"	dep	117	SENT_72	[p5l711t1629r952b1690],
108	'	''	O	'	_	0	SENT_72	[p5l711t1629r952b1690],
109	~	FW	O	~	dep	117	SENT_72	[p5l711t1629r952b1690],
110	‘	FW	O	‘	dep	117	SENT_72	[p5l711t1629r952b1690],
111	17	CD	NUMBER	17	dep	117	SENT_72	[p5l711t1629r952b1690],
112	/	:	O	/	dep	117	SENT_72	[p5l711t1629r952b1690],
113	"	``	O	"	dep	117	SENT_72	[p5l711t1629r952b1690],
114	"	``	O	"	dep	117	SENT_72	[p5l711t1629r952b1690],
115	‘	CD	NUMBER	‘	dep	117	SENT_72	[p5l711t1629r952b1690],
116	17	CD	NUMBER	17	dep	117	SENT_72	[p5l711t1629r952b1690],
117	)	NN	O	)	_	0	SENT_72	[p5l711t1629r952b1690],
118	.	.	O	.	_	0	SENT_72	[p5l711t1629r952b1690],

1	As	IN	O	as	_	0	SENT_73	[p5l984t1630r1051b1675],
2	per	IN	O	per	prepc_as_per	8	SENT_73	[p5l1082t1644r1169b1690],
3	the	DT	O	the	det	5	SENT_73	[p5l1196t1627r1279b1675],
4	analysis	NN	O	analysis	nn	5	SENT_73	[p5l1310t1627r1517b1690],
5	plan	NN	O	plan	pobj	8	SENT_73	[p5l8t1703r137b1766],
6	,	,	O	,	_	0	SENT_73	[p5l8t1703r137b1766],
7	we	PRP	O	we	nsubj	8	SENT_73	[p5l166t1721r239b1752],
8	used	VBD	O	use	_	0	SENT_73	[p5l267t1703r393b1752],
9	a	DT	O	a	det	12	SENT_73	[p5l421t1720r447b1751],
10	data-driven	JJ	O	data-driven	amod	12	SENT_73	[p5l476t1703r772b1751],
11	statistical	JJ	O	statistical	amod	12	SENT_73	[p5l802t1703r1047b1752],
12	approach	NN	O	approach	dobj	8	SENT_73	[p5l1077t1703r1320b1766],
13	with	IN	O	with	_	0	SENT_73	[p5l1347t1703r1464b1752],
14	a	DT	O	a	det	16	SENT_73	[p5l1493t1720r1519b1751],
15	guided	VBN	O	guide	amod	16	SENT_73	[p5l9t1781r190b1845],
16	decision	NN	O	decision	prep_with	8	SENT_73	[p5l206t1781r426b1829],
17	to	TO	O	to	aux	18	SENT_73	[p5l440t1791r489b1829],
18	choose	VB	O	choose	infmod	16	SENT_73	[p5l507t1781r687b1829],
19	the	DT	O	the	det	23	SENT_73	[p5l703t1781r785b1829],
20	most	RBS	O	most	advmod	21	SENT_73	[p5l802t1791r935b1829],
21	appropriate	JJ	O	appropriate	amod	23	SENT_73	[p5l950t1784r1254b1844],
22	C	NN	O	c	nn	23	SENT_73	[p5l1275t1784r1314b1829],
23	YPZC	NN	O	ypzc	dobj	18	SENT_73	[p5l1318t1784r1465b1829],
24	19	CD	NUMBER	19	num	26	SENT_73	[p5l1469t1785r1522b1830],
25	genotype	NN	O	genotype	nn	26	SENT_73	[p5l9t1869r247b1923],
26	groupings	NNS	O	grouping	tmod	18	SENT_73	[p5l269t1863r537b1923],
27	for	IN	O	for	_	0	SENT_73	[p5l560t1859r635b1908],
28	each	DT	O	each	det	30	SENT_73	[p5l656t1859r775b1908],
29	composite	JJ	O	composite	amod	30	SENT_73	[p5l796t1863r1068b1923],
30	endpoint	NN	O	endpoint	prep_for	26	SENT_73	[p5l1090t1859r1329b1923],
31	within	IN	O	within	_	0	SENT_73	[p5l1347t1859r1519b1908],
32	each	DT	O	each	det	34	SENT_73	[p5l9t1936r128b1985],
33	treatment	NN	O	treatment	nn	34	SENT_73	[p5l172t1946r433b1985],
34	arm	NN	O	arm	prep_within	30	SENT_73	[p5l478t1953r597b1984],
35	.	.	O	.	_	0	SENT_73	[p5l478t1953r597b1984],

1	The	DT	O	the	det	3	SENT_74	[p5l644t1936r746b1984],
2	ﬁrst	JJ	O	ﬁrst	amod	3	SENT_74	[p5l791t1936r897b1985],
3	step	NN	O	step	nsubj	7	SENT_74	[p5l943t1946r1047b1999],
4	was	VBD	O	be	cop	7	SENT_74	[p5l1091t1953r1189b1985],
5	an	DT	O	a	det	7	SENT_74	[p5l1237t1953r1300b1984],
6	overall	JJ	O	overall	amod	7	SENT_74	[p5l1345t1936r1519b1985],
7	assessment	NN	O	assessment	_	0	SENT_74	[p5l9t2024r314b2063],
8	of	IN	O	of	_	0	SENT_74	[p5l358t2015r416b2063],
9	any	DT	O	any	det	10	SENT_74	[p5l452t2032r545b2078],
10	effect	NN	O	effect	prep_of	7	SENT_74	[p5l588t2015r731b2063],
11	of	IN	O	of	_	0	SENT_74	[p5l775t2015r834b2063],
12	gain-of-function	NN	O	gain-of-function	nn	13	SENT_74	[p5l870t2015r1296b2079],
13	alleles	NNS	O	allele	prep_of	10	SENT_74	[p5l1341t2015r1517b2071],
14	,	,	O	,	_	0	SENT_74	[p5l1341t2015r1517b2071],
15	followed	VBN	O	follow	_	0	SENT_74	[p5l8t2092r234b2141],
16	by	IN	O	by	prepc_followed_by	7	SENT_74	[p5l261t2092r323b2156],
17	an	DT	O	a	det	19	SENT_74	[p5l351t2110r414b2141],
18	ordered	VBN	O	order	amod	19	SENT_74	[p5l445t2092r649b2141],
19	assessment	NN	O	assessment	pobj	7	SENT_74	[p5l678t2102r983b2141],
20	of	IN	O	of	_	0	SENT_74	[p5l1012t2092r1071b2141],
21	diﬁerent	JJ	O	diﬁerent	amod	23	SENT_74	[p5l1092t2092r1321b2141],
22	logical	JJ	O	logical	amod	23	SENT_74	[p5l1348t2092r1519b2156],
23	groupings	NNS	O	grouping	prep_of	19	SENT_74	[p5l9t2173r277b2234],
24	of	IN	O	of	_	0	SENT_74	[p5l297t2170r356b2219],
25	the	DT	O	the	det	26	SENT_74	[p5l363t2170r446b2219],
26	six	CD	NUMBER	six	prep_of	23	SENT_74	[p5l466t2173r536b2219],
27	predicted	VBN	O	predict	partmod	19	SENT_74	[p5l551t2170r799b2233],
28	C	NN	O	c	nn	29	SENT_74	[p5l821t2174r859b2219],
29	YPZC	NN	O	ypzc	dobj	27	SENT_74	[p5l864t2174r1010b2219],
30	19	CD	NUMBER	19	num	31	SENT_74	[p5l1014t2174r1067b2219],
31	phenotypes	NNS	O	phenotype	nsubj	37	SENT_74	[p5l1082t2170r1384b2234],
32	with	IN	O	with	_	0	SENT_74	[p5l1402t2170r1519b2219],
33	calculation	NN	O	calculation	prep_with	31	SENT_74	[p5l9t2249r295b2297],
34	of	IN	O	of	_	0	SENT_74	[p5l321t2249r380b2297],
35	hazard	NN	O	hazard	nn	36	SENT_74	[p5l395t2249r577b2297],
36	ratios	NNS	O	ratio	prep_of	33	SENT_74	[p5l601t2252r746b2297],
37	(	VBP	O	(	rcmod	29	SENT_74	[p5l777t2254r928b2313],
38	I-IRs	JJ	O	i-irs	amod	39	SENT_74	[p5l777t2254r928b2313],
39	)	NN	O	)	dobj	37	SENT_74	[p5l777t2254r928b2313],
40	and	CC	O	and	_	0	SENT_74	[p5l958t2249r1056b2297],
41	95	CD	PERCENT	95	number	42	SENT_74	[p5l1082t2252r1195b2299],
42	%	NN	PERCENT	%	amod	43	SENT_74	[p5l1082t2252r1195b2299],
43	CIs	NNS	O	ci	dobj	37	SENT_74	[p5l1223t2252r1325b2297],
44	.	.	O	.	_	0	SENT_74	[p5l1223t2252r1325b2297],

1	In	IN	O	in	_	0	SENT_75	[p5l1356t2254r1412b2296],
2	the	DT	O	the	det	3	SENT_75	[p5l1436t2249r1518b2297],
3	absence	NN	O	absence	pobj	1	SENT_75	[p5l9t2326r218b2375],
4	of	IN	O	of	_	0	SENT_75	[p5l255t2326r313b2375],
5	signiﬁcant	JJ	O	signiﬁcant	amod	6	SENT_75	[p5l342t2326r621b2390],
6	effects	NNS	O	effect	prep_of	3	SENT_75	[p5l656t2327r823b2375],
7	with	IN	O	with	_	0	SENT_75	[p5l859t2326r977b2375],
8	application	NN	O	application	prep_with	6	SENT_75	[p5l1013t2326r1305b2389],
9	of	IN	O	of	_	0	SENT_75	[p5l1342t2326r1400b2375],
10	any	DT	O	any	prep_of	8	SENT_75	[p5l1428t2344r1521b2390],

1	90	CD	NUMBER	90	num	3	SENT_76	[p6l708t103r759b139],
2	mg	NN	O	mg	nn	3	SENT_76	[p6l773t110r834b145],
3	ticagrelor	NN	O	ticagrelor	_	0	SENT_76	[p6l844t98r1036b145],
4	75	CD	NUMBER	75	num	6	SENT_76	[p6l1093t103r1139b139],
5	mg	NN	O	mg	nn	6	SENT_76	[p6l1154t109r1215b145],
6	clopidogrel	NN	O	clopidogrel	npadvmod	7	SENT_76	[p6l1228t98r1449b145],
7	twice	RB	O	twice	advmod	12	SENT_76	[p6l706t159r815b194],
8	daily	RB	SET	daily	advmod	12	SENT_76	[p6l826t158r921b205],
9	once	RB	DATE	once	advmod	12	SENT_76	[p6l1094t170r1186b194],
10	daily	JJ	SET	daily	amod	12	SENT_76	[p6l1197t158r1293b205],
11	(	NN	O	(	nn	12	SENT_76	[p6l708t220r885b264],
12	n	NN	O	n	dep	3	SENT_76	[p6l708t220r885b264],
13	=	JJ	O	=	quantmod	15	SENT_76	[p6l708t220r885b264],
14	5137	CD	NUMBER	5137	number	15	SENT_76	[p6l708t220r885b264],
15	)	CD	NUMBER	)	num	17	SENT_76	[p6l708t220r885b264],
16	(	NN	O	(	nn	17	SENT_76	[p6l1095t217r1277b264],
17	n	NN	O	n	npadvmod	18	SENT_76	[p6l1095t217r1277b264],
18	=	JJ	O	=	amod	12	SENT_76	[p6l1095t217r1277b264],
19	5148	CD	NUMBER	5148	num	20	SENT_76	[p6l1095t217r1277b264],
20	)	CD	NUMBER	)	dep	3	SENT_76	[p6l1095t217r1277b264],

1	Age	NNP	O	Age	dep	150	SENT_77	[p6l70t318r142b362],
2	(	CD	NUMBER	(	dep	150	SENT_77	[p6l156t317r279b362],
3	years	NNS	NUMBER	year	dep	150	SENT_77	[p6l156t317r279b362],
4	)	VBP	O	)	dep	150	SENT_77	[p6l156t317r279b362],
5	62-5	CD	NUMBER	62-5	dep	150	SENT_77	[p6l765t314r846b356],
6	(	CD	NUMBER	(	dep	150	SENT_77	[p6l860t317r997b360],
7	10-90	CD	NUMBER	10-90	dep	150	SENT_77	[p6l860t317r997b360],
8	)	NN	O	)	dep	150	SENT_77	[p6l860t317r997b360],
9	62-5	CD	NUMBER	62-5	dep	150	SENT_77	[p6l1152t314r1232b356],
10	(	CD	NUMBER	(	dep	150	SENT_77	[p6l1247t317r1379b360],
11	11-04	CD	NUMBER	11-04	dep	150	SENT_77	[p6l1247t317r1379b360],
12	)	NN	O	)	dep	150	SENT_77	[p6l1247t317r1379b360],
13	275	CD	NUMBER	275	dep	150	SENT_77	[p6l111t400r178b436],
14	760	CD	NUMBER	760	dep	150	SENT_77	[p6l738t394r811b435],
15	(	NN	O	(	dep	150	SENT_77	[p6l825t396r931b440],
16	15	CD	PERCENT	15	dep	150	SENT_77	[p6l825t396r931b440],
17	%	NN	PERCENT	%	dep	150	SENT_77	[p6l825t396r931b440],
18	)	CD	NUMBER	)	dep	150	SENT_77	[p6l825t396r931b440],
19	835	CD	NUMBER	835	dep	150	SENT_77	[p6l1128t394r1197b436],
20	(	NN	O	(	dep	150	SENT_77	[p6l1212t394r1321b440],
21	16	CD	PERCENT	16	dep	150	SENT_77	[p6l1212t394r1321b440],
22	%	NN	PERCENT	%	dep	150	SENT_77	[p6l1212t394r1321b440],
23	)	CD	NUMBER	)	dep	150	SENT_77	[p6l1212t394r1321b440],
24	Men	NN	O	man	dep	150	SENT_77	[p6l72t478r151b510],
25	3560	CD	PERCENT	3560	dep	150	SENT_77	[p6l714t474r811b516],
26	(	CD	PERCENT	(	dep	150	SENT_77	[p6l825t474r938b520],
27	69	CD	PERCENT	69	dep	150	SENT_77	[p6l825t474r938b520],
28	%	NN	PERCENT	%	dep	150	SENT_77	[p6l825t474r938b520],
29	)	CD	PERCENT	)	dep	150	SENT_77	[p6l825t474r938b520],
30	3571	CD	PERCENT	3571	dep	150	SENT_77	[p6l1108t479r1198b516],
31	(	CD	PERCENT	(	dep	150	SENT_77	[p6l1212t474r1325b520],
32	69	CD	PERCENT	69	dep	150	SENT_77	[p6l1212t474r1325b520],
33	%	NN	PERCENT	%	dep	150	SENT_77	[p6l1212t474r1325b520],
34	)	CD	NUMBER	)	dep	150	SENT_77	[p6l1212t474r1325b520],
35	White	NNP	O	White	dep	150	SENT_77	[p6l69t554r182b590],
36	5057	CD	PERCENT	5057	dep	150	SENT_77	[p6l719t559r812b595],
37	(	CD	PERCENT	(	dep	150	SENT_77	[p6l825t553r938b600],
38	98	CD	PERCENT	98	dep	150	SENT_77	[p6l825t553r938b600],
39	%	NN	PERCENT	%	dep	150	SENT_77	[p6l825t553r938b600],
40	)	CD	PERCENT	)	dep	150	SENT_77	[p6l825t553r938b600],
41	5058	CD	PERCENT	5058	dep	150	SENT_77	[p6l1101t553r1197b595],
42	(	CD	PERCENT	(	dep	150	SENT_77	[p6l1212t553r1325b600],
43	98	CD	PERCENT	98	dep	150	SENT_77	[p6l1212t553r1325b600],
44	%	NN	PERCENT	%	dep	150	SENT_77	[p6l1212t553r1325b600],
45	)	CD	NUMBER	)	dep	150	SENT_77	[p6l1212t553r1325b600],
46	Weight	NNP	O	Weight	dep	150	SENT_77	[p6l70t634r206b681],
47	(	CD	NUMBER	(	dep	150	SENT_77	[p6l219t634r290b681],
48	kg	NN	O	kg	dep	150	SENT_77	[p6l219t634r290b681],
49	)	NN	O	)	dep	150	SENT_77	[p6l219t634r290b681],
50	81-9	CD	NUMBER	81-9	dep	150	SENT_77	[p6l767t633r848b675],
51	(	CD	NUMBER	(	dep	150	SENT_77	[p6l863t636r992b679],
52	15-27	CD	NUMBER	15-27	dep	150	SENT_77	[p6l863t636r992b679],
53	)	NN	O	)	dep	150	SENT_77	[p6l863t636r992b679],
54	81-8	CD	NUMBER	81-8	dep	150	SENT_77	[p6l1153t633r1235b670],
55	(	CD	NUMBER	(	dep	150	SENT_77	[p6l1250t636r1381b679],
56	15-47	CD	NUMBER	15-47	dep	150	SENT_77	[p6l1250t636r1381b679],
57	)	CD	NUMBER	)	dep	150	SENT_77	[p6l1250t636r1381b679],
58	Body	NN	O	body	dep	150	SENT_77	[p6l112t714r317b761],
59	—	CD	NUMBER	—	dep	150	SENT_77	[p6l112t714r317b761],
60	mass	NN	O	mass	dep	150	SENT_77	[p6l112t714r317b761],
61	index	NN	O	index	dep	150	SENT_77	[p6l330t714r432b750],
62	230	CD	NUMBER	230	dep	150	SENT_77	[p6l444t718r514b755],
63	kg/ml	JJ	O	kg/ml	dep	150	SENT_77	[p6l528t713r638b761],
64	1560	CD	DATE	1560	dep	150	SENT_77	[p6l716t713r811b755],
65	(	CD	PERCENT	(	dep	150	SENT_77	[p6l825t715r934b759],
66	30	CD	PERCENT	30	dep	150	SENT_77	[p6l825t715r934b759],
67	%	NN	PERCENT	%	dep	150	SENT_77	[p6l825t715r934b759],
68	)	CD	NUMBER	)	dep	150	SENT_77	[p6l825t715r934b759],
69	1520	CD	DATE	1520	dep	150	SENT_77	[p6l1106t718r1198b755],
70	(	CD	PERCENT	(	dep	150	SENT_77	[p6l1212t715r1321b759],
71	30	CD	PERCENT	30	dep	150	SENT_77	[p6l1212t715r1321b759],
72	%	NN	PERCENT	%	dep	150	SENT_77	[p6l1212t715r1321b759],
73	)	CD	NUMBER	)	dep	150	SENT_77	[p6l1212t715r1321b759],
74	Smoking	NN	MISC	smoking	dep	150	SENT_77	[p6l71t793r235b841],
75	status	NN	O	status	dep	150	SENT_77	[p6l249t800r362b830],
76	Non-smoker	NN	O	non-smoker	dep	150	SENT_77	[p6l112t873r348b909],
77	1994	CD	DATE	1994	dep	150	SENT_77	[p6l713t878r813b914],
78	(	CD	PERCENT	(	dep	150	SENT_77	[p6l825t875r935b919],
79	39	CD	PERCENT	39	dep	150	SENT_77	[p6l825t875r935b919],
80	%	NN	PERCENT	%	dep	150	SENT_77	[p6l825t875r935b919],
81	)	CD	NUMBER	)	dep	150	SENT_77	[p6l825t875r935b919],
82	2049	CD	DATE	2049	dep	150	SENT_77	[p6l1099t878r1197b914],
83	(	CD	PERCENT	(	dep	150	SENT_77	[p6l1212t875r1323b919],
84	40	CD	PERCENT	40	dep	150	SENT_77	[p6l1212t875r1323b919],
85	%	NN	PERCENT	%	dep	150	SENT_77	[p6l1212t875r1323b919],
86	)	CD	NUMBER	)	dep	150	SENT_77	[p6l1212t875r1323b919],
87	Ex	FW	O	ex	dep	150	SENT_77	[p6l112t953r308b989],
88	—	FW	O	—	dep	150	SENT_77	[p6l112t953r308b989],
89	smoker	FW	O	smoker	dep	150	SENT_77	[p6l112t953r308b989],
90	1347	CD	DATE	1347	dep	150	SENT_77	[p6l720t958r812b994],
91	(	CD	PERCENT	(	dep	150	SENT_77	[p6l825t952r935b998],
92	26	CD	PERCENT	26	dep	150	SENT_77	[p6l825t952r935b998],
93	%	NN	PERCENT	%	dep	150	SENT_77	[p6l825t952r935b998],
94	)	CD	NUMBER	)	dep	150	SENT_77	[p6l825t952r935b998],
95	1270	CD	DATE	1270	dep	150	SENT_77	[p6l1107t958r1198b994],
96	(	CD	PERCENT	(	dep	150	SENT_77	[p6l1212t955r1319b998],
97	25	CD	PERCENT	25	dep	150	SENT_77	[p6l1212t955r1319b998],
98	%	NN	PERCENT	%	dep	150	SENT_77	[p6l1212t955r1319b998],
99	)	CD	NUMBER	)	dep	150	SENT_77	[p6l1212t955r1319b998],
100	Habitual	JJ	O	habitual	dep	150	SENT_77	[p6l112t1033r267b1069],
101	smoker	NN	O	smoker	dep	150	SENT_77	[p6l281t1033r419b1069],
102	1796	CD	DATE	1796	dep	150	SENT_77	[p6l716t1032r811b1074],
103	(	CD	PERCENT	(	dep	150	SENT_77	[p6l825t1035r933b1078],
104	35	CD	PERCENT	35	dep	150	SENT_77	[p6l825t1035r933b1078],
105	%	NN	PERCENT	%	dep	150	SENT_77	[p6l825t1035r933b1078],
106	)	CD	NUMBER	)	dep	150	SENT_77	[p6l825t1035r933b1078],
107	1829	CD	DATE	1829	dep	150	SENT_77	[p6l1102t1032r1197b1074],
108	(	CD	PERCENT	(	dep	150	SENT_77	[p6l1212t1032r1322b1078],
109	36	CD	PERCENT	36	dep	150	SENT_77	[p6l1212t1032r1322b1078],
110	%	NN	PERCENT	%	dep	150	SENT_77	[p6l1212t1032r1322b1078],
111	)	CD	NUMBER	)	dep	150	SENT_77	[p6l1212t1032r1322b1078],
112	Diabetes	NNP	MISC	Diabetes	dep	150	SENT_77	[p6l72t1113r232b1149],
113	mellitus	NN	O	mellitus	dep	150	SENT_77	[p6l246t1113r393b1149],
114	1177	CD	DATE	1177	dep	150	SENT_77	[p6l725t1118r812b1153],
115	(	CD	PERCENT	(	dep	150	SENT_77	[p6l825t1114r932b1158],
116	23	CD	PERCENT	23	dep	150	SENT_77	[p6l825t1114r932b1158],
117	%	NN	PERCENT	%	dep	150	SENT_77	[p6l825t1114r932b1158],
118	)	CD	PERCENT	)	dep	150	SENT_77	[p6l825t1114r932b1158],
119	1189	CD	PERCENT	1189	dep	150	SENT_77	[p6l1103t1112r1197b1154],
120	(	CD	PERCENT	(	dep	150	SENT_77	[p6l1212t1114r1319b1158],
121	23	CD	PERCENT	23	dep	150	SENT_77	[p6l1212t1114r1319b1158],
122	%	NN	PERCENT	%	dep	150	SENT_77	[p6l1212t1114r1319b1158],
123	)	CD	NUMBER	)	dep	150	SENT_77	[p6l1212t1114r1319b1158],
124	Drug	NN	O	drug	dep	150	SENT_77	[p6l72t1196r159b1240],
125	use	NN	O	use	dep	150	SENT_77	[p6l173t1204r234b1228],
126	at	IN	O	at	dep	150	SENT_77	[p6l245t1199r281b1228],
127	randomisation	NN	O	randomisation	dep	150	SENT_77	[p6l295t1192r569b1228],
128	Proton-pump	NN	MISC	proton-pump	dep	150	SENT_77	[p6l112t1276r368b1319],
129	inhibitor	NN	O	inhibitor	dep	150	SENT_77	[p6l382t1272r544b1308],
130	2154	CD	DATE	2154	dep	150	SENT_77	[p6l719t1277r812b1313],
131	(	CD	PERCENT	(	dep	150	SENT_77	[p6l825t1274r935b1318],
132	42	CD	PERCENT	42	dep	150	SENT_77	[p6l825t1274r935b1318],
133	%	NN	PERCENT	%	dep	150	SENT_77	[p6l825t1274r935b1318],
134	)	CD	NUMBER	)	dep	150	SENT_77	[p6l825t1274r935b1318],
135	2083	CD	DATE	2083	dep	150	SENT_77	[p6l1101t1272r1197b1313],
136	(	CD	PERCENT	(	dep	150	SENT_77	[p6l1212t1274r1323b1318],
137	40	CD	PERCENT	40	dep	150	SENT_77	[p6l1212t1274r1323b1318],
138	%	NN	PERCENT	%	dep	150	SENT_77	[p6l1212t1274r1323b1318],
139	)	CD	NUMBER	)	dep	150	SENT_77	[p6l1212t1274r1323b1318],
140	Statin	NN	O	statin	dep	150	SENT_77	[p6l111t1355r220b1388],
141	4079	CD	PERCENT	4079	dep	150	SENT_77	[p6l713t1357r810b1393],
142	(	CD	PERCENT	(	dep	150	SENT_77	[p6l825t1354r934b1397],
143	79	CD	PERCENT	79	dep	150	SENT_77	[p6l825t1354r934b1397],
144	%	NN	PERCENT	%	dep	150	SENT_77	[p6l825t1354r934b1397],
145	)	CD	PERCENT	)	dep	150	SENT_77	[p6l825t1354r934b1397],
146	4059	CD	PERCENT	4059	dep	150	SENT_77	[p6l1098t1357r1197b1393],
147	(	CD	PERCENT	(	dep	150	SENT_77	[p6l1212t1354r1321b1397],
148	79	CD	PERCENT	79	dep	150	SENT_77	[p6l1212t1354r1321b1397],
149	%	NN	PERCENT	%	dep	150	SENT_77	[p6l1212t1354r1321b1397],
150	)	CD	NUMBER	)	_	0	SENT_77	[p6l1212t1354r1321b1397],

1	_	NN	O	_	nn	2	SENT_78	[p6l183t1435r189b1440],
2	_	NN	O	_	_	0	SENT_78	[p6l210t1435r215b1440],
3	For	IN	O	for	dep	2	SENT_78	[p6l1583t1400r1637b1431],
4	more	RBR	O	more	pobj	3	SENT_78	[p6l1649t1409r1739b1431],
5	on	IN	O	on	_	0	SENT_78	[p6l1749t1409r1792b1431],
6	CYP2C19	NN	O	cyp2c19	nn	7	SENT_78	[p6l1805t1400r1966b1436],
7	alleles	NNS	O	allele	prep_on	4	SENT_78	[p6l1976t1397r2087b1431],
8	see	VBP	O	see	rcmod	7	SENT_78	[p6l2098t1409r2152b1431],

1	Asplrm	NNP	O	Asplrm	_	0	SENT_79	[p6l110t1435r241b1479],
2	4962	CD	PERCENT	4962	number	3	SENT_79	[p6l710t1431r810b1473],
3	(	CD	PERCENT	(	dep	1	SENT_79	[p6l825t1434r934b1477],
4	97	CD	PERCENT	97	num	5	SENT_79	[p6l825t1434r934b1477],
5	%	NN	PERCENT	%	dep	3	SENT_79	[p6l825t1434r934b1477],
6	)	CD	PERCENT	)	number	7	SENT_79	[p6l825t1434r934b1477],
7	4946	CD	PERCENT	4946	dep	1	SENT_79	[p6l1095t1431r1197b1473],
8	(	CD	PERCENT	(	num	10	SENT_79	[p6l1212t1431r1325b1477],
9	96	CD	PERCENT	96	num	10	SENT_79	[p6l1212t1431r1325b1477],
10	%	NN	PERCENT	%	dep	7	SENT_79	[p6l1212t1431r1325b1477],
11	)	CD	NUMBER	)	num	12	SENT_79	[p6l1212t1431r1325b1477],
12	http://www.cypa	NN	O	http://www.cypa	dep	1	SENT_79	[p6l1583t1459r2050b1503],
13	|	CD	NUMBER	|	number	14	SENT_79	[p6l1583t1459r2050b1503],
14	|	CD	NUMBER	|	num	15	SENT_79	[p6l1583t1459r2050b1503],
15	eles	NNS	O	ele	dep	12	SENT_79	[p6l1583t1459r2050b1503],
16	.	.	O	.	_	0	SENT_79	[p6l1583t1459r2050b1503],

1	ki	NN	O	kus	_	0	SENT_80	[p6l1583t1459r2050b1503],
2	.	.	O	.	_	0	SENT_80	[p6l1583t1459r2050b1503],

1	se	FW	O	se	dep	9	SENT_81	[p6l1583t1459r2050b1503],
2	Open	NNP	MISC	Open	nn	4	SENT_81	[p6l111t1511r314b1559],
3	—	CD	NUMBER	—	num	4	SENT_81	[p6l111t1511r314b1559],
4	label	NN	O	label	dep	1	SENT_81	[p6l111t1511r314b1559],
5	clopidogrel	NN	O	clopidogrel	dep	9	SENT_81	[p6l328t1511r534b1559],
6	2467	CD	DATE	2467	num	5	SENT_81	[p6l715t1511r812b1552],
7	(	CD	PERCENT	(	num	9	SENT_81	[p6l825t1511r938b1557],
8	48	CD	PERCENT	48	num	9	SENT_81	[p6l825t1511r938b1557],
9	%	NN	PERCENT	%	dep	15	SENT_81	[p6l825t1511r938b1557],
10	)	CD	NUMBER	)	number	11	SENT_81	[p6l825t1511r938b1557],
11	2486	CD	DATE	2486	dep	9	SENT_81	[p6l1098t1511r1197b1552],
12	(	CD	PERCENT	(	num	14	SENT_81	[p6l1212t1511r1324b1557],
13	48	CD	PERCENT	48	num	14	SENT_81	[p6l1212t1511r1324b1557],
14	%	NN	PERCENT	%	dep	11	SENT_81	[p6l1212t1511r1324b1557],
15	)	CD	NUMBER	)	dep	18	SENT_81	[p6l1212t1511r1324b1557],
16	Planned	NNP	O	Planned	nn	18	SENT_81	[p6l72t1591r221b1627],
17	invasive	JJ	O	invasive	amod	18	SENT_81	[p6l235t1594r383b1627],
18	treatment	NN	O	treatment	dep	27	SENT_81	[p6l393t1598r586b1627],
19	3403	CD	PERCENT	3403	num	20	SENT_81	[p6l715t1596r811b1632],
20	(	CD	PERCENT	(	dep	18	SENT_81	[p6l825t1591r939b1637],
21	66	CD	PERCENT	66	num	22	SENT_81	[p6l825t1591r939b1637],
22	%	NN	PERCENT	%	dep	20	SENT_81	[p6l825t1591r939b1637],
23	)	CD	PERCENT	)	number	24	SENT_81	[p6l825t1591r939b1637],
24	3375	CD	PERCENT	3375	num	22	SENT_81	[p6l1106t1596r1197b1632],
25	(	CD	PERCENT	(	num	27	SENT_81	[p6l1212t1591r1325b1637],
26	66	CD	PERCENT	66	num	27	SENT_81	[p6l1212t1591r1325b1637],
27	%	NN	PERCENT	%	dep	34	SENT_81	[p6l1212t1591r1325b1637],
28	)	CD	NUMBER	)	num	29	SENT_81	[p6l1212t1591r1325b1637],
29	Troponin	NN	MISC	troponin	dep	27	SENT_81	[p6l69t1674r241b1718],
30	positive	JJ	O	positive	amod	29	SENT_81	[p6l254t1674r401b1718],
31	4149	CD	PERCENT	4149	tmod	30	SENT_81	[p6l713t1676r811b1712],
32	(	CD	PERCENT	(	num	34	SENT_81	[p6l825t1671r934b1716],
33	81	CD	PERCENT	81	num	34	SENT_81	[p6l825t1671r934b1716],
34	%	NN	PERCENT	%	dep	40	SENT_81	[p6l825t1671r934b1716],
35	)	CD	PERCENT	)	number	36	SENT_81	[p6l825t1671r934b1716],
36	4199	CD	PERCENT	4199	dep	34	SENT_81	[p6l1099t1676r1197b1712],
37	(	CD	PERCENT	(	num	39	SENT_81	[p6l1212t1671r1322b1717],
38	82	CD	PERCENT	82	num	39	SENT_81	[p6l1212t1671r1322b1717],
39	%	NN	PERCENT	%	dep	36	SENT_81	[p6l1212t1671r1322b1717],
40	)	CD	NUMBER	)	_	0	SENT_81	[p6l1212t1671r1322b1717],

1	Data	NNS	O	datum	nsubj	6	SENT_82	[p6l52t1793r130b1823],
2	are	VBP	O	be	cop	6	SENT_82	[p6l141t1801r193b1823],
3	mean	JJ	O	mean	amod	6	SENT_82	[p6l206t1801r300b1823],
4	(	JJ	O	(	amod	6	SENT_82	[p6l314t1791r386b1832],
5	SD	NN	O	sd	nn	6	SENT_82	[p6l314t1791r386b1832],
6	)	NN	O	)	_	0	SENT_82	[p6l314t1791r386b1832],
7	or	CC	O	or	_	0	SENT_82	[p6l398t1801r433b1823],
8	number	NN	O	number	conj_or	6	SENT_82	[p6l445t1790r582b1823],
9	(	CD	PERCENT	(	num	10	SENT_82	[p6l593t1791r658b1832],
10	%	NN	PERCENT	%	dep	8	SENT_82	[p6l593t1791r658b1832],
11	)	CD	NUMBER	)	dep	8	SENT_82	[p6l593t1791r658b1832],
12	.	.	O	.	_	0	SENT_82	[p6l593t1791r658b1832],

1	Table	NNP	O	Table	_	0	SENT_83	[p6l50t1900r149b1937],
2	1	CD	NUMBER	1	num	1	SENT_83	[p6l161t1906r193b1937],
3	:	:	O	:	_	0	SENT_83	[p6l161t1906r193b1937],
4	Selected	VBN	O	select	dep	1	SENT_83	[p6l205t1901r370b1937],
5	characteristics	NNS	O	characteristic	dobj	4	SENT_83	[p6l381t1901r666b1937],
6	at	IN	O	at	_	0	SENT_83	[p6l677t1907r716b1937],
7	baseline	NN	O	baseline	prep_at	4	SENT_83	[p6l728t1901r889b1937],
8	for	IN	O	for	_	0	SENT_83	[p6l899t1900r957b1937],
9	the	DT	O	the	det	12	SENT_83	[p6l965t1901r1031b1937],
10	genetic	JJ	O	genetic	amod	12	SENT_83	[p6l1043t1902r1189b1948],
11	substudy	JJ	O	substudy	amod	12	SENT_83	[p6l50t1964r233b2012],
12	population	NN	O	population	prep_for	4	SENT_83	[p6l243t1964r462b2012],

1	Articles	NNPS	O	Articles	dep	15	SENT_84	[p6l101t2443r251b2479],
2	appropriate	JJ	O	appropriate	amod	7	SENT_84	[p6l643t2689r945b2748],
3	C	NN	O	c	nn	7	SENT_84	[p6l971t2689r1009b2733],
4	YPZC	NN	O	ypzc	nn	7	SENT_84	[p6l1014t2689r1160b2733],
5	19	CD	NUMBER	19	num	7	SENT_84	[p6l1164t2690r1216b2733],
6	genotype	NN	O	genotype	nn	7	SENT_84	[p6l1235t2695r1472b2748],
7	groups	NNS	O	group	nsubj	8	SENT_84	[p6l1494t2702r1674b2748],
8	derived	VBN	O	derive	rcmod	1	SENT_84	[p6l1698t2685r1891b2733],
9	from	IN	O	from	_	0	SENT_84	[p6l1911t2685r2041b2733],
10	the	DT	O	the	det	12	SENT_84	[p6l2061t2685r2143b2733],
11	within-arm	NN	O	within-arm	nn	12	SENT_84	[p6l641t2761r938b2809],
12	analysis	NN	O	analysis	prep_from	8	SENT_84	[p6l965t2761r1186b2824],
13	,	,	O	,	_	0	SENT_84	[p6l965t2761r1186b2824],
14	we	PRP	O	we	nsubj	15	SENT_84	[p6l1214t2778r1287b2809],
15	did	VBD	O	do	_	0	SENT_84	[p6l1315t2761r1398b2809],
16	a	DT	O	a	det	18	SENT_84	[p6l1425t2778r1451b2809],
17	between-arm	JJ	O	between-arm	amod	18	SENT_84	[p6l1477t2761r1823b2809],
18	analysis	NN	O	analysis	dobj	15	SENT_84	[p6l1850t2761r2056b2824],
19	by	IN	O	by	_	0	SENT_84	[p6l2084t2761r2145b2824],
20	use	NN	O	use	prep_by	15	SENT_84	[p6l641t2855r731b2885],
21	of	IN	O	of	_	0	SENT_84	[p6l761t2838r820b2885],
22	phenotype	NN	O	phenotype	nn	23	SENT_84	[p6l840t2838r1115b2900],
23	groupings	NNS	O	grouping	prep_of	20	SENT_84	[p6l1146t2841r1412b2901],
24	based	VBN	O	base	_	0	SENT_84	[p6l1442t2838r1593b2885],
25	on	IN	O	on	prepc_based_on	15	SENT_84	[p6l1622t2855r1688b2885],
26	the	DT	O	the	det	27	SENT_84	[p6l1716t2838r1798b2885],
27	presence	NN	O	presence	pobj	15	SENT_84	[p6l1827t2855r2061b2900],
28	or	CC	O	or	_	0	SENT_84	[p6l2091t2855r2145b2885],
29	absence	NN	O	absence	nsubj	33	SENT_84	[p6l643t2913r850b2961],
30	of	IN	O	of	_	0	SENT_84	[p6l887t2913r945b2961],
31	loss-of-function	JJ	O	loss-of-function	amod	32	SENT_84	[p6l970t2913r1382b2961],
32	alleles	NNS	O	allele	prep_of	29	SENT_84	[p6l1418t2913r1578b2961],
33	(	VBP	O	(	conj_or	15	SENT_84	[p6l1619t2916r1692b2976],
34	ie	FW	O	ie	dobj	33	SENT_84	[p6l1619t2916r1692b2976],
35	,	,	O	,	_	0	SENT_84	[p6l1619t2916r1692b2976],
36	extensive	JJ	O	extensive	amod	39	SENT_84	[p6l1730t2916r1984b2968],
37	,	,	O	,	_	0	SENT_84	[p6l1730t2916r1984b2968],
38	ultra	JJ	O	ultra	amod	39	SENT_84	[p6l2021t2913r2144b2961],
39	rapid	JJ	O	rapid	amod	34	SENT_84	[p6l642t2989r791b3051],
40	,	,	O	,	_	0	SENT_84	[p6l642t2989r791b3051],
41	and	CC	O	and	_	0	SENT_84	[p6l817t2989r914b3037],
42	rapid	JJ	O	rapid	amod	43	SENT_84	[p6l935t2989r1072b3051],
43	heterozygote	NN	O	heterozygote	amod	34	SENT_84	[p6l1092t2989r1429b3052],
44	vs	CC	O	vs	_	0	SENT_84	[p6l1452t3006r1498b3036],
45	intermediate	JJ	O	intermediate	dep	50	SENT_84	[p6l1519t2989r1870b3044],
46	,	,	O	,	_	0	SENT_84	[p6l1519t2989r1870b3044],
47	poor	JJ	O	poor	conj_and	50	SENT_84	[p6l1894t3006r2022b3051],
48	,	,	O	,	_	0	SENT_84	[p6l1894t3006r2022b3051],
49	and	CC	O	and	_	0	SENT_84	[p6l2048t2989r2145b3037],
50	poor	JJ	O	poor	amod	54	SENT_84	[p6l642t3083r763b3128],
51	or	CC	O	or	_	0	SENT_84	[p6l786t3083r839b3113],
52	rapid	JJ	O	rapid	amod	54	SENT_84	[p6l862t3066r999b3128],
53	heterozygote	NN	O	heterozygote	nn	54	SENT_84	[p6l1020t3066r1373b3129],
54	)	NN	O	)	conj_vs	34	SENT_84	[p6l1020t3066r1373b3129],
55	to	TO	O	to	aux	56	SENT_84	[p6l1400t3075r1448b3113],
56	allow	VB	O	allow	xcomp	33	SENT_84	[p6l1473t3066r1611b3113],
57	direct	JJ	O	direct	amod	58	SENT_84	[p6l1634t3066r1782b3113],
58	comparisons	NNS	O	comparison	dobj	56	SENT_84	[p6l1805t3069r2142b3128],
59	with	IN	O	with	_	0	SENT_84	[p6l641t3141r758b3189],
60	previous	JJ	O	previous	amod	61	SENT_84	[p6l806t3144r1030b3203],
61	reports	NNS	O	report	prep_with	56	SENT_84	[p6l1080t3145r1337b3203],
62	.	.	O	.	_	0	SENT_84	[p6l1080t3145r1337b3203],

1	”	NN	O	”	npadvmod	9	SENT_85	[p6l1080t3145r1337b3203],
2	For	IN	O	for	_	0	SENT_85	[p6l1389t3144r1475b3189],
3	the	DT	O	the	det	5	SENT_85	[p6l1522t3141r1604b3189],
4	ABCB1	NN	O	abcb1	nn	5	SENT_85	[p6l1653t3145r1842b3189],
5	genotype	NN	O	genotype	prep_for	9	SENT_85	[p6l1891t3151r2141b3204],
6	,	,	O	,	_	0	SENT_85	[p6l1891t3151r2141b3204],
7	patients	NNS	O	patient	nsubjpass	9	SENT_85	[p6l642t3220r849b3279],
8	were	VBD	O	be	auxpass	9	SENT_85	[p6l884t3234r1010b3265],
9	stratiﬁed	VBN	O	stratiﬁed	_	0	SENT_85	[p6l1047t3217r1279b3265],
10	by	IN	O	by	_	0	SENT_85	[p6l1312t3217r1373b3280],
11	predicted	VBN	O	predict	amod	13	SENT_85	[p6l1407t3217r1653b3279],
12	gene	NN	O	gene	nn	13	SENT_85	[p6l1688t3234r1811b3280],
13	expression	NN	O	expression	agent	9	SENT_85	[p6l1847t3220r2141b3279],
14	:	:	O	:	_	0	SENT_85	[p6l1847t3220r2141b3279],
15	high	JJ	O	high	amod	16	SENT_85	[p6l641t3294r762b3357],
16	(	NN	O	(	dep	9	SENT_85	[p6l784t3297r859b3357],
17	C	NN	O	c	dep	16	SENT_85	[p6l784t3297r859b3357],
18	/	:	O	/	punct	16	SENT_85	[p6l784t3297r859b3357],
19	C	NN	O	c	nn	20	SENT_85	[p6l865t3297r936b3357],
20	)	NN	O	)	dep	16	SENT_85	[p6l865t3297r936b3357],
21	,	,	O	,	_	0	SENT_85	[p6l865t3297r936b3357],
22	intermediate	JJ	O	intermediate	amod	25	SENT_85	[p6l957t3294r1294b3341],
23	(	NN	O	(	nn	25	SENT_85	[p6l1316t3297r1465b3357],
24	C/T	NN	O	c/t	nn	25	SENT_85	[p6l1316t3297r1465b3357],
25	)	NN	O	)	conj_and	20	SENT_85	[p6l1316t3297r1465b3357],
26	,	,	O	,	_	0	SENT_85	[p6l1316t3297r1465b3357],
27	and	CC	O	and	_	0	SENT_85	[p6l1486t3294r1583b3341],
28	low	JJ	O	low	amod	31	SENT_85	[p6l1599t3294r1693b3341],
29	(	NN	O	(	nn	31	SENT_85	[p6l1714t3297r1853b3357],
30	T/T	NN	O	t/t	nn	31	SENT_85	[p6l1714t3297r1853b3357],
31	)	NN	O	)	conj_and	20	SENT_85	[p6l1714t3297r1853b3357],
32	.	.	O	.	_	0	SENT_85	[p6l1714t3297r1853b3357],

1	This	DT	O	this	det	2	SENT_86	[p6l691t3369r805b3417],
2	substudy	NN	O	substudy	nsubjpass	8	SENT_86	[p6l824t3369r1057b3432],
3	was	VBD	O	be	auxpass	6	SENT_86	[p6l1070t3386r1166b3417],
4	not	RB	O	not	neg	6	SENT_86	[p6l1184t3379r1269b3417],
5	prospectively	RB	O	prospectively	advmod	6	SENT_86	[p6l1283t3369r1622b3432],
6	powered	VBN	O	power	_	0	SENT_86	[p6l1636t3369r1859b3431],
7	and	CC	O	and	_	0	SENT_86	[p6l1874t3369r1970b3417],
8	had	VBD	O	have	conj_and	6	SENT_86	[p6l1984t3369r2081b3417],
9	to	TO	O	to	aux	11	SENT_86	[p6l2095t3379r2143b3417],
10	be	VB	O	be	auxpass	11	SENT_86	[p6l641t3445r701b3493],
11	based	VBN	O	base	xcomp	8	SENT_86	[p6l716t3445r865b3493],
12	on	IN	O	on	_	0	SENT_86	[p6l881t3462r946b3493],
13	the	DT	O	the	det	15	SENT_86	[p6l960t3445r1041b3493],
14	maximum	NN	O	maximum	nn	15	SENT_86	[p6l1057t3448r1330b3493],
15	number	NN	O	number	prep_on	11	SENT_86	[p6l1345t3445r1557b3493],
16	of	IN	O	of	_	0	SENT_86	[p6l1572t3445r1630b3493],
17	patients	NNS	O	patient	prep_of	15	SENT_86	[p6l1636t3448r1840b3507],
18	consenting	VBG	O	consent	partmod	17	SENT_86	[p6l1857t3448r2144b3508],
19	to	TO	O	to	aux	20	SENT_86	[p6l641t3531r689b3569],
20	provide	VB	O	provide	xcomp	18	SENT_86	[p6l706t3522r898b3584],
21	a	DT	O	a	det	23	SENT_86	[p6l916t3539r942b3569],
22	blood	NN	O	blood	nn	23	SENT_86	[p6l956t3522r1102b3569],
23	sample	NN	O	sample	dobj	20	SENT_86	[p6l1118t3522r1303b3584],
24	for	IN	O	for	_	0	SENT_86	[p6l1319t3522r1393b3569],
25	genetic	JJ	O	genetic	amod	26	SENT_86	[p6l1409t3525r1594b3585],
26	analysis	NN	O	analysis	prep_for	20	SENT_86	[p6l1611t3522r1827b3584],
27	.	.	O	.	_	0	SENT_86	[p6l1611t3522r1827b3584],

1	As	IN	O	as	mark	4	SENT_87	[p6l1844t3525r1910b3569],
2	analyses	NNS	O	analysis	nsubjpass	4	SENT_87	[p6l1929t3522r2142b3584],
3	were	VBD	O	be	auxpass	4	SENT_87	[p6l641t3614r765b3645],
4	based	VBN	O	base	advcl	19	SENT_87	[p6l790t3597r939b3645],
5	on	IN	O	on	_	0	SENT_87	[p6l965t3614r1031b3645],
6	a	DT	O	a	det	8	SENT_87	[p6l1057t3614r1083b3645],
7	data-driven	JJ	O	data-driven	amod	8	SENT_87	[p6l1110t3597r1399b3645],
8	approach	NN	O	approach	prep_on	4	SENT_87	[p6l1425t3597r1677b3659],
9	,	,	O	,	_	0	SENT_87	[p6l1425t3597r1677b3659],
10	the	DT	O	the	det	11	SENT_87	[p6l1704t3597r1785b3645],
11	number	NN	O	number	nsubj	19	SENT_87	[p6l1812t3597r2023b3645],
12	and	CC	O	and	_	0	SENT_87	[p6l2049t3597r2145b3645],
13	size	NN	O	size	nsubj	19	SENT_87	[p6l644t3676r741b3721],
14	of	IN	O	of	_	0	SENT_87	[p6l782t3673r840b3721],
15	the	DT	O	the	det	17	SENT_87	[p6l869t3673r950b3721],
16	ﬁnal	JJ	O	ﬁnal	amod	17	SENT_87	[p6l990t3673r1106b3721],
17	groupings	NNS	O	grouping	prep_of	11	SENT_87	[p6l1146t3676r1409b3736],
18	were	VBD	O	be	cop	19	SENT_87	[p6l1448t3690r1572b3721],
19	unknown	JJ	O	unknown	_	0	SENT_87	[p6l1611t3673r1862b3721],
20	until	IN	O	until	mark	24	SENT_87	[p6l1901t3673r2024b3721],
21	the	DT	O	the	det	22	SENT_87	[p6l2062t3673r2143b3721],
22	analyses	NNS	O	analysis	nsubj	24	SENT_87	[p6l643t3749r856b3812],
23	were	VBD	O	be	cop	24	SENT_87	[p6l898t3766r1022b3797],
24	complete	JJ	O	complete	advcl	19	SENT_87	[p6l1065t3749r1314b3812],
25	.	.	O	.	_	0	SENT_87	[p6l1065t3749r1314b3812],

1	For	IN	O	for	_	0	SENT_88	[p6l1361t3752r1446b3797],
2	the	DT	O	the	det	5	SENT_88	[p6l1486t3749r1567b3797],
3	C	NN	O	c	nn	5	SENT_88	[p6l1613t3753r1652b3797],
4	YPZCI9	NN	O	ypzci9	nn	5	SENT_88	[p6l1656t3753r1856b3797],
5	genotype	NN	O	genotype	pobj	1	SENT_88	[p6l1895t3759r2141b3812],
6	,	,	O	,	_	0	SENT_88	[p6l1895t3759r2141b3812],

1	892	CD	NUMBER	892	num	4	SENT_89	[p7l643t18r732b61],
2	primary	JJ	O	primary	amod	4	SENT_89	[p7l749t16r958b76],
3	outcome	NN	O	outcome	nn	4	SENT_89	[p7l973t23r1198b61],
4	events	NNS	O	event	nsubj	5	SENT_89	[p7l1215t23r1376b61],
5	occurred	VBD	O	occur	_	0	SENT_89	[p7l1395t13r1622b61],
6	in	IN	O	in	_	0	SENT_89	[p7l1637t16r1689b60],
7	the	DT	O	the	det	10	SENT_89	[p7l1704t13r1785b61],
8	two	CD	NUMBER	two	num	10	SENT_89	[p7l1801t23r1893b61],
9	genotype	NN	O	genotype	nn	10	SENT_89	[p7l1910t23r2143b76],
10	groups	NNS	O	group	prep_in	5	SENT_89	[p7l643t106r834b152],
11	:	:	O	:	_	0	SENT_89	[p7l643t106r834b152],
12	264	CD	NUMBER	264	dep	10	SENT_89	[p7l852t93r942b136],
13	in	IN	O	in	_	0	SENT_89	[p7l952t92r1004b136],
14	the	DT	O	the	det	15	SENT_89	[p7l1016t89r1097b137],
15	group	NN	O	group	prep_in	12	SENT_89	[p7l1112t106r1264b152],
16	with	IN	O	with	_	0	SENT_89	[p7l1277t89r1392b137],
17	and	CC	O	and	cc	18	SENT_89	[p7l1406t89r1502b137],
18	628	CD	NUMBER	628	prep_with	5	SENT_89	[p7l1515t93r1605b137],
19	in	IN	O	in	_	0	SENT_89	[p7l1619t92r1671b136],
20	the	DT	O	the	det	21	SENT_89	[p7l1683t89r1764b137],
21	group	NN	O	group	prep_in	18	SENT_89	[p7l1779t106r1931b152],
22	Without	IN	O	without	_	0	SENT_89	[p7l1944t89r2145b137],
23	any	DT	O	any	det	25	SENT_89	[p7l643t182r734b228],
24	loss-of-function	JJ	O	loss-of-function	amod	25	SENT_89	[p7l750t165r1154b213],
25	allele	NN	O	allele	prep_without	5	SENT_89	[p7l1173t165r1318b213],
26	.	.	O	.	_	0	SENT_89	[p7l1173t165r1318b213],

1	These	DT	O	these	det	2	SENT_90	[p7l1338t165r1493b213],
2	numbers	NNS	O	number	nsubj	15	SENT_90	[p7l1511t165r1746b213],
3	of	IN	O	of	_	0	SENT_90	[p7l1766t165r1824b213],
4	events	NNS	O	event	prep_of	2	SENT_90	[p7l1834t175r2010b221],
5	,	,	O	,	_	0	SENT_90	[p7l1834t175r2010b221],
6	with	IN	O	with	_	0	SENT_90	[p7l2029t165r2144b213],
7	a	DT	O	a	det	10	SENT_90	[p7l643t258r669b289],
8	two-sided	JJ	O	two-sided	amod	10	SENT_90	[p7l691t241r940b289],
9	01	NN	NUMBER	01	nn	10	SENT_90	[p7l964t258r996b289],
10	level	NN	O	level	prep_with	2	SENT_90	[p7l1018t241r1134b289],
11	of	IN	O	of	_	0	SENT_90	[p7l1158t241r1216b289],
12	0-05	CD	NUMBER	0-05	prep_of	10	SENT_90	[p7l1230t244r1364b296],
13	,	,	O	,	_	0	SENT_90	[p7l1230t244r1364b296],
14	could	MD	O	could	aux	15	SENT_90	[p7l1390t241r1532b289],
15	detect	VB	O	detect	_	0	SENT_90	[p7l1554t241r1707b289],
16	hazard	NN	O	hazard	nn	17	SENT_90	[p7l1728t241r1906b289],
17	ratios	NNS	O	ratio	dobj	15	SENT_90	[p7l1928t244r2070b289],
18	of	IN	O	of	prep	15	SENT_90	[p7l2095t241r2153b289],

1	90	CD	NUMBER	90	num	3	SENT_91	[p7l1330t384r1381b420],
2	mg	NN	O	mg	nn	3	SENT_91	[p7l1394t390r1455b426],
3	ticagrelor	NN	O	ticagrelor	dep	18	SENT_91	[p7l1465t379r1656b426],
4	75	CD	NUMBER	75	num	6	SENT_91	[p7l1717t384r1763b420],
5	mg	NN	O	mg	nn	6	SENT_91	[p7l1778t390r1838b426],
6	clopidogrel	NN	O	clopidogrel	npadvmod	7	SENT_91	[p7l1851t378r2070b426],
7	twice	RB	O	twice	advmod	12	SENT_91	[p7l1328t440r1436b474],
8	daily	RB	SET	daily	advmod	12	SENT_91	[p7l1447t438r1542b485],
9	once	RB	DATE	once	advmod	12	SENT_91	[p7l1718t450r1810b474],
10	daily	JJ	SET	daily	amod	12	SENT_91	[p7l1821t438r1915b485],
11	(	NN	O	(	nn	12	SENT_91	[p7l1330t500r1506b543],
12	n	NN	O	n	dep	3	SENT_91	[p7l1330t500r1506b543],
13	=	JJ	O	=	amod	12	SENT_91	[p7l1330t500r1506b543],
14	5137	CD	NUMBER	5137	number	15	SENT_91	[p7l1330t500r1506b543],
15	)	CD	NUMBER	)	dep	13	SENT_91	[p7l1330t500r1506b543],
16	(	CD	NUMBER	(	num	17	SENT_91	[p7l1719t497r1900b543],
17	|	NN	O	|	dep	18	SENT_91	[p7l1719t497r1900b543],
18	1	CD	NUMBER	1	dep	21	SENT_91	[p7l1719t497r1900b543],
19	=	JJ	O	=	dep	18	SENT_91	[p7l1719t497r1900b543],
20	5143	CD	NUMBER	5143	num	21	SENT_91	[p7l1719t497r1900b543],
21	)	CD	NUMBER	)	_	0	SENT_91	[p7l1719t497r1900b543],

1	CYP2C19	NN	O	cyp2c19	dep	455	SENT_92	[p7l704t596r876b635],
2	genotype	NN	O	genotype	dep	455	SENT_92	[p7l888t599r1076b641],
3	*	NN	O	*	dep	455	SENT_92	[p7l705t674r802b714],
4	1	CD	NUMBER	1	dep	455	SENT_92	[p7l705t674r802b714],
5	/	:	O	/	dep	455	SENT_92	[p7l705t674r802b714],
6	*	CD	NUMBER	*	dep	455	SENT_92	[p7l705t674r802b714],
7	1	CD	NUMBER	1	dep	455	SENT_92	[p7l705t674r802b714],
8	1849	CD	DATE	1849	dep	455	SENT_92	[p7l1330t673r1427b714],
9	(	CD	PERCENT	(	dep	455	SENT_92	[p7l1442t673r1551b718],
10	36	CD	PERCENT	36	dep	455	SENT_92	[p7l1442t673r1551b718],
11	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1442t673r1551b718],
12	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1442t673r1551b718],
13	1862	CD	DATE	1862	dep	455	SENT_92	[p7l1719t673r1813b709],
14	(	CD	PERCENT	(	dep	455	SENT_92	[p7l1828t673r1938b718],
15	36	CD	PERCENT	36	dep	455	SENT_92	[p7l1828t673r1938b718],
16	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1828t673r1938b718],
17	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1828t673r1938b718],
18	*	CD	NUMBER	*	dep	455	SENT_92	[p7l705t754r826b793],
19	1F17	NN	O	1f17	dep	455	SENT_92	[p7l705t754r826b793],
20	1437	CD	DATE	1437	dep	455	SENT_92	[p7l1335t752r1549b798],
21	(	CD	PERCENT	(	dep	455	SENT_92	[p7l1335t752r1549b798],
22	28	CD	PERCENT	28	dep	455	SENT_92	[p7l1335t752r1549b798],
23	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1335t752r1549b798],
24	)	CD	PERCENT	)	dep	455	SENT_92	[p7l1335t752r1549b798],
25	1386	CD	PERCENT	1386	dep	455	SENT_92	[p7l1719t752r1934b797],
26	(	CD	PERCENT	(	dep	455	SENT_92	[p7l1719t752r1934b797],
27	27	CD	PERCENT	27	dep	455	SENT_92	[p7l1719t752r1934b797],
28	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1719t752r1934b797],
29	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1719t752r1934b797],
30	*	NN	O	*	dep	455	SENT_92	[p7l705t833r802b872],
31	1	CD	NUMBER	1	dep	455	SENT_92	[p7l705t833r802b872],
32	/	:	O	/	dep	455	SENT_92	[p7l705t833r802b872],
33	*	CD	NUMBER	*	dep	455	SENT_92	[p7l705t833r802b872],
34	2	CD	NUMBER	2	dep	455	SENT_92	[p7l705t833r802b872],
35	855	CD	NUMBER	855	dep	455	SENT_92	[p7l1356t831r1425b873],
36	(	NN	O	(	dep	455	SENT_92	[p7l1439t833r1543b877],
37	17	CD	PERCENT	17	dep	455	SENT_92	[p7l1439t833r1543b877],
38	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1439t833r1543b877],
39	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1439t833r1543b877],
40	898	CD	NUMBER	898	dep	455	SENT_92	[p7l1739t831r1813b873],
41	(	NN	O	(	dep	455	SENT_92	[p7l1828t834r1932b877],
42	17	CD	PERCENT	17	dep	455	SENT_92	[p7l1828t834r1932b877],
43	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1828t834r1932b877],
44	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1828t834r1932b877],
45	*	NN	O	*	dep	455	SENT_92	[p7l705t912r803b952],
46	1	CD	NUMBER	1	dep	455	SENT_92	[p7l705t912r803b952],
47	/	:	O	/	dep	455	SENT_92	[p7l705t912r803b952],
48	*	CD	NUMBER	*	dep	455	SENT_92	[p7l705t912r803b952],
49	3	CD	NUMBER	3	dep	455	SENT_92	[p7l705t912r803b952],
50	8	CD	NUMBER	8	dep	455	SENT_92	[p7l1404t911r1425b947],
51	(	NN	O	(	dep	455	SENT_92	[p7l1439t913r1545b956],
52	<	JJR	O	<	dep	455	SENT_92	[p7l1439t913r1545b956],
53	1	CD	PERCENT	1	dep	455	SENT_92	[p7l1439t913r1545b956],
54	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1439t913r1545b956],
55	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1439t913r1545b956],
56	6	CD	NUMBER	6	dep	455	SENT_92	[p7l1792t910r1814b947],
57	(	NN	O	(	dep	455	SENT_92	[p7l1828t913r1934b956],
58	<	JJR	O	<	dep	455	SENT_92	[p7l1828t913r1934b956],
59	1	CD	PERCENT	1	dep	455	SENT_92	[p7l1828t913r1934b956],
60	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1828t913r1934b956],
61	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1828t913r1934b956],
62	*	NN	O	*	dep	455	SENT_92	[p7l705t992r807b1031],
63	1	CD	NUMBER	1	dep	455	SENT_92	[p7l705t992r807b1031],
64	/	:	O	/	dep	455	SENT_92	[p7l705t992r807b1031],
65	*	CD	NUMBER	*	dep	455	SENT_92	[p7l705t992r807b1031],
66	4	CD	NUMBER	4	dep	455	SENT_92	[p7l705t992r807b1031],
67	10	CD	NUMBER	10	dep	455	SENT_92	[p7l1382t995r1426b1026],
68	(	NN	O	(	dep	455	SENT_92	[p7l1439t992r1545b1035],
69	<	JJR	O	<	dep	455	SENT_92	[p7l1439t992r1545b1035],
70	1	CD	PERCENT	1	dep	455	SENT_92	[p7l1439t992r1545b1035],
71	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1439t992r1545b1035],
72	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1439t992r1545b1035],
73	8	CD	NUMBER	8	dep	455	SENT_92	[p7l1792t990r1813b1026],
74	(	NN	O	(	dep	455	SENT_92	[p7l1828t992r1934b1035],
75	<	JJR	O	<	dep	455	SENT_92	[p7l1828t992r1934b1035],
76	1	CD	PERCENT	1	dep	455	SENT_92	[p7l1828t992r1934b1035],
77	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1828t992r1934b1035],
78	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1828t992r1934b1035],
79	*	NN	O	*	dep	455	SENT_92	[p7l705t1069r806b1110],
80	1	CD	NUMBER	1	dep	455	SENT_92	[p7l705t1069r806b1110],
81	/	:	O	/	dep	455	SENT_92	[p7l705t1069r806b1110],
82	*	CD	NUMBER	*	dep	455	SENT_92	[p7l705t1069r806b1110],
83	6	CD	NUMBER	6	dep	455	SENT_92	[p7l705t1069r806b1110],
84	o	NN	O	o	dep	455	SENT_92	[p7l1404t1074r1426b1105],
85	2	CD	NUMBER	2	dep	455	SENT_92	[p7l1794t1074r1813b1105],
86	(	NN	O	(	dep	455	SENT_92	[p7l1828t1071r1934b1114],
87	<	JJR	O	<	dep	455	SENT_92	[p7l1828t1071r1934b1114],
88	1	CD	PERCENT	1	dep	455	SENT_92	[p7l1828t1071r1934b1114],
89	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1828t1071r1934b1114],
90	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1828t1071r1934b1114],
91	*	NN	O	*	dep	455	SENT_92	[p7l705t1148r806b1189],
92	1	CD	NUMBER	1	dep	455	SENT_92	[p7l705t1148r806b1189],
93	/	:	O	/	dep	455	SENT_92	[p7l705t1148r806b1189],
94	*	CD	NUMBER	*	dep	455	SENT_92	[p7l705t1148r806b1189],
95	8	CD	NUMBER	8	dep	455	SENT_92	[p7l705t1148r806b1189],
96	21	CD	NUMBER	21	dep	455	SENT_92	[p7l1383t1154r1426b1184],
97	(	NN	O	(	dep	455	SENT_92	[p7l1439t1151r1545b1194],
98	<	JJR	O	<	dep	455	SENT_92	[p7l1439t1151r1545b1194],
99	1	CD	PERCENT	1	dep	455	SENT_92	[p7l1439t1151r1545b1194],
100	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1439t1151r1545b1194],
101	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1439t1151r1545b1194],
102	21	CD	NUMBER	21	dep	455	SENT_92	[p7l1772t1154r1815b1184],
103	(	NN	O	(	dep	455	SENT_92	[p7l1828t1151r1934b1194],
104	<	JJR	O	<	dep	455	SENT_92	[p7l1828t1151r1934b1194],
105	1	CD	PERCENT	1	dep	455	SENT_92	[p7l1828t1151r1934b1194],
106	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1828t1151r1934b1194],
107	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1828t1151r1934b1194],
108	*	CD	NUMBER	*	dep	455	SENT_92	[p7l705t1229r849b1269],
109	17	CD	NUMBER	17	dep	455	SENT_92	[p7l705t1229r849b1269],
110	/	:	O	/	dep	455	SENT_92	[p7l705t1229r849b1269],
111	*	CD	NUMBER	*	dep	455	SENT_92	[p7l705t1229r849b1269],
112	17	CD	NUMBER	17	dep	455	SENT_92	[p7l705t1229r849b1269],
113	268	CD	NUMBER	268	dep	455	SENT_92	[p7l1352t1228r1425b1264],
114	(	NN	O	(	dep	455	SENT_92	[p7l1439t1230r1522b1273],
115	5	CD	PERCENT	5	dep	455	SENT_92	[p7l1439t1230r1522b1273],
116	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1439t1230r1522b1273],
117	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1439t1230r1522b1273],
118	268	CD	NUMBER	268	dep	455	SENT_92	[p7l1741t1228r1813b1264],
119	(	NN	O	(	dep	455	SENT_92	[p7l1828t1230r1911b1273],
120	5	CD	PERCENT	5	dep	455	SENT_92	[p7l1828t1230r1911b1273],
121	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1828t1230r1911b1273],
122	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1828t1230r1911b1273],
123	*	CD	NUMBER	*	dep	455	SENT_92	[p7l705t1309r827b1348],
124	2F17	NN	O	2f17	dep	455	SENT_92	[p7l705t1309r827b1348],
125	353	CD	NUMBER	353	dep	455	SENT_92	[p7l1357t1309r1521b1353],
126	(	NN	O	(	dep	455	SENT_92	[p7l1357t1309r1521b1353],
127	7	CD	PERCENT	7	dep	455	SENT_92	[p7l1357t1309r1521b1353],
128	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1357t1309r1521b1353],
129	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1357t1309r1521b1353],
130	318	CD	NUMBER	318	dep	455	SENT_92	[p7l1745t1307r1914b1353],
131	(	NN	O	(	dep	455	SENT_92	[p7l1745t1307r1914b1353],
132	6	CD	PERCENT	6	dep	455	SENT_92	[p7l1745t1307r1914b1353],
133	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1745t1307r1914b1353],
134	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1745t1307r1914b1353],
135	*	NN	O	*	dep	455	SENT_92	[p7l705t1388r804b1427],
136	2	CD	NUMBER	2	dep	455	SENT_92	[p7l705t1388r804b1427],
137	/	:	O	/	dep	455	SENT_92	[p7l705t1388r804b1427],
138	*	CD	NUMBER	*	dep	455	SENT_92	[p7l705t1388r804b1427],
139	2	CD	NUMBER	2	dep	455	SENT_92	[p7l705t1388r804b1427],
140	114	CD	NUMBER	114	dep	455	SENT_92	[p7l1359t1391r1427b1427],
141	(	NN	O	(	dep	455	SENT_92	[p7l1439t1389r1522b1432],
142	2	CD	PERCENT	2	dep	455	SENT_92	[p7l1439t1389r1522b1432],
143	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1439t1389r1522b1432],
144	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1439t1389r1522b1432],
145	115	CD	NUMBER	115	dep	455	SENT_92	[p7l1750t1392r1813b1428],
146	(	NN	O	(	dep	455	SENT_92	[p7l1828t1389r1911b1432],
147	2	CD	PERCENT	2	dep	455	SENT_92	[p7l1828t1389r1911b1432],
148	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1828t1389r1911b1432],
149	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1828t1389r1911b1432],
150	*	NN	O	*	dep	455	SENT_92	[p7l705t1467r809b1506],
151	2	CD	NUMBER	2	dep	455	SENT_92	[p7l705t1467r809b1506],
152	/	:	O	/	dep	455	SENT_92	[p7l705t1467r809b1506],
153	*	CD	NUMBER	*	dep	455	SENT_92	[p7l705t1467r809b1506],
154	4	CD	NUMBER	4	dep	455	SENT_92	[p7l705t1467r809b1506],
155	4	CD	NUMBER	4	dep	455	SENT_92	[p7l1402t1471r1427b1506],
156	(	NN	O	(	dep	455	SENT_92	[p7l1439t1468r1545b1511],
157	<	JJR	O	<	dep	455	SENT_92	[p7l1439t1468r1545b1511],
158	1	CD	PERCENT	1	dep	455	SENT_92	[p7l1439t1468r1545b1511],
159	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1439t1468r1545b1511],
160	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1439t1468r1545b1511],
161	3	CD	NUMBER	3	dep	455	SENT_92	[p7l1794t1471r1813b1507],
162	(	NN	O	(	dep	455	SENT_92	[p7l1828t1468r1934b1511],
163	<	JJR	O	<	dep	455	SENT_92	[p7l1828t1468r1934b1511],
164	1	CD	PERCENT	1	dep	455	SENT_92	[p7l1828t1468r1934b1511],
165	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1828t1468r1934b1511],
166	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1828t1468r1934b1511],
167	*	NN	O	*	dep	455	SENT_92	[p7l705t1546r805b1586],
168	2	CD	NUMBER	2	dep	455	SENT_92	[p7l705t1546r805b1586],
169	/	:	O	/	dep	455	SENT_92	[p7l705t1546r805b1586],
170	*	CD	NUMBER	*	dep	455	SENT_92	[p7l705t1546r805b1586],
171	5	CD	NUMBER	5	dep	455	SENT_92	[p7l705t1546r805b1586],
172	o	NN	O	o	dep	455	SENT_92	[p7l1404t1550r1426b1581],
173	1	CD	NUMBER	1	dep	455	SENT_92	[p7l1796t1550r1815b1581],
174	(	NN	O	(	dep	455	SENT_92	[p7l1828t1547r1934b1590],
175	<	JJR	O	<	dep	455	SENT_92	[p7l1828t1547r1934b1590],
176	1	CD	PERCENT	1	dep	455	SENT_92	[p7l1828t1547r1934b1590],
177	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1828t1547r1934b1590],
178	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1828t1547r1934b1590],
179	*	NN	O	*	dep	455	SENT_92	[p7l705t1624r807b1665],
180	2	CD	NUMBER	2	dep	455	SENT_92	[p7l705t1624r807b1665],
181	/	:	O	/	dep	455	SENT_92	[p7l705t1624r807b1665],
182	*	CD	NUMBER	*	dep	455	SENT_92	[p7l705t1624r807b1665],
183	8	CD	NUMBER	8	dep	455	SENT_92	[p7l705t1624r807b1665],
184	3	CD	NUMBER	3	dep	455	SENT_92	[p7l1405t1629r1425b1666],
185	(	NN	O	(	dep	455	SENT_92	[p7l1439t1626r1545b1670],
186	<	JJR	O	<	dep	455	SENT_92	[p7l1439t1626r1545b1670],
187	1	CD	PERCENT	1	dep	455	SENT_92	[p7l1439t1626r1545b1670],
188	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1439t1626r1545b1670],
189	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1439t1626r1545b1670],
190	6	CD	NUMBER	6	dep	455	SENT_92	[p7l1792t1624r1814b1660],
191	(	NN	O	(	dep	455	SENT_92	[p7l1828t1627r1934b1670],
192	<	JJR	O	<	dep	455	SENT_92	[p7l1828t1627r1934b1670],
193	1	CD	PERCENT	1	dep	455	SENT_92	[p7l1828t1627r1934b1670],
194	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1828t1627r1934b1670],
195	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1828t1627r1934b1670],
196	*	NN	O	*	dep	455	SENT_92	[p7l705t1705r827b1745],
197	3	CD	NUMBER	3	dep	455	SENT_92	[p7l705t1705r827b1745],
198	/	:	O	/	dep	455	SENT_92	[p7l705t1705r827b1745],
199	*	CD	NUMBER	*	dep	455	SENT_92	[p7l705t1705r827b1745],
200	17	CD	NUMBER	17	dep	455	SENT_92	[p7l705t1705r827b1745],
201	1	CD	NUMBER	1	dep	455	SENT_92	[p7l1407t1709r1426b1739],
202	(	NN	O	(	dep	455	SENT_92	[p7l1439t1706r1545b1749],
203	<	JJR	O	<	dep	455	SENT_92	[p7l1439t1706r1545b1749],
204	1	CD	PERCENT	1	dep	455	SENT_92	[p7l1439t1706r1545b1749],
205	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1439t1706r1545b1749],
206	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1439t1706r1545b1749],
207	1	CD	NUMBER	1	dep	455	SENT_92	[p7l1796t1709r1815b1739],
208	(	NN	O	(	dep	455	SENT_92	[p7l1828t1706r1934b1749],
209	<	JJR	O	<	dep	455	SENT_92	[p7l1828t1706r1934b1749],
210	1	CD	PERCENT	1	dep	455	SENT_92	[p7l1828t1706r1934b1749],
211	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1828t1706r1934b1749],
212	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1828t1706r1934b1749],
213	*	NN	O	*	dep	455	SENT_92	[p7l705t1784r830b1824],
214	4	CD	NUMBER	4	dep	455	SENT_92	[p7l705t1784r830b1824],
215	/	:	O	/	dep	455	SENT_92	[p7l705t1784r830b1824],
216	*	CD	NUMBER	*	dep	455	SENT_92	[p7l705t1784r830b1824],
217	17	CD	NUMBER	17	dep	455	SENT_92	[p7l705t1784r830b1824],
218	o	NN	O	o	dep	455	SENT_92	[p7l1404t1788r1426b1819],
219	1	CD	NUMBER	1	dep	455	SENT_92	[p7l1796t1788r1815b1818],
220	(	NN	O	(	dep	455	SENT_92	[p7l1828t1785r1934b1828],
221	<	JJR	O	<	dep	455	SENT_92	[p7l1828t1785r1934b1828],
222	1	CD	PERCENT	1	dep	455	SENT_92	[p7l1828t1785r1934b1828],
223	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1828t1785r1934b1828],
224	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1828t1785r1934b1828],
225	*	NN	O	*	dep	455	SENT_92	[p7l705t1862r830b1903],
226	8	CD	NUMBER	8	dep	455	SENT_92	[p7l705t1862r830b1903],
227	/	:	O	/	dep	455	SENT_92	[p7l705t1862r830b1903],
228	*	CD	NUMBER	*	dep	455	SENT_92	[p7l705t1862r830b1903],
229	17	CD	NUMBER	17	dep	455	SENT_92	[p7l705t1862r830b1903],
230	15	CD	NUMBER	15	dep	455	SENT_92	[p7l1383t1867r1425b1903],
231	(	NN	O	(	dep	455	SENT_92	[p7l1439t1864r1545b1908],
232	<	JJR	O	<	dep	455	SENT_92	[p7l1439t1864r1545b1908],
233	1	CD	PERCENT	1	dep	455	SENT_92	[p7l1439t1864r1545b1908],
234	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1439t1864r1545b1908],
235	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1439t1864r1545b1908],
236	8	CD	NUMBER	8	dep	455	SENT_92	[p7l1792t1862r1813b1898],
237	(	NN	O	(	dep	455	SENT_92	[p7l1828t1864r1934b1908],
238	<	JJR	O	<	dep	455	SENT_92	[p7l1828t1864r1934b1908],
239	1	CD	PERCENT	1	dep	455	SENT_92	[p7l1828t1864r1934b1908],
240	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1828t1864r1934b1908],
241	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1828t1864r1934b1908],
242	Missing	VBG	O	miss	dep	455	SENT_92	[p7l705t1945r845b1989],
243	199	CD	PERCENT	199	dep	455	SENT_92	[p7l1354t1946r1425b1983],
244	(	CD	PERCENT	(	dep	455	SENT_92	[p7l1439t1944r1525b1987],
245	4	CD	PERCENT	4	dep	455	SENT_92	[p7l1439t1944r1525b1987],
246	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1439t1944r1525b1987],
247	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1439t1944r1525b1987],
248	244	CD	NUMBER	244	dep	455	SENT_92	[p7l1742t1946r1816b1982],
249	(	NN	O	(	dep	455	SENT_92	[p7l1828t1944r1911b1987],
250	5	CD	PERCENT	5	dep	455	SENT_92	[p7l1828t1944r1911b1987],
251	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1828t1944r1911b1987],
252	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1828t1944r1911b1987],
253	CYP2C	NN	O	cyp2c	dep	455	SENT_92	[p7l704t2024r827b2057],
254	19	CD	NUMBER	19	dep	455	SENT_92	[p7l830t2026r876b2063],
255	predicted	VBD	O	predict	dep	455	SENT_92	[p7l887t2021r1076b2068],
256	phenotype	NN	O	phenotype	dep	455	SENT_92	[p7l1086t2021r1302b2068],
257	Extensive	JJ	O	extensive	dep	455	SENT_92	[p7l706t2104r881b2136],
258	(	NN	O	(	dep	455	SENT_92	[p7l894t2102r1021b2146],
259	*	NN	O	*	dep	455	SENT_92	[p7l894t2102r1021b2146],
260	1	CD	NUMBER	1	dep	455	SENT_92	[p7l894t2102r1021b2146],
261	/	:	O	/	dep	455	SENT_92	[p7l894t2102r1021b2146],
262	*	CD	NUMBER	*	dep	455	SENT_92	[p7l894t2102r1021b2146],
263	1	CD	NUMBER	1	dep	455	SENT_92	[p7l894t2102r1021b2146],
264	)	CD	NUMBER	)	dep	455	SENT_92	[p7l894t2102r1021b2146],
265	1849	CD	DATE	1849	dep	455	SENT_92	[p7l1330t2100r1427b2142],
266	(	CD	PERCENT	(	dep	455	SENT_92	[p7l1442t2100r1551b2146],
267	36	CD	PERCENT	36	dep	455	SENT_92	[p7l1442t2100r1551b2146],
268	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1442t2100r1551b2146],
269	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1442t2100r1551b2146],
270	1862	CD	DATE	1862	dep	455	SENT_92	[p7l1719t2100r1813b2136],
271	(	CD	PERCENT	(	dep	455	SENT_92	[p7l1828t2100r1938b2146],
272	36	CD	PERCENT	36	dep	455	SENT_92	[p7l1828t2100r1938b2146],
273	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1828t2100r1938b2146],
274	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1828t2100r1938b2146],
275	See	VB	O	see	dep	455	SENT_92	[p7l90t2191r148b2222],
276	Online	NNP	O	Online	dep	455	SENT_92	[p7l160t2188r278b2221],
277	for	IN	O	for	dep	455	SENT_92	[p7l287t2188r338b2222],
278	webappendix	JJ	O	webappendix	dep	455	SENT_92	[p7l346t2188r581b2232],
279	lntermedlate	JJ	O	lntermedlate	dep	455	SENT_92	[p7l706t2180r946b2216],
280	(	NN	O	(	dep	455	SENT_92	[p7l960t2180r1154b2225],
281	*	NN	O	*	dep	455	SENT_92	[p7l960t2180r1154b2225],
282	1	CD	NUMBER	1	dep	455	SENT_92	[p7l960t2180r1154b2225],
283	/	:	O	/	dep	455	SENT_92	[p7l960t2180r1154b2225],
284	*	CD	NUMBER	*	dep	455	SENT_92	[p7l960t2180r1154b2225],
285	2	LS	NUMBER	2	dep	455	SENT_92	[p7l960t2180r1154b2225],
286	-	:	O	-	_	0	SENT_92	[p7l960t2180r1154b2225],
287	*	NN	O	*	dep	455	SENT_92	[p7l960t2180r1154b2225],
288	8	CD	NUMBER	8	dep	455	SENT_92	[p7l960t2180r1154b2225],
289	)	NN	O	)	dep	455	SENT_92	[p7l960t2180r1154b2225],
290	894	CD	NUMBER	894	dep	455	SENT_92	[p7l1351t2180r1427b2221],
291	(	NN	O	(	dep	455	SENT_92	[p7l1439t2182r1543b2225],
292	17	CD	PERCENT	17	dep	455	SENT_92	[p7l1439t2182r1543b2225],
293	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1439t2182r1543b2225],
294	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1439t2182r1543b2225],
295	935	CD	NUMBER	935	dep	455	SENT_92	[p7l1745t2185r1813b2221],
296	(	NN	O	(	dep	455	SENT_92	[p7l1828t2180r1936b2225],
297	18	CD	PERCENT	18	dep	455	SENT_92	[p7l1828t2180r1936b2225],
298	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1828t2180r1936b2225],
299	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1828t2180r1936b2225],
300	Poor	NNP	O	Poor	dep	455	SENT_92	[p7l706t2262r791b2295],
301	(	CD	NUMBER	(	dep	455	SENT_92	[p7l803t2259r1064b2305],
302	*	NN	O	*	dep	455	SENT_92	[p7l803t2259r1064b2305],
303	2	CD	NUMBER	2	dep	455	SENT_92	[p7l803t2259r1064b2305],
304	—	CD	NUMBER	—	dep	455	SENT_92	[p7l803t2259r1064b2305],
305	*	NN	O	*	dep	455	SENT_92	[p7l803t2259r1064b2305],
306	8	CD	NUMBER	8	dep	455	SENT_92	[p7l803t2259r1064b2305],
307	/	:	O	/	dep	455	SENT_92	[p7l803t2259r1064b2305],
308	*	CD	NUMBER	*	dep	455	SENT_92	[p7l803t2259r1064b2305],
309	2	CD	NUMBER	2	dep	455	SENT_92	[p7l803t2259r1064b2305],
310	—	CD	NUMBER	—	dep	455	SENT_92	[p7l803t2259r1064b2305],
311	*	NN	O	*	dep	455	SENT_92	[p7l803t2259r1064b2305],
312	8	CD	NUMBER	8	dep	455	SENT_92	[p7l803t2259r1064b2305],
313	)	NN	O	)	dep	455	SENT_92	[p7l803t2259r1064b2305],
314	121	CD	NUMBER	121	dep	455	SENT_92	[p7l1361t2264r1426b2295],
315	(	NN	O	(	dep	455	SENT_92	[p7l1439t2261r1522b2304],
316	2	CD	PERCENT	2	dep	455	SENT_92	[p7l1439t2261r1522b2304],
317	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1439t2261r1522b2304],
318	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1439t2261r1522b2304],
319	125	CD	NUMBER	125	dep	455	SENT_92	[p7l1748t2264r1813b2300],
320	(	NN	O	(	dep	455	SENT_92	[p7l1828t2261r1911b2304],
321	2	CD	PERCENT	2	dep	455	SENT_92	[p7l1828t2261r1911b2304],
322	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1828t2261r1911b2304],
323	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1828t2261r1911b2304],
324	Poor	NNP	O	Poor	dep	455	SENT_92	[p7l706t2342r791b2374],
325	or	CC	O	or	dep	455	SENT_92	[p7l801t2351r839b2374],
326	rapid	JJ	O	rapid	dep	455	SENT_92	[p7l852t2338r944b2385],
327	heterozygote	NN	O	heterozygote	dep	455	SENT_92	[p7l957t2338r1204b2386],
328	369	CD	NUMBER	369	dep	455	SENT_92	[p7l1352t2338r1425b2380],
329	(	NN	O	(	dep	455	SENT_92	[p7l1439t2340r1521b2384],
330	7	CD	PERCENT	7	dep	455	SENT_92	[p7l1439t2340r1521b2384],
331	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1439t2340r1521b2384],
332	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1439t2340r1521b2384],
333	328	CD	NUMBER	328	dep	455	SENT_92	[p7l1743t2338r1813b2379],
334	(	NN	O	(	dep	455	SENT_92	[p7l1828t2338r1914b2384],
335	6	CD	PERCENT	6	dep	455	SENT_92	[p7l1828t2338r1914b2384],
336	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1828t2338r1914b2384],
337	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1828t2338r1914b2384],
338	(	CD	NUMBER	(	dep	455	SENT_92	[p7l705t2398r922b2443],
339	*	NN	O	*	dep	455	SENT_92	[p7l705t2398r922b2443],
340	2	CD	NUMBER	2	dep	455	SENT_92	[p7l705t2398r922b2443],
341	-	:	O	-	_	0	SENT_92	[p7l705t2398r922b2443],
342	*	CD	NUMBER	*	dep	455	SENT_92	[p7l705t2398r922b2443],
343	8	CD	NUMBER	8	dep	455	SENT_92	[p7l705t2398r922b2443],
344	/	:	O	/	dep	455	SENT_92	[p7l705t2398r922b2443],
345	*	CD	NUMBER	*	dep	455	SENT_92	[p7l705t2398r922b2443],
346	17	CD	NUMBER	17	dep	455	SENT_92	[p7l705t2398r922b2443],
347	)	CD	NUMBER	)	dep	455	SENT_92	[p7l705t2398r922b2443],
348	Rapid	JJ	O	rapid	dep	455	SENT_92	[p7l706t2477r808b2524],
349	heterozygote	NN	O	heterozygote	dep	455	SENT_92	[p7l821t2477r1068b2525],
350	(	CD	NUMBER	(	dep	455	SENT_92	[p7l1082t2479r1231b2523],
351	*	NN	O	*	dep	455	SENT_92	[p7l1082t2479r1231b2523],
352	1	CD	NUMBER	1	dep	455	SENT_92	[p7l1082t2479r1231b2523],
353	/	:	O	/	dep	455	SENT_92	[p7l1082t2479r1231b2523],
354	*	CD	NUMBER	*	dep	455	SENT_92	[p7l1082t2479r1231b2523],
355	17	CD	NUMBER	17	dep	455	SENT_92	[p7l1082t2479r1231b2523],
356	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1082t2479r1231b2523],
357	1437	CD	DATE	1437	dep	455	SENT_92	[p7l1335t2482r1427b2519],
358	(	CD	PERCENT	(	dep	455	SENT_92	[p7l1439t2477r1549b2523],
359	28	CD	PERCENT	28	dep	455	SENT_92	[p7l1439t2477r1549b2523],
360	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1439t2477r1549b2523],
361	)	CD	PERCENT	)	dep	455	SENT_92	[p7l1439t2477r1549b2523],
362	1386	CD	PERCENT	1386	dep	455	SENT_92	[p7l1719t2477r1814b2519],
363	(	CD	PERCENT	(	dep	455	SENT_92	[p7l1828t2480r1934b2523],
364	27	CD	PERCENT	27	dep	455	SENT_92	[p7l1828t2480r1934b2523],
365	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1828t2480r1934b2523],
366	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1828t2480r1934b2523],
367	Ultra	NNP	O	Ultra	dep	455	SENT_92	[p7l706t2557r795b2593],
368	rapid	JJ	O	rapid	dep	455	SENT_92	[p7l809t2557r900b2603],
369	(	NN	O	(	dep	455	SENT_92	[p7l913t2558r1085b2602],
370	*	NN	O	*	dep	455	SENT_92	[p7l913t2558r1085b2602],
371	17	CD	NUMBER	17	dep	455	SENT_92	[p7l913t2558r1085b2602],
372	/	:	O	/	dep	455	SENT_92	[p7l913t2558r1085b2602],
373	*	CD	NUMBER	*	dep	455	SENT_92	[p7l913t2558r1085b2602],
374	17	CD	NUMBER	17	dep	455	SENT_92	[p7l913t2558r1085b2602],
375	)	NN	O	)	dep	455	SENT_92	[p7l913t2558r1085b2602],
376	268	CD	NUMBER	268	dep	455	SENT_92	[p7l1352t2556r1425b2593],
377	(	NN	O	(	dep	455	SENT_92	[p7l1439t2559r1522b2602],
378	5	CD	PERCENT	5	dep	455	SENT_92	[p7l1439t2559r1522b2602],
379	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1439t2559r1522b2602],
380	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1439t2559r1522b2602],
381	268	CD	NUMBER	268	dep	455	SENT_92	[p7l1741t2556r1813b2593],
382	(	NN	O	(	dep	455	SENT_92	[p7l1828t2559r1911b2602],
383	5	CD	PERCENT	5	dep	455	SENT_92	[p7l1828t2559r1911b2602],
384	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1828t2559r1911b2602],
385	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1828t2559r1911b2602],
386	Missing	VBG	O	miss	dep	455	SENT_92	[p7l705t2639r845b2683],
387	199	CD	PERCENT	199	dep	455	SENT_92	[p7l1354t2641r1425b2677],
388	(	CD	PERCENT	(	dep	455	SENT_92	[p7l1439t2638r1525b2681],
389	4	CD	PERCENT	4	dep	455	SENT_92	[p7l1439t2638r1525b2681],
390	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1439t2638r1525b2681],
391	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1439t2638r1525b2681],
392	244	CD	NUMBER	244	dep	455	SENT_92	[p7l1742t2641r1816b2677],
393	(	NN	O	(	dep	455	SENT_92	[p7l1828t2638r1911b2681],
394	5	CD	PERCENT	5	dep	455	SENT_92	[p7l1828t2638r1911b2681],
395	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1828t2638r1911b2681],
396	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1828t2638r1911b2681],
397	ABCB1	NN	O	abcb1	dep	455	SENT_92	[p7l702t2718r829b2752],
398	predicted	VBD	O	predict	dep	455	SENT_92	[p7l842t2716r1030b2762],
399	phenotype	NN	O	phenotype	dep	455	SENT_92	[p7l1041t2716r1256b2763],
400	High	JJ	O	high	dep	455	SENT_92	[p7l706t2795r790b2842],
401	expression	NN	O	expression	dep	455	SENT_92	[p7l804t2798r1000b2842],
402	(	CD	NUMBER	(	dep	455	SENT_92	[p7l1015t2796r1107b2840],
403	C/C	NN	O	c/c	dep	455	SENT_92	[p7l1015t2796r1107b2840],
404	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1015t2796r1107b2840],
405	1167	CD	DATE	1167	dep	455	SENT_92	[p7l1335t2795r1427b2836],
406	(	CD	PERCENT	(	dep	455	SENT_92	[p7l1439t2797r1546b2840],
407	23	CD	PERCENT	23	dep	455	SENT_92	[p7l1439t2797r1546b2840],
408	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1439t2797r1546b2840],
409	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1439t2797r1546b2840],
410	1195	CD	DATE	1195	dep	455	SENT_92	[p7l1723t2800r1813b2836],
411	(	CD	PERCENT	(	dep	455	SENT_92	[p7l1828t2797r1935b2840],
412	23	CD	PERCENT	23	dep	455	SENT_92	[p7l1828t2797r1935b2840],
413	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1828t2797r1935b2840],
414	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1828t2797r1935b2840],
415	Intermediate	NNP	O	Intermediate	dep	455	SENT_92	[p7l706t2874r946b2910],
416	expression	NN	O	expression	dep	455	SENT_92	[p7l958t2877r1155b2921],
417	(	CD	NUMBER	(	dep	455	SENT_92	[p7l1169t2876r1261b2920],
418	C/T	NN	O	c/t	dep	455	SENT_92	[p7l1169t2876r1261b2920],
419	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1169t2876r1261b2920],
420	2570	CD	DATE	2570	dep	455	SENT_92	[p7l1334t2879r1426b2915],
421	(	CD	PERCENT	(	dep	455	SENT_92	[p7l1439t2876r1548b2920],
422	50	CD	PERCENT	50	dep	455	SENT_92	[p7l1439t2876r1548b2920],
423	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1439t2876r1548b2920],
424	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1439t2876r1548b2920],
425	2518	CD	DATE	2518	dep	455	SENT_92	[p7l1722t2874r1813b2915],
426	(	CD	PERCENT	(	dep	455	SENT_92	[p7l1828t2876r1940b2920],
427	49	CD	PERCENT	49	dep	455	SENT_92	[p7l1828t2876r1940b2920],
428	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1828t2876r1940b2920],
429	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1828t2876r1940b2920],
430	Low	JJ	O	low	dep	455	SENT_92	[p7l706t2957r782b2989],
431	expression	NN	O	expression	dep	455	SENT_92	[p7l793t2957r989b3000],
432	(	CD	NUMBER	(	dep	455	SENT_92	[p7l1004t2955r1097b2999],
433	T/T	NN	O	t/t	dep	455	SENT_92	[p7l1004t2955r1097b2999],
434	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1004t2955r1097b2999],
435	1349	CD	DATE	1349	dep	455	SENT_92	[p7l1331t2958r1425b2995],
436	(	CD	PERCENT	(	dep	455	SENT_92	[p7l1439t2953r1549b2999],
437	26	CD	PERCENT	26	dep	455	SENT_92	[p7l1439t2953r1549b2999],
438	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1439t2953r1549b2999],
439	)	CD	PERCENT	)	dep	455	SENT_92	[p7l1439t2953r1549b2999],
440	1386	CD	PERCENT	1386	dep	455	SENT_92	[p7l1719t2953r1814b2995],
441	(	CD	PERCENT	(	dep	455	SENT_92	[p7l1828t2956r1934b2999],
442	27	CD	PERCENT	27	dep	455	SENT_92	[p7l1828t2956r1934b2999],
443	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1828t2956r1934b2999],
444	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1828t2956r1934b2999],
445	Missing	VBG	O	miss	dep	455	SENT_92	[p7l705t3036r845b3080],
446	51	CD	NUMBER	51	dep	455	SENT_92	[p7l1383t3038r1426b3074],
447	(	NN	O	(	dep	455	SENT_92	[p7l1439t3035r1521b3078],
448	1	CD	PERCENT	1	dep	455	SENT_92	[p7l1439t3035r1521b3078],
449	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1439t3035r1521b3078],
450	)	CD	NUMBER	)	dep	455	SENT_92	[p7l1439t3035r1521b3078],
451	49	CD	NUMBER	49	dep	455	SENT_92	[p7l1764t3038r1813b3074],
452	(	NN	O	(	dep	455	SENT_92	[p7l1828t3035r1909b3078],
453	1	CD	PERCENT	1	dep	455	SENT_92	[p7l1828t3035r1909b3078],
454	%	NN	PERCENT	%	dep	455	SENT_92	[p7l1828t3035r1909b3078],
455	)	CD	NUMBER	)	_	0	SENT_92	[p7l1828t3035r1909b3078],

1	Table	NNP	O	Table	_	0	SENT_93	[p7l684t3141r783b3178],
2	2	CD	NUMBER	2	num	1	SENT_93	[p7l792t3147r826b3178],
3	:	:	O	:	_	0	SENT_93	[p7l792t3147r826b3178],
4	Genotype	NN	O	genotype	dep	1	SENT_93	[p7l837t3144r1029b3189],
5	and	CC	O	and	_	0	SENT_93	[p7l1040t3142r1113b3178],
6	predicted	VBD	O	predict	amod	7	SENT_93	[p7l1124t3142r1312b3189],
7	phenotypes	NNS	O	phenotype	conj_and	4	SENT_93	[p7l1323t3142r1568b3189],
8	,	,	O	,	_	0	SENT_93	[p7l1323t3142r1568b3189],
9	by	IN	O	by	_	0	SENT_93	[p7l1582t3142r1628b3189],
10	treatment	NN	O	treatment	prep_by	1	SENT_93	[p7l1636t3148r1842b3178],

1	0-786	CD	NUMBER	0-786	_	0	SENT_94	[p7l9t3575r216b3641],
2	and	CC	O	and	_	0	SENT_94	[p7l270t3570r407b3638],
3	0-855	CD	NUMBER	0-855	conj_and	1	SENT_94	[p7l457t3575r691b3648],
4	,	,	O	,	_	0	SENT_94	[p7l457t3575r691b3648],
5	respectively	RB	O	respectively	advmod	1	SENT_94	[p7l745t3570r1183b3660],
6	.	.	O	.	_	0	SENT_94	[p7l745t3570r1183b3660],

1	The	DT	O	the	det	2	SENT_95	[p7l1237t3570r1379b3638],
2	reliability	NN	O	reliability	nsubjpass	8	SENT_95	[p7l1431t3570r1777b3660],
3	of	IN	O	of	_	0	SENT_95	[p7l1827t3570r1909b3638],
4	other	JJ	O	other	amod	5	SENT_95	[p7l1948t3570r2141b3638],
5	results	NNS	O	result	prep_of	2	SENT_95	[p7l8t3680r251b3748],
6	should	MD	O	should	aux	8	SENT_95	[p7l281t3680r529b3748],
7	be	VB	O	be	auxpass	8	SENT_95	[p7l551t3680r636b3748],
8	based	VBN	O	base	_	0	SENT_95	[p7l660t3680r871b3748],
9	on	IN	O	on	_	0	SENT_95	[p7l895t3704r989b3748],
10	the	DT	O	the	det	14	SENT_95	[p7l1011t3680r1126b3748],
11	ﬁnal	JJ	O	ﬁnal	amod	14	SENT_95	[p7l1151t3680r1315b3748],
12	95	CD	PERCENT	95	number	13	SENT_95	[p7l1341t3684r1500b3751],
13	%	NN	PERCENT	%	amod	14	SENT_95	[p7l1341t3684r1500b3751],
14	CIs	NNS	O	ci	prep_on	8	SENT_95	[p7l1528t3685r1669b3748],
15	.	.	O	.	_	0	SENT_95	[p7l1528t3685r1669b3748],

1	Cox	NN	PERSON	cox	nn	2	SENT_96	[p8l82t32r220b95],
2	regression	NN	O	regression	nsubjpass	4	SENT_96	[p8l239t31r631b116],
3	was	VBD	O	be	auxpass	4	SENT_96	[p8l651t51r789b95],
4	used	VBN	O	use	_	0	SENT_96	[p8l811t26r989b95],
5	to	TO	O	to	aux	6	SENT_96	[p8l1008t40r1077b95],
6	compare	VB	O	compare	ccomp	4	SENT_96	[p8l1101t51r1423b115],
7	outcomes	NNS	O	outcome	dobj	6	SENT_96	[p8l1447t40r1805b95],
8	between	IN	O	between	_	0	SENT_96	[p8l1828t27r2140b95],
9	treatment	NN	O	treatment	nn	10	SENT_96	[p8l7t149r376b203],
10	groups	NNS	O	group	prep_between	6	SENT_96	[p8l408t159r662b225],
11	and	CC	O	and	_	0	SENT_96	[p8l697t135r835b203],
12	between	IN	O	between	_	0	SENT_96	[p8l864t135r1176b203],
13	genotype	NN	O	genotype	nn	14	SENT_96	[p8l1208t149r1544b225],
14	groups	NNS	O	group	conj_and	10	SENT_96	[p8l1577t159r1832b225],
15	in	IN	O	in	_	0	SENT_96	[p8l1866t140r1940b202],
16	each	DT	O	each	det	18	SENT_96	[p8l1972t135r2140b203],
17	treatment	NN	O	treatment	nn	18	SENT_96	[p8l7t258r376b313],
18	group	NN	O	group	prep_in	14	SENT_96	[p8l430t269r669b335],
19	,	,	O	,	_	0	SENT_96	[p8l430t269r669b335],
20	and	CC	O	and	_	0	SENT_96	[p8l727t245r865b312],
21	to	TO	O	to	aux	22	SENT_96	[p8l917t258r986b312],
22	analyse	VB	O	analyse	conj_and	6	SENT_96	[p8l1042t245r1314b334],
23	interaction	NN	O	interaction	dobj	22	SENT_96	[p8l1370t249r1776b313],
24	between	IN	O	between	_	0	SENT_96	[p8l1828t245r2140b313],
25	treatment	NN	O	treatment	nn	26	SENT_96	[p8l7t367r376b422],
26	groups	NNS	O	group	prep_between	23	SENT_96	[p8l403t378r658b443],
27	and	CC	O	and	_	0	SENT_96	[p8l688t353r826b422],
28	genotype	NN	O	genotype	nn	29	SENT_96	[p8l853t367r1188b443],
29	groups	NNS	O	group	prep_between	23	SENT_96	[p8l1218t378r1494b443],
30	,	,	O	,	_	0	SENT_96	[p8l1218t378r1494b443],
31	with	IN	O	with	_	0	SENT_96	[p8l1522t354r1688b422],
32	adjustment	NN	O	adjustment	prep_with	4	SENT_96	[p8l1715t354r2141b443],
33	for	IN	O	for	_	0	SENT_96	[p8l8t463r115b531],
34	covariates	NNS	O	covariate	prep_for	32	SENT_96	[p8l150t468r535b531],
35	:	:	O	:	_	0	SENT_96	[p8l150t468r535b531],
36	ethnic	JJ	O	ethnic	amod	37	SENT_96	[p8l576t463r808b531],
37	group	NN	O	group	prep_for	32	SENT_96	[p8l845t488r1083b553],
38	,	,	O	,	_	0	SENT_96	[p8l845t488r1083b553],
39	sex	NN	O	sex	prep_for	32	SENT_96	[p8l1125t487r1257b541],
40	,	,	O	,	_	0	SENT_96	[p8l1125t487r1257b541],
41	use	NN	O	use	prep_for	32	SENT_96	[p8l1295t487r1422b531],
42	of	IN	O	of	_	0	SENT_96	[p8l1460t463r1543b531],
43	a	DT	O	a	det	45	SENT_96	[p8l1567t488r1604b531],
44	proton-pump	JJ	O	proton-pump	amod	45	SENT_96	[p8l1639t477r2139b552],
45	inhibitor	NN	O	inhibitor	prep_of	41	SENT_96	[p8l8t573r349b651],
46	,	,	O	,	_	0	SENT_96	[p8l8t573r349b651],
47	aspirin	NN	O	aspirin	nn	48	SENT_96	[p8l404t577r664b662],
48	dose	NN	O	dose	prep_for	32	SENT_96	[p8l715t573r901b651],
49	,	,	O	,	_	0	SENT_96	[p8l715t573r901b651],
50	smoking	NN	O	smoking	nn	51	SENT_96	[p8l958t573r1283b663],
51	status	NN	O	status	appos	48	SENT_96	[p8l1336t586r1570b651],
52	,	,	O	,	_	0	SENT_96	[p8l1336t586r1570b651],
53	and	CC	O	and	_	0	SENT_96	[p8l1625t573r1763b640],
54	diabetes	NN	O	diabetes	conj_and	34	SENT_96	[p8l1813t573r2136b641],
55	.	.	O	.	_	0	SENT_96	[p8l1813t573r2136b641],

1	Primary	JJ	O	primary	dep	101	SENT_97	[p8l13t686r314b771],
2	analyses	NNS	O	analysis	dep	101	SENT_97	[p8l364t681r672b771],
3	for	IN	O	for	dep	101	SENT_97	[p8l725t681r832b750],
4	comparisons	NNS	O	comparison	dep	101	SENT_97	[p8l882t686r1360b770],
5	between	IN	O	between	dep	101	SENT_97	[p8l1411t681r1723b750],
6	treatment	NN	O	treatment	dep	101	SENT_97	[p8l1772t695r2141b750],
7	groups	NNS	O	group	dep	101	SENT_97	[p8l9t814r265b880],
8	yielded	VBD	O	yield	dep	101	SENT_97	[p8l317t790r584b880],
9	I-IRS	NN	O	i-ir	dep	101	SENT_97	[p8l640t797r802b858],
10	stratiﬁed	VBN	O	stratiﬁed	dep	101	SENT_97	[p8l859t790r1187b858],
11	by	IN	O	by	dep	101	SENT_97	[p8l1236t790r1324b880],
12	genotype	NN	O	genotype	dep	101	SENT_97	[p8l1375t804r1710b880],
13	group	NN	O	group	dep	101	SENT_97	[p8l1765t815r1983b880],
14	(	CD	NUMBER	(	dep	101	SENT_97	[p8l2043t797r2137b880],
15	as	IN	O	as	dep	101	SENT_97	[p8l2043t797r2137b880],
16	established	VBN	O	establish	dep	101	SENT_97	[p8l9t900r428b967],
17	by	IN	O	by	dep	101	SENT_97	[p8l452t900r539b989],
18	analyses	NNS	O	analysis	dep	101	SENT_97	[p8l565t900r874b989],
19	within	IN	O	within	dep	101	SENT_97	[p8l901t900r1144b968],
20	each	DT	O	each	dep	101	SENT_97	[p8l1171t900r1339b968],
21	treatment	NN	O	treatment	dep	101	SENT_97	[p8l1365t913r1734b968],
22	group	NN	O	group	dep	101	SENT_97	[p8l1760t906r2002b990],
23	)	CD	NUMBER	)	dep	101	SENT_97	[p8l1760t906r2002b990],
24	for	IN	O	for	dep	101	SENT_97	[p8l2035t900r2141b967],
25	six	CD	NUMBER	six	dep	101	SENT_97	[p8l11t1014r110b1078],
26	outcomes	NNS	O	outcome	dep	101	SENT_97	[p8l194t1023r574b1078],
27	:	:	O	:	_	0	SENT_97	[p8l194t1023r574b1078],
28	composite	NN	O	composite	dep	101	SENT_97	[p8l665t1014r1048b1098],
29	of	IN	O	of	dep	101	SENT_97	[p8l1135t1009r1219b1078],
30	cardiovascular	JJ	O	cardiovascular	dep	101	SENT_97	[p8l1292t1009r1829b1078],
31	death	NN	O	death	dep	101	SENT_97	[p8l1914t1009r2136b1088],
32	,	,	O	,	_	0	SENT_97	[p8l1914t1009r2136b1088],
33	myocardial	JJ	O	myocardial	dep	101	SENT_97	[p8l8t1118r421b1207],
34	infarction	NN	O	infarction	dep	101	SENT_97	[p8l484t1118r869b1196],
35	,	,	O	,	_	0	SENT_97	[p8l484t1118r869b1196],
36	or	CC	O	or	dep	101	SENT_97	[p8l937t1142r1013b1186],
37	stroke	NN	O	stroke	dep	101	SENT_97	[p8l1077t1118r1301b1186],
38	(	CD	NUMBER	(	dep	101	SENT_97	[p8l1371t1123r1693b1208],
39	primary	JJ	O	primary	dep	101	SENT_97	[p8l1371t1123r1693b1208],
40	endpoint	NN	O	endpoint	dep	101	SENT_97	[p8l1754t1118r2136b1208],
41	)	NN	O	)	dep	101	SENT_97	[p8l1754t1118r2136b1208],
42	;	:	O	;	_	0	SENT_97	[p8l1754t1118r2136b1208],
43	composite	NN	O	composite	dep	101	SENT_97	[p8l9t1233r393b1318],
44	of	IN	O	of	dep	101	SENT_97	[p8l483t1229r567b1297],
45	cardiovascular	JJ	O	cardiovascular	dep	101	SENT_97	[p8l644t1229r1180b1297],
46	death	NN	O	death	dep	101	SENT_97	[p8l1269t1229r1473b1297],
47	or	CC	O	or	dep	101	SENT_97	[p8l1563t1253r1640b1297],
48	myocardial	JJ	O	myocardial	dep	101	SENT_97	[p8l1727t1229r2140b1318],
49	infarction	NN	O	infarction	dep	101	SENT_97	[p8l8t1337r394b1416],
50	;	:	O	;	_	0	SENT_97	[p8l8t1337r394b1416],
51	stent	NN	O	stent	dep	101	SENT_97	[p8l438t1351r619b1406],
52	thrombosis	NN	O	thrombosis	dep	101	SENT_97	[p8l653t1337r1099b1416],
53	;	:	O	;	_	0	SENT_97	[p8l653t1337r1099b1416],
54	total	JJ	O	total	dep	101	SENT_97	[p8l1139t1337r1302b1406],
55	major	JJ	O	major	dep	101	SENT_97	[p8l1339t1342r1562b1427],
56	bleeding	NN	O	bleeding	dep	101	SENT_97	[p8l1596t1337r1938b1427],
57	;	:	O	;	_	0	SENT_97	[p8l1596t1337r1938b1427],
58	total	JJ	O	total	dep	101	SENT_97	[p8l1978t1337r2140b1406],
59	major	JJ	O	major	dep	101	SENT_97	[p8l8t1451r231b1536],
60	bleeding	NN	O	bleeding	dep	101	SENT_97	[p8l246t1446r569b1536],
61	related	JJ	O	related	dep	101	SENT_97	[p8l587t1446r841b1514],
62	to	TO	O	to	dep	101	SENT_97	[p8l857t1459r925b1514],
63	non-CABG	JJ	O	non-cabg	dep	101	SENT_97	[p8l945t1451r1357b1514],
64	;	:	O	;	_	0	SENT_97	[p8l1367t1470r1379b1524],
65	total	JJ	O	total	dep	101	SENT_97	[p8l1400t1446r1562b1514],
66	major	JJ	O	major	dep	101	SENT_97	[p8l1580t1451r1802b1536],
67	bleeding	NN	O	bleeding	dep	101	SENT_97	[p8l1817t1446r2140b1536],
68	related	VBN	O	relate	dep	101	SENT_97	[p8l8t1556r262b1623],
69	to	TO	O	to	dep	101	SENT_97	[p8l333t1569r402b1623],
70	CABG	NNP	O	CABG	dep	101	SENT_97	[p8l479t1561r735b1634],
71	;	:	O	;	_	0	SENT_97	[p8l479t1561r735b1634],
72	and	CC	O	and	dep	101	SENT_97	[p8l813t1555r951b1623],
73	the	DT	O	the	dep	101	SENT_97	[p8l1022t1556r1138b1623],
74	net	JJ	O	net	dep	101	SENT_97	[p8l1211t1569r1330b1623],
75	clinical	JJ	O	clinical	dep	101	SENT_97	[p8l1402t1555r1667b1623],
76	beneﬁt	NN	O	beneﬁt	dep	101	SENT_97	[p8l1739t1555r2000b1623],
77	to	TO	O	to	dep	101	SENT_97	[p8l2069t1569r2139b1623],
78	cardiovascular	JJ	O	cardiovascular	dep	101	SENT_97	[p8l9t1664r546b1733],
79	death	NN	O	death	dep	101	SENT_97	[p8l565t1664r787b1743],
80	,	,	O	,	_	0	SENT_97	[p8l565t1664r787b1743],
81	myocardial	JJ	O	myocardial	dep	101	SENT_97	[p8l810t1664r1223b1754],
82	infarction	NN	O	infarction	dep	101	SENT_97	[p8l1242t1664r1627b1743],
83	,	,	O	,	_	0	SENT_97	[p8l1242t1664r1627b1743],
84	stroke	NN	O	stroke	dep	101	SENT_97	[p8l1652t1664r1897b1743],
85	,	,	O	,	_	0	SENT_97	[p8l1652t1664r1897b1743],
86	major	JJ	O	major	dep	101	SENT_97	[p8l1919t1669r2141b1754],
87	bleeding	NN	O	bleeding	dep	101	SENT_97	[p8l7t1773r330b1863],
88	related	JJ	O	related	dep	101	SENT_97	[p8l372t1773r627b1841],
89	to	TO	O	to	dep	101	SENT_97	[p8l667t1786r736b1841],
90	non-CABG	JJ	O	non-cabg	dep	101	SENT_97	[p8l780t1778r1214b1851],
91	,	,	O	,	_	0	SENT_97	[p8l780t1778r1214b1851],
92	and	CC	O	and	dep	101	SENT_97	[p8l1261t1773r1399b1841],
93	major	JJ	O	major	dep	101	SENT_97	[p8l1441t1778r1663b1863],
94	fatal	JJ	O	fatal	dep	101	SENT_97	[p8l1704t1773r1862b1841],
95	or	CC	O	or	dep	101	SENT_97	[p8l1906t1797r1982b1841],
96	life	NN	O	life	dep	101	SENT_97	[p8l2022t1773r2139b1841],
97	threatening	JJ	O	threatening	dep	101	SENT_97	[p8l7t1882r443b1972],
98	bleeding	NN	O	bleeding	dep	101	SENT_97	[p8l484t1882r808b1972],
99	related	VBN	O	relate	dep	101	SENT_97	[p8l851t1882r1105b1951],
100	to	TO	O	to	dep	101	SENT_97	[p8l1145t1896r1215b1951],
101	CABG	NNP	ORGANIZATION	CABG	_	0	SENT_97	[p8l1261t1888r1518b1951],
102	.	.	O	.	_	0	SENT_97	[p8l1261t1888r1518b1951],

1	No	DT	O	no	det	2	SENT_98	[p8l1568t1889r1670b1951],
2	adjustment	NN	O	adjustment	nsubjpass	7	SENT_98	[p8l1715t1883r2141b1972],
3	for	IN	O	for	_	0	SENT_98	[p8l8t1992r115b2061],
4	multiple	JJ	O	multiple	amod	5	SENT_98	[p8l190t1992r506b2081],
5	comparisons	NNS	O	comparison	prep_for	2	SENT_98	[p8l585t1997r1063b2081],
6	was	VBD	O	be	auxpass	7	SENT_98	[p8l1140t2016r1279b2061],
7	used	VBN	O	use	_	0	SENT_98	[p8l1357t1992r1552b2061],
8	.	.	O	.	_	0	SENT_98	[p8l1357t1992r1552b2061],

1	Kaplan-Meier	JJR	O	kaplan-meier	amod	2	SENT_99	[p8l1637t1992r2141b2081],
2	estimates	NNS	O	estimate	nsubjpass	17	SENT_99	[p8l9t2106r360b2169],
3	of	IN	O	of	_	0	SENT_99	[p8l389t2101r471b2169],
4	the	DT	O	the	det	6	SENT_99	[p8l482t2101r598b2169],
5	cumulative	JJ	O	cumulative	amod	6	SENT_99	[p8l624t2101r1038b2169],
6	risk	NN	O	risk	prep_of	2	SENT_99	[p8l1063t2101r1204b2169],
7	to	TO	O	to	_	0	SENT_99	[p8l1225t2114r1295b2169],
8	the	DT	O	the	det	10	SENT_99	[p8l1319t2101r1435b2169],
9	ﬁrst	JJ	O	ﬁrst	amod	10	SENT_99	[p8l1461t2101r1610b2169],
10	occurrence	NN	O	occurrence	prep_to	6	SENT_99	[p8l1633t2125r2043b2169],
11	of	IN	O	of	_	0	SENT_99	[p8l2070t2101r2153b2169],
12	outcome	NN	O	outcome	nn	13	SENT_99	[p8l9t2225r333b2280],
13	events	NNS	O	event	prep_of	10	SENT_99	[p8l360t2225r592b2280],
14	were	VBD	O	be	auxpass	15	SENT_99	[p8l618t2236r796b2280],
15	calculated	VBN	O	calculate	_	0	SENT_99	[p8l824t2211r1195b2280],
16	and	CC	O	and	_	0	SENT_99	[p8l1221t2212r1359b2280],
17	plotted	VBN	O	plot	conj_and	15	SENT_99	[p8l1383t2212r1659b2300],
18	.	.	O	.	_	0	SENT_99	[p8l1383t2212r1659b2300],

1	Role	NN	O	role	nsubj	12	SENT_100	[p8l13t2431r169b2500],
2	of	IN	O	of	_	0	SENT_100	[p8l191t2430r272b2500],
3	the	DT	O	the	det	7	SENT_100	[p8l284t2430r411b2500],
4	funding	NN	O	funding	nn	7	SENT_100	[p8l431t2430r733b2521],
5	source	NN	O	source	nn	7	SENT_100	[p8l757t2453r1000b2500],
6	Academic	NNP	O	Academic	nn	7	SENT_100	[p8l7t2540r376b2608],
7	members	NNS	O	member	prep_of	1	SENT_100	[p8l399t2540r754b2608],
8	of	IN	O	of	_	0	SENT_100	[p8l781t2540r864b2608],
9	the	DT	O	the	det	11	SENT_100	[p8l873t2540r990b2608],
10	executive	NN	O	executive	nn	11	SENT_100	[p8l1015t2545r1355b2608],
11	committee	NN	O	committee	prep_of	7	SENT_100	[p8l1381t2545r1780b2608],
12	designed	VBD	O	design	_	0	SENT_100	[p8l1805t2540r2141b2630],
13	the	DT	O	the	det	14	SENT_100	[p8l7t2651r124b2719],
14	trial	NN	O	trial	dobj	12	SENT_100	[p8l189t2651r338b2719],
15	in	IN	O	in	_	0	SENT_100	[p8l403t2655r478b2718],
16	collaboration	NN	O	collaboration	prep_in	12	SENT_100	[p8l544t2651r1030b2719],
17	with	IN	O	with	_	0	SENT_100	[p8l1094t2651r1259b2719],
18	representatives	NNS	O	representative	prep_with	12	SENT_100	[p8l1325t2655r1888b2740],
19	from	IN	O	from	_	0	SENT_100	[p8l1955t2651r2140b2719],
20	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_from	18	SENT_100	[p8l7t2765r496b2829],
21	.	.	O	.	_	0	SENT_100	[p8l7t2765r496b2829],

1	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	nn	2	SENT_101	[p8l547t2765r1017b2829],
2	Research	NNP	ORGANIZATION	Research	nsubj	5	SENT_101	[p8l1069t2760r1404b2829],
3	and	CC	O	and	_	0	SENT_101	[p8l1453t2760r1591b2829],
4	Development	NNP	O	Development	nsubj	5	SENT_101	[p8l1641t2760r2141b2849],
5	coordinated	VBN	O	coordinate	_	0	SENT_101	[p8l9t2869r452b2937],
6	data	NNS	O	datum	nn	7	SENT_101	[p8l496t2869r649b2937],
7	management	NN	O	management	dobj	5	SENT_101	[p8l693t2883r1208b2959],
8	.	.	O	.	_	0	SENT_101	[p8l693t2883r1208b2959],

1	Statistical	JJ	O	statistical	amod	2	SENT_102	[p8l1261t2869r1617b2937],
2	analysis	NN	O	analysis	nsubjpass	4	SENT_102	[p8l1662t2869r1954b2959],
3	was	VBD	O	be	auxpass	4	SENT_102	[p8l1999t2893r2138b2937],
4	done	VBN	O	do	_	0	SENT_102	[p8l9t2980r191b3048],
5	by	IN	O	by	_	0	SENT_102	[p8l232t2980r320b3069],
6	Worldwide	NNP	O	Worldwide	nn	8	SENT_102	[p8l358t2980r764b3049],
7	Clinical	JJ	O	clinical	amod	8	SENT_102	[p8l809t2980r1093b3048],
8	Trials	NNS	O	trial	agent	4	SENT_102	[p8l1133t2980r1357b3058],
9	,	,	O	,	_	0	SENT_102	[p8l1133t2980r1357b3058],
10	a	DT	O	a	det	13	SENT_102	[p8l1404t3004r1441b3048],
11	contract	NN	O	contract	nn	13	SENT_102	[p8l1484t2993r1784b3048],
12	research	NN	O	research	nn	13	SENT_102	[p8l1824t2980r2140b3048],
13	organisation	NN	O	organisation	appos	8	SENT_102	[p8l9t3093r496b3178],
14	,	,	O	,	_	0	SENT_102	[p8l9t3093r496b3178],
15	in	IN	O	in	_	0	SENT_102	[p8l524t3093r598b3155],
16	collaboration	NN	O	collaboration	prep_in	8	SENT_102	[p8l624t3088r1110b3157],
17	with	IN	O	with	_	0	SENT_102	[p8l1132t3088r1298b3156],
18	investigators	NNS	O	investigator	prep_with	4	SENT_102	[p8l1322t3093r1795b3178],
19	who	WP	O	who	nsubj	20	SENT_102	[p8l1820t3088r1978b3157],
20	had	VBD	O	have	rcmod	18	SENT_102	[p8l2002t3088r2141b3157],
21	full	JJ	O	full	amod	22	SENT_102	[p8l8t3198r134b3266],
22	access	NN	O	access	dobj	20	SENT_102	[p8l155t3222r383b3266],
23	to	TO	O	to	_	0	SENT_102	[p8l405t3211r474b3266],
24	the	DT	O	the	det	27	SENT_102	[p8l494t3198r610b3266],
25	ﬁnal	JJ	O	ﬁnal	amod	27	SENT_102	[p8l632t3198r798b3266],
26	study	NN	O	study	nn	27	SENT_102	[p8l821t3198r1020b3287],
27	data	NNS	O	datum	prep_to	22	SENT_102	[p8l1040t3198r1210b3266],
28	.	.	O	.	_	0	SENT_102	[p8l1040t3198r1210b3266],

1	Results	NNS	O	result	nsubjpass	3	SENT_103	[p8l1238t3198r1504b3266],
2	were	VBD	O	be	auxpass	3	SENT_103	[p8l1525t3222r1703b3266],
3	interpreted	VBN	O	interpret	_	0	SENT_103	[p8l1724t3198r2141b3287],
4	by	IN	O	by	_	0	SENT_103	[p8l7t3309r94b3398],
5	the	DT	O	the	det	6	SENT_103	[p8l126t3309r243b3377],
6	authors	NNS	O	author	agent	3	SENT_103	[p8l280t3309r582b3387],
7	,	,	O	,	_	0	SENT_103	[p8l280t3309r582b3387],
8	with	IN	O	with	_	0	SENT_103	[p8l618t3309r784b3377],
9	representatives	NNS	O	representative	prep_with	3	SENT_103	[p8l818t3313r1382b3398],
10	from	IN	O	from	_	0	SENT_103	[p8l1419t3309r1604b3377],
11	the	DT	O	the	det	13	SENT_103	[p8l1638t3309r1754b3377],
12	academic	JJ	O	academic	amod	13	SENT_103	[p8l1791t3309r2140b3377],
13	investigators	NNS	O	investigator	prep_from	9	SENT_103	[p8l8t3422r481b3507],
14	and	CC	O	and	_	0	SENT_103	[p8l512t3417r649b3486],
15	the	DT	O	the	det	16	SENT_103	[p8l673t3417r789b3486],
16	sponsor	NN	O	sponsor	conj_and	13	SENT_103	[p8l818t3442r1125b3506],
17	.	.	O	.	_	0	SENT_103	[p8l818t3442r1125b3506],

1	The	DT	O	the	det	3	SENT_104	[p8l1153t3417r1297b3486],
2	corresponding	JJ	O	corresponding	amod	3	SENT_104	[p8l1325t3417r1868b3507],
3	author	NN	O	author	nsubj	9	SENT_104	[p8l1895t3417r2141b3486],
4	drafted	VBD	O	draft	_	0	SENT_104	[p8l9t3527r273b3595],
5	the	DT	O	the	det	6	SENT_104	[p8l294t3527r411b3595],
6	report	NN	O	report	dobj	4	SENT_104	[p8l436t3540r664b3616],
7	and	CC	O	and	_	0	SENT_104	[p8l688t3527r825b3595],
8	was	VBD	O	be	cop	9	SENT_104	[p8l846t3551r985b3595],
9	responsible	JJ	O	responsible	conj_and	4	SENT_104	[p8l1011t3527r1442b3616],
10	for	IN	O	for	_	0	SENT_104	[p8l1467t3527r1574b3595],
11	the	DT	O	the	det	12	SENT_104	[p8l1595t3527r1712b3595],
12	decision	NN	O	decision	prep_for	9	SENT_104	[p8l1737t3527r2047b3595],
13	to	TO	O	to	aux	14	SENT_104	[p8l2070t3540r2139b3595],
14	submit	VB	O	submit	infmod	12	SENT_104	[p8l11t3638r275b3706],
15	for	IN	O	for	_	0	SENT_104	[p8l298t3637r405b3706],
16	publication	NN	O	publication	prep_for	14	SENT_104	[p8l428t3638r851b3726],
17	after	IN	O	after	mark	20	SENT_104	[p8l876t3637r1045b3706],
18	all	DT	O	all	det	19	SENT_104	[p8l1069t3638r1154b3706],
19	coauthors	NNS	O	coauthor	nsubj	20	SENT_104	[p8l1180t3637r1544b3706],
20	commented	VBD	O	comment	advcl	14	SENT_104	[p8l1573t3637r2022b3706],
21	on	IN	O	on	_	0	SENT_104	[p8l2047t3662r2140b3706],
22	the	DT	O	the	det	23	SENT_104	[p9l7t18r124b87],
23	report	NN	O	report	prep_on	20	SENT_104	[p9l150t32r395b107],
24	.	.	O	.	_	0	SENT_104	[p9l150t32r395b107],

1	Results	NNS	O	result	_	0	SENT_105	[p9l14t226r321b305],

1	10	CD	NUMBER	10	number	2	SENT_106	[p9l11t353r85b415],
2	285	CD	NUMBER	285	num	3	SENT_106	[p9l101t351r225b415],
3	patients	NNS	O	patient	nsubj	4	SENT_106	[p9l246t351r534b435],
4	consented	VBD	O	consent	_	0	SENT_106	[p9l555t346r929b415],
5	to	TO	O	to	aux	6	SENT_106	[p9l945t360r1013b415],
6	give	VB	O	give	xcomp	4	SENT_106	[p9l1034t351r1178b436],
7	a	DT	O	a	det	8	SENT_106	[p9l1198t371r1235b415],
8	blood	NN	O	blood	iobj	6	SENT_106	[p9l1251t346r1457b415],
9	sample	NN	O	sample	dobj	6	SENT_106	[p9l1476t346r1737b435],
10	for	IN	O	for	_	0	SENT_106	[p9l1756t346r1861b415],
11	genetic	JJ	O	genetic	amod	12	SENT_106	[p9l1879t351r2140b436],
12	analysis	NN	O	analysis	prep_for	9	SENT_106	[p9l9t455r315b545],
13	.	.	O	.	_	0	SENT_106	[p9l9t455r315b545],

1	Demographic	JJ	MISC	demographic	amod	2	SENT_107	[p9l352t455r852b545],
2	indicators	NNS	O	indicator	nsubj	8	SENT_107	[p9l880t455r1240b523],
3	and	CC	O	and	_	0	SENT_107	[p9l1273t455r1409b523],
4	drug	NN	O	drug	nn	5	SENT_107	[p9l1437t455r1609b545],
5	use	NN	O	use	conj_and	2	SENT_107	[p9l1636t479r1762b523],
6	were	VBD	O	be	cop	8	SENT_107	[p9l1789t480r1964b523],
7	well	RB	O	well	advmod	8	SENT_107	[p9l1991t455r2140b523],
8	balanced	JJ	O	balanced	_	0	SENT_107	[p9l7t565r334b633],
9	between	IN	O	between	_	0	SENT_107	[p9l399t565r706b633],
10	the	DT	O	the	det	12	SENT_107	[p9l773t565r888b633],
11	treatment	NN	O	treatment	nn	12	SENT_107	[p9l956t578r1318b633],
12	groups	NNS	O	group	prep_between	8	SENT_107	[p9l1386t589r1636b655],
13	at	IN	O	at	_	0	SENT_107	[p9l1708t578r1772b632],
14	baseline	NN	O	baseline	nn	16	SENT_107	[p9l1838t565r2139b633],
15	(	CD	NUMBER	(	num	16	SENT_107	[p9l14t673r208b763],
16	table	NN	O	table	prep_at	12	SENT_107	[p9l14t673r208b763],
17	1	CD	NUMBER	1	num	16	SENT_107	[p9l234t679r265b740],
18	and	CC	O	and	_	0	SENT_107	[p9l288t673r424b742],
19	webappendix	JJ	O	webappendix	amod	20	SENT_107	[p9l444t673r973b763],
20	)	NN	O	)	conj_and	12	SENT_107	[p9l444t673r973b763],
21	.	.	O	.	_	0	SENT_107	[p9l444t673r973b763],

1	These	DT	O	these	det	2	SENT_108	[p9l998t673r1217b742],
2	characteristics	NNS	O	characteristic	nsubj	8	SENT_108	[p9l1242t673r1760b742],
3	and	CC	O	and	_	0	SENT_108	[p9l1786t673r1922b742],
4	study	NN	O	study	nn	5	SENT_108	[p9l1946t673r2142b763],
5	outcomes	NNS	O	outcome	conj_and	2	SENT_108	[p9l9t796r362b850],
6	did	VBD	O	do	aux	8	SENT_108	[p9l411t782r528b850],
7	not	RB	O	not	neg	8	SENT_108	[p9l572t796r693b850],
8	differ	VB	O	differ	_	0	SENT_108	[p9l738t782r936b850],
9	from	IN	O	from	_	0	SENT_108	[p9l980t782r1162b850],
10	that	DT	O	that	prep_from	8	SENT_108	[p9l1206t782r1349b850],
11	of	IN	O	of	_	0	SENT_108	[p9l1393t782r1476b850],
12	the	DT	O	the	det	14	SENT_108	[p9l1507t782r1622b850],
13	total	JJ	O	total	amod	14	SENT_108	[p9l1667t782r1825b850],
14	PLATO	NNP	O	PLATO	prep_of	10	SENT_108	[p9l1874t787r2137b850],

1	population	NN	O	population	_	0	SENT_109	[p9l8t892r423b981],
2	,	,	O	,	_	0	SENT_109	[p9l8t892r423b981],
3	apart	RB	O	apart	_	0	SENT_109	[p9l438t905r623b981],
4	from	IN	O	from	_	0	SENT_109	[p9l632t892r814b959],
5	ethnic	JJ	O	ethnic	amod	6	SENT_109	[p9l825t892r1052b960],
6	group	NN	O	group	prep_apart_from	1	SENT_109	[p9l1064t916r1297b982],
7	:	:	O	:	_	0	SENT_109	[p9l1064t916r1297b982],
8	98	CD	PERCENT	98	num	9	SENT_109	[p9l1313t896r1472b963],
9	%	NN	PERCENT	%	dep	1	SENT_109	[p9l1313t896r1472b963],
10	(	CD	NUMBER	(	num	11	SENT_109	[p9l1489t898r1686b982],
11	n	NN	O	n	nsubj	12	SENT_109	[p9l1489t898r1686b982],
12	=	JJ	O	=	rcmod	9	SENT_109	[p9l1489t898r1686b982],
13	10	CD	NUMBER	10	number	14	SENT_109	[p9l1489t898r1686b982],
14	115	CD	NUMBER	115	num	15	SENT_109	[p9l1703t896r1809b959],
15	patients	NNS	O	patient	dobj	12	SENT_109	[p9l1823t896r2134b982],
16	)	CD	NUMBER	)	dep	15	SENT_109	[p9l1823t896r2134b982],
17	of	IN	O	of	_	0	SENT_109	[p9l9t1000r92b1069],
18	the	DT	O	the	det	20	SENT_109	[p9l99t1000r213b1069],
19	genetics	NNS	O	genetics	nn	20	SENT_109	[p9l237t1005r532b1090],
20	cohort	NN	O	cohort	prep_of	16	SENT_109	[p9l556t1000r790b1069],
21	compared	VBN	O	compare	_	0	SENT_109	[p9l811t1000r1177b1089],
22	with	IN	O	with	prepc_compared_with	20	SENT_109	[p9l1194t1000r1357b1069],
23	92	CD	PERCENT	92	num	24	SENT_109	[p9l1380t1005r1538b1071],
24	%	NN	PERCENT	%	pobj	20	SENT_109	[p9l1380t1005r1538b1071],
25	(	CD	NUMBER	(	num	26	SENT_109	[p9l1566t1005r1759b1090],
26	n	NN	O	n	dep	1	SENT_109	[p9l1566t1005r1759b1090],
27	=	JJ	O	=	amod	30	SENT_109	[p9l1566t1005r1759b1090],
28	17	CD	NUMBER	17	number	29	SENT_109	[p9l1566t1005r1759b1090],
29	077	CD	NUMBER	077	dep	27	SENT_109	[p9l1771t1005r1908b1090],
30	)	NN	O	)	nsubj	36	SENT_109	[p9l1771t1005r1908b1090],
31	of	IN	O	of	_	0	SENT_109	[p9l1936t1000r2018b1069],
32	the	DT	O	the	det	34	SENT_109	[p9l2025t1000r2139b1069],
33	total	JJ	O	total	amod	34	SENT_109	[p9l7t1109r166b1177],
34	cohort	NN	O	cohort	prep_of	30	SENT_109	[p9l203t1109r437b1177],
35	were	VBD	O	be	cop	36	SENT_109	[p9l469t1133r645b1177],
36	white	JJ	O	white	rcmod	26	SENT_109	[p9l679t1109r900b1177],
37	.	.	O	.	_	0	SENT_109	[p9l679t1109r900b1177],

1	Predicted	VBN	O	predict	csubj	7	SENT_110	[p9l944t1109r1288b1177],
2	phenotypes	NNS	O	phenotype	dobj	1	SENT_110	[p9l1322t1109r1741b1198],
3	and	CC	O	and	_	0	SENT_110	[p9l1781t1109r1917b1177],
4	allele	NN	O	allele	nn	5	SENT_110	[p9l1953t1109r2139b1177],
5	frequencies	NNS	O	frequency	conj_and	2	SENT_110	[p9l8t1219r432b1308],
6	were	VBD	O	be	cop	7	SENT_110	[p9l458t1243r633b1287],
7	representative	JJ	O	representative	_	0	SENT_110	[p9l659t1223r1174b1308],
8	of	IN	O	of	_	0	SENT_110	[p9l1201t1219r1283b1287],
9	a	DT	O	a	det	11	SENT_110	[p9l1296t1243r1332b1287],
10	white	JJ	O	white	amod	11	SENT_110	[p9l1355t1219r1557b1287],
11	population	NN	O	population	prep_of	7	SENT_110	[p9l1583t1219r1980b1308],
12	and	CC	O	and	_	0	SENT_110	[p9l2005t1219r2141b1287],
13	were	VBD	O	be	cop	14	SENT_110	[p9l7t1352r182b1396],
14	balanced	JJ	O	balanced	conj_and	7	SENT_110	[p9l205t1327r531b1396],
15	between	IN	O	between	_	0	SENT_110	[p9l553t1327r859b1396],
16	treatment	NN	O	treatment	nn	17	SENT_110	[p9l882t1341r1244b1396],
17	groups	NNS	O	group	prep_between	14	SENT_110	[p9l1267t1352r1518b1417],
18	(	RB	O	(	advmod	14	SENT_110	[p9l1550t1327r1744b1417],
19	table	NN	O	table	nn	21	SENT_110	[p9l1550t1327r1744b1417],
20	2	CD	NUMBER	2	num	21	SENT_110	[p9l1771t1334r1855b1417],
21	)	NN	O	)	dep	14	SENT_110	[p9l1771t1334r1855b1417],
22	.	.	O	.	_	0	SENT_110	[p9l1771t1334r1855b1417],

1	In	IN	O	in	_	0	SENT_111	[p9l83t1443r160b1503],
2	outcomes	NNS	O	outcome	prepc_in	23	SENT_111	[p9l192t1449r540b1504],
3	within	IN	O	within	_	0	SENT_111	[p9l572t1436r807b1504],
4	each	DT	O	each	det	6	SENT_111	[p9l838t1436r1002b1504],
5	treatment	NN	O	treatment	nn	6	SENT_111	[p9l1031t1449r1387b1504],
6	group	NN	O	group	prep_within	2	SENT_111	[p9l1418t1460r1630b1526],
7	in	IN	O	in	_	0	SENT_111	[p9l1662t1441r1735b1503],
8	relation	NN	O	relation	prep_in	6	SENT_111	[p9l1766t1436r2042b1504],
9	to	TO	O	to	_	0	SENT_111	[p9l2071t1449r2139b1504],
10	the	DT	O	the	det	14	SENT_111	[p9l7t1546r121b1614],
11	C	NN	O	c	nn	14	SENT_111	[p9l147t1551r201b1614],
12	YPZC	NN	O	ypzc	nn	14	SENT_111	[p9l206t1551r408b1614],
13	19	CD	NUMBER	19	num	14	SENT_111	[p9l412t1552r486b1614],
14	genotype	NN	O	genotype	prep_to	2	SENT_111	[p9l501t1559r826b1635],
15	and	CC	O	and	_	0	SENT_111	[p9l846t1545r981b1614],
16	predicted	VBD	O	predict	conj_and	2	SENT_111	[p9l998t1545r1335b1634],
17	phenotype	NN	O	phenotype	nn	18	SENT_111	[p9l1352t1545r1731b1635],
18	groupings	NNS	O	grouping	dobj	16	SENT_111	[p9l1752t1550r2136b1635],
19	,	,	O	,	_	0	SENT_111	[p9l1752t1550r2136b1635],
20	we	PRP	O	we	nsubj	23	SENT_111	[p9l7t1679r108b1722],
21	did	VBD	O	do	aux	23	SENT_111	[p9l142t1654r257b1722],
22	not	RB	O	not	neg	23	SENT_111	[p9l288t1668r408b1722],
23	identify	VB	O	identify	_	0	SENT_111	[p9l439t1654r714b1744],
24	any	DT	O	any	det	25	SENT_111	[p9l746t1679r874b1744],
25	model	NN	O	model	dobj	23	SENT_111	[p9l904t1654r1132b1722],
26	explaining	VBG	O	explain	partmod	25	SENT_111	[p9l1166t1654r1542b1744],
27	the	DT	O	the	det	28	SENT_111	[p9l1573t1654r1686b1722],
28	variation	NN	O	variation	dobj	26	SENT_111	[p9l1718t1659r2035b1722],
29	in	IN	O	in	_	0	SENT_111	[p9l2068t1659r2140b1721],
30	clinical	JJ	O	clinical	amod	31	SENT_111	[p9l9t1763r263b1831],
31	outcomes	NNS	O	outcome	prep_in	28	SENT_111	[p9l322t1776r669b1831],
32	so	RB	O	so	advmod	26	SENT_111	[p9l732t1787r807b1831],
33	genotype	NN	O	genotype	nn	34	SENT_111	[p9l867t1776r1192b1853],
34	groupings	NNS	O	grouping	nsubjpass	26	SENT_111	[p9l1252t1768r1617b1853],
35	in	IN	O	in	_	0	SENT_111	[p9l1677t1768r1750b1830],
36	the	DT	O	the	det	38	SENT_111	[p9l1807t1763r1920b1831],
37	ﬁnal	JJ	O	ﬁnal	amod	38	SENT_111	[p9l1979t1763r2140b1831],
38	comparisons	NNS	O	comparison	prep_in	34	SENT_111	[p9l9t1877r471b1961],
39	were	VBD	O	be	auxpass	26	SENT_111	[p9l495t1897r668b1941],
40	based	VBN	O	base	_	0	SENT_111	[p9l690t1872r899b1941],
41	on	IN	O	on	_	0	SENT_111	[p9l921t1897r1013b1941],
42	the	DT	O	the	det	43	SENT_111	[p9l1034t1873r1148b1941],
43	presence	NN	O	presence	prep_based_on	26	SENT_111	[p9l1171t1897r1490b1961],
44	or	CC	O	or	_	0	SENT_111	[p9l1515t1897r1590b1941],
45	absence	NN	O	absence	prep_based_on	26	SENT_111	[p9l1613t1873r1897b1941],
46	of	IN	O	of	_	0	SENT_111	[p9l1922t1872r2004b1941],
47	any	DT	O	any	det	49	SENT_111	[p9l2014t1897r2142b1962],
48	loss-of-function	JJ	O	loss-of-function	amod	49	SENT_111	[p9l7t1981r568b2049],
49	allele	NN	O	allele	prep_of	43	SENT_111	[p9l599t1981r799b2049],
50	.	.	O	.	_	0	SENT_111	[p9l599t1981r799b2049],

1	The	DT	O	the	det	4	SENT_112	[p9l833t1981r973b2049],
2	primary	JJ	O	primary	amod	4	SENT_112	[p9l1004t1986r1294b2071],
3	composite	JJ	O	composite	amod	4	SENT_112	[p9l1324t1986r1694b2070],
4	outcome	NN	O	outcome	nsubjpass	20	SENT_112	[p9l1726t1995r2039b2049],
5	of	IN	O	of	_	0	SENT_112	[p9l2072t1981r2153b2049],
6	cardiovascular	JJ	O	cardiovascular	amod	7	SENT_112	[p9l9t2092r524b2160],
7	death	NN	O	death	prep_of	4	SENT_112	[p9l549t2092r763b2170],
8	,	,	O	,	_	0	SENT_112	[p9l549t2092r763b2170],
9	myocardial	JJ	O	myocardial	amod	10	SENT_112	[p9l791t2092r1190b2181],
10	infarction	NN	O	infarction	prep_of	4	SENT_112	[p9l1214t2092r1583b2170],
11	,	,	O	,	_	0	SENT_112	[p9l1214t2092r1583b2170],
12	or	CC	O	or	_	0	SENT_112	[p9l1612t2116r1687b2160],
13	stroke	NN	O	stroke	prep_of	4	SENT_112	[p9l1712t2092r1928b2160],
14	up	RB	DURATION	up	advmod	4	SENT_112	[p9l1952t2116r2047b2181],
15	to	TO	DURATION	to	_	0	SENT_112	[p9l2071t2105r2139b2160],
16	12	CD	DURATION	12	num	17	SENT_112	[p9l11t2207r83b2267],
17	months	NNS	NUMBER	month	prep_to	14	SENT_112	[p9l113t2200r391b2269],
18	was	VBD	O	be	auxpass	20	SENT_112	[p9l420t2225r555b2269],
19	consistently	RB	O	consistently	advmod	20	SENT_112	[p9l586t2200r1015b2290],
20	reduced	VBN	O	reduce	_	0	SENT_112	[p9l1041t2200r1331b2269],
21	with	IN	O	with	_	0	SENT_112	[p9l1356t2201r1516b2269],
22	ticagrelor	NN	O	ticagrelor	prep_with	20	SENT_112	[p9l1542t2201r1883b2290],
23	versus	CC	O	versus	xcomp	20	SENT_112	[p9l1908t2225r2138b2269],

1	Articles	NNPS	O	Articles	_	0	SENT_113	[p9l6t2769r156b2805],
2	I	PRP	O	I	dep	1	SENT_113	[p9l205t2606r252b2805],

1	clopidogrel	NN	O	clopidogrel	_	0	SENT_114	[p9l9t3064r408b3153],
2	in	IN	O	in	_	0	SENT_114	[p9l447t3068r520b3130],
3	patients	NNS	O	patient	prep_in	1	SENT_114	[p9l559t3068r841b3152],
4	in	IN	O	in	_	0	SENT_114	[p9l883t3068r955b3130],
5	each	DT	O	each	det	7	SENT_114	[p9l995t3064r1159b3132],
6	genotype	NN	O	genotype	nn	7	SENT_114	[p9l1199t3077r1522b3153],
7	group	NN	O	group	prep_in	3	SENT_114	[p9l1564t3088r1776b3153],
8	(	CD	NUMBER	(	num	9	SENT_114	[p9l1821t3064r2012b3153],
9	table	NN	O	table	dep	1	SENT_114	[p9l1821t3064r2012b3153],
10	3	CD	NUMBER	3	num	11	SENT_114	[p9l2056t3070r2135b3153],
11	)	NN	O	)	dep	9	SENT_114	[p9l2056t3070r2135b3153],
12	.	.	O	.	_	0	SENT_114	[p9l2056t3070r2135b3153],

1	This	DT	O	this	det	2	SENT_115	[p9l7t3172r166b3240],
2	difference	NN	O	difference	nsubjpass	4	SENT_115	[p9l218t3172r578b3240],
3	was	VBD	O	be	auxpass	4	SENT_115	[p9l626t3196r761b3240],
4	driven	VBN	O	drive	_	0	SENT_115	[p9l814t3172r1041b3240],
5	by	IN	O	by	_	0	SENT_115	[p9l1089t3172r1174b3262],
6	consistent	JJ	O	consistent	amod	7	SENT_115	[p9l1222t3177r1589b3240],
7	reductions	NNS	O	reduction	agent	4	SENT_115	[p9l1636t3172r2016b3240],
8	in	IN	O	in	_	0	SENT_115	[p9l2067t3177r2140b3239],
9	vwvw	NN	O	vwvw	prep_in	7	SENT_115	[p9l794t2471r1327b2522],
10	.	.	O	.	_	0	SENT_115	[p9l794t2471r1327b2522],

1	the	DT	O	the	det	2	SENT_116	[p9l794t2471r1327b2522],
2	|	NN	O	|	_	0	SENT_116	[p9l794t2471r1327b2522],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_116	[p9l794t2471r1327b2522],
4	Vol	NNP	O	Vol	dep	2	SENT_116	[p9l1370t2471r1457b2522],
5	376	CD	NUMBER	376	num	6	SENT_116	[p9l1477t2470r1580b2529],
6	October	NNP	DATE	October	dep	2	SENT_116	[p9l1626t2471r1850b2522],
7	16,2010	CD	DATE	16,2010	num	6	SENT_116	[p9l1867t2470r2111b2531],

1	cardiovascular	JJ	O	cardiovascular	amod	2	SENT_117	[p10l9t17r524b85],
2	death	NN	O	death	_	0	SENT_117	[p10l566t17r764b85],
3	and	CC	O	and	_	0	SENT_117	[p10l806t17r941b85],
4	myocardial	JJ	O	myocardial	amod	5	SENT_117	[p10l981t17r1379b106],
5	infarction	NN	O	infarction	conj_and	2	SENT_117	[p10l1420t17r1789b85],
6	.	.	O	.	_	0	SENT_117	[p10l1420t17r1789b85],

1	Rates	NNS	O	rate	nsubj	6	SENT_118	[p10l1839t23r2026b85],
2	of	IN	O	of	_	0	SENT_118	[p10l2071t17r2153b85],
3	stent	JJ	O	stent	amod	4	SENT_118	[p10l11t139r186b194],
4	thrombosis	NN	O	thrombosis	prep_of	1	SENT_118	[p10l217t125r627b194],
5	were	VBD	O	be	cop	6	SENT_118	[p10l662t150r835b194],
6	low	JJ	O	low	_	0	SENT_118	[p10l869t125r998b194],
7	in	IN	O	in	prep	6	SENT_118	[p10l1030t130r1103b192],
8	both	CC	O	both	prep	6	SENT_118	[p10l1135t125r1300b194],
9	treatment	NN	O	treatment	nn	10	SENT_118	[p10l1332t139r1689b194],
10	groups	NNS	O	group	dep	8	SENT_118	[p10l1722t150r1969b215],
11	and	CC	O	and	_	0	SENT_118	[p10l2007t125r2141b194],
12	were	VBD	O	be	cop	15	SENT_118	[p10l7t258r180b302],
13	also	RB	O	also	advmod	15	SENT_118	[p10l217t234r355b302],
14	consistently	RB	O	consistently	advmod	15	SENT_118	[p10l393t234r821b323],
15	lower	JJR	O	lower	conj_and	6	SENT_118	[p10l854t234r1055b302],
16	in	IN	O	in	_	0	SENT_118	[p10l1089t239r1162b301],
17	the	DT	O	the	det	18	SENT_118	[p10l1196t234r1309b302],
18	ticagrelor	NN	O	ticagrelor	prep_in	15	SENT_118	[p10l1345t234r1685b324],
19	than	IN	O	than	prep	15	SENT_118	[p10l1718t234r1883b302],
20	in	IN	O	in	pcomp	19	SENT_118	[p10l1919t239r1992b301],
21	the	DT	O	the	det	23	SENT_118	[p10l2026t234r2139b302],
22	clopidogrel	NN	O	clopidogrel	nn	23	SENT_118	[p10l9t344r408b434],
23	group	NN	O	group	pobj	20	SENT_118	[p10l458t368r670b434],
24	(	CD	NUMBER	(	num	27	SENT_118	[p10l725t344r916b434],
25	table	NN	O	table	nn	27	SENT_118	[p10l725t344r916b434],
26	3	CD	NUMBER	3	num	27	SENT_118	[p10l969t350r1049b434],
27	)	NN	O	)	nsubj	15	SENT_118	[p10l969t350r1049b434],
28	.	.	O	.	_	0	SENT_118	[p10l969t350r1049b434],

1	For	IN	O	for	_	0	SENT_119	[p10l1106t348r1223b411],
2	the	DT	O	the	det	5	SENT_119	[p10l1269t344r1382b411],
3	primary	JJ	O	primary	amod	5	SENT_119	[p10l1431t348r1722b433],
4	composite	JJ	O	composite	amod	5	SENT_119	[p10l1769t348r2139b433],
5	endpoint	NN	O	endpoint	prep_for	9	SENT_119	[p10l9t452r351b541],
6	,	,	O	,	_	0	SENT_119	[p10l9t452r351b541],
7	Kaplan-Meier	NNP	O	Kaplan-Meier	nn	8	SENT_119	[p10l384t452r871b541],
8	curves	NNS	O	curve	nsubj	9	SENT_119	[p10l897t477r1124b521],
9	showed	VBD	O	show	_	0	SENT_119	[p10l1156t452r1429b521],
10	an	DT	O	a	det	12	SENT_119	[p10l1455t477r1543b521],
11	early	JJ	O	early	amod	12	SENT_119	[p10l1570t452r1740b542],
12	separation	NN	O	separation	dobj	9	SENT_119	[p10l1767t457r2140b541],
13	of	IN	O	of	_	0	SENT_119	[p10l9t562r91b630],
14	event	NN	O	event	nn	15	SENT_119	[p10l126t575r318b630],
15	rates	NNS	O	rate	prep_of	12	SENT_119	[p10l363t575r532b630],
16	at	IN	O	at	_	0	SENT_119	[p10l583t575r646b630],
17	30	CD	DURATION	30	num	18	SENT_119	[p10l696t568r776b630],
18	days	NNS	NUMBER	day	prep_at	9	SENT_119	[p10l825t562r979b651],
19	for	IN	O	for	_	0	SENT_119	[p10l1029t562r1132b630],
20	patients	NNS	O	patient	prep_for	18	SENT_119	[p10l1177t567r1460b651],
21	with	IN	O	with	_	0	SENT_119	[p10l1508t562r1668b630],
22	any	DT	O	any	det	24	SENT_119	[p10l1716t586r1843b651],
23	lossoffunction	NN	O	lossoffunction	nn	24	SENT_119	[p10l1887t562r2138b630, p10l8t671r315b740],
24	allele	NN	O	allele	prep_with	20	SENT_119	[p10l332t671r515b740],
25	between	IN	O	between	_	0	SENT_119	[p10l530t672r833b740],
26	the	DT	O	the	det	28	SENT_119	[p10l848t672r961b740],
27	ticagrelor	NN	O	ticagrelor	nn	28	SENT_119	[p10l977t672r1318b761],
28	(	NN	O	(	prep_between	24	SENT_119	[p10l1339t678r1423b761],
29	4	CD	NUMBER	4	dep	28	SENT_119	[p10l1339t678r1423b761],
30	-	:	O	-	_	0	SENT_119	[p10l1339t678r1423b761],
31	1	CD	PERCENT	1	num	32	SENT_119	[p10l1442t676r1567b761],
32	%	NN	PERCENT	%	dep	28	SENT_119	[p10l1442t676r1567b761],
33	)	CD	NUMBER	)	nsubj	37	SENT_119	[p10l1442t676r1567b761],
34	and	CC	O	and	_	0	SENT_119	[p10l1590t672r1725b740],
35	clopidogrel	NN	O	clopidogrel	nn	36	SENT_119	[p10l1741t672r2140b761],
36	groups	NNS	O	group	nsubj	37	SENT_119	[p10l10t805r257b870],
37	(	VBP	O	(	rcmod	32	SENT_119	[p10l292t785r523b870],
38	5-7	CD	PERCENT	5-7	num	39	SENT_119	[p10l292t785r523b870],
39	%	NN	PERCENT	%	dobj	37	SENT_119	[p10l292t785r523b870],
40	;	:	O	;	_	0	SENT_119	[p10l292t785r523b870],
41	HR	NN	DURATION	hr	dep	32	SENT_119	[p10l559t787r685b847],
42	0-73	CD	NUMBER	0-73	num	41	SENT_119	[p10l712t785r891b858],
43	,	,	O	,	_	0	SENT_119	[p10l712t785r891b858],
44	95	CD	PERCENT	95	number	45	SENT_119	[p10l924t785r1080b851],
45	%	NN	PERCENT	%	amod	47	SENT_119	[p10l924t785r1080b851],
46	CI	NN	O	ci	nn	47	SENT_119	[p10l1111t786r1193b849],
47	O-52-1-O3	NN	O	o-52-1-o3	appos	41	SENT_119	[p10l1224t785r1616b859],
48	,	,	O	,	_	0	SENT_119	[p10l1224t785r1616b859],
49	p	NN	O	p	appos	32	SENT_119	[p10l1646t785r1990b870],
50	=	JJ	O	=	amod	62	SENT_119	[p10l1646t785r1990b870],
51	0-078	CD	NUMBER	0-078	num	52	SENT_119	[p10l1646t785r1990b870],
52	)	NN	O	)	nn	62	SENT_119	[p10l1646t785r1990b870],
53	,	,	O	,	_	0	SENT_119	[p10l1646t785r1990b870],
54	but	CC	O	but	_	0	SENT_119	[p10l2020t780r2141b849],
55	not	RB	O	not	nn	62	SENT_119	[p10l8t902r128b957],
56	for	IN	O	for	_	0	SENT_119	[p10l150t889r254b957],
57	patients	NNS	O	patient	prep_for	55	SENT_119	[p10l275t894r558b978],
58	without	IN	O	without	_	0	SENT_119	[p10l583t889r863b957],
59	any	DT	O	any	det	61	SENT_119	[p10l887t913r1014b978],
60	loss-of-function	JJ	O	loss-of-function	amod	61	SENT_119	[p10l1035t889r1595b957],
61	allele	NN	O	allele	prep_without	55	SENT_119	[p10l1620t889r1803b957],
62	(	NN	O	(	dep	49	SENT_119	[p10l1833t895r1891b979],
63	3	CD	NUMBER	3	dep	49	SENT_119	[p10l1833t895r1891b979],
64	-	:	O	-	_	0	SENT_119	[p10l1911t928r1922b940],
65	8	CD	PERCENT	8	num	66	SENT_119	[p10l1939t893r2053b960],
66	%	NN	PERCENT	%	dep	32	SENT_119	[p10l1939t893r2053b960],
67	vs	CC	O	vs	_	0	SENT_119	[p10l2077t913r2141b956],
68	3-8	CD	PERCENT	3-8	num	69	SENT_119	[p10l13t1003r226b1077],
69	%	NN	PERCENT	%	dep	32	SENT_119	[p10l13t1003r226b1077],
70	;	:	O	;	_	0	SENT_119	[p10l13t1003r226b1077],
71	0-96	CD	NUMBER	0-96	dep	32	SENT_119	[p10l306t1005r492b1077],
72	,	,	O	,	_	0	SENT_119	[p10l306t1005r492b1077],
73	0-76-1-22	CD	NUMBER	0-76-1-22	appos	71	SENT_119	[p10l572t1003r957b1077],
74	,	,	O	,	_	0	SENT_119	[p10l572t1003r957b1077],
75	p	NN	O	p	appos	32	SENT_119	[p10l1036t1003r1311b1087],
76	=	JJ	O	=	amod	75	SENT_119	[p10l1036t1003r1311b1087],
77	0-76	CD	NUMBER	0-76	tmod	76	SENT_119	[p10l1036t1003r1311b1087],
78	;	:	O	;	_	0	SENT_119	[p10l1036t1003r1311b1087],
79	interaction	NN	O	interaction	nn	80	SENT_119	[p10l1390t1003r1780b1067],
80	p	NN	O	p	dep	32	SENT_119	[p10l1855t1005r2136b1087],
81	=	JJ	O	=	amod	80	SENT_119	[p10l1855t1005r2136b1087],
82	0-20	CD	NUMBER	0-20	tmod	81	SENT_119	[p10l1855t1005r2136b1087],
83	;	:	O	;	_	0	SENT_119	[p10l1855t1005r2136b1087],
84	ﬁgure	NN	O	ﬁgure	dep	32	SENT_119	[p10l8t1107r222b1197],
85	1	CD	NUMBER	1	num	86	SENT_119	[p10l252t1113r326b1197],
86	)	NN	O	)	dep	84	SENT_119	[p10l252t1113r326b1197],
87	.	.	O	.	_	0	SENT_119	[p10l252t1113r326b1197],

1	In	IN	O	in	_	0	SENT_120	[p10l361t1114r438b1174],
2	a	DT	O	a	det	4	SENT_120	[p10l465t1132r502b1175],
3	landmark	NN	O	landmark	nn	4	SENT_120	[p10l527t1107r881b1175],
4	analysis	NN	O	analysis	prep_in	22	SENT_120	[p10l907t1107r1187b1197],
5	of	IN	O	of	_	0	SENT_120	[p10l1218t1107r1299b1175],
6	the	DT	O	the	det	9	SENT_120	[p10l1312t1107r1425b1175],
7	primary	JJ	O	primary	amod	9	SENT_120	[p10l1453t1112r1743b1197],
8	composite	JJ	O	composite	amod	9	SENT_120	[p10l1769t1112r2139b1196],
9	endpoint	NN	O	endpoint	prep_of	4	SENT_120	[p10l9t1217r335b1306],
10	from	IN	O	from	_	0	SENT_120	[p10l356t1217r535b1285],
11	day	NN	DURATION	day	nn	13	SENT_120	[p10l559t1217r682b1306],
12	31	CD	NUMBER	31	num	13	SENT_120	[p10l707t1223r779b1285],
13	onwards	NNS	O	onward	prep_from	9	SENT_120	[p10l803t1217r1127b1295],
14	,	,	O	,	_	0	SENT_120	[p10l803t1217r1127b1295],
15	event	NN	O	event	nn	16	SENT_120	[p10l1155t1230r1347b1285],
16	rates	NNS	O	rate	nsubj	22	SENT_120	[p10l1368t1230r1537b1285],
17	at	IN	O	at	_	0	SENT_120	[p10l1563t1230r1627b1285],
18	end	NN	O	end	prep_at	16	SENT_120	[p10l1649t1217r1783b1285],
19	of	IN	O	of	_	0	SENT_120	[p10l1806t1217r1887b1285],
20	followup	NN	O	followup	prep_of	18	SENT_120	[p10l1897t1217r2138b1285, p10l7t1351r102b1415],
21	were	VBD	O	be	cop	22	SENT_120	[p10l122t1351r294b1395],
22	similar	JJ	O	similar	_	0	SENT_120	[p10l318t1327r571b1395],
23	between	IN	O	between	_	0	SENT_120	[p10l587t1327r890b1395],
24	treatment	NN	O	treatment	nn	25	SENT_120	[p10l909t1340r1265b1395],
25	groups	NNS	O	group	prep_between	22	SENT_120	[p10l1285t1351r1532b1416],
26	for	IN	O	for	_	0	SENT_120	[p10l1554t1326r1658b1395],
27	patients	NNS	O	patient	prep_for	25	SENT_120	[p10l1676t1331r1959b1415],
28	with	IN	O	with	_	0	SENT_120	[p10l1979t1327r2140b1395],
29	any	DT	O	any	det	32	SENT_120	[p10l9t1460r137b1525],
30	loss-of-function	JJ	O	loss-of-function	amod	32	SENT_120	[p10l173t1435r734b1503],
31	allele	NN	O	allele	nn	32	SENT_120	[p10l774t1435r956b1503],
32	(	NN	O	(	prep_with	22	SENT_120	[p10l1003t1441r1209b1525],
33	0-82	CD	NUMBER	0-82	dep	32	SENT_120	[p10l1003t1441r1209b1525],
34	,	,	O	,	_	0	SENT_120	[p10l1003t1441r1209b1525],
35	0-58-1-17	CD	NUMBER	0-58-1-17	appos	32	SENT_120	[p10l1253t1440r1629b1513],
36	,	,	O	,	_	0	SENT_120	[p10l1253t1440r1629b1513],
37	p	NN	O	p	appos	35	SENT_120	[p10l1671t1441r1978b1525],
38	=	JJ	O	=	amod	40	SENT_120	[p10l1671t1441r1978b1525],
39	0-28	CD	NUMBER	0-28	tmod	38	SENT_120	[p10l1671t1441r1978b1525],
40	)	NN	O	)	dep	37	SENT_120	[p10l1671t1441r1978b1525],
41	,	,	O	,	_	0	SENT_120	[p10l1671t1441r1978b1525],
42	but	CC	O	but	_	0	SENT_120	[p10l2020t1435r2141b1503],
43	were	VBD	O	be	cop	44	SENT_120	[p10l7t1569r180b1612],
44	lower	JJR	O	lower	conj_but	22	SENT_120	[p10l210t1545r411b1612],
45	in	IN	O	in	_	0	SENT_120	[p10l440t1549r513b1611],
46	the	DT	O	the	det	48	SENT_120	[p10l542t1545r655b1612],
47	ticagrelor	NN	O	ticagrelor	nn	48	SENT_120	[p10l685t1545r1026b1635],
48	group	NN	O	group	prep_in	44	SENT_120	[p10l1056t1569r1269b1635],
49	than	IN	O	than	dep	44	SENT_120	[p10l1299t1545r1463b1612],
50	in	IN	O	in	_	0	SENT_120	[p10l1493t1549r1567b1611],
51	the	DT	O	the	det	53	SENT_120	[p10l1596t1545r1709b1612],
52	clopidogrel	NN	O	clopidogrel	nn	53	SENT_120	[p10l1741t1545r2140b1635],
53	group	NN	O	group	prep_in	44	SENT_120	[p10l10t1678r222b1743],
54	for	IN	O	for	_	0	SENT_120	[p10l262t1653r365b1722],
55	those	DT	O	those	prep_for	53	SENT_120	[p10l402t1654r595b1722],
56	without	IN	O	without	_	0	SENT_120	[p10l632t1654r913b1722],
57	any	DT	O	any	det	59	SENT_120	[p10l951t1678r1078b1743],
58	loss-offunction	JJ	O	loss-offunction	amod	59	SENT_120	[p10l1114t1653r1675b1722],
59	allele	NN	O	allele	prep_without	55	SENT_120	[p10l1715t1653r1897b1722],
60	(	CD	NUMBER	(	num	61	SENT_120	[p10l1943t1658r2136b1743],
61	0-77	CD	NUMBER	0-77	tmod	55	SENT_120	[p10l1943t1658r2136b1743],
62	,	,	O	,	_	0	SENT_120	[p10l1943t1658r2136b1743],
63	o	NN	O	o	appos	61	SENT_120	[p10l9t1768r49b1830],
64	-	:	O	-	_	0	SENT_120	[p10l66t1801r77b1813],
65	63-0	CD	NUMBER	63-0	dep	53	SENT_120	[p10l94t1768r263b1830],
66	-	:	O	-	_	0	SENT_120	[p10l280t1801r291b1813],
67	96	CD	DATE	96	dep	53	SENT_120	[p10l308t1768r409b1840],
68	,	,	O	,	_	0	SENT_120	[p10l308t1768r409b1840],
69	p	NN	O	p	nn	71	SENT_120	[p10l434t1768r571b1851],
70	=	JJ	O	=	amod	71	SENT_120	[p10l434t1768r571b1851],
71	o	NN	O	o	appos	67	SENT_120	[p10l434t1768r571b1851],
72	-	:	O	-	_	0	SENT_120	[p10l587t1801r597b1813],
73	017	CD	NUMBER	017	dep	53	SENT_120	[p10l614t1767r744b1840],
74	;	:	O	;	_	0	SENT_120	[p10l614t1767r744b1840],
75	interaction	NN	O	interaction	nn	76	SENT_120	[p10l770t1767r1160b1830],
76	p	NN	O	p	dep	53	SENT_120	[p10l1182t1768r1317b1851],
77	=	JJ	O	=	amod	78	SENT_120	[p10l1182t1768r1317b1851],
78	o	NN	O	o	dep	76	SENT_120	[p10l1182t1768r1317b1851],
79	-	:	O	-	_	0	SENT_120	[p10l1334t1801r1345b1813],
80	77	CD	DATE	77	dep	53	SENT_120	[p10l1360t1767r1449b1840],
81	;	:	O	;	_	0	SENT_120	[p10l1360t1767r1449b1840],
82	ﬁgure	NN	O	ﬁgure	nn	84	SENT_120	[p10l1476t1762r1689b1852],
83	2	CD	NUMBER	2	num	84	SENT_120	[p10l1715t1769r1797b1852],
84	)	NN	O	)	dep	53	SENT_120	[p10l1715t1769r1797b1852],
85	.	.	O	.	_	0	SENT_120	[p10l1715t1769r1797b1852],

1	In	IN	O	in	_	0	SENT_121	[p10l83t1878r161b1938],
2	analysis	NN	O	analysis	prep_in	24	SENT_121	[p10l190t1872r475b1961],
3	of	IN	O	of	_	0	SENT_121	[p10l507t1872r589b1939],
4	outcome	NN	O	outcome	prep_of	2	SENT_121	[p10l605t1885r922b1939],
5	between	IN	O	between	_	0	SENT_121	[p10l949t1872r1256b1940],
6	the	DT	O	the	det	8	SENT_121	[p10l1283t1872r1397b1939],
7	genotype	NN	O	genotype	nn	8	SENT_121	[p10l1427t1885r1756b1962],
8	groups	NNS	O	group	prep_between	4	SENT_121	[p10l1786t1896r2036b1962],
9	in	IN	O	in	_	0	SENT_121	[p10l2067t1876r2140b1938],
10	each	DT	O	each	det	12	SENT_121	[p10l9t2009r175b2078],
11	treatment	NN	O	treatment	nn	12	SENT_121	[p10l225t2023r587b2078],
12	group	NN	O	group	prep_in	8	SENT_121	[p10l638t2034r872b2099],
13	,	,	O	,	_	0	SENT_121	[p10l638t2034r872b2099],
14	the	DT	O	the	det	16	SENT_121	[p10l926t2009r1040b2078],
15	event	NN	O	event	nn	16	SENT_121	[p10l1094t2023r1289b2078],
16	rate	NN	O	rate	nsubj	24	SENT_121	[p10l1339t2023r1475b2078],
17	for	IN	O	for	_	0	SENT_121	[p10l1527t2009r1632b2078],
18	the	DT	O	the	det	21	SENT_121	[p10l1680t2009r1795b2078],
19	primary	JJ	O	primary	amod	21	SENT_121	[p10l1847t2014r2142b2099],
20	composite	JJ	O	composite	amod	21	SENT_121	[p10l9t2153r385b2237],
21	endpoint	NN	O	endpoint	prep_for	16	SENT_121	[p10l455t2148r785b2237],
22	was	VBD	O	be	cop	24	SENT_121	[p10l849t2172r986b2216],
23	numerically	RB	O	numerically	advmod	24	SENT_121	[p10l1056t2148r1496b2238],
24	greater	JJR	O	greater	_	0	SENT_121	[p10l1563t2162r1819b2238],
25	in	IN	O	in	_	0	SENT_121	[p10l1885t2153r1958b2215],
26	the	DT	O	the	det	28	SENT_121	[p10l2025t2148r2139b2216],
27	clopidogrel	NN	O	clopidogrel	nn	28	SENT_121	[p10l9t2257r416b2347],
28	group	NN	O	group	prep_in	24	SENT_121	[p10l452t2282r667b2347],
29	for	IN	O	for	_	0	SENT_121	[p10l702t2257r807b2325],
30	patients	NNS	O	patient	prep_for	28	SENT_121	[p10l840t2262r1127b2346],
31	with	IN	O	with	_	0	SENT_121	[p10l1163t2257r1325b2325],
32	versus	CC	O	versus	cc	33	SENT_121	[p10l1358t2281r1591b2325],
33	those	DT	O	those	prep_with	24	SENT_121	[p10l1627t2257r1823b2325],
34	without	IN	O	without	_	0	SENT_121	[p10l1857t2257r2141b2325],
35	any	DT	O	any	det	39	SENT_121	[p10l9t2391r138b2456],
36	loss-of-function	JJ	O	loss-of-function	amod	39	SENT_121	[p10l154t2367r726b2434],
37	allele	NN	O	allele	nn	39	SENT_121	[p10l746t2367r932b2434],
38	(	NN	O	(	nn	39	SENT_121	[p10l958t2373r1117b2457],
39	p	NN	O	p	prep_without	33	SENT_121	[p10l958t2373r1117b2457],
40	=	JJ	O	=	amod	41	SENT_121	[p10l958t2373r1117b2457],
41	o	NN	O	o	dep	33	SENT_121	[p10l958t2373r1117b2457],
42	-	:	O	-	_	0	SENT_121	[p10l1134t2406r1144b2417],
43	25	CD	DATE	25	dep	33	SENT_121	[p10l1164t2371r1264b2445],
44	;	:	O	;	_	0	SENT_121	[p10l1164t2371r1264b2445],
45	table	NN	O	table	nn	47	SENT_121	[p10l1286t2367r1460b2434],
46	3	CD	NUMBER	3	num	47	SENT_121	[p10l1485t2373r1567b2457],
47	)	NN	O	)	dep	33	SENT_121	[p10l1485t2373r1567b2457],
48	.	.	O	.	_	0	SENT_121	[p10l1485t2373r1567b2457],

1	This	DT	O	this	det	2	SENT_122	[p10l1589t2367r1750b2434],
2	difference	NN	O	difference	nsubjpass	4	SENT_122	[p10l1773t2367r2139b2434],
3	was	VBD	O	be	auxpass	4	SENT_122	[p10l7t2500r143b2544],
4	caused	VBN	O	cause	dep	19	SENT_122	[p10l177t2475r427b2544],
5	by	IN	O	by	_	0	SENT_122	[p10l455t2475r541b2565],
6	an	DT	O	a	det	8	SENT_122	[p10l571t2500r659b2544],
7	early	JJ	O	early	amod	8	SENT_122	[p10l690t2475r864b2565],
8	separation	NN	O	separation	agent	4	SENT_122	[p10l895t2480r1275b2564],
9	of	IN	O	of	_	0	SENT_122	[p10l1306t2475r1388b2544],
10	event	NN	O	event	nn	11	SENT_122	[p10l1406t2489r1601b2544],
11	rates	NNS	O	rate	prep_of	8	SENT_122	[p10l1630t2489r1801b2544],
12	between	IN	O	between	_	0	SENT_122	[p10l1833t2475r2140b2544],
13	the	DT	O	the	det	15	SENT_122	[p10l7t2584r122b2652],
14	genotype	NN	O	genotype	nn	15	SENT_122	[p10l145t2597r474b2674],
15	groups	NNS	O	group	prep_between	11	SENT_122	[p10l497t2608r748b2674],
16	at	IN	O	at	_	0	SENT_122	[p10l773t2597r837b2652],
17	30	CD	DURATION	30	num	18	SENT_122	[p10l860t2590r941b2652],
18	days	NNS	NUMBER	day	prep_at	4	SENT_122	[p10l964t2584r1121b2673],
19	(	VBP	O	(	_	0	SENT_122	[p10l1150t2588r1345b2674],
20	1-37	CD	NUMBER	1-37	nsubj	19	SENT_122	[p10l1150t2588r1345b2674],
21	,	,	O	,	_	0	SENT_122	[p10l1150t2588r1345b2674],
22	1	LS	NUMBER	1	appos	20	SENT_122	[p10l1374t2590r1431b2651],
23	-	:	O	-	_	0	SENT_122	[p10l1374t2590r1431b2651],
24	04-1	CD	NUMBER	04-1	num	26	SENT_122	[p10l1448t2590r1608b2652],
25	-	:	O	-	_	0	SENT_122	[p10l1625t2623r1636b2635],
26	82	CD	DATE	82	dep	22	SENT_122	[p10l1653t2590r1756b2662],
27	,	,	O	,	_	0	SENT_122	[p10l1653t2590r1756b2662],
28	p	NN	O	p	nn	30	SENT_122	[p10l1780t2590r1917b2673],
29	=	JJ	O	=	amod	30	SENT_122	[p10l1780t2590r1917b2673],
30	o	NN	O	o	appos	26	SENT_122	[p10l1780t2590r1917b2673],
31	-	:	O	-	_	0	SENT_122	[p10l1934t2623r1945b2635],
32	028	CD	NUMBER	028	num	33	SENT_122	[p10l1963t2590r2135b2674],
33	)	NN	O	)	dep	22	SENT_122	[p10l1963t2590r2135b2674],
34	.	.	O	.	_	0	SENT_122	[p10l1963t2590r2135b2674],

1	For	IN	O	for	_	0	SENT_123	[p10l13t2698r132b2761],
2	all	DT	O	all	det	5	SENT_123	[p10l170t2694r253b2761],
3	other	JJ	O	other	amod	5	SENT_123	[p10l292t2694r484b2761],
4	efficacy	NN	O	efficacy	nn	5	SENT_123	[p10l522t2694r794b2783],
5	events	NNS	O	event	prep_for	13	SENT_123	[p10l832t2707r1080b2772],
6	,	,	O	,	_	0	SENT_123	[p10l832t2707r1080b2772],
7	no	DT	O	no	det	8	SENT_123	[p10l1122t2718r1215b2761],
8	differences	NNS	O	difference	appos	5	SENT_123	[p10l1255t2694r1656b2761],
9	in	IN	O	in	_	0	SENT_123	[p10l1697t2698r1770b2760],
10	genotype	NN	O	genotype	nn	11	SENT_123	[p10l1810t2707r2139b2784],
11	group	NN	O	group	prep_in	8	SENT_123	[p10l10t2827r225b2892],
12	were	VBD	O	be	cop	13	SENT_123	[p10l287t2827r462b2871],
13	signiﬁcant	JJ	O	signiﬁcant	_	0	SENT_123	[p10l528t2802r912b2892],
14	for	IN	O	for	_	0	SENT_123	[p10l974t2802r1078b2871],
15	comparisons	NNS	O	comparison	prep_for	13	SENT_123	[p10l1140t2807r1610b2891],
16	within	IN	O	within	_	0	SENT_123	[p10l1673t2802r1911b2871],
17	each	DT	O	each	det	19	SENT_123	[p10l1975t2802r2140b2871],
18	treatment	NN	O	treatment	nn	19	SENT_123	[p10l7t2924r369b2979],
19	group	NN	O	group	prep_within	13	SENT_123	[p10l393t2935r608b3001],
20	(	CD	NUMBER	(	num	23	SENT_123	[p10l639t2911r832b3001],
21	table	NN	O	table	nn	23	SENT_123	[p10l639t2911r832b3001],
22	3	CD	NUMBER	3	num	23	SENT_123	[p10l861t2917r943b3001],
23	)	NN	O	)	nsubj	13	SENT_123	[p10l861t2917r943b3001],
24	.	.	O	.	_	0	SENT_123	[p10l861t2917r943b3001],

1	For	IN	O	for	_	0	SENT_124	[p10l83t3026r202b3090],
2	major	JJ	O	major	amod	4	SENT_124	[p10l238t3026r456b3111],
3	bleeding	JJ	O	bleeding	amod	4	SENT_124	[p10l490t3022r807b3111],
4	events	NNS	O	event	prep_for	38	SENT_124	[p10l845t3035r1072b3090],
5	in	IN	O	in	_	0	SENT_124	[p10l1112t3026r1185b3088],
6	relation	NN	O	relation	prep_in	4	SENT_124	[p10l1222t3022r1502b3090],
7	to	TO	O	to	_	0	SENT_124	[p10l1538t3035r1606b3090],
8	the	DT	O	the	det	11	SENT_124	[p10l1643t3022r1757b3090],
9	C	NN	O	c	nn	11	SENT_124	[p10l1801t3027r1855b3090],
10	YPZCI9	NN	O	ypzci9	nn	11	SENT_124	[p10l1861t3027r2144b3090],
11	genotype	NN	O	genotype	prep_to	6	SENT_124	[p10l10t3144r358b3220],
12	,	,	O	,	_	0	SENT_124	[p10l10t3144r358b3220],
13	patients	NNS	O	patient	nsubj	38	SENT_124	[p10l393t3135r681b3219],
14	in	IN	O	in	_	0	SENT_124	[p10l716t3135r790b3197],
15	the	DT	O	the	det	17	SENT_124	[p10l821t3130r935b3199],
16	clopidogrel	NN	O	clopidogrel	nn	17	SENT_124	[p10l969t3130r1375b3220],
17	group	NN	O	group	prep_in	13	SENT_124	[p10l1409t3155r1624b3220],
18	who	WP	O	who	nsubj	19	SENT_124	[p10l1656t3130r1811b3199],
19	had	VBD	O	have	rcmod	17	SENT_124	[p10l1844t3130r1981b3199],
20	any	DT	O	any	det	22	SENT_124	[p10l2013t3155r2142b3220],
21	gain-of-function	NN	O	gain-of-function	nn	22	SENT_124	[p10l10t3239r598b3329],
22	allele	NN	O	allele	nsubj	23	SENT_124	[p10l623t3239r809b3307],
23	had	VBD	O	have	ccomp	19	SENT_124	[p10l834t3239r971b3307],
24	a	DT	O	a	det	26	SENT_124	[p10l995t3263r1032b3307],
25	higher	JJR	O	higher	amod	26	SENT_124	[p10l1055t3239r1299b3329],
26	rate	NN	O	rate	dobj	23	SENT_124	[p10l1321t3252r1458b3307],
27	of	IN	O	of	_	0	SENT_124	[p10l1485t3239r1567b3307],
28	events	NNS	O	event	prep_of	26	SENT_124	[p10l1579t3252r1807b3307],
29	than	IN	O	than	mark	30	SENT_124	[p10l1833t3239r2000b3307],
30	did	VBD	O	do	advcl	19	SENT_124	[p10l2025t3239r2141b3307],
31	those	DT	O	those	dobj	30	SENT_124	[p10l7t3349r203b3417],
32	without	IN	O	without	_	0	SENT_124	[p10l261t3349r545b3417],
33	any	DT	O	any	det	34	SENT_124	[p10l603t3373r732b3438],
34	gain-of-function	NN	O	gain-of-function	prep_without	30	SENT_124	[p10l790t3348r1378b3438],
35	or	CC	O	or	_	0	SENT_124	[p10l1437t3373r1513b3417],
36	loss-of-function	JJ	O	loss-of-function	amod	37	SENT_124	[p10l1569t3348r2140b3417],
37	alleles	NNS	O	allele	conj_or	34	SENT_124	[p10l9t3457r231b3525],
38	(	VBP	O	(	_	0	SENT_124	[p10l329t3463r706b3547],
39	p	NN	O	p	dobj	38	SENT_124	[p10l329t3463r706b3547],
40	=	JJ	O	=	advmod	38	SENT_124	[p10l329t3463r706b3547],
41	0-022	CD	NUMBER	0-022	num	42	SENT_124	[p10l329t3463r706b3547],
42	)	NN	O	)	dep	40	SENT_124	[p10l329t3463r706b3547],
43	.	.	O	.	_	0	SENT_124	[p10l329t3463r706b3547],

1	Therefore	RB	O	therefore	advmod	8	SENT_125	[p10l799t3457r1179b3535],
2	,	,	O	,	_	0	SENT_125	[p10l799t3457r1179b3535],
3	comparisons	NNS	O	comparison	nsubjpass	8	SENT_125	[p10l1273t3462r1742b3546],
4	between	IN	O	between	_	0	SENT_125	[p10l1833t3457r2140b3525],
5	treatment	NN	O	treatment	nn	6	SENT_125	[p10l7t3579r369b3634],
6	groups	NNS	O	group	prep_between	3	SENT_125	[p10l393t3590r643b3656],
7	were	VBD	O	be	auxpass	8	SENT_125	[p10l667t3590r843b3634],
8	separated	VBN	O	separate	_	0	SENT_125	[p10l870t3566r1217b3655],
9	for	IN	O	for	_	0	SENT_125	[p10l1240t3566r1344b3634],
10	patients	NNS	O	patient	prep_for	8	SENT_125	[p10l1365t3571r1654b3655],
11	with	IN	O	with	_	0	SENT_125	[p10l1678t3566r1841b3634],
12	gainoffunction	NN	O	gainoffunction	nn	13	SENT_125	[p10l1866t3566r2138b3656, p10l8t3675r320b3744],
13	alleles	NNS	O	allele	prep_with	10	SENT_125	[p10l343t3675r585b3754],
14	,	,	O	,	_	0	SENT_125	[p10l343t3675r585b3754],
15	those	DT	O	those	appos	13	SENT_125	[p10l610t3675r806b3744],
16	with	IN	O	with	_	0	SENT_125	[p10l828t3676r990b3744],
17	loss-of-function	JJ	O	loss-of-function	prep_with	8	SENT_125	[p10l1011t3675r1583b3744],
18	but	CC	O	but	prep	17	SENT_125	[p10l1604t3676r1727b3744],
19	no	DT	O	no	det	20	SENT_125	[p10l1748t3700r1841b3744],
20	gainoffunction	NN	O	gainoffunction	dep	18	SENT_125	[p10l1866t3675r2138b3765, p11l8t16r320b84],

1	alleles	NNS	O	allele	_	0	SENT_126	[p11l348t16r589b94],
2	,	,	O	,	_	0	SENT_126	[p11l348t16r589b94],
3	and	CC	O	and	dep	1	SENT_126	[p11l621t16r757b84],
4	those	DT	O	those	dep	1	SENT_126	[p11l781t16r978b84],
5	Without	IN	O	without	dep	4	SENT_126	[p11l1003t16r1288b85],
6	any	DT	O	any	det	10	SENT_126	[p11l1314t41r1443b106],
7	loss-of-function	JJ	O	loss-of-function	amod	10	SENT_126	[p11l1467t16r2038b84],
8	or	CC	O	or	_	0	SENT_126	[p11l2066t41r2141b84],
9	gain-of-function	NN	O	gain-of-function	amod	10	SENT_126	[p11l10t126r598b216],
10	alleles	NNS	O	allele	pobj	5	SENT_126	[p11l629t126r851b193],
11	(	RB	O	(	advmod	12	SENT_126	[p11l889t126r1083b216],
12	table	NN	O	table	rcmod	10	SENT_126	[p11l889t126r1083b216],
13	3	CD	NUMBER	3	num	14	SENT_126	[p11l1119t132r1200b216],
14	)	NN	O	)	dep	12	SENT_126	[p11l1119t132r1200b216],
15	.	.	O	.	_	0	SENT_126	[p11l1119t132r1200b216],

1	Irrespective	RB	O	irrespective	_	0	SENT_127	[p11l1239t130r1663b215],
2	of	IN	O	of	_	0	SENT_127	[p11l1695t126r1777b193],
3	C	NN	O	c	nn	6	SENT_127	[p11l1801t131r1855b193],
4	YPZCI9	NN	O	ypzci9	nn	6	SENT_127	[p11l1861t131r2144b194],
5	genotype	NN	O	genotype	nn	6	SENT_127	[p11l10t249r339b325],
6	group	NN	O	group	prep_irrespective_of	18	SENT_127	[p11l363t260r597b325],
7	,	,	O	,	_	0	SENT_127	[p11l363t260r597b325],
8	the	DT	O	the	det	9	SENT_127	[p11l621t236r736b304],
9	interaction	NN	O	interaction	nsubj	18	SENT_127	[p11l759t240r1156b304],
10	between	IN	O	between	_	0	SENT_127	[p11l1176t236r1483b304],
11	treatment	NN	O	treatment	nn	12	SENT_127	[p11l1503t249r1865b304],
12	groups	NNS	O	group	prep_between	9	SENT_127	[p11l1887t260r2138b325],
13	and	CC	O	and	_	0	SENT_127	[p11l9t344r146b412],
14	genotype	NN	O	genotype	nn	15	SENT_127	[p11l181t358r510b434],
15	groups	NNS	O	group	prep_between	9	SENT_127	[p11l548t368r797b434],
16	was	VBD	O	be	cop	18	SENT_127	[p11l833t368r970b412],
17	not	RB	O	not	neg	18	SENT_127	[p11l1007t358r1129b412],
18	signiﬁcant	JJ	O	signiﬁcant	_	0	SENT_127	[p11l1164t344r1549b434],
19	for	IN	O	for	_	0	SENT_127	[p11l1583t344r1688b412],
20	any	DT	O	any	det	21	SENT_127	[p11l1722t369r1851b434],
21	type	NN	O	type	prep_for	18	SENT_127	[p11l1883t358r2034b434],
22	of	IN	O	of	_	0	SENT_127	[p11l2070t344r2153b412],
23	major	JJ	O	major	amod	24	SENT_127	[p11l8t458r227b543],
24	bleeding	NN	O	bleeding	prep_of	21	SENT_127	[p11l255t454r589b544],
25	.	.	O	.	_	0	SENT_127	[p11l255t454r589b544],

1	Accordingly	RB	O	accordingly	advmod	10	SENT_128	[p11l621t454r1070b544],
2	,	,	O	,	_	0	SENT_128	[p11l621t454r1070b544],
3	the	DT	O	the	det	4	SENT_128	[p11l1103t454r1217b521],
4	results	NNS	O	result	nsubj	10	SENT_128	[p11l1248t454r1490b521],
5	for	IN	O	for	_	0	SENT_128	[p11l1522t454r1627b521],
6	these	DT	O	these	det	8	SENT_128	[p11l1655t454r1847b521],
7	genetic	JJ	O	genetic	amod	8	SENT_128	[p11l1879t458r2140b544],
8	groups	NNS	O	group	prep_for	4	SENT_128	[p11l10t587r260b652],
9	were	VBD	O	be	cop	10	SENT_128	[p11l308t587r484b631],
10	consistent	JJ	O	consistent	_	0	SENT_128	[p11l533t567r906b631],
11	with	IN	O	with	_	0	SENT_128	[p11l950t562r1113b631],
12	the	DT	O	the	det	13	SENT_128	[p11l1159t562r1274b631],
13	results	NNS	O	result	prep_with	10	SENT_128	[p11l1322t562r1564b631],
14	for	IN	O	for	_	0	SENT_128	[p11l1614t562r1719b631],
15	the	DT	O	the	det	19	SENT_128	[p11l1764t562r1878b631],
16	entire	JJ	O	entire	amod	19	SENT_128	[p11l1928t567r2139b631],
17	PLATO	NNP	O	PLATO	nn	19	SENT_128	[p11l13t677r275b741],
18	patient	NN	O	patient	nn	19	SENT_128	[p11l301t677r557b761],
19	population	NN	O	population	prep_for	13	SENT_128	[p11l579t672r992b761],
20	.	.	O	.	_	0	SENT_128	[p11l579t672r992b761],

1	For	IN	O	for	_	0	SENT_129	[p11l1025t677r1144b741],
2	the	DT	O	the	det	3	SENT_129	[p11l1165t672r1280b741],
3	outcome	NN	O	outcome	pobj	1	SENT_129	[p11l1305t686r1623b741],
4	of	IN	O	of	_	0	SENT_129	[p11l1649t672r1731b741],
5	net	JJ	O	net	amod	7	SENT_129	[p11l1741t686r1859b741],
6	clinical	JJ	O	clinical	amod	7	SENT_129	[p11l1881t672r2140b741],
7	beneﬁt	NN	O	beneﬁt	prep_of	3	SENT_129	[p11l7t782r280b860],
8	,	,	O	,	_	0	SENT_129	[p11l7t782r280b860],
9	the	DT	O	the	det	10	SENT_129	[p11l299t782r413b849],
10	improvement	NN	O	improvement	appos	7	SENT_129	[p11l430t786r932b871],
11	with	IN	O	with	_	0	SENT_129	[p11l944t782r1107b849],
12	ticagrelor	NN	O	ticagrelor	prep_with	10	SENT_129	[p11l1122t782r1469b872],
13	versus	CC	O	versus	prep	12	SENT_129	[p11l1481t806r1715b850],
14	clopidogrel	NN	O	clopidogrel	dep	13	SENT_129	[p11l1734t782r2140b872],

1	90	CD	NUMBER	90	num	3	SENT_130	[p11l623t939r653b960],
2	mg	NN	O	mg	nn	3	SENT_130	[p11l660t943r696b963],
3	ticagrelortwice	NN	O	ticagrelortwice	npadvmod	4	SENT_130	[p11l701t936r878b963],
4	daily	RB	SET	daily	dep	15	SENT_130	[p11l885t936r939b963],
5	75	CD	NUMBER	75	num	7	SENT_130	[p11l1125t939r1151b960],
6	mg	NN	O	mg	nn	7	SENT_130	[p11l1160t943r1195b963],
7	clopidogrel	NN	O	clopidogrel	pobj	4	SENT_130	[p11l1202t936r1328b963],
8	once	RB	DATE	once	advmod	4	SENT_130	[p11l1335t943r1389b957],
9	daily	JJ	SET	daily	amod	11	SENT_130	[p11l1395t936r1450b963],
10	Hazard	NN	O	hazard	nn	11	SENT_130	[p11l1614t936r1693b957],
11	ratio	NN	O	ratio	pobj	4	SENT_130	[p11l1700t937r1753b957],
12	p	NN	O	p	nn	15	SENT_130	[p11l1826t943r1840b963],
13	value	NN	O	value	nn	15	SENT_130	[p11l1846t936r1907b957],
14	p	NN	O	p	nn	15	SENT_130	[p11l1959t943r1973b963],
15	value	NN	O	value	_	0	SENT_130	[p11l1979t936r2040b957],

1	(	NN	O	(	_	0	SENT_131	[p11l1614t972r1671b997],
2	95	CD	PERCENT	95	num	3	SENT_131	[p11l1614t972r1671b997],
3	%	NN	PERCENT	%	dep	1	SENT_131	[p11l1614t972r1671b997],
4	Cl	NN	O	cl	nn	7	SENT_131	[p11l1678t972r1706b997],
5	)	CD	NUMBER	)	num	7	SENT_131	[p11l1678t972r1706b997],
6	(	NN	O	(	nn	7	SENT_131	[p11l1960t971r2115b997],
7	interaction	NN	O	interaction	dep	3	SENT_131	[p11l1960t971r2115b997],
8	)	CD	NUMBER	)	num	9	SENT_131	[p11l1960t971r2115b997],
9	*	NN	O	*	dep	1	SENT_131	[p11l1960t971r2115b997],

1	Number	NN	O	number	_	0	SENT_132	[p11l624t1025r712b1046],
2	of	IN	O	of	_	0	SENT_132	[p11l718t1025r741b1046],
3	Patients	NNS	O	patient	prep_of	1	SENT_132	[p11l768t1027r854b1046],
4	with	IN	O	with	_	0	SENT_132	[p11l860t1025r908b1046],
5	Kap	NN	O	kap	prep_with	1	SENT_132	[p11l942t1025r1085b1053],
6	|	CD	NUMBER	|	num	5	SENT_132	[p11l942t1025r1085b1053],
7	an	DT	O	a	dep	5	SENT_132	[p11l942t1025r1085b1053],
8	.	.	O	.	_	0	SENT_132	[p11l942t1025r1085b1053],

1	—	NN	O	—	_	0	SENT_133	[p11l942t1025r1085b1053],
2	.	.	O	.	_	0	SENT_133	[p11l942t1025r1085b1053],

1	Meier	NNP	O	Meier	nn	3	SENT_134	[p11l942t1025r1085b1053],
2	Number	NNP	O	Number	nn	3	SENT_134	[p11l1126t1025r1214b1046],
3	Patients	NNPS	O	Patients	_	0	SENT_134	[p11l1266t1027r1352b1046],
4	with	IN	O	with	_	0	SENT_134	[p11l1358t1025r1406b1046],
5	Kaplan	NNP	PERSON	Kaplan	prep_with	3	SENT_134	[p11l1437t1025r1580b1053],
6	.	.	O	.	_	0	SENT_134	[p11l1437t1025r1580b1053],

1	—	NN	O	—	_	0	SENT_135	[p11l1437t1025r1580b1053],
2	.	.	O	.	_	0	SENT_135	[p11l1437t1025r1580b1053],

1	Meier	JJR	PERSON	meier	amod	2	SENT_136	[p11l1437t1025r1580b1053],
2	patients	NNS	O	patient	_	0	SENT_136	[p11l623t1062r710b1087],
3	events	NNS	O	event	nn	5	SENT_136	[p11l767t1064r837b1081],
4	event	NN	O	event	nn	5	SENT_136	[p11l941t1064r1001b1081],
5	rate	NN	O	rate	dep	2	SENT_136	[p11l1009t1064r1049b1081],
6	of	IN	O	of	_	0	SENT_136	[p11l1125t1060r1148b1081],
7	patients	NNS	O	patient	nn	8	SENT_136	[p11l1153t1062r1241b1087],
8	events	NNS	O	event	prep_of	5	SENT_136	[p11l1265t1064r1335b1081],
9	event	NN	O	event	nn	10	SENT_136	[p11l1436t1064r1497b1081],
10	rate	NN	O	rate	dep	2	SENT_136	[p11l1504t1064r1544b1081],

1	Cardiovascular	NNP	O	Cardiovascular	dep	522	SENT_137	[p11l42t1115r209b1136],
2	death	NN	O	death	dep	522	SENT_137	[p11l214t1115r286b1139],
3	,	,	O	,	_	0	SENT_137	[p11l214t1115r286b1139],
4	myocardial	JJ	O	myocardial	dep	522	SENT_137	[p11l294t1115r419b1142],
5	infarction	NN	O	infarction	dep	522	SENT_137	[p11l427t1114r545b1139],
6	,	,	O	,	_	0	SENT_137	[p11l427t1114r545b1139],
7	and	CC	O	and	dep	522	SENT_137	[p11l551t1115r594b1136],
8	stroke	NN	O	stroke	dep	522	SENT_137	[p11l600t1115r671b1136],
9	Any	DT	O	any	dep	522	SENT_137	[p11l42t1162r85b1188],
10	loss-of-function	JJ	O	loss-of-function	dep	522	SENT_137	[p11l92t1160r264b1181],
11	allele	NN	O	allele	dep	522	SENT_137	[p11l271t1161r325b1181],
12	1384	CD	DATE	1384	dep	522	SENT_137	[p11l623t1160r679b1184],
13	115	CD	NUMBER	115	dep	522	SENT_137	[p11l773t1163r810b1184],
14	(	NN	O	(	dep	522	SENT_137	[p11l818t1160r888b1187],
15	83	CD	PERCENT	83	dep	522	SENT_137	[p11l818t1160r888b1187],
16	%	NN	PERCENT	%	dep	522	SENT_137	[p11l818t1160r888b1187],
17	)	CD	PERCENT	)	dep	522	SENT_137	[p11l818t1160r888b1187],
18	86	CD	PERCENT	86	dep	522	SENT_137	[p11l955t1160r1009b1181],
19	%	NN	PERCENT	%	dep	522	SENT_137	[p11l955t1160r1009b1181],
20	1388	CD	DATE	1388	dep	522	SENT_137	[p11l1126t1160r1180b1184],
21	149	CD	NUMBER	149	dep	522	SENT_137	[p11l1267t1163r1308b1184],
22	(	NN	O	(	dep	522	SENT_137	[p11l1317t1162r1398b1187],
23	10-7	CD	PERCENT	10-7	dep	522	SENT_137	[p11l1317t1162r1398b1187],
24	%	NN	PERCENT	%	dep	522	SENT_137	[p11l1317t1162r1398b1187],
25	)	CD	PERCENT	)	dep	522	SENT_137	[p11l1317t1162r1398b1187],
26	11-2	CD	PERCENT	11-2	dep	522	SENT_137	[p11l1440t1163r1503b1181],
27	%	NN	PERCENT	%	dep	522	SENT_137	[p11l1440t1163r1503b1181],
28	0-77	CD	NUMBER	0-77	dep	522	SENT_137	[p11l1616t1163r1662b1184],
29	(	CD	NUMBER	(	dep	522	SENT_137	[p11l1669t1160r1797b1187],
30	O-60-0-99	NN	O	o-60-0-99	dep	522	SENT_137	[p11l1669t1160r1797b1187],
31	)	CD	NUMBER	)	dep	522	SENT_137	[p11l1669t1160r1797b1187],
32	0-0380	CD	NUMBER	0-0380	dep	522	SENT_137	[p11l1829t1160r1907b1184],
33	0-46	CD	NUMBER	0-46	dep	522	SENT_137	[p11l1962t1160r2011b1184],
34	No	DT	O	no	dep	522	SENT_137	[p11l43t1208r73b1227],
35	loss-o	NN	O	loss-o	dep	522	SENT_137	[p11l81t1206r143b1227],
36	—	NN	O	—	dep	522	SENT_137	[p11l154t1219r161b1221],
37	unction	NN	O	unction	dep	522	SENT_137	[p11l172t1208r253b1227],
38	allele	NN	O	allele	dep	522	SENT_137	[p11l261t1206r315b1227],
39	3554	CD	NUMBER	3554	dep	522	SENT_137	[p11l624t1209r679b1230],
40	296	CD	NUMBER	296	dep	522	SENT_137	[p11l768t1206r810b1230],
41	(	NN	O	(	dep	522	SENT_137	[p11l818t1206r888b1233],
42	8-3	CD	PERCENT	8-3	dep	522	SENT_137	[p11l818t1206r888b1233],
43	%	NN	PERCENT	%	dep	522	SENT_137	[p11l818t1206r888b1233],
44	)	CD	PERCENT	)	dep	522	SENT_137	[p11l818t1206r888b1233],
45	8-8	CD	PERCENT	8-8	dep	522	SENT_137	[p11l955t1206r1009b1227],
46	%	NN	PERCENT	%	dep	522	SENT_137	[p11l955t1206r1009b1227],
47	3516	CD	NUMBER	3516	dep	522	SENT_137	[p11l1127t1206r1181b1230],
48	332	CD	NUMBER	332	dep	522	SENT_137	[p11l1269t1209r1308b1230],
49	(	NN	O	(	dep	522	SENT_137	[p11l1317t1207r1387b1232],
50	9-4	CD	PERCENT	9-4	dep	522	SENT_137	[p11l1317t1207r1387b1232],
51	%	NN	PERCENT	%	dep	522	SENT_137	[p11l1317t1207r1387b1232],
52	)	CD	PERCENT	)	dep	522	SENT_137	[p11l1317t1207r1387b1232],
53	10-0	CD	PERCENT	10-0	dep	522	SENT_137	[p11l1438t1209r1504b1227],
54	%	NN	PERCENT	%	dep	522	SENT_137	[p11l1438t1209r1504b1227],
55	0-86	CD	NUMBER	0-86	dep	522	SENT_137	[p11l1616t1206r1665b1227],
56	(	CD	NUMBER	(	dep	522	SENT_137	[p11l1673t1207r1793b1232],
57	0-74-1-O1	NN	O	0-74-1-o1	dep	522	SENT_137	[p11l1673t1207r1793b1232],
58	)	CD	NUMBER	)	dep	522	SENT_137	[p11l1673t1207r1793b1232],
59	0-0608	CD	NUMBER	0-0608	dep	522	SENT_137	[p11l1829t1206r1908b1227],
60	Cardiovascular	NNP	O	Cardiovascular	dep	522	SENT_137	[p11l42t1252r209b1273],
61	death	NN	O	death	dep	522	SENT_137	[p11l214t1252r279b1273],
62	and	CC	O	and	dep	522	SENT_137	[p11l286t1252r329b1273],
63	myocardial	JJ	O	myocardial	dep	522	SENT_137	[p11l336t1252r460b1279],
64	infarction	NN	O	infarction	dep	522	SENT_137	[p11l468t1252r579b1273],
65	Any	DT	O	any	dep	522	SENT_137	[p11l42t1299r85b1325],
66	loss-of-function	JJ	O	loss-of-function	dep	522	SENT_137	[p11l92t1297r264b1319],
67	allele	NN	O	allele	dep	522	SENT_137	[p11l271t1298r325b1319],
68	1384	CD	DATE	1384	dep	522	SENT_137	[p11l623t1297r679b1322],
69	102	CD	PERCENT	102	dep	522	SENT_137	[p11l771t1301r810b1319],
70	(	CD	PERCENT	(	dep	522	SENT_137	[p11l818t1299r887b1324],
71	74	CD	PERCENT	74	dep	522	SENT_137	[p11l818t1299r887b1324],
72	%	NN	PERCENT	%	dep	522	SENT_137	[p11l818t1299r887b1324],
73	)	CD	PERCENT	)	dep	522	SENT_137	[p11l818t1299r887b1324],
74	77	CD	PERCENT	77	dep	522	SENT_137	[p11l956t1301r1007b1321],
75	%	NN	PERCENT	%	dep	522	SENT_137	[p11l956t1301r1007b1321],
76	1388	CD	DATE	1388	dep	522	SENT_137	[p11l1126t1297r1180b1322],
77	138	CD	PERCENT	138	dep	522	SENT_137	[p11l1269t1297r1308b1322],
78	(	CD	PERCENT	(	dep	522	SENT_137	[p11l1317t1299r1388b1324],
79	9-9	CD	PERCENT	9-9	dep	522	SENT_137	[p11l1317t1299r1388b1324],
80	%	NN	PERCENT	%	dep	522	SENT_137	[p11l1317t1299r1388b1324],
81	)	CD	PERCENT	)	dep	522	SENT_137	[p11l1317t1299r1388b1324],
82	10-4	CD	PERCENT	10-4	dep	522	SENT_137	[p11l1438t1300r1504b1321],
83	%	NN	PERCENT	%	dep	522	SENT_137	[p11l1438t1300r1504b1321],
84	0-73	CD	NUMBER	0-73	dep	522	SENT_137	[p11l1616t1301r1661b1322],
85	(	CD	NUMBER	(	dep	522	SENT_137	[p11l1669t1299r1792b1324],
86	O-57-0-95	NN	O	o-57-0-95	dep	522	SENT_137	[p11l1669t1299r1792b1324],
87	)	CD	NUMBER	)	dep	522	SENT_137	[p11l1669t1299r1792b1324],
88	0-0184	CD	NUMBER	0-0184	dep	522	SENT_137	[p11l1829t1297r1907b1321],
89	0-30	CD	NUMBER	0-30	dep	522	SENT_137	[p11l1962t1301r2009b1322],
90	No	DT	O	no	dep	522	SENT_137	[p11l43t1345r73b1364],
91	|	NN	O	|	dep	522	SENT_137	[p11l81t1343r143b1364],
92	oss	NN	O	oss	dep	522	SENT_137	[p11l81t1343r143b1364],
93	»	CD	NUMBER	»	dep	522	SENT_137	[p11l81t1343r143b1364],
94	o	NN	O	o	dep	522	SENT_137	[p11l81t1343r143b1364],
95	—	NN	O	—	dep	522	SENT_137	[p11l154t1356r161b1358],
96	unction	NN	O	unction	dep	522	SENT_137	[p11l172t1345r253b1364],
97	allele	NN	O	allele	dep	522	SENT_137	[p11l261t1343r315b1364],
98	3554	CD	NUMBER	3554	dep	522	SENT_137	[p11l624t1346r679b1367],
99	273	CD	NUMBER	273	dep	522	SENT_137	[p11l772t1346r810b1367],
100	(	NN	O	(	dep	522	SENT_137	[p11l818t1345r885b1370],
101	7-7	CD	PERCENT	7-7	dep	522	SENT_137	[p11l818t1345r885b1370],
102	%	NN	PERCENT	%	dep	522	SENT_137	[p11l818t1345r885b1370],
103	)	CD	PERCENT	)	dep	522	SENT_137	[p11l818t1345r885b1370],
104	8-0	CD	PERCENT	8-0	dep	522	SENT_137	[p11l955t1343r1008b1364],
105	%	NN	PERCENT	%	dep	522	SENT_137	[p11l955t1343r1008b1364],
106	3516	CD	NUMBER	3516	dep	522	SENT_137	[p11l1127t1343r1181b1367],
107	306	CD	NUMBER	306	dep	522	SENT_137	[p11l1267t1343r1309b1367],
108	(	NN	O	(	dep	522	SENT_137	[p11l1317t1343r1385b1370],
109	8-7	CD	PERCENT	8-7	dep	522	SENT_137	[p11l1317t1343r1385b1370],
110	%	NN	PERCENT	%	dep	522	SENT_137	[p11l1317t1343r1385b1370],
111	)	CD	PERCENT	)	dep	522	SENT_137	[p11l1317t1343r1385b1370],
112	9-2	CD	PERCENT	9-2	dep	522	SENT_137	[p11l1451t1346r1503b1367],
113	%	NN	PERCENT	%	dep	522	SENT_137	[p11l1451t1346r1503b1367],
114	0-86	CD	NUMBER	0-86	dep	522	SENT_137	[p11l1616t1343r1665b1364],
115	(	CD	NUMBER	(	dep	522	SENT_137	[p11l1673t1345r1793b1370],
116	0-73-1-01	CD	NUMBER	0-73-1-01	dep	522	SENT_137	[p11l1673t1345r1793b1370],
117	)	NN	O	)	dep	522	SENT_137	[p11l1673t1345r1793b1370],
118	0-0734	CD	NUMBER	0-0734	dep	522	SENT_137	[p11l1829t1346r1905b1367],
119	Deﬁnite	NNP	O	Deﬁnite	dep	522	SENT_137	[p11l43t1389r133b1410],
120	stent	NN	O	stent	dep	522	SENT_137	[p11l139t1393r199b1410],
121	thrombosis	NN	O	thrombosis	dep	522	SENT_137	[p11l204t1389r348b1412],
122	'	''	O	'	_	0	SENT_137	[p11l204t1389r348b1412],
123	l'	JJ	O	l'	dep	522	SENT_137	[p11l204t1389r348b1412],
124	Any	DT	O	any	dep	522	SENT_137	[p11l42t1437r85b1462],
125	|	NN	O	|	dep	522	SENT_137	[p11l92t1435r264b1456],
126	oss	NN	O	oss	dep	522	SENT_137	[p11l92t1435r264b1456],
127	—	CD	NUMBER	—	dep	522	SENT_137	[p11l92t1435r264b1456],
128	of-function	JJ	O	of-function	dep	522	SENT_137	[p11l92t1435r264b1456],
129	allele	NN	O	allele	dep	522	SENT_137	[p11l271t1435r325b1456],
130	943	CD	NUMBER	943	dep	522	SENT_137	[p11l637t1438r678b1459],
131	15	CD	NUMBER	15	dep	522	SENT_137	[p11l786t1438r810b1459],
132	(	NN	O	(	dep	522	SENT_137	[p11l818t1435r887b1461],
133	1-6	CD	PERCENT	1-6	dep	522	SENT_137	[p11l818t1435r887b1461],
134	%	NN	PERCENT	%	dep	522	SENT_137	[p11l818t1435r887b1461],
135	)	CD	PERCENT	)	dep	522	SENT_137	[p11l818t1435r887b1461],
136	1-6	CD	PERCENT	1-6	dep	522	SENT_137	[p11l957t1435r1009b1456],
137	%	NN	PERCENT	%	dep	522	SENT_137	[p11l957t1435r1009b1456],
138	934	CD	NUMBER	934	dep	522	SENT_137	[p11l1139t1438r1182b1459],
139	21	CD	NUMBER	21	dep	522	SENT_137	[p11l1284t1438r1309b1455],
140	(	NN	O	(	dep	522	SENT_137	[p11l1317t1436r1384b1461],
141	2-2	CD	PERCENT	2-2	dep	522	SENT_137	[p11l1317t1436r1384b1461],
142	%	NN	PERCENT	%	dep	522	SENT_137	[p11l1317t1436r1384b1461],
143	)	CD	PERCENT	)	dep	522	SENT_137	[p11l1317t1436r1384b1461],
144	2-3	CD	PERCENT	2-3	dep	522	SENT_137	[p11l1452t1438r1503b1459],
145	%	NN	PERCENT	%	dep	522	SENT_137	[p11l1452t1438r1503b1459],
146	0-71	CD	NUMBER	0-71	dep	522	SENT_137	[p11l1616t1438r1661b1458],
147	(	CD	NUMBER	(	dep	522	SENT_137	[p11l1669t1435r1790b1461],
148	036-137	CD	NUMBER	036-137	dep	522	SENT_137	[p11l1669t1435r1790b1461],
149	)	NN	O	)	dep	522	SENT_137	[p11l1669t1435r1790b1461],
150	030	CD	NUMBER	030	dep	522	SENT_137	[p11l1829t1438r1876b1459],
151	1	CD	NUMBER	1	dep	522	SENT_137	[p11l1964t1436r1974b1457],
152	No	DT	O	no	dep	522	SENT_137	[p11l43t1483r73b1502],
153	|	NN	O	|	dep	522	SENT_137	[p11l81t1481r143b1502],
154	oss	NN	O	oss	dep	522	SENT_137	[p11l81t1481r143b1502],
155	»	CD	NUMBER	»	dep	522	SENT_137	[p11l81t1481r143b1502],
156	o	NN	O	o	dep	522	SENT_137	[p11l81t1481r143b1502],
157	—	NN	O	—	dep	522	SENT_137	[p11l154t1493r161b1495],
158	unction	NN	O	unction	dep	522	SENT_137	[p11l172t1482r253b1502],
159	allele	NN	O	allele	dep	522	SENT_137	[p11l261t1481r315b1502],
160	2341	CD	DATE	2341	dep	522	SENT_137	[p11l625t1483r679b1505],
161	22	CD	NUMBER	22	dep	522	SENT_137	[p11l785t1484r810b1501],
162	(	NN	O	(	dep	522	SENT_137	[p11l818t1482r889b1507],
163	0-9	CD	PERCENT	0-9	dep	522	SENT_137	[p11l818t1482r889b1507],
164	%	NN	PERCENT	%	dep	522	SENT_137	[p11l818t1482r889b1507],
165	)	CD	PERCENT	)	dep	522	SENT_137	[p11l818t1482r889b1507],
166	10	CD	PERCENT	10	dep	522	SENT_137	[p11l957t1484r1008b1502],
167	%	NN	PERCENT	%	dep	522	SENT_137	[p11l957t1484r1008b1502],
168	2300	CD	DATE	2300	dep	522	SENT_137	[p11l1126t1484r1181b1505],
169	35	CD	NUMBER	35	dep	522	SENT_137	[p11l1283t1484r1308b1505],
170	(	NN	O	(	dep	522	SENT_137	[p11l1317t1482r1384b1507],
171	1-5	CD	PERCENT	1-5	dep	522	SENT_137	[p11l1317t1482r1384b1507],
172	%	NN	PERCENT	%	dep	522	SENT_137	[p11l1317t1482r1384b1507],
173	)	CD	PERCENT	)	dep	522	SENT_137	[p11l1317t1482r1384b1507],
174	1-5	CD	PERCENT	1-5	dep	522	SENT_137	[p11l1453t1484r1503b1505],
175	%	NN	PERCENT	%	dep	522	SENT_137	[p11l1453t1484r1503b1505],
176	0-62	CD	NUMBER	0-62	dep	522	SENT_137	[p11l1616t1481r1663b1502],
177	(	CD	NUMBER	(	dep	522	SENT_137	[p11l1672t1480r1795b1507],
178	0-36-1-05	CD	NUMBER	0-36-1-05	dep	522	SENT_137	[p11l1672t1480r1795b1507],
179	)	NN	O	)	dep	522	SENT_137	[p11l1672t1480r1795b1507],
180	0-0772	CD	NUMBER	0-0772	dep	522	SENT_137	[p11l1829t1484r1902b1504],
181	Major	JJ	O	major	dep	522	SENT_137	[p11l43t1527r109b1554],
182	bleeding	NN	O	bleeding	dep	522	SENT_137	[p11l115t1526r212b1554],
183	(	CD	NUMBER	(	dep	522	SENT_137	[p11l220t1526r412b1553],
184	|	CD	NUMBER	|	dep	522	SENT_137	[p11l220t1526r412b1553],
185	oss	NN	O	oss	dep	522	SENT_137	[p11l220t1526r412b1553],
186	—	NN	O	—	dep	522	SENT_137	[p11l220t1526r412b1553],
187	of	IN	O	of	dep	522	SENT_137	[p11l220t1526r412b1553],
188	—	CD	NUMBER	—	dep	522	SENT_137	[p11l220t1526r412b1553],
189	function	NN	O	function	dep	522	SENT_137	[p11l220t1526r412b1553],
190	allele	NN	O	allele	dep	522	SENT_137	[p11l419t1526r485b1553],
191	)	CD	NUMBER	)	dep	522	SENT_137	[p11l419t1526r485b1553],
192	Any	DT	O	any	dep	522	SENT_137	[p11l42t1574r85b1599],
193	loss	NN	O	loss	dep	522	SENT_137	[p11l92t1572r264b1593],
194	—	CD	NUMBER	—	dep	522	SENT_137	[p11l92t1572r264b1593],
195	of-function	JJ	O	of-function	dep	522	SENT_137	[p11l92t1572r264b1593],
196	allele	NN	O	allele	dep	522	SENT_137	[p11l271t1572r325b1593],
197	1380	CD	DATE	1380	dep	522	SENT_137	[p11l624t1572r678b1596],
198	149	CD	NUMBER	149	dep	522	SENT_137	[p11l769t1575r810b1596],
199	(	NN	O	(	dep	522	SENT_137	[p11l818t1572r902b1598],
200	10-8	CD	PERCENT	10-8	dep	522	SENT_137	[p11l818t1572r902b1598],
201	%	NN	PERCENT	%	dep	522	SENT_137	[p11l818t1572r902b1598],
202	)	CD	PERCENT	)	dep	522	SENT_137	[p11l818t1572r902b1598],
203	11-8	CD	PERCENT	11-8	dep	522	SENT_137	[p11l944t1572r1009b1593],
204	%	NN	PERCENT	%	dep	522	SENT_137	[p11l944t1572r1009b1593],
205	1380	CD	DATE	1380	dep	522	SENT_137	[p11l1126t1572r1181b1596],
206	143	CD	NUMBER	143	dep	522	SENT_137	[p11l1269t1575r1308b1596],
207	(	NN	O	(	dep	522	SENT_137	[p11l1317t1573r1400b1598],
208	10-4	CD	PERCENT	10-4	dep	522	SENT_137	[p11l1317t1573r1400b1598],
209	%	NN	PERCENT	%	dep	522	SENT_137	[p11l1317t1573r1400b1598],
210	)	CD	PERCENT	)	dep	522	SENT_137	[p11l1317t1573r1400b1598],
211	11-3	CD	PERCENT	11-3	dep	522	SENT_137	[p11l1440t1575r1503b1596],
212	%	NN	PERCENT	%	dep	522	SENT_137	[p11l1440t1575r1503b1596],
213	1-04	CD	NUMBER	1-04	dep	522	SENT_137	[p11l1618t1575r1665b1596],
214	(	CD	NUMBER	(	dep	522	SENT_137	[p11l1672t1572r1795b1598],
215	0-82-1-30	CD	NUMBER	0-82-1-30	dep	522	SENT_137	[p11l1672t1572r1795b1598],
216	)	NN	O	)	dep	522	SENT_137	[p11l1672t1572r1795b1598],
217	0-77	CD	NUMBER	0-77	dep	522	SENT_137	[p11l1829t1575r1875b1596],
218	0-60	CD	NUMBER	0-60	dep	522	SENT_137	[p11l1962t1572r2011b1593],
219	No	DT	O	no	dep	522	SENT_137	[p11l43t1620r73b1639],
220	loss-o	NN	O	loss-o	dep	522	SENT_137	[p11l81t1618r143b1639],
221	-	:	O	-	_	0	SENT_137	[p11l154t1631r161b1633],
222	unction	NN	O	unction	dep	522	SENT_137	[p11l172t1620r253b1639],
223	allele	NN	O	allele	dep	522	SENT_137	[p11l261t1618r315b1639],
224	3547	CD	NUMBER	3547	dep	522	SENT_137	[p11l625t1621r679b1642],
225	331	CD	NUMBER	331	dep	522	SENT_137	[p11l772t1621r811b1642],
226	(	NN	O	(	dep	522	SENT_137	[p11l818t1619r888b1644],
227	93	CD	PERCENT	93	dep	522	SENT_137	[p11l818t1619r888b1644],
228	%	NN	PERCENT	%	dep	522	SENT_137	[p11l818t1619r888b1644],
229	)	NN	PERCENT	)	dep	522	SENT_137	[p11l818t1619r888b1644],
230	103	CD	PERCENT	103	dep	522	SENT_137	[p11l942t1621r1007b1642],
231	%	NN	PERCENT	%	dep	522	SENT_137	[p11l942t1621r1007b1642],
232	3506	CD	NUMBER	3506	dep	522	SENT_137	[p11l1125t1618r1181b1642],
233	340	CD	NUMBER	340	dep	522	SENT_137	[p11l1267t1621r1309b1642],
234	(	NN	O	(	dep	522	SENT_137	[p11l1317t1619r1385b1644],
235	9-7	CD	PERCENT	9-7	dep	522	SENT_137	[p11l1317t1619r1385b1644],
236	%	NN	PERCENT	%	dep	522	SENT_137	[p11l1317t1619r1385b1644],
237	)	CD	PERCENT	)	dep	522	SENT_137	[p11l1317t1619r1385b1644],
238	10-6	CD	PERCENT	10-6	dep	522	SENT_137	[p11l1438t1618r1505b1639],
239	%	NN	PERCENT	%	dep	522	SENT_137	[p11l1438t1618r1505b1639],
240	0-96	CD	NUMBER	0-96	dep	522	SENT_137	[p11l1616t1618r1665b1642],
241	(	CD	NUMBER	(	dep	522	SENT_137	[p11l1673t1618r1794b1644],
242	0-83-1-12	CD	NUMBER	0-83-1-12	dep	522	SENT_137	[p11l1673t1618r1794b1644],
243	)	NN	O	)	dep	522	SENT_137	[p11l1673t1618r1794b1644],
244	0-61	CD	NUMBER	0-61	dep	522	SENT_137	[p11l1829t1618r1877b1639],
245	Major	JJ	O	major	dep	522	SENT_137	[p11l43t1664r109b1691],
246	bleeding	NN	O	bleeding	dep	522	SENT_137	[p11l115t1664r212b1691],
247	(	CD	NUMBER	(	dep	522	SENT_137	[p11l220t1663r419b1691],
248	gain-of-function	NN	O	gain-of-function	dep	522	SENT_137	[p11l220t1663r419b1691],
249	allele	NN	O	allele	dep	522	SENT_137	[p11l426t1664r493b1690],
250	)	CD	NUMBER	)	dep	522	SENT_137	[p11l426t1664r493b1690],
251	No	DT	O	no	dep	522	SENT_137	[p11l43t1711r73b1730],
252	|	NN	O	|	dep	522	SENT_137	[p11l81t1709r143b1730],
253	oss	NN	O	oss	dep	522	SENT_137	[p11l81t1709r143b1730],
254	»	CD	NUMBER	»	dep	522	SENT_137	[p11l81t1709r143b1730],
255	o	NN	O	o	dep	522	SENT_137	[p11l81t1709r143b1730],
256	—	NN	O	—	dep	522	SENT_137	[p11l154t1722r161b1724],
257	unction	NN	O	unction	dep	522	SENT_137	[p11l172t1711r253b1730],
258	or	CC	O	or	dep	522	SENT_137	[p11l261t1716r283b1730],
259	gain	NN	O	gain	dep	522	SENT_137	[p11l289t1709r468b1737],
260	—	NN	O	—	dep	522	SENT_137	[p11l289t1709r468b1737],
261	of	IN	O	of	dep	522	SENT_137	[p11l289t1709r468b1737],
262	—	CD	NUMBER	—	dep	522	SENT_137	[p11l289t1709r468b1737],
263	function	NN	O	function	dep	522	SENT_137	[p11l289t1709r468b1737],
264	allele	NN	O	allele	dep	522	SENT_137	[p11l476t1709r530b1730],
265	1846	CD	DATE	1846	dep	522	SENT_137	[p11l623t1709r680b1733],
266	176	CD	NUMBER	176	dep	522	SENT_137	[p11l771t1709r810b1733],
267	(	NN	O	(	dep	522	SENT_137	[p11l818t1711r888b1736],
268	9-5	CD	PERCENT	9-5	dep	522	SENT_137	[p11l818t1711r888b1736],
269	%	NN	PERCENT	%	dep	522	SENT_137	[p11l818t1711r888b1736],
270	)	CD	PERCENT	)	dep	522	SENT_137	[p11l818t1711r888b1736],
271	10-5	CD	PERCENT	10-5	dep	522	SENT_137	[p11l942t1712r1007b1733],
272	%	NN	PERCENT	%	dep	522	SENT_137	[p11l942t1712r1007b1733],
273	1856	CD	DATE	1856	dep	522	SENT_137	[p11l1125t1709r1181b1733],
274	161	CD	NUMBER	161	dep	522	SENT_137	[p11l1270t1709r1309b1730],
275	(	NN	O	(	dep	522	SENT_137	[p11l1317t1709r1385b1736],
276	8-7	CD	PERCENT	8-7	dep	522	SENT_137	[p11l1317t1709r1385b1736],
277	%	NN	PERCENT	%	dep	522	SENT_137	[p11l1317t1709r1385b1736],
278	)	CD	PERCENT	)	dep	522	SENT_137	[p11l1317t1709r1385b1736],
279	9-5	CD	PERCENT	9-5	dep	522	SENT_137	[p11l1451t1712r1503b1733],
280	%	NN	PERCENT	%	dep	522	SENT_137	[p11l1451t1712r1503b1733],
281	1-12	CD	NUMBER	1-12	dep	522	SENT_137	[p11l1618t1712r1661b1730],
282	(	CD	NUMBER	(	dep	522	SENT_137	[p11l1669t1709r1794b1736],
283	0-90-1-38	CD	NUMBER	0-90-1-38	dep	522	SENT_137	[p11l1669t1709r1794b1736],
284	)	NN	O	)	dep	522	SENT_137	[p11l1669t1709r1794b1736],
285	0-31	CD	NUMBER	0-31	dep	522	SENT_137	[p11l1829t1712r1875b1733],
286	0-19	CD	NUMBER	0-19	dep	522	SENT_137	[p11l1962t1712r2008b1733],
287	Any	DT	O	any	dep	522	SENT_137	[p11l42t1757r85b1782],
288	loss	NN	O	loss	dep	522	SENT_137	[p11l92t1755r264b1776],
289	—	NN	O	—	dep	522	SENT_137	[p11l92t1755r264b1776],
290	of-function	NN	O	of-function	dep	522	SENT_137	[p11l92t1755r264b1776],
291	but	CC	O	but	dep	522	SENT_137	[p11l272t1755r308b1776],
292	no	DT	O	no	dep	522	SENT_137	[p11l316t1762r342b1776],
293	gain	NN	O	gain	dep	522	SENT_137	[p11l349t1755r528b1782],
294	—	NN	O	—	dep	522	SENT_137	[p11l349t1755r528b1782],
295	of	IN	O	of	dep	522	SENT_137	[p11l349t1755r528b1782],
296	—	CD	NUMBER	—	dep	522	SENT_137	[p11l349t1755r528b1782],
297	function	NN	O	function	dep	522	SENT_137	[p11l349t1755r528b1782],
298	allele	NN	O	allele	dep	522	SENT_137	[p11l536t1755r590b1776],
299	1011	CD	DATE	1011	dep	522	SENT_137	[p11l627t1758r679b1776],
300	108	CD	NUMBER	108	dep	522	SENT_137	[p11l770t1755r810b1776],
301	(	NN	O	(	dep	522	SENT_137	[p11l818t1756r899b1781],
302	10-7	CD	PERCENT	10-7	dep	522	SENT_137	[p11l818t1756r899b1781],
303	%	NN	PERCENT	%	dep	522	SENT_137	[p11l818t1756r899b1781],
304	)	CD	PERCENT	)	dep	522	SENT_137	[p11l818t1756r899b1781],
305	11-6	CD	PERCENT	11-6	dep	522	SENT_137	[p11l944t1755r1009b1776],
306	%	NN	PERCENT	%	dep	522	SENT_137	[p11l944t1755r1009b1776],
307	1053	CD	DATE	1053	dep	522	SENT_137	[p11l1128t1758r1181b1779],
308	108	CD	NUMBER	108	dep	522	SENT_137	[p11l1268t1755r1308b1776],
309	(	NN	O	(	dep	522	SENT_137	[p11l1317t1756r1398b1781],
310	10-3	CD	PERCENT	10-3	dep	522	SENT_137	[p11l1317t1756r1398b1781],
311	%	NN	PERCENT	%	dep	522	SENT_137	[p11l1317t1756r1398b1781],
312	)	CD	PERCENT	)	dep	522	SENT_137	[p11l1317t1756r1398b1781],
313	11-1	CD	PERCENT	11-1	dep	522	SENT_137	[p11l1440t1758r1502b1776],
314	%	NN	PERCENT	%	dep	522	SENT_137	[p11l1440t1758r1502b1776],
315	1-03	CD	NUMBER	1-03	dep	522	SENT_137	[p11l1618t1758r1663b1779],
316	(	CD	NUMBER	(	dep	522	SENT_137	[p11l1671t1756r1793b1781],
317	0-79-1-34	CD	NUMBER	0-79-1-34	dep	522	SENT_137	[p11l1671t1756r1793b1781],
318	)	NN	O	)	dep	522	SENT_137	[p11l1671t1756r1793b1781],
319	0-84	CD	NUMBER	0-84	dep	522	SENT_137	[p11l1829t1755r1879b1779],
320	Any	DT	O	any	dep	522	SENT_137	[p11l42t1803r85b1828],
321	gain-o	NN	O	gain-o	dep	522	SENT_137	[p11l91t1803r160b1828],
322	-	:	O	-	_	0	SENT_137	[p11l171t1801r200b1822],
323	fu	NN	O	fu	dep	522	SENT_137	[p11l171t1801r200b1822],
324	nction	NN	O	nction	dep	522	SENT_137	[p11l204t1803r270b1822],
325	allele	NN	O	allele	dep	522	SENT_137	[p11l278t1801r332b1822],
326	2070	CD	DATE	2070	dep	522	SENT_137	[p11l624t1804r678b1824],
327	196	CD	NUMBER	196	dep	522	SENT_137	[p11l769t1801r810b1825],
328	(	NN	O	(	dep	522	SENT_137	[p11l818t1802r888b1827],
329	95	CD	PERCENT	95	dep	522	SENT_137	[p11l818t1802r888b1827],
330	%	NN	PERCENT	%	dep	522	SENT_137	[p11l818t1802r888b1827],
331	)	CD	PERCENT	)	dep	522	SENT_137	[p11l818t1802r888b1827],
332	105	CD	PERCENT	105	dep	522	SENT_137	[p11l942t1804r1007b1825],
333	%	NN	PERCENT	%	dep	522	SENT_137	[p11l942t1804r1007b1825],
334	1977	CD	DATE	1977	dep	522	SENT_137	[p11l1129t1804r1181b1825],
335	214	CD	NUMBER	214	dep	522	SENT_137	[p11l1269t1804r1310b1824],
336	(	NN	O	(	dep	522	SENT_137	[p11l1317t1801r1400b1827],
337	10-8	CD	PERCENT	10-8	dep	522	SENT_137	[p11l1317t1801r1400b1827],
338	%	NN	PERCENT	%	dep	522	SENT_137	[p11l1317t1801r1400b1827],
339	)	CD	PERCENT	)	dep	522	SENT_137	[p11l1317t1801r1400b1827],
340	11-9	CD	PERCENT	11-9	dep	522	SENT_137	[p11l1440t1804r1504b1825],
341	%	NN	PERCENT	%	dep	522	SENT_137	[p11l1440t1804r1504b1825],
342	0-86	CD	NUMBER	0-86	dep	522	SENT_137	[p11l1616t1801r1665b1822],
343	(	CD	NUMBER	(	dep	522	SENT_137	[p11l1673t1802r1793b1827],
344	071-105	CD	NUMBER	071-105	dep	522	SENT_137	[p11l1673t1802r1793b1827],
345	)	NN	O	)	dep	522	SENT_137	[p11l1673t1802r1793b1827],
346	013	CD	NUMBER	013	dep	522	SENT_137	[p11l1829t1804r1874b1825],
347	Major	JJ	O	major	dep	522	SENT_137	[p11l43t1847r109b1874],
348	bleeding	NN	O	bleeding	dep	522	SENT_137	[p11l115t1846r212b1874],
349	related	JJ	O	related	dep	522	SENT_137	[p11l221t1846r299b1867],
350	to	TO	O	to	dep	522	SENT_137	[p11l304t1850r329b1867],
351	non-CABG	JJ	O	non-cabg	dep	522	SENT_137	[p11l336t1848r453b1867],
352	Any	DT	O	any	dep	522	SENT_137	[p11l42t1894r85b1919],
353	loss	NN	O	loss	dep	522	SENT_137	[p11l92t1892r264b1913],
354	—	CD	NUMBER	—	dep	522	SENT_137	[p11l92t1892r264b1913],
355	of-function	JJ	O	of-function	dep	522	SENT_137	[p11l92t1892r264b1913],
356	allele	NN	O	allele	dep	522	SENT_137	[p11l271t1892r325b1913],
357	1380	CD	DATE	1380	dep	522	SENT_137	[p11l624t1892r678b1916],
358	56	CD	NUMBER	56	dep	522	SENT_137	[p11l783t1892r810b1916],
359	(	NN	O	(	dep	522	SENT_137	[p11l818t1893r886b1919],
360	4-1	CD	PERCENT	4-1	dep	522	SENT_137	[p11l818t1893r886b1919],
361	%	NN	PERCENT	%	dep	522	SENT_137	[p11l818t1893r886b1919],
362	)	CD	PERCENT	)	dep	522	SENT_137	[p11l818t1893r886b1919],
363	4-6	CD	PERCENT	4-6	dep	522	SENT_137	[p11l954t1892r1009b1916],
364	%	NN	PERCENT	%	dep	522	SENT_137	[p11l954t1892r1009b1916],
365	1380	CD	DATE	1380	dep	522	SENT_137	[p11l1126t1892r1181b1916],
366	41	CD	NUMBER	41	dep	522	SENT_137	[p11l1282t1895r1309b1916],
367	(	NN	O	(	dep	522	SENT_137	[p11l1317t1894r1385b1918],
368	3-0	CD	PERCENT	3-0	dep	522	SENT_137	[p11l1317t1894r1385b1918],
369	%	NN	PERCENT	%	dep	522	SENT_137	[p11l1317t1894r1385b1918],
370	)	CD	PERCENT	)	dep	522	SENT_137	[p11l1317t1894r1385b1918],
371	3-2	CD	PERCENT	3-2	dep	522	SENT_137	[p11l1451t1895r1503b1916],
372	%	NN	PERCENT	%	dep	522	SENT_137	[p11l1451t1895r1503b1916],
373	1-39	CD	NUMBER	1-39	dep	522	SENT_137	[p11l1618t1895r1663b1916],
374	(	CD	NUMBER	(	dep	522	SENT_137	[p11l1672t1892r1797b1919],
375	0-93-2-08	CD	NUMBER	0-93-2-08	dep	522	SENT_137	[p11l1672t1892r1797b1919],
376	)	NN	O	)	dep	522	SENT_137	[p11l1672t1892r1797b1919],
377	0-11	CD	NUMBER	0-11	dep	522	SENT_137	[p11l1829t1895r1874b1913],
378	0-31	CD	NUMBER	0-31	dep	522	SENT_137	[p11l1962t1895r2007b1916],
379	No	DT	O	no	dep	522	SENT_137	[p11l43t1940r73b1959],
380	loss	NN	O	loss	dep	522	SENT_137	[p11l81t1938r183b1959],
381	—	NN	O	—	dep	522	SENT_137	[p11l81t1938r183b1959],
382	of	IN	O	of	dep	522	SENT_137	[p11l81t1938r183b1959],
383	—	CD	NUMBER	—	dep	522	SENT_137	[p11l81t1938r183b1959],
384	fu	NN	O	fu	dep	522	SENT_137	[p11l81t1938r183b1959],
385	nction	NN	O	nction	dep	522	SENT_137	[p11l187t1940r253b1959],
386	allele	NN	O	allele	dep	522	SENT_137	[p11l261t1938r315b1959],
387	3547	CD	NUMBER	3547	dep	522	SENT_137	[p11l625t1941r679b1962],
388	121	CD	NUMBER	121	dep	522	SENT_137	[p11l773t1941r811b1959],
389	(	NN	O	(	dep	522	SENT_137	[p11l818t1939r887b1964],
390	3-4	CD	PERCENT	3-4	dep	522	SENT_137	[p11l818t1939r887b1964],
391	%	NN	PERCENT	%	dep	522	SENT_137	[p11l818t1939r887b1964],
392	)	CD	PERCENT	)	dep	522	SENT_137	[p11l818t1939r887b1964],
393	3-9	CD	PERCENT	3-9	dep	522	SENT_137	[p11l956t1941r1009b1962],
394	%	NN	PERCENT	%	dep	522	SENT_137	[p11l956t1941r1009b1962],
395	3506	CD	NUMBER	3506	dep	522	SENT_137	[p11l1125t1938r1181b1962],
396	110	CD	NUMBER	110	dep	522	SENT_137	[p11l1270t1941r1309b1959],
397	(	NN	O	(	dep	522	SENT_137	[p11l1317t1939r1383b1964],
398	3-1	CD	PERCENT	3-1	dep	522	SENT_137	[p11l1317t1939r1383b1964],
399	%	NN	PERCENT	%	dep	522	SENT_137	[p11l1317t1939r1383b1964],
400	)	CD	PERCENT	)	dep	522	SENT_137	[p11l1317t1939r1383b1964],
401	3-6	CD	PERCENT	3-6	dep	522	SENT_137	[p11l1451t1938r1505b1962],
402	%	NN	PERCENT	%	dep	522	SENT_137	[p11l1451t1938r1505b1962],
403	1-08	CD	NUMBER	1-08	dep	522	SENT_137	[p11l1618t1938r1664b1959],
404	(	CD	NUMBER	(	dep	522	SENT_137	[p11l1673t1938r1798b1964],
405	084-140	CD	NUMBER	084-140	dep	522	SENT_137	[p11l1673t1938r1798b1964],
406	)	NN	O	)	dep	522	SENT_137	[p11l1673t1938r1798b1964],
407	055	CD	NUMBER	055	dep	522	SENT_137	[p11l1829t1941r1875b1962],
408	Major	JJ	O	major	dep	522	SENT_137	[p11l43t1985r109b2011],
409	bleeding	NN	O	bleeding	dep	522	SENT_137	[p11l115t1984r212b2011],
410	related	VBN	O	relate	dep	522	SENT_137	[p11l221t1984r299b2005],
411	to	TO	O	to	dep	522	SENT_137	[p11l304t1987r329b2005],
412	CABG	NNP	O	CABG	dep	522	SENT_137	[p11l335t1985r397b2005],
413	Any	DT	O	any	dep	522	SENT_137	[p11l42t2031r85b2057],
414	loss-of-function	JJ	O	loss-of-function	dep	522	SENT_137	[p11l92t2029r264b2050],
415	allele	NN	O	allele	dep	522	SENT_137	[p11l271t2029r325b2050],
416	1380	CD	DATE	1380	dep	522	SENT_137	[p11l624t2029r678b2053],
417	96	CD	NUMBER	96	dep	522	SENT_137	[p11l782t2029r810b2053],
418	(	NN	O	(	dep	522	SENT_137	[p11l818t2031r886b2056],
419	7-0	CD	PERCENT	7-0	dep	522	SENT_137	[p11l818t2031r886b2056],
420	%	NN	PERCENT	%	dep	522	SENT_137	[p11l818t2031r886b2056],
421	)	CD	PERCENT	)	dep	522	SENT_137	[p11l818t2031r886b2056],
422	76	CD	PERCENT	76	dep	522	SENT_137	[p11l956t2029r1009b2053],
423	%	NN	PERCENT	%	dep	522	SENT_137	[p11l956t2029r1009b2053],
424	1380	CD	DATE	1380	dep	522	SENT_137	[p11l1126t2029r1181b2053],
425	107	CD	NUMBER	107	dep	522	SENT_137	[p11l1270t2032r1309b2053],
426	(	NN	O	(	dep	522	SENT_137	[p11l1317t2029r1385b2056],
427	78	CD	PERCENT	78	dep	522	SENT_137	[p11l1317t2029r1385b2056],
428	%	NN	PERCENT	%	dep	522	SENT_137	[p11l1317t2029r1385b2056],
429	)	CD	PERCENT	)	dep	522	SENT_137	[p11l1317t2029r1385b2056],
430	8-6	CD	PERCENT	8-6	dep	522	SENT_137	[p11l1451t2029r1505b2050],
431	%	NN	PERCENT	%	dep	522	SENT_137	[p11l1451t2029r1505b2050],
432	0-87	CD	NUMBER	0-87	dep	522	SENT_137	[p11l1616t2029r1664b2053],
433	(	CD	NUMBER	(	dep	522	SENT_137	[p11l1671t2029r1795b2056],
434	0-66-1-14	CD	NUMBER	0-66-1-14	dep	522	SENT_137	[p11l1671t2029r1795b2056],
435	)	NN	O	)	dep	522	SENT_137	[p11l1671t2029r1795b2056],
436	0-31	CD	NUMBER	0-31	dep	522	SENT_137	[p11l1829t2032r1875b2053],
437	0-93	CD	NUMBER	0-93	dep	522	SENT_137	[p11l1962t2032r2009b2053],
438	No	DT	O	no	dep	522	SENT_137	[p11l43t2077r73b2096],
439	|	NN	O	|	dep	522	SENT_137	[p11l81t2075r183b2096],
440	oss	NN	O	oss	dep	522	SENT_137	[p11l81t2075r183b2096],
441	»	NN	O	»	dep	522	SENT_137	[p11l81t2075r183b2096],
442	of	IN	O	of	dep	522	SENT_137	[p11l81t2075r183b2096],
443	—	CD	NUMBER	—	dep	522	SENT_137	[p11l81t2075r183b2096],
444	fu	NN	O	fu	dep	522	SENT_137	[p11l81t2075r183b2096],
445	nction	NN	O	nction	dep	522	SENT_137	[p11l187t2077r253b2096],
446	allele	NN	O	allele	dep	522	SENT_137	[p11l261t2075r315b2096],
447	3547	CD	NUMBER	3547	dep	522	SENT_137	[p11l625t2078r679b2099],
448	218	CD	NUMBER	218	dep	522	SENT_137	[p11l771t2075r810b2096],
449	(	NN	O	(	dep	522	SENT_137	[p11l818t2075r887b2101],
450	6-1	CD	PERCENT	6-1	dep	522	SENT_137	[p11l818t2075r887b2101],
451	%	NN	PERCENT	%	dep	522	SENT_137	[p11l818t2075r887b2101],
452	)	CD	PERCENT	)	dep	522	SENT_137	[p11l818t2075r887b2101],
453	6-8	CD	PERCENT	6-8	dep	522	SENT_137	[p11l955t2075r1009b2096],
454	%	NN	PERCENT	%	dep	522	SENT_137	[p11l955t2075r1009b2096],
455	3506	CD	NUMBER	3506	dep	522	SENT_137	[p11l1125t2075r1181b2099],
456	246	CD	NUMBER	246	dep	522	SENT_137	[p11l1267t2075r1309b2099],
457	(	NN	O	(	dep	522	SENT_137	[p11l1317t2076r1385b2101],
458	7-0	CD	PERCENT	7-0	dep	522	SENT_137	[p11l1317t2076r1385b2101],
459	%	NN	PERCENT	%	dep	522	SENT_137	[p11l1317t2076r1385b2101],
460	)	CD	PERCENT	)	dep	522	SENT_137	[p11l1317t2076r1385b2101],
461	7-7	CD	PERCENT	7-7	dep	522	SENT_137	[p11l1452t2078r1502b2099],
462	%	NN	PERCENT	%	dep	522	SENT_137	[p11l1452t2078r1502b2099],
463	0-88	CD	NUMBER	0-88	dep	522	SENT_137	[p11l1616t2075r1665b2096],
464	(	CD	NUMBER	(	dep	522	SENT_137	[p11l1673t2076r1794b2101],
465	0-73-1-05	CD	NUMBER	0-73-1-05	dep	522	SENT_137	[p11l1673t2076r1794b2101],
466	)	NN	O	)	dep	522	SENT_137	[p11l1673t2076r1794b2101],
467	0-16	CD	NUMBER	0-16	dep	522	SENT_137	[p11l1829t2075r1876b2096],
468	Net	JJ	O	net	dep	522	SENT_137	[p11l43t2123r84b2142],
469	clinical	JJ	O	clinical	dep	522	SENT_137	[p11l90t2121r166b2142],
470	beneﬁt	NN	O	beneﬁt	dep	522	SENT_137	[p11l174t2121r255b2142],
471	Any	DT	O	any	dep	522	SENT_137	[p11l42t2169r85b2194],
472	loss-of-function	JJ	O	loss-of-function	dep	522	SENT_137	[p11l92t2167r264b2188],
473	allele	NN	O	allele	dep	522	SENT_137	[p11l272t2167r326b2188],
474	1384	CD	DATE	1384	dep	522	SENT_137	[p11l623t2167r679b2191],
475	204	CD	NUMBER	204	dep	522	SENT_137	[p11l770t2170r811b2190],
476	(	NN	O	(	dep	522	SENT_137	[p11l818t2168r898b2193],
477	14-7	CD	PERCENT	14-7	dep	522	SENT_137	[p11l818t2168r898b2193],
478	%	NN	PERCENT	%	dep	522	SENT_137	[p11l818t2168r898b2193],
479	)	CD	PERCENT	)	dep	522	SENT_137	[p11l818t2168r898b2193],
480	152	CD	PERCENT	152	dep	522	SENT_137	[p11l943t2170r1007b2191],
481	%	NN	PERCENT	%	dep	522	SENT_137	[p11l943t2170r1007b2191],
482	1388	CD	DATE	1388	dep	522	SENT_137	[p11l1126t2167r1180b2191],
483	231	CD	NUMBER	231	dep	522	SENT_137	[p11l1271t2170r1309b2191],
484	(	NN	O	(	dep	522	SENT_137	[p11l1317t2167r1401b2193],
485	16-6	CD	PERCENT	16-6	dep	522	SENT_137	[p11l1317t2167r1401b2193],
486	%	NN	PERCENT	%	dep	522	SENT_137	[p11l1317t2167r1401b2193],
487	)	CD	PERCENT	)	dep	522	SENT_137	[p11l1317t2167r1401b2193],
488	17-1	CD	PERCENT	17-1	dep	522	SENT_137	[p11l1440t2170r1502b2190],
489	%	NN	PERCENT	%	dep	522	SENT_137	[p11l1440t2170r1502b2190],
490	0-88	CD	NUMBER	0-88	dep	522	SENT_137	[p11l1616t2167r1665b2188],
491	(	CD	NUMBER	(	dep	522	SENT_137	[p11l1673t2167r1796b2193],
492	O-72-1-06	NN	O	o-72-1-06	dep	522	SENT_137	[p11l1673t2167r1796b2193],
493	)	CD	NUMBER	)	dep	522	SENT_137	[p11l1673t2167r1796b2193],
494	0-17	CD	NUMBER	0-17	dep	522	SENT_137	[p11l1829t2170r1875b2190],
495	0-88	CD	NUMBER	0-88	dep	522	SENT_137	[p11l1962t2167r2011b2188],
496	No	DT	O	no	dep	522	SENT_137	[p11l43t2214r73b2233],
497	loss	NN	O	loss	dep	522	SENT_137	[p11l81t2212r183b2233],
498	~	NN	O	~	dep	522	SENT_137	[p11l81t2212r183b2233],
499	of-fu	NN	O	of-fu	dep	522	SENT_137	[p11l81t2212r183b2233],
500	nction	NN	O	nction	dep	522	SENT_137	[p11l187t2214r253b2233],
501	allele	NN	O	allele	dep	522	SENT_137	[p11l261t2212r315b2233],
502	3554	CD	NUMBER	3554	dep	522	SENT_137	[p11l624t2215r679b2236],
503	476	CD	NUMBER	476	dep	522	SENT_137	[p11l769t2212r810b2236],
504	(	NN	O	(	dep	522	SENT_137	[p11l818t2214r898b2239],
505	134	CD	PERCENT	134	dep	522	SENT_137	[p11l818t2214r898b2239],
506	%	NN	PERCENT	%	dep	522	SENT_137	[p11l818t2214r898b2239],
507	)	CD	PERCENT	)	dep	522	SENT_137	[p11l818t2214r898b2239],
508	140	CD	PERCENT	140	dep	522	SENT_137	[p11l942t2215r1008b2236],
509	%	NN	PERCENT	%	dep	522	SENT_137	[p11l942t2215r1008b2236],
510	3516	CD	NUMBER	3516	dep	522	SENT_137	[p11l1127t2212r1181b2236],
511	533	CD	NUMBER	533	dep	522	SENT_137	[p11l1270t2215r1308b2236],
512	(	NN	O	(	dep	522	SENT_137	[p11l1317t2214r1397b2239],
513	15-2	CD	PERCENT	15-2	dep	522	SENT_137	[p11l1317t2214r1397b2239],
514	%	NN	PERCENT	%	dep	522	SENT_137	[p11l1317t2214r1397b2239],
515	)	CD	PERCENT	)	dep	522	SENT_137	[p11l1317t2214r1397b2239],
516	15-8	CD	PERCENT	15-8	dep	522	SENT_137	[p11l1439t2212r1505b2236],
517	%	NN	PERCENT	%	dep	522	SENT_137	[p11l1439t2212r1505b2236],
518	0-86	CD	NUMBER	0-86	dep	522	SENT_137	[p11l1616t2212r1665b2233],
519	(	CD	NUMBER	(	dep	522	SENT_137	[p11l1674t2212r1798b2239],
520	O-76-0-97	NN	O	o-76-0-97	dep	522	SENT_137	[p11l1674t2212r1798b2239],
521	)	CD	NUMBER	)	dep	522	SENT_137	[p11l1674t2212r1798b2239],
522	0-0172	CD	NUMBER	0-0172	_	0	SENT_137	[p11l1829t2215r1902b2236],

1	CABG	NN	O	cabg	nn	6	SENT_138	[p11l31t2282r190b2306],
2	=	JJ	O	=	amod	6	SENT_138	[p11l31t2282r190b2306],
3	coronary	JJ	O	coronary	amod	6	SENT_138	[p11l31t2282r190b2306],
4	artery	NN	O	artery	nn	6	SENT_138	[p11l196t2284r254b2306],
5	bypass	NN	O	bypass	nn	6	SENT_138	[p11l260t2280r326b2306],
6	graft	NN	O	graft	nsubj	13	SENT_138	[p11l332t2280r385b2306],
7	,	,	O	,	_	0	SENT_138	[p11l332t2280r385b2306],
8	*	NN	O	*	nn	10	SENT_138	[p11l393t2281r415b2306],
9	p	NN	O	p	nn	10	SENT_138	[p11l393t2281r415b2306],
10	value	NN	O	value	appos	6	SENT_138	[p11l421t2281r474b2300],
11	of	IN	O	of	_	0	SENT_138	[p11l479t2280r501b2300],
12	interaction	NN	O	interaction	prep_of	10	SENT_138	[p11l506t2282r615b2300],
13	indicates	VBZ	O	indicate	_	0	SENT_138	[p11l622t2280r710b2300],
14	signiﬁcance	NN	O	signiﬁcance	dobj	13	SENT_138	[p11l716t2280r833b2306],
15	of	IN	O	of	_	0	SENT_138	[p11l839t2280r860b2300],
16	effects	NNS	O	effect	prep_of	14	SENT_138	[p11l865t2280r930b2300],
17	of	IN	O	of	_	0	SENT_138	[p11l936t2280r957b2300],
18	genotype	NN	O	genotype	nn	19	SENT_138	[p11l962t2284r1057b2306],
19	groups	NNS	O	group	prep_of	16	SENT_138	[p11l1063t2287r1132b2306],
20	on	IN	O	on	_	0	SENT_138	[p11l1137t2287r1162b2300],
21	the	DT	O	the	det	22	SENT_138	[p11l1168t2280r1201b2300],
22	results	NNS	O	result	prep_on	13	SENT_138	[p11l1208t2280r1272b2300],
23	of	IN	O	of	_	0	SENT_138	[p11l1278t2280r1299b2300],
24	comparisons	NNS	O	comparison	prep_of	22	SENT_138	[p11l1304t2282r1431b2306],
25	between	IN	O	between	_	0	SENT_138	[p11l1438t2280r1523b2300],
26	treatment	NN	O	treatment	nn	27	SENT_138	[p11l1529t2284r1632b2300],
27	gr	NN	O	gr	prep_between	24	SENT_138	[p11l1638t2287r1658b2306],
28	.	.	O	.	_	0	SENT_138	[p11l1708t2297r1712b2300],

1	tStent	JJ	O	tstent	amod	3	SENT_139	[p11l1719t2282r1784b2301],
2	thrombosis	NN	O	thrombosis	nn	3	SENT_139	[p11l1789t2280r1904b2300],
3	population	NN	O	population	nsubj	4	SENT_139	[p11l1910t2281r2019b2306],
4	includes	VBZ	O	include	_	0	SENT_139	[p11l2027t2280r2107b2300],
5	patients	NNS	O	patient	dobj	4	SENT_139	[p11l30t2317r112b2340],
6	who	WP	O	who	nsubj	7	SENT_139	[p11l117t2315r161b2335],
7	received	VBD	O	receive	rcmod	5	SENT_139	[p11l168t2315r249b2335],
8	at	IN	O	at	quantmod	10	SENT_139	[p11l256t2319r275b2335],
9	least	JJS	O	least	mwe	8	SENT_139	[p11l282t2315r327b2335],
10	one	CD	NUMBER	one	num	11	SENT_139	[p11l332t2322r369b2335],
11	stent	NN	O	stent	dobj	7	SENT_139	[p11l376t2319r427b2335],
12	at	IN	O	at	_	0	SENT_139	[p11l433t2319r452b2335],
13	any	DT	O	any	det	14	SENT_139	[p11l458t2322r494b2340],
14	time	NN	O	time	prep_at	11	SENT_139	[p11l498t2317r545b2335],
15	during	IN	O	during	_	0	SENT_139	[p11l550t2315r615b2341],
16	the	DT	O	the	det	17	SENT_139	[p11l621t2315r654b2335],
17	study	NN	O	study	prep_during	7	SENT_139	[p11l660t2315r719b2340],
18	,	,	O	,	_	0	SENT_139	[p11l660t2315r719b2340],
19	which	WDT	O	which	nsubj	20	SENT_139	[p11l725t2315r784b2335],
20	was	VBD	O	be	rcmod	17	SENT_139	[p11l790t2322r828b2335],
21	about	IN	O	about	_	0	SENT_139	[p11l834t2315r893b2335],
22	64	CD	PERCENT	64	num	23	SENT_139	[p11l900t2315r944b2337],
23	%	NN	PERCENT	%	prep_about	20	SENT_139	[p11l900t2315r944b2337],
24	of	IN	O	of	_	0	SENT_139	[p11l950t2315r972b2335],
25	patients	NNS	O	patient	prep_of	23	SENT_139	[p11l976t2317r1058b2340],
26	participating	VBG	O	participate	partmod	25	SENT_139	[p11l1064t2317r1191b2341],
27	in	IN	O	in	_	0	SENT_139	[p11l1199t2317r1215b2334],
28	the	DT	O	the	det	30	SENT_139	[p11l1221t2315r1254b2335],
29	genetic	JJ	O	genetic	amod	30	SENT_139	[p11l1260t2317r1334b2341],
30	substudy	NN	O	substudy	prep_in	26	SENT_139	[p11l1340t2315r1434b2340],
31	.	.	O	.	_	0	SENT_139	[p11l1340t2315r1434b2340],

1	ilnteraction	NN	O	ilnteraction	nn	2	SENT_140	[p11l1441t2317r1562b2336],
2	p	NN	O	p	nsubj	5	SENT_140	[p11l1569t2322r1580b2340],
3	value	NN	O	value	nn	4	SENT_140	[p11l1586t2315r1639b2335],
4	n	NN	O	n	dep	2	SENT_140	[p11l1646t2322r1657b2334],
5	culated	VBD	O	culate	_	0	SENT_140	[p11l1713t2315r1785b2335],
6	because	IN	O	because	_	0	SENT_140	[p11l1792t2315r1870b2335],
7	of	IN	O	of	_	0	SENT_140	[p11l1876t2315r1898b2335],
8	low	JJ	O	low	amod	9	SENT_140	[p11l1903t2315r1939b2335],
9	number	NN	O	number	prep_because_of	5	SENT_140	[p11l1945t2315r2024b2335],
10	of	IN	O	of	_	0	SENT_140	[p11l2029t2315r2050b2335],
11	events	NNS	O	event	prep_of	9	SENT_140	[p11l2055t2319r2125b2335],
12	.	.	O	.	_	0	SENT_140	[p11l2055t2319r2125b2335],

1	Table	NNP	O	Table	_	0	SENT_141	[p11l31t2379r88b2400],
2	3	CD	NUMBER	3	num	1	SENT_141	[p11l92t2382r113b2403],
3	:	:	O	:	_	0	SENT_141	[p11l92t2382r113b2403],
4	Outcomes	NNS	O	outcome	dep	1	SENT_141	[p11l119t2380r235b2400],
5	in	IN	O	in	_	0	SENT_141	[p11l242t2380r261b2400],
6	relation	NN	O	relation	prep_in	4	SENT_141	[p11l269t2379r356b2400],
7	to	TO	O	to	_	0	SENT_141	[p11l362t2382r387b2400],
8	the	DT	O	the	det	11	SENT_141	[p11l392t2379r430b2400],
9	CYP2C19	NN	O	cyp2c19	nn	11	SENT_141	[p11l437t2380r536b2403],
10	genotype	NN	O	genotype	nn	11	SENT_141	[p11l543t2382r652b2406],
11	vwvw	NN	O	vwvw	prep_to	6	SENT_141	[p11l6t2500r229b2522],
12	.	.	O	.	_	0	SENT_141	[p11l6t2500r229b2522],

1	the	DT	O	the	det	2	SENT_142	[p11l6t2500r229b2522],
2	|	NN	O	|	_	0	SENT_142	[p11l6t2500r229b2522],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_142	[p11l6t2500r229b2522],
4	Vol	NNP	O	Vol	dep	2	SENT_142	[p11l274t2500r311b2522],
5	376	CD	NUMBER	376	num	4	SENT_142	[p11l346t2500r390b2525],
6	October	NNP	DATE	October	tmod	4	SENT_142	[p11l436t2500r530b2522],
7	16	CD	DATE	16	num	6	SENT_142	[p11l564t2500r599b2526],
8	,	,	DATE	,	_	0	SENT_142	[p11l564t2500r599b2526],
9	2010	CD	DATE	2010	num	6	SENT_142	[p11l635t2503r694b2522],
10	1323	CD	DATE	1323	dep	2	SENT_142	[p11l6t2544r61b2566],

1	Articles	NNPS	O	Articles	_	0	SENT_143	[p11l101t2804r251b2840],

1	Event	NN	O	event	nn	2	SENT_144	[p12l611t513r629b568],
2	rate	NN	O	rate	_	0	SENT_144	[p12l613t468r629b506],
3	(	CD	NUMBER	(	num	4	SENT_144	[p12l611t430r634b461],
4	°	CD	NUMBER	°	dep	2	SENT_144	[p12l611t430r634b461],
5	/	:	O	/	punct	2	SENT_144	[p12l611t430r634b461],
6	n	NN	O	n	dep	2	SENT_144	[p12l611t430r634b461],
7	)	CD	NUMBER	)	dep	6	SENT_144	[p12l611t430r634b461],

1	Number	NN	O	number	_	0	SENT_145	[p12l507t971r593b991],
2	at	IN	O	at	_	0	SENT_145	[p12l598t975r619b991],
3	risk	NN	O	risk	nn	4	SENT_145	[p12l626t971r662b991],
4	Clopidogrel	NN	O	clopidogrel	prep_at	1	SENT_145	[p12l541t1003r661b1028],

1	12	CD	NUMBER	12	_	0	SENT_146	[p12l665t79r687b95],
2	-	:	O	-	_	0	SENT_146	[p12l693t85r706b88],
3	T	NN	O	t	nn	4	SENT_146	[p12l732t86r778b88],
4	Clopidogrel	NN	O	clopidogrel	dep	1	SENT_146	[p12l787t76r906b101],
5	,	,	O	,	_	0	SENT_146	[p12l787t76r906b101],
6	any	DT	O	any	det	8	SENT_146	[p12l914t83r949b101],
7	loss-of-function	JJ	O	loss-of-function	amod	8	SENT_146	[p12l956t76r1115b95],
8	allele	NN	O	allele	appos	4	SENT_146	[p12l1122t76r1173b95],
9	T	NN	O	t	dep	16	SENT_146	[p12l732t118r778b120],
10	Clopidogrel	NNP	O	Clopidogrel	dep	9	SENT_146	[p12l787t108r907b133],
11	,	,	O	,	_	0	SENT_146	[p12l787t108r907b133],
12	no	DT	O	no	det	14	SENT_146	[p12l915t114r939b127],
13	loss-of-function	JJ	O	loss-of-function	amod	14	SENT_146	[p12l946t107r1106b127],
14	allele	NN	O	allele	appos	10	SENT_146	[p12l1113t108r1163b127],
15	—	CD	NUMBER	—	dep	16	SENT_146	[p12l732t149r778b152],
16	Ticagrelor	NNP	O	Ticagrelor	dep	1	SENT_146	[p12l786t139r890b165],
17	,	,	O	,	_	0	SENT_146	[p12l786t139r890b165],
18	any	DT	O	any	det	22	SENT_146	[p12l897t146r932b164],
19	loss-of-function	JJ	O	loss-of-function	amod	22	SENT_146	[p12l939t139r1099b159],
20	allele	NN	O	allele	nn	22	SENT_146	[p12l1106t139r1156b159],
21	T	NN	O	t	nn	22	SENT_146	[p12l732t182r778b183],
22	Ticagrelor	NN	O	ticagrelor	appos	16	SENT_146	[p12l786t171r890b196],
23	,	,	O	,	_	0	SENT_146	[p12l786t171r890b196],
24	no	DT	O	no	det	26	SENT_146	[p12l898t177r922b190],
25	loss-of-function	JJ	O	loss-of-function	amod	26	SENT_146	[p12l929t171r1089b190],
26	allele	NN	O	allele	appos	16	SENT_146	[p12l1096t171r1146b190],

1	Ticag	NNP	O	Ticag	_	0	SENT_147	[p12l557t1099r612b1123],
2	relo	NN	O	relo	nn	3	SENT_147	[p12l615t1098r653b1117],
3	r	NN	O	r	dep	1	SENT_147	[p12l656t1104r663b1117],

1	Days	NNS	DURATION	day	_	0	SENT_148	[p12l1249t956r1294b980],
2	from	IN	O	from	_	0	SENT_148	[p12l1300t954r1348b974],
3	randomisation	NN	O	randomisation	prep_from	1	SENT_148	[p12l1356t955r1502b974],

1	Any	DT	O	any	det	3	SENT_149	[p12l399t1036r438b1060],
2	loss-of-function	JJ	O	loss-of-function	amod	3	SENT_149	[p12l445t1034r605b1054],
3	allele	NN	O	allele	_	0	SENT_149	[p12l612t1035r662b1054],
4	1388 1275 1259 1226	CD	NUMBER	1388 1275 1259 1226	number	5	SENT_149	[p12l1353t1034r1402b1054],[p12l681t1034r732b1056],
5	1027 801 658	CD	NUMBER	1027 801 658	dep	3	SENT_149	[p12l2034t1034r2073b1056],[p12l1577t1037r1626b1056],
6	No	DT	O	no	det	8	SENT_149	[p12l410t1068r438b1085],
7	loss-of-function	NN	O	loss-of-function	nn	8	SENT_149	[p12l445t1066r605b1086],
8	allele	NN	O	allele	dep	5	SENT_149	[p12l612t1066r662b1086],
9	3516 3321 3256 3186	CD	NUMBER	3516 3321 3256 3186	num	10	SENT_149	[p12l1351t1066r1402b1088],[p12l682t1066r732b1088],
10	2691 2123 1757	CD	NUMBER	2691 2123 1757	dep	3	SENT_149	[p12l2026t1069r2074b1088],[p12l1575t1066r1626b1088],

1	Any	DT	O	any	det	3	SENT_150	[p12l399t1131r438b1154],
2	loss-of-function	JJ	O	loss-of-function	amod	3	SENT_150	[p12l445t1129r605b1149],
3	allele	NN	O	allele	_	0	SENT_150	[p12l612t1129r662b1149],
4	1384 1305 1274 1250	CD	NUMBER	1384 1305 1274 1250	number	5	SENT_150	[p12l1353t1132r1402b1151],[p12l681t1129r733b1151],
5	1053 834 683	CD	NUMBER	1053 834 683	dep	3	SENT_150	[p12l2034t1129r2073b1151],[p12l1577t1132r1626b1151],
6	No	DT	O	no	det	8	SENT_150	[p12l410t1163r438b1180],
7	loss-of-function	NN	O	loss-of-function	nn	8	SENT_150	[p12l445t1161r605b1180],
8	allele	NN	O	allele	dep	5	SENT_150	[p12l612t1161r662b1180],
9	3554 3352 3301 3222	CD	NUMBER	3554 3352 3301 3222	num	10	SENT_150	[p12l1353t1163r1402b1183],[p12l681t1163r733b1183],
10	2718 2127 1761	CD	NUMBER	2718 2127 1761	dep	3	SENT_150	[p12l2025t1160r2073b1182],[p12l1577t1160r1626b1182],

1	Figure	NNP	O	Figure	_	0	SENT_151	[p12l374t1235r440b1261],
2	1	CD	NUMBER	1	dep	1	SENT_151	[p12l446t1237r465b1255],
3	:	:	O	:	_	0	SENT_151	[p12l446t1237r465b1255],
4	Kaplan-Meier	NNP	O	Kaplan-Meier	nn	5	SENT_151	[p12l473t1234r624b1261],
5	estimates	NNS	O	estimate	dep	21	SENT_151	[p12l630t1235r741b1255],
6	of	IN	O	of	_	0	SENT_151	[p12l747t1234r772b1255],
7	events	NNS	O	event	prep_of	5	SENT_151	[p12l777t1237r852b1255],
8	of	IN	O	of	_	0	SENT_151	[p12l858t1234r883b1255],
9	the	DT	O	the	det	12	SENT_151	[p12l886t1234r924b1255],
10	primaw	NN	O	primaw	nn	12	SENT_151	[p12l930t1235r1021b1261],
11	efﬁcacy	NN	O	efﬁcacy	nn	12	SENT_151	[p12l1027t1234r1112b1261],
12	outcome	NN	O	outcome	prep_of	7	SENT_151	[p12l1118t1237r1219b1255],
13	in	IN	O	in	_	0	SENT_151	[p12l1227t1235r1246b1254],
14	relation	NN	O	relation	prep_in	12	SENT_151	[p12l1255t1234r1341b1255],
15	to	TO	O	to	_	0	SENT_151	[p12l1347t1237r1372b1255],
16	the	DT	O	the	det	18	SENT_151	[p12l1377t1234r1415b1255],
17	CYP2C19	NN	O	cyp2c19	nn	18	SENT_151	[p12l1422t1235r1521b1258],
18	genotype	NN	O	genotype	prep_to	5	SENT_151	[p12l1528t1237r1636b1261],
19	was	VBD	O	be	auxpass	21	SENT_151	[p12l643t1356r740b1387],
20	not	RB	O	not	neg	21	SENT_151	[p12l791t1349r876b1387],
21	affected	VBN	O	affect	dep	1	SENT_151	[p12l925t1339r1126b1387],
22	by	IN	O	by	_	0	SENT_151	[p12l1173t1339r1235b1402],
23	the	DT	O	the	det	25	SENT_151	[p12l1281t1339r1362b1387],
24	genotype	NN	O	genotype	nn	25	SENT_151	[p12l1413t1349r1645b1402],
25	group	NN	O	group	agent	21	SENT_151	[p12l1696t1356r1848b1402],
26	(	CD	NUMBER	(	num	29	SENT_151	[p12l1902t1339r2039b1402],
27	table	NN	O	table	nn	29	SENT_151	[p12l1902t1339r2039b1402],
28	3	CD	NUMBER	3	num	29	SENT_151	[p12l2092t1344r2150b1402],
29	)	NN	O	)	nsubjpass	21	SENT_151	[p12l2092t1344r2150b1402],
30	.	.	O	.	_	0	SENT_151	[p12l2092t1344r2150b1402],

1	Differences	NNS	O	difference	nsubj	10	SENT_152	[p12l647t1416r942b1463],
2	in	IN	O	in	_	0	SENT_152	[p12l960t1419r1012b1463],
3	Kaplan-Meier	NNP	O	Kaplan-Meier	nn	5	SENT_152	[p12l1030t1416r1380b1478],
4	event	NN	O	event	nn	5	SENT_152	[p12l1395t1425r1533b1463],
5	rates	NNS	O	rate	prep_in	1	SENT_152	[p12l1548t1425r1669b1463],
6	between	IN	O	between	_	0	SENT_152	[p12l1686t1416r1903b1463],
7	genotype	NN	O	genotype	nn	8	SENT_152	[p12l1919t1425r2152b1479],
8	groups	NNS	O	group	prep_between	5	SENT_152	[p12l646t1508r822b1554],
9	were	VBD	O	be	cop	10	SENT_152	[p12l844t1508r968b1539],
10	similar	JJ	O	similar	dep	33	SENT_152	[p12l991t1491r1173b1539],
11	for	IN	O	for	_	0	SENT_152	[p12l1193t1491r1267b1539],
12	ticagrelor	NN	O	ticagrelor	prep_for	10	SENT_152	[p12l1286t1491r1531b1554],
13	(	CD	PERCENT	(	num	15	SENT_152	[p12l1555t1494r1722b1554],
14	1-2	CD	PERCENT	1-2	num	15	SENT_152	[p12l1555t1494r1722b1554],
15	%	NN	PERCENT	%	dep	12	SENT_152	[p12l1555t1494r1722b1554],
16	)	CD	NUMBER	)	dep	12	SENT_152	[p12l1555t1494r1722b1554],
17	and	CC	O	and	_	0	SENT_152	[p12l1748t1491r1844b1539],
18	clopidogrel	NN	O	clopidogrel	nn	19	SENT_152	[p12l1865t1491r2152b1554],
19	(	NN	O	(	prep_for	10	SENT_152	[p12l649t1571r706b1630],
20	1	CD	NUMBER	1	dep	19	SENT_152	[p12l649t1571r706b1630],
21	-	:	O	-	_	0	SENT_152	[p12l649t1571r706b1630],
22	3	CD	PERCENT	3	num	23	SENT_152	[p12l721t1570r833b1630],
23	%	NN	PERCENT	%	conj_and	12	SENT_152	[p12l721t1570r833b1630],
24	)	CD	NUMBER	)	dep	23	SENT_152	[p12l721t1570r833b1630],
25	,	,	O	,	_	0	SENT_152	[p12l721t1570r833b1630],
26	and	CC	O	and	_	0	SENT_152	[p12l854t1567r950b1615],
27	event	NN	O	event	nn	28	SENT_152	[p12l969t1577r1107b1615],
28	rates	NNS	O	rate	conj_and	12	SENT_152	[p12l1124t1577r1245b1615],
29	in	IN	O	in	_	0	SENT_152	[p12l1265t1570r1318b1614],
30	the	DT	O	the	det	32	SENT_152	[p12l1335t1567r1416b1615],
31	ticagrelor	NN	O	ticagrelor	nn	32	SENT_152	[p12l1434t1567r1679b1630],
32	group	NN	O	group	prep_in	28	SENT_152	[p12l1697t1584r1849b1630],
33	were	VBD	O	be	_	0	SENT_152	[p12l1867t1584r1991b1615],
34	lower	JJR	O	lower	dep	35	SENT_152	[p12l2009t1567r2153b1615],
35	than	IN	O	than	advmod	33	SENT_152	[p12l644t1644r761b1691],
36	in	IN	O	in	_	0	SENT_152	[p12l793t1647r845b1691],
37	the	DT	O	the	det	39	SENT_152	[p12l875t1644r956b1691],
38	clopidogrel	NN	O	clopidogrel	nn	39	SENT_152	[p12l989t1644r1276b1707],
39	group	NN	O	group	prep_in	33	SENT_152	[p12l1309t1661r1474b1707],
40	,	,	O	,	_	0	SENT_152	[p12l1309t1661r1474b1707],
41	irrespective	RB	O	irrespective	_	0	SENT_152	[p12l1508t1647r1805b1706],
42	of	IN	O	of	_	0	SENT_152	[p12l1838t1644r1896b1691],
43	genotype	NN	O	genotype	nn	44	SENT_152	[p12l1919t1653r2152b1707],
44	group	NN	O	group	prep_irrespective_of	39	SENT_152	[p12l646t1736r798b1782],
45	(	CD	NUMBER	(	num	48	SENT_152	[p12l819t1719r956b1782],
46	table	NN	O	table	nn	48	SENT_152	[p12l819t1719r956b1782],
47	3	CD	NUMBER	3	num	48	SENT_152	[p12l977t1724r1035b1782],
48	)	NN	O	)	nsubj	33	SENT_152	[p12l977t1724r1035b1782],
49	.	.	O	.	_	0	SENT_152	[p12l977t1724r1035b1782],

1	In	IN	O	in	_	0	SENT_153	[p12l697t1800r752b1842],
2	relation	NN	O	relation	prep_in	23	SENT_153	[p12l764t1795r962b1843],
3	to	TO	O	to	_	0	SENT_153	[p12l973t1804r1021b1843],
4	the	DT	O	the	det	8	SENT_153	[p12l1033t1795r1114b1843],
5	AB	NNP	O	AB	nn	8	SENT_153	[p12l1125t1798r1206b1842],
6	C	NNP	O	C	nn	8	SENT_153	[p12l1213t1798r1251b1843],
7	B1	NN	O	b1	nn	8	SENT_153	[p12l1254t1799r1313b1842],
8	genotype	NN	O	genotype	prep_to	2	SENT_153	[p12l1325t1804r1571b1858],
9	,	,	O	,	_	0	SENT_153	[p12l1325t1804r1571b1858],
10	rates	NNS	O	rate	nsubj	23	SENT_153	[p12l1585t1804r1707b1843],
11	of	IN	O	of	_	0	SENT_153	[p12l1721t1795r1779b1843],
12	cardiovascular	JJ	O	cardiovascular	amod	13	SENT_153	[p12l1782t1795r2153b1843],
13	death	NN	O	death	prep_of	10	SENT_153	[p12l645t1872r800b1927],
14	,	,	O	,	_	0	SENT_153	[p12l645t1872r800b1927],
15	myocardial	JJ	O	myocardial	amod	16	SENT_153	[p12l828t1872r1114b1935],
16	infarction	NN	O	infarction	prep_of	10	SENT_153	[p12l1139t1872r1406b1927],
17	,	,	O	,	_	0	SENT_153	[p12l1139t1872r1406b1927],
18	and	CC	O	and	_	0	SENT_153	[p12l1435t1872r1531b1920],
19	stent	NN	O	stent	nn	20	SENT_153	[p12l1558t1881r1683b1920],
20	thrombosis	NN	O	thrombosis	conj_and	13	SENT_153	[p12l1707t1872r2002b1920],
21	were	VBD	O	be	cop	23	SENT_153	[p12l2028t1889r2152b1920],
22	consistently	RB	O	consistently	advmod	23	SENT_153	[p12l645t1948r954b2011],
23	lower	JJR	O	lower	_	0	SENT_153	[p12l986t1948r1130b1996],
24	in	IN	O	in	_	0	SENT_153	[p12l1164t1951r1216b1995],
25	the	DT	O	the	det	27	SENT_153	[p12l1250t1948r1331b1996],
26	ticagrelor	NN	O	ticagrelor	nn	27	SENT_153	[p12l1365t1948r1611b2011],
27	group	NN	O	group	prep_in	23	SENT_153	[p12l1646t1965r1798b2011],
28	than	IN	O	than	prep	23	SENT_153	[p12l1832t1948r1950b1996],
29	in	IN	O	in	pcomp	28	SENT_153	[p12l1985t1951r2037b1995],
30	the	DT	O	the	det	32	SENT_153	[p12l2071t1948r2152b1996],
31	clopidogrel	NN	O	clopidogrel	nn	32	SENT_153	[p12l645t2024r933b2087],
32	group	NN	O	group	pobj	29	SENT_153	[p12l957t2041r1123b2087],
33	,	,	O	,	_	0	SENT_153	[p12l957t2041r1123b2087],
34	irrespective	RB	O	irrespective	_	0	SENT_153	[p12l1149t2027r1445b2086],
35	of	IN	O	of	_	0	SENT_153	[p12l1470t2024r1528b2072],
36	ABCB1	NN	O	abcb1	nn	37	SENT_153	[p12l1542t2027r1729b2072],
37	polymorphism	NN	O	polymorphism	prep_irrespective_of	23	SENT_153	[p12l1752t2024r2150b2087],
38	.	.	O	.	_	0	SENT_153	[p12l1752t2024r2150b2087],

1	Differences	NNS	O	difference	nsubj	15	SENT_154	[p12l647t2101r942b2148],
2	in	IN	O	in	_	0	SENT_154	[p12l972t2103r1025b2147],
3	rates	NNS	O	rate	prep_in	1	SENT_154	[p12l1052t2110r1174b2148],
4	of	IN	O	of	_	0	SENT_154	[p12l1205t2100r1262b2148],
5	cardiovascular	JJ	O	cardiovascular	amod	6	SENT_154	[p12l1282t2100r1653b2148],
6	death	NN	O	death	prep_of	3	SENT_154	[p12l1681t2100r1836b2155],
7	,	,	O	,	_	0	SENT_154	[p12l1681t2100r1836b2155],
8	myocardial	JJ	O	myocardial	amod	9	SENT_154	[p12l1866t2100r2152b2163],
9	infarction	NN	O	infarction	prep_of	3	SENT_154	[p12l645t2176r911b2231],
10	,	,	O	,	_	0	SENT_154	[p12l645t2176r911b2231],
11	and	CC	O	and	_	0	SENT_154	[p12l941t2176r1038b2224],
12	stent	NN	O	stent	nn	13	SENT_154	[p12l1066t2186r1191b2224],
13	thrombosis	NN	O	thrombosis	prep_of	3	SENT_154	[p12l1217t2176r1512b2224],
14	were	VBD	O	be	cop	15	SENT_154	[p12l1540t2193r1664b2224],
15	signiﬁcant	JJ	O	signiﬁcant	_	0	SENT_154	[p12l1694t2176r1966b2239],
16	in	IN	O	in	_	0	SENT_154	[p12l1992t2179r2044b2223],
17	the	DT	O	the	det	18	SENT_154	[p12l2071t2176r2152b2224],
18	group	NN	O	group	prep_in	15	SENT_154	[p12l646t2269r798b2315],
19	with	IN	O	with	_	0	SENT_154	[p12l857t2252r972b2300],
20	the	DT	O	the	det	21	SENT_154	[p12l1031t2252r1112b2300],
21	putative	JJ	O	putative	prep_with	15	SENT_154	[p12l1172t2255r1378b2314],
22	predicted	VBN	O	predict	partmod	21	SENT_154	[p12l1438t2252r1680b2314],
23	high-expression	NN	O	high-expression	nn	24	SENT_154	[p12l1738t2252r2152b2315],
24	genotype	NN	O	genotype	dobj	22	SENT_154	[p12l646t2338r892b2391],
25	,	,	O	,	_	0	SENT_154	[p12l646t2338r892b2391],
26	although	IN	O	although	mark	40	SENT_154	[p12l915t2328r1145b2391],
27	the	DT	O	the	det	28	SENT_154	[p12l1164t2328r1245b2376],
28	interaction	NN	O	interaction	nsubj	40	SENT_154	[p12l1266t2331r1546b2376],
29	between	IN	O	between	_	0	SENT_154	[p12l1565t2328r1782b2376],
30	genotype	NN	O	genotype	nn	33	SENT_154	[p12l1803t2338r2036b2391],
31	and	CC	O	and	_	0	SENT_154	[p12l2057t2328r2153b2376],
32	treatment	NN	O	treatment	conj_and	30	SENT_154	[p12l644t2414r900b2452],
33	group	NN	O	group	prep_between	28	SENT_154	[p12l936t2421r1088b2467],
34	was	VBD	O	be	cop	40	SENT_154	[p12l1124t2421r1221b2452],
35	not	RB	O	not	neg	40	SENT_154	[p12l1260t2414r1345b2452],
36	signiﬁcant	JJ	O	signiﬁcant	amod	40	SENT_154	[p12l1383t2404r1655b2467],
37	(	NN	O	(	nn	40	SENT_154	[p12l1695t2404r1832b2467],
38	table	NN	O	table	nn	40	SENT_154	[p12l1695t2404r1832b2467],
39	4	CD	NUMBER	4	num	40	SENT_154	[p12l1868t2409r1927b2467],
40	)	NN	O	)	advcl	15	SENT_154	[p12l1868t2409r1927b2467],
41	.	.	O	.	_	0	SENT_154	[p12l1868t2409r1927b2467],

1	ABCB1	NN	O	abcb1	nn	3	SENT_155	[p12l1965t2407r2153b2452],
2	genotype	NN	O	genotype	nn	3	SENT_155	[p12l646t2489r878b2543],
3	group	NN	O	group	nsubj	4	SENT_155	[p12l897t2497r1049b2543],
4	had	VBD	O	have	_	0	SENT_155	[p12l1066t2480r1163b2528],
5	no	DT	O	no	det	6	SENT_155	[p12l1179t2497r1244b2528],
6	effect	NN	O	effect	dobj	4	SENT_155	[p12l1262t2480r1403b2528],
7	on	IN	O	on	_	0	SENT_155	[p12l1419t2497r1485b2528],
8	major	JJ	O	major	amod	24	SENT_155	[p12l1502t2483r1656b2543],
9	bleeding	JJ	O	bleeding	amod	10	SENT_155	[p12l1671t2480r1895b2543],
10	overall	JJ	O	overall	amod	24	SENT_155	[p12l1913t2480r2082b2528],
11	or	CC	O	or	_	0	SENT_155	[p12l2100t2497r2153b2527],
12	that	IN	O	that	dep	13	SENT_155	[p12l644t2556r745b2605],
13	related	JJ	O	related	conj_or	10	SENT_155	[p12l781t2556r958b2605],
14	to	TO	O	to	_	0	SENT_155	[p12l994t2566r1042b2605],
15	non-CABG	JJ	O	non-cabg	prep_to	13	SENT_155	[p12l1081t2560r1369b2605],
16	or	CC	O	or	_	0	SENT_155	[p12l1410t2574r1463b2605],
17	CABG	NNP	O	CABG	conj_or	15	SENT_155	[p12l1502t2560r1667b2605],
18	for	IN	O	for	_	0	SENT_155	[p12l1707t2556r1781b2605],
19	comparisons	NNS	O	comparison	conj_or	19	SENT_155	[p12l1819t2560r2150b2619],
20	between	IN	O	between	_	0	SENT_155	[p12l643t2633r861b2681],
21	or	CC	O	or	_	0	SENT_155	[p12l895t2650r949b2681],
22	within	IN	O	within	_	0	SENT_155	[p12l980t2633r1149b2681],
23	treatment	NN	O	treatment	prep_between	19	SENT_155	[p12l1182t2643r1438b2681],
24	groups	NNS	O	group	prep_on	6	SENT_155	[p12l1472t2650r1663b2696],
25	,	,	O	,	_	0	SENT_155	[p12l1472t2650r1663b2696],
26	and	CC	O	and	cc	4	SENT_155	[p12l1701t2633r1809b2688],
27	,	,	O	,	_	0	SENT_155	[p12l1701t2633r1809b2688],
28	accordingly	RB	O	accordingly	dep	4	SENT_155	[p12l1846t2633r2150b2696],
29	,	,	O	,	_	0	SENT_155	[p12l1846t2633r2150b2696],
30	interactions	NNS	O	interaction	nsubj	42	SENT_155	[p12l645t2713r949b2757],
31	between	IN	O	between	_	0	SENT_155	[p12l971t2710r1188b2757],
32	genotype	NN	O	genotype	nn	35	SENT_155	[p12l1209t2719r1442b2773],
33	and	CC	O	and	_	0	SENT_155	[p12l1464t2710r1560b2757],
34	treatment	NN	O	treatment	conj_and	32	SENT_155	[p12l1579t2719r1835b2757],
35	group	NN	O	group	prep_between	30	SENT_155	[p12l1856t2727r2008b2773],
36	were	VBD	O	be	cop	42	SENT_155	[p12l2028t2727r2152b2757],
37	not	RB	O	not	neg	42	SENT_155	[p12l645t2795r730b2833],
38	signiﬁcant	JJ	O	signiﬁcant	amod	42	SENT_155	[p12l748t2785r1020b2848],
39	(	NN	O	(	nn	42	SENT_155	[p12l1040t2785r1177b2848],
40	table	NN	O	table	nn	42	SENT_155	[p12l1040t2785r1177b2848],
41	4	CD	NUMBER	4	num	42	SENT_155	[p12l1193t2790r1252b2848],
42	)	NN	O	)	ccomp	4	SENT_155	[p12l1193t2790r1252b2848],
43	.	.	O	.	_	0	SENT_155	[p12l1193t2790r1252b2848],

1	To	TO	O	to	aux	2	SENT_156	[p12l694t2864r755b2909],
2	quantify	VB	O	quantify	purpcl	16	SENT_156	[p12l832t2861r1047b2924],
3	the	DT	O	the	det	5	SENT_156	[p12l1120t2861r1201b2909],
4	maximum	JJ	O	maximum	amod	5	SENT_156	[p12l1277t2864r1550b2909],
5	effect	NN	O	effect	dobj	2	SENT_156	[p12l1626t2861r1767b2909],
6	of	IN	O	of	_	0	SENT_156	[p12l1842t2861r1900b2909],
7	genetic	JJ	O	genetic	amod	8	SENT_156	[p12l1967t2864r2152b2924],
8	polymorphisms	NNS	O	polymorphism	prep_of	5	SENT_156	[p12l644t2938r1054b3001],
9	on	IN	O	on	_	0	SENT_156	[p12l1106t2955r1172b2986],
10	the	DT	O	the	det	13	SENT_156	[p12l1221t2938r1302b2986],
11	composite	JJ	O	composite	amod	13	SENT_156	[p12l1353t2941r1619b3001],
12	efﬁcacy	NN	O	efﬁcacy	nn	13	SENT_156	[p12l1670t2938r1863b3001],
13	outcome	NN	O	outcome	prep_on	2	SENT_156	[p12l1912t2947r2150b2994],
14	,	,	O	,	_	0	SENT_156	[p12l1912t2947r2150b2994],
15	we	PRP	O	we	nsubj	16	SENT_156	[p12l643t3031r715b3062],
16	did	VBD	O	do	_	0	SENT_156	[p12l755t3014r837b3062],
17	a	DT	O	a	det	19	SENT_156	[p12l875t3031r901b3062],
18	post-hoc	JJ	O	post-hoc	amod	19	SENT_156	[p12l939t3014r1157b3076],
19	analysis	NN	O	analysis	dobj	16	SENT_156	[p12l1196t3014r1398b3077],
20	with	IN	O	with	_	0	SENT_156	[p12l1437t3014r1552b3062],
21	combination	NN	O	combination	prep_with	16	SENT_156	[p12l1591t3014r1920b3062],
22	of	IN	O	of	_	0	SENT_156	[p12l1958t3014r2017b3062],
23	data	NNS	O	datum	prep_of	21	SENT_156	[p12l2046t3014r2152b3062],
24	for	IN	O	for	_	0	SENT_156	[p12l645t3090r719b3138],
25	C	NN	O	c	nn	26	SENT_156	[p12l737t3094r776b3138],
26	YPZC	NN	O	ypzc	prep_for	16	SENT_156	[p12l780t3094r924b3138],
27	19	CD	NUMBER	19	nn	31	SENT_156	[p12l928t3094r980b3138],
28	and	CC	O	and	_	0	SENT_156	[p12l993t3090r1089b3138],
29	AB	NNP	O	AB	conj_and	27	SENT_156	[p12l1102t3093r1183b3137],
30	CB1	NN	O	cb1	nn	31	SENT_156	[p12l1189t3094r1290b3138],
31	polymorphisms	NNS	O	polymorphism	dep	26	SENT_156	[p12l1304t3090r1728b3153],
32	.	.	O	.	_	0	SENT_156	[p12l1304t3090r1728b3153],

1	In	IN	O	in	_	0	SENT_157	[p12l1749t3095r1803b3137],
2	patients	NNS	O	patient	prep_in	21	SENT_157	[p12l1818t3093r2022b3152],
3	with	IN	O	with	_	0	SENT_157	[p12l2037t3090r2152b3138],
4	either	CC	O	either	advmod	8	SENT_157	[p12l645t3167r796b3215],
5	any	DT	O	any	det	8	SENT_157	[p12l882t3184r973b3230],
6	loss-of-function	JJ	O	loss-of-function	amod	8	SENT_157	[p12l1058t3167r1462b3215],
7	CYPZCI9	NN	O	cypzci9	nn	8	SENT_157	[p12l1553t3170r1796b3215],
8	allele	NN	O	allele	prep_with	2	SENT_157	[p12l1880t3167r2012b3215],
9	or	CC	O	or	_	0	SENT_157	[p12l2100t3184r2153b3215],
10	the	DT	O	the	det	14	SENT_157	[p12l644t3243r725b3291],
11	predicted	VBN	O	predict	amod	14	SENT_157	[p12l800t3243r1042b3305],
12	high-expression	NN	O	high-expression	nn	14	SENT_157	[p12l1115t3243r1530b3306],
13	ABCB1	NN	O	abcb1	nn	14	SENT_157	[p12l1603t3247r1792b3291],
14	phenotype	NN	O	phenotype	conj_or	8	SENT_157	[p12l1865t3243r2150b3306],
15	,	,	O	,	_	0	SENT_157	[p12l1865t3243r2150b3306],
16	Kaplan-Meier	NNP	O	Kaplan-Meier	nn	18	SENT_157	[p12l647t3319r998b3381],
17	event	NN	O	event	nn	18	SENT_157	[p12l1033t3328r1171b3367],
18	rates	NNS	O	rate	nsubj	21	SENT_157	[p12l1206t3328r1328b3367],
19	were	VBD	O	be	cop	21	SENT_157	[p12l1364t3336r1488b3367],
20	8-6	CD	PERCENT	8-6	num	21	SENT_157	[p12l1525t3322r1667b3369],
21	%	NN	PERCENT	%	_	0	SENT_157	[p12l1525t3322r1667b3369],
22	in	IN	O	in	_	0	SENT_157	[p12l1704t3322r1756b3366],
23	the	DT	O	the	det	27	SENT_157	[p12l1791t3319r1872b3367],
24	ticagrelor	NN	O	ticagrelor	nn	27	SENT_157	[p12l1908t3319r2153b3382],
25	group	NN	O	group	nn	27	SENT_157	[p12l646t3413r798b3459],
26	(	CD	NUMBER	(	num	27	SENT_157	[p12l834t3399r1057b3459],
27	n	NN	O	n	prep_in	21	SENT_157	[p12l834t3399r1057b3459],
28	=	JJ	O	=	amod	27	SENT_157	[p12l834t3399r1057b3459],
29	2253	CD	DATE	2253	number	30	SENT_157	[p12l834t3399r1057b3459],
30	)	CD	NUMBER	)	dep	28	SENT_157	[p12l834t3399r1057b3459],
31	versus	CC	O	versus	_	0	SENT_157	[p12l1091t3413r1256b3443],
32	11-2	CD	PERCENT	11-2	num	33	SENT_157	[p12l1291t3399r1451b3446],
33	%	NN	PERCENT	%	conj_versus	21	SENT_157	[p12l1291t3399r1451b3446],
34	in	IN	O	in	_	0	SENT_157	[p12l1483t3399r1535b3443],
35	the	DT	O	the	det	39	SENT_157	[p12l1566t3396r1647b3443],
36	clopidogrel	NN	O	clopidogrel	nn	39	SENT_157	[p12l1680t3396r1967b3459],
37	group	NN	O	group	nn	39	SENT_157	[p12l1999t3413r2151b3459],
38	(	CD	NUMBER	(	num	39	SENT_157	[p12l649t3476r866b3534],
39	n	NN	O	n	prep_in	33	SENT_157	[p12l649t3476r866b3534],
40	=	JJ	O	=	amod	39	SENT_157	[p12l649t3476r866b3534],
41	2248	CD	DATE	2248	tmod	40	SENT_157	[p12l649t3476r866b3534],
42	;	:	O	;	_	0	SENT_157	[p12l649t3476r866b3534],
43	0-75	CD	NUMBER	0-75	conj_versus	21	SENT_157	[p12l895t3474r1024b3526],
44	,	,	O	,	_	0	SENT_157	[p12l895t3474r1024b3526],
45	O-62-0-91	NN	O	o-62-0-91	nn	50	SENT_157	[p12l1053t3475r1334b3526],
46	,	,	O	,	_	0	SENT_157	[p12l1053t3475r1334b3526],
47	p	NN	O	p	nn	50	SENT_157	[p12l1362t3476r1610b3534],
48	=	JJ	O	=	amod	50	SENT_157	[p12l1362t3476r1610b3534],
49	0-O04	NN	O	0-o04	nn	50	SENT_157	[p12l1362t3476r1610b3534],
50	)	NN	O	)	appos	43	SENT_157	[p12l1362t3476r1610b3534],
51	.	.	O	.	_	0	SENT_157	[p12l1362t3476r1610b3534],

1	In	IN	O	in	_	0	SENT_158	[p12l1642t3476r1697b3518],
2	patients	NNS	O	patient	prep_in	10	SENT_158	[p12l1722t3474r1926b3533],
3	without	IN	O	without	_	0	SENT_158	[p12l1952t3471r2153b3519],
4	these	DT	O	these	det	5	SENT_158	[p13l7t117r199b185],
5	alleles	NNS	O	allele	prep_without	2	SENT_158	[p13l223t117r465b195],
6	,	,	O	,	_	0	SENT_158	[p13l223t117r465b195],
7	event	NN	O	event	nn	8	SENT_158	[p13l492t130r687b185],
8	rates	NNS	O	rate	nsubj	10	SENT_158	[p13l707t130r879b185],
9	were	VBD	O	be	cop	10	SENT_158	[p13l901t141r1077b184],
10	8	CD	NUMBER	8	_	0	SENT_158	[p13l1101t123r1168b184],
11	-	:	O	-	_	0	SENT_158	[p13l1101t123r1168b184],
12	9	CD	PERCENT	9	num	13	SENT_158	[p13l1187t121r1301b188],
13	%	NN	PERCENT	%	dep	10	SENT_158	[p13l1187t121r1301b188],
14	in	IN	O	in	_	0	SENT_158	[p13l1325t121r1398b183],
15	the	DT	O	the	det	19	SENT_158	[p13l1418t117r1533b184],
16	ticagrelor	NN	O	ticagrelor	nn	19	SENT_158	[p13l1555t117r1902b207],
17	group	NN	O	group	nn	19	SENT_158	[p13l1924t141r2139b207],
18	(	CD	NUMBER	(	num	19	SENT_158	[p13l14t230r315b315],
19	n	NN	O	n	prep_in	13	SENT_158	[p13l14t230r315b315],
20	=	JJ	O	=	amod	19	SENT_158	[p13l14t230r315b315],
21	2710	CD	DATE	2710	number	22	SENT_158	[p13l14t230r315b315],
22	)	CD	NUMBER	)	dep	20	SENT_158	[p13l14t230r315b315],
23	versus	CC	O	versus	_	0	SENT_158	[p13l354t250r588b294],
24	9-5	CD	PERCENT	9-5	num	25	SENT_158	[p13l627t230r827b296],
25	%	NN	PERCENT	%	conj_versus	10	SENT_158	[p13l627t230r827b296],
26	in	IN	O	in	_	0	SENT_158	[p13l864t230r937b292],
27	the	DT	O	the	det	31	SENT_158	[p13l972t225r1086b294],
28	clopidogrel	NN	O	clopidogrel	nn	31	SENT_158	[p13l1124t225r1530b315],
29	group	NN	O	group	nn	31	SENT_158	[p13l1566t250r1781b315],
30	(	CD	NUMBER	(	num	31	SENT_158	[p13l1824t231r2136b315],
31	n	NN	O	n	prep_in	25	SENT_158	[p13l1824t231r2136b315],
32	=	JJ	O	=	amod	31	SENT_158	[p13l1824t231r2136b315],
33	2698	CD	DATE	2698	tmod	32	SENT_158	[p13l1824t231r2136b315],
34	;	:	O	;	_	0	SENT_158	[p13l1824t231r2136b315],
35	0-92	CD	NUMBER	0-92	conj_versus	10	SENT_158	[p13l9t340r198b412],
36	,	,	O	,	_	0	SENT_158	[p13l9t340r198b412],
37	O-77-1-11	NN	O	o-77-1-11	appos	35	SENT_158	[p13l231t338r598b412],
38	,	,	O	,	_	0	SENT_158	[p13l231t338r598b412],
39	p	NN	O	p	conj_versus	10	SENT_158	[p13l630t340r942b424],
40	=	JJ	O	=	amod	42	SENT_158	[p13l630t340r942b424],
41	0-39	CD	NUMBER	0-39	tmod	40	SENT_158	[p13l630t340r942b424],
42	)	NN	O	)	dep	39	SENT_158	[p13l630t340r942b424],
43	.	.	O	.	_	0	SENT_158	[p13l630t340r942b424],

1	However	RB	O	however	advmod	8	SENT_159	[p13l979t341r1315b412],
2	,	,	O	,	_	0	SENT_159	[p13l979t341r1315b412],
3	this	DT	O	this	det	5	SENT_159	[p13l1346t334r1480b402],
4	genetic	JJ	O	genetic	amod	5	SENT_159	[p13l1512t339r1774b424],
5	grouping	NN	O	grouping	nsubj	8	SENT_159	[p13l1803t339r2140b424],
6	did	VBD	O	do	aux	8	SENT_159	[p13l9t443r126b512],
7	not	RB	O	not	neg	8	SENT_159	[p13l173t457r294b512],
8	have	VB	O	have	_	0	SENT_159	[p13l341t443r509b512],
9	a	DT	O	a	det	11	SENT_159	[p13l559t468r596b512],
10	signiﬁcant	JJ	O	signiﬁcant	amod	11	SENT_159	[p13l648t443r1033b533],
11	interaction	NN	O	interaction	iobj	8	SENT_159	[p13l1080t448r1477b512],
12	with	IN	O	with	_	0	SENT_159	[p13l1524t444r1687b512],
13	the	DT	O	the	det	15	SENT_159	[p13l1734t444r1849b512],
14	overall	JJ	O	overall	amod	15	SENT_159	[p13l1900t444r2140b512],
15	eﬁ	NN	O	eﬁ	prep_with	11	SENT_159	[p13l9t553r241b621],
16	"	''	O	"	punct	11	SENT_159	[p13l9t553r241b621],
17	ects	NNS	O	ect	dep	11	SENT_159	[p13l9t553r241b621],
18	of	IN	O	of	_	0	SENT_159	[p13l268t552r351b621],
19	ticagrelor	NN	O	ticagrelor	prep_of	17	SENT_159	[p13l360t552r707b642],
20	versus	CC	O	versus	_	0	SENT_159	[p13l727t577r961b621],
21	clopidogrel	NN	O	clopidogrel	nn	23	SENT_159	[p13l988t552r1394b642],
22	(	NN	O	(	nn	23	SENT_159	[p13l1424t558r1582b642],
23	p	NN	O	p	dep	11	SENT_159	[p13l1424t558r1582b642],
24	=	JJ	O	=	amod	25	SENT_159	[p13l1424t558r1582b642],
25	O	NN	O	o	dep	23	SENT_159	[p13l1424t558r1582b642],
26	-	:	O	-	_	0	SENT_159	[p13l1599t592r1610b603],
27	13	CD	DATE	13	num	28	SENT_159	[p13l1629t558r1748b642],
28	)	NN	O	)	dobj	8	SENT_159	[p13l1629t558r1748b642],
29	.	.	O	.	_	0	SENT_159	[p13l1629t558r1748b642],

1	Discussion	NN	O	discussion	_	0	SENT_160	[p13l14t764r467b841],

1	Treatment	NN	O	treatment	nsubjpass	15	SENT_161	[p13l7t887r395b950],
2	with	IN	O	with	_	0	SENT_161	[p13l431t883r597b951],
3	ticagrelor	NN	O	ticagrelor	prep_with	1	SENT_161	[p13l636t883r991b973],
4	versus	CC	O	versus	prep	3	SENT_161	[p13l1028t907r1265b951],
5	clopidogrel	NN	O	clopidogrel	dep	4	SENT_161	[p13l1309t883r1725b973],
6	in	IN	O	in	_	0	SENT_161	[p13l1765t887r1839b949],
7	a	DT	O	a	det	9	SENT_161	[p13l1880t907r1917b951],
8	large	JJ	O	large	amod	9	SENT_161	[p13l1956t883r2139b973],
9	population	NN	O	population	prep_in	5	SENT_161	[p13l8t992r413b1081],
10	with	IN	O	with	_	0	SENT_161	[p13l429t992r595b1061],
11	acute	JJ	O	acute	amod	13	SENT_161	[p13l615t1006r808b1061],
12	coronary	JJ	O	coronary	amod	13	SENT_161	[p13l828t1017r1156b1082],
13	syndromes	NNS	O	syndrome	prep_with	9	SENT_161	[p13l1175t992r1582b1082],
14	was	VBD	O	be	auxpass	15	SENT_161	[p13l1601t1017r1739b1061],
15	associated	VBN	O	associate	_	0	SENT_161	[p13l1761t992r2141b1061],
16	with	IN	O	with	_	0	SENT_161	[p13l7t1101r172b1169],
17	lower	JJR	O	lower	amod	18	SENT_161	[p13l203t1101r410b1169],
18	rates	NNS	O	rate	prep_with	15	SENT_161	[p13l440t1115r615b1169],
19	of	IN	O	of	_	0	SENT_161	[p13l651t1101r734b1169],
20	cardiovascular	JJ	O	cardiovascular	amod	21	SENT_161	[p13l754t1101r1290b1169],
21	death	NN	O	death	prep_of	18	SENT_161	[p13l1322t1101r1526b1169],
22	and	CC	O	and	_	0	SENT_161	[p13l1559t1101r1696b1169],
23	myocardial	JJ	O	myocardial	amod	24	SENT_161	[p13l1727t1101r2140b1191],
24	infarction	NN	O	infarction	conj_and	21	SENT_161	[p13l8t1211r394b1289],
25	,	,	O	,	_	0	SENT_161	[p13l8t1211r394b1289],
26	similar	JJ	O	similar	amod	27	SENT_161	[p13l452t1211r715b1279],
27	rates	NNS	O	rate	conj_and	18	SENT_161	[p13l766t1224r941b1279],
28	of	IN	O	of	_	0	SENT_161	[p13l997t1211r1080b1278],
29	total	JJ	O	total	amod	31	SENT_161	[p13l1118t1211r1280b1279],
30	major	JJ	O	major	amod	31	SENT_161	[p13l1333t1215r1555b1300],
31	bleeding	NN	O	bleeding	prep_of	27	SENT_161	[p13l1605t1211r1946b1301],
32	,	,	O	,	_	0	SENT_161	[p13l1605t1211r1946b1301],
33	and	CC	O	and	_	0	SENT_161	[p13l2003t1211r2141b1278],
34	higher	JJR	O	higher	amod	35	SENT_161	[p13l7t1319r255b1409],
35	rates	NNS	O	rate	prep_with	15	SENT_161	[p13l301t1333r476b1388],
36	of	IN	O	of	_	0	SENT_161	[p13l528t1319r611b1388],
37	major	JJ	O	major	amod	38	SENT_161	[p13l646t1324r869b1409],
38	bleeding	NN	O	bleeding	prep_of	35	SENT_161	[p13l914t1319r1237b1409],
39	related	JJ	O	related	amod	41	SENT_161	[p13l1284t1319r1539b1388],
40	to	TO	O	to	dep	41	SENT_161	[p13l1584t1333r1653b1388],
41	non-CABG	JJ	O	non-cabg	amod	35	SENT_161	[p13l1703t1325r2136b1397],
42	,	,	O	,	_	0	SENT_161	[p13l1703t1325r2136b1397],
43	irrespective	JJ	O	irrespective	appos	35	SENT_161	[p13l8t1434r438b1518],
44	of	IN	O	of	_	0	SENT_161	[p13l492t1429r575b1497],
45	CYPZCI9	NN	O	cypzci9	nn	48	SENT_161	[p13l621t1434r969b1498],
46	and	CC	O	and	_	0	SENT_161	[p13l1018t1429r1156b1497],
47	ABCB1	NN	O	abcb1	nn	48	SENT_161	[p13l1205t1434r1475b1497],
48	polymorphisms	NNS	O	polymorphism	prep_of	43	SENT_161	[p13l1525t1429r2136b1518],
49	.	.	O	.	_	0	SENT_161	[p13l1525t1429r2136b1518],

1	These	DT	O	these	det	2	SENT_162	[p13l7t1539r230b1607],
2	ﬁndings	NNS	O	ﬁndings	nsubj	3	SENT_162	[p13l315t1539r622b1629],
3	are	VBP	O	be	_	0	SENT_162	[p13l711t1563r821b1607],
4	from	IN	O	from	_	0	SENT_162	[p13l907t1539r1091b1606],
5	the	DT	O	the	det	11	SENT_162	[p13l1174t1539r1291b1606],
6	large	JJ	O	large	amod	11	SENT_162	[p13l1375t1539r1577b1629],
7	,	,	O	,	_	0	SENT_162	[p13l1375t1539r1577b1629],
8	double-blind	JJ	O	double-blind	amod	11	SENT_162	[p13l1666t1539r2141b1607],
9	randomised	JJ	O	randomised	amod	11	SENT_162	[p13l8t1647r458b1716],
10	PLATO	NN	ORGANIZATION	plato	nn	11	SENT_162	[p13l489t1652r755b1716],
11	trial	NN	O	trial	prep_from	3	SENT_162	[p13l785t1647r953b1726],
12	,	,	O	,	_	0	SENT_162	[p13l785t1647r953b1726],
13	so	IN	O	so	dep	3	SENT_162	[p13l987t1672r1063b1716],
14	they	PRP	O	they	nsubj	16	SENT_162	[p13l1091t1647r1251b1737],
15	should	MD	O	should	aux	16	SENT_162	[p13l1279t1647r1532b1716],
16	provide	VB	O	provide	ccomp	3	SENT_162	[p13l1558t1647r1836b1736],
17	reliable	JJ	O	reliable	amod	18	SENT_162	[p13l1865t1647r2139b1716],
18	information	NN	O	information	dobj	16	SENT_162	[p13l8t1756r461b1824],
19	about	IN	O	about	_	0	SENT_162	[p13l525t1756r734b1824],
20	pharmacogenomic	JJ	O	pharmacogenomic	amod	21	SENT_162	[p13l796t1756r1499b1846],
21	interactions	NNS	O	interaction	prep_about	18	SENT_162	[p13l1562t1761r2003b1824],
22	of	IN	O	of	_	0	SENT_162	[p13l2070t1756r2153b1824],
23	these	DT	O	these	det	25	SENT_162	[p13l7t1865r203b1934],
24	genetic	JJ	O	genetic	amod	25	SENT_162	[p13l290t1870r557b1955],
25	polymorphisms	NNS	O	polymorphism	prep_of	21	SENT_162	[p13l641t1865r1230b1955],
26	with	IN	O	with	_	0	SENT_162	[p13l1315t1865r1481b1934],
27	outcomes	NNS	O	outcome	prep_with	16	SENT_162	[p13l1566t1879r1947b1944],
28	,	,	O	,	_	0	SENT_162	[p13l1566t1879r1947b1944],
29	for	IN	O	for	_	0	SENT_162	[p13l2035t1865r2141b1934],
30	comparisons	NNS	O	comparison	prep_for	16	SENT_162	[p13l9t1980r487b2064],
31	between	IN	O	between	_	0	SENT_162	[p13l531t1975r843b2044],
32	and	CC	O	and	_	0	SENT_162	[p13l886t1975r1023b2044],
33	within	IN	O	within	_	0	SENT_162	[p13l1062t1975r1306b2044],
34	drug	NN	O	drug	nn	35	SENT_162	[p13l1348t1975r1522b2065],
35	groups	NNS	O	group	prep_within	30	SENT_162	[p13l1565t2000r1842b2065],
36	,	,	O	,	_	0	SENT_162	[p13l1565t2000r1842b2065],
37	during	IN	O	during	_	0	SENT_162	[p13l1888t1975r2140b2065],
38	long-term	JJ	O	long-term	amod	39	SENT_162	[p13l7t2084r378b2174],
39	treatment	NN	O	treatment	prep_during	16	SENT_162	[p13l408t2097r777b2152],
40	of	IN	O	of	_	0	SENT_162	[p13l806t2084r889b2152],
41	patients	NNS	O	patient	prep_of	39	SENT_162	[p13l907t2089r1201b2173],
42	managed	VBD	O	manage	partmod	41	SENT_162	[p13l1234t2084r1580b2174],
43	invasively	RB	O	invasively	advmod	42	SENT_162	[p13l1609t2084r1974b2173],
44	and	CC	O	and	_	0	SENT_162	[p13l2003t2084r2141b2152],
45	non-invasively	RB	O	non-invasively	conj_and	43	SENT_162	[p13l8t2193r557b2283],
46	.	.	O	.	_	0	SENT_162	[p13l8t2193r557b2283],

1	Furthermore	RB	O	furthermore	advmod	10	SENT_163	[p13l584t2194r1080b2272],
2	,	,	O	,	_	0	SENT_163	[p13l584t2194r1080b2272],
3	98	CD	PERCENT	98	num	4	SENT_163	[p13l1103t2198r1263b2265],
4	%	NN	PERCENT	%	nsubj	10	SENT_163	[p13l1103t2198r1263b2265],
5	of	IN	O	of	_	0	SENT_163	[p13l1284t2193r1367b2262],
6	our	PRP$	O	we	poss	8	SENT_163	[p13l1373t2218r1501b2262],
7	study	NN	O	study	nn	8	SENT_163	[p13l1520t2194r1719b2283],
8	population	NN	O	population	prep_of	4	SENT_163	[p13l1735t2193r2140b2282],
9	was	VBD	O	be	cop	10	SENT_163	[p13l7t2326r145b2370],
10	white	JJ	O	white	_	0	SENT_163	[p13l182t2302r387b2371],
11	and	CC	O	and	_	0	SENT_163	[p13l425t2302r562b2370],
12	comparison	NN	O	comparison	nsubj	19	SENT_163	[p13l598t2307r1041b2391],
13	of	IN	O	of	_	0	SENT_163	[p13l1078t2302r1161b2370],
14	genotype	NN	O	genotype	nn	15	SENT_163	[p13l1185t2316r1520b2392],
15	data	NNS	O	datum	prep_of	12	SENT_163	[p13l1558t2302r1710b2370],
16	with	IN	O	with	_	0	SENT_163	[p13l1744t2302r1909b2370],
17	other	JJ	O	other	amod	18	SENT_163	[p13l1946t2302r2141b2370],
18	reports	NNS	O	report	prep_with	15	SENT_163	[p13l8t2424r270b2500],
19	indicated	VBD	O	indicate	conj_and	10	SENT_163	[p13l289t2411r634b2479],
20	that	IN	O	that	complm	25	SENT_163	[p13l648t2411r794b2479],
21	our	PRP$	O	we	poss	23	SENT_163	[p13l810t2435r938b2479],
22	study	NN	O	study	nn	23	SENT_163	[p13l956t2411r1155b2501],
23	sample	NN	O	sample	nsubj	25	SENT_163	[p13l1173t2411r1438b2500],
24	was	VBD	O	be	cop	25	SENT_163	[p13l1454t2435r1593b2479],
25	representative	NN	O	representative	ccomp	19	SENT_163	[p13l1612t2416r2139b2500],
26	of	IN	O	of	_	0	SENT_163	[p13l9t2521r93b2590],
27	other	JJ	O	other	amod	29	SENT_163	[p13l117t2522r312b2590],
28	white	JJ	O	white	amod	29	SENT_163	[p13l345t2522r551b2590],
29	populations	NNS	O	population	prep_of	25	SENT_163	[p13l587t2522r1049b2610],
30	:	:	O	:	_	0	SENT_163	[p13l587t2522r1049b2610],
31	C	NN	O	c	nn	34	SENT_163	[p13l1096t2527r1150b2590],
32	YP2C19	NN	O	yp2c19	nn	34	SENT_163	[p13l1156t2527r1444b2590],
33	allele	NN	O	allele	nn	34	SENT_163	[p13l1477t2521r1667b2590],
34	frequencies	NNS	O	frequency	nsubj	36	SENT_163	[p13l1704t2521r2137b2610],
35	were	VBD	O	be	cop	36	SENT_163	[p13l7t2656r184b2700],
36	consistent	JJ	O	consistent	conj_and	10	SENT_163	[p13l220t2636r601b2700],
37	with	IN	O	with	_	0	SENT_163	[p13l632t2631r797b2700],
38	those	DT	O	those	prep_with	36	SENT_163	[p13l829t2631r1028b2700],
39	of	IN	O	of	_	0	SENT_163	[p13l1064t2631r1147b2700],
40	white	JJ	O	white	amod	41	SENT_163	[p13l1165t2631r1371b2700],
41	populations	NNS	O	population	prep_of	38	SENT_163	[p13l1405t2631r1968b2720],
42	,2	CD	NUMBER	,2	number	43	SENT_163	[p13l1405t2631r1968b2720],
43	“	CD	NUMBER	“	num	44	SENT_163	[p13l1405t2631r1968b2720],
44	'25	CD	NUMBER	'25	dep	41	SENT_163	[p13l1405t2631r1968b2720],
45	and	CC	O	and	_	0	SENT_163	[p13l2003t2632r2141b2700],
46	the	DT	O	the	det	47	SENT_163	[p13l7t2740r124b2808],
47	percentages	NNS	O	percentage	prep_of	38	SENT_163	[p13l149t2754r591b2830],
48	of	IN	O	of	_	0	SENT_163	[p13l620t2740r703b2808],
49	the	DT	O	the	det	51	SENT_163	[p13l713t2740r830b2808],
50	predicted	VBN	O	predict	amod	51	SENT_163	[p13l855t2740r1205b2829],
51	phenotypes	NNS	O	phenotype	prep_of	47	SENT_163	[p13l1228t2740r1655b2830],
52	of	IN	O	of	_	0	SENT_163	[p13l1683t2740r1766b2808],
53	AB	NNP	O	AB	nn	55	SENT_163	[p13l1776t2745r1891b2807],
54	C	NNP	O	C	nn	55	SENT_163	[p13l1902t2745r1956b2808],
55	B1	NN	O	b1	prep_of	51	SENT_163	[p13l1960t2746r2045b2807],
56	of	IN	O	of	_	0	SENT_163	[p13l2070t2740r2153b2808],
57	high	JJ	O	high	prep_of	51	SENT_163	[p13l7t2850r197b2940],
58	,	,	O	,	_	0	SENT_163	[p13l7t2850r197b2940],
59	intermediate	JJ	O	intermediate	acomp	36	SENT_163	[p13l238t2850r736b2928],
60	,	,	O	,	_	0	SENT_163	[p13l238t2850r736b2928],
61	and	CC	O	and	_	0	SENT_163	[p13l779t2850r916b2918],
62	low	JJ	O	low	amod	63	SENT_163	[p13l951t2850r1084b2918],
63	expression	NN	O	expression	nsubj	65	SENT_163	[p13l1120t2854r1519b2939],
64	were	VBD	O	be	cop	65	SENT_163	[p13l1554t2874r1732b2918],
65	similar	JJ	O	similar	conj_and	10	SENT_163	[p13l1773t2850r2035b2918],
66	to	TO	O	to	_	0	SENT_163	[p13l2070t2863r2139b2917],
67	those	DT	O	those	prep_to	65	SENT_163	[p13l7t2959r207b3028],
68	in	IN	O	in	_	0	SENT_163	[p13l233t2964r308b3027],
69	another	DT	O	another	det	71	SENT_163	[p13l334t2959r623b3028],
70	white	JJ	O	white	amod	71	SENT_163	[p13l645t2959r851b3028],
71	population	NN	O	population	prep_in	67	SENT_163	[p13l877t2959r1350b3048],
72	?	.	O	?	_	0	SENT_163	[p13l877t2959r1350b3048],
73	"	''	O	"	punct	10	SENT_163	[p13l877t2959r1350b3048],

1	The	DT	O	the	det	2	SENT_164	[p13l78t3068r221b3136],
2	results	NNS	O	result	nsubj	7	SENT_164	[p13l262t3068r509b3136],
3	of	IN	O	of	_	0	SENT_164	[p13l551t3068r634b3136],
4	our	PRP$	O	we	poss	5	SENT_164	[p13l661t3093r790b3136],
5	study	NN	O	study	prep_of	2	SENT_164	[p13l829t3068r1029b3158],
6	clearly	RB	O	clearly	advmod	7	SENT_164	[p13l1067t3068r1307b3158],
7	show	VBP	O	show	_	0	SENT_164	[p13l1347t3068r1541b3136],
8	the	DT	O	the	det	9	SENT_164	[p13l1577t3068r1694b3136],
9	absence	NN	O	absence	dobj	7	SENT_164	[p13l1734t3068r2029b3136],
10	of	IN	O	of	_	0	SENT_164	[p13l2070t3068r2153b3136],
11	interaction	NN	O	interaction	prep_of	9	SENT_164	[p13l8t3183r414b3247],
12	between	IN	O	between	_	0	SENT_164	[p13l469t3179r781b3247],
13	the	DT	O	the	det	14	SENT_164	[p13l835t3179r952b3247],
14	occurrence	NN	O	occurrence	prep_between	11	SENT_164	[p13l1010t3203r1420b3247],
15	of	IN	O	of	_	0	SENT_164	[p13l1478t3179r1561b3247],
16	any	DT	O	any	det	18	SENT_164	[p13l1605t3203r1735b3268],
17	C	NN	O	c	nn	18	SENT_164	[p13l1796t3184r1850b3247],
18	YPZCI9	NN	O	ypzci9	prep_of	14	SENT_164	[p13l1857t3184r2144b3247],

1	Articles	NNPS	O	Articles	_	0	SENT_165	[p13l6t3747r156b3783],
2	I	PRP	O	I	dep	1	SENT_165	[p13l204t3584r252b3782],

1	vwvw	NN	O	vwvw	_	0	SENT_166	[p13l794t3449r1327b3500],
2	.	.	O	.	_	0	SENT_166	[p13l794t3449r1327b3500],

1	the	DT	O	the	det	2	SENT_167	[p13l794t3449r1327b3500],
2	|	NN	O	|	_	0	SENT_167	[p13l794t3449r1327b3500],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_167	[p13l794t3449r1327b3500],
4	Vol	NNP	O	Vol	dep	2	SENT_167	[p13l1370t3449r1457b3500],
5	376	CD	NUMBER	376	num	6	SENT_167	[p13l1477t3448r1580b3507],
6	October	NNP	DATE	October	dep	2	SENT_167	[p13l1626t3449r1850b3500],
7	16,2010	CD	DATE	16,2010	num	6	SENT_167	[p13l1867t3448r2111b3509],

1	6	CD	NUMBER	6	_	0	SENT_168	[p14l308t297r320b316],
2	ica	NN	O	ica	dep	1	SENT_168	[p14l434t280r459b298],
3	re	NN	O	re	rcmod	2	SENT_168	[p14l474t285r491b298],
4	or	CC	O	or	advmod	3	SENT_168	[p14l498t285r522b301],
5	,	,	O	,	_	0	SENT_168	[p14l498t285r522b301],
6	no	DT	O	no	det	9	SENT_168	[p14l530t285r555b298],
7	oss	NN	O	oss	nn	9	SENT_168	[p14l567t285r620b298],
8	—	NN	O	—	nn	9	SENT_168	[p14l567t285r620b298],
9	o	NN	O	o	appos	3	SENT_168	[p14l567t285r620b298],
10	-	:	O	-	_	0	SENT_168	[p14l629t290r636b292],
11	unc	NN	O	unc	dep	3	SENT_168	[p14l646t285r681b298],
12	ion	NN	O	ion	dep	11	SENT_168	[p14l692t280r722b298],
13	a	DT	O	a	dobj	12	SENT_168	[p14l729t285r739b298],
14	e	SYM	O	e	dep	13	SENT_168	[p14l752t285r762b298],
15	e	SYM	O	e	dep	3	SENT_168	[p14l769t285r779b298],

1	Event	NN	O	event	nn	2	SENT_169	[p14l244t620r262b676],
2	rate	NN	O	rate	nsubj	5	SENT_169	[p14l246t576r262b613],
3	(	CD	NUMBER	(	dep	2	SENT_169	[p14l243t537r266b569],
4	We	PRP	O	we	dep	2	SENT_169	[p14l243t537r266b569],
5	)	VBP	O	)	_	0	SENT_169	[p14l243t537r266b569],

1	/	:	O	/	punct	3	SENT_170	[p14l349t990r379b1020],
2	I	PRP	O	I	dep	3	SENT_170	[p14l633t1007r635b1019],
3	l	NN	O	l	_	0	SENT_170	[p14l866t1005r869b1019],
4	I	PRP	O	I	nsubj	7	SENT_170	[p14l1100t1007r1102b1019],
5	l	NN	O	l	tmod	7	SENT_170	[p14l1333t1005r1336b1019],
6	I	PRP	O	I	nsubj	7	SENT_170	[p14l1567t1007r1569b1019],
7	31 90 150 210	VBP	O	31 90 150 210	rcmod	3	SENT_170	[p14l1082t1023r1119b1040],[p14l389t1023r412b1043],
8	270	CD	NUMBER	270	number	9	SENT_170	[p14l1316t1023r1352b1043],
9	330	CD	NUMBER	330	dobj	7	SENT_170	[p14l1548t1023r1586b1043],

1	Days	NNS	DURATION	day	_	0	SENT_171	[p14l920t1059r965b1082],
2	from	IN	O	from	_	0	SENT_171	[p14l971t1057r1019b1077],
3	randomisation	NN	O	randomisation	prep_from	1	SENT_171	[p14l1027t1057r1173b1077],

1	o	NN	O	o	_	0	SENT_172	[p14l241t1117r254b1130],
2	re	SYM	O	re	dep	1	SENT_172	[p14l270t1117r288b1130],

1	Any	DT	O	any	det	3	SENT_173	[p14l32t1143r71b1167],
2	loss-of-func	JJ	O	loss-of-func	amod	3	SENT_173	[p14l78t1142r197b1161],
3	ion	NN	O	ion	dep	10	SENT_173	[p14l208t1144r237b1161],
4	allele	NN	O	allele	dep	3	SENT_173	[p14l244t1142r295b1161],
5	1302 1266 1247 1066	CD	NUMBER	1302 1266 1247 1066	dep	10	SENT_173	[p14l1074t1142r1126b1161],[p14l375t1144r423b1164],
6	996	CD	NUMBER	996	number	7	SENT_173	[p14l1319t1142r1359b1164],
7	771	CD	NUMBER	771	num	10	SENT_173	[p14l1555t1144r1590b1163],
8	No	DT	O	no	det	10	SENT_173	[p14l43t1175r70b1193],
9	loss	NN	O	loss	nn	10	SENT_173	[p14l78t1173r237b1193],
10	~	NN	O	~	dep	14	SENT_173	[p14l78t1173r237b1193],
11	of	IN	O	of	_	0	SENT_173	[p14l78t1173r237b1193],
12	~	NN	O	~	nn	13	SENT_173	[p14l78t1173r237b1193],
13	function	NN	O	function	prep_of	10	SENT_173	[p14l78t1173r237b1193],
14	allele	NN	O	allele	dep	17	SENT_173	[p14l244t1173r294b1193],
15	3370 3291 3223 2756	CD	NUMBER	3370 3291 3223 2756	num	14	SENT_173	[p14l1076t1173r1126b1195],[p14l374t1176r424b1195],
16	2600	CD	DATE	2600	num	17	SENT_173	[p14l1307t1173r1359b1193],
17	2027	CD	DATE	2027	_	0	SENT_173	[p14l1541t1176r1590b1195],

1	Any	DT	O	any	det	3	SENT_174	[p14l32t1238r71b1262],
2	loss-of-function	JJ	O	loss-of-function	amod	3	SENT_174	[p14l78t1236r237b1256],
3	allele	NN	O	allele	_	0	SENT_174	[p14l244t1237r294b1256],
4	1320 1296 1267 1082	CD	NUMBER	1320 1296 1267 1082	num	3	SENT_174	[p14l1076t1236r1126b1256],[p14l375t1239r424b1259],
5	1028	CD	DATE	1028	number	6	SENT_174	[p14l1309t1236r1359b1256],
6	800	CD	NUMBER	800	num	9	SENT_174	[p14l1551t1236r1590b1256],
7	No	DT	O	no	det	9	SENT_174	[p14l43t1270r70b1288],
8	loss-of-function	NN	O	loss-of-function	nn	9	SENT_174	[p14l78t1268r237b1288],
9	allele	NN	O	allele	dep	3	SENT_174	[p14l244t1268r294b1288],
10	3393 3324 3276 2803	CD	NUMBER	3393 3324 3276 2803	number	11	SENT_174	[p14l1075t1268r1126b1290],[p14l373t1271r423b1290],
11	2615	CD	DATE	2615	dep	3	SENT_174	[p14l1309t1268r1359b1290],
12	2035	CD	DATE	2035	dep	11	SENT_174	[p14l1540t1271r1590b1290],

1	Figure	NN	O	figure	_	0	SENT_175	[p14l7t1339r73b1365],
2	2	CD	NUMBER	2	num	1	SENT_175	[p14l78t1341r98b1359],
3	:	:	O	:	_	0	SENT_175	[p14l78t1341r98b1359],
4	Kaplan	NNP	PERSON	Kaplan	dep	1	SENT_175	[p14l105t1338r257b1365],
5	.	.	O	.	_	0	SENT_175	[p14l105t1338r257b1365],

1	—	NN	O	—	_	0	SENT_176	[p14l105t1338r257b1365],
2	.	.	O	.	_	0	SENT_176	[p14l105t1338r257b1365],

1	Meier	JJR	PERSON	meier	amod	2	SENT_177	[p14l105t1338r257b1365],
2	estimates	NNS	O	estimate	_	0	SENT_177	[p14l263t1339r374b1359],
3	of	IN	O	of	_	0	SENT_177	[p14l380t1338r404b1359],
4	events	NNS	O	event	prep_of	2	SENT_177	[p14l410t1341r485b1359],
5	of	IN	O	of	_	0	SENT_177	[p14l491t1338r515b1359],
6	the	DT	O	the	det	9	SENT_177	[p14l519t1338r557b1359],
7	primary	JJ	O	primary	amod	9	SENT_177	[p14l563t1339r653b1365],
8	efﬁcacy	NN	O	efﬁcacy	nn	9	SENT_177	[p14l659t1338r745b1365],
9	outcome	NN	O	outcome	prep_of	2	SENT_177	[p14l750t1341r852b1359],
10	in	IN	O	in	_	0	SENT_177	[p14l859t1339r879b1358],
11	relation	NN	O	relation	prep_in	2	SENT_177	[p14l887t1338r974b1359],
12	to	TO	O	to	_	0	SENT_177	[p14l980t1341r1004b1359],
13	the	DT	O	the	det	15	SENT_177	[p14l1009t1338r1048b1359],
14	CYP2C19	NN	O	cyp2c19	nn	15	SENT_177	[p14l1054t1339r1153b1362],
15	genotype	NN	O	genotype	prep_to	2	SENT_177	[p14l1160t1341r1275b1365],
16	,	,	O	,	_	0	SENT_177	[p14l1160t1341r1275b1365],
17	as	IN	O	as	mark	25	SENT_177	[p14l1282t1345r1305b1359],
18	a	DT	O	a	det	20	SENT_177	[p14l1311t1345r1323b1359],
19	landmark	NN	O	landmark	nn	20	SENT_177	[p14l1331t1338r1438b1359],
20	analysis	NN	O	analysis	nsubj	25	SENT_177	[p14l1445t1338r1534b1365],
21	from	IN	O	from	_	0	SENT_177	[p14l1540t1338r1595b1359],
22	day	NN	DURATION	day	prep_from	20	SENT_177	[p14l1602t1338r1643b1365],
23	31	CD	NUMBER	31	num	22	SENT_177	[p14l1649t1341r1676b1362],
24	to	TO	O	to	aux	25	SENT_177	[p14l1681t1341r1706b1359],
25	end	VB	O	end	infmod	15	SENT_177	[p14l1712t1338r1754b1359],
26	of	IN	O	of	_	0	SENT_177	[p14l1760t1338r1785b1359],
27	follow-up	JJ	O	follow-up	amod	29	SENT_177	[p14l7t1385r282b1452],
28	loss-oﬁfunction	JJ	O	loss-oﬁfunction	amod	29	SENT_177	[p14l9t1585r594b1653],
29	allele	NN	O	allele	prep_of	2	SENT_177	[p14l640t1585r830b1652],
30	and	CC	O	and	_	0	SENT_177	[p14l877t1585r1015b1653],
31	the	DT	O	the	det	32	SENT_177	[p14l1058t1585r1174b1653],
32	superiority	NN	O	superiority	prep_of	2	SENT_177	[p14l1223t1589r1627b1674],
33	of	IN	O	of	_	0	SENT_177	[p14l1672t1585r1754b1653],
34	ticagrelor	NN	O	ticagrelor	prep_of	2	SENT_177	[p14l1786t1585r2140b1675],
35	over	IN	O	over	_	0	SENT_177	[p14l12t1718r170b1762],
36	clopidogrel	NN	O	clopidogrel	prep_over	2	SENT_177	[p14l203t1693r618b1783],
37	for	IN	O	for	_	0	SENT_177	[p14l652t1693r759b1762],
38	all	DT	O	all	det	40	SENT_177	[p14l793t1693r878b1762],
39	eﬂicacy	NN	O	eﬂicacy	nn	40	SENT_177	[p14l914t1693r1190b1783],
40	events	NNS	O	event	prep_for	2	SENT_177	[p14l1224t1707r1456b1762],
41	tested	VBN	O	test	partmod	2	SENT_177	[p14l1492t1693r1730b1762],
42	.	.	O	.	_	0	SENT_177	[p14l1492t1693r1730b1762],

1	So	RB	O	so	advmod	2	SENT_178	[p14l1774t1699r1858b1762],
2	far	RB	O	far	advmod	26	SENT_178	[p14l1894t1693r2006b1771],
3	,	,	O	,	_	0	SENT_178	[p14l1894t1693r2006b1771],
4	no	DT	O	no	det	6	SENT_178	[p14l2045t1718r2138b1762],
5	direct	JJ	O	direct	amod	6	SENT_178	[p14l12t1802r223b1870],
6	comparison	NN	O	comparison	nsubjpass	26	SENT_178	[p14l270t1807r712b1891],
7	of	IN	O	of	_	0	SENT_178	[p14l761t1802r844b1870],
8	outcomes	NNS	O	outcome	prep_of	6	SENT_178	[p14l880t1816r1238b1870],
9	with	IN	O	with	_	0	SENT_178	[p14l1287t1802r1452b1870],
10	prasugrel	NN	O	prasugrel	prep_with	8	SENT_178	[p14l1499t1802r1853b1892],
11	versus	CC	O	versus	prep	10	SENT_178	[p14l1899t1826r2137b1871],
12	clopidogrel	NN	O	clopidogrel	dep	11	SENT_178	[p14l12t1912r427b2002],
13	in	IN	O	in	_	0	SENT_178	[p14l462t1916r537b1978],
14	relation	NN	O	relation	prep_in	12	SENT_178	[p14l572t1912r858b1980],
15	to	TO	O	to	_	0	SENT_178	[p14l892t1925r962b1979],
16	the	DT	O	the	det	17	SENT_178	[p14l997t1912r1114b1980],
17	presence	NN	O	presence	prep_to	14	SENT_178	[p14l1149t1936r1481b2001],
18	of	IN	O	of	_	0	SENT_178	[p14l1518t1912r1601b1979],
19	any	DT	O	any	det	23	SENT_178	[p14l1625t1936r1755b2001],
20	C	NN	O	c	nn	23	SENT_178	[p14l1796t1917r1850b1980],
21	YPZCJ9	NN	O	ypzcj9	nn	23	SENT_178	[p14l1856t1917r2143b1980],
22	loss-of-function	NN	O	loss-of-function	nn	23	SENT_178	[p14l10t2020r594b2088],
23	allele	NN	O	allele	prep_of	17	SENT_178	[p14l650t2020r841b2088],
24	have	VBP	O	have	aux	26	SENT_178	[p14l896t2020r1066b2088],
25	been	VBN	O	be	auxpass	26	SENT_178	[p14l1122t2020r1302b2088],
26	published	VBN	O	publish	_	0	SENT_178	[p14l1357t2020r1729b2108],
27	from	IN	O	from	_	0	SENT_178	[p14l1784t2020r1968b2088],
28	the	DT	O	the	det	30	SENT_178	[p14l2022t2020r2138b2088],
29	genetic	JJ	O	genetic	amod	30	SENT_178	[p14l13t2133r279b2218],
30	substudy	NN	O	substudy	prep_from	26	SENT_178	[p14l315t2128r650b2218],
31	of	IN	O	of	_	0	SENT_178	[p14l683t2128r766b2196],
32	the	DT	O	the	det	35	SENT_178	[p14l786t2128r903b2196],
33	TRITON-TIMI	NN	O	triton-timus	nn	35	SENT_178	[p14l936t2132r1488b2196],
34	38	CD	NUMBER	38	num	35	SENT_178	[p14l1531t2134r1612b2196],
35	trial	NN	O	trial	prep_of	30	SENT_178	[p14l1646t2128r1894b2196],
36	.	.	O	.	_	0	SENT_178	[p14l1646t2128r1894b2196],

1	”	NN	O	”	ccomp	9	SENT_179	[p14l1646t2128r1894b2196],
2	Thus	RB	O	thus	advmod	1	SENT_179	[p14l1925t2128r2135b2206],
3	,	,	O	,	_	0	SENT_179	[p14l1925t2128r2135b2206],
4	ticagrelor	NN	O	ticagrelor	nsubj	9	SENT_179	[p14l10t2238r364b2328],
5	is	VBZ	O	be	cop	9	SENT_179	[p14l404t2242r461b2306],
6	the	DT	O	the	det	9	SENT_179	[p14l504t2238r620b2305],
7	only	JJ	O	only	amod	9	SENT_179	[p14l664t2238r822b2327],
8	PZYIZ	NN	O	pzyiz	nn	9	SENT_179	[p14l866t2244r1053b2322],
9	inhibitor	NN	O	inhibitor	_	0	SENT_179	[p14l1094t2238r1424b2305],
10	with	IN	O	with	_	0	SENT_179	[p14l1462t2238r1628b2306],
11	evidence	NN	O	evidence	prep_with	9	SENT_179	[p14l1670t2238r1992b2306],
12	for	IN	O	for	_	0	SENT_179	[p14l2034t2238r2140b2305],
13	superiority	NN	O	superiority	prep_for	11	SENT_179	[p14l14t2351r418b2436],
14	over	IN	O	over	_	0	SENT_179	[p14l486t2371r643b2415],
15	clopidogrel	NN	O	clopidogrel	prep_over	13	SENT_179	[p14l712t2346r1126b2436],
16	for	IN	O	for	_	0	SENT_179	[p14l1195t2346r1301b2415],
17	treatment	NN	O	treatment	prep_for	15	SENT_179	[p14l1368t2360r1736b2415],
18	of	IN	O	of	_	0	SENT_179	[p14l1804t2346r1888b2415],
19	acute	JJ	O	acute	amod	21	SENT_179	[p14l1945t2360r2138b2415],
20	coronary	JJ	O	coronary	amod	21	SENT_179	[p14l12t2480r339b2545],
21	syndromes	NNS	O	syndrome	prep_of	17	SENT_179	[p14l413t2455r841b2545],
22	,	,	O	,	_	0	SENT_179	[p14l413t2455r841b2545],
23	irrespective	RB	O	irrespective	_	0	SENT_179	[p14l918t2460r1347b2544],
24	of	IN	O	of	_	0	SENT_179	[p14l1422t2455r1505b2523],
25	the	DT	O	the	det	26	SENT_179	[p14l1565t2455r1681b2523],
26	effects	NNS	O	effect	prep_irrespective_of	21	SENT_179	[p14l1756t2455r1992b2523],
27	of	IN	O	of	_	0	SENT_179	[p14l2069t2455r2152b2523],
28	C	NN	O	c	nn	29	SENT_179	[p14l18t2570r72b2633],
29	YPZC	NN	O	ypzc	prep_of	26	SENT_179	[p14l78t2570r285b2633],
30	19	CD	NUMBER	19	num	32	SENT_179	[p14l290t2571r365b2633],
31	genetic	JJ	O	genetic	amod	32	SENT_179	[p14l388t2569r655b2655],
32	polymorphisms	NNS	O	polymorphism	dep	21	SENT_179	[p14l679t2565r1289b2654],
33	.	.	O	.	_	0	SENT_179	[p14l679t2565r1289b2654],

1	We	PRP	O	we	nsubj	4	SENT_180	[p14l80t2680r197b2742],
2	did	VBD	O	do	aux	4	SENT_180	[p14l240t2673r356b2742],
3	not	RB	O	not	neg	4	SENT_180	[p14l395t2687r517b2742],
4	record	VB	O	record	conj_and	4	SENT_180	[p14l556t2673r792b2742],
5	any	DT	O	any	det	6	SENT_180	[p14l832t2698r962b2763],
6	evidence	NN	O	evidence	dobj	4	SENT_180	[p14l1001t2673r1320b2742],
7	of	IN	O	of	_	0	SENT_180	[p14l1363t2673r1445b2742],
8	interaction	NN	O	interaction	prep_of	6	SENT_180	[p14l1472t2678r1874b2742],
9	of	IN	O	of	_	0	SENT_180	[p14l1914t2673r1997b2742],
10	the	DT	O	the	det	15	SENT_180	[p14l2023t2673r2139b2742],
11	C	NN	O	c	nn	15	SENT_180	[p14l18t2787r72b2850],
12	YPZC	NN	O	ypzc	nn	15	SENT_180	[p14l78t2787r283b2850],
13	19	CD	NUMBER	19	num	15	SENT_180	[p14l289t2788r362b2850],
14	genotype	NN	O	genotype	nn	15	SENT_180	[p14l394t2795r726b2872],
15	group	NN	O	group	prep_of	8	SENT_180	[p14l763t2806r980b2872],
16	in	IN	O	in	_	0	SENT_180	[p14l1015t2787r1090b2849],
17	patients	NNS	O	patient	prep_in	15	SENT_180	[p14l1124t2787r1414b2871],
18	on	IN	O	on	_	0	SENT_180	[p14l1453t2806r1545b2850],
19	ticagrelor	NN	O	ticagrelor	prep_on	17	SENT_180	[p14l1579t2782r1939b2872],
20	,	,	O	,	_	0	SENT_180	[p14l1579t2782r1939b2872],
21	with	IN	O	with	_	0	SENT_180	[p14l1976t2782r2140b2850],
22	almost	RB	O	almost	advmod	23	SENT_180	[p14l12t2892r261b2959],
23	identical	JJ	O	identical	amod	26	SENT_180	[p14l296t2892r612b2959],
24	ischaemic	JJ	O	ischaemic	amod	26	SENT_180	[p14l649t2892r1020b2959],
25	event	NN	O	event	nn	26	SENT_180	[p14l1057t2905r1254b2959],
26	rates	NNS	O	rate	prep_with	17	SENT_180	[p14l1290t2905r1463b2959],
27	between	IN	O	between	_	0	SENT_180	[p14l1501t2892r1810b2959],
28	patients	NNS	O	patient	prep_between	26	SENT_180	[p14l1846t2896r2137b2980],
29	with	IN	O	with	_	0	SENT_180	[p14l9t2999r173b3068],
30	and	CC	O	and	_	0	SENT_180	[p14l205t2999r343b3068],
31	without	IN	O	without	_	0	SENT_180	[p14l371t2999r658b3068],
32	any	DT	O	any	det	34	SENT_180	[p14l689t3024r819b3089],
33	loss-of-function	JJ	O	loss-of-function	amod	34	SENT_180	[p14l848t2999r1425b3068],
34	allele	NN	O	allele	prep_with	4	SENT_180	[p14l1458t2999r1665b3068],
35	.	.	O	.	_	0	SENT_180	[p14l1458t2999r1665b3068],

1	By	IN	O	by	_	0	SENT_181	[p14l1705t3006r1792b3089],
2	contrast	NN	O	contrast	agent	21	SENT_181	[p14l1823t3013r2136b3077],
3	,	,	O	,	_	0	SENT_181	[p14l1823t3013r2136b3077],
4	during	IN	O	during	_	0	SENT_181	[p14l12t3108r261b3198],
5	the	DT	O	the	det	6	SENT_181	[p14l294t3108r409b3176],
6	ﬁrst	NN	O	ﬁrst	prep_during	21	SENT_181	[p14l443t3108r591b3176],
7	30	CD	DURATION	30	num	8	SENT_181	[p14l627t3114r709b3176],
8	days	NNS	NUMBER	day	tmod	6	SENT_181	[p14l744t3108r902b3197],
9	of	IN	O	of	_	0	SENT_181	[p14l939t3108r1022b3176],
10	treatment	NN	O	treatment	prep_of	6	SENT_181	[p14l1042t3121r1407b3176],
11	with	IN	O	with	_	0	SENT_181	[p14l1437t3108r1601b3176],
12	clopidogrel	NN	O	clopidogrel	prep_with	10	SENT_181	[p14l1636t3108r2064b3198],
13	,	,	O	,	_	0	SENT_181	[p14l1636t3108r2064b3198],
14	a	DT	O	a	det	16	SENT_181	[p14l2103t3132r2139b3176],
15	higher	JJR	O	higher	amod	16	SENT_181	[p14l9t3218r255b3307],
16	rate	NN	O	rate	nsubjpass	21	SENT_181	[p14l284t3231r422b3286],
17	of	IN	O	of	_	0	SENT_181	[p14l454t3217r536b3286],
18	ischaemic	JJ	O	ischaemic	amod	19	SENT_181	[p14l554t3218r926b3286],
19	events	NNS	O	event	prep_of	16	SENT_181	[p14l957t3231r1187b3286],
20	was	VBD	O	be	auxpass	21	SENT_181	[p14l1218t3242r1355b3286],
21	recorded	VBN	O	record	_	0	SENT_181	[p14l1388t3218r1712b3286],
22	in	IN	O	in	_	0	SENT_181	[p14l1742t3222r1816b3284],
23	patients	NNS	O	patient	prep_in	21	SENT_181	[p14l1846t3222r2137b3306],
24	with	IN	O	with	prep	21	SENT_181	[p14l9t3326r173b3395],
25	than	IN	O	than	dep	26	SENT_181	[p14l218t3326r386b3395],
26	in	IN	O	in	pcomp	24	SENT_181	[p14l433t3331r507b3393],
27	those	DT	O	those	pobj	26	SENT_181	[p14l553t3326r750b3395],
28	without	IN	O	without	_	0	SENT_181	[p14l796t3326r1083b3395],
29	any	DT	O	any	det	31	SENT_181	[p14l1130t3351r1259b3416],
30	loss-of-function	JJ	O	loss-of-function	amod	31	SENT_181	[p14l1303t3326r1881b3395],
31	allele	NN	O	allele	prep_without	27	SENT_181	[p14l1928t3326r2136b3404],
32	,	,	O	,	_	0	SENT_181	[p14l1928t3326r2136b3404],
33	which	WDT	O	which	nsubj	35	SENT_181	[p14l9t3435r235b3503],
34	is	VBZ	O	be	cop	35	SENT_181	[p14l274t3440r331b3502],
35	consistent	JJ	O	consistent	rcmod	31	SENT_181	[p14l374t3440r751b3502],
36	with	IN	O	with	_	0	SENT_181	[p14l786t3435r950b3502],
37	previous	JJ	O	previous	amod	38	SENT_181	[p14l989t3440r1303b3523],
38	reports	NNS	O	report	prep_with	35	SENT_181	[p14l1344t3440r1752b3523],
39	.	.	O	.	_	0	SENT_181	[p14l1344t3440r1752b3523],

1	°	NN	O	°	nn	2	SENT_182	[p14l1344t3440r1752b3523],
2	’	NN	O	’	_	0	SENT_182	[p14l1344t3440r1752b3523],
3	1	CD	NUMBER	1	num	4	SENT_182	[p14l1344t3440r1752b3523],
4	‘	CD	NUMBER	‘	dep	2	SENT_182	[p14l1344t3440r1752b3523],
5	*	NN	O	*	dep	4	SENT_182	[p14l1344t3440r1752b3523],
6	’23	CD	NUMBER	’23	dobj	5	SENT_182	[p14l1344t3440r1752b3523],
7	However	RB	O	however	advmod	6	SENT_182	[p14l1797t3442r2136b3513],
8	,	,	O	,	_	0	SENT_182	[p14l1797t3442r2136b3513],

1	when	WRB	O	when	advmod	7	SENT_183	[p15l9t17r214b84],
2	the	DT	O	the	det	5	SENT_183	[p15l273t17r389b84],
3	full	JJ	O	full	amod	5	SENT_183	[p15l450t17r574b84],
4	follow-up	JJ	O	follow-up	amod	5	SENT_183	[p15l634t17r981b105],
5	period	NN	O	period	nsubjpass	7	SENT_183	[p15l1043t17r1280b105],
6	was	VBD	O	be	auxpass	7	SENT_183	[p15l1338t41r1475b84],
7	considered	VBN	O	consider	advcl	23	SENT_183	[p15l1539t17r1960b94],
8	,	,	O	,	_	0	SENT_183	[p15l1539t17r1960b94],
9	the	DT	O	the	det	10	SENT_183	[p15l2023t17r2139b84],
10	difference	NN	O	difference	nsubj	27	SENT_183	[p15l12t124r381b192],
11	in	IN	O	in	_	0	SENT_183	[p15l402t129r477b191],
12	outcomes	NNS	O	outcome	prep_in	10	SENT_183	[p15l498t138r853b192],
13	between	IN	O	between	_	0	SENT_183	[p15l874t124r1183b192],
14	patients	NNS	O	patient	prep_between	12	SENT_183	[p15l1203t129r1494b212],
15	with	IN	O	with	_	0	SENT_183	[p15l1515t124r1679b192],
16	and	CC	O	and	_	0	SENT_183	[p15l1700t124r1837b192],
17	without	IN	O	without	_	0	SENT_183	[p15l1854t124r2141b192],
18	any	DT	O	any	det	20	SENT_183	[p15l12t257r142b322],
19	loss-of-function	JJ	O	loss-of-function	amod	20	SENT_183	[p15l160t232r738b300],
20	allele	NN	O	allele	prep_without	14	SENT_183	[p15l761t232r949b300],
21	was	VBD	O	be	cop	23	SENT_183	[p15l970t256r1107b300],
22	not	RB	O	not	neg	23	SENT_183	[p15l1131t246r1253b300],
23	signiﬁcant	JJ	O	signiﬁcant	_	0	SENT_183	[p15l1276t232r1664b322],
24	and	CC	O	and	_	0	SENT_183	[p15l1686t232r1822b300],
25	was	VBD	O	be	cop	27	SENT_183	[p15l1841t256r1979b300],
26	less	JJR	O	less	dep	27	SENT_183	[p15l2002t232r2137b300],
27	prominent	JJ	O	prominent	conj_and	23	SENT_183	[p15l10t346r410b431],
28	than	IN	O	than	_	0	SENT_183	[p15l444t342r612b410],
29	that	DT	O	that	prep_than	27	SENT_183	[p15l647t342r791b409],
30	seen	VBN	O	see	partmod	29	SENT_183	[p15l830t366r995b410],
31	in	IN	O	in	_	0	SENT_183	[p15l1032t346r1106b408],
32	some	DT	O	some	prep_in	30	SENT_183	[p15l1146t366r1361b420],
33	,	,	O	,	_	0	SENT_183	[p15l1146t366r1361b420],
34	although	IN	O	although	mark	35	SENT_183	[p15l1403t342r1730b432],
35	not	RB	O	not	dep	32	SENT_183	[p15l1767t355r1889b409],
36	all	DT	O	all	dep	35	SENT_183	[p15l1926t342r2028b420],
37	,	,	O	,	_	0	SENT_183	[p15l1926t342r2028b420],
38	of	IN	O	of	_	0	SENT_183	[p15l2070t342r2152b409],
39	previous	JJ	O	previous	amod	41	SENT_183	[p15l10t455r325b539],
40	observational	JJ	O	observational	amod	41	SENT_183	[p15l351t450r842b519],
41	trials	NNS	O	trial	prep_of	32	SENT_183	[p15l864t450r1113b519],
42	.	.	O	.	_	0	SENT_183	[p15l864t450r1113b519],

1	”	NN	O	”	nsubjpass	51	SENT_184	[p15l864t450r1113b519],
2	In	IN	O	in	_	0	SENT_184	[p15l1142t457r1220b517],
3	most	JJS	O	most	amod	4	SENT_184	[p15l1243t464r1429b519],
4	reports	NNS	O	report	prep_in	51	SENT_184	[p15l1450t464r1709b539],
5	of	IN	O	of	_	0	SENT_184	[p15l1736t450r1819b519],
6	stronger	JJR	O	stronger	amod	7	SENT_184	[p15l1832t464r2140b540],
7	interactions	NNS	O	interaction	prep_of	4	SENT_184	[p15l11t564r446b627],
8	than	IN	O	than	mark	10	SENT_184	[p15l470t559r638b627],
9	we	PRP	O	we	nsubj	10	SENT_184	[p15l658t584r760b627],
10	recorded	VBD	O	record	advcl	17	SENT_184	[p15l784t559r1125b637],
11	,	,	O	,	_	0	SENT_184	[p15l784t559r1125b637],
12	ischaemic	JJ	O	ischaemic	amod	13	SENT_184	[p15l1151t559r1522b627],
13	events	NNS	O	event	nsubj	17	SENT_184	[p15l1546t573r1776b627],
14	and	CC	O	and	_	0	SENT_184	[p15l1802t559r1938b627],
15	stent	JJ	O	stent	amod	16	SENT_184	[p15l1962t573r2141b627],
16	thrombosis	NN	O	thrombosis	conj_and	13	SENT_184	[p15l10t669r430b737],
17	occurred	VBD	O	occur	rcmod	7	SENT_184	[p15l500t669r824b737],
18	early	RB	O	early	advmod	17	SENT_184	[p15l891t669r1067b758],
19	after	IN	O	after	_	0	SENT_184	[p15l1132t669r1298b736],
20	start	NN	O	start	prep_after	17	SENT_184	[p15l1366t682r1526b737],
21	of	IN	O	of	_	0	SENT_184	[p15l1592t669r1674b736],
22	clopidogrel	NN	O	clopidogrel	nn	23	SENT_184	[p15l1729t669r2140b759],
23	treatment	NN	O	treatment	prep_of	20	SENT_184	[p15l10t791r375b846],
24	in	IN	O	in	_	0	SENT_184	[p15l433t782r507b844],
25	association	NN	O	association	prep_in	20	SENT_184	[p15l568t782r975b846],
26	with	IN	O	with	_	0	SENT_184	[p15l1033t777r1197b846],
27	percutaneous	JJ	O	percutaneous	amod	29	SENT_184	[p15l1256t791r1754b866],
28	coronary	JJ	O	coronary	amod	29	SENT_184	[p15l1817t802r2141b867],
29	intervention	NN	O	intervention	prep_with	20	SENT_184	[p15l11t891r465b954],
30	and	CC	O	and	_	0	SENT_184	[p15l491t886r627b954],
31	stent	NN	O	stent	nn	32	SENT_184	[p15l653t900r832b954],
32	procedures	NNS	O	procedure	prep_with	20	SENT_184	[p15l855t886r1521b974],
33	.9	CD	NUMBER	.9	number	34	SENT_184	[p15l855t886r1521b974],
34	’	CD	NUMBER	’	dep	20	SENT_184	[p15l855t886r1521b974],
35	1	CD	NUMBER	1	num	36	SENT_184	[p15l855t886r1521b974],
36	°	NN	O	°	dep	34	SENT_184	[p15l855t886r1521b974],
37	’	CD	NUMBER	’	number	38	SENT_184	[p15l855t886r1521b974],
38	14	CD	NUMBER	14	num	39	SENT_184	[p15l855t886r1521b974],
39	’	NN	O	’	dep	7	SENT_184	[p15l855t886r1521b974],
40	28	CD	NUMBER	28	number	41	SENT_184	[p15l855t886r1521b974],
41	'29	CD	NUMBER	'29	num	42	SENT_184	[p15l855t886r1521b974],
42	Fewer	JJR	O	fewer	dep	7	SENT_184	[p15l1550t891r1770b954],
43	or	CC	O	or	_	0	SENT_184	[p15l1794t911r1870b954],
44	milder	JJR	O	milder	amod	45	SENT_184	[p15l1894t886r2141b954],
45	interactions	NNS	O	interaction	prep_of	4	SENT_184	[p15l11t999r446b1062],
46	than	IN	O	than	mark	48	SENT_184	[p15l500t995r668b1062],
47	we	PRP	O	we	nsubj	48	SENT_184	[p15l719t1019r821b1062],
48	recorded	VBD	O	record	dep	45	SENT_184	[p15l874t995r1199b1062],
49	have	VBP	O	have	aux	51	SENT_184	[p15l1249t995r1417b1062],
50	been	VBN	O	be	auxpass	51	SENT_184	[p15l1470t995r1648b1062],
51	reported	VBN	O	report	_	0	SENT_184	[p15l1701t995r2014b1083],
52	in	IN	O	in	_	0	SENT_184	[p15l2066t999r2139b1061],
53	www	NN	O	www	prep_in	51	SENT_184	[p15l9t1263r542b1314],
54	.	.	O	.	_	0	SENT_184	[p15l9t1263r542b1314],

1	the	DT	O	the	det	2	SENT_185	[p15l9t1263r542b1314],
2	|	NN	O	|	_	0	SENT_185	[p15l9t1263r542b1314],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_185	[p15l9t1263r542b1314],
4	Vol	NNP	O	Vol	dep	2	SENT_185	[p15l584t1263r672b1314],
5	376	CD	NUMBER	376	num	6	SENT_185	[p15l691t1262r795b1321],
6	October	NNP	DATE	October	dep	2	SENT_185	[p15l840t1263r1064b1314],
7	16,2010	CD	DATE	16,2010	num	6	SENT_185	[p15l1081t1262r1324b1323],

1	mixed	JJ	O	mixed	amod	2	SENT_186	[p15l9t1451r173b1499],
2	populations	NNS	O	population	dep	5	SENT_186	[p15l203t1451r513b1514],
3	of	IN	O	of	_	0	SENT_186	[p15l547t1451r606b1499],
4	patients	NNS	O	patient	prep_of	2	SENT_186	[p15l628t1454r836b1514],
5	managed	VBD	O	manage	_	0	SENT_186	[p15l869t1451r1114b1515],
6	invasively	RB	O	invasively	advmod	5	SENT_186	[p15l1144t1451r1401b1514],
7	and	CC	O	and	_	0	SENT_186	[p15l1432t1451r1529b1499],
8	non-invasively	RB	O	non-invasively	advmod	5	SENT_186	[p15l9t1528r389b1592],
9	during	IN	O	during	_	0	SENT_186	[p15l470t1528r648b1592],
10	long-term	JJ	O	long-term	amod	11	SENT_186	[p15l729t1528r991b1592],
11	treatment	NN	O	treatment	prep_during	5	SENT_186	[p15l1072t1538r1332b1577],
12	with	IN	O	with	_	0	SENT_186	[p15l1412t1528r1529b1577],
13	clopidogrel	NN	O	clopidogrel	prep_with	11	SENT_186	[p15l10t1606r408b1670],
14	.9	CD	NUMBER	.9	number	15	SENT_186	[p15l10t1606r408b1670],
15	’	CD	NUMBER	’	num	13	SENT_186	[p15l10t1606r408b1670],
16	17	CD	NUMBER	17	num	19	SENT_186	[p15l10t1606r408b1670],
17	’	NN	O	’	nn	19	SENT_186	[p15l10t1606r408b1670],
18	3	CD	NUMBER	3	num	19	SENT_186	[p15l10t1606r408b1670],
19	°	NN	O	°	nsubj	5	SENT_186	[p15l10t1606r408b1670],

1	Patients	NNS	O	patient	nsubjpass	7	SENT_187	[p15l62t1687r272b1732],
2	with	IN	O	with	_	0	SENT_187	[p15l289t1684r408b1732],
3	acute	JJ	O	acute	amod	5	SENT_187	[p15l425t1693r564b1732],
4	coronary	JJ	O	coronary	amod	5	SENT_187	[p15l582t1701r817b1747],
5	syndromes	NNS	O	syndrome	prep_with	1	SENT_187	[p15l834t1684r1125b1747],
6	were	VBD	O	be	auxpass	7	SENT_187	[p15l1142t1701r1269b1732],
7	recruited	VBN	O	recruit	_	0	SENT_187	[p15l1287t1684r1529b1732],
8	to	TO	O	to	_	0	SENT_187	[p15l8t1770r58b1809],
9	the	DT	O	the	det	11	SENT_187	[p15l91t1760r174b1809],
10	PLATO	NNP	O	PLATO	nn	11	SENT_187	[p15l211t1763r402b1809],
11	trial	NN	O	trial	prep_to	7	SENT_187	[p15l436t1760r543b1809],
12	irrespective	RB	O	irrespective	_	0	SENT_187	[p15l576t1763r885b1823],
13	of	IN	O	of	_	0	SENT_187	[p15l920t1760r979b1809],
14	previous	JJ	O	previous	amod	15	SENT_187	[p15l1003t1763r1230b1823],
15	treatment	NN	O	treatment	prep_irrespective_of	7	SENT_187	[p15l1265t1770r1529b1809],
16	with	IN	O	with	_	0	SENT_187	[p15l8t1838r126b1887],
17	clopidogrel	NN	O	clopidogrel	prep_with	15	SENT_187	[p15l185t1838r483b1902],
18	or	CC	O	or	_	0	SENT_187	[p15l542t1856r597b1887],
19	whether	IN	O	whether	dep	25	SENT_187	[p15l653t1838r874b1887],
20	invasive	JJ	O	invasive	amod	23	SENT_187	[p15l932t1841r1146b1887],
21	or	CC	O	or	_	0	SENT_187	[p15l1205t1856r1260b1887],
22	medical	JJ	O	medical	conj_or	20	SENT_187	[p15l1317t1838r1528b1887],
23	management	NN	O	management	nsubjpass	25	SENT_187	[p15l9t1926r366b1981],
24	was	VBD	O	be	auxpass	25	SENT_187	[p15l386t1934r485b1965],
25	planned	VBN	O	plan	conj_or	15	SENT_187	[p15l509t1917r740b1980],
26	,	,	O	,	_	0	SENT_187	[p15l509t1917r740b1980],
27	and	CC	O	and	_	0	SENT_187	[p15l766t1917r865b1965],
28	only	RB	O	only	quantmod	29	SENT_187	[p15l887t1917r1001b1980],
29	64	CD	PERCENT	64	num	30	SENT_187	[p15l1023t1920r1134b1967],
30	%	NN	PERCENT	%	nsubj	35	SENT_187	[p15l1023t1920r1134b1967],
31	of	IN	O	of	_	0	SENT_187	[p15l1158t1917r1217b1965],
32	the	DT	O	the	det	34	SENT_187	[p15l1230t1917r1313b1965],
33	genetic	JJ	O	genetic	amod	34	SENT_187	[p15l1337t1920r1528b1981],
34	cohort	NN	O	cohort	prep_of	30	SENT_187	[p15l10t1994r181b2043],
35	had	VBD	O	have	conj_and	7	SENT_187	[p15l207t1994r306b2043],
36	a	DT	O	a	det	41	SENT_187	[p15l334t2012r360b2043],
37	percutaneous	JJ	O	percutaneous	amod	41	SENT_187	[p15l388t2004r749b2057],
38	coronary	JJ	O	coronary	amod	41	SENT_187	[p15l779t2012r1014b2058],
39	intervention	NN	O	intervention	nn	41	SENT_187	[p15l1040t1997r1370b2043],
40	stent	NN	O	stent	nn	41	SENT_187	[p15l1399t2004r1529b2043],
41	procedure	NN	O	procedure	dobj	35	SENT_187	[p15l9t2072r280b2135],
42	at	IN	O	at	_	0	SENT_187	[p15l307t2082r353b2120],
43	any	DT	O	any	det	44	SENT_187	[p15l378t2089r472b2136],
44	time	NN	O	time	prep_at	41	SENT_187	[p15l495t2075r617b2120],
45	during	IN	O	during	_	0	SENT_187	[p15l644t2072r824b2136],
46	the	DT	O	the	det	47	SENT_187	[p15l848t2072r932b2120],
47	trial	NN	O	trial	prep_during	35	SENT_187	[p15l957t2072r1077b2120],
48	.	.	O	.	_	0	SENT_187	[p15l957t2072r1077b2120],

1	The	DT	O	the	det	3	SENT_188	[p15l1105t2072r1207b2120],
2	low	JJ	O	low	amod	3	SENT_188	[p15l1232t2072r1327b2120],
3	rate	NN	O	rate	nsubj	33	SENT_188	[p15l1352t2082r1451b2120],
4	of	IN	O	of	_	0	SENT_188	[p15l1478t2072r1537b2120],
5	percutaneous	JJ	O	percutaneous	amod	8	SENT_188	[p15l9t2160r370b2214],
6	coronary	JJ	O	coronary	amod	8	SENT_188	[p15l433t2168r668b2214],
7	intervention	NN	O	intervention	nn	8	SENT_188	[p15l727t2154r1056b2199],
8	procedures	NNS	O	procedure	prep_of	3	SENT_188	[p15l1116t2151r1413b2214],
9	in	IN	O	in	_	0	SENT_188	[p15l1475t2154r1528b2198],
10	association	NN	O	association	prep_in	8	SENT_188	[p15l10t2231r306b2277],
11	with	IN	O	with	_	0	SENT_188	[p15l340t2228r458b2277],
12	the	DT	O	the	det	14	SENT_188	[p15l493t2228r576b2277],
13	acute	JJ	O	acute	amod	14	SENT_188	[p15l613t2238r752b2277],
14	event	NN	O	event	prep_with	10	SENT_188	[p15l789t2238r931b2277],
15	and	CC	O	and	_	0	SENT_188	[p15l967t2228r1065b2277],
16	the	DT	O	the	det	17	SENT_188	[p15l1099t2228r1182b2277],
17	aversion	NN	O	aversion	conj_and	10	SENT_188	[p15l1219t2231r1443b2277],
18	to	TO	O	to	_	0	SENT_188	[p15l1478t2238r1527b2277],
19	undertaking	NN	O	undertaking	prep_to	17	SENT_188	[p15l8t2307r339b2371],
20	of	IN	O	of	_	0	SENT_188	[p15l392t2307r452b2355],
21	percutaneous	JJ	O	percutaneous	amod	24	SENT_188	[p15l496t2316r856b2370],
22	coronary	JJ	O	coronary	amod	24	SENT_188	[p15l912t2324r1147b2371],
23	intervention	NN	O	intervention	nn	24	SENT_188	[p15l1199t2310r1528b2355],
24	procedures	NNS	O	procedure	prep_of	19	SENT_188	[p15l9t2385r306b2449],
25	very	RB	O	very	advmod	26	SENT_188	[p15l340t2403r452b2449],
26	early	RB	O	early	advmod	33	SENT_188	[p15l485t2385r612b2449],
27	after	IN	O	after	_	0	SENT_188	[p15l645t2385r766b2434],
28	start	NN	O	start	prep_after	26	SENT_188	[p15l801t2395r917b2434],
29	of	IN	O	of	_	0	SENT_188	[p15l951t2385r1010b2434],
30	clopidogrel	NN	O	clopidogrel	prep_of	28	SENT_188	[p15l1035t2385r1333b2449],
31	might	MD	O	might	aux	33	SENT_188	[p15l1367t2385r1529b2449],
32	have	VB	O	have	aux	33	SENT_188	[p15l8t2463r130b2512],
33	contributed	VBN	O	contribute	_	0	SENT_188	[p15l159t2463r470b2512],
34	to	TO	O	to	_	0	SENT_188	[p15l496t2473r545b2512],
35	the	DT	O	the	det	37	SENT_188	[p15l573t2463r656b2512],
36	lower	JJR	O	lower	amod	37	SENT_188	[p15l683t2463r832b2512],
37	rate	NN	O	rate	prep_to	33	SENT_188	[p15l858t2473r958b2512],
38	of	IN	O	of	_	0	SENT_188	[p15l987t2463r1046b2512],
39	stent	JJ	O	stent	amod	40	SENT_188	[p15l1066t2473r1196b2512],
40	thrombosis	NN	O	thrombosis	prep_of	37	SENT_188	[p15l1222t2463r1526b2512],
41	and	CC	O	and	_	0	SENT_188	[p15l10t2541r109b2589],
42	reduced	VBD	O	reduce	conj_and	33	SENT_188	[p15l132t2541r347b2589],
43	interaction	NN	O	interaction	iobj	42	SENT_188	[p15l371t2544r662b2589],
44	with	IN	O	with	_	0	SENT_188	[p15l685t2541r804b2589],
45	C	NN	O	c	nn	46	SENT_188	[p15l833t2544r872b2589],
46	YPZC	NN	O	ypzc	prep_with	43	SENT_188	[p15l876t2544r1025b2589],
47	19	CD	NUMBER	19	num	48	SENT_188	[p15l1029t2545r1082b2590],
48	polymorphisms	NNS	O	polymorphism	dobj	42	SENT_188	[p15l1104t2541r1526b2605],
49	in	IN	O	in	_	0	SENT_188	[p15l9t2623r63b2667],
50	this	DT	O	this	det	51	SENT_188	[p15l85t2619r183b2668],
51	trial	NN	O	trial	prep_in	48	SENT_188	[p15l208t2619r316b2668],
52	than	IN	O	than	prep	51	SENT_188	[p15l339t2619r460b2668],
53	in	IN	O	in	pcomp	52	SENT_188	[p15l484t2623r537b2667],
54	previous	JJ	O	previous	amod	55	SENT_188	[p15l561t2623r789b2683],
55	reports	NNS	O	report	pobj	53	SENT_188	[p15l815t2629r1017b2683],
56	.	.	O	.	_	0	SENT_188	[p15l815t2629r1017b2683],

1	During	IN	O	during	_	0	SENT_189	[p15l1047t2623r1239b2683],
2	long-term	JJ	O	long-term	amod	4	SENT_189	[p15l1262t2619r1528b2683],
3	clopidogrel	NN	O	clopidogrel	nn	4	SENT_189	[p15l10t2697r308b2761],
4	treatment	NN	O	treatment	prep_during	8	SENT_189	[p15l338t2707r616b2753],
5	,	,	O	,	_	0	SENT_189	[p15l338t2707r616b2753],
6	CYPZCI9	NN	O	cypzci9	nn	7	SENT_189	[p15l654t2701r903b2746],
7	polymorphisms	NNS	O	polymorphism	nsubj	8	SENT_189	[p15l932t2697r1354b2761],
8	seem	VBP	O	seem	_	0	SENT_189	[p15l1389t2714r1528b2746],
9	to	TO	O	to	aux	10	SENT_189	[p15l8t2785r58b2824],
10	have	VB	O	have	xcomp	8	SENT_189	[p15l86t2775r208b2824],
11	moderate	JJ	O	moderate	amod	12	SENT_189	[p15l237t2775r490b2824],
12	effect	NN	O	effect	dobj	10	SENT_189	[p15l520t2775r665b2824],
13	on	IN	O	on	_	0	SENT_189	[p15l693t2792r760b2824],
14	concentration	NN	O	concentration	prep_on	12	SENT_189	[p15l789t2778r1159b2824],
15	of	IN	O	of	_	0	SENT_189	[p15l1188t2775r1247b2824],
16	the	DT	O	the	det	19	SENT_189	[p15l1265t2775r1349b2824],
17	active	JJ	O	active	amod	19	SENT_189	[p15l1379t2778r1528b2824],
18	metabolite	NN	O	metabolite	nn	19	SENT_189	[p15l9t2853r320b2902],
19	“	NN	O	“	prep_of	14	SENT_189	[p15l9t2853r320b2902],
20	and	CC	O	and	_	0	SENT_189	[p15l334t2854r433b2902],
21	platelet	NN	O	platelet	nn	22	SENT_189	[p15l447t2854r642b2917],
22	aggregation	NN	O	aggregation	prep_of	14	SENT_189	[p15l656t2857r1058b2918],
23	,	,	O	,	_	0	SENT_189	[p15l656t2857r1058b2918],
24	”’	CD	NUMBER	”’	number	25	SENT_189	[p15l656t2857r1058b2918],
25	3	CD	NUMBER	3	num	26	SENT_189	[p15l656t2857r1058b2918],
26	°	NN	O	°	appos	19	SENT_189	[p15l656t2857r1058b2918],
27	which	WDT	O	which	nsubj	30	SENT_189	[p15l1071t2854r1234b2902],
28	also	RB	O	also	advmod	30	SENT_189	[p15l1249t2854r1352b2902],
29	might	MD	O	might	aux	30	SENT_189	[p15l1367t2854r1529b2918],
30	explain	VB	O	explain	rcmod	26	SENT_189	[p15l10t2931r202b2994],
31	the	DT	O	the	det	33	SENT_189	[p15l224t2931r308b2980],
32	restricted	JJ	O	restricted	amod	33	SENT_189	[p15l332t2931r584b2980],
33	effect	NN	O	effect	dobj	30	SENT_189	[p15l608t2932r752b2980],
34	of	IN	O	of	_	0	SENT_189	[p15l776t2931r835b2980],
35	these	DT	O	these	det	36	SENT_189	[p15l849t2931r989b2980],
36	polymorphisms	NNS	O	polymorphism	prep_of	33	SENT_189	[p15l1013t2931r1435b2995],
37	on	IN	O	on	_	0	SENT_189	[p15l1462t2949r1528b2980],
38	clinical	JJ	O	clinical	amod	39	SENT_189	[p15l10t3009r200b3058],
39	events	NNS	O	event	prep_on	30	SENT_189	[p15l219t3019r386b3058],
40	in	IN	O	in	_	0	SENT_189	[p15l406t3012r460b3057],
41	our	PRP$	O	we	poss	42	SENT_189	[p15l479t3027r570b3058],
42	study	NN	O	study	prep_in	39	SENT_189	[p15l590t3009r739b3073],
43	.	.	O	.	_	0	SENT_189	[p15l590t3009r739b3073],

1	Potential	JJ	O	potential	amod	2	SENT_190	[p15l62t3087r293b3135],
2	interactions	NNS	O	interaction	nsubj	13	SENT_190	[p15l314t3090r625b3135],
3	between	IN	O	between	_	0	SENT_190	[p15l647t3087r867b3135],
4	polymorphisms	NNS	O	polymorphism	prep_between	2	SENT_190	[p15l888t3087r1305b3150],
5	and	CC	O	and	_	0	SENT_190	[p15l1329t3087r1426b3135],
6	the	DT	O	the	det	7	SENT_190	[p15l1446t3087r1528b3135],
7	effects	NNS	O	effect	conj_and	4	SENT_190	[p15l10t3165r176b3213],
8	of	IN	O	of	_	0	SENT_190	[p15l196t3164r255b3213],
9	clopidogrel	NN	O	clopidogrel	prep_of	7	SENT_190	[p15l264t3164r556b3228],
10	on	IN	O	on	_	0	SENT_190	[p15l574t3182r640b3213],
11	clinical	JJ	O	clinical	amod	12	SENT_190	[p15l658t3164r845b3213],
12	events	NNS	O	event	prep_on	9	SENT_190	[p15l863t3174r1027b3213],
13	seemed	VBD	O	seem	_	0	SENT_190	[p15l1048t3164r1249b3213],
14	to	TO	O	to	aux	16	SENT_190	[p15l1264t3174r1313b3213],
15	be	VB	O	be	cop	16	SENT_190	[p15l1330t3164r1391b3213],
16	time	NN	O	time	xcomp	13	SENT_190	[p15l1408t3167r1528b3213],
17	dependent	JJ	O	dependent	amod	16	SENT_190	[p15l10t3242r290b3305],
18	in	IN	O	in	_	0	SENT_190	[p15l317t3245r369b3290],
19	our	PRP$	O	we	poss	20	SENT_190	[p15l398t3259r488b3290],
20	study	NN	O	study	prep_in	17	SENT_190	[p15l516t3242r664b3305],
21	,	,	O	,	_	0	SENT_190	[p15l516t3242r664b3305],
22	with	IN	O	with	_	0	SENT_190	[p15l693t3242r810b3290],
23	signiﬁcantly	RB	O	signiﬁcantly	advmod	24	SENT_190	[p15l839t3242r1162b3306],
24	higher	JJR	O	higher	amod	26	SENT_190	[p15l1187t3242r1362b3306],
25	event	NN	O	event	nn	26	SENT_190	[p15l1389t3252r1530b3290],
26	rates	NNS	O	rate	prep_with	13	SENT_190	[p15l9t3329r133b3368],
27	in	IN	O	in	_	0	SENT_190	[p15l155t3323r208b3367],
28	patients	NNS	O	patient	prep_in	26	SENT_190	[p15l228t3323r436b3383],
29	with	IN	O	with	_	0	SENT_190	[p15l457t3320r574b3368],
30	versus	CC	O	versus	dep	49	SENT_190	[p15l593t3337r761b3368],
31	those	DT	O	those	dep	30	SENT_190	[p15l782t3320r924b3368],
32	without	IN	O	without	_	0	SENT_190	[p15l943t3320r1148b3368],
33	any	DT	O	any	det	37	SENT_190	[p15l1169t3337r1261b3383],
34	C	NN	O	c	nn	37	SENT_190	[p15l1285t3323r1324b3368],
35	YPZCI9	NN	O	ypzci9	nn	37	SENT_190	[p15l1328t3323r1531b3368],
36	loss-of-function	NN	O	loss-of-function	nn	37	SENT_190	[p15l8t3397r420b3446],
37	allele	NN	O	allele	prep_without	31	SENT_190	[p15l464t3397r599b3446],
38	at	IN	O	at	_	0	SENT_190	[p15l643t3407r689b3446],
39	30	CD	DURATION	30	num	40	SENT_190	[p15l735t3402r792b3446],
40	days	NNS	NUMBER	day	prep_at	37	SENT_190	[p15l837t3397r965b3461],
41	,	,	O	,	_	0	SENT_190	[p15l837t3397r965b3461],
42	but	CC	O	but	_	0	SENT_190	[p15l1009t3397r1098b3446],
43	no	DT	O	no	det	45	SENT_190	[p15l1140t3415r1206b3446],
44	signiﬁcant	NN	O	signiﬁcant	nn	45	SENT_190	[p15l1252t3397r1530b3461],
45	difference	NN	O	difference	dep	49	SENT_190	[p15l10t3475r274b3523],
46	between	IN	O	between	_	0	SENT_190	[p15l298t3475r518b3523],
47	the	DT	O	the	det	48	SENT_190	[p15l542t3475r625b3523],
48	genotype	NN	O	genotype	prep_between	45	SENT_190	[p15l651t3485r888b3539],
49	groups	NNS	O	group	prep_with	13	SENT_190	[p15l915t3492r1094b3539],
50	thereafter	RB	O	thereafter	advmod	13	SENT_190	[p15l1120t3475r1384b3523],
51	.	.	O	.	_	0	SENT_190	[p15l1120t3475r1384b3523],

1	This	DT	O	this	det	2	SENT_191	[p15l1411t3475r1527b3523],
2	ﬁnding	JJ	O	ﬁnding	nsubj	3	SENT_191	[p15l9t3553r202b3617],
3	corresponds	VBZ	O	correspond	_	0	SENT_191	[p15l237t3553r559b3617],
4	with	IN	O	with	_	0	SENT_191	[p15l594t3553r711b3602],
5	the	DT	O	the	det	7	SENT_191	[p15l746t3553r828b3602],
6	genetic	JJ	O	genetic	amod	7	SENT_191	[p15l865t3557r1053b3617],
7	substudy	NN	O	substudy	prep_with	3	SENT_191	[p15l1090t3553r1327b3617],
8	of	IN	O	of	_	0	SENT_191	[p15l1362t3553r1420b3602],
9	the	DT	O	the	prep_of	7	SENT_191	[p15l1446t3553r1528b3602],

1	Articles	NNPS	O	Articles	_	0	SENT_192	[p16l101t219r251b255],

1	90	CD	NUMBER	90	num	3	SENT_193	[p16l617t470r646b492],
2	mg	NN	O	mg	nn	3	SENT_193	[p16l654t474r689b495],
3	ticagrelor	NN	O	ticagrelor	_	0	SENT_193	[p16l694t468r805b495],
4	twice	RB	O	twice	advmod	5	SENT_193	[p16l809t468r872b488],
5	daily	RB	SET	daily	dep	3	SENT_193	[p16l878t468r933b495],
6	75	CD	NUMBER	75	num	8	SENT_193	[p16l1130t471r1157b492],
7	mg	NN	O	mg	nn	8	SENT_193	[p16l1165t474r1200b495],
8	clopidogrel	NN	O	clopidogrel	npadvmod	9	SENT_193	[p16l1207t468r1334b495],
9	once	RB	DATE	once	advmod	5	SENT_193	[p16l1341t474r1394b488],
10	daily	JJ	SET	daily	amod	16	SENT_193	[p16l1400t468r1455b495],
11	Hazard	NN	O	hazard	nn	16	SENT_193	[p16l1604t468r1682b488],
12	ratio	NN	O	ratio	nn	16	SENT_193	[p16l1689t468r1742b488],
13	p	NN	O	p	nn	16	SENT_193	[p16l1833t474r1847b495],
14	value	NN	O	value	nn	16	SENT_193	[p16l1853t468r1913b488],
15	p	NN	O	p	nn	16	SENT_193	[p16l1966t474r1980b495],
16	value	NN	O	value	dep	3	SENT_193	[p16l1986t468r2047b488],

1	(	NN	O	(	_	0	SENT_194	[p16l1603t503r1661b528],
2	95	CD	PERCENT	95	num	3	SENT_194	[p16l1603t503r1661b528],
3	%	NN	PERCENT	%	dep	1	SENT_194	[p16l1603t503r1661b528],
4	Cl	NN	O	cl	nn	7	SENT_194	[p16l1667t503r1696b528],
5	)	CD	NUMBER	)	num	7	SENT_194	[p16l1667t503r1696b528],
6	(	NN	O	(	nn	7	SENT_194	[p16l1967t503r2122b528],
7	interaction	NN	O	interaction	dep	3	SENT_194	[p16l1967t503r2122b528],
8	)	CD	NUMBER	)	num	9	SENT_194	[p16l1967t503r2122b528],
9	*	NN	O	*	dep	1	SENT_194	[p16l1967t503r2122b528],

1	Numberof	NNP	MISC	Numberof	nn	3	SENT_195	[p16l617t557r734b578],
2	Patientswith	NNP	MISC	Patientswith	nn	3	SENT_195	[p16l762t557r901b578],
3	Kap	NNP	MISC	Kap	nsubj	4	SENT_195	[p16l931t557r1074b584],
4	|	VBD	O	|	_	0	SENT_195	[p16l931t557r1074b584],
5	an	DT	O	a	dobj	4	SENT_195	[p16l931t557r1074b584],
6	.	.	O	.	_	0	SENT_195	[p16l931t557r1074b584],

1	—	NN	O	—	_	0	SENT_196	[p16l931t557r1074b584],
2	.	.	O	.	_	0	SENT_196	[p16l931t557r1074b584],

1	Meier	NNP	O	Meier	_	0	SENT_197	[p16l931t557r1074b584],
2	Numberof	NNP	O	Numberof	nn	4	SENT_197	[p16l1132t557r1248b578],
3	Patients	NNPS	O	Patients	nn	4	SENT_197	[p16l1273t559r1359b578],
4	Kaplan	NNP	PERSON	Kaplan	dep	1	SENT_197	[p16l1435t557r1578b584],
5	.	.	O	.	_	0	SENT_197	[p16l1435t557r1578b584],

1	—	NN	O	—	_	0	SENT_198	[p16l1435t557r1578b584],
2	.	.	O	.	_	0	SENT_198	[p16l1435t557r1578b584],

1	Meier	JJR	PERSON	meier	amod	2	SENT_199	[p16l1435t557r1578b584],
2	patients	NNS	O	patient	_	0	SENT_199	[p16l616t593r704b618],
3	events	NNS	O	event	dep	2	SENT_199	[p16l760t595r831b612],
4	event	NN	O	event	nn	6	SENT_199	[p16l930t595r990b612],
5	rate	NN	O	rate	nn	6	SENT_199	[p16l998t595r1038b612],
6	patients	NNS	O	patient	dep	3	SENT_199	[p16l1130t593r1218b618],
7	withevents	NNS	O	withevent	nn	9	SENT_199	[p16l1272t591r1397b612],
8	event	NN	O	event	nn	9	SENT_199	[p16l1434t595r1494b612],
9	rate	NN	O	rate	dep	2	SENT_199	[p16l1502t595r1542b612],

1	Cardiovascular	NNP	O	Cardiovascular	dep	515	SENT_200	[p16l42t646r209b667],
2	death	NN	O	death	dep	515	SENT_200	[p16l214t646r286b671],
3	,	,	O	,	_	0	SENT_200	[p16l214t646r286b671],
4	myocardial	JJ	O	myocardial	dep	515	SENT_200	[p16l294t646r419b673],
5	infarction	NN	O	infarction	dep	515	SENT_200	[p16l427t646r544b671],
6	,	,	O	,	_	0	SENT_200	[p16l427t646r544b671],
7	and	CC	O	and	dep	515	SENT_200	[p16l551t646r594b667],
8	stroke	NN	O	stroke	dep	515	SENT_200	[p16l600t646r671b667],
9	LOW	RB	O	low	dep	515	SENT_200	[p16l43t694r87b713],
10	expression	NN	O	expression	dep	515	SENT_200	[p16l93t694r207b719],
11	1349	CD	DATE	1349	dep	515	SENT_200	[p16l617t695r671b716],
12	122	CD	NUMBER	122	dep	515	SENT_200	[p16l766t695r803b713],
13	(	NN	O	(	dep	515	SENT_200	[p16l812t693r882b718],
14	90	CD	PERCENT	90	dep	515	SENT_200	[p16l812t693r882b718],
15	%	NN	PERCENT	%	dep	515	SENT_200	[p16l812t693r882b718],
16	)	CD	PERCENT	)	dep	515	SENT_200	[p16l812t693r882b718],
17	9-5	CD	PERCENT	9-5	dep	515	SENT_200	[p16l944t695r996b716],
18	%	NN	PERCENT	%	dep	515	SENT_200	[p16l944t695r996b716],
19	1386	CD	DATE	1386	dep	515	SENT_200	[p16l1131t692r1186b716],
20	137	CD	PERCENT	137	dep	515	SENT_200	[p16l1278t695r1316b716],
21	99	CD	PERCENT	99	dep	515	SENT_200	[p16l1332t693r1395b718],
22	%	NN	PERCENT	%	dep	515	SENT_200	[p16l1332t693r1395b718],
23	)	CD	PERCENT	)	dep	515	SENT_200	[p16l1332t693r1395b718],
24	10-5	CD	PERCENT	10-5	dep	515	SENT_200	[p16l1434t695r1499b716],
25	%	NN	PERCENT	%	dep	515	SENT_200	[p16l1434t695r1499b716],
26	0-90	CD	NUMBER	0-90	dep	515	SENT_200	[p16l1605t695r1654b716],
27	(	CD	NUMBER	(	dep	515	SENT_200	[p16l1662t693r1782b718],
28	0-70-1-15	CD	NUMBER	0-70-1-15	dep	515	SENT_200	[p16l1662t693r1782b718],
29	)	NN	O	)	dep	515	SENT_200	[p16l1662t693r1782b718],
30	0-40	CD	NUMBER	0-40	dep	515	SENT_200	[p16l1836t695r1884b716],
31	0-39	CD	NUMBER	0-39	dep	515	SENT_200	[p16l1967t695r2014b716],
32	Intermediate	NNP	O	Intermediate	dep	515	SENT_200	[p16l43t742r182b763],
33	expression	NN	O	expression	dep	515	SENT_200	[p16l189t744r302b769],
34	2570	CD	DATE	2570	dep	515	SENT_200	[p16l619t745r672b766],
35	208	CD	NUMBER	208	dep	515	SENT_200	[p16l762t742r803b763],
36	(	NN	O	(	dep	515	SENT_200	[p16l812t742r880b768],
37	8-1	CD	PERCENT	8-1	dep	515	SENT_200	[p16l812t742r880b768],
38	%	NN	PERCENT	%	dep	515	SENT_200	[p16l812t742r880b768],
39	)	CD	PERCENT	)	dep	515	SENT_200	[p16l812t742r880b768],
40	8-5	CD	PERCENT	8-5	dep	515	SENT_200	[p16l944t742r996b766],
41	%	NN	PERCENT	%	dep	515	SENT_200	[p16l944t742r996b766],
42	2518	CD	DATE	2518	dep	515	SENT_200	[p16l1132t742r1186b766],
43	233	CD	NUMBER	233	dep	515	SENT_200	[p16l1277t745r1315b766],
44	(	NN	O	(	dep	515	SENT_200	[p16l1323t743r1393b768],
45	9-3	CD	PERCENT	9-3	dep	515	SENT_200	[p16l1323t743r1393b768],
46	%	NN	PERCENT	%	dep	515	SENT_200	[p16l1323t743r1393b768],
47	)	CD	PERCENT	)	dep	515	SENT_200	[p16l1323t743r1393b768],
48	9-8	CD	PERCENT	9-8	dep	515	SENT_200	[p16l1444t742r1498b766],
49	%	NN	PERCENT	%	dep	515	SENT_200	[p16l1444t742r1498b766],
50	0-86	CD	NUMBER	0-86	dep	515	SENT_200	[p16l1605t742r1655b763],
51	(	CD	NUMBER	(	dep	515	SENT_200	[p16l1663t743r1782b768],
52	0-71-1-03	CD	NUMBER	0-71-1-03	dep	515	SENT_200	[p16l1663t743r1782b768],
53	)	NN	O	)	dep	515	SENT_200	[p16l1663t743r1782b768],
54	0-11	CD	NUMBER	0-11	dep	515	SENT_200	[p16l1836t745r1880b763],
55	High	JJ	O	high	dep	515	SENT_200	[p16l43t788r92b815],
56	e	SYM	O	e	dep	515	SENT_200	[p16l100t789r213b815],
57	>	JJR	O	>	dep	515	SENT_200	[p16l100t789r213b815],
58	q3ression	NN	O	q3ression	dep	515	SENT_200	[p16l100t789r213b815],
59	1167	CD	DATE	1167	dep	515	SENT_200	[p16l619t787r672b811],
60	98	CD	NUMBER	98	dep	515	SENT_200	[p16l776t787r803b811],
61	(	NN	O	(	dep	515	SENT_200	[p16l812t787r883b814],
62	8-4	CD	PERCENT	8-4	dep	515	SENT_200	[p16l812t787r883b814],
63	%	NN	PERCENT	%	dep	515	SENT_200	[p16l812t787r883b814],
64	)	CD	PERCENT	)	dep	515	SENT_200	[p16l812t787r883b814],
65	8-8	CD	PERCENT	8-8	dep	515	SENT_200	[p16l944t787r998b808],
66	%	NN	PERCENT	%	dep	515	SENT_200	[p16l944t787r998b808],
67	1195	CD	DATE	1195	dep	515	SENT_200	[p16l1133t790r1186b811],
68	138	CD	PERCENT	138	dep	515	SENT_200	[p16l1276t787r1315b811],
69	11-5	CD	PERCENT	11-5	dep	515	SENT_200	[p16l1332t789r1403b814],
70	%	NN	PERCENT	%	dep	515	SENT_200	[p16l1332t789r1403b814],
71	)	CD	PERCENT	)	dep	515	SENT_200	[p16l1332t789r1403b814],
72	11-9	CD	PERCENT	11-9	dep	515	SENT_200	[p16l1434t790r1499b811],
73	%	NN	PERCENT	%	dep	515	SENT_200	[p16l1434t790r1499b811],
74	0-71	CD	NUMBER	0-71	dep	515	SENT_200	[p16l1605t789r1782b814],
75	(	CD	NUMBER	(	dep	515	SENT_200	[p16l1605t789r1782b814],
76	0-55-0-92	CD	NUMBER	0-55-0-92	dep	515	SENT_200	[p16l1605t789r1782b814],
77	)	NN	O	)	dep	515	SENT_200	[p16l1605t789r1782b814],
78	0-0104	CD	NUMBER	0-0104	dep	515	SENT_200	[p16l1836t790r1912b811],
79	Cardiovascular	NNP	O	Cardiovascular	dep	515	SENT_200	[p16l42t833r209b854],
80	death	NN	O	death	dep	515	SENT_200	[p16l214t833r279b854],
81	and	CC	O	and	dep	515	SENT_200	[p16l286t833r329b854],
82	myocardial	JJ	O	myocardial	dep	515	SENT_200	[p16l336t833r460b860],
83	infarction	NN	O	infarction	dep	515	SENT_200	[p16l468t833r579b854],
84	Low	JJ	PERSON	low	dep	515	SENT_200	[p16l43t881r87b900],
85	expression	NN	O	expression	dep	515	SENT_200	[p16l93t881r207b906],
86	1349	CD	DATE	1349	dep	515	SENT_200	[p16l617t882r671b903],
87	110	CD	NUMBER	110	dep	515	SENT_200	[p16l766t882r804b900],
88	(	NN	O	(	dep	515	SENT_200	[p16l812t879r881b905],
89	8-2	CD	PERCENT	8-2	dep	515	SENT_200	[p16l812t879r881b905],
90	%	NN	PERCENT	%	dep	515	SENT_200	[p16l812t879r881b905],
91	)	CD	PERCENT	)	dep	515	SENT_200	[p16l812t879r881b905],
92	8-5	CD	PERCENT	8-5	dep	515	SENT_200	[p16l944t879r996b903],
93	%	NN	PERCENT	%	dep	515	SENT_200	[p16l944t879r996b903],
94	1386	CD	DATE	1386	dep	515	SENT_200	[p16l1131t879r1186b903],
95	124	CD	PERCENT	124	dep	515	SENT_200	[p16l1276t882r1316b903],
96	8-9	CD	PERCENT	8-9	dep	515	SENT_200	[p16l1332t879r1395b905],
97	%	NN	PERCENT	%	dep	515	SENT_200	[p16l1332t879r1395b905],
98	)	CD	PERCENT	)	dep	515	SENT_200	[p16l1332t879r1395b905],
99	9-5	CD	PERCENT	9-5	dep	515	SENT_200	[p16l1444t882r1496b903],
100	%	NN	PERCENT	%	dep	515	SENT_200	[p16l1444t882r1496b903],
101	089	CD	NUMBER	089	dep	515	SENT_200	[p16l1605t879r1654b903],
102	(	NN	O	(	dep	515	SENT_200	[p16l1663t879r1787b905],
103	069-116	CD	NUMBER	069-116	dep	515	SENT_200	[p16l1663t879r1787b905],
104	)	CD	NUMBER	)	dep	515	SENT_200	[p16l1663t879r1787b905],
105	0-40	CD	NUMBER	0-40	dep	515	SENT_200	[p16l1836t882r1884b903],
106	0-46	CD	NUMBER	0-46	dep	515	SENT_200	[p16l1967t879r2015b903],
107	Intermediate	NNP	O	Intermediate	dep	515	SENT_200	[p16l43t925r182b946],
108	expression	NN	O	expression	dep	515	SENT_200	[p16l189t926r302b952],
109	2570	CD	DATE	2570	dep	515	SENT_200	[p16l619t927r672b948],
110	188	CD	NUMBER	188	dep	515	SENT_200	[p16l762t924r803b946],
111	(	NN	O	(	dep	515	SENT_200	[p16l812t926r879b951],
112	7-3	CD	PERCENT	7-3	dep	515	SENT_200	[p16l812t926r879b951],
113	%	NN	PERCENT	%	dep	515	SENT_200	[p16l812t926r879b951],
114	)	CD	PERCENT	)	dep	515	SENT_200	[p16l812t926r879b951],
115	7-7	CD	PERCENT	7-7	dep	515	SENT_200	[p16l945t928r996b948],
116	%	NN	PERCENT	%	dep	515	SENT_200	[p16l945t928r996b948],
117	2518	CD	DATE	2518	dep	515	SENT_200	[p16l1132t924r1186b948],
118	218	CD	PERCENT	218	dep	515	SENT_200	[p16l1276t924r1315b946],
119	8-7	CD	PERCENT	8-7	dep	515	SENT_200	[p16l1332t924r1392b951],
120	%	NN	PERCENT	%	dep	515	SENT_200	[p16l1332t924r1392b951],
121	)	CD	PERCENT	)	dep	515	SENT_200	[p16l1332t924r1392b951],
122	9-2	CD	PERCENT	9-2	dep	515	SENT_200	[p16l1444t927r1496b948],
123	%	NN	PERCENT	%	dep	515	SENT_200	[p16l1444t927r1496b948],
124	0-83	CD	NUMBER	0-83	dep	515	SENT_200	[p16l1605t924r1653b948],
125	(	CD	NUMBER	(	dep	515	SENT_200	[p16l1661t924r1785b951],
126	0-68-1-01	CD	NUMBER	0-68-1-01	dep	515	SENT_200	[p16l1661t924r1785b951],
127	)	NN	O	)	dep	515	SENT_200	[p16l1661t924r1785b951],
128	0-0571	CD	NUMBER	0-0571	dep	515	SENT_200	[p16l1836t927r1909b948],
129	High	JJ	O	high	dep	515	SENT_200	[p16l43t970r92b998],
130	expression	NN	O	expression	dep	515	SENT_200	[p16l100t972r213b997],
131	1167	CD	DATE	1167	dep	515	SENT_200	[p16l619t970r672b994],
132	91	CD	NUMBER	91	dep	515	SENT_200	[p16l778t973r804b994],
133	(	NN	O	(	dep	515	SENT_200	[p16l812t970r881b997],
134	7-8	CD	PERCENT	7-8	dep	515	SENT_200	[p16l812t970r881b997],
135	%	NN	PERCENT	%	dep	515	SENT_200	[p16l812t970r881b997],
136	)	CD	PERCENT	)	dep	515	SENT_200	[p16l812t970r881b997],
137	8-2	CD	PERCENT	8-2	dep	515	SENT_200	[p16l944t970r996b991],
138	%	NN	PERCENT	%	dep	515	SENT_200	[p16l944t970r996b991],
139	1195	CD	DATE	1195	dep	515	SENT_200	[p16l1133t973r1186b994],
140	128	CD	PERCENT	128	dep	515	SENT_200	[p16l1276t970r1315b991],
141	10-7	CD	PERCENT	10-7	dep	515	SENT_200	[p16l1332t972r1405b997],
142	%	NN	PERCENT	%	dep	515	SENT_200	[p16l1332t972r1405b997],
143	)	CD	PERCENT	)	dep	515	SENT_200	[p16l1332t972r1405b997],
144	11-1	CD	PERCENT	11-1	dep	515	SENT_200	[p16l1434t973r1496b991],
145	%	NN	PERCENT	%	dep	515	SENT_200	[p16l1434t973r1496b991],
146	0-71	CD	NUMBER	0-71	dep	515	SENT_200	[p16l1605t973r1650b994],
147	(	CD	NUMBER	(	dep	515	SENT_200	[p16l1658t972r1783b997],
148	0-54-0-93	CD	NUMBER	0-54-0-93	dep	515	SENT_200	[p16l1658t972r1783b997],
149	)	NN	O	)	dep	515	SENT_200	[p16l1658t972r1783b997],
150	O-0128	NN	O	o-0128	dep	515	SENT_200	[p16l1836t970r1910b991],
151	Deﬁnite	NN	O	deﬁnite	dep	515	SENT_200	[p16l43t1016r133b1037],
152	stent	NN	O	stent	dep	515	SENT_200	[p16l139t1020r199b1037],
153	tl1rombosis	NN	O	tl1rombosis	dep	515	SENT_200	[p16l203t1016r348b1038],
154	'	''	O	'	_	0	SENT_200	[p16l203t1016r348b1038],
155	I	PRP	O	I	dep	515	SENT_200	[p16l203t1016r348b1038],
156	'	''	O	'	_	0	SENT_200	[p16l203t1016r348b1038],
157	Low	JJ	O	low	dep	515	SENT_200	[p16l43t1064r87b1083],
158	expression	NN	O	expression	dep	515	SENT_200	[p16l93t1064r207b1089],
159	905	CD	NUMBER	905	dep	515	SENT_200	[p16l630t1065r671b1086],
160	9	CD	NUMBER	9	dep	515	SENT_200	[p16l791t1065r803b1086],
161	(	NN	O	(	dep	515	SENT_200	[p16l812t1063r880b1088],
162	1-0	CD	PERCENT	1-0	dep	515	SENT_200	[p16l812t1063r880b1088],
163	%	NN	PERCENT	%	dep	515	SENT_200	[p16l812t1063r880b1088],
164	)	CD	PERCENT	)	dep	515	SENT_200	[p16l812t1063r880b1088],
165	1-1	CD	PERCENT	1-1	dep	515	SENT_200	[p16l946t1065r996b1083],
166	%	NN	PERCENT	%	dep	515	SENT_200	[p16l946t1065r996b1083],
167	917	CD	PERCENT	917	dep	515	SENT_200	[p16l1147t1065r1187b1086],
168	14	CD	PERCENT	14	dep	515	SENT_200	[p16l1290t1065r1317b1085],
169	1-5	CD	PERCENT	1-5	dep	515	SENT_200	[p16l1332t1063r1390b1088],
170	%	NN	PERCENT	%	dep	515	SENT_200	[p16l1332t1063r1390b1088],
171	)	CD	PERCENT	)	dep	515	SENT_200	[p16l1332t1063r1390b1088],
172	1-5	CD	PERCENT	1-5	dep	515	SENT_200	[p16l1446t1065r1496b1086],
173	%	NN	PERCENT	%	dep	515	SENT_200	[p16l1446t1065r1496b1086],
174	0-65	CD	NUMBER	0-65	dep	515	SENT_200	[p16l1605t1062r1653b1086],
175	(	CD	NUMBER	(	dep	515	SENT_200	[p16l1661t1062r1784b1088],
176	0-28-1-50	CD	NUMBER	0-28-1-50	dep	515	SENT_200	[p16l1661t1062r1784b1088],
177	)	NN	O	)	dep	515	SENT_200	[p16l1661t1062r1784b1088],
178	0-31	CD	NUMBER	0-31	dep	515	SENT_200	[p16l1836t1065r1881b1086],
179	1	CD	NUMBER	1	dep	515	SENT_200	[p16l1967t1063r1977b1084],
180	:	:	O	:	_	0	SENT_200	[p16l1967t1063r1977b1084],
181	Intermediate	NNP	O	Intermediate	dep	515	SENT_200	[p16l43t1107r182b1128],
182	e	SYM	O	e	dep	515	SENT_200	[p16l189t1109r302b1135],
183	>	JJR	O	>	dep	515	SENT_200	[p16l189t1109r302b1135],
184	q3ression	NN	O	q3ression	dep	515	SENT_200	[p16l189t1109r302b1135],
185	1711	CD	DATE	1711	dep	515	SENT_200	[p16l622t1110r672b1131],
186	23	CD	NUMBER	23	dep	515	SENT_200	[p16l779t1110r803b1131],
187	(	NN	O	(	dep	515	SENT_200	[p16l812t1109r879b1134],
188	1-3	CD	PERCENT	1-3	dep	515	SENT_200	[p16l812t1109r879b1134],
189	%	NN	PERCENT	%	dep	515	SENT_200	[p16l812t1109r879b1134],
190	)	CD	PERCENT	)	dep	515	SENT_200	[p16l812t1109r879b1134],
191	1-4	CD	PERCENT	1-4	dep	515	SENT_200	[p16l946t1110r998b1131],
192	%	NN	PERCENT	%	dep	515	SENT_200	[p16l946t1110r998b1131],
193	1653	CD	PERCENT	1653	dep	515	SENT_200	[p16l1132t1107r1186b1131],
194	28	CD	PERCENT	28	dep	515	SENT_200	[p16l1289t1107r1315b1128],
195	1-7	CD	PERCENT	1-7	dep	515	SENT_200	[p16l1332t1109r1390b1134],
196	%	NN	PERCENT	%	dep	515	SENT_200	[p16l1332t1109r1390b1134],
197	)	CD	PERCENT	)	dep	515	SENT_200	[p16l1332t1109r1390b1134],
198	1-6	CD	PERCENT	1-6	dep	515	SENT_200	[p16l1446t1107r1498b1128],
199	%	NN	PERCENT	%	dep	515	SENT_200	[p16l1446t1107r1498b1128],
200	0-80	CD	NUMBER	0-80	dep	515	SENT_200	[p16l1605t1107r1654b1128],
201	(	CD	NUMBER	(	dep	515	SENT_200	[p16l1662t1107r1787b1134],
202	0-46-1-38	CD	NUMBER	0-46-1-38	dep	515	SENT_200	[p16l1662t1107r1787b1134],
203	)	NN	O	)	dep	515	SENT_200	[p16l1662t1107r1787b1134],
204	0-42	CD	NUMBER	0-42	dep	515	SENT_200	[p16l1836t1110r1883b1131],
205	High	JJ	O	high	dep	515	SENT_200	[p16l43t1153r92b1181],
206	expression	NN	O	expression	dep	515	SENT_200	[p16l100t1155r213b1180],
207	756	CD	NUMBER	756	dep	515	SENT_200	[p16l631t1153r671b1177],
208	6	CD	NUMBER	6	dep	515	SENT_200	[p16l791t1153r804b1174],
209	(	NN	O	(	dep	515	SENT_200	[p16l812t1153r882b1179],
210	0-8	CD	PERCENT	0-8	dep	515	SENT_200	[p16l812t1153r882b1179],
211	%	NN	PERCENT	%	dep	515	SENT_200	[p16l812t1153r882b1179],
212	)	CD	PERCENT	)	dep	515	SENT_200	[p16l812t1153r882b1179],
213	0-8	CD	PERCENT	0-8	dep	515	SENT_200	[p16l945t1153r998b1174],
214	%	NN	PERCENT	%	dep	515	SENT_200	[p16l945t1153r998b1174],
215	793	CD	NUMBER	793	dep	515	SENT_200	[p16l1145t1156r1186b1177],
216	17	CD	NUMBER	17	dep	515	SENT_200	[p16l1292t1156r1316b1177],
217	(	NN	O	(	dep	515	SENT_200	[p16l1324t1154r1390b1179],
218	2-1	CD	PERCENT	2-1	dep	515	SENT_200	[p16l1324t1154r1390b1179],
219	%	NN	PERCENT	%	dep	515	SENT_200	[p16l1324t1154r1390b1179],
220	)	CD	PERCENT	)	dep	515	SENT_200	[p16l1324t1154r1390b1179],
221	2-2	CD	PERCENT	2-2	dep	515	SENT_200	[p16l1446t1156r1496b1174],
222	%	NN	PERCENT	%	dep	515	SENT_200	[p16l1446t1156r1496b1174],
223	037	CD	NUMBER	037	dep	515	SENT_200	[p16l1605t1156r1652b1177],
224	(	NN	O	(	dep	515	SENT_200	[p16l1659t1154r1783b1179],
225	014-093	CD	NUMBER	014-093	dep	515	SENT_200	[p16l1659t1154r1783b1179],
226	)	CD	NUMBER	)	dep	515	SENT_200	[p16l1659t1154r1783b1179],
227	0-0351	CD	NUMBER	0-0351	dep	515	SENT_200	[p16l1836t1156r1910b1177],
228	Major	JJ	O	major	dep	515	SENT_200	[p16l43t1200r109b1226],
229	bleeding	NN	O	bleeding	dep	515	SENT_200	[p16l115t1199r212b1226],
230	Low	JJ	PERSON	low	dep	515	SENT_200	[p16l43t1247r87b1265],
231	expression	NN	O	expression	dep	515	SENT_200	[p16l93t1246r207b1272],
232	1345	CD	DATE	1345	dep	515	SENT_200	[p16l618t1247r671b1268],
233	132	CD	NUMBER	132	dep	515	SENT_200	[p16l766t1247r803b1268],
234	(	NN	O	(	dep	515	SENT_200	[p16l812t1244r883b1271],
235	9-8	CD	PERCENT	9-8	dep	515	SENT_200	[p16l812t1244r883b1271],
236	%	NN	PERCENT	%	dep	515	SENT_200	[p16l812t1244r883b1271],
237	)	CD	PERCENT	)	dep	515	SENT_200	[p16l812t1244r883b1271],
238	10-9	CD	PERCENT	10-9	dep	515	SENT_200	[p16l932t1247r998b1268],
239	%	NN	PERCENT	%	dep	515	SENT_200	[p16l932t1247r998b1268],
240	1382	CD	DATE	1382	dep	515	SENT_200	[p16l1132t1244r1185b1268],
241	137	CD	PERCENT	137	dep	515	SENT_200	[p16l1278t1247r1316b1268],
242	9-9	CD	PERCENT	9-9	dep	515	SENT_200	[p16l1332t1246r1395b1271],
243	%	NN	PERCENT	%	dep	515	SENT_200	[p16l1332t1246r1395b1271],
244	)	CD	PERCENT	)	dep	515	SENT_200	[p16l1332t1246r1395b1271],
245	10-9	CD	PERCENT	10-9	dep	515	SENT_200	[p16l1434t1247r1500b1268],
246	%	NN	PERCENT	%	dep	515	SENT_200	[p16l1434t1247r1500b1268],
247	0-97	CD	NUMBER	0-97	dep	515	SENT_200	[p16l1605t1247r1653b1268],
248	(	CD	NUMBER	(	dep	515	SENT_200	[p16l1660t1244r1782b1271],
249	0-76-1-23	CD	NUMBER	0-76-1-23	dep	515	SENT_200	[p16l1660t1244r1782b1271],
250	)	NN	O	)	dep	515	SENT_200	[p16l1660t1244r1782b1271],
251	0-77	CD	NUMBER	0-77	dep	515	SENT_200	[p16l1836t1247r1881b1268],
252	080	CD	NUMBER	080	dep	515	SENT_200	[p16l1966t1244r2015b1265],
253	Intermediate	NNP	O	Intermediate	dep	515	SENT_200	[p16l43t1290r182b1311],
254	expression	NN	O	expression	dep	515	SENT_200	[p16l189t1292r302b1317],
255	2567	CD	DATE	2567	dep	515	SENT_200	[p16l618t1290r672b1314],
256	240	CD	NUMBER	240	dep	515	SENT_200	[p16l763t1293r804b1314],
257	(	NN	O	(	dep	515	SENT_200	[p16l812t1292r881b1317],
258	9-3	CD	PERCENT	9-3	dep	515	SENT_200	[p16l812t1292r881b1317],
259	%	NN	PERCENT	%	dep	515	SENT_200	[p16l812t1292r881b1317],
260	)	CD	PERCENT	)	dep	515	SENT_200	[p16l812t1292r881b1317],
261	10-3	CD	PERCENT	10-3	dep	515	SENT_200	[p16l932t1293r996b1314],
262	%	NN	PERCENT	%	dep	515	SENT_200	[p16l932t1293r996b1314],
263	2508	CD	DATE	2508	dep	515	SENT_200	[p16l1131t1290r1186b1314],
264	245	CD	PERCENT	245	dep	515	SENT_200	[p16l1275t1293r1315b1314],
265	9-8	CD	PERCENT	9-8	dep	515	SENT_200	[p16l1332t1290r1395b1317],
266	%	NN	PERCENT	%	dep	515	SENT_200	[p16l1332t1290r1395b1317],
267	)	CD	PERCENT	)	dep	515	SENT_200	[p16l1332t1290r1395b1317],
268	10-6	CD	PERCENT	10-6	dep	515	SENT_200	[p16l1434t1290r1501b1311],
269	%	NN	PERCENT	%	dep	515	SENT_200	[p16l1434t1290r1501b1311],
270	0-96	CD	NUMBER	0-96	dep	515	SENT_200	[p16l1605t1290r1655b1314],
271	(	CD	NUMBER	(	dep	515	SENT_200	[p16l1663t1290r1785b1317],
272	0-80-1-15	CD	NUMBER	0-80-1-15	dep	515	SENT_200	[p16l1663t1290r1785b1317],
273	)	NN	O	)	dep	515	SENT_200	[p16l1663t1290r1785b1317],
274	0-66	CD	NUMBER	0-66	dep	515	SENT_200	[p16l1836t1290r1885b1311],
275	High	JJ	O	high	dep	515	SENT_200	[p16l43t1336r92b1363],
276	expression	NN	O	expression	dep	515	SENT_200	[p16l100t1338r213b1363],
277	1164	CD	DATE	1164	dep	515	SENT_200	[p16l617t1336r672b1360],
278	121	CD	NUMBER	121	dep	515	SENT_200	[p16l767t1339r804b1357],
279	(	NN	O	(	dep	515	SENT_200	[p16l812t1337r895b1362],
280	10-4	CD	PERCENT	10-4	dep	515	SENT_200	[p16l812t1337r895b1362],
281	%	NN	PERCENT	%	dep	515	SENT_200	[p16l812t1337r895b1362],
282	)	CD	PERCENT	)	dep	515	SENT_200	[p16l812t1337r895b1362],
283	11-5	CD	PERCENT	11-5	dep	515	SENT_200	[p16l933t1339r996b1360],
284	%	NN	PERCENT	%	dep	515	SENT_200	[p16l933t1339r996b1360],
285	1188	CD	DATE	1188	dep	515	SENT_200	[p16l1132t1336r1186b1357],
286	116	CD	PERCENT	116	dep	515	SENT_200	[p16l1277t1336r1315b1357],
287	9-8	CD	PERCENT	9-8	dep	515	SENT_200	[p16l1332t1336r1395b1362],
288	%	NN	PERCENT	%	dep	515	SENT_200	[p16l1332t1336r1395b1362],
289	)	CD	PERCENT	)	dep	515	SENT_200	[p16l1332t1336r1395b1362],
290	10-8	CD	PERCENT	10-8	dep	515	SENT_200	[p16l1434t1336r1501b1357],
291	%	NN	PERCENT	%	dep	515	SENT_200	[p16l1434t1336r1501b1357],
292	1-06	CD	NUMBER	1-06	dep	515	SENT_200	[p16l1607t1336r1654b1357],
293	(	CD	NUMBER	(	dep	515	SENT_200	[p16l1662t1336r1783b1362],
294	0-83-1-37	CD	NUMBER	0-83-1-37	dep	515	SENT_200	[p16l1662t1336r1783b1362],
295	)	NN	O	)	dep	515	SENT_200	[p16l1662t1336r1783b1362],
296	063	CD	NUMBER	063	dep	515	SENT_200	[p16l1835t1336r1883b1360],
297	Major	JJ	O	major	dep	515	SENT_200	[p16l43t1383r109b1409],
298	bleeding	NN	O	bleeding	dep	515	SENT_200	[p16l115t1382r212b1409],
299	related	JJ	O	related	dep	515	SENT_200	[p16l221t1382r299b1403],
300	to	TO	O	to	dep	515	SENT_200	[p16l304t1385r329b1403],
301	non-CABG	JJ	O	non-cabg	dep	515	SENT_200	[p16l336t1383r453b1403],
302	Low	JJ	O	low	dep	515	SENT_200	[p16l43t1429r87b1448],
303	expression	NN	O	expression	dep	515	SENT_200	[p16l93t1429r207b1455],
304	1345	CD	DATE	1345	dep	515	SENT_200	[p16l618t1430r671b1451],
305	47	CD	NUMBER	47	dep	515	SENT_200	[p16l777t1430r805b1451],
306	(	NN	O	(	dep	515	SENT_200	[p16l812t1429r879b1454],
307	3-5	CD	PERCENT	3-5	dep	515	SENT_200	[p16l812t1429r879b1454],
308	%	NN	PERCENT	%	dep	515	SENT_200	[p16l812t1429r879b1454],
309	)	CD	PERCENT	)	dep	515	SENT_200	[p16l812t1429r879b1454],
310	4-0	JJ	PERCENT	4-0	dep	515	SENT_200	[p16l944t1430r997b1451],
311	%	NN	PERCENT	%	dep	515	SENT_200	[p16l944t1430r997b1451],
312	1382	CD	PERCENT	1382	dep	515	SENT_200	[p16l1132t1427r1185b1451],
313	35	CD	PERCENT	35	dep	515	SENT_200	[p16l1290t1430r1315b1451],
314	2-5	CD	PERCENT	2-5	dep	515	SENT_200	[p16l1332t1429r1391b1454],
315	%	NN	PERCENT	%	dep	515	SENT_200	[p16l1332t1429r1391b1454],
316	)	CD	PERCENT	)	dep	515	SENT_200	[p16l1332t1429r1391b1454],
317	3-0	CD	PERCENT	3-0	dep	515	SENT_200	[p16l1445t1430r1497b1451],
318	%	NN	PERCENT	%	dep	515	SENT_200	[p16l1445t1430r1497b1451],
319	1-39	CD	NUMBER	1-39	dep	515	SENT_200	[p16l1607t1430r1653b1451],
320	(	CD	NUMBER	(	dep	515	SENT_200	[p16l1661t1429r1784b1454],
321	0-90-2-15	CD	NUMBER	0-90-2-15	dep	515	SENT_200	[p16l1661t1429r1784b1454],
322	)	NN	O	)	dep	515	SENT_200	[p16l1661t1429r1784b1454],
323	0-14	CD	NUMBER	0-14	dep	515	SENT_200	[p16l1835t1430r1883b1451],
324	0-64	CD	NUMBER	0-64	dep	515	SENT_200	[p16l1966t1427r2017b1451],
325	Intermediate	NNP	O	Intermediate	dep	515	SENT_200	[p16l43t1473r182b1494],
326	expression	NN	O	expression	dep	515	SENT_200	[p16l189t1475r302b1500],
327	2567	CD	DATE	2567	dep	515	SENT_200	[p16l618t1473r672b1497],
328	91	CD	NUMBER	91	dep	515	SENT_200	[p16l778t1476r804b1497],
329	(	NN	O	(	dep	515	SENT_200	[p16l812t1474r879b1499],
330	3-5	CD	PERCENT	3-5	dep	515	SENT_200	[p16l812t1474r879b1499],
331	%	NN	PERCENT	%	dep	515	SENT_200	[p16l812t1474r879b1499],
332	)	CD	PERCENT	)	dep	515	SENT_200	[p16l812t1474r879b1499],
333	4-0	JJ	PERCENT	4-0	dep	515	SENT_200	[p16l944t1476r997b1497],
334	%	NN	PERCENT	%	dep	515	SENT_200	[p16l944t1476r997b1497],
335	2508	CD	PERCENT	2508	dep	515	SENT_200	[p16l1131t1473r1186b1497],
336	80	CD	PERCENT	80	dep	515	SENT_200	[p16l1288t1473r1316b1494],
337	3-2	CD	PERCENT	3-2	dep	515	SENT_200	[p16l1331t1474r1391b1499],
338	%	NN	PERCENT	%	dep	515	SENT_200	[p16l1331t1474r1391b1499],
339	)	CD	PERCENT	)	dep	515	SENT_200	[p16l1331t1474r1391b1499],
340	3-5	CD	PERCENT	3-5	dep	515	SENT_200	[p16l1445t1476r1496b1497],
341	%	NN	PERCENT	%	dep	515	SENT_200	[p16l1445t1476r1496b1497],
342	1-10	CD	NUMBER	1-10	dep	515	SENT_200	[p16l1607t1476r1652b1494],
343	(	CD	NUMBER	(	dep	515	SENT_200	[p16l1660t1473r1783b1499],
344	0-81-1-49	CD	NUMBER	0-81-1-49	dep	515	SENT_200	[p16l1660t1473r1783b1499],
345	)	NN	O	)	dep	515	SENT_200	[p16l1660t1473r1783b1499],
346	0-53	CD	NUMBER	0-53	dep	515	SENT_200	[p16l1836t1476r1881b1497],
347	High	JJ	O	high	dep	515	SENT_200	[p16l43t1519r92b1546],
348	expression	NN	O	expression	dep	515	SENT_200	[p16l100t1521r213b1546],
349	1164	CD	DATE	1164	dep	515	SENT_200	[p16l618t1519r672b1543],
350	39	CD	NUMBER	39	dep	515	SENT_200	[p16l776t1522r803b1543],
351	(	NN	O	(	dep	515	SENT_200	[p16l812t1520r881b1545],
352	3-4	CD	PERCENT	3-4	dep	515	SENT_200	[p16l812t1520r881b1545],
353	%	NN	PERCENT	%	dep	515	SENT_200	[p16l812t1520r881b1545],
354	)	CD	PERCENT	)	dep	515	SENT_200	[p16l812t1520r881b1545],
355	3-7	CD	PERCENT	3-7	dep	515	SENT_200	[p16l945t1522r996b1543],
356	%	NN	PERCENT	%	dep	515	SENT_200	[p16l945t1522r996b1543],
357	1188	CD	PERCENT	1188	dep	515	SENT_200	[p16l1132t1519r1186b1540],
358	37	CD	PERCENT	37	dep	515	SENT_200	[p16l1291t1522r1316b1543],
359	3-1	CD	PERCENT	3-1	dep	515	SENT_200	[p16l1331t1520r1390b1545],
360	%	NN	PERCENT	%	dep	515	SENT_200	[p16l1331t1520r1390b1545],
361	)	CD	PERCENT	)	dep	515	SENT_200	[p16l1331t1520r1390b1545],
362	3-5	CD	PERCENT	3-5	dep	515	SENT_200	[p16l1445t1522r1496b1543],
363	%	NN	PERCENT	%	dep	515	SENT_200	[p16l1445t1522r1496b1543],
364	1-07	CD	NUMBER	1-07	dep	515	SENT_200	[p16l1607t1522r1652b1542],
365	(	CD	NUMBER	(	dep	515	SENT_200	[p16l1660t1519r1787b1545],
366	O-68-1-68	NN	O	o-68-1-68	dep	515	SENT_200	[p16l1660t1519r1787b1545],
367	)	CD	NUMBER	)	dep	515	SENT_200	[p16l1660t1519r1787b1545],
368	0-77	CD	NUMBER	0-77	dep	515	SENT_200	[p16l1836t1522r1881b1542],
369	Major	JJ	O	major	dep	515	SENT_200	[p16l43t1566r109b1592],
370	bleeding	NN	O	bleeding	dep	515	SENT_200	[p16l115t1565r212b1592],
371	related	VBN	O	relate	dep	515	SENT_200	[p16l221t1565r299b1585],
372	to	TO	O	to	dep	515	SENT_200	[p16l304t1568r329b1585],
373	CABG	NNP	MISC	CABG	dep	515	SENT_200	[p16l335t1566r397b1585],
374	Low	NNP	MISC	Low	dep	515	SENT_200	[p16l43t1612r87b1631],
375	expression	NN	O	expression	dep	515	SENT_200	[p16l93t1612r207b1637],
376	1345	CD	PERCENT	1345	dep	515	SENT_200	[p16l618t1613r671b1634],
377	88	CD	PERCENT	88	dep	515	SENT_200	[p16l776t1610r803b1631],
378	(	NN	PERCENT	(	dep	515	SENT_200	[p16l812t1610r881b1636],
379	6-5	CD	PERCENT	6-5	dep	515	SENT_200	[p16l812t1610r881b1636],
380	%	NN	PERCENT	%	dep	515	SENT_200	[p16l812t1610r881b1636],
381	)	CD	PERCENT	)	dep	515	SENT_200	[p16l812t1610r881b1636],
382	7-2	CD	PERCENT	7-2	dep	515	SENT_200	[p16l945t1613r996b1634],
383	%	NN	PERCENT	%	dep	515	SENT_200	[p16l945t1613r996b1634],
384	1382	CD	DATE	1382	dep	515	SENT_200	[p16l1132t1610r1185b1634],
385	105	CD	PERCENT	105	dep	515	SENT_200	[p16l1276t1613r1315b1634],
386	7-6	CD	PERCENT	7-6	dep	515	SENT_200	[p16l1331t1610r1392b1636],
387	%	NN	PERCENT	%	dep	515	SENT_200	[p16l1331t1610r1392b1636],
388	)	CD	PERCENT	)	dep	515	SENT_200	[p16l1331t1610r1392b1636],
389	8-2	CD	PERCENT	8-2	dep	515	SENT_200	[p16l1444t1610r1496b1631],
390	%	NN	PERCENT	%	dep	515	SENT_200	[p16l1444t1610r1496b1631],
391	0-83	CD	NUMBER	0-83	dep	515	SENT_200	[p16l1605t1610r1653b1634],
392	(	CD	NUMBER	(	dep	515	SENT_200	[p16l1661t1610r1783b1637],
393	O-63-1-10	NN	O	o-63-1-10	dep	515	SENT_200	[p16l1661t1610r1783b1637],
394	)	CD	NUMBER	)	dep	515	SENT_200	[p16l1661t1610r1783b1637],
395	0-20	CD	NUMBER	0-20	dep	515	SENT_200	[p16l1836t1613r1883b1631],
396	0-56	CD	NUMBER	0-56	dep	515	SENT_200	[p16l1967t1610r2014b1634],
397	Intermediate	NNP	O	Intermediate	dep	515	SENT_200	[p16l43t1656r182b1677],
398	expression	NN	O	expression	dep	515	SENT_200	[p16l189t1658r302b1683],
399	2567	CD	DATE	2567	dep	515	SENT_200	[p16l618t1656r672b1680],
400	155	CD	NUMBER	155	dep	515	SENT_200	[p16l766t1659r804b1680],
401	(	NN	O	(	dep	515	SENT_200	[p16l812t1656r882b1682],
402	60	CD	PERCENT	60	dep	515	SENT_200	[p16l812t1656r882b1682],
403	%	NN	PERCENT	%	dep	515	SENT_200	[p16l812t1656r882b1682],
404	)	CD	PERCENT	)	dep	515	SENT_200	[p16l812t1656r882b1682],
405	66	CD	PERCENT	66	dep	515	SENT_200	[p16l944t1656r998b1677],
406	%	NN	PERCENT	%	dep	515	SENT_200	[p16l944t1656r998b1677],
407	2508	CD	DATE	2508	dep	515	SENT_200	[p16l1131t1656r1186b1680],
408	178	CD	PERCENT	178	dep	515	SENT_200	[p16l1276t1656r1315b1680],
409	7-1	CD	PERCENT	7-1	dep	515	SENT_200	[p16l1331t1657r1390b1682],
410	%	NN	PERCENT	%	dep	515	SENT_200	[p16l1331t1657r1390b1682],
411	)	CD	PERCENT	)	dep	515	SENT_200	[p16l1331t1657r1390b1682],
412	7-8	CD	PERCENT	7-8	dep	515	SENT_200	[p16l1445t1656r1498b1679],
413	%	NN	PERCENT	%	dep	515	SENT_200	[p16l1445t1656r1498b1679],
414	0-85	CD	NUMBER	0-85	dep	515	SENT_200	[p16l1605t1656r1653b1680],
415	(	CD	NUMBER	(	dep	515	SENT_200	[p16l1661t1656r1787b1682],
416	0-69-1-06	CD	NUMBER	0-69-1-06	dep	515	SENT_200	[p16l1661t1656r1787b1682],
417	)	NN	O	)	dep	515	SENT_200	[p16l1661t1656r1787b1682],
418	0-15	CD	NUMBER	0-15	dep	515	SENT_200	[p16l1836t1659r1881b1680],
419	High	JJ	O	high	dep	515	SENT_200	[p16l43t1702r92b1729],
420	expression	NN	O	expression	dep	515	SENT_200	[p16l100t1703r213b1729],
421	1164	CD	DATE	1164	dep	515	SENT_200	[p16l617t1702r672b1725],
422	83	CD	NUMBER	83	dep	515	SENT_200	[p16l777t1702r803b1726],
423	(	NN	O	(	dep	515	SENT_200	[p16l812t1703r878b1728],
424	7-1	CD	PERCENT	7-1	dep	515	SENT_200	[p16l812t1703r878b1728],
425	%	NN	PERCENT	%	dep	515	SENT_200	[p16l812t1703r878b1728],
426	)	CD	PERCENT	)	dep	515	SENT_200	[p16l812t1703r878b1728],
427	7-9	CD	PERCENT	7-9	dep	515	SENT_200	[p16l945t1705r998b1726],
428	%	NN	PERCENT	%	dep	515	SENT_200	[p16l945t1705r998b1726],
429	1188	CD	DATE	1188	dep	515	SENT_200	[p16l1132t1702r1186b1723],
430	83	CD	NUMBER	83	dep	515	SENT_200	[p16l1289t1702r1315b1726],
431	(	NN	O	(	dep	515	SENT_200	[p16l1323t1703r1392b1728],
432	7-0	CD	PERCENT	7-0	dep	515	SENT_200	[p16l1323t1703r1392b1728],
433	%	NN	PERCENT	%	dep	515	SENT_200	[p16l1323t1703r1392b1728],
434	)	CD	PERCENT	)	dep	515	SENT_200	[p16l1323t1703r1392b1728],
435	7-8	CD	PERCENT	7-8	dep	515	SENT_200	[p16l1445t1702r1498b1725],
436	%	NN	PERCENT	%	dep	515	SENT_200	[p16l1445t1702r1498b1725],
437	1-02	CD	NUMBER	1-02	dep	515	SENT_200	[p16l1607t1705r1652b1723],
438	(	CD	NUMBER	(	dep	515	SENT_200	[p16l1660t1702r1782b1728],
439	0-75-1-38	CD	NUMBER	0-75-1-38	dep	515	SENT_200	[p16l1660t1702r1782b1728],
440	)	NN	O	)	dep	515	SENT_200	[p16l1660t1702r1782b1728],
441	0-89	CD	NUMBER	0-89	dep	515	SENT_200	[p16l1836t1702r1885b1726],
442	Net	JJ	O	net	dep	515	SENT_200	[p16l43t1749r84b1768],
443	clinical	JJ	O	clinical	dep	515	SENT_200	[p16l90t1747r166b1768],
444	beneﬁt	NN	O	beneﬁt	dep	515	SENT_200	[p16l174t1747r255b1768],
445	Low	JJ	PERSON	low	dep	515	SENT_200	[p16l43t1795r87b1814],
446	expression	NN	O	expression	dep	515	SENT_200	[p16l93t1795r207b1820],
447	1349	CD	DATE	1349	dep	515	SENT_200	[p16l617t1796r671b1817],
448	192	CD	NUMBER	192	dep	515	SENT_200	[p16l764t1796r803b1817],
449	(	NN	O	(	dep	515	SENT_200	[p16l812t1794r894b1819],
450	14-2	CD	PERCENT	14-2	dep	515	SENT_200	[p16l812t1794r894b1819],
451	%	NN	PERCENT	%	dep	515	SENT_200	[p16l812t1794r894b1819],
452	)	CD	PERCENT	)	dep	515	SENT_200	[p16l812t1794r894b1819],
453	148	CD	PERCENT	148	dep	515	SENT_200	[p16l931t1793r998b1817],
454	%	NN	PERCENT	%	dep	515	SENT_200	[p16l931t1793r998b1817],
455	1386 219 158	CD	PERCENT	1386 219 158	dep	515	SENT_200	[p16l1332t1793r1406b1819],[p16l1131t1793r1186b1817],
456	%	NN	PERCENT	%	dep	515	SENT_200	[p16l1332t1793r1406b1819],
457	)	CD	PERCENT	)	dep	515	SENT_200	[p16l1332t1793r1406b1819],
458	166	CD	PERCENT	166	dep	515	SENT_200	[p16l1434t1793r1501b1814],
459	%	NN	PERCENT	%	dep	515	SENT_200	[p16l1434t1793r1501b1814],
460	0-87	CD	NUMBER	0-87	dep	515	SENT_200	[p16l1605t1793r1653b1817],
461	(	NN	O	(	dep	515	SENT_200	[p16l1660t1793r1783b1819],
462	0	CD	NUMBER	0	dep	515	SENT_200	[p16l1660t1793r1783b1819],
463	~	NN	O	~	dep	515	SENT_200	[p16l1660t1793r1783b1819],
464	72	CD	NUMBER	72	dep	515	SENT_200	[p16l1660t1793r1783b1819],
465	—	CD	NUMBER	—	dep	515	SENT_200	[p16l1660t1793r1783b1819],
466	1-O6	NN	O	1-o6	dep	515	SENT_200	[p16l1660t1793r1783b1819],
467	)	CD	NUMBER	)	dep	515	SENT_200	[p16l1660t1793r1783b1819],
468	0-16	CD	NUMBER	0-16	dep	515	SENT_200	[p16l1836t1793r1882b1814],
469	0-19	CD	NUMBER	0-19	dep	515	SENT_200	[p16l1967t1796r2013b1817],
470	Intermediate	NNP	O	Intermediate	dep	515	SENT_200	[p16l43t1839r182b1860],
471	expression	NN	O	expression	dep	515	SENT_200	[p16l189t1841r302b1866],
472	2570	CD	DATE	2570	dep	515	SENT_200	[p16l619t1842r672b1863],
473	357	CD	NUMBER	357	dep	515	SENT_200	[p16l765t1842r804b1863],
474	(	NN	O	(	dep	515	SENT_200	[p16l812t1840r894b1865],
475	13-9	CD	PERCENT	13-9	dep	515	SENT_200	[p16l812t1840r894b1865],
476	%	NN	PERCENT	%	dep	515	SENT_200	[p16l812t1840r894b1865],
477	)	CD	PERCENT	)	dep	515	SENT_200	[p16l812t1840r894b1865],
478	14-4	CD	PERCENT	14-4	dep	515	SENT_200	[p16l931t1842r998b1862],
479	%	NN	PERCENT	%	dep	515	SENT_200	[p16l931t1842r998b1862],
480	2518	CD	DATE	2518	dep	515	SENT_200	[p16l1132t1839r1186b1863],
481	370	CD	PERCENT	370	dep	515	SENT_200	[p16l1276t1842r1316b1863],
482	14-7	CD	PERCENT	14-7	dep	515	SENT_200	[p16l1332t1840r1405b1865],
483	%	NN	PERCENT	%	dep	515	SENT_200	[p16l1332t1840r1405b1865],
484	)	CD	PERCENT	)	dep	515	SENT_200	[p16l1332t1840r1405b1865],
485	15-3	CD	PERCENT	15-3	dep	515	SENT_200	[p16l1434t1842r1498b1863],
486	%	NN	PERCENT	%	dep	515	SENT_200	[p16l1434t1842r1498b1863],
487	0-93	CD	NUMBER	0-93	dep	515	SENT_200	[p16l1605t1842r1653b1863],
488	(	CD	NUMBER	(	dep	515	SENT_200	[p16l1661t1839r1785b1865],
489	0-81-1-08	CD	NUMBER	0-81-1-08	dep	515	SENT_200	[p16l1661t1839r1785b1865],
490	)	NN	O	)	dep	515	SENT_200	[p16l1661t1839r1785b1865],
491	0-35	CD	NUMBER	0-35	dep	515	SENT_200	[p16l1836t1842r1881b1863],
492	High	JJ	O	high	dep	515	SENT_200	[p16l43t1885r92b1912],
493	e	SYM	O	e	dep	515	SENT_200	[p16l100t1886r213b1912],
494	>	JJR	O	>	dep	515	SENT_200	[p16l100t1886r213b1912],
495	q3ression	NN	O	q3ression	dep	515	SENT_200	[p16l100t1886r213b1912],
496	1167	CD	DATE	1167	dep	515	SENT_200	[p16l619t1884r672b1908],
497	157	CD	NUMBER	157	dep	515	SENT_200	[p16l766t1888r805b1908],
498	(	NN	O	(	dep	515	SENT_200	[p16l812t1886r892b1911],
499	13-5	CD	PERCENT	13-5	dep	515	SENT_200	[p16l812t1886r892b1911],
500	%	NN	PERCENT	%	dep	515	SENT_200	[p16l812t1886r892b1911],
501	)	CD	PERCENT	)	dep	515	SENT_200	[p16l812t1886r892b1911],
502	14-0	CD	PERCENT	14-0	dep	515	SENT_200	[p16l931t1887r997b1908],
503	%	NN	PERCENT	%	dep	515	SENT_200	[p16l931t1887r997b1908],
504	1195	CD	DATE	1195	dep	515	SENT_200	[p16l1133t1887r1186b1909],
505	210	CD	PERCENT	210	dep	515	SENT_200	[p16l1277t1887r1316b1905],
506	17-6	CD	PERCENT	17-6	dep	515	SENT_200	[p16l1332t1884r1405b1911],
507	%	NN	PERCENT	%	dep	515	SENT_200	[p16l1332t1884r1405b1911],
508	)	CD	PERCENT	)	dep	515	SENT_200	[p16l1332t1884r1405b1911],
509	18-1	CD	PERCENT	18-1	dep	515	SENT_200	[p16l1434t1884r1499b1905],
510	%	NN	PERCENT	%	dep	515	SENT_200	[p16l1434t1884r1499b1905],
511	0-74	CD	NUMBER	0-74	dep	515	SENT_200	[p16l1605t1887r1652b1908],
512	(	CD	NUMBER	(	dep	515	SENT_200	[p16l1659t1884r1784b1911],
513	0-60-0-91	CD	NUMBER	0-60-0-91	dep	515	SENT_200	[p16l1659t1884r1784b1911],
514	)	NN	O	)	dep	515	SENT_200	[p16l1659t1884r1784b1911],
515	0-0041	CD	NUMBER	0-0041	_	0	SENT_200	[p16l1836t1887r1912b1908],

1	CABG	NN	O	cabg	nn	5	SENT_201	[p16l31t1954r190b1977],
2	=	JJ	O	=	amod	5	SENT_201	[p16l31t1954r190b1977],
3	coronary	JJ	O	coronary	amod	5	SENT_201	[p16l31t1954r190b1977],
4	artery	NN	O	artery	nn	5	SENT_201	[p16l196t1956r254b1977],
5	bypass	NN	O	bypass	_	0	SENT_201	[p16l260t1952r326b1978],
6	graft	NN	O	graft	dep	5	SENT_201	[p16l332t1952r385b1978],
7	.	.	O	.	_	0	SENT_201	[p16l332t1952r385b1978],

1	*	NN	O	*	nn	3	SENT_202	[p16l393t1953r415b1978],
2	p	NN	O	p	nn	3	SENT_202	[p16l393t1953r415b1978],
3	value	NN	O	value	nsubj	6	SENT_202	[p16l421t1952r474b1972],
4	of	IN	O	of	_	0	SENT_202	[p16l479t1952r501b1972],
5	interaction	NN	O	interaction	prep_of	3	SENT_202	[p16l506t1954r614b1972],
6	indicates	VBZ	O	indicate	_	0	SENT_202	[p16l622t1952r710b1972],
7	signiﬁcance	NN	O	signiﬁcance	dobj	6	SENT_202	[p16l716t1952r833b1978],
8	of	IN	O	of	_	0	SENT_202	[p16l839t1952r860b1972],
9	effects	NNS	O	effect	prep_of	7	SENT_202	[p16l865t1952r930b1972],
10	of	IN	O	of	_	0	SENT_202	[p16l936t1952r957b1972],
11	genotype	NN	O	genotype	nn	12	SENT_202	[p16l962t1956r1056b1978],
12	groups	NNS	O	group	prep_of	9	SENT_202	[p16l1063t1959r1131b1978],
13	on	IN	O	on	_	0	SENT_202	[p16l1137t1959r1162b1972],
14	the	DT	O	the	det	15	SENT_202	[p16l1168t1952r1201b1972],
15	results	NNS	O	result	prep_on	6	SENT_202	[p16l1208t1952r1272b1972],
16	of	IN	O	of	_	0	SENT_202	[p16l1278t1952r1299b1972],
17	comparisons	NNS	O	comparison	prep_of	15	SENT_202	[p16l1304t1954r1431b1978],
18	between	IN	O	between	_	0	SENT_202	[p16l1438t1952r1523b1972],
19	treatment	NN	O	treatment	nn	20	SENT_202	[p16l1529t1956r1632b1972],
20	groups	NNS	O	group	prep_between	17	SENT_202	[p16l1637t1959r1711b1978],
21	.	.	O	.	_	0	SENT_202	[p16l1637t1959r1711b1978],

1	i	LS	O	i	dep	5	SENT_203	[p16l1719t1954r1784b1973],
2	'	''	O	'	_	0	SENT_203	[p16l1719t1954r1784b1973],
3	Stent	JJ	O	stent	amod	5	SENT_203	[p16l1719t1954r1784b1973],
4	thrombosis	NN	O	thrombosis	nn	5	SENT_203	[p16l1788t1952r1903b1972],
5	population	NN	O	population	csubj	6	SENT_203	[p16l1909t1952r2019b1978],
6	includes	VBZ	O	include	_	0	SENT_203	[p16l2026t1952r2107b1972],
7	patients	NNS	O	patient	dobj	6	SENT_203	[p16l31t1988r112b2012],
8	who	WP	O	who	nsubj	9	SENT_203	[p16l117t1987r161b2006],
9	received	VBD	O	receive	rcmod	7	SENT_203	[p16l168t1987r249b2006],
10	at	IN	O	at	quantmod	12	SENT_203	[p16l256t1990r275b2006],
11	least	JJS	O	least	mwe	10	SENT_203	[p16l282t1987r327b2006],
12	one	CD	NUMBER	one	num	13	SENT_203	[p16l332t1993r369b2006],
13	stent	NN	O	stent	dobj	9	SENT_203	[p16l376t1990r427b2006],
14	at	IN	O	at	_	0	SENT_203	[p16l433t1990r452b2006],
15	any	DT	O	any	det	16	SENT_203	[p16l458t1993r494b2012],
16	time	NN	O	time	prep_at	13	SENT_203	[p16l498t1988r544b2006],
17	during	IN	O	during	_	0	SENT_203	[p16l550t1987r615b2012],
18	the	DT	O	the	det	19	SENT_203	[p16l621t1987r654b2006],
19	study	NN	O	study	prep_during	9	SENT_203	[p16l660t1987r719b2012],
20	,	,	O	,	_	0	SENT_203	[p16l660t1987r719b2012],
21	which	WDT	O	which	nsubj	22	SENT_203	[p16l725t1987r784b2006],
22	was	VBD	O	be	rcmod	19	SENT_203	[p16l790t1993r828b2006],
23	about	IN	O	about	_	0	SENT_203	[p16l834t1987r893b2006],
24	64	CD	PERCENT	64	num	25	SENT_203	[p16l900t1987r944b2009],
25	%	NN	PERCENT	%	prep_about	22	SENT_203	[p16l900t1987r944b2009],
26	of	IN	O	of	_	0	SENT_203	[p16l950t1987r971b2006],
27	patients	NNS	O	patient	prep_of	25	SENT_203	[p16l976t1988r1057b2012],
28	participating	VBG	O	participate	partmod	27	SENT_203	[p16l1064t1988r1191b2012],
29	in	IN	O	in	_	0	SENT_203	[p16l1199t1989r1215b2006],
30	the	DT	O	the	det	32	SENT_203	[p16l1221t1987r1254b2006],
31	genetic	JJ	O	genetic	amod	32	SENT_203	[p16l1260t1989r1333b2012],
32	substudy	NN	O	substudy	prep_in	28	SENT_203	[p16l1339t1987r1434b2012],
33	.	.	O	.	_	0	SENT_203	[p16l1339t1987r1434b2012],

1	ilnteraction	NN	O	ilnteraction	nn	3	SENT_204	[p16l1441t1988r1561b2008],
2	p	NN	O	p	nn	3	SENT_204	[p16l1568t1993r1580b2012],
3	value	NN	O	value	nsubj	5	SENT_204	[p16l1586t1987r1638b2006],
4	not	RB	O	not	neg	5	SENT_204	[p16l1646t1990r1679b2006],
5	calculated	VBN	O	calculate	_	0	SENT_204	[p16l1686t1987r1785b2006],
6	because	IN	O	because	_	0	SENT_204	[p16l1792t1987r1870b2006],
7	of	IN	O	of	_	0	SENT_204	[p16l1876t1987r1898b2006],
8	low	JJ	O	low	amod	9	SENT_204	[p16l1903t1987r1938b2006],
9	number	NN	O	number	prep_because_of	5	SENT_204	[p16l1945t1987r2023b2006],
10	of	IN	O	of	_	0	SENT_204	[p16l2028t1987r2050b2006],
11	events	NNS	O	event	prep_of	9	SENT_204	[p16l2055t1990r2125b2006],
12	.	.	O	.	_	0	SENT_204	[p16l2055t1990r2125b2006],

1	Table	NNP	O	Table	_	0	SENT_205	[p16l31t2050r88b2071],
2	4	CD	NUMBER	4	num	1	SENT_205	[p16l92t2053r113b2074],
3	:	:	O	:	_	0	SENT_205	[p16l92t2053r113b2074],
4	Outcomes	NNS	O	outcome	dep	1	SENT_205	[p16l119t2052r234b2071],
5	in	IN	O	in	_	0	SENT_205	[p16l242t2051r261b2071],
6	relation	NN	O	relation	prep_in	4	SENT_205	[p16l270t2051r356b2071],
7	to	TO	O	to	_	0	SENT_205	[p16l362t2054r387b2071],
8	the	DT	O	the	det	10	SENT_205	[p16l392t2051r430b2071],
9	ABCB1	NN	O	abcb1	nn	10	SENT_205	[p16l435t2052r509b2071],
10	genotype	NN	O	genotype	prep_to	6	SENT_205	[p16l517t2054r625b2078],

1	TRITON-TIMI	NN	O	triton-timus	nn	3	SENT_206	[p16l644t2224r1031b2270],
2	38	CD	NUMBER	38	num	3	SENT_206	[p16l1072t2226r1129b2270],
3	trial	NN	O	trial	nsubj	38	SENT_206	[p16l1163t2222r1299b2277],
4	,9	CD	NUMBER	,9	dobj	9	SENT_206	[p16l1163t2222r1299b2277],
5	in	IN	O	in	_	0	SENT_206	[p16l1333t2225r1386b2269],
6	which	WDT	O	which	det	7	SENT_206	[p16l1419t2222r1579b2270],
7	event	NN	O	event	prep_in	4	SENT_206	[p16l1614t2231r1753b2270],
8	rates	NNS	O	rate	nsubj	9	SENT_206	[p16l1787t2231r1910b2270],
9	differed	VBD	O	differ	rcmod	3	SENT_206	[p16l1947t2222r2151b2270],
10	between	IN	O	between	_	0	SENT_206	[p16l643t2298r862b2346],
11	patients	NNS	O	patient	prep_between	9	SENT_206	[p16l883t2301r1088b2360],
12	with	IN	O	with	_	0	SENT_206	[p16l1110t2298r1226b2346],
13	and	CC	O	and	_	0	SENT_206	[p16l1248t2298r1345b2346],
14	without	IN	O	without	_	0	SENT_206	[p16l1364t2298r1567b2346],
15	any	DT	O	any	det	17	SENT_206	[p16l1588t2315r1679b2361],
16	CYP2C19lossoffunction	NN	O	cyp2c19lossoffunction	nn	17	SENT_206	[p16l1704t2298r2148b2346, p16l645t2375r867b2422],
17	allele	NN	O	allele	prep_without	9	SENT_206	[p16l890t2375r1023b2422],
18	in	IN	O	in	_	0	SENT_206	[p16l1047t2378r1099b2422],
19	the	DT	O	the	det	20	SENT_206	[p16l1122t2375r1203b2422],
20	ﬁrst	NN	O	ﬁrst	prep_in	17	SENT_206	[p16l1227t2375r1331b2422],
21	week	NN	DURATION	week	tmod	9	SENT_206	[p16l1352t2375r1487b2422],
22	after	IN	O	after	_	0	SENT_206	[p16l1509t2375r1627b2422],
23	start	NN	O	start	prep_after	9	SENT_206	[p16l1651t2384r1764b2422],
24	of	IN	O	of	_	0	SENT_206	[p16l1787t2375r1845b2422],
25	clopidogrel	NN	O	clopidogrel	nn	26	SENT_206	[p16l1859t2375r2150b2438],
26	treatment	NN	O	treatment	prep_of	23	SENT_206	[p16l644t2460r914b2506],
27	,	,	O	,	_	0	SENT_206	[p16l644t2460r914b2506],
28	in	IN	O	in	conj_and	23	SENT_206	[p16l944t2453r996b2498],
29	association	NN	O	association	pobj	28	SENT_206	[p16l1024t2453r1312b2499],
30	with	IN	O	with	_	0	SENT_206	[p16l1338t2450r1454b2499],
31	the	DT	O	the	det	33	SENT_206	[p16l1481t2450r1562b2499],
32	stent	NN	O	stent	nn	33	SENT_206	[p16l1592t2460r1719b2499],
33	procedure	NN	O	procedure	prep_with	29	SENT_206	[p16l1745t2450r2023b2513],
34	,	,	O	,	_	0	SENT_206	[p16l1745t2450r2023b2513],
35	and	CC	O	and	_	0	SENT_206	[p16l2054t2450r2150b2499],
36	this	DT	O	this	det	37	SENT_206	[p16l644t2527r739b2575],
37	difference	NN	O	difference	conj_and	23	SENT_206	[p16l786t2527r1047b2575],
38	persisted	VBD	O	persist	_	0	SENT_206	[p16l1092t2527r1329b2589],
39	thereafter	RB	O	thereafter	advmod	38	SENT_206	[p16l1372t2527r1626b2575],
40	during	IN	O	during	_	0	SENT_206	[p16l1670t2527r1847b2590],
41	long-term	JJ	O	long-term	amod	42	SENT_206	[p16l1890t2527r2150b2590],
42	treatment	NN	O	treatment	prep_during	38	SENT_206	[p16l644t2613r913b2651],
43	.	.	O	.	_	0	SENT_206	[p16l644t2613r913b2651],

1	Our	PRP$	O	we	poss	2	SENT_207	[p16l942t2608r1046b2651],
2	results	NNS	O	result	nsubj	4	SENT_207	[p16l1068t2604r1241b2651],
3	also	RB	O	also	advmod	4	SENT_207	[p16l1268t2604r1367b2651],
4	showed	VBD	O	show	_	0	SENT_207	[p16l1394t2604r1592b2651],
5	that	IN	O	that	complm	26	SENT_207	[p16l1614t2604r1715b2651],
6	the	DT	O	the	det	9	SENT_207	[p16l1738t2604r1819b2651],
7	lower	JJR	O	lower	amod	9	SENT_207	[p16l1843t2604r1988b2651],
8	event	NN	O	event	nn	9	SENT_207	[p16l2011t2613r2151b2651],
9	rate	NN	O	rate	nsubjpass	26	SENT_207	[p16l645t2689r742b2727],
10	in	IN	O	in	_	0	SENT_207	[p16l768t2682r820b2726],
11	the	DT	O	the	det	12	SENT_207	[p16l845t2679r927b2727],
12	ticagrelor	NN	O	ticagrelor	prep_in	9	SENT_207	[p16l952t2679r1200b2742],
13	versus	CC	O	versus	prep	12	SENT_207	[p16l1223t2696r1389b2727],
14	the	DT	O	the	det	16	SENT_207	[p16l1416t2679r1497b2727],
15	clopidogrel	NN	O	clopidogrel	nn	16	SENT_207	[p16l1524t2679r1814b2742],
16	group	NN	O	group	dep	13	SENT_207	[p16l1841t2696r1994b2742],
17	from	IN	O	from	_	0	SENT_207	[p16l2021t2679r2150b2727],
18	31	CD	DURATION	31	num	19	SENT_207	[p16l647t2759r699b2803],
19	days	NNS	NUMBER	day	prep_from	16	SENT_207	[p16l713t2755r825b2817],
20	until	IN	O	until	_	0	SENT_207	[p16l839t2755r963b2802],
21	end	NN	O	end	prep_until	19	SENT_207	[p16l976t2755r1074b2802],
22	of	IN	O	of	_	0	SENT_207	[p16l1086t2755r1145b2802],
23	follow-up	NN	O	follow-up	prep_of	21	SENT_207	[p16l1149t2755r1394b2817],
24	was	VBD	O	be	auxpass	26	SENT_207	[p16l1406t2772r1503b2803],
25	not	RB	O	not	neg	26	SENT_207	[p16l1518t2764r1604b2802],
26	affected	VBN	O	affect	ccomp	4	SENT_207	[p16l1617t2755r1820b2803],
27	by	IN	O	by	_	0	SENT_207	[p16l1831t2755r1892b2817],
28	C	NN	O	c	nn	29	SENT_207	[p16l1909t2758r1947b2803],
29	YPZC	NN	O	ypzc	agent	26	SENT_207	[p16l1951t2758r2096b2803],
30	19	CD	NUMBER	19	num	32	SENT_207	[p16l2100t2759r2152b2803],
31	genotype	NN	O	genotype	nn	32	SENT_207	[p16l646t2841r880b2895],
32	group	NN	O	group	dep	29	SENT_207	[p16l899t2849r1065b2895],
33	.	.	O	.	_	0	SENT_207	[p16l899t2849r1065b2895],

1	Findings	NNS	O	finding	nsubj	6	SENT_208	[p16l697t2908r924b2971],
2	of	IN	O	of	_	0	SENT_208	[p16l964t2908r1022b2956],
3	the	DT	O	the	det	5	SENT_208	[p16l1049t2908r1130b2956],
4	PLATO	NNP	O	PLATO	nn	5	SENT_208	[p16l1171t2911r1358b2956],
5	trial	NN	O	trial	prep_of	1	SENT_208	[p16l1395t2908r1499b2956],
6	showed	VBD	O	show	_	0	SENT_208	[p16l1538t2908r1735b2956],
7	no	DT	O	no	det	9	SENT_208	[p16l1771t2925r1837b2956],
8	signiﬁcant	NN	O	signiﬁcant	nn	9	SENT_208	[p16l1876t2908r2151b2971],
9	difference	NN	O	difference	dobj	6	SENT_208	[p16l645t2984r906b3032],
10	in	IN	O	in	_	0	SENT_208	[p16l925t2987r977b3031],
11	rates	NNS	O	rate	prep_in	6	SENT_208	[p16l995t2993r1117b3032],
12	of	IN	O	of	_	0	SENT_208	[p16l1137t2984r1196b3031],
13	total	JJ	O	total	amod	16	SENT_208	[p16l1203t2984r1316b3031],
14	major	JJ	O	major	amod	16	SENT_208	[p16l1334t2987r1490b3047],
15	bleeding	NN	O	bleeding	nn	16	SENT_208	[p16l1505t2984r1731b3047],
16	events	NNS	O	event	prep_of	11	SENT_208	[p16l1750t2993r1912b3032],
17	between	IN	O	between	_	0	SENT_208	[p16l1931t2984r2150b3032],
18	the	DT	O	the	det	20	SENT_208	[p16l643t3061r725b3109],
19	treatment	NN	O	treatment	nn	20	SENT_208	[p16l772t3070r1031b3109],
20	groups	NNS	O	group	prep_between	16	SENT_208	[p16l1078t3078r1271b3124],
21	.	.	O	.	_	0	SENT_208	[p16l1078t3078r1271b3124],

1	In	IN	O	in	_	0	SENT_209	[p16l1324t3065r1379b3108],
2	accordance	NN	O	accordance	_	0	SENT_209	[p16l1427t3061r1716b3109],
3	with	IN	O	with	_	0	SENT_209	[p16l1763t3061r1879b3109],
4	previous	JJ	O	previous	amod	5	SENT_209	[p16l1926t3064r2148b3124],
5	research	NN	O	research	prep_in_accordance_with	9	SENT_209	[p16l644t3137r908b3192],
6	,	,	O	,	_	0	SENT_209	[p16l644t3137r908b3192],
7	“	CD	NUMBER	“	appos	5	SENT_209	[p16l644t3137r908b3192],
8	we	PRP	O	we	nsubj	9	SENT_209	[p16l936t3154r1008b3185],
9	showed	VBD	O	show	_	0	SENT_209	[p16l1039t3137r1236b3185],
10	that	IN	O	that	complm	31	SENT_209	[p16l1263t3137r1364b3185],
11	patients	NNS	O	patient	nsubj	31	SENT_209	[p16l1391t3140r1597b3200],
12	on	IN	O	on	_	0	SENT_209	[p16l1627t3154r1693b3185],
13	clopidogrel	NN	O	clopidogrel	prep_on	11	SENT_209	[p16l1722t3137r2012b3200],
14	who	WP	O	who	nsubj	15	SENT_209	[p16l2038t3137r2149b3185],
15	had	VBD	O	have	rcmod	13	SENT_209	[p16l644t3213r741b3261],
16	any	DT	O	any	det	18	SENT_209	[p16l757t3230r848b3276],
17	C	NN	O	c	nn	18	SENT_209	[p16l868t3216r906b3261],
18	YPZC	NN	O	ypzc	dobj	15	SENT_209	[p16l910t3216r1055b3261],
19	19	CD	NUMBER	19	num	21	SENT_209	[p16l1059t3217r1111b3261],
20	gain-of-function	NN	O	gain-of-function	nn	21	SENT_209	[p16l1125t3213r1545b3276],
21	allele	NN	O	allele	nsubj	22	SENT_209	[p16l1561t3213r1695b3261],
22	had	VBD	O	have	rcmod	18	SENT_209	[p16l1710t3213r1807b3261],
23	a	DT	O	a	det	25	SENT_209	[p16l1823t3230r1849b3261],
24	higher	JJR	O	higher	amod	25	SENT_209	[p16l1864t3213r2037b3276],
25	rate	NN	O	rate	dobj	22	SENT_209	[p16l2052t3223r2149b3261],
26	of	IN	O	of	_	0	SENT_209	[p16l645t3290r704b3337],
27	major	JJ	O	major	amod	29	SENT_209	[p16l711t3293r867b3352],
28	bleeding	JJ	O	bleeding	amod	29	SENT_209	[p16l882t3290r1108b3353],
29	events	NNS	O	event	prep_of	25	SENT_209	[p16l1125t3299r1287b3337],
30	than	IN	O	than	prep	22	SENT_209	[p16l1305t3290r1423b3337],
31	did	VBD	O	do	ccomp	9	SENT_209	[p16l1441t3290r1523b3337],
32	those	DT	O	those	dobj	31	SENT_209	[p16l1538t3290r1678b3337],
33	without	IN	O	without	_	0	SENT_209	[p16l1694t3290r1897b3337],
34	any	DT	O	any	det	35	SENT_209	[p16l1913t3307r2004b3352],
35	gainoﬂfunction	NN	O	gainoﬂfunction	prep_without	31	SENT_209	[p16l2021t3293r2148b3353, p16l645t3365r934b3413],
36	or	CC	O	or	_	0	SENT_209	[p16l952t3382r1005b3413],
37	loss-of-function	JJ	O	loss-of-function	amod	38	SENT_209	[p16l1021t3365r1429b3413],
38	alleles	NNS	O	allele	conj_or	35	SENT_209	[p16l1447t3365r1620b3420],
39	,	,	O	,	_	0	SENT_209	[p16l1447t3365r1620b3420],
40	but	CC	O	but	_	0	SENT_209	[p16l1639t3365r1726b3413],
41	presence	NN	O	presence	nsubj	49	SENT_209	[p16l1742t3382r1974b3427],
42	of	IN	O	of	_	0	SENT_209	[p16l1992t3365r2050b3413],
43	any	DT	O	any	det	45	SENT_209	[p16l2059t3382r2151b3428],
44	loss-oﬁfunction	JJ	O	loss-oﬁfunction	amod	45	SENT_209	[p16l644t3441r1052b3489],
45	allele	NN	O	allele	prep_of	41	SENT_209	[p16l1067t3441r1200b3489],
46	was	VBD	O	be	cop	49	SENT_209	[p16l1213t3458r1310b3489],
47	not	RB	O	not	neg	49	SENT_209	[p16l1325t3451r1411b3489],
48	signiﬁcantly	RB	O	signiﬁcantly	advmod	49	SENT_209	[p16l1426t3441r1746b3504],
49	related	JJ	O	related	conj_but	9	SENT_209	[p16l1758t3441r1936b3489],
50	to	TO	O	to	_	0	SENT_209	[p16l1948t3451r1996b3489],
51	event	NN	O	event	nn	52	SENT_209	[p16l2012t3451r2151b3489],
52	rate	NN	O	rate	prep_to	49	SENT_209	[p16l645t3527r755b3566],
53	.	.	O	.	_	0	SENT_209	[p16l645t3527r755b3566],

1	By	IN	O	by	_	0	SENT_210	[p16l791t3523r853b3581],
2	contrast	NN	O	contrast	prep_by	5	SENT_210	[p16l882t3527r1103b3573],
3	,	,	O	,	_	0	SENT_210	[p16l882t3527r1103b3573],
4	we	PRP	O	we	nsubj	5	SENT_210	[p16l1135t3535r1207b3566],
5	recorded	VBD	O	record	_	0	SENT_210	[p16l1238t3518r1467b3566],
6	no	DT	O	no	det	7	SENT_210	[p16l1497t3535r1562b3566],
7	interactions	NNS	O	interaction	dobj	5	SENT_210	[p16l1593t3521r1901b3566],
8	between	IN	O	between	_	0	SENT_210	[p16l1932t3518r2150b3566],
9	genetic	JJ	O	genetic	amod	10	SENT_210	[p17l10t148r274b233],
10	polymorphisms	NNS	O	polymorphism	prep_between	7	SENT_210	[p17l311t143r896b233],
11	and	CC	O	and	_	0	SENT_210	[p17l937t143r1074b212],
12	bleeding	VBG	O	bleed	amod	14	SENT_210	[p17l1109t143r1429b233],
13	event	NN	O	event	nn	14	SENT_210	[p17l1468t157r1665b212],
14	rates	NNS	O	rate	conj_or	14	SENT_210	[p17l1700t157r1874b212],
15	in	IN	O	in	_	0	SENT_210	[p17l1914t148r1988b210],
16	the	DT	O	the	det	18	SENT_210	[p17l2025t143r2140b212],
17	ticagrelor	NN	O	ticagrelor	nn	18	SENT_210	[p17l7t252r359b342],
18	group	NN	O	group	prep_in	14	SENT_210	[p17l396t276r613b342],
19	or	CC	O	or	_	0	SENT_210	[p17l653t276r729b320],
20	between	IN	O	between	_	0	SENT_210	[p17l763t252r1073b320],
21	bleeding	JJ	O	bleeding	amod	23	SENT_210	[p17l1109t252r1429b342],
22	event	NN	O	event	nn	23	SENT_210	[p17l1467t265r1664b320],
23	rates	NNS	O	rate	prep_between	14	SENT_210	[p17l1700t265r1874b320],
24	in	IN	O	in	_	0	SENT_210	[p17l1915t257r1988b319],
25	the	DT	O	the	det	28	SENT_210	[p17l2025t252r2140b320],
26	two	CD	NUMBER	two	num	28	SENT_210	[p17l7t375r139b429],
27	treatment	NN	O	treatment	nn	28	SENT_210	[p17l161t375r527b429],
28	groups	NNS	O	group	prep_in	23	SENT_210	[p17l549t386r823b452],
29	.	.	O	.	_	0	SENT_210	[p17l549t386r823b452],

1	In	IN	O	in	_	0	SENT_211	[p17l853t368r931b428],
2	the	DT	O	the	det	5	SENT_211	[p17l953t362r1069b429],
3	main	JJ	O	main	amod	5	SENT_211	[p17l1092t366r1285b429],
4	PLATO	NNP	ORGANIZATION	PLATO	nn	5	SENT_211	[p17l1311t366r1576b429],
5	trial	NN	O	trial	prep_in	10	SENT_211	[p17l1600t362r1766b440],
6	,	,	O	,	_	0	SENT_211	[p17l1600t362r1766b440],
7	ticagrelor	NN	O	ticagrelor	nn	8	SENT_211	[p17l1791t362r2142b452],
8	treatment	NN	O	treatment	nsubjpass	10	SENT_211	[p17l7t484r373b539],
9	was	VBD	O	be	auxpass	10	SENT_211	[p17l395t495r533b539],
10	associated	VBN	O	associate	_	0	SENT_211	[p17l562t470r937b539],
11	with	IN	O	with	_	0	SENT_211	[p17l960t470r1124b539],
12	a	DT	O	a	det	15	SENT_211	[p17l1151t495r1187b539],
13	19	CD	PERCENT	19	number	14	SENT_211	[p17l1216t475r1366b541],
14	%	NN	PERCENT	%	amod	15	SENT_211	[p17l1216t475r1366b541],
15	increase	NN	O	increase	prep_with	10	SENT_211	[p17l1392t475r1697b539],
16	in	IN	O	in	_	0	SENT_211	[p17l1723t475r1797b537],
17	bleeding	VBG	O	bleed	amod	18	SENT_211	[p17l1821t470r2141b560],
18	events	NNS	O	event	prep_in	15	SENT_211	[p17l9t592r240b647],
19	related	JJ	O	related	amod	21	SENT_211	[p17l314t579r566b647],
20	to	TO	O	to	dep	21	SENT_211	[p17l636t592r705b647],
21	non-CABG	JJ	O	non-cabg	amod	18	SENT_211	[p17l778t584r1209b657],
22	,	,	O	,	_	0	SENT_211	[p17l778t584r1209b657],
23	but	CC	O	but	_	0	SENT_211	[p17l1283t579r1407b647],
24	we	PRP	O	we	nsubj	25	SENT_211	[p17l1475t603r1578b647],
25	recorded	VBD	O	record	conj_but	10	SENT_211	[p17l1651t579r1976b647],
26	no	DT	O	no	det	28	SENT_211	[p17l2047t603r2140b647],
27	signiﬁcant	JJ	O	signiﬁcant	amod	28	SENT_211	[p17l11t688r400b778],
28	interactions	NNS	O	interaction	dobj	25	SENT_211	[p17l422t693r858b757],
29	of	IN	O	of	_	0	SENT_211	[p17l885t688r968b757],
30	these	DT	O	these	det	31	SENT_211	[p17l977t689r1172b757],
31	events	NNS	O	event	prep_of	28	SENT_211	[p17l1197t702r1427b757],
32	with	IN	O	with	_	0	SENT_211	[p17l1452t689r1616b757],
33	any	DT	O	any	det	37	SENT_211	[p17l1641t713r1770b778],
34	C	NN	O	c	nn	37	SENT_211	[p17l1799t694r1853b757],
35	YPZC	NN	O	ypzc	nn	37	SENT_211	[p17l1859t694r2065b757],
36	19	CD	NUMBER	19	num	37	SENT_211	[p17l2070t695r2144b757],
37	gain-of-function	NN	O	gain-of-function	prep_with	25	SENT_211	[p17l10t797r604b887],
38	or	CC	O	or	_	0	SENT_211	[p17l674t822r750b865],
39	loss-of-function	JJ	O	loss-of-function	amod	40	SENT_211	[p17l816t797r1394b865],
40	alleles	NNS	O	allele	conj_or	37	SENT_211	[p17l1463t797r1687b865],
41	within	IN	O	within	_	0	SENT_211	[p17l1756t797r1996b866],
42	or	CC	O	or	_	0	SENT_211	[p17l2066t822r2142b865],
43	between	IN	O	between	_	0	SENT_211	[p17l7t906r316b974],
44	the	DT	O	the	det	46	SENT_211	[p17l366t906r482b974],
45	treatment	NN	O	treatment	nn	46	SENT_211	[p17l532t919r898b974],
46	groups	NNS	O	group	prep_between	40	SENT_211	[p17l949t930r1222b996],
47	.	.	O	.	_	0	SENT_211	[p17l949t930r1222b996],

1	Accordingly	RB	O	accordingly	advmod	10	SENT_212	[p17l1276t906r1730b996],
2	,	,	O	,	_	0	SENT_212	[p17l1276t906r1730b996],
3	events	NNS	O	event	nsubj	10	SENT_212	[p17l1786t919r2016b974],
4	of	IN	O	of	_	0	SENT_212	[p17l2070t906r2153b974],
5	bleeding	VBG	O	bleed	prepc_of	3	SENT_212	[p17l7t1017r327b1106],
6	related	JJ	O	related	acomp	5	SENT_212	[p17l348t1017r600b1085],
7	to	TO	O	to	_	0	SENT_212	[p17l619t1030r687b1085],
8	non-CABG	JJ	O	non-cabg	prep_to	6	SENT_212	[p17l710t1022r1119b1085],
9	consistently	RB	O	consistently	advmod	5	SENT_212	[p17l1144t1017r1585b1106],
10	increased	VBN	O	increase	_	0	SENT_212	[p17l1605t1017r1958b1085],
11	with	IN	O	with	_	0	SENT_212	[p17l1977t1017r2140b1085],
12	ticagrelor	NN	O	ticagrelor	prep_with	10	SENT_212	[p17l7t1125r369b1215],
13	,	,	O	,	_	0	SENT_212	[p17l7t1125r369b1215],
14	irrespective	RB	O	irrespective	_	0	SENT_212	[p17l397t1130r821b1214],
15	of	IN	O	of	_	0	SENT_212	[p17l848t1125r931b1193],
16	C	NN	O	c	nn	18	SENT_212	[p17l949t1130r1003b1193],
17	YP2C19	NN	O	yp2c19	nn	18	SENT_212	[p17l1009t1130r1294b1194],
18	polymorphisms	NNS	O	polymorphism	prep_irrespective_of	10	SENT_212	[p17l1315t1125r1920b1214],
19	.	.	O	.	_	0	SENT_212	[p17l1315t1125r1920b1214],

1	This	DT	O	this	det	2	SENT_213	[p17l78t1235r240b1302],
2	study	NN	O	study	nsubj	4	SENT_213	[p17l306t1235r504b1324],
3	also	RB	O	also	advmod	4	SENT_213	[p17l563t1235r705b1302],
4	investigated	VBD	O	investigate	_	0	SENT_213	[p17l767t1235r1211b1325],
5	effects	NNS	O	effect	dobj	4	SENT_213	[p17l1272t1235r1505b1302],
6	of	IN	O	of	_	0	SENT_213	[p17l1569t1235r1652b1302],
7	the	DT	O	the	det	9	SENT_213	[p17l1698t1235r1814b1302],
8	ABCB1	NN	O	abcb1	nn	9	SENT_213	[p17l1874t1240r2141b1302],
9	polymorphism	NN	O	polymorphism	prep_of	5	SENT_213	[p17l8t1345r576b1434],
10	.	.	O	.	_	0	SENT_213	[p17l8t1345r576b1434],

1	The	DT	O	the	det	4	SENT_214	[p17l597t1345r739b1413],
2	AB	NNP	O	AB	nn	4	SENT_214	[p17l757t1350r871b1411],
3	CB1	NN	O	cb1	nn	4	SENT_214	[p17l882t1350r1024b1413],
4	3435C	NN	O	3435c	nsubj	10	SENT_214	[p17l1045t1349r1414b1413],
5	—	CD	NUMBER	—	num	8	SENT_214	[p17l1045t1349r1414b1413],
6	>	JJR	O	>	amod	8	SENT_214	[p17l1045t1349r1414b1413],
7	T	NN	O	t	nn	8	SENT_214	[p17l1045t1349r1414b1413],
8	genotype	NN	O	genotype	dep	4	SENT_214	[p17l1432t1358r1764b1434],
9	putatively	RB	O	putatively	advmod	8	SENT_214	[p17l1783t1345r2142b1434],
10	affects	VBZ	O	affect	_	0	SENT_214	[p17l9t1454r243b1521],
11	expression	NN	O	expression	dobj	10	SENT_214	[p17l270t1458r664b1542],
12	of	IN	O	of	_	0	SENT_214	[p17l689t1453r772b1521],
13	the	DT	O	the	det	16	SENT_214	[p17l781t1453r897b1521],
14	P-glycoprotein	NN	O	p-glycoprotein	nn	16	SENT_214	[p17l926t1453r1458b1543],
15	efﬂux	NN	O	efﬂux	nn	16	SENT_214	[p17l1483t1453r1690b1521],
16	transporter	NN	O	transporter	prep_of	11	SENT_214	[p17l1711t1467r2137b1542],
17	,	,	O	,	_	0	SENT_214	[p17l1711t1467r2137b1542],
18	although	IN	O	although	mark	22	SENT_214	[p17l9t1562r338b1652],
19	this	DT	O	this	det	20	SENT_214	[p17l374t1562r509b1629],
20	data	NN	O	datum	nsubj	22	SENT_214	[p17l550t1562r701b1629],
21	is	VBZ	O	be	cop	22	SENT_214	[p17l739t1566r796b1629],
22	ambiguous	JJ	O	ambiguous	advcl	10	SENT_214	[p17l837t1562r1370b1652],
23	?	.	O	?	_	0	SENT_214	[p17l837t1562r1370b1652],

1	”	NN	O	”	nn	3	SENT_215	[p17l837t1562r1370b1652],
2	I-Iigh	NN	O	i-iigh	nn	3	SENT_215	[p17l1412t1562r1599b1652],
3	expression	NN	O	expression	nsubj	8	SENT_215	[p17l1638t1567r2032b1651],
4	of	IN	O	of	_	0	SENT_215	[p17l2070t1562r2153b1630],
5	ABCB1	NN	O	abcb1	prep_of	3	SENT_215	[p17l7t1677r274b1739],
6	might	MD	O	might	aux	8	SENT_215	[p17l340t1672r564b1762],
7	therefore	RB	O	therefore	advmod	8	SENT_215	[p17l628t1672r966b1739],
8	increase	VB	O	increase	_	0	SENT_215	[p17l1033t1676r1337b1739],
9	expression	NN	O	expression	dobj	8	SENT_215	[p17l1406t1676r1800b1761],
10	of	IN	O	of	_	0	SENT_215	[p17l1868t1672r1950b1739],
11	this	DT	O	this	det	12	SENT_215	[p17l2003t1672r2138b1739],
12	transporter	NN	O	transporter	prep_of	9	SENT_215	[p17l7t1794r433b1869],
13	,	,	O	,	_	0	SENT_215	[p17l7t1794r433b1869],
14	and	CC	O	and	_	0	SENT_215	[p17l475t1780r611b1849],
15	thereby	RB	O	thereby	advmod	8	SENT_215	[p17l645t1780r924b1870],
16	affect	VB	O	affect	conj_and	8	SENT_215	[p17l960t1781r1160b1849],
17	the	DT	O	the	det	19	SENT_215	[p17l1193t1780r1309b1849],
18	systemic	JJ	O	systemic	amod	19	SENT_215	[p17l1349t1785r1667b1870],
19	exposure	NN	O	exposure	dobj	16	SENT_215	[p17l1704t1805r2035b1869],
20	to	TO	O	to	_	0	SENT_215	[p17l2070t1794r2139b1849],
21	either	CC	O	either	preconj	22	SENT_215	[p17l9t1889r225b1957],
22	ticagrelor	NN	O	ticagrelor	prep_to	16	SENT_215	[p17l259t1889r610b1979],
23	or	CC	O	or	_	0	SENT_215	[p17l647t1914r723b1957],
24	clopidogrel	NN	O	clopidogrel	prep_to	16	SENT_215	[p17l760t1889r1171b1979],
25	and	CC	O	and	_	0	SENT_215	[p17l1209t1889r1345b1957],
26	its	PRP$	O	its	poss	28	SENT_215	[p17l1382t1894r1465b1957],
27	active	JJ	O	active	amod	28	SENT_215	[p17l1506t1894r1712b1957],
28	metabolite	NN	O	metabolite	prep_to	16	SENT_215	[p17l1749t1889r2140b1957],
29	and	CC	O	and	_	0	SENT_215	[p17l9t1999r146b2066],
30	the	DT	O	the	det	32	SENT_215	[p17l194t1999r310b2066],
31	clinical	JJ	O	clinical	amod	32	SENT_215	[p17l361t1999r622b2066],
32	effects	NNS	O	effect	conj_and	22	SENT_215	[p17l673t1999r907b2066],
33	of	IN	O	of	_	0	SENT_215	[p17l960t1999r1043b2066],
34	these	DT	O	these	det	35	SENT_215	[p17l1079t1999r1272b2066],
35	drugs	NNS	O	drug	prep_of	32	SENT_215	[p17l1324t1999r1596b2089],
36	.	.	O	.	_	0	SENT_215	[p17l1324t1999r1596b2089],

1	“	NN	O	“	_	0	SENT_216	[p17l1324t1999r1596b2089],
2	Even	RB	O	even	advmod	1	SENT_216	[p17l1650t2003r1825b2067],
3	though	IN	O	though	dep	1	SENT_216	[p17l1874t1999r2140b2089],

1	Articles	NNPS	O	Articles	_	0	SENT_217	[p17l6t2568r156b2604],
2	I	PRP	O	I	dep	1	SENT_217	[p17l204t2405r252b2603],

1	ticagrelor	NN	O	ticagrelor	nsubj	6	SENT_218	[p17l6t2864r360b2954],
2	is	VBZ	O	be	cop	6	SENT_218	[p17l422t2869r479b2933],
3	a	DT	O	a	det	6	SENT_218	[p17l546t2889r584b2933],
4	putative	JJ	O	putative	amod	6	SENT_218	[p17l647t2869r943b2953],
5	P-glycoprotein	NN	MISC	p-glycoprotein	nn	6	SENT_218	[p17l1012t2864r1547b2954],
6	substrate	NN	O	substrate	ccomp	12	SENT_218	[p17l1613t2864r1968b2943],
7	,	,	O	,	_	0	SENT_218	[p17l1613t2864r1968b2943],
8	the	DT	O	the	det	11	SENT_218	[p17l2034t2864r2150b2933],
9	AB	NNP	O	AB	nn	11	SENT_218	[p17l6t2978r122b3040],
10	CB1	NN	O	cb1	nn	11	SENT_218	[p17l131t2978r275b3041],
11	polymorphism	NN	O	polymorphism	nsubj	12	SENT_218	[p17l299t2973r852b3063],
12	had	VBD	O	have	_	0	SENT_218	[p17l876t2973r1015b3041],
13	no	DT	O	no	det	14	SENT_218	[p17l1040t2998r1133b3041],
14	interaction	NN	O	interaction	dobj	12	SENT_218	[p17l1160t2978r1563b3041],
15	with	IN	O	with	_	0	SENT_218	[p17l1587t2973r1752b3041],
16	ischaemic	JJ	O	ischaemic	amod	19	SENT_218	[p17l1777t2973r2152b3041],
17	or	CC	O	or	_	0	SENT_218	[p17l8t3107r85b3150],
18	bleeding	JJ	O	bleeding	conj_or	16	SENT_218	[p17l148t3083r471b3173],
19	events	NNS	O	event	prep_with	14	SENT_218	[p17l538t3096r769b3151],
20	in	IN	O	in	_	0	SENT_218	[p17l838t3087r912b3149],
21	the	DT	O	the	det	23	SENT_218	[p17l977t3083r1094b3151],
22	ticagrelor	NN	O	ticagrelor	nn	23	SENT_218	[p17l1160t3083r1513b3173],
23	group	NN	O	group	prep_in	12	SENT_218	[p17l1579t3107r1816b3173],
24	.	.	O	.	_	0	SENT_218	[p17l1579t3107r1816b3173],

1	In	IN	O	in	_	0	SENT_219	[p17l1891t3089r1969b3149],
2	the	DT	O	the	det	4	SENT_219	[p17l2034t3083r2151b3151],
3	clopidogrel	NN	O	clopidogrel	nn	4	SENT_219	[p17l8t3191r421b3281],
4	group	NN	O	group	prep_in	12	SENT_219	[p17l487t3216r724b3281],
5	,	,	O	,	_	0	SENT_219	[p17l487t3216r724b3281],
6	patients	NNS	O	patient	nsubj	12	SENT_219	[p17l792t3196r1084b3280],
7	with	IN	O	with	_	0	SENT_219	[p17l1149t3191r1314b3260],
8	the	DT	O	the	det	11	SENT_219	[p17l1377t3191r1492b3260],
9	high-expression	JJ	O	high-expression	amod	11	SENT_219	[p17l1556t3191r2151b3281],
10	ABCB1	NN	O	abcb1	nn	11	SENT_219	[p17l6t3305r275b3368],
11	polymorphism	NN	O	polymorphism	prep_with	6	SENT_219	[p17l320t3300r872b3389],
12	had	VBD	O	have	_	0	SENT_219	[p17l917t3300r1056b3368],
13	a	DT	O	a	det	15	SENT_219	[p17l1102t3324r1139b3368],
14	higher	JJR	O	higher	amod	15	SENT_219	[p17l1184t3300r1431b3390],
15	rate	NN	O	rate	dobj	12	SENT_219	[p17l1475t3313r1613b3368],
16	of	IN	O	of	_	0	SENT_219	[p17l1661t3300r1744b3368],
17	ischaemic	JJ	O	ischaemic	amod	18	SENT_219	[p17l1777t3300r2151b3368],
18	vwvvv	NN	O	vwvvv	prep_of	15	SENT_219	[p17l794t2270r1327b2321],
19	.	.	O	.	_	0	SENT_219	[p17l794t2270r1327b2321],

1	the	DT	O	the	det	2	SENT_220	[p17l794t2270r1327b2321],
2	|	NN	O	|	_	0	SENT_220	[p17l794t2270r1327b2321],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_220	[p17l794t2270r1327b2321],
4	Vol	NNP	O	Vol	dep	2	SENT_220	[p17l1370t2270r1457b2321],
5	376	CD	NUMBER	376	num	6	SENT_220	[p17l1477t2269r1580b2328],
6	October	NNP	DATE	October	dep	2	SENT_220	[p17l1626t2270r1850b2321],
7	16,2010	CD	DATE	16,2010	num	6	SENT_220	[p17l1867t2269r2111b2330],

1	events	NNS	O	event	nsubj	3	SENT_221	[p18l8t30r240b85],
2	than	IN	O	than	advmod	3	SENT_221	[p18l259t17r428b85],
3	did	VBD	O	do	_	0	SENT_221	[p18l447t17r564b85],
4	those	DT	O	those	dobj	3	SENT_221	[p18l580t17r779b85],
5	with	IN	O	with	_	0	SENT_221	[p18l795t17r960b85],
6	polymorphisms	NNS	O	polymorphism	prep_with	3	SENT_221	[p18l977t17r1565b106],
7	of	IN	O	of	_	0	SENT_221	[p18l1586t17r1669b85],
8	intermediate	JJ	O	intermediate	amod	11	SENT_221	[p18l1674t17r2151b85],
9	or	CC	O	or	_	0	SENT_221	[p18l8t150r85b194],
10	low	JJ	O	low	amod	11	SENT_221	[p18l139t125r271b194],
11	expression	NN	O	expression	prep_of	6	SENT_221	[p18l327t130r741b214],
12	.	.	O	.	_	0	SENT_221	[p18l327t130r741b214],

1	Despite	IN	O	despite	_	0	SENT_222	[p18l806t130r1084b214],
2	biological	JJ	O	biological	amod	3	SENT_222	[p18l1140t125r1497b215],
3	plausibility	NN	O	plausibility	prep_despite	10	SENT_222	[p18l1553t125r1975b215],
4	,	,	O	,	_	0	SENT_222	[p18l1553t125r1975b215],
5	the	DT	O	the	det	6	SENT_222	[p18l2034t125r2150b194],
6	direction	NN	O	direction	nsubj	10	SENT_222	[p18l8t234r339b302],
7	of	IN	O	of	_	0	SENT_222	[p18l372t234r455b302],
8	this	DT	O	this	det	9	SENT_222	[p18l472t234r608b302],
9	effect	NN	O	effect	prep_of	6	SENT_222	[p18l642t234r844b302],
10	contrasts	VBZ	O	contrast	_	0	SENT_222	[p18l874t247r1206b302],
11	with	IN	O	with	_	0	SENT_222	[p18l1238t234r1403b302],
12	previous	JJ	O	previous	amod	13	SENT_222	[p18l1433t239r1749b323],
13	ﬁndings	NNS	O	ﬁndings	prep_with	10	SENT_222	[p18l1783t234r2152b324],
14	.	.	O	.	_	0	SENT_222	[p18l1783t234r2152b324],
15	"	''	O	"	punct	10	SENT_222	[p18l1783t234r2152b324],

1	Although	IN	O	although	mark	6	SENT_223	[p18l6t344r359b434],
2	no	DT	O	no	det	4	SENT_223	[p18l379t368r472b411],
3	signiﬁcant	JJ	O	signiﬁcant	amod	4	SENT_223	[p18l497t344r887b434],
4	interactions	NNS	O	interaction	nsubjpass	6	SENT_223	[p18l906t348r1344b412],
5	were	VBD	O	be	auxpass	6	SENT_223	[p18l1366t368r1544b412],
6	recorded	VBN	O	record	advcl	26	SENT_223	[p18l1565t344r1891b412],
7	within	IN	O	within	_	0	SENT_223	[p18l1909t344r2151b412],
8	each	DT	O	each	det	10	SENT_223	[p18l8t452r176b521],
9	treatment	NN	O	treatment	nn	10	SENT_223	[p18l198t466r566b521],
10	group	NN	O	group	prep_within	6	SENT_223	[p18l588t477r826b542],
11	,	,	O	,	_	0	SENT_223	[p18l588t477r826b542],
12	event	NN	O	event	nn	13	SENT_223	[p18l854t466r1052b521],
13	rates	NNS	O	rate	nsubj	26	SENT_223	[p18l1074t466r1248b521],
14	of	IN	O	of	_	0	SENT_223	[p18l1275t452r1358b521],
15	cardiovascular	JJ	O	cardiovascular	amod	16	SENT_223	[p18l1369t452r1903b521],
16	death	NN	O	death	prep_of	13	SENT_223	[p18l1925t452r2147b531],
17	,	,	O	,	_	0	SENT_223	[p18l1925t452r2147b531],
18	myocardial	JJ	O	myocardial	amod	19	SENT_223	[p18l7t561r419b651],
19	infarction	NN	O	infarction	prep_of	13	SENT_223	[p18l504t561r887b639],
20	,	,	O	,	_	0	SENT_223	[p18l504t561r887b639],
21	and	CC	O	and	_	0	SENT_223	[p18l976t561r1114b629],
22	stent	NN	O	stent	nn	23	SENT_223	[p18l1201t575r1381b629],
23	thrombosis	NN	O	thrombosis	prep_of	13	SENT_223	[p18l1463t561r1886b629],
24	were	VBD	O	be	cop	26	SENT_223	[p18l1972t586r2150b629],
25	signiﬁcantly	RB	O	signiﬁcantly	advmod	26	SENT_223	[p18l10t671r465b761],
26	lower	JJR	O	lower	_	0	SENT_223	[p18l483t671r690b739],
27	with	IN	O	with	_	0	SENT_223	[p18l708t671r873b739],
28	ticagrelor	NN	O	ticagrelor	prep_with	26	SENT_223	[p18l894t671r1247b761],
29	than	IN	O	than	dep	26	SENT_223	[p18l1266t671r1435b738],
30	with	IN	O	with	_	0	SENT_223	[p18l1454t671r1619b738],
31	clopidogrel	NN	O	clopidogrel	prep_with	26	SENT_223	[p18l1642t671r2055b761],
32	in	IN	O	in	_	0	SENT_223	[p18l2076t675r2151b737],
33	patients	NNS	O	patient	prep_in	31	SENT_223	[p18l7t784r300b868],
34	with	IN	O	with	_	0	SENT_223	[p18l327t779r492b848],
35	the	DT	O	the	det	39	SENT_223	[p18l518t779r634b848],
36	high-expression	JJ	O	high-expression	amod	39	SENT_223	[p18l661t779r1256b869],
37	AB	NNP	O	AB	nn	39	SENT_223	[p18l1282t785r1397b846],
38	CB1	NN	O	cb1	nn	39	SENT_223	[p18l1407t785r1551b848],
39	polymorphism	NN	O	polymorphism	prep_with	33	SENT_223	[p18l1576t779r2147b869],
40	.	.	O	.	_	0	SENT_223	[p18l1576t779r2147b869],

1	These	DT	O	these	det	2	SENT_224	[p18l6t888r229b956],
2	ﬁndings	NNS	O	ﬁndings	nsubj	3	SENT_224	[p18l260t888r567b978],
3	led	VBD	O	lead	_	0	SENT_224	[p18l599t888r711b956],
4	to	TO	O	to	_	0	SENT_224	[p18l740t901r809b956],
5	a	DT	O	a	det	7	SENT_224	[p18l842t912r880b956],
6	post-hoc	JJ	O	post-hoc	amod	7	SENT_224	[p18l911t888r1224b977],
7	analysis	NN	O	analysis	prep_to	3	SENT_224	[p18l1256t888r1568b978],
8	,	,	O	,	_	0	SENT_224	[p18l1256t888r1568b978],
9	indicating	VBG	O	indicate	xcomp	3	SENT_224	[p18l1603t888r1978b978],
10	that	IN	O	that	complm	19	SENT_224	[p18l2007t888r2152b956],
11	combination	NN	O	combination	nsubj	19	SENT_224	[p18l8t998r481b1066],
12	of	IN	O	of	_	0	SENT_224	[p18l511t998r595b1065],
13	information	NN	O	information	prep_of	11	SENT_224	[p18l611t998r1062b1066],
14	from	IN	O	from	_	0	SENT_224	[p18l1091t998r1275b1065],
15	several	JJ	O	several	amod	16	SENT_224	[p18l1307t998r1559b1066],
16	genes	NNS	O	gene	prep_from	13	SENT_224	[p18l1590t1022r1801b1088],
17	could	MD	O	could	aux	19	SENT_224	[p18l1834t998r2037b1066],
18	be	VB	O	be	cop	19	SENT_224	[p18l2064t998r2150b1065],
19	useful	JJ	O	useful	ccomp	9	SENT_224	[p18l6t1106r238b1175],
20	to	TO	O	to	aux	21	SENT_224	[p18l267t1120r336b1175],
21	identify	VB	O	identify	xcomp	19	SENT_224	[p18l368t1106r652b1196],
22	patients	NNS	O	patient	dobj	21	SENT_224	[p18l681t1111r974b1195],
23	who	WP	O	who	nsubj	25	SENT_224	[p18l1005t1106r1162b1175],
24	would	MD	O	would	aux	25	SENT_224	[p18l1192t1106r1423b1175],
25	beneﬁt	VB	O	beneﬁt	rcmod	22	SENT_224	[p18l1450t1106r1711b1175],
26	more	RBR	O	more	advmod	25	SENT_224	[p18l1740t1131r1935b1175],
27	from	IN	O	from	_	0	SENT_224	[p18l1967t1106r2151b1175],
28	ticagrelor	NN	O	ticagrelor	prep_from	26	SENT_224	[p18l6t1215r360b1305],
29	than	IN	O	than	prep	25	SENT_224	[p18l402t1215r571b1283],
30	from	IN	O	from	pcomp	29	SENT_224	[p18l615t1215r799b1283],
31	clopidogrel	NN	O	clopidogrel	pobj	30	SENT_224	[p18l845t1215r1276b1305],
32	.	.	O	.	_	0	SENT_224	[p18l845t1215r1276b1305],

1	Although	IN	O	although	mark	5	SENT_225	[p18l1324t1215r1676b1305],
2	we	PRP	O	we	nsubj	5	SENT_225	[p18l1719t1239r1822b1283],
3	did	VBD	O	do	aux	5	SENT_225	[p18l1869t1215r1986b1283],
4	not	RB	O	not	neg	5	SENT_225	[p18l2030t1228r2153b1283],
5	record	VB	O	record	advcl	18	SENT_225	[p18l7t1324r246b1393],
6	any	DT	O	any	det	8	SENT_225	[p18l272t1349r402b1414],
7	signiﬁcant	JJ	O	signiﬁcant	amod	8	SENT_225	[p18l430t1324r821b1414],
8	interactions	NNS	O	interaction	dobj	5	SENT_225	[p18l846t1329r1284b1393],
9	between	IN	O	between	_	0	SENT_225	[p18l1313t1325r1624b1393],
10	genotype	NN	O	genotype	nn	13	SENT_225	[p18l1652t1338r1986b1414],
11	and	CC	O	and	_	0	SENT_225	[p18l2014t1325r2152b1393],
12	treatment	NN	O	treatment	conj_and	10	SENT_225	[p18l6t1447r374b1502],
13	group	NN	O	group	prep_between	8	SENT_225	[p18l436t1458r674b1523],
14	,	,	O	,	_	0	SENT_225	[p18l436t1458r674b1523],
15	future	JJ	DATE	future	amod	16	SENT_225	[p18l740t1433r968b1502],
16	studies	NNS	O	study	nsubj	18	SENT_225	[p18l1035t1433r1293b1502],
17	might	MD	O	might	aux	18	SENT_225	[p18l1358t1433r1584b1523],
18	explore	VB	O	explore	_	0	SENT_225	[p18l1646t1433r1913b1522],
19	such	JJ	O	such	amod	21	SENT_225	[p18l1978t1433r2151b1502],
20	combined	JJ	O	combined	amod	21	SENT_225	[p18l8t1542r382b1610],
21	approaches	NNS	O	approach	dobj	18	SENT_225	[p18l446t1542r864b1631],
22	for	IN	O	for	_	0	SENT_225	[p18l931t1542r1038b1610],
23	tailoring	VBG	O	tailor	prepc_for	18	SENT_225	[p18l1100t1542r1415b1632],
24	of	IN	O	of	_	0	SENT_225	[p18l1480t1542r1564b1610],
25	treatments	NNS	O	treatment	prep_of	23	SENT_225	[p18l1614t1555r2015b1610],
26	to	TO	O	to	_	0	SENT_225	[p18l2081t1555r2150b1610],
27	individual	JJ	O	individual	amod	28	SENT_225	[p18l7t1652r382b1721],
28	patients	NNS	O	patient	prep_to	25	SENT_225	[p18l406t1657r720b1741],
29	.	.	O	.	_	0	SENT_225	[p18l406t1657r720b1741],

1	This	DT	O	this	det	2	SENT_226	[p18l77t1761r240b1829],
2	study	NN	O	study	nsubj	3	SENT_226	[p18l292t1761r491b1851],
3	has	VBZ	O	have	_	0	SENT_226	[p18l534t1761r659b1829],
4	several	JJ	O	several	amod	5	SENT_226	[p18l711t1761r963b1829],
5	limitations	NNS	O	limitation	dobj	3	SENT_226	[p18l1008t1761r1431b1829],
6	.	.	O	.	_	0	SENT_226	[p18l1008t1761r1431b1829],

1	First	RB	ORDINAL	first	advmod	6	SENT_227	[p18l1485t1766r1668b1839],
2	,	,	O	,	_	0	SENT_227	[p18l1485t1766r1668b1839],
3	we	PRP	O	we	nsubj	6	SENT_227	[p18l1716t1786r1819b1829],
4	did	VBD	O	do	aux	6	SENT_227	[p18l1868t1761r1985b1829],
5	not	RB	O	not	neg	6	SENT_227	[p18l2030t1775r2153b1829],
6	include	VB	O	include	_	0	SENT_227	[p18l7t1870r283b1938],
7	all	DT	O	all	det	9	SENT_227	[p18l322t1870r407b1938],
8	genetic	JJ	O	genetic	amod	9	SENT_227	[p18l446t1875r711b1960],
9	polymorphisms	NNS	O	polymorphism	dobj	6	SENT_227	[p18l748t1870r1336b1959],
10	that	WDT	O	that	nsubj	12	SENT_227	[p18l1375t1870r1520b1938],
11	could	MD	O	could	aux	12	SENT_227	[p18l1557t1870r1761b1938],
12	affect	VB	O	affect	rcmod	9	SENT_227	[p18l1798t1870r1999b1938],
13	the	DT	O	the	det	16	SENT_227	[p18l2034t1870r2150b1938],
14	pharmacokinetic	JJ	O	pharmacokinetic	amod	16	SENT_227	[p18l7t1980r654b2068],
15	,	,	O	,	_	0	SENT_227	[p18l7t1980r654b2068],
16	pharmacodynamic	JJ	O	pharmacodynamic	dobj	12	SENT_227	[p18l691t1979r1406b2069],
17	,	,	O	,	_	0	SENT_227	[p18l691t1979r1406b2069],
18	and	CC	O	and	_	0	SENT_227	[p18l1444t1979r1582b2048],
19	clinical	JJ	O	clinical	amod	20	SENT_227	[p18l1615t1979r1879b2048],
20	effects	NNS	O	effect	dobj	12	SENT_227	[p18l1913t1980r2148b2048],
21	of	IN	O	of	_	0	SENT_227	[p18l8t2088r92b2156],
22	ticagrelor	NN	O	ticagrelor	prep_of	16	SENT_227	[p18l102t2088r465b2178],
23	,	,	O	,	_	0	SENT_227	[p18l102t2088r465b2178],
24	such	JJ	O	such	_	0	SENT_227	[p18l495t2088r668b2156],
25	as	IN	O	as	_	0	SENT_227	[p18l693t2112r764b2156],
26	CYP3A4	NN	O	cyp3a4	prep_such_as	22	SENT_227	[p18l798t2093r1107b2156],
27	or	CC	O	or	_	0	SENT_227	[p18l1127t2113r1204b2156],
28	CYP3A5	NN	O	cyp3a5	prep_such_as	22	SENT_227	[p18l1233t2093r1544b2156],
29	or	CC	O	or	_	0	SENT_227	[p18l1566t2113r1643b2156],
30	other	JJ	O	other	amod	32	SENT_227	[p18l1667t2088r1862b2156],
31	genetic	JJ	O	genetic	amod	32	SENT_227	[p18l1886t2093r2152b2178],
32	variants	NNS	O	variant	prep_such_as	22	SENT_227	[p18l6t2202r298b2266],
33	possibly	RB	O	possibly	advmod	34	SENT_227	[p18l342t2198r645b2287],
34	participating	VBG	O	participate	partmod	32	SENT_227	[p18l685t2202r1158b2288],
35	in	IN	O	in	_	0	SENT_227	[p18l1200t2202r1274b2264],
36	the	DT	O	the	det	37	SENT_227	[p18l1315t2198r1431b2266],
37	response	NN	O	response	prep_in	34	SENT_227	[p18l1474t2222r1807b2287],
38	to	TO	O	to	_	0	SENT_227	[p18l1848t2211r1917b2265],
39	P2Y	NN	O	p2y	prep_to	37	SENT_227	[p18l1964t2204r2151b2283],
40	,	,	O	,	_	0	SENT_227	[p18l1964t2204r2151b2283],
41	,	,	O	,	_	0	SENT_227	[p18l1964t2204r2151b2283],
42	inhibitors	NNS	O	inhibitor	appos	22	SENT_227	[p18l7t2307r438b2375],
43	.	.	O	.	_	0	SENT_227	[p18l7t2307r438b2375],

1	”	NN	O	”	ccomp	8	SENT_228	[p18l7t2307r438b2375],
2	However	RB	O	however	advmod	1	SENT_228	[p18l476t2313r818b2385],
3	,	,	O	,	_	0	SENT_228	[p18l476t2313r818b2385],
4	such	JJ	O	such	amod	5	SENT_228	[p18l858t2307r1030b2375],
5	investigations	NNS	O	investigation	nsubjpass	8	SENT_228	[p18l1063t2311r1577b2397],
6	could	MD	O	could	aux	8	SENT_228	[p18l1614t2307r1816b2374],
7	be	VB	O	be	auxpass	8	SENT_228	[p18l1847t2307r1933b2374],
8	done	VBN	O	do	conj_and	8	SENT_228	[p18l1969t2307r2150b2375],
9	in	IN	O	in	_	0	SENT_228	[p18l7t2420r82b2482],
10	a	DT	O	a	det	14	SENT_228	[p18l121t2440r159b2484],
11	pharmacokinetic	JJ	O	pharmacokinetic	amod	14	SENT_228	[p18l197t2415r825b2504],
12	and	CC	O	and	_	0	SENT_228	[p18l865t2415r1002b2484],
13	pharmacodynamic	JJ	O	pharmacodynamic	conj_and	11	SENT_228	[p18l1039t2415r1737b2505],
14	study	NN	O	study	prep_in	8	SENT_228	[p18l1777t2415r1976b2505],
15	and	CC	O	and	_	0	SENT_228	[p18l2014t2415r2152b2484],
16	by	IN	O	by	_	0	SENT_228	[p18l6t2524r93b2614],
17	expansion	NN	O	expansion	agent	8	SENT_228	[p18l120t2529r497b2613],
18	of	IN	O	of	_	0	SENT_228	[p18l525t2524r608b2592],
19	analyses	NNS	O	analysis	prep_of	17	SENT_228	[p18l624t2524r930b2614],
20	of	IN	O	of	_	0	SENT_228	[p18l961t2524r1045b2592],
21	available	JJ	O	available	amod	22	SENT_228	[p18l1060t2524r1378b2592],
22	data	NNS	O	datum	prep_of	19	SENT_228	[p18l1407t2524r1559b2592],
23	into	IN	O	into	_	0	SENT_228	[p18l1586t2529r1731b2592],
24	a	DT	O	a	det	27	SENT_228	[p18l1761t2549r1798b2592],
25	genomewide	JJ	O	genomewide	amod	27	SENT_228	[p18l1827t2549r2149b2614, p18l6t2634r181b2702],
26	association	NN	O	association	nn	27	SENT_228	[p18l266t2638r677b2702],
27	study	NN	O	study	prep_into	8	SENT_228	[p18l763t2634r970b2723],
28	.	.	O	.	_	0	SENT_228	[p18l763t2634r970b2723],

1	Second	RB	ORDINAL	second	advmod	6	SENT_229	[p18l1064t2634r1346b2712],
2	,	,	O	,	_	0	SENT_229	[p18l1064t2634r1346b2712],
3	our	PRP$	O	we	poss	4	SENT_229	[p18l1434t2658r1561b2702],
4	study	NN	O	study	nsubj	6	SENT_229	[p18l1646t2634r1845b2723],
5	might	MD	O	might	aux	6	SENT_229	[p18l1927t2634r2152b2724],
6	underestimate	VB	O	underestimate	_	0	SENT_229	[p18l6t2742r547b2811],
7	the	DT	O	the	det	8	SENT_229	[p18l588t2742r705b2811],
8	inﬂuence	NN	O	inﬂuence	dobj	6	SENT_229	[p18l747t2742r1097b2811],
9	of	IN	O	of	_	0	SENT_229	[p18l1141t2742r1224b2811],
10	genetic	JJ	O	genetic	amod	11	SENT_229	[p18l1254t2747r1520b2832],
11	polymorphisms	NNS	O	polymorphism	prep_of	8	SENT_229	[p18l1561t2742r2148b2832],
12	on	IN	O	on	_	0	SENT_229	[p18l8t2875r102b2919],
13	the	DT	O	the	det	14	SENT_229	[p18l141t2851r257b2919],
14	effects	NNS	O	effect	prep_on	6	SENT_229	[p18l298t2851r533b2919],
15	of	IN	O	of	_	0	SENT_229	[p18l577t2851r660b2919],
16	clopidogrel	NN	O	clopidogrel	prep_of	14	SENT_229	[p18l688t2851r1101b2941],
17	in	IN	O	in	_	0	SENT_229	[p18l1141t2856r1215b2918],
18	certain	JJ	O	certain	amod	19	SENT_229	[p18l1255t2856r1509b2919],
19	settings	NNS	O	setting	prep_in	6	SENT_229	[p18l1552t2856r2033b2941],
20	—	VBP	O	—	dep	19	SENT_229	[p18l1552t2856r2033b2941],
21	eg	FW	O	eg	dobj	20	SENT_229	[p18l1552t2856r2033b2941],
22	,	,	O	,	_	0	SENT_229	[p18l1552t2856r2033b2941],
23	in	IN	O	in	_	0	SENT_229	[p18l2076t2856r2151b2918],
24	clopidogrel-naive	JJ	O	clopidogrel-naive	amod	25	SENT_229	[p18l8t2961r643b3051],
25	patients	NNS	O	patient	conj_and	25	SENT_229	[p18l663t2965r956b3050],
26	at	IN	O	at	_	0	SENT_229	[p18l978t2974r1043b3028],
27	start	NN	O	start	prep_at	25	SENT_229	[p18l1063t2974r1224b3029],
28	of	IN	O	of	_	0	SENT_229	[p18l1242t2961r1325b3028],
29	clopidogrel	NN	O	clopidogrel	nn	30	SENT_229	[p18l1332t2961r1745b3051],
30	treatment	NN	O	treatment	prep_of	27	SENT_229	[p18l1763t2974r2147b3039],
31	,	,	O	,	_	0	SENT_229	[p18l1763t2974r2147b3039],
32	and	CC	O	and	_	0	SENT_229	[p18l8t3069r146b3138],
33	in	IN	O	in	_	0	SENT_229	[p18l166t3074r241b3136],
34	patients	NNS	O	patient	prep_in	25	SENT_229	[p18l262t3074r555b3158],
35	with	IN	O	with	_	0	SENT_229	[p18l576t3069r741b3138],
36	high	JJ	O	high	amod	37	SENT_229	[p18l761t3069r932b3159],
37	risk	NN	O	risk	prep_with	34	SENT_229	[p18l953t3069r1093b3138],
38	of	IN	O	of	_	0	SENT_229	[p18l1114t3069r1197b3138],
39	ischaemic	JJ	O	ischaemic	amod	40	SENT_229	[p18l1205t3069r1579b3138],
40	events	NNS	O	event	prep_of	37	SENT_229	[p18l1601t3083r1833b3138],
41	because	IN	O	because	mark	44	SENT_229	[p18l1855t3069r2150b3138],
42	treatment	NN	O	treatment	nsubjpass	44	SENT_229	[p18l6t3192r374b3247],
43	is	VBZ	O	be	auxpass	44	SENT_229	[p18l435t3184r492b3247],
44	accompanied	VBN	O	accompany	dep	34	SENT_229	[p18l558t3179r1052b3268],
45	by	IN	O	by	_	0	SENT_229	[p18l1112t3179r1199b3268],
46	percutaneous	JJ	O	percutaneous	amod	48	SENT_229	[p18l1259t3192r1760b3268],
47	coronary	JJ	O	coronary	amod	48	SENT_229	[p18l1827t3203r2153b3268],
48	intervention	NN	O	intervention	agent	44	SENT_229	[p18l7t3293r465b3357],
49	and	CC	O	and	_	0	SENT_229	[p18l492t3289r630b3357],
50	stent	NN	O	stent	nn	51	SENT_229	[p18l658t3302r839b3357],
51	procedures	NNS	O	procedure	conj_and	48	SENT_229	[p18l864t3289r1296b3377],
52	.	.	O	.	_	0	SENT_229	[p18l864t3289r1296b3377],

1	Because	IN	O	because	mark	7	SENT_230	[p18l1331t3295r1631b3357],
2	the	DT	O	the	det	3	SENT_230	[p18l1657t3288r1774b3357],
3	data	NNS	O	datum	nsubjpass	7	SENT_230	[p18l1802t3288r1955b3357],
4	have	VBP	O	have	aux	7	SENT_230	[p18l1980t3289r2150b3357],
5	not	RB	O	not	neg	7	SENT_230	[p18l7t3411r130b3466],
6	been	VBN	O	be	auxpass	7	SENT_230	[p18l209t3397r389b3466],
7	adjusted	VBN	O	adjust	advcl	32	SENT_230	[p18l472t3397r786b3487],
8	for	IN	O	for	_	0	SENT_230	[p18l866t3397r973b3466],
9	multiple	JJ	O	multiple	amod	11	SENT_230	[p18l1053t3397r1367b3486],
10	statistical	JJ	O	statistical	amod	11	SENT_230	[p18l1452t3397r1796b3466],
11	testing	NN	O	testing	prep_for	7	SENT_230	[p18l1876t3402r2147b3487],
12	,	,	O	,	_	0	SENT_230	[p18l1876t3402r2147b3487],
13	signiﬁcant	JJ	O	signiﬁcant	amod	14	SENT_230	[p18l10t3506r401b3596],
14	results	NNS	O	result	nsubjpass	32	SENT_230	[p18l429t3506r675b3574],
15	that	WDT	O	that	nsubjpass	26	SENT_230	[p18l706t3506r851b3574],
16	do	VBP	O	do	aux	18	SENT_230	[p18l880t3506r968b3574],
17	not	RB	O	not	neg	18	SENT_230	[p18l999t3519r1121b3574],
18	follow	VB	O	follow	rcmod	14	SENT_230	[p18l1150t3506r1378b3574],
19	a	DT	O	a	det	21	SENT_230	[p18l1408t3530r1444b3574],
20	general	JJ	O	general	amod	21	SENT_230	[p18l1475t3506r1749b3596],
21	pattern	NN	O	pattern	dobj	18	SENT_230	[p18l1779t3519r2045b3595],
22	or	CC	O	or	_	0	SENT_230	[p18l2076t3530r2152b3574],
23	have	VBP	O	have	aux	26	SENT_230	[p18l6t3616r176b3684],
24	not	RB	O	not	neg	26	SENT_230	[p18l236t3629r358b3684],
25	been	VBN	O	be	auxpass	26	SENT_230	[p18l414t3616r595b3684],
26	veriﬁed	VBN	O	veriﬁed	rcmod	14	SENT_230	[p18l651t3615r932b3684],
27	by	IN	O	by	_	0	SENT_230	[p18l988t3616r1075b3705],
28	other	JJ	O	other	amod	29	SENT_230	[p18l1133t3615r1329b3684],
29	ﬁndings	NNS	O	ﬁndings	agent	26	SENT_230	[p18l1386t3615r1692b3705],
30	should	MD	O	should	aux	32	SENT_230	[p18l1756t3615r2008b3684],
31	be	VB	O	be	auxpass	32	SENT_230	[p18l2064t3616r2150b3684],
32	interpreted	VBN	O	interpret	_	0	SENT_230	[p18l7t3724r422b3813],
33	with	IN	O	with	_	0	SENT_230	[p18l441t3724r607b3793],
34	caution	NN	O	caution	prep_with	32	SENT_230	[p18l629t3729r922b3792],
35	.	.	O	.	_	0	SENT_230	[p18l629t3729r922b3792],

1	Last	JJ	O	last	nsubj	10	SENT_231	[p18l952t3731r1117b3802],
2	,	,	O	,	_	0	SENT_231	[p18l952t3731r1117b3802],
3	98	CD	PERCENT	98	num	4	SENT_231	[p18l1143t3729r1304b3795],
4	%	NN	PERCENT	%	appos	1	SENT_231	[p18l1143t3729r1304b3795],
5	of	IN	O	of	_	0	SENT_231	[p18l1327t3724r1411b3792],
6	the	DT	O	the	det	8	SENT_231	[p18l1419t3724r1535b3792],
7	substudy	JJ	O	substudy	amod	8	SENT_231	[p18l1560t3724r1894b3814],
8	cohort	NN	O	cohort	prep_of	4	SENT_231	[p18l1916t3724r2153b3792],
9	were	VBD	O	be	cop	10	SENT_231	[p19l6t40r183b84],
10	white	JJ	O	white	_	0	SENT_231	[p19l225t16r450b94],
11	,	,	O	,	_	0	SENT_231	[p19l225t16r450b94],
12	so	IN	O	so	dep	10	SENT_231	[p19l498t40r575b84],
13	these	DT	O	these	det	14	SENT_231	[p19l618t16r813b84],
14	results	NNS	O	result	nsubj	18	SENT_231	[p19l856t16r1102b84],
15	might	MD	O	might	aux	18	SENT_231	[p19l1148t16r1373b106],
16	only	RB	O	only	advmod	18	SENT_231	[p19l1416t16r1574b105],
17	be	VB	O	be	cop	18	SENT_231	[p19l1614t16r1700b84],
18	relevant	JJ	O	relevant	ccomp	10	SENT_231	[p19l1744t16r2041b84],
19	to	TO	O	to	_	0	SENT_231	[p19l2081t29r2150b84],
20	White	NNP	O	White	nn	21	SENT_231	[p19l6t126r211b195],
21	populations	NNS	O	population	prep_to	18	SENT_231	[p19l236t127r695b215],
22	.	.	O	.	_	0	SENT_231	[p19l236t127r695b215],

1	Contributors	NNS	O	contributor	_	0	SENT_232	[p19l8t274r369b325],

1	S	NN	O	s	nn	2	SENT_233	[p19l12t363r84b427],
2	]	NN	O	]	nsubj	20	SENT_233	[p19l12t363r84b427],
3	,	,	O	,	_	0	SENT_233	[p19l12t363r84b427],
4	RFS	NN	O	rf	appos	2	SENT_233	[p19l110t362r245b421],
5	,	,	O	,	_	0	SENT_233	[p19l110t362r245b421],
6	MA	NNP	LOCATION	MA	appos	2	SENT_233	[p19l270t363r390b420],
7	,	,	O	,	_	0	SENT_233	[p19l270t363r390b420],
8	BIB	NNP	O	BIB	appos	2	SENT_233	[p19l416t365r540b428],
9	,	,	O	,	_	0	SENT_233	[p19l416t365r540b428],
10	IH	NN	O	ih	appos	2	SENT_233	[p19l564t365r660b427],
11	,	,	O	,	_	0	SENT_233	[p19l564t365r660b427],
12	SH	NN	O	sh	conj_and	10	SENT_233	[p19l687t363r793b421],
13	,	,	O	,	_	0	SENT_233	[p19l687t363r793b421],
14	HK	NN	LOCATION	hk	conj_and	10	SENT_233	[p19l819t365r933b420],
15	,	,	O	,	_	0	SENT_233	[p19l819t365r933b420],
16	PCS	NN	O	pc	appos	2	SENT_233	[p19l958t363r1101b421],
17	,	,	O	,	_	0	SENT_233	[p19l958t363r1101b421],
18	and	CC	O	and	_	0	SENT_233	[p19l1125t359r1233b412],
19	RCB	NN	O	rcb	conj_and	10	SENT_233	[p19l1255t363r1384b412],
20	designed	VBD	O	design	_	0	SENT_233	[p19l1408t359r1670b429],
21	the	DT	O	the	det	22	SENT_233	[p19l1688t359r1780b412],
22	study	NN	O	study	dobj	20	SENT_233	[p19l1802t359r1958b429],
23	under	IN	O	under	_	0	SENT_233	[p19l1976t359r2152b412],
24	the	DT	O	the	det	25	SENT_233	[p19l6t430r98b483],
25	leadership	NN	O	leadership	prep_under	20	SENT_233	[p19l117t430r421b500],
26	of	IN	O	of	_	0	SENT_233	[p19l443t430r508b483],
27	LW	NN	O	lw	prep_of	25	SENT_233	[p19l521t436r620b484],
28	.	.	O	.	_	0	SENT_233	[p19l521t436r620b484],

1	LW	NN	O	lw	nsubj	10	SENT_234	[p19l646t436r746b492],
2	,	,	O	,	_	0	SENT_234	[p19l646t436r746b492],
3	MA	NNP	LOCATION	MA	nsubj	10	SENT_234	[p19l771t434r892b491],
4	,	,	O	,	_	0	SENT_234	[p19l771t434r892b491],
5	BIB	NNP	O	BIB	nsubj	10	SENT_234	[p19l918t436r1042b499],
6	,	,	O	,	_	0	SENT_234	[p19l918t436r1042b499],
7	and	CC	O	and	_	0	SENT_234	[p19l1065t430r1173b483],
8	]	NN	O	]	nn	9	SENT_234	[p19l1194t436r1271b498],
9	H	NN	O	h	nsubj	10	SENT_234	[p19l1194t436r1271b498],
10	planned	VBD	O	plan	_	0	SENT_234	[p19l1294t430r1532b500],
11	the	DT	O	the	det	15	SENT_234	[p19l1551t430r1642b483],
12	genetic	JJ	O	genetic	amod	15	SENT_234	[p19l1663t434r1873b501],
13	and	CC	O	and	_	0	SENT_234	[p19l1893t430r2001b483],
14	statistical	JJ	O	statistical	amod	15	SENT_234	[p19l9t501r280b554],
15	analyses	NNS	O	analysis	dobj	10	SENT_234	[p19l300t501r558b571],
16	,	,	O	,	_	0	SENT_234	[p19l300t501r558b571],
17	which	WDT	O	which	nsubjpass	19	SENT_234	[p19l579t501r758b554],
18	were	VBD	O	be	auxpass	19	SENT_234	[p19l776t520r916b554],
19	done	VBN	O	do	rcmod	15	SENT_234	[p19l937t501r1079b554],
20	at	IN	O	at	_	0	SENT_234	[p19l1100t512r1151b554],
21	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	nn	22	SENT_234	[p19l1169t504r1537b554],
22	Research	NNP	ORGANIZATION	Research	prep_at	19	SENT_234	[p19l1560t501r1822b554],
23	and	CC	ORGANIZATION	and	_	0	SENT_234	[p19l1842t501r1950b554],
24	Development	NNP	ORGANIZATION	Development	conj_and	22	SENT_234	[p19l11t576r402b646],
25	and	CC	ORGANIZATION	and	_	0	SENT_234	[p19l421t576r529b629],
26	Genetics	NNP	ORGANIZATION	Genetics	nn	30	SENT_234	[p19l550t579r801b629],
27	Laboratory	NNP	ORGANIZATION	Laboratory	nn	30	SENT_234	[p19l826t576r1136b646],
28	(	NNP	O	(	nn	30	SENT_234	[p19l1159t576r1419b646],
29	Alderley	NNP	O	Alderley	nn	30	SENT_234	[p19l1159t576r1419b646],
30	Park	NNP	O	Park	conj_and	15	SENT_234	[p19l1441t576r1585b637],
31	,	,	O	,	_	0	SENT_234	[p19l1441t576r1585b637],
32	UK	NNP	LOCATION	UK	appos	30	SENT_234	[p19l1610t581r1720b638],
33	;	:	O	;	_	0	SENT_234	[p19l1610t581r1720b638],
34	genetic	JJ	O	genetic	amod	35	SENT_234	[p19l1744t579r1953b646],
35	analyses	NNS	O	analysis	conj_and	15	SENT_234	[p19l8t646r268b716],
36	)	CD	NUMBER	)	dep	35	SENT_234	[p19l8t646r268b716],
37	and	CC	O	and	_	0	SENT_234	[p19l293t646r401b699],
38	Worldwide	NNP	MISC	Worldwide	conj_and	15	SENT_234	[p19l420t646r737b699],
39	Clinical	JJ	MISC	clinical	amod	40	SENT_234	[p19l759t646r982b699],
40	Trials	NNS	MISC	trial	nsubj	41	SENT_234	[p19l1000t646r1159b699],
41	(	VBP	O	(	rcmod	38	SENT_234	[p19l1185t646r1573b716],
42	Nottingham	NNP	LOCATION	Nottingham	dobj	41	SENT_234	[p19l1185t646r1573b716],
43	,	,	O	,	_	0	SENT_234	[p19l1185t646r1573b716],
44	UK	NNP	LOCATION	UK	appos	42	SENT_234	[p19l1598t651r1708b707],
45	;	:	O	;	_	0	SENT_234	[p19l1598t651r1708b707],
46	statistical	JJ	O	statistical	amod	47	SENT_234	[p19l1733t646r2004b699],
47	analyses	NNS	O	analysis	nsubj	48	SENT_234	[p19l8t716r268b786],
48	)	VBP	O	)	parataxis	10	SENT_234	[p19l8t716r268b786],
49	under	IN	O	under	_	0	SENT_234	[p19l292t716r468b769],
50	the	DT	O	the	det	51	SENT_234	[p19l486t716r578b769],
51	leadership	NN	O	leadership	prep_under	48	SENT_234	[p19l597t716r901b785],
52	of	IN	O	of	_	0	SENT_234	[p19l923t716r988b769],
53	MA	NNP	O	MA	prep_of	51	SENT_234	[p19l1000t719r1106b768],
54	and	CC	O	and	_	0	SENT_234	[p19l1126t716r1234b769],
55	BIB	NNP	O	BIB	prep_of	51	SENT_234	[p19l1256t721r1380b784],
56	.	.	O	.	_	0	SENT_234	[p19l1256t721r1380b784],

1	LW	NN	O	lw	nsubj	5	SENT_235	[p19l1407t721r1500b769],
2	was	VBD	O	be	cop	5	SENT_235	[p19l1517t735r1626b769],
3	the	DT	O	the	det	5	SENT_235	[p19l1647t716r1738b769],
4	principal	JJ	O	principal	amod	5	SENT_235	[p19l1758t716r2020b785],
5	investigator	NN	O	investigator	_	0	SENT_235	[p19l7t789r359b856],
6	,	,	O	,	_	0	SENT_235	[p19l7t789r359b856],
7	and	CC	O	and	_	0	SENT_235	[p19l382t786r490b839],
8	S	NN	O	s	nn	9	SENT_235	[p19l514t789r586b854],
9	]	NN	O	]	nsubj	24	SENT_235	[p19l514t789r586b854],
10	,	,	O	,	_	0	SENT_235	[p19l514t789r586b854],
11	RFS	NN	O	rf	nsubj	24	SENT_235	[p19l612t789r747b847],
12	,	,	O	,	_	0	SENT_235	[p19l612t789r747b847],
13	IH	NN	O	ih	nsubj	24	SENT_235	[p19l771t791r867b854],
14	,	,	O	,	_	0	SENT_235	[p19l771t791r867b854],
15	SI-I	NN	O	si-i	nsubj	24	SENT_235	[p19l894t790r1000b847],
16	,	,	O	,	_	0	SENT_235	[p19l894t790r1000b847],
17	HK	NNP	LOCATION	HK	nsubj	24	SENT_235	[p19l1026t791r1140b847],
18	,	,	O	,	_	0	SENT_235	[p19l1026t791r1140b847],
19	PGS	NNP	ORGANIZATION	PGS	nsubj	24	SENT_235	[p19l1166t790r1309b847],
20	,	,	O	,	_	0	SENT_235	[p19l1166t790r1309b847],
21	and	CC	O	and	_	0	SENT_235	[p19l1332t786r1440b839],
22	RCB	NN	O	rcb	nsubj	24	SENT_235	[p19l1462t789r1591b839],
23	were	VBD	O	be	cop	24	SENT_235	[p19l1613t805r1752b839],
24	members	NNS	O	member	conj_and	5	SENT_235	[p19l1773t786r2050b839],
25	of	IN	O	of	_	0	SENT_235	[p19l2072t786r2138b839],
26	the	DT	O	the	det	28	SENT_235	[p19l6t856r98b909],
27	executive	NN	O	executive	nn	28	SENT_235	[p19l119t859r385b909],
28	committee	NN	O	committee	prep_of	24	SENT_235	[p19l406t859r719b909],
29	of	IN	O	of	_	0	SENT_235	[p19l740t856r804b909],
30	the	DT	O	the	det	32	SENT_235	[p19l814t856r905b909],
31	PLATO	NNP	O	PLATO	nn	32	SENT_235	[p19l929t859r1137b909],
32	trial	NN	O	trial	prep_of	28	SENT_235	[p19l1158t856r1275b909],
33	and	CC	O	and	_	0	SENT_235	[p19l1295t856r1403b909],
34	accrued	VBN	O	accrue	amod	36	SENT_235	[p19l1423t856r1650b909],
35	clinical	JJ	O	clinical	amod	36	SENT_235	[p19l1669t856r1876b909],
36	data	NNS	O	datum	conj_and	28	SENT_235	[p19l1897t856r2031b909],
37	.	.	O	.	_	0	SENT_235	[p19l1897t856r2031b909],

1	All	DT	O	all	det	2	SENT_236	[p19l2053t856r2136b908],
2	authors	NNS	O	author	nsubj	3	SENT_236	[p19l8t925r227b978],
3	interpreted	VBD	O	interpret	_	0	SENT_236	[p19l249t925r575b994],
4	the	DT	O	the	det	5	SENT_236	[p19l593t925r685b978],
5	results	NNS	O	result	dobj	3	SENT_236	[p19l705t925r915b978],
6	.	.	O	.	_	0	SENT_236	[p19l705t925r915b978],

1	LW	NN	O	lw	nsubj	2	SENT_237	[p19l941t930r1035b979],
2	drafted	VBD	O	draft	_	0	SENT_237	[p19l1055t925r1260b978],
3	the	DT	O	the	det	4	SENT_237	[p19l1279t925r1370b978],
4	report	NN	O	report	dobj	2	SENT_237	[p19l1390t936r1569b994],
5	in	IN	O	in	_	0	SENT_237	[p19l1587t928r1646b977],
6	collaboration	NN	O	collaboration	prep_in	2	SENT_237	[p19l1667t925r2047b978],
7	with	IN	O	with	_	0	SENT_237	[p19l6t995r135b1048],
8	the	DT	O	the	det	9	SENT_237	[p19l154t995r245b1048],
9	coauthors	NNS	O	coauthor	prep_with	2	SENT_237	[p19l266t995r551b1048],
10	who	WP	O	who	nsubj	11	SENT_237	[p19l572t995r695b1048],
11	vouch	VBP	O	vouch	rcmod	9	SENT_237	[p19l714t995r890b1048],
12	for	IN	O	for	_	0	SENT_237	[p19l910t995r993b1048],
13	the	DT	O	the	det	14	SENT_237	[p19l1011t995r1102b1048],
14	accuracy	NN	O	accuracy	prep_for	11	SENT_237	[p19l1124t1014r1374b1065],
15	and	CC	O	and	_	0	SENT_237	[p19l1393t995r1501b1048],
16	completeness	NN	O	completeness	prep_for	11	SENT_237	[p19l1521t995r1918b1064],
17	of	IN	O	of	_	0	SENT_237	[p19l1941t995r2006b1048],
18	the	DT	O	the	det	20	SENT_237	[p19l2015t995r2106b1048],
19	reported	VBN	O	report	amod	20	SENT_237	[p19l7t1065r255b1135],
20	data	NNS	O	datum	prep_of	14	SENT_237	[p19l275t1065r408b1119],
21	.	.	O	.	_	0	SENT_237	[p19l275t1065r408b1119],

1	Conﬂicts	NNS	O	conﬂicts	nsubj	6	SENT_238	[p19l8t1158r253b1210],
2	of	IN	O	of	_	0	SENT_238	[p19l269t1158r329b1210],
3	interest	NN	O	interest	nn	4	SENT_238	[p19l343t1160r561b1210],
4	LW	NN	O	lw	prep_of	1	SENT_238	[p19l11t1230r104b1278],
5	has	VBZ	O	have	aux	6	SENT_238	[p19l122t1225r220b1278],
6	received	VBN	O	receive	_	0	SENT_238	[p19l242t1225r483b1278],
7	research	NN	O	research	nn	8	SENT_238	[p19l502t1225r749b1278],
8	grants	NNS	O	grant	dobj	6	SENT_238	[p19l770t1236r950b1295],
9	from	IN	O	from	_	0	SENT_238	[p19l971t1225r1116b1278],
10	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_from	6	SENT_238	[p19l1135t1228r1518b1286],
11	,	,	O	,	_	0	SENT_238	[p19l1135t1228r1518b1286],
12	Boehringer	NNP	PERSON	Boehringer	nn	13	SENT_238	[p19l1543t1225r1873b1295],
13	Ingelheim	NNP	PERSON	Ingelheim	prep_from	6	SENT_238	[p19l11t1295r327b1365],
14	,	,	O	,	_	0	SENT_238	[p19l11t1295r327b1365],
15	Bristol-Myers	NNP	O	Bristol-Myers	nn	16	SENT_238	[p19l353t1295r743b1365],
16	Squibb	NNP	O	Squibb	prep_from	6	SENT_238	[p19l770t1295r987b1364],
17	,	,	O	,	_	0	SENT_238	[p19l770t1295r987b1364],
18	GlaxoSmithKline	NNP	ORGANIZATION	GlaxoSmithKline	conj_and	10	SENT_238	[p19l1012t1295r1531b1356],
19	,	,	O	,	_	0	SENT_238	[p19l1012t1295r1531b1356],
20	and	CC	O	and	_	0	SENT_238	[p19l1555t1295r1662b1348],
21	Schering-Plough	NNP	ORGANIZATION	Schering-Plough	conj_and	10	SENT_238	[p19l12t1366r515b1436],
22	;	:	O	;	_	0	SENT_238	[p19l12t1366r515b1436],
23	honoraria	NN	O	honorarium	dep	10	SENT_238	[p19l537t1366r824b1419],
24	from	IN	O	from	_	0	SENT_238	[p19l844t1365r988b1419],
25	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_from	23	SENT_238	[p19l1007t1369r1390b1427],
26	,	,	O	,	_	0	SENT_238	[p19l1007t1369r1390b1427],
27	Boehringer	NNP	PERSON	Boehringer	nn	28	SENT_238	[p19l1415t1366r1745b1436],
28	Ingelheim	NNP	PERSON	Ingelheim	conj_and	25	SENT_238	[p19l1767t1366r2084b1436],
29	,	,	O	,	_	0	SENT_238	[p19l1767t1366r2084b1436],
30	Bristol-Myers	NNP	O	Bristol-Myers	nn	31	SENT_238	[p19l11t1436r401b1506],
31	Squibb	NNP	O	Squibb	prep_from	23	SENT_238	[p19l427t1436r644b1506],
32	,	,	O	,	_	0	SENT_238	[p19l427t1436r644b1506],
33	GlaxoSmithKline	NNP	ORGANIZATION	GlaxoSmithKline	prep_from	23	SENT_238	[p19l669t1436r1188b1498],
34	,	,	O	,	_	0	SENT_238	[p19l669t1436r1188b1498],
35	Schering-Plough	NNP	ORGANIZATION	Schering-Plough	prep_from	23	SENT_238	[p19l1215t1436r1719b1507],
36	,	,	O	,	_	0	SENT_238	[p19l1215t1436r1719b1507],
37	and	CC	O	and	_	0	SENT_238	[p19l1743t1437r1851b1490],
38	Eli	NNP	ORGANIZATION	Eli	nn	39	SENT_238	[p19l1873t1436r1946b1489],
39	Lilly	NNP	ORGANIZATION	Lilly	prep_from	23	SENT_238	[p19l1970t1436r2103b1506],
40	;	:	O	;	_	0	SENT_238	[p19l1970t1436r2103b1506],
41	consultancy	NN	O	consultancy	nn	42	SENT_238	[p19l8t1507r356b1578],
42	fees	NNS	O	fee	dep	10	SENT_238	[p19l374t1507r487b1561],
43	from	IN	O	from	_	0	SENT_238	[p19l509t1507r654b1561],
44	Regado	NNP	ORGANIZATION	Regado	nn	45	SENT_238	[p19l676t1507r887b1578],
45	Biotechnologies	NNP	ORGANIZATION	Biotechnologies	prep_from	42	SENT_238	[p19l911t1507r1390b1578],
46	,	,	O	,	_	0	SENT_238	[p19l911t1507r1390b1578],
47	Athera	NNP	ORGANIZATION	Athera	nn	48	SENT_238	[p19l1411t1507r1605b1561],
48	Biotechnologies	NNP	ORGANIZATION	Biotechnologies	appos	10	SENT_238	[p19l1628t1507r2106b1578],
49	,	,	O	,	_	0	SENT_238	[p19l1628t1507r2106b1578],

1	www	NN	O	www	_	0	SENT_239	[p19l6t1760r542b1811],
2	.	.	O	.	_	0	SENT_239	[p19l6t1760r542b1811],

1	the	DT	O	the	det	2	SENT_240	[p19l6t1760r542b1811],
2	|	NN	O	|	_	0	SENT_240	[p19l6t1760r542b1811],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_240	[p19l6t1760r542b1811],
4	Vol	NNP	O	Vol	dep	2	SENT_240	[p19l585t1760r673b1811],
5	376	CD	NUMBER	376	num	6	SENT_240	[p19l692t1759r797b1818],
6	October	NNP	DATE	October	dep	2	SENT_240	[p19l843t1760r1068b1811],
7	16,2010	CD	DATE	16,2010	num	6	SENT_240	[p19l1085t1759r1330b1820],

1	Boehringer	NNP	PERSON	Boehringer	nn	2	SENT_241	[p19l10t1948r243b1997],
2	Ingelheim	NNP	PERSON	Ingelheim	_	0	SENT_241	[p19l259t1948r484b1997],
3	,	,	O	,	_	0	SENT_241	[p19l259t1948r484b1997],
4	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	appos	2	SENT_241	[p19l499t1950r771b1991],
5	,	,	O	,	_	0	SENT_241	[p19l499t1950r771b1991],
6	GlaxoSmithKline	NNP	ORGANIZATION	GlaxoSmithKline	conj_and	4	SENT_241	[p19l788t1948r1156b1991],
7	,	,	O	,	_	0	SENT_241	[p19l788t1948r1156b1991],
8	and	CC	O	and	_	0	SENT_241	[p19l1173t1948r1249b1985],
9	Eli	NNP	PERSON	Eli	nn	10	SENT_241	[p19l1265t1948r1318b1985],
10	Lilly	NNP	PERSON	Lilly	conj_and	4	SENT_241	[p19l1334t1948r1429b1997],
11	;	:	O	;	_	0	SENT_241	[p19l1334t1948r1429b1997],
12	and	CC	O	and	_	0	SENT_241	[p19l1445t1948r1522b1985],
13	lecture	NN	O	lecture	nn	14	SENT_241	[p19l7t2009r148b2046],
14	fees	NNS	O	fee	conj_and	4	SENT_241	[p19l163t2008r243b2046],
15	from	IN	O	from	_	0	SENT_241	[p19l258t2008r361b2046],
16	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_from	14	SENT_241	[p19l374t2011r645b2052],
17	,	,	O	,	_	0	SENT_241	[p19l374t2011r645b2052],
18	Boehringer	NNP	PERSON	Boehringer	nn	19	SENT_241	[p19l664t2009r897b2058],
19	Ingelheim	NNP	PERSON	Ingelheim	conj_and	16	SENT_241	[p19l913t2009r1137b2058],
20	,	,	O	,	_	0	SENT_241	[p19l913t2009r1137b2058],
21	and	CC	O	and	_	0	SENT_241	[p19l1154t2009r1231b2046],
22	Eli	NNP	PERSON	Eli	nn	23	SENT_241	[p19l1246t2009r1299b2045],
23	Lilly	NNP	PERSON	Lilly	prep_from	14	SENT_241	[p19l1315t2008r1406b2058],
24	.	.	O	.	_	0	SENT_241	[p19l1315t2008r1406b2058],

1	S	NN	O	s	nn	2	SENT_242	[p19l1426t2011r1465b2057],
2	]	NN	O	]	nsubj	4	SENT_242	[p19l1426t2011r1465b2057],
3	has	VBZ	O	have	aux	4	SENT_242	[p19l7t2070r77b2107],
4	received	VBN	O	receive	_	0	SENT_242	[p19l92t2069r263b2107],
5	research	NN	O	research	nn	6	SENT_242	[p19l276t2069r452b2107],
6	grants	NNS	O	grant	dobj	4	SENT_242	[p19l466t2077r594b2119],
7	from	IN	O	from	_	0	SENT_242	[p19l609t2069r712b2107],
8	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_from	4	SENT_242	[p19l725t2072r986b2107],
9	and	CC	O	and	_	0	SENT_242	[p19l1001t2070r1077b2107],
10	Eli	NNP	ORGANIZATION	Eli	nn	11	SENT_242	[p19l1093t2069r1145b2106],
11	Lilly	NNP	ORGANIZATION	Lilly	prep_from	4	SENT_242	[p19l1161t2070r1256b2119],
12	;	:	O	;	_	0	SENT_242	[p19l1161t2070r1256b2119],
13	advisory	JJ	O	advisory	amod	16	SENT_242	[p19l1273t2069r1444b2119],
14	board	NN	O	board	nn	16	SENT_242	[p19l7t2130r126b2168],
15	member	NN	O	member	nn	16	SENT_242	[p19l139t2130r318b2168],
16	fees	NNS	O	fee	prep_from	4	SENT_242	[p19l331t2130r423b2173],
17	,	,	O	,	_	0	SENT_242	[p19l331t2130r423b2173],
18	travel	NN	O	travel	nn	19	SENT_242	[p19l438t2130r552b2168],
19	support	NN	O	support	appos	16	SENT_242	[p19l567t2138r736b2179],
20	,	,	O	,	_	0	SENT_242	[p19l567t2138r736b2179],
21	and	CC	O	and	_	0	SENT_242	[p19l753t2130r829b2168],
22	lecture	NN	O	lecture	nn	23	SENT_242	[p19l842t2130r983b2168],
23	fees	NNS	O	fee	conj_and	8	SENT_242	[p19l998t2130r1078b2168],
24	from	IN	O	from	_	0	SENT_242	[p19l1093t2130r1195b2168],
25	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_from	23	SENT_242	[p19l1209t2132r1480b2173],
26	;	:	O	;	_	0	SENT_242	[p19l1209t2132r1480b2173],
27	and	CC	O	and	_	0	SENT_242	[p19l8t2191r85b2229],
28	honoraria	NN	O	honorarium	prep_from	4	SENT_242	[p19l98t2191r301b2229],
29	from	IN	O	from	_	0	SENT_242	[p19l315t2191r418b2229],
30	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_from	28	SENT_242	[p19l431t2194r702b2234],
31	,	,	O	,	_	0	SENT_242	[p19l431t2194r702b2234],
32	Bristol-Myers	NNP	O	Bristol-Myers	nn	33	SENT_242	[p19l721t2191r997b2240],
33	Squibb	NNP	O	Squibb	prep_from	28	SENT_242	[p19l1016t2191r1170b2240],
34	,	,	O	,	_	0	SENT_242	[p19l1016t2191r1170b2240],
35	Merck	NNP	PERSON	Merck	prep_from	28	SENT_242	[p19l1188t2191r1327b2234],
36	,	,	O	,	_	0	SENT_242	[p19l1188t2191r1327b2234],
37	Sanoﬁ-Aventis	NNP	PERSON	Sanoﬁ-Aventis	prep_from	28	SENT_242	[p19l11t2252r316b2295],
38	,	,	O	,	_	0	SENT_242	[p19l11t2252r316b2295],
39	and	CC	O	and	_	0	SENT_242	[p19l333t2252r409b2290],
40	Eli-Lilly	NNP	O	Eli-Lilly	conj_and	30	SENT_242	[p19l425t2252r586b2301],
41	.	.	O	.	_	0	SENT_242	[p19l425t2252r586b2301],

1	RFS	NN	O	rf	nsubj	3	SENT_243	[p19l605t2254r687b2290],
2	has	VBZ	O	have	aux	3	SENT_243	[p19l703t2252r773b2290],
3	received	VBN	O	receive	_	0	SENT_243	[p19l788t2252r959b2290],
4	research	NN	O	research	nn	5	SENT_243	[p19l973t2252r1148b2290],
5	grants	NNS	O	grant	dobj	3	SENT_243	[p19l1162t2260r1290b2302],
6	from	IN	O	from	_	0	SENT_243	[p19l1306t2252r1408b2290],
7	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_from	5	SENT_243	[p19l7t2315r278b2356],
8	,	,	O	,	_	0	SENT_243	[p19l7t2315r278b2356],
9	Dynabyte	NNP	O	Dynabyte	conj_and	7	SENT_243	[p19l297t2313r500b2362],
10	,	,	O	,	_	0	SENT_243	[p19l297t2313r500b2362],
11	Eli	NNP	PERSON	Eli	nn	14	SENT_243	[p19l518t2313r571b2350],
12	Lilly/Daiichi	NNP	PERSON	Lilly/Daiichi	nn	14	SENT_243	[p19l587t2313r844b2362],
13	Sankyo	NNP	PERSON	Sankyo	nn	14	SENT_243	[p19l861t2313r1007b2362],
14	alliance	NN	O	alliance	conj_and	7	SENT_243	[p19l1022t2313r1190b2356],
15	,	,	O	,	_	0	SENT_243	[p19l1022t2313r1190b2356],
16	and	CC	O	and	_	0	SENT_243	[p19l1206t2313r1283b2350],
17	Schering-Plough	NNP	ORGANIZATION	Schering-Plough	prep_from	5	SENT_243	[p19l11t2374r368b2424],
18	;	:	O	;	_	0	SENT_243	[p19l11t2374r368b2424],
19	advisory	JJ	O	advisory	amod	21	SENT_243	[p19l385t2374r556b2423],
20	board	NN	O	board	nn	21	SENT_243	[p19l568t2374r687b2412],
21	fees	NNS	O	fee	dep	5	SENT_243	[p19l700t2374r780b2412],
22	from	IN	O	from	_	0	SENT_243	[p19l796t2374r898b2412],
23	Eli	NNP	ORGANIZATION	Eli	nn	26	SENT_243	[p19l914t2374r967b2411],
24	Lilly/Daiichi	NNP	ORGANIZATION	Lilly/Daiichi	nn	26	SENT_243	[p19l983t2374r1240b2423],
25	Sankyo	NNP	ORGANIZATION	Sankyo	nn	26	SENT_243	[p19l1257t2374r1403b2423],
26	alliance	NN	O	alliance	prep_from	21	SENT_243	[p19l8t2436r165b2473],
27	and	CC	O	and	_	0	SENT_243	[p19l180t2436r257b2473],
28	Schering-Plough	NNP	ORGANIZATION	Schering-Plough	prep_from	21	SENT_243	[p19l273t2436r630b2485],
29	;	:	O	;	_	0	SENT_243	[p19l273t2436r630b2485],
30	honoraria	NN	O	honorarium	dep	5	SENT_243	[p19l646t2436r849b2473],
31	from	IN	O	from	_	0	SENT_243	[p19l863t2436r966b2473],
32	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_from	30	SENT_243	[p19l979t2438r1250b2479],
33	,	,	O	,	_	0	SENT_243	[p19l979t2438r1250b2479],
34	Eli	NNP	ORGANIZATION	Eli	nn	88	SENT_243	[p19l1269t2436r1321b2473],
35	Lilly	NNP	ORGANIZATION	Lilly	nn	88	SENT_243	[p19l1337t2436r1442b2485],
36	/	:	ORGANIZATION	/	punct	39	SENT_243	[p19l1337t2436r1442b2485],
37	Daiichi	NNP	ORGANIZATION	Daiichi	nn	39	SENT_243	[p19l10t2497r157b2534],
38	Sankyo	NNP	ORGANIZATION	Sankyo	nn	39	SENT_243	[p19l175t2497r320b2546],
39	alliance	NN	O	alliance	dep	88	SENT_243	[p19l335t2497r503b2540],
40	,	,	O	,	_	0	SENT_243	[p19l335t2497r503b2540],
41	Novartis	NNP	ORGANIZATION	Novartis	nn	45	SENT_243	[p19l521t2499r702b2540],
42	,	,	O	,	_	0	SENT_243	[p19l521t2499r702b2540],
43	Medscape	NNP	ORGANIZATION	Medscape	appos	45	SENT_243	[p19l720t2497r935b2546],
44	,	,	O	,	_	0	SENT_243	[p19l720t2497r935b2546],
45	GlaxoSmithKline	NNP	ORGANIZATION	GlaxoSmithKline	appos	39	SENT_243	[p19l952t2497r1321b2540],
46	,	,	O	,	_	0	SENT_243	[p19l952t2497r1321b2540],
47	and	CC	O	and	_	0	SENT_243	[p19l1337t2497r1414b2534],
48	Schering-Plough	NNP	ORGANIZATION	Schering-Plough	appos	39	SENT_243	[p19l11t2558r368b2607],
49	;	:	O	;	_	0	SENT_243	[p19l11t2558r368b2607],
50	consultancy	NN	O	consultancy	nn	51	SENT_243	[p19l385t2558r632b2607],
51	fees	NNS	O	fee	dep	45	SENT_243	[p19l644t2558r724b2595],
52	from	IN	O	from	_	0	SENT_243	[p19l740t2558r843b2595],
53	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_from	51	SENT_243	[p19l856t2560r1127b2601],
54	,	,	O	,	_	0	SENT_243	[p19l856t2560r1127b2601],
55	Eli	NNP	ORGANIZATION	Eli	nn	56	SENT_243	[p19l1145t2558r1198b2595],
56	Lilly	NNP	ORGANIZATION	Lilly	appos	53	SENT_243	[p19l1214t2558r1318b2607],
57	/	:	ORGANIZATION	/	punct	60	SENT_243	[p19l1214t2558r1318b2607],
58	Daiichi	NNP	ORGANIZATION	Daiichi	nn	60	SENT_243	[p19l10t2619r157b2656],
59	Sankyo	NNP	ORGANIZATION	Sankyo	nn	60	SENT_243	[p19l175t2619r320b2668],
60	alliance	NN	O	alliance	dep	53	SENT_243	[p19l335t2619r503b2662],
61	,	,	O	,	_	0	SENT_243	[p19l335t2619r503b2662],
62	Schering-Plough	NNP	ORGANIZATION	Schering-Plough	nn	70	SENT_243	[p19l522t2619r879b2668],
63	,	,	O	,	_	0	SENT_243	[p19l522t2619r879b2668],
64	Teva	NNP	ORGANIZATION	Teva	appos	70	SENT_243	[p19l895t2621r997b2662],
65	,	,	O	,	_	0	SENT_243	[p19l895t2621r997b2662],
66	Novartis	NNP	ORGANIZATION	Novartis	appos	70	SENT_243	[p19l1014t2621r1196b2662],
67	,	,	O	,	_	0	SENT_243	[p19l1014t2621r1196b2662],
68	GlaxoSmithKline	NNP	ORGANIZATION	GlaxoSmithKline	appos	70	SENT_243	[p19l9t2679r377b2723],
69	,	,	O	,	_	0	SENT_243	[p19l9t2679r377b2723],
70	Sanoﬁ-Aventis	NNP	O	Sanoﬁ-Aventis	appos	60	SENT_243	[p19l397t2679r992b2729],
71	/	:	O	/	punct	60	SENT_243	[p19l397t2679r992b2729],
72	Bristol-Myers	NNP	O	Bristol-Myers	nn	73	SENT_243	[p19l397t2679r992b2729],
73	Squibb	NNP	O	Squibb	dep	53	SENT_243	[p19l1011t2680r1165b2728],
74	,	,	O	,	_	0	SENT_243	[p19l1011t2680r1165b2728],
75	and	CC	O	and	_	0	SENT_243	[p19l1182t2680r1258b2717],
76	the	DT	O	the	det	78	SENT_243	[p19l1271t2680r1336b2717],
77	Medicines	NNP	ORGANIZATION	Medicines	nn	78	SENT_243	[p19l9t2740r220b2778],
78	Company	NN	ORGANIZATION	company	conj_and	51	SENT_243	[p19l237t2743r445b2790],
79	;	:	O	;	_	0	SENT_243	[p19l237t2743r445b2790],
80	travel	NN	O	travel	nn	81	SENT_243	[p19l461t2740r574b2778],
81	support	NN	O	support	dep	45	SENT_243	[p19l590t2748r749b2789],
82	from	IN	O	from	_	0	SENT_243	[p19l762t2740r865b2778],
83	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_from	81	SENT_243	[p19l878t2743r1150b2783],
84	,	,	O	,	_	0	SENT_243	[p19l878t2743r1150b2783],
85	Eli	NNP	ORGANIZATION	Eli	nn	86	SENT_243	[p19l1168t2740r1220b2777],
86	Lilly	NNP	ORGANIZATION	Lilly	appos	39	SENT_243	[p19l1236t2740r1341b2790],
87	/	:	ORGANIZATION	/	punct	39	SENT_243	[p19l1236t2740r1341b2790],
88	Daiichi	NNP	ORGANIZATION	Daiichi	dobj	3	SENT_243	[p19l10t2802r157b2839],
89	Sankyo	NNP	ORGANIZATION	Sankyo	nn	90	SENT_243	[p19l175t2802r320b2851],
90	alliance	NN	O	alliance	dep	88	SENT_243	[p19l335t2802r503b2845],
91	,	,	O	,	_	0	SENT_243	[p19l335t2802r503b2845],
92	and	CC	O	and	_	0	SENT_243	[p19l520t2802r596b2839],
93	Schering-Plough	NNP	ORGANIZATION	Schering-Plough	conj_and	5	SENT_243	[p19l613t2802r970b2851],
94	.	.	O	.	_	0	SENT_243	[p19l613t2802r970b2851],

1	MA	NNP	O	MA	nn	3	SENT_244	[p19l988t2804r1073b2845],
2	,	,	O	,	_	0	SENT_244	[p19l988t2804r1073b2845],
3	BIB	NNP	O	BIB	nsubj	13	SENT_244	[p19l1091t2805r1180b2850],
4	,	,	O	,	_	0	SENT_244	[p19l1091t2805r1180b2850],
5	and	CC	O	and	_	0	SENT_244	[p19l1196t2802r1273b2839],
6	]	NN	O	]	nn	7	SENT_244	[p19l1287t2805r1342b2849],
7	H	NN	O	h	conj_and	3	SENT_244	[p19l1287t2805r1342b2849],
8	are	VBP	O	be	cop	9	SENT_244	[p19l1359t2815r1421b2839],
9	employees	NNS	O	employee	_	0	SENT_244	[p19l8t2862r226b2911],
10	of	IN	O	of	_	0	SENT_244	[p19l242t2862r288b2900],
11	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_of	9	SENT_244	[p19l294t2865r555b2900],
12	and	CC	O	and	_	0	SENT_244	[p19l570t2862r646b2900],
13	have	VBP	O	have	conj_and	9	SENT_244	[p19l659t2862r754b2900],
14	equity	NN	O	equity	nn	15	SENT_244	[p19l769t2865r896b2911],
15	ownership	NN	O	ownership	dobj	13	SENT_244	[p19l910t2862r1128b2911],
16	in	IN	O	in	_	0	SENT_244	[p19l1142t2865r1184b2899],
17	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_in	15	SENT_244	[p19l1197t2864r1468b2900],
18	.	.	O	.	_	0	SENT_244	[p19l1197t2864r1468b2900],

1	SH	NN	O	sh	nsubj	3	SENT_245	[p19l11t2926r74b2961],
2	has	VBZ	O	have	aux	3	SENT_245	[p19l89t2923r159b2961],
3	received	VBN	O	receive	_	0	SENT_245	[p19l174t2923r345b2961],
4	advisory	JJ	O	advisory	amod	7	SENT_245	[p19l359t2923r530b2972],
5	board	NN	O	board	nn	7	SENT_245	[p19l542t2923r661b2961],
6	membership	NN	O	membership	nn	7	SENT_245	[p19l675t2923r941b2972],
7	fees	NNS	O	fee	dobj	3	SENT_245	[p19l956t2923r1036b2961],
8	from	IN	O	from	_	0	SENT_245	[p19l1051t2923r1154b2961],
9	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_from	3	SENT_245	[p19l1167t2926r1438b2966],
10	,	,	O	,	_	0	SENT_245	[p19l1167t2926r1438b2966],
11	Bristol-Myers	NNP	O	Bristol-Myers	nn	12	SENT_245	[p19l10t2984r287b3033],
12	Squibb	NNP	O	Squibb	conj_and	9	SENT_245	[p19l305t2984r460b3033],
13	,	,	O	,	_	0	SENT_245	[p19l305t2984r460b3033],
14	Pﬁzer	NNP	O	Pﬁzer	conj_and	9	SENT_245	[p19l478t2984r605b3027],
15	,	,	O	,	_	0	SENT_245	[p19l478t2984r605b3027],
16	Sanoﬁ-Aventis	NNP	PERSON	Sanoﬁ-Aventis	conj_and	9	SENT_245	[p19l624t2984r929b3027],
17	,	,	O	,	_	0	SENT_245	[p19l624t2984r929b3027],
18	and	CC	O	and	_	0	SENT_245	[p19l945t2984r1022b3022],
19	Bayer	NNP	ORGANIZATION	Bayer	conj_and	9	SENT_245	[p19l1038t2988r1161b3033],
20	;	:	O	;	_	0	SENT_245	[p19l1038t2988r1161b3033],
21	research	NN	O	research	nn	22	SENT_245	[p19l1177t2984r1352b3022],
22	grants	NNS	O	grant	conj_and	9	SENT_245	[p19l1367t2992r1495b3034],
23	from	IN	O	from	_	0	SENT_245	[p19l8t3045r110b3082],
24	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_from	22	SENT_245	[p19l124t3047r395b3088],
25	,	,	O	,	_	0	SENT_245	[p19l124t3047r395b3088],
26	Bristol-Myers	NNP	O	Bristol-Myers	nn	33	SENT_245	[p19l413t3045r690b3094],
27	Squibb	NNP	O	Squibb	nn	33	SENT_245	[p19l708t3045r863b3094],
28	,	,	O	,	_	0	SENT_245	[p19l708t3045r863b3094],
29	Pﬁzer	NNP	O	Pﬁzer	appos	33	SENT_245	[p19l881t3045r1008b3088],
30	,	,	O	,	_	0	SENT_245	[p19l881t3045r1008b3088],
31	Sanoﬁ-Aventis	NNP	PERSON	Sanoﬁ-Aventis	appos	33	SENT_245	[p19l1027t3045r1332b3088],
32	,	,	O	,	_	0	SENT_245	[p19l1027t3045r1332b3088],
33	Bayer	NNP	ORGANIZATION	Bayer	appos	24	SENT_245	[p19l1350t3049r1471b3094],
34	,	,	O	,	_	0	SENT_245	[p19l1350t3049r1471b3094],
35	and	CC	O	and	_	0	SENT_245	[p19l8t3106r85b3144],
36	Boehringer	NNP	LOCATION	Boehringer	nn	37	SENT_245	[p19l101t3106r334b3156],
37	Ingelheim	NNP	LOCATION	Ingelheim	conj_and	33	SENT_245	[p19l350t3106r574b3156],
38	;	:	O	;	_	0	SENT_245	[p19l350t3106r574b3156],
39	honoraria	NN	O	honorarium	conj_and	9	SENT_245	[p19l590t3106r793b3144],
40	from	IN	O	from	_	0	SENT_245	[p19l807t3106r910b3144],
41	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_from	39	SENT_245	[p19l923t3108r1194b3149],
42	,	,	O	,	_	0	SENT_245	[p19l923t3108r1194b3149],
43	Bristol-Myers	NNP	O	Bristol-Myers	nn	44	SENT_245	[p19l1213t3106r1489b3155],
44	Squibb	NNP	O	Squibb	prep_from	39	SENT_245	[p19l11t3168r165b3217],
45	,	,	O	,	_	0	SENT_245	[p19l11t3168r165b3217],
46	Bayer	NNP	ORGANIZATION	Bayer	prep_from	39	SENT_245	[p19l183t3172r304b3217],
47	,	,	O	,	_	0	SENT_245	[p19l183t3172r304b3217],
48	Sanoﬁ-Aventis	NNP	PERSON	Sanoﬁ-Aventis	conj_and	41	SENT_245	[p19l323t3168r629b3211],
49	,	,	O	,	_	0	SENT_245	[p19l323t3168r629b3211],
50	and	CC	O	and	_	0	SENT_245	[p19l645t3168r722b3205],
51	Pﬁzer	NN	PERSON	pﬁzer	conj_and	41	SENT_245	[p19l737t3168r866b3211],
52	;	:	O	;	_	0	SENT_245	[p19l737t3168r866b3211],
53	lecture	NN	O	lecture	nn	54	SENT_245	[p19l882t3168r1023b3205],
54	fees	NNS	O	fee	conj_and	9	SENT_245	[p19l1038t3168r1117b3205],
55	from	IN	O	from	_	0	SENT_245	[p19l1133t3168r1235b3205],
56	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_from	54	SENT_245	[p19l1248t3170r1520b3211],
57	;	:	O	;	_	0	SENT_245	[p19l1248t3170r1520b3211],
58	travel	NN	O	travel	nn	59	SENT_245	[p19l7t3229r121b3266],
59	support	NN	O	support	conj_and	9	SENT_245	[p19l136t3236r296b3278],
60	from	IN	O	from	_	0	SENT_245	[p19l309t3229r411b3266],
61	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_from	59	SENT_245	[p19l425t3231r696b3272],
62	,	,	O	,	_	0	SENT_245	[p19l425t3231r696b3272],
63	Boehringer	NNP	PERSON	Boehringer	nn	64	SENT_245	[p19l714t3229r948b3278],
64	Ingelheim	NNP	PERSON	Ingelheim	conj_and	61	SENT_245	[p19l963t3229r1188b3278],
65	,	,	O	,	_	0	SENT_245	[p19l963t3229r1188b3278],
66	Pﬁzer	NNP	O	Pﬁzer	conj_and	61	SENT_245	[p19l1206t3229r1333b3272],
67	,	,	O	,	_	0	SENT_245	[p19l1206t3229r1333b3272],
68	and	CC	O	and	_	0	SENT_245	[p19l1350t3229r1426b3266],
69	Eli	NNP	PERSON	Eli	nn	70	SENT_245	[p19l10t3290r63b3327],
70	Lilly	NNP	PERSON	Lilly	conj_and	61	SENT_245	[p19l78t3290r174b3339],
71	;	:	O	;	_	0	SENT_245	[p19l78t3290r174b3339],
72	and	CC	O	and	_	0	SENT_245	[p19l190t3290r267b3327],
73	consultancy	NN	O	consultancy	nn	74	SENT_245	[p19l281t3290r528b3339],
74	fees	NNS	O	fee	prep_from	3	SENT_245	[p19l541t3290r621b3327],
75	from	IN	O	from	_	0	SENT_245	[p19l636t3290r739b3327],
76	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_from	74	SENT_245	[p19l752t3292r1013b3327],
77	and	CC	O	and	_	0	SENT_245	[p19l1027t3290r1104b3327],
78	Leo	NNP	PERSON	Leo	nn	79	SENT_245	[p19l1120t3293r1190b3327],
79	Pharmaceuticals	NNP	PERSON	Pharmaceuticals	conj_and	9	SENT_245	[p19l10t3351r363b3388],
80	.	.	O	.	_	0	SENT_245	[p19l10t3351r363b3388],

1	HK	NNP	LOCATION	HK	nsubj	23	SENT_246	[p19l381t3354r453b3388],
2	has	VBZ	O	have	aux	3	SENT_246	[p19l465t3351r535b3388],
3	received	VBN	O	receive	_	0	SENT_246	[p19l550t3351r721b3388],
4	honoraria	NN	O	honorarium	dobj	3	SENT_246	[p19l733t3351r937b3388],
5	from	IN	O	from	_	0	SENT_246	[p19l951t3351r1053b3388],
6	Eli-Lilly	NNP	O	Eli-Lilly	nn	10	SENT_246	[p19l1070t3351r1231b3400],
7	,	,	O	,	_	0	SENT_246	[p19l1070t3351r1231b3400],
8	GlaxoSmithKline	NNP	ORGANIZATION	GlaxoSmithKline	appos	10	SENT_246	[p19l9t3412r377b3455],
9	,	,	O	,	_	0	SENT_246	[p19l9t3412r377b3455],
10	Roche	NNP	PERSON	Roche	prep_from	3	SENT_246	[p19l396t3412r532b3455],
11	,	,	O	,	_	0	SENT_246	[p19l396t3412r532b3455],
12	and	CC	O	and	_	0	SENT_246	[p19l548t3412r625b3449],
13	Bayer	NNP	ORGANIZATION	Bayer	conj_and	10	SENT_246	[p19l641t3415r763b3461],
14	;	:	O	;	_	0	SENT_246	[p19l641t3415r763b3461],
15	and	CC	O	and	_	0	SENT_246	[p19l780t3412r857b3449],
16	holds	VBZ	O	hold	conj_and	3	SENT_246	[p19l870t3412r981b3449],
17	a	DT	O	a	det	18	SENT_246	[p19l997t3425r1018b3449],
18	patent	NN	O	patent	dobj	16	SENT_246	[p19l1032t3419r1162b3460],
19	jointly	RB	O	jointly	advmod	16	SENT_246	[p19l1175t3412r1307b3461],
20	with	IN	O	with	_	0	SENT_246	[p19l1319t3412r1411b3449],
21	Roche	NNP	PERSON	Roche	prep_with	16	SENT_246	[p19l10t3473r135b3510],
22	and	CC	O	and	_	0	SENT_246	[p19l150t3472r226b3510],
23	receives	VBZ	O	receive	conj_and	3	SENT_246	[p19l240t3475r403b3510],
24	royalties	NNS	O	royalty	dobj	23	SENT_246	[p19l418t3473r590b3522],
25	for	IN	O	for	_	0	SENT_246	[p19l606t3472r665b3510],
26	this	DT	O	this	det	27	SENT_246	[p19l677t3473r753b3510],
27	patent	NN	O	patent	prep_for	24	SENT_246	[p19l769t3480r908b3521],
28	.	.	O	.	_	0	SENT_246	[p19l769t3480r908b3521],

1	PGS	NNP	O	PGS	nsubj	3	SENT_247	[p19l927t3475r1015b3510],
2	has	VBZ	O	have	aux	3	SENT_247	[p19l1031t3473r1101b3510],
3	received	VBN	O	receive	ccomp	61	SENT_247	[p19l1117t3473r1287b3510],
4	research	NN	O	research	nn	5	SENT_247	[p19l1300t3473r1476b3510],
5	grants	NNS	O	grant	nsubj	10	SENT_247	[p19l9t3541r136b3583],
6	from	IN	O	from	_	0	SENT_247	[p19l152t3533r254b3571],
7	Servier	NNP	ORGANIZATION	Servier	prep_from	5	SENT_247	[p19l271t3536r422b3576],
8	;	:	O	;	_	0	SENT_247	[p19l271t3536r422b3576],
9	has	VBZ	O	have	aux	10	SENT_247	[p19l437t3534r507b3571],
10	received	VBN	O	receive	ccomp	3	SENT_247	[p19l522t3533r693b3571],
11	fees	NNS	O	fee	dobj	10	SENT_247	[p19l706t3533r786b3571],
12	for	IN	O	for	_	0	SENT_247	[p19l801t3533r861b3571],
13	consultancy	NN	O	consultancy	prep_for	11	SENT_247	[p19l874t3534r1122b3583],
14	or	CC	O	or	_	0	SENT_247	[p19l1135t3547r1177b3571],
15	participation	NN	O	participation	conj_or	13	SENT_247	[p19l1190t3536r1454b3582],
16	in	IN	O	in	_	0	SENT_247	[p19l1468t3536r1510b3570],
17	advisory	JJ	O	advisory	amod	19	SENT_247	[p19l8t3594r180b3643],
18	board	NN	O	board	nn	19	SENT_247	[p19l192t3594r311b3632],
19	meetings	NNS	O	meeting	prep_in	10	SENT_247	[p19l324t3597r515b3644],
20	from	IN	O	from	_	0	SENT_247	[p19l531t3594r633b3632],
21	Astellas	NNP	LOCATION	Astellas	nn	28	SENT_247	[p19l646t3594r818b3637],
22	,	,	O	,	_	0	SENT_247	[p19l646t3594r818b3637],
23	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	appos	28	SENT_247	[p19l834t3597r1105b3637],
24	,	,	O	,	_	0	SENT_247	[p19l834t3597r1105b3637],
25	Bayer	NNP	ORGANIZATION	Bayer	appos	28	SENT_247	[p19l1123t3598r1244b3643],
26	,	,	O	,	_	0	SENT_247	[p19l1123t3598r1244b3643],
27	Boehringer	NNP	PERSON	Boehringer	appos	28	SENT_247	[p19l10t3655r244b3705],
28	Ingelheim	NNP	PERSON	Ingelheim	prep_from	10	SENT_247	[p19l259t3655r484b3705],
29	,	,	O	,	_	0	SENT_247	[p19l259t3655r484b3705],
30	Bristol-Myers	NNP	O	Bristol-Myers	nn	31	SENT_247	[p19l502t3655r779b3704],
31	Squibb	NNP	O	Squibb	appos	28	SENT_247	[p19l797t3655r952b3704],
32	,	,	O	,	_	0	SENT_247	[p19l797t3655r952b3704],
33	Daiichi	NNP	ORGANIZATION	Daiichi	nn	34	SENT_247	[p19l970t3655r1117b3693],
34	Sankyo	NNP	ORGANIZATION	Sankyo	nsubj	61	SENT_247	[p19l1135t3655r1280b3705],
35	/	:	ORGANIZATION	/	punct	38	SENT_247	[p19l1284t3659r1300b3704],
36	Eli	NNP	ORGANIZATION	Eli	nn	38	SENT_247	[p19l1305t3655r1357b3692],
37	Lilly	NNP	ORGANIZATION	Lilly	nn	38	SENT_247	[p19l1374t3655r1460b3705],
38	alliance	NN	ORGANIZATION	alliance	dep	34	SENT_247	[p19l8t3716r176b3760],
39	,	,	O	,	_	0	SENT_247	[p19l8t3716r176b3760],
40	GlaxoSmithKline	NNP	ORGANIZATION	GlaxoSmithKline	nn	53	SENT_247	[p19l194t3716r562b3760],
41	,	,	O	,	_	0	SENT_247	[p19l194t3716r562b3760],
42	Medtronic	NNP	ORGANIZATION	Medtronic	appos	53	SENT_247	[p19l579t3716r803b3760],
43	,	,	O	,	_	0	SENT_247	[p19l579t3716r803b3760],
44	Merck	NNP	PERSON	Merck	appos	53	SENT_247	[p19l821t3716r960b3760],
45	,	,	O	,	_	0	SENT_247	[p19l821t3716r960b3760],
46	Otsuka	NNP	ORGANIZATION	Otsuka	appos	53	SENT_247	[p19l977t3716r1124b3754],
47	Pharmaceutical	NNP	ORGANIZATION	Pharmaceutical	nn	53	SENT_247	[p19l1140t3716r1472b3760],
48	,	,	O	,	_	0	SENT_247	[p19l1140t3716r1472b3760],
49	Roche	NNP	PERSON	Roche	appos	53	SENT_247	[p19l10t3778r146b3821],
50	,	,	O	,	_	0	SENT_247	[p19l10t3778r146b3821],
51	Sanoﬁ-Aventis	NNP	PERSON	Sanoﬁ-Aventis	appos	53	SENT_247	[p19l165t3778r470b3821],
52	,	,	O	,	_	0	SENT_247	[p19l165t3778r470b3821],
53	Servier	NNP	ORGANIZATION	Servier	conj_and	38	SENT_247	[p19l489t3780r637b3821],
54	,	,	O	,	_	0	SENT_247	[p19l489t3780r637b3821],
55	and	CC	O	and	_	0	SENT_247	[p19l654t3778r731b3815],
56	the	DT	O	the	det	58	SENT_247	[p19l743t3778r808b3815],
57	Medicines	NNP	ORGANIZATION	Medicines	nn	58	SENT_247	[p19l824t3778r1035b3815],
58	Company	NN	ORGANIZATION	company	dep	34	SENT_247	[p19l1052t3781r1260b3827],
59	;	:	O	;	_	0	SENT_247	[p19l1052t3781r1260b3827],
60	has	VBZ	O	have	aux	61	SENT_247	[p19l1276t3778r1345b3815],
61	received	VBN	O	receive	_	0	SENT_247	[p20l8t15r179b53],
62	payment	NN	O	payment	dobj	61	SENT_247	[p20l192t22r373b64],
63	for	IN	O	for	_	0	SENT_247	[p20l386t15r446b52],
64	development	NN	O	development	prep_for	62	SENT_247	[p20l459t15r728b64],
65	of	IN	O	of	_	0	SENT_247	[p20l742t15r788b52],
66	educational	JJ	O	educational	amod	67	SENT_247	[p20l796t15r1035b52],
67	presentations	NNS	O	presentation	prep_of	64	SENT_247	[p20l1048t18r1328b64],
68	from	IN	O	from	_	0	SENT_247	[p20l1344t15r1446b52],
69	Boehringer	NNP	LOCATION	Boehringer	nn	70	SENT_247	[p20l10t77r244b126],
70	Ingelheim	NNP	LOCATION	Ingelheim	prep_from	61	SENT_247	[p20l259t77r484b126],
71	,	,	O	,	_	0	SENT_247	[p20l259t77r484b126],
72	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_from	61	SENT_247	[p20l499t79r771b120],
73	,	,	O	,	_	0	SENT_247	[p20l499t79r771b120],
74	and	CC	O	and	_	0	SENT_247	[p20l787t77r864b114],
75	Merck	NNP	PERSON	Merck	prep_from	61	SENT_247	[p20l879t77r1018b120],
76	;	:	O	;	_	0	SENT_247	[p20l879t77r1018b120],
77	and	CC	O	and	_	0	SENT_247	[p20l1035t77r1111b114],
78	has	VBZ	O	have	conj_and	61	SENT_247	[p20l1124t77r1194b114],
79	equity	NN	O	equity	nn	80	SENT_247	[p20l1210t79r1337b126],
80	ownership	NN	O	ownership	dobj	78	SENT_247	[p20l8t138r227b187],
81	in	IN	O	in	_	0	SENT_247	[p20l241t140r283b175],
82	Aterovax	NNP	LOCATION	Aterovax	prep_in	80	SENT_247	[p20l296t141r484b175],
83	.	.	O	.	_	0	SENT_247	[p20l296t141r484b175],

1	SHS	NNP	O	SHS	nsubj	2	SENT_248	[p20l503t141r594b175],
2	has	VBZ	O	have	_	0	SENT_248	[p20l610t138r679b175],
3	no	DT	O	no	det	4	SENT_248	[p20l695t151r747b175],
4	conﬂicts	NNS	O	conﬂicts	dobj	2	SENT_248	[p20l762t138r934b175],
5	of	IN	O	of	_	0	SENT_248	[p20l950t138r996b175],
6	interest	NN	O	interest	prep_of	4	SENT_248	[p20l1003t140r1170b175],
7	.	.	O	.	_	0	SENT_248	[p20l1003t140r1170b175],

1	RCB	NN	O	rcb	nsubj	3	SENT_249	[p20l1188t141r1280b175],
2	has	VBZ	O	have	aux	3	SENT_249	[p20l1295t138r1365b175],
3	received	VBN	O	receive	_	0	SENT_249	[p20l8t199r178b236],
4	research	NN	O	research	nn	5	SENT_249	[p20l192t199r367b236],
5	grants	NNS	O	grant	dobj	3	SENT_249	[p20l382t206r510b248],
6	from	IN	O	from	_	0	SENT_249	[p20l525t199r628b236],
7	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_from	3	SENT_249	[p20l641t201r912b242],
8	,	,	O	,	_	0	SENT_249	[p20l641t201r912b242],
9	Bristol-Myers	NNP	O	Bristol-Myers	nn	10	SENT_249	[p20l930t199r1207b248],
10	Squibb	NNP	O	Squibb	appos	7	SENT_249	[p20l1225t199r1388b248],
11	/	:	O	/	punct	12	SENT_249	[p20l1225t199r1388b248],
12	Sanoﬁ-Aventis	NNP	O	Sanoﬁ-Aventis	dep	7	SENT_249	[p20l11t260r316b303],
13	,	,	O	,	_	0	SENT_249	[p20l11t260r316b303],
14	Iohnson	NNP	PERSON	Iohnson	dep	7	SENT_249	[p20l333t260r505b308],
15	and	CC	O	and	_	0	SENT_249	[p20l519t260r596b297],
16	Iohnson	NNP	PERSON	Iohnson	dep	7	SENT_249	[p20l610t260r792b308],
17	,	,	O	,	_	0	SENT_249	[p20l610t260r792b308],
18	Regado	NNP	ORGANIZATION	Regado	nn	19	SENT_249	[p20l810t260r959b309],
19	Biosciences	NNP	ORGANIZATION	Biosciences	dep	7	SENT_249	[p20l976t262r1226b303],
20	,	,	O	,	_	0	SENT_249	[p20l976t262r1226b303],
21	Schering-Plough	NNP	ORGANIZATION	Schering-Plough	dep	7	SENT_249	[p20l11t320r368b370],
22	,	,	O	,	_	0	SENT_249	[p20l11t320r368b370],
23	and	CC	O	and	_	0	SENT_249	[p20l385t321r461b358],
24	the	DT	O	the	det	26	SENT_249	[p20l474t321r539b358],
25	Medicines	NNP	ORGANIZATION	Medicines	nn	26	SENT_249	[p20l555t320r766b358],
26	Company	NN	ORGANIZATION	company	dep	7	SENT_249	[p20l782t323r990b370],
27	;	:	O	;	_	0	SENT_249	[p20l782t323r990b370],
28	consultancy	NN	O	consultancy	nn	29	SENT_249	[p20l1007t320r1254b370],
29	fees	NNS	O	fee	dep	7	SENT_249	[p20l1267t320r1347b358],
30	from	IN	O	from	_	0	SENT_249	[p20l1363t320r1465b358],
31	Portola	NNP	ORGANIZATION	Portola	nn	32	SENT_249	[p20l10t382r155b419],
32	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	prep_from	29	SENT_249	[p20l171t382r524b425],
33	,	,	O	,	_	0	SENT_249	[p20l171t382r524b425],
34	Regado	NNP	ORGANIZATION	Regado	nn	35	SENT_249	[p20l542t382r691b431],
35	Biosciences	NNP	ORGANIZATION	Biosciences	prep_from	29	SENT_249	[p20l708t384r958b425],
36	,	,	O	,	_	0	SENT_249	[p20l708t384r958b425],
37	and	CC	O	and	_	0	SENT_249	[p20l975t382r1051b419],
38	the	DT	O	the	det	40	SENT_249	[p20l1064t382r1129b419],
39	Medicines	NNP	ORGANIZATION	Medicines	nn	40	SENT_249	[p20l1145t382r1356b419],
40	Company	NN	ORGANIZATION	company	prep_from	29	SENT_249	[p20l9t445r217b492],
41	;	:	O	;	_	0	SENT_249	[p20l9t445r217b492],
42	travel	NN	O	travel	nn	45	SENT_249	[p20l233t442r347b480],
43	or	CC	O	or	_	0	SENT_249	[p20l361t456r404b480],
44	accommodation	NN	O	accommodation	conj_or	42	SENT_249	[p20l417t443r751b480],
45	expenses	NNS	O	expense	dep	7	SENT_249	[p20l766t456r950b491],
46	from	IN	O	from	_	0	SENT_249	[p20l966t442r1068b480],
47	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_from	45	SENT_249	[p20l1082t445r1353b486],
48	,	,	O	,	_	0	SENT_249	[p20l1082t445r1353b486],
49	Regado	NNP	ORGANIZATION	Regado	nn	50	SENT_249	[p20l10t503r160b553],
50	Biosciences	NNP	ORGANIZATION	Biosciences	conj_and	47	SENT_249	[p20l177t506r426b546],
51	,	,	O	,	_	0	SENT_249	[p20l177t506r426b546],
52	and	CC	O	and	_	0	SENT_249	[p20l443t503r519b541],
53	Merck	NNP	PERSON	Merck	conj_and	47	SENT_249	[p20l534t503r674b546],
54	;	:	O	;	_	0	SENT_249	[p20l534t503r674b546],
55	and	CC	O	and	_	0	SENT_249	[p20l690t503r767b541],
56	honoraria	NN	O	honorarium	conj_and	12	SENT_249	[p20l780t503r983b541],
57	from	IN	O	from	_	0	SENT_249	[p20l997t503r1100b541],
58	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_from	56	SENT_249	[p20l1113t506r1374b541],
59	and	CC	O	and	_	0	SENT_249	[p20l1389t503r1465b541],
60	Daiichi	NNP	ORGANIZATION	Daiichi	nn	61	SENT_249	[p20l10t564r158b602],
61	Sanl	NNP	O	Sanl	dep	62	SENT_249	[p20l175t564r320b613],
62	<	JJR	O	<	conj_and	12	SENT_249	[p20l175t564r320b613],
63	yo	FW	O	yo	dep	62	SENT_249	[p20l175t564r320b613],
64	/	:	O	/	punct	12	SENT_249	[p20l324t568r340b613],
65	Eli	NNP	PERSON	Eli	nn	67	SENT_249	[p20l345t564r397b601],
66	Lilly	NNP	PERSON	Lilly	nn	67	SENT_249	[p20l414t564r500b613],
67	alliance	NN	O	alliance	dep	7	SENT_249	[p20l514t564r681b602],
68	.	.	O	.	_	0	SENT_249	[p20l514t564r681b602],

1	Acknowledgments	NNS	O	acknowledgment	nsubj	3	SENT_250	[p20l8t657r385b705],
2	We	PRP	O	we	nsubj	3	SENT_250	[p20l7t721r73b755],
3	thank	VBP	O	thank	_	0	SENT_250	[p20l86t718r207b755],
4	the	DT	O	the	det	5	SENT_250	[p20l219t718r284b755],
5	patients	NNS	O	patient	dobj	3	SENT_250	[p20l298t720r473b766],
6	,	,	O	,	_	0	SENT_250	[p20l298t720r473b766],
7	investigators	NNS	O	investigator	conj_and	5	SENT_250	[p20l489t720r764b767],
8	,	,	O	,	_	0	SENT_250	[p20l489t720r764b767],
9	and	CC	O	and	_	0	SENT_250	[p20l780t717r857b755],
10	members	NNS	O	member	dobj	3	SENT_250	[p20l870t718r1067b755],
11	of	IN	O	of	_	0	SENT_250	[p20l1083t717r1129b755],
12	all	DT	O	all	det	13	SENT_250	[p20l1137t718r1184b755],
13	committees	NNS	O	committee	prep_of	10	SENT_250	[p20l1198t720r1440b755],
14	who	WP	O	who	nsubj	15	SENT_250	[p20l7t779r94b816],
15	participated	VBD	O	participate	rcmod	10	SENT_250	[p20l108t779r354b827],
16	in	IN	O	in	_	0	SENT_250	[p20l368t781r409b815],
17	the	DT	O	the	det	19	SENT_250	[p20l422t779r487b816],
18	PLATO	NNP	O	PLATO	nn	19	SENT_250	[p20l504t781r652b816],
19	trial	NN	O	trial	prep_in	15	SENT_250	[p20l666t778r759b816],
20	.	.	O	.	_	0	SENT_250	[p20l666t778r759b816],

1	This	DT	O	this	det	2	SENT_251	[p20l775t778r866b816],
2	study	NN	O	study	nsubjpass	4	SENT_251	[p20l883t778r994b828],
3	was	VBD	O	be	auxpass	4	SENT_251	[p20l1005t792r1082b816],
4	funded	VBN	O	fund	_	0	SENT_251	[p20l1098t778r1246b816],
5	by	IN	O	by	_	0	SENT_251	[p20l1259t779r1307b828],
6	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	agent	4	SENT_251	[p20l7t841r279b882],
7	,	,	O	,	_	0	SENT_251	[p20l7t841r279b882],
8	which	WDT	O	which	nsubj	9	SENT_251	[p20l293t839r420b877],
9	provided	VBD	O	provide	rcmod	6	SENT_251	[p20l434t839r616b888],
10	research	NN	O	research	nn	11	SENT_251	[p20l629t839r804b877],
11	grants	NNS	O	grant	dobj	9	SENT_251	[p20l819t847r947b889],
12	for	IN	O	for	_	0	SENT_251	[p20l962t839r1022b877],
13	the	DT	O	the	det	16	SENT_251	[p20l1034t839r1099b877],
14	PLATO	NNP	O	PLATO	nn	16	SENT_251	[p20l1115t841r1263b877],
15	clinical	JJ	O	clinical	amod	16	SENT_251	[p20l1279t839r1426b877],
16	trial	NN	O	trial	prep_for	9	SENT_251	[p20l1440t839r1523b877],
17	and	CC	O	and	_	0	SENT_251	[p20l8t900r85b938],
18	biomarker	NN	O	biomarker	nn	19	SENT_251	[p20l98t900r315b938],
19	analyses	NNS	O	analysis	conj_and	16	SENT_251	[p20l329t900r512b950],
20	,	,	O	,	_	0	SENT_251	[p20l329t900r512b950],
21	consulting	VBG	O	consult	amod	22	SENT_251	[p20l529t900r748b950],
22	fees	NNS	O	fee	dobj	9	SENT_251	[p20l762t900r842b938],
23	or	CC	O	or	_	0	SENT_251	[p20l858t914r900b938],
24	honorarium	NN	O	honorarium	dobj	9	SENT_251	[p20l913t900r1176b943],
25	,	,	O	,	_	0	SENT_251	[p20l913t900r1176b943],
26	support	NN	O	support	dobj	9	SENT_251	[p20l1194t908r1353b949],
27	for	IN	O	for	_	0	SENT_251	[p20l1367t900r1426b938],
28	travel	NN	O	travel	prep_for	26	SENT_251	[p20l7t961r121b999],
29	to	TO	O	to	_	0	SENT_251	[p20l134t969r173b999],
30	executive	JJ	O	executive	amod	32	SENT_251	[p20l188t964r377b999],
31	committee	NN	O	committee	nn	32	SENT_251	[p20l392t964r613b999],
32	meetings	NNS	O	meeting	prep_to	28	SENT_251	[p20l628t963r830b1011],
33	,	,	O	,	_	0	SENT_251	[p20l628t963r830b1011],
34	and	CC	O	and	_	0	SENT_251	[p20l847t961r924b999],
35	fees	NNS	O	fee	conj_and	22	SENT_251	[p20l937t961r1017b999],
36	for	IN	O	for	_	0	SENT_251	[p20l1032t961r1092b999],
37	participation	NN	O	participation	prep_for	35	SENT_251	[p20l1105t963r1368b1010],
38	in	IN	O	in	_	0	SENT_251	[p20l1382t963r1424b998],
39	review	NN	O	review	nn	40	SENT_251	[p20l8t1024r143b1059],
40	activities	NNS	O	activity	prep_in	37	SENT_251	[p20l157t1024r347b1059],
41	.	.	O	.	_	0	SENT_251	[p20l157t1024r347b1059],

1	References	NNS	O	reference	_	0	SENT_252	[p20l10t1115r221b1152],

1	1	CD	NUMBER	1	num	3	SENT_253	[p20l9t1174r27b1207],
2	Anderson	NNP	PERSON	Anderson	nn	3	SENT_253	[p20l108t1170r313b1207],
3	IL	NN	PERSON	il	_	0	SENT_253	[p20l328t1174r380b1218],
4	,	,	O	,	_	0	SENT_253	[p20l328t1174r380b1218],
5	Adams	NNP	PERSON	Adams	nn	6	SENT_253	[p20l395t1170r540b1207],
6	CD	NNP	O	CD	appos	3	SENT_253	[p20l556t1173r634b1213],
7	,	,	O	,	_	0	SENT_253	[p20l556t1173r634b1213],
8	Antman	NNP	ORGANIZATION	Antman	nn	9	SENT_253	[p20l649t1173r821b1207],
9	EM	NNP	ORGANIZATION	EM	appos	3	SENT_253	[p20l838t1172r918b1213],
10	,	,	O	,	_	0	SENT_253	[p20l838t1172r918b1213],
11	et	FW	O	et	nn	12	SENT_253	[p20l934t1177r971b1207],
12	al.	FW	O	al.	appos	3	SENT_253	[p20l985t1170r1029b1207],
13	.	.	O	.	_	0	SENT_253	[p20l985t1170r1029b1207],

1	ACC/AHA	NNP	O	ACC/AHA	_	0	SENT_254	[p20l1044t1173r1270b1219],
2	2007	CD	DATE	2007	dep	1	SENT_254	[p20l1285t1172r1378b1209],

1	guidelines	NNS	O	guideline	nsubj	80	SENT_255	[p20l109t1227r323b1276],
2	for	IN	O	for	_	0	SENT_255	[p20l338t1227r397b1264],
3	the	DT	O	the	det	4	SENT_255	[p20l410t1227r475b1264],
4	management	NN	O	management	prep_for	1	SENT_255	[p20l489t1234r766b1276],
5	of	IN	O	of	_	0	SENT_255	[p20l779t1227r826b1264],
6	patients	NNS	O	patient	prep_of	4	SENT_255	[p20l832t1229r996b1276],
7	with	IN	O	with	_	0	SENT_255	[p20l1010t1227r1102b1264],
8	unstable	JJ	O	unstable	amod	9	SENT_255	[p20l1115t1227r1292b1264],
9	angina	NN	O	angina	prep_with	6	SENT_255	[p20l1307t1229r1448b1276],
10	/	:	O	/	punct	1	SENT_255	[p20l1451t1230r1466b1276],
11	non	JJ	O	non	amod	14	SENT_255	[p20l109t1296r190b1320],
12	ST-elevation	JJ	O	st-elevation	amod	14	SENT_255	[p20l207t1282r457b1320],
13	myocardial	JJ	O	myocardial	amod	14	SENT_255	[p20l471t1283r700b1332],
14	infarction	NN	O	infarction	dep	1	SENT_255	[p20l714t1282r927b1320],
15	:	:	O	:	_	0	SENT_255	[p20l714t1282r927b1320],
16	a	DT	O	a	det	17	SENT_255	[p20l944t1296r965b1320],
17	report	NN	O	report	dep	14	SENT_255	[p20l979t1290r1105b1331],
18	of	IN	O	of	_	0	SENT_255	[p20l1119t1282r1165b1320],
19	the	DT	O	the	det	21	SENT_255	[p20l1172t1283r1236b1320],
20	American	NNP	ORGANIZATION	American	nn	21	SENT_255	[p20l1250t1285r1456b1320],
21	College	NNP	ORGANIZATION	College	prep_of	17	SENT_255	[p20l110t1338r261b1388],
22	of	IN	ORGANIZATION	of	_	0	SENT_255	[p20l276t1338r323b1376],
23	Cardiology/American	NNP	ORGANIZATION	Cardiology/American	nn	27	SENT_255	[p20l331t1338r779b1388],
24	Heart	NNP	ORGANIZATION	Heart	nn	27	SENT_255	[p20l795t1342r912b1376],
25	Association	NNP	ORGANIZATION	Association	nn	27	SENT_255	[p20l925t1340r1166b1376],
26	Task	NNP	ORGANIZATION	Task	nn	27	SENT_255	[p20l1179t1338r1273b1376],
27	Force	NNP	ORGANIZATION	Force	prep_of	1	SENT_255	[p20l1288t1340r1399b1376],
28	on	IN	O	on	_	0	SENT_255	[p20l1414t1351r1465b1376],
29	Practice	NNP	O	Practice	nn	30	SENT_255	[p20l111t1397r273b1432],
30	Guidelines	NNS	O	guideline	prep_on	27	SENT_255	[p20l288t1395r511b1432],
31	(	CD	NUMBER	(	dep	30	SENT_255	[p20l530t1397r692b1444],
32	writing	VBG	O	write	partmod	27	SENT_255	[p20l530t1397r692b1444],
33	committee	NN	O	committee	dobj	32	SENT_255	[p20l707t1397r928b1432],
34	to	TO	O	to	aux	35	SENT_255	[p20l942t1402r980b1432],
35	revise	VB	O	revise	infmod	33	SENT_255	[p20l995t1397r1115b1432],
36	the	DT	O	the	det	38	SENT_255	[p20l1128t1395r1193b1432],
37	2002	CD	DATE	2002	num	38	SENT_255	[p20l1209t1398r1304b1432],
38	guidelines	NNS	O	guideline	dobj	35	SENT_255	[p20l109t1451r323b1500],
39	for	IN	O	for	_	0	SENT_255	[p20l338t1450r397b1488],
40	the	DT	O	the	det	41	SENT_255	[p20l410t1451r475b1488],
41	management	NN	O	management	prep_for	38	SENT_255	[p20l489t1458r766b1500],
42	of	IN	O	of	_	0	SENT_255	[p20l779t1450r826b1488],
43	patients	NNS	O	patient	prep_of	41	SENT_255	[p20l832t1453r996b1499],
44	with	IN	O	with	_	0	SENT_255	[p20l1010t1450r1102b1488],
45	unstable	JJ	O	unstable	prep_with	35	SENT_255	[p20l1115t1450r1292b1488],
46	angina	NN	O	angina	dep	32	SENT_255	[p20l1307t1453r1448b1500],
47	/	:	O	/	punct	46	SENT_255	[p20l1451t1454r1466b1499],
48	non	JJ	O	non	dep	46	SENT_255	[p20l109t1519r190b1544],
49	ST-elevation	JJ	O	st-elevation	amod	50	SENT_255	[p20l207t1506r457b1544],
50	myocardial	JJ	O	myocardial	amod	52	SENT_255	[p20l471t1506r700b1555],
51	infarction	NN	O	infarction	nn	52	SENT_255	[p20l714t1506r943b1556],
52	)	NN	O	)	dep	48	SENT_255	[p20l714t1506r943b1556],
53	:	:	O	:	_	0	SENT_255	[p20l714t1506r943b1556],
54	developed	VBN	O	develop	dep	46	SENT_255	[p20l960t1506r1167b1555],
55	in	IN	O	in	_	0	SENT_255	[p20l1181t1509r1222b1543],
56	collaboration	NN	O	collaboration	prep_in	54	SENT_255	[p20l1236t1506r1506b1544],
57	with	IN	O	with	_	0	SENT_255	[p20l107t1563r199b1600],
58	the	DT	O	the	det	60	SENT_255	[p20l212t1563r277b1600],
59	American	NNP	ORGANIZATION	American	nn	60	SENT_255	[p20l291t1565r497b1600],
60	College	NNP	ORGANIZATION	College	prep_with	54	SENT_255	[p20l512t1563r663b1612],
61	of	IN	ORGANIZATION	of	_	0	SENT_255	[p20l678t1563r724b1600],
62	Emergency	NNP	ORGANIZATION	Emergency	nn	63	SENT_255	[p20l734t1565r966b1612],
63	Physicians	NNP	ORGANIZATION	Physicians	prep_of	60	SENT_255	[p20l981t1563r1211b1612],
64	,	,	O	,	_	0	SENT_255	[p20l981t1563r1211b1612],
65	the	DT	O	the	det	66	SENT_255	[p20l1226t1563r1291b1600],
66	Society	NNP	ORGANIZATION	Society	nsubj	80	SENT_255	[p20l1309t1565r1453b1612],
67	for	IN	ORGANIZATION	for	_	0	SENT_255	[p20l1465t1563r1525b1600],
68	Cardiovascular	NNP	ORGANIZATION	Cardiovascular	nn	69	SENT_255	[p20l110t1619r417b1656],
69	Angiography	NNP	ORGANIZATION	Angiography	prep_for	66	SENT_255	[p20l429t1618r700b1668],
70	and	CC	O	and	_	0	SENT_255	[p20l714t1619r790b1656],
71	Interventions	NNS	O	intervention	conj_and	69	SENT_255	[p20l806t1621r1094b1662],
72	,	,	O	,	_	0	SENT_255	[p20l806t1621r1094b1662],
73	and	CC	O	and	_	0	SENT_255	[p20l1111t1618r1188b1656],
74	the	DT	O	the	det	75	SENT_255	[p20l1201t1618r1265b1656],
75	Society	NNP	MISC	Society	nsubj	80	SENT_255	[p20l1283t1621r1426b1668],
76	of	IN	MISC	of	_	0	SENT_255	[p20l1440t1618r1486b1656],
77	Thoracic	NNP	MISC	Thoracic	nn	78	SENT_255	[p20l108t1674r289b1712],
78	Surgeons	NNPS	MISC	Surgeons	prep_of	75	SENT_255	[p20l306t1677r508b1724],
79	:	:	O	:	_	0	SENT_255	[p20l306t1677r508b1724],
80	endorsed	VBN	O	endorse	_	0	SENT_255	[p20l525t1674r716b1712],
81	by	IN	O	by	_	0	SENT_255	[p20l729t1674r777b1723],
82	the	DT	O	the	det	84	SENT_255	[p20l789t1674r854b1712],
83	American	NNP	ORGANIZATION	American	nn	84	SENT_255	[p20l868t1677r1073b1712],
84	Association	NNP	ORGANIZATION	Association	prep_by	80	SENT_255	[p20l1086t1676r1327b1712],
85	of	IN	ORGANIZATION	of	_	0	SENT_255	[p20l1342t1674r1388b1712],
86	Cardiovascular	NNP	ORGANIZATION	Cardiovascular	nn	89	SENT_255	[p20l110t1731r417b1768],
87	and	CC	ORGANIZATION	and	_	0	SENT_255	[p20l431t1731r507b1768],
88	Pulmonary	NNP	ORGANIZATION	Pulmonary	nn	89	SENT_255	[p20l523t1731r752b1780],
89	Rehabilitation	NNP	ORGANIZATION	Rehabilitation	prep_of	84	SENT_255	[p20l767t1731r1057b1768],
90	and	CC	O	and	_	0	SENT_255	[p20l1072t1731r1148b1768],
91	the	DT	O	the	det	92	SENT_255	[p20l1161t1731r1226b1768],
92	Society	NNP	ORGANIZATION	Society	conj_and	84	SENT_255	[p20l1243t1733r1387b1780],
93	for	IN	ORGANIZATION	for	_	0	SENT_255	[p20l1400t1731r1459b1768],
94	Academic	NNP	ORGANIZATION	Academic	nn	96	SENT_255	[p20l108t1787r312b1824],
95	Emergency	NNP	ORGANIZATION	Emergency	nn	96	SENT_255	[p20l328t1789r561b1836],
96	Medicine	NNP	ORGANIZATION	Medicine	prep_for	92	SENT_255	[p20l575t1787r777b1824],
97	.	.	O	.	_	0	SENT_255	[p20l575t1787r777b1824],

1	Circulation	NN	O	circulation	_	0	SENT_256	[p20l797t1787r1018b1824],
2	2007	CD	DATE	2007	num	1	SENT_256	[p20l1032t1789r1135b1830],
3	;	:	O	;	_	0	SENT_256	[p20l1032t1789r1135b1830],
4	116	CD	NUMBER	116	num	6	SENT_256	[p20l1153t1790r1228b1824],
5	:	:	O	:	_	0	SENT_256	[p20l1153t1790r1228b1824],
6	e148	CD	NUMBER	e148	dep	1	SENT_256	[p20l1245t1790r1440b1824],
7	—	NN	O	—	dep	6	SENT_256	[p20l1245t1790r1440b1824],
8	304	CD	NUMBER	304	num	7	SENT_256	[p20l1245t1790r1440b1824],
9	.	.	O	.	_	0	SENT_256	[p20l1245t1790r1440b1824],

1	2	CD	NUMBER	2	num	4	SENT_257	[p20l9t1853r30b1887],
2	Bassand	JJ	O	bassand	amod	4	SENT_257	[p20l111t1850r282b1888],
3	]	NN	O	]	nn	4	SENT_257	[p20l297t1854r352b1899],
4	P	NN	O	p	_	0	SENT_257	[p20l297t1854r352b1899],
5	,	,	O	,	_	0	SENT_257	[p20l297t1854r352b1899],
6	Hamm	NNP	ORGANIZATION	Hamm	nn	7	SENT_257	[p20l370t1854r518b1888],
7	CW	NNP	ORGANIZATION	CW	appos	4	SENT_257	[p20l533t1853r616b1894],
8	,	,	O	,	_	0	SENT_257	[p20l533t1853r616b1894],
9	Ardissino	NN	O	ardissino	nn	10	SENT_257	[p20l631t1850r832b1888],
10	D	NN	O	d	appos	4	SENT_257	[p20l849t1854r892b1894],
11	,	,	O	,	_	0	SENT_257	[p20l849t1854r892b1894],
12	et	FW	O	et	nn	13	SENT_257	[p20l909t1858r945b1888],
13	al.	FW	O	al.	appos	4	SENT_257	[p20l959t1850r1003b1888],
14	.	.	O	.	_	0	SENT_257	[p20l959t1850r1003b1888],

1	Guidelines	NNS	O	guideline	_	0	SENT_258	[p20l1021t1850r1244b1888],
2	for	IN	O	for	_	0	SENT_258	[p20l1259t1850r1319b1888],
3	the	DT	O	the	det	4	SENT_258	[p20l1331t1850r1396b1888],
4	diagnosis	NN	O	diagnosis	prep_for	1	SENT_258	[p20l109t1907r304b1956],
5	and	CC	O	and	_	0	SENT_258	[p20l320t1907r397b1944],
6	treatment	NN	O	treatment	prep_for	1	SENT_258	[p20l409t1914r614b1944],
7	of	IN	O	of	_	0	SENT_258	[p20l628t1907r674b1944],
8	non-ST-segment	JJ	O	non-st-segment	amod	9	SENT_258	[p20l681t1909r1024b1956],
9	elevation	NN	O	elevation	prep_of	4	SENT_258	[p20l1038t1907r1223b1944],
10	acute	JJ	O	acute	amod	12	SENT_258	[p20l1237t1914r1345b1944],
11	coronary	JJ	O	coronary	amod	12	SENT_258	[p20l109t1976r291b2012],
12	syndromes	NNS	O	syndrome	dep	9	SENT_258	[p20l305t1962r543b2011],
13	.	.	O	.	_	0	SENT_258	[p20l305t1962r543b2011],

1	Ear	NN	O	ear	nn	2	SENT_259	[p20l562t1965r634b2000],
2	Heart	NNP	O	Heart	_	0	SENT_259	[p20l648t1966r794b2012],
3	]	CD	NUMBER	]	num	4	SENT_259	[p20l648t1966r794b2012],
4	2007	CD	DATE	2007	dep	2	SENT_259	[p20l807t1965r910b2005],
5	;	:	O	;	_	0	SENT_259	[p20l807t1965r910b2005],
6	28	CD	NUMBER	28	num	8	SENT_259	[p20l927t1965r985b2000],
7	:	:	O	:	_	0	SENT_259	[p20l927t1965r985b2000],
8	1598-660	CD	NUMBER	1598-660	dep	2	SENT_259	[p20l1002t1964r1204b2000],
9	.	.	O	.	_	0	SENT_259	[p20l1002t1964r1204b2000],

1	3	CD	NUMBER	3	num	3	SENT_260	[p20l10t2029r29b2064],
2	Kushner	NN	ORGANIZATION	kushner	nn	3	SENT_260	[p20l111t2026r287b2064],
3	FG	NN	ORGANIZATION	fg	nsubj	15	SENT_260	[p20l303t2028r375b2069],
4	,	,	O	,	_	0	SENT_260	[p20l303t2028r375b2069],
5	Hand	NN	O	hand	nn	6	SENT_260	[p20l393t2026r509b2064],
6	M	NN	O	m	appos	3	SENT_260	[p20l524t2029r576b2069],
7	,	,	O	,	_	0	SENT_260	[p20l524t2029r576b2069],
8	Smith	NNP	ORGANIZATION	Smith	nn	10	SENT_260	[p20l595t2026r720b2064],
9	SC	NNP	ORGANIZATION	SC	nn	10	SENT_260	[p20l736t2028r792b2064],
10	Ir	NNP	ORGANIZATION	Ir	appos	3	SENT_260	[p20l808t2029r849b2075],
11	,	,	O	,	_	0	SENT_260	[p20l808t2029r849b2075],
12	et	FW	O	et	nn	13	SENT_260	[p20l865t2033r902b2064],
13	al.	FW	O	al.	appos	3	SENT_260	[p20l916t2026r960b2064],
14	2009	CD	DATE	2009	dep	13	SENT_260	[p20l977t2029r1073b2064],
15	focused	VBD	O	focus	_	0	SENT_260	[p20l1088t2026r1248b2064],
16	updates	NNS	O	update	dobj	15	SENT_260	[p20l1261t2026r1434b2075],
17	:	:	O	:	_	0	SENT_260	[p20l1261t2026r1434b2075],

1	ACC/AHA	NN	O	acc/aha	nn	2	SENT_261	[p20l108t2085r333b2131],
2	guidelines	NNS	O	guideline	nsubj	20	SENT_261	[p20l347t2083r561b2132],
3	for	IN	O	for	_	0	SENT_261	[p20l576t2082r635b2120],
4	the	DT	O	the	det	5	SENT_261	[p20l648t2082r713b2120],
5	management	NN	O	management	prep_for	2	SENT_261	[p20l727t2090r1004b2132],
6	of	IN	O	of	_	0	SENT_261	[p20l1018t2082r1064b2120],
7	patients	NNS	O	patient	prep_of	5	SENT_261	[p20l1070t2085r1234b2131],
8	with	IN	O	with	_	0	SENT_261	[p20l1248t2082r1340b2120],
9	ST-elevation	NN	MISC	st-elevation	prep_with	7	SENT_261	[p20l112t2138r361b2176],
10	myocardial	JJ	O	myocardial	amod	12	SENT_261	[p20l375t2138r604b2187],
11	infarction	NN	O	infarction	nn	12	SENT_261	[p20l618t2138r822b2176],
12	(	NN	O	(	nsubj	19	SENT_261	[p20l839t2138r1037b2188],
13	updating	VBG	O	update	partmod	12	SENT_261	[p20l839t2138r1037b2188],
14	the	DT	O	the	det	16	SENT_261	[p20l1050t2138r1115b2176],
15	2004	CD	DATE	2004	num	16	SENT_261	[p20l1131t2141r1227b2176],
16	guideline	NN	O	guideline	dobj	13	SENT_261	[p20l1240t2138r1433b2188],
17	and	CC	O	and	_	0	SENT_261	[p20l109t2195r186b2232],
18	2007	CD	DATE	2007	conj_and	16	SENT_261	[p20l200t2197r294b2234],
19	focused	VBD	O	focus	rcmod	2	SENT_261	[p20l307t2195r468b2232],
20	update	VBP	O	update	_	0	SENT_261	[p20l481t2195r634b2244],
21	)	NN	O	)	nsubj	39	SENT_261	[p20l481t2195r634b2244],
22	and	CC	O	and	_	0	SENT_261	[p20l652t2195r729b2232],
23	ACC/AHA	NN	O	acc/aha	conj_and	21	SENT_261	[p20l741t2198r982b2244],
24	/	:	O	/	punct	32	SENT_261	[p20l741t2198r982b2244],
25	SCAI	NN	O	scaus	nn	26	SENT_261	[p20l989t2197r1095b2232],
26	guidelines	NNS	O	guideline	nsubj	32	SENT_261	[p20l1112t2195r1325b2244],
27	on	IN	O	on	_	0	SENT_261	[p20l1341t2208r1393b2232],
28	percutaneous	JJ	O	percutaneous	amod	31	SENT_261	[p20l108t2258r388b2299],
29	coronary	JJ	O	coronary	amod	31	SENT_261	[p20l404t2264r586b2300],
30	intervention	NN	O	intervention	nn	31	SENT_261	[p20l599t2253r854b2288],
31	(	NN	O	(	prep_on	26	SENT_261	[p20l871t2251r1069b2300],
32	updating	VBG	O	update	dep	21	SENT_261	[p20l871t2251r1069b2300],
33	the	DT	O	the	det	35	SENT_261	[p20l1082t2251r1147b2288],
34	2005	CD	DATE	2005	num	35	SENT_261	[p20l1163t2253r1257b2288],
35	guideline	NN	O	guideline	nsubj	38	SENT_261	[p20l1274t2251r1467b2300],
36	and	CC	O	and	_	0	SENT_261	[p20l109t2306r186b2344],
37	2007	CD	DATE	2007	nsubj	38	SENT_261	[p20l200t2308r294b2345],
38	focused	VBD	O	focus	ccomp	32	SENT_261	[p20l307t2306r468b2344],
39	update	VBP	O	update	ccomp	20	SENT_261	[p20l481t2306r647b2356],
40	)	CD	NUMBER	)	dobj	39	SENT_261	[p20l481t2306r647b2356],
41	:	:	O	:	_	0	SENT_261	[p20l481t2306r647b2356],
42	a	DT	O	a	det	43	SENT_261	[p20l664t2319r685b2344],
43	report	NN	O	report	dep	40	SENT_261	[p20l699t2314r826b2355],
44	of	IN	O	of	_	0	SENT_261	[p20l839t2306r885b2344],
45	the	DT	O	the	det	47	SENT_261	[p20l892t2306r956b2344],
46	American	NNP	ORGANIZATION	American	nn	47	SENT_261	[p20l970t2309r1176b2344],
47	College	NNP	ORGANIZATION	College	prep_of	43	SENT_261	[p20l1191t2306r1342b2356],
48	of	IN	ORGANIZATION	of	_	0	SENT_261	[p20l1358t2306r1403b2344],
49	Cardiology	NNP	ORGANIZATION	Cardiology	nn	54	SENT_261	[p20l110t2363r333b2412],
50	Foundation/American	NNP	ORGANIZATION	Foundation/American	nn	54	SENT_261	[p20l348t2363r812b2412],
51	Heart	NNP	ORGANIZATION	Heart	nn	54	SENT_261	[p20l828t2367r945b2400],
52	Association	NNP	ORGANIZATION	Association	nn	54	SENT_261	[p20l957t2365r1198b2400],
53	Task	NNP	ORGANIZATION	Task	nn	54	SENT_261	[p20l1211t2363r1306b2400],
54	Force	NNP	ORGANIZATION	Force	prep_of	47	SENT_261	[p20l1321t2365r1431b2400],
55	on	IN	O	on	_	0	SENT_261	[p20l1446t2376r1498b2400],
56	Practice	NNP	O	Practice	nn	57	SENT_261	[p20l111t2421r273b2457],
57	Guidelines	NNS	O	guideline	prep_on	54	SENT_261	[p20l288t2419r523b2457],
58	.	.	O	.	_	0	SENT_261	[p20l288t2419r523b2457],

1	Circulation	NN	O	circulation	_	0	SENT_262	[p20l543t2419r764b2457],
2	2009	CD	DATE	2009	num	1	SENT_262	[p20l778t2422r885b2462],
3	;	:	O	;	_	0	SENT_262	[p20l778t2422r885b2462],
4	120	CD	NUMBER	120	num	6	SENT_262	[p20l903t2422r982b2457],
5	:	:	O	:	_	0	SENT_262	[p20l903t2422r982b2457],
6	2271-306	CD	NUMBER	2271-306	dep	1	SENT_262	[p20l999t2421r1197b2458],
7	.	.	O	.	_	0	SENT_262	[p20l999t2421r1197b2458],

1	Articles	NNPS	O	Articles	_	0	SENT_263	[p20l101t2865r251b2901],

1	Van	NNP	PERSON	Van	nn	3	SENT_264	[p20l746t3111r826b3145],
2	de	NNP	PERSON	de	nn	3	SENT_264	[p20l840t3107r887b3145],
3	Werf	NNP	PERSON	Werf	_	0	SENT_264	[p20l900t3107r1008b3145],
4	F	NN	PERSON	f	dep	3	SENT_264	[p20l1017t3109r1052b3150],
5	,	,	O	,	_	0	SENT_264	[p20l1017t3109r1052b3150],
6	Bax	NN	PERSON	bax	nn	7	SENT_264	[p20l1070t3111r1143b3145],
7	]	NN	O	]	appos	4	SENT_264	[p20l1157t3111r1183b3155],
8	,	,	O	,	_	0	SENT_264	[p20l1157t3111r1183b3155],
9	Betriu	NNP	MISC	Betriu	nn	10	SENT_264	[p20l1200t3109r1327b3145],
10	A	NNP	MISC	A	appos	4	SENT_264	[p20l1340t3110r1383b3150],
11	,	,	O	,	_	0	SENT_264	[p20l1340t3110r1383b3150],
12	et	FW	O	et	nn	13	SENT_264	[p20l1399t3115r1436b3145],
13	al.	FW	O	al.	appos	4	SENT_264	[p20l1449t3107r1493b3145],
14	.	.	O	.	_	0	SENT_264	[p20l1449t3107r1493b3145],

1	Management	NN	O	management	_	0	SENT_265	[p20l1511t3111r1784b3157],
2	of	IN	O	of	_	0	SENT_265	[p20l1797t3107r1843b3145],
3	acute	JJ	O	acute	amod	5	SENT_265	[p20l1851t3115r1958b3145],
4	myocardial	JJ	O	myocardial	amod	5	SENT_265	[p20l747t3164r974b3213],
5	infarction	NN	O	infarction	prep_of	1	SENT_265	[p20l988t3164r1191b3201],
6	in	IN	O	in	_	0	SENT_265	[p20l1205t3166r1246b3201],
7	patients	NNS	O	patient	prep_in	5	SENT_265	[p20l1259t3166r1422b3213],
8	presenting	VBG	O	present	partmod	7	SENT_265	[p20l1437t3166r1659b3213],
9	with	IN	O	with	_	0	SENT_265	[p20l1671t3164r1763b3201],
10	persistent	JJ	O	persistent	amod	12	SENT_265	[p20l1776t3166r1981b3213],
11	ST-segment	NN	O	st-segment	nn	12	SENT_265	[p20l750t3222r992b3269],
12	elevation	NN	O	elevation	prep_with	8	SENT_265	[p20l1005t3219r1199b3257],
13	:	:	O	:	_	0	SENT_265	[p20l1005t3219r1199b3257],
14	the	DT	O	the	det	16	SENT_265	[p20l1215t3219r1279b3257],
15	Task	NNP	O	Task	nn	16	SENT_265	[p20l1293t3219r1386b3257],
16	Force	NNP	O	Force	dep	1	SENT_265	[p20l1401t3222r1511b3257],
17	on	IN	O	on	_	0	SENT_265	[p20l1526t3233r1578b3257],
18	the	DT	O	the	det	19	SENT_265	[p20l1591t3219r1655b3257],
19	Management	NN	O	management	prep_on	16	SENT_265	[p20l1671t3223r1944b3269],
20	of	IN	O	of	_	0	SENT_265	[p20l1958t3219r2004b3257],
21	ST-Segment	NN	O	st-segment	nn	22	SENT_265	[p20l750t3277r998b3325],
22	Elevation	NN	O	elevation	prep_of	19	SENT_265	[p20l1013t3275r1201b3313],
23	Acute	JJ	O	acute	amod	25	SENT_265	[p20l1214t3278r1332b3313],
24	Myocardial	JJ	O	myocardial	amod	25	SENT_265	[p20l1348t3275r1575b3324],
25	Infarction	NN	O	infarction	dep	16	SENT_265	[p20l1591t3275r1796b3313],
26	of	IN	O	of	_	0	SENT_265	[p20l1810t3275r1856b3313],
27	the	DT	O	the	det	29	SENT_265	[p20l1862t3275r1927b3313],
28	European	JJ	ORGANIZATION	european	amod	29	SENT_265	[p20l1943t3277r2141b3324],
29	Society	NNP	ORGANIZATION	Society	prep_of	25	SENT_265	[p20l750t3334r893b3381],
30	of	IN	ORGANIZATION	of	_	0	SENT_265	[p20l906t3332r952b3369],
31	Cardiology	NNP	ORGANIZATION	Cardiology	prep_of	29	SENT_265	[p20l960t3332r1187b3381],
32	.	.	O	.	_	0	SENT_265	[p20l960t3332r1187b3381],

1	Ear	NN	O	ear	nn	2	SENT_266	[p20l1206t3334r1278b3369],
2	Heart	NNP	O	Heart	_	0	SENT_266	[p20l1291t3335r1436b3381],
3	]	CD	NUMBER	]	num	4	SENT_266	[p20l1291t3335r1436b3381],
4	2008	CD	DATE	2008	dep	2	SENT_266	[p20l1449t3335r1555b3375],
5	;	:	O	;	_	0	SENT_266	[p20l1449t3335r1555b3375],
6	29	CD	NUMBER	29	num	8	SENT_266	[p20l1573t3335r1630b3369],
7	:	:	O	:	_	0	SENT_266	[p20l1573t3335r1630b3369],
8	2909-45	CD	NUMBER	2909-45	dep	2	SENT_266	[p20l1647t3334r1825b3369],
9	.	.	O	.	_	0	SENT_266	[p20l1647t3334r1825b3369],

1	Wiviott	NNP	PERSON	Wiviott	nn	2	SENT_267	[p20l746t3396r895b3432],
2	SD	NN	O	sd	_	0	SENT_267	[p20l911t3397r981b3437],
3	,	,	O	,	_	0	SENT_267	[p20l911t3397r981b3437],
4	Braunwald	NNP	PERSON	Braunwald	nn	5	SENT_267	[p20l999t3394r1223b3432],
5	E	NNP	O	E	appos	2	SENT_267	[p20l1238t3396r1274b3437],
6	,	,	O	,	_	0	SENT_267	[p20l1238t3396r1274b3437],
7	McCabe	NNP	PERSON	McCabe	nn	8	SENT_267	[p20l1291t3394r1456b3432],
8	CH	NN	O	ch	appos	2	SENT_267	[p20l1472t3397r1554b3437],
9	,	,	O	,	_	0	SENT_267	[p20l1472t3397r1554b3437],
10	et	FW	O	et	nn	11	SENT_267	[p20l1571t3402r1607b3432],
11	al.	FW	O	al.	appos	2	SENT_267	[p20l1621t3394r1664b3432],
12	.	.	O	.	_	0	SENT_267	[p20l1621t3394r1664b3432],

1	Prasugrel	NNP	O	Prasugrel	_	0	SENT_268	[p20l1683t3394r1879b3444],
2	versus	CC	O	versus	prep	1	SENT_268	[p20l1892t3407r2023b3432],
3	clopidogrel	NN	O	clopidogrel	dep	2	SENT_268	[p21l747t18r976b67],
4	in	IN	O	in	_	0	SENT_268	[p21l990t20r1031b55],
5	patients	NNS	O	patient	prep_in	1	SENT_268	[p21l1045t20r1207b67],
6	with	IN	O	with	_	0	SENT_268	[p21l1222t18r1313b55],
7	acute	JJ	O	acute	amod	9	SENT_268	[p21l1328t25r1435b55],
8	coronary	JJ	O	coronary	amod	9	SENT_268	[p21l1450t31r1630b67],
9	syndromes	NNS	O	syndrome	prep_with	5	SENT_268	[p21l1645t18r1881b67],
10	.	.	O	.	_	0	SENT_268	[p21l1645t18r1881b67],

1	N	NN	O	n	nn	3	SENT_269	[p21l749t78r785b112],
2	Engl	NNP	O	Engl	nn	3	SENT_269	[p21l799t75r883b124],
3	]	NNP	O	]	nsubj	4	SENT_269	[p21l891t78r916b124],
4	Med	VBD	O	med	_	0	SENT_269	[p21l929t75r1013b112],
5	2007	CD	DATE	2007	dobj	4	SENT_269	[p21l1027t77r1130b118],
6	;	:	O	;	_	0	SENT_269	[p21l1027t77r1130b118],
7	357	CD	NUMBER	357	num	9	SENT_269	[p21l1147t76r1229b113],
8	:	:	O	:	_	0	SENT_269	[p21l1147t76r1229b113],
9	2001-15	CD	NUMBER	2001-15	dep	5	SENT_269	[p21l1247t77r1418b112],
10	.	.	O	.	_	0	SENT_269	[p21l1247t77r1418b112],

1	Hulot	NNP	PERSON	Hulot	nn	3	SENT_270	[p21l749t138r867b175],
2	]	CD	NUMBER	]	num	3	SENT_270	[p21l881t141r935b186],
3	S	NN	O	s	_	0	SENT_270	[p21l881t141r935b186],
4	,	,	O	,	_	0	SENT_270	[p21l881t141r935b186],
5	Bura	NNP	PERSON	Bura	nn	6	SENT_270	[p21l953t142r1049b175],
6	A	NNP	O	A	appos	3	SENT_270	[p21l1062t141r1105b181],
7	,	,	O	,	_	0	SENT_270	[p21l1062t141r1105b181],
8	Villard	NNP	O	Villard	nn	9	SENT_270	[p21l1120t138r1258b176],
9	E	NNP	O	E	appos	3	SENT_270	[p21l1274t140r1309b181],
10	,	,	O	,	_	0	SENT_270	[p21l1274t140r1309b181],
11	et	FW	O	et	nn	12	SENT_270	[p21l1326t145r1362b175],
12	al.	FW	O	al.	appos	3	SENT_270	[p21l1376t138r1420b175],
13	.	.	O	.	_	0	SENT_270	[p21l1376t138r1420b175],

1	Cytochrome	NN	O	cytochrome	nn	2	SENT_271	[p21l1437t138r1687b187],
2	P450	NN	O	p450	nsubj	8	SENT_271	[p21l1703t140r1800b175],
3	2C191ossoffunction	NN	O	2c191ossoffunction	nn	4	SENT_271	[p21l1816t138r2074b175, p21l747t194r922b231],
4	polymorphism	NN	O	polymorphism	dep	2	SENT_271	[p21l936t194r1241b243],
5	is	VBZ	O	be	cop	8	SENT_271	[p21l1255t196r1287b231],
6	a	DT	O	a	det	8	SENT_271	[p21l1303t207r1324b231],
7	major	JJ	O	major	amod	8	SENT_271	[p21l1338t196r1460b243],
8	determinant	NN	O	determinant	_	0	SENT_271	[p21l1474t194r1731b231],
9	of	IN	O	of	_	0	SENT_271	[p21l1744t194r1790b231],
10	clopidogrel	NN	O	clopidogrel	nn	11	SENT_271	[p21l1797t194r2027b243],
11	responsiveness	NN	O	responsiveness	prep_of	8	SENT_271	[p21l747t252r1059b298],
12	in	IN	O	in	_	0	SENT_271	[p21l1074t252r1116b286],
13	healthy	JJ	O	healthy	amod	14	SENT_271	[p21l1129t249r1280b298],
14	subjects	NNS	O	subject	prep_in	11	SENT_271	[p21l1295t249r1470b298],
15	.	.	O	.	_	0	SENT_271	[p21l1295t249r1470b298],

1	Blood	NN	O	blood	_	0	SENT_272	[p21l1490t249r1597b287],
2	2006	CD	DATE	2006	num	1	SENT_272	[p21l1612t253r1718b292],
3	;	:	O	;	_	0	SENT_272	[p21l1612t253r1718b292],
4	108	CD	NUMBER	108	num	6	SENT_272	[p21l1735t252r1813b287],
5	:	:	O	:	_	0	SENT_272	[p21l1735t252r1813b287],
6	2244-47	CD	NUMBER	2244-47	dep	1	SENT_272	[p21l1831t251r1991b288],
7	.	.	O	.	_	0	SENT_272	[p21l1831t251r1991b288],

1	Savi	NNP	PERSON	Savi	nn	2	SENT_273	[p21l750t315r830b350],
2	P	NN	O	p	_	0	SENT_273	[p21l846t317r883b356],
3	,	,	O	,	_	0	SENT_273	[p21l846t317r883b356],
4	Pereillo	NNP	O	Pereillo	nn	5	SENT_273	[p21l901t313r1054b350],
5	IM	NNP	O	IM	appos	2	SENT_273	[p21l1070t317r1140b361],
6	,	,	O	,	_	0	SENT_273	[p21l1070t317r1140b361],
7	Uzabiaga	NNP	O	Uzabiaga	nn	8	SENT_273	[p21l1158t313r1349b362],
8	MF	NN	O	mf	appos	2	SENT_273	[p21l1365t315r1445b356],
9	,	,	O	,	_	0	SENT_273	[p21l1365t315r1445b356],
10	et	FW	O	et	nn	11	SENT_273	[p21l1461t320r1498b350],
11	al.	FW	O	al.	appos	2	SENT_273	[p21l1511t313r1555b350],
12	.	.	O	.	_	0	SENT_273	[p21l1511t313r1555b350],

1	Identiﬁcation	NN	O	identiﬁcation	nn	4	SENT_274	[p21l1573t313r1850b350],
2	and	CC	O	and	_	0	SENT_274	[p21l1864t313r1941b350],
3	biological	JJ	O	biological	nn	4	SENT_274	[p21l1953t313r2152b362],
4	activity	NN	O	activity	_	0	SENT_274	[p21l747t371r891b418],
5	of	IN	O	of	_	0	SENT_274	[p21l905t368r951b406],
6	the	DT	O	the	det	8	SENT_274	[p21l957t368r1021b406],
7	active	JJ	O	active	amod	8	SENT_274	[p21l1036t371r1151b406],
8	metabolite	NN	O	metabolite	prep_of	4	SENT_274	[p21l1165t368r1383b406],
9	of	IN	O	of	_	0	SENT_274	[p21l1398t368r1444b406],
10	clopidogrel	NN	O	clopidogrel	prep_of	4	SENT_274	[p21l1451t368r1690b418],
11	.	.	O	.	_	0	SENT_274	[p21l1451t368r1690b418],

1	Thromb	NNP	O	Thromb	nn	2	SENT_275	[p21l1710t368r1862b406],
2	Haemost	NNP	O	Haemost	_	0	SENT_275	[p21l1879t372r2052b406],
3	2000	CD	DATE	2000	num	2	SENT_275	[p21l748t427r854b467],
4	;	:	O	;	_	0	SENT_275	[p21l748t427r854b467],
5	84	CD	NUMBER	84	num	7	SENT_275	[p21l872t427r929b461],
6	:	:	O	:	_	0	SENT_275	[p21l872t427r929b461],
7	891-96	CD	NUMBER	891-96	dep	2	SENT_275	[p21l945t427r1097b462],
8	.	.	O	.	_	0	SENT_275	[p21l945t427r1097b462],

1	Savi	NNP	PERSON	Savi	nn	2	SENT_276	[p21l750t490r830b525],
2	P	NN	O	p	_	0	SENT_276	[p21l846t491r883b531],
3	,	,	O	,	_	0	SENT_276	[p21l846t491r883b531],
4	Herbert	NNP	PERSON	Herbert	nn	5	SENT_276	[p21l901t488r1062b525],
5	IM	NNP	PERSON	IM	appos	2	SENT_276	[p21l1076t491r1146b536],
6	.	.	O	.	_	0	SENT_276	[p21l1076t491r1146b536],

1	Clopidogrel	NNP	O	Clopidogrel	_	0	SENT_277	[p21l1164t488r1404b537],
2	and	CC	O	and	_	0	SENT_277	[p21l1418t488r1494b525],
3	ticlopidine	NN	O	ticlopidine	conj_and	1	SENT_277	[p21l1507t488r1737b537],
4	:	:	O	:	_	0	SENT_277	[p21l1507t488r1737b537],
5	P2Y12	NN	O	p2y12	nn	8	SENT_277	[p21l1755t491r1879b525],
6	adenosine	NN	O	adenosine	nn	8	SENT_277	[p21l1896t488r2105b525],
7	diphosphate-receptor	NN	O	diphosphate-receptor	nn	8	SENT_277	[p21l747t543r1186b592],
8	antagonists	NNS	O	antagonist	dep	1	SENT_277	[p21l1200t546r1434b593],
9	for	IN	O	for	_	0	SENT_277	[p21l1449t543r1508b581],
10	the	DT	O	the	det	11	SENT_277	[p21l1521t543r1585b581],
11	prevention	NN	O	prevention	prep_for	8	SENT_277	[p21l1599t546r1822b592],
12	of	IN	O	of	_	0	SENT_277	[p21l1836t543r1882b581],
13	atherothrombosis	NN	O	atherothrombosis	prep_of	11	SENT_277	[p21l747t599r1124b636],
14	.	.	O	.	_	0	SENT_277	[p21l747t599r1124b636],

1	Semin	NNP	O	Semin	nn	3	SENT_278	[p21l1144t600r1266b636],
2	Thromb	NNP	O	Thromb	nn	3	SENT_278	[p21l1283t599r1435b636],
3	Hemost	NNP	O	Hemost	_	0	SENT_278	[p21l1452t603r1600b636],
4	2005	CD	DATE	2005	num	3	SENT_278	[p21l1614t601r1720b642],
5	;	:	O	;	_	0	SENT_278	[p21l1614t601r1720b642],
6	31	CD	NUMBER	31	num	8	SENT_278	[p21l1737t602r1791b636],
7	:	:	O	:	_	0	SENT_278	[p21l1737t602r1791b636],
8	174-83	CD	NUMBER	174-83	dep	3	SENT_278	[p21l1808t601r1953b638],
9	.	.	O	.	_	0	SENT_278	[p21l1808t601r1953b638],

1	Mega	JJ	O	mega	amod	2	SENT_279	[p21l748t665r859b711],
2	IL	NN	O	il	_	0	SENT_279	[p21l874t665r926b709],
3	,	,	O	,	_	0	SENT_279	[p21l874t665r926b709],
4	Close	NNP	O	Close	nn	5	SENT_279	[p21l943t662r1055b699],
5	SL	NNP	O	SL	appos	2	SENT_279	[p21l1072t664r1132b705],
6	,	,	O	,	_	0	SENT_279	[p21l1072t664r1132b705],
7	Wiviott	NNP	PERSON	Wiviott	nn	8	SENT_279	[p21l1147t664r1296b699],
8	SD	NN	O	sd	appos	2	SENT_279	[p21l1312t664r1383b705],
9	,	,	O	,	_	0	SENT_279	[p21l1312t664r1383b705],
10	et	FW	O	et	nn	11	SENT_279	[p21l1399t669r1435b699],
11	al.	FW	O	al.	appos	2	SENT_279	[p21l1449t662r1493b699],
12	.	.	O	.	_	0	SENT_279	[p21l1449t662r1493b699],

1	Cytochrome	NN	O	cytochrome	nn	3	SENT_280	[p21l1510t662r1760b711],
2	p-450	NN	O	p-450	nn	3	SENT_280	[p21l1774t664r1884b710],
3	polymorphisms	NNS	O	polymorphism	_	0	SENT_280	[p21l746t717r1072b766],
4	and	CC	O	and	_	0	SENT_280	[p21l1088t717r1164b755],
5	response	NN	O	response	conj_and	3	SENT_280	[p21l1177t730r1361b766],
6	to	TO	O	to	_	0	SENT_280	[p21l1375t725r1414b755],
7	clopidogrel	NN	O	clopidogrel	prep_to	3	SENT_280	[p21l1429t717r1668b767],
8	.	.	O	.	_	0	SENT_280	[p21l1429t717r1668b767],

1	N	NN	O	n	nn	3	SENT_281	[p21l1686t721r1722b755],
2	Engl	NNP	O	Engl	nn	3	SENT_281	[p21l1736t717r1820b767],
3	]	NNP	O	]	nsubj	4	SENT_281	[p21l1828t721r1853b766],
4	Med	VBD	O	med	_	0	SENT_281	[p21l1866t717r1951b755],
5	2009	CD	DATE	2009	dobj	4	SENT_281	[p21l1965t720r2071b760],
6	;	:	O	;	_	0	SENT_281	[p21l1965t720r2071b760],
7	360	CD	NUMBER	360	num	9	SENT_281	[p21l748t777r830b811],
8	:	:	O	:	_	0	SENT_281	[p21l748t777r830b811],
9	354-62	CD	NUMBER	354-62	dep	5	SENT_281	[p21l848t776r1000b811],
10	.	.	O	.	_	0	SENT_281	[p21l848t776r1000b811],

1	Shuldiner	NNP	PERSON	Shuldiner	nn	2	SENT_282	[p21l750t836r954b874],
2	AR	NNS	O	ar	_	0	SENT_282	[p21l966t839r1041b879],
3	,	,	O	,	_	0	SENT_282	[p21l966t839r1041b879],
4	O’Connell	NNP	O	O’Connell	nn	5	SENT_282	[p21l1059t836r1268b874],
5	IR	NNP	O	IR	appos	2	SENT_282	[p21l1283t840r1341b884],
6	,	,	O	,	_	0	SENT_282	[p21l1283t840r1341b884],
7	Bliden	NNP	PERSON	Bliden	nn	8	SENT_282	[p21l1360t836r1491b874],
8	KP	NNP	O	KP	appos	2	SENT_282	[p21l1507t840r1576b879],
9	,	,	O	,	_	0	SENT_282	[p21l1507t840r1576b879],
10	et	FW	O	et	nn	11	SENT_282	[p21l1592t844r1629b874],
11	al.	FW	O	al.	appos	2	SENT_282	[p21l1642t836r1686b874],
12	.	.	O	.	_	0	SENT_282	[p21l1642t836r1686b874],

1	Association	NNP	O	Association	_	0	SENT_283	[p21l1702t839r1941b874],
2	of	IN	O	of	_	0	SENT_283	[p21l1956t836r2001b874],
3	cytochrome	NN	O	cytochrome	nn	6	SENT_283	[p21l747t893r987b942],
4	P450	NN	O	p450	nn	6	SENT_283	[p21l1004t895r1101b930],
5	2C19	NN	O	2c19	nn	6	SENT_283	[p21l1117t896r1215b930],
6	genotype	NN	O	genotype	prep_of	1	SENT_283	[p21l1231t900r1416b942],
7	with	IN	O	with	_	0	SENT_283	[p21l1429t893r1521b930],
8	the	DT	O	the	det	10	SENT_283	[p21l1534t893r1598b930],
9	antiplatelet	JJ	O	antiplatelet	amod	10	SENT_283	[p21l1613t893r1843b942],
10	effect	NN	O	effect	prep_with	1	SENT_283	[p21l1857t893r1968b930],
11	and	CC	O	and	_	0	SENT_283	[p21l1982t893r2058b930],
12	clinical	JJ	O	clinical	amod	13	SENT_283	[p21l747t949r894b986],
13	efficacy	NN	O	efficacy	conj_and	10	SENT_283	[p21l908t948r1061b998],
14	of	IN	O	of	_	0	SENT_283	[p21l1074t948r1120b986],
15	clopidogrel	NN	O	clopidogrel	nn	16	SENT_283	[p21l1127t948r1356b998],
16	therapy	NN	O	therapy	prep_of	1	SENT_283	[p21l1370t949r1530b998],
17	.	.	O	.	_	0	SENT_283	[p21l1370t949r1530b998],

1	JAMA	NNP	O	JAMA	_	0	SENT_284	[p21l1541t951r1676b998],
2	2009	CD	DATE	2009	num	1	SENT_284	[p21l1690t952r1796b992],
3	;	:	O	;	_	0	SENT_284	[p21l1690t952r1796b992],
4	302	CD	NUMBER	302	num	6	SENT_284	[p21l1814t952r1896b986],
5	:	:	O	:	_	0	SENT_284	[p21l1814t952r1896b986],
6	849-57	CD	NUMBER	849-57	dep	1	SENT_284	[p21l1912t951r2054b987],
7	.	.	O	.	_	0	SENT_284	[p21l1912t951r2054b987],

1	Varenhorst	NNP	O	Varenhorst	nn	2	SENT_285	[p21l746t1011r975b1049],
2	C	NNP	O	C	_	0	SENT_285	[p21l990t1014r1030b1054],
3	,	,	O	,	_	0	SENT_285	[p21l990t1014r1030b1054],
4	Iames	NNP	O	Iames	nn	5	SENT_285	[p21l1048t1015r1170b1059],
5	S	NNP	O	S	appos	2	SENT_285	[p21l1188t1014r1222b1054],
6	,	,	O	,	_	0	SENT_285	[p21l1188t1014r1222b1054],
7	Erlinge	NNP	O	Erlinge	nn	8	SENT_285	[p21l1240t1011r1387b1061],
8	D	NNP	O	D	appos	2	SENT_285	[p21l1404t1015r1447b1054],
9	,	,	O	,	_	0	SENT_285	[p21l1404t1015r1447b1054],
10	et	FW	O	et	nn	11	SENT_285	[p21l1464t1019r1500b1049],
11	al.	FW	O	al.	appos	2	SENT_285	[p21l1513t1011r1557b1049],
12	.	.	O	.	_	0	SENT_285	[p21l1513t1011r1557b1049],

1	Genetic	JJ	O	genetic	amod	2	SENT_286	[p21l1575t1013r1732b1049],
2	variation	NN	O	variation	nsubj	5	SENT_286	[p21l1745t1013r1927b1049],
3	of	IN	O	of	_	0	SENT_286	[p21l1941t1011r1987b1049],
4	CYPZC19	NN	O	cypzc19	prep_of	2	SENT_286	[p21l748t1070r940b1105],
5	affects	VBZ	O	affect	_	0	SENT_286	[p21l955t1068r1085b1105],
6	both	CC	O	both	preconj	7	SENT_286	[p21l1100t1068r1193b1105],
7	pharmacokinetic	JJ	O	pharmacokinetic	amod	10	SENT_286	[p21l1207t1068r1555b1117],
8	and	CC	O	and	_	0	SENT_286	[p21l1569t1068r1645b1105],
9	pharrnacodynamic	JJ	O	pharrnacodynamic	amod	10	SENT_286	[p21l1658t1068r2044b1117],
10	responses	NNS	O	response	dobj	5	SENT_286	[p21l747t1136r951b1172],
11	to	TO	O	to	_	0	SENT_286	[p21l966t1131r1004b1161],
12	clopidogrel	NN	O	clopidogrel	prep_to	10	SENT_286	[p21l1019t1123r1248b1173],
13	but	CC	O	but	_	0	SENT_286	[p21l1261t1123r1330b1161],
14	not	RB	O	not	_	0	SENT_286	[p21l1343t1131r1411b1161],
15	prasugrel	NN	O	prasugrel	conj_negcc	10	SENT_286	[p21l1424t1123r1619b1173],
16	in	IN	O	in	_	0	SENT_286	[p21l1633t1126r1675b1160],
17	aspirin-treated	JJ	O	aspirin-treated	amod	18	SENT_286	[p21l1689t1123r1989b1172],
18	patients	NNS	O	patient	prep_in	15	SENT_286	[p21l746t1182r909b1228],
19	with	IN	O	with	_	0	SENT_286	[p21l923t1179r1015b1217],
20	coronary	JJ	O	coronary	amod	22	SENT_286	[p21l1029t1192r1210b1228],
21	artery	NN	O	artery	nn	22	SENT_286	[p21l1223t1187r1342b1228],
22	disease	NN	O	disease	prep_with	5	SENT_286	[p21l1355t1179r1513b1216],
23	.	.	O	.	_	0	SENT_286	[p21l1355t1179r1513b1216],

1	Eur	NNP	O	Eur	nn	2	SENT_287	[p21l1533t1181r1604b1216],
2	Heart	NNP	O	Heart	_	0	SENT_287	[p21l1618t1183r1763b1228],
3	]	CD	NUMBER	]	num	4	SENT_287	[p21l1618t1183r1763b1228],
4	2009	CD	DATE	2009	dep	2	SENT_287	[p21l1775t1182r1882b1222],
5	;	:	O	;	_	0	SENT_287	[p21l1775t1182r1882b1222],
6	30	CD	NUMBER	30	num	8	SENT_287	[p21l1899t1182r1956b1217],
7	:	:	O	:	_	0	SENT_287	[p21l1899t1182r1956b1217],
8	1744-52	CD	NUMBER	1744-52	dep	2	SENT_287	[p21l1974t1181r2140b1218],
9	.	.	O	.	_	0	SENT_287	[p21l1974t1181r2140b1218],

1	Varenhorst	NNP	O	Varenhorst	nn	2	SENT_288	[p21l746t1242r975b1280],
2	C	NNP	O	C	_	0	SENT_288	[p21l990t1245r1030b1286],
3	,	,	O	,	_	0	SENT_288	[p21l990t1245r1030b1286],
4	Iames	NNP	O	Iames	nn	5	SENT_288	[p21l1048t1246r1170b1290],
5	S	NNP	O	S	appos	2	SENT_288	[p21l1189t1245r1222b1286],
6	,	,	O	,	_	0	SENT_288	[p21l1189t1245r1222b1286],
7	Erlinge	NNP	O	Erlinge	nn	8	SENT_288	[p21l1240t1242r1387b1292],
8	D	NNP	O	D	appos	2	SENT_288	[p21l1404t1246r1447b1286],
9	,	,	O	,	_	0	SENT_288	[p21l1404t1246r1447b1286],
10	et	FW	O	et	nn	11	SENT_288	[p21l1464t1250r1500b1280],
11	al.	FW	O	al.	appos	2	SENT_288	[p21l1513t1242r1557b1280],
12	.	.	O	.	_	0	SENT_288	[p21l1513t1242r1557b1280],

1	Assessment	NNP	O	Assessment	nsubj	22	SENT_289	[p21l1573t1245r1822b1280],
2	of	IN	O	of	_	0	SENT_289	[p21l1836t1242r1882b1280],
3	P2Y	NN	O	p2y	prep_of	1	SENT_289	[p21l1891t1246r1994b1289],
4	,	,	O	,	_	0	SENT_289	[p21l1891t1246r1994b1289],
5	,	,	O	,	_	0	SENT_289	[p21l1891t1246r1994b1289],
6	inhibition	NN	O	inhibition	nsubj	22	SENT_289	[p21l747t1298r952b1335],
7	with	IN	O	with	_	0	SENT_289	[p21l965t1298r1056b1335],
8	the	DT	O	the	det	12	SENT_289	[p21l1070t1298r1134b1335],
9	point	NN	O	point	nn	12	SENT_289	[p21l1148t1298r1408b1347],
10	—	CD	NUMBER	—	num	12	SENT_289	[p21l1148t1298r1408b1347],
11	of-care	JJ	O	of-care	amod	12	SENT_289	[p21l1148t1298r1408b1347],
12	device	NN	O	device	prep_with	6	SENT_289	[p21l1423t1298r1549b1336],
13	VerifyNow	NNP	O	VerifyNow	nn	14	SENT_289	[p21l1563t1298r1782b1347],
14	P2Y12	NNP	O	P2Y12	dep	12	SENT_289	[p21l1797t1302r1921b1335],
15	in	IN	O	in	_	0	SENT_289	[p21l1936t1301r1978b1335],
16	patients	NNS	O	patient	prep_in	14	SENT_289	[p21l1991t1300r2153b1347],
17	treated	VBN	O	treat	partmod	16	SENT_289	[p21l746t1355r889b1392],
18	with	IN	O	with	_	0	SENT_289	[p21l901t1355r992b1392],
19	prasugrel	NN	O	prasugrel	prep_with	17	SENT_289	[p21l1006t1355r1201b1404],
20	or	CC	O	or	_	0	SENT_289	[p21l1216t1368r1258b1392],
21	clopidogrel	NN	O	clopidogrel	conj_or	19	SENT_289	[p21l1272t1355r1501b1404],
22	coadministered	VBN	O	coadminister	_	0	SENT_289	[p21l1515t1355r1835b1392],
23	with	IN	O	with	_	0	SENT_289	[p21l1848t1355r1939b1392],
24	aspirin	NN	O	aspirin	prep_with	22	SENT_289	[p21l1953t1357r2107b1404],
25	.	.	O	.	_	0	SENT_289	[p21l1953t1357r2107b1404],

1	Am	VBP	O	be	dep	2	SENT_290	[p21l746t1413r819b1447],
2	Heart	NNP	O	Heart	_	0	SENT_290	[p21l835t1414r979b1460],
3	]	CD	NUMBER	]	num	2	SENT_290	[p21l835t1414r979b1460],
4	2009	CD	DATE	2009	dep	2	SENT_290	[p21l992t1413r1099b1453],
5	;	:	O	;	_	0	SENT_290	[p21l992t1413r1099b1453],
6	157	CD	NUMBER	157	dep	4	SENT_290	[p21l1116t1412r1194b1448],
7	:	:	O	:	_	0	SENT_290	[p21l1116t1412r1194b1448],
8	562	CD	NUMBER	562	dep	6	SENT_290	[p21l1212t1412r1397b1448],
9	.	.	O	.	_	0	SENT_290	[p21l1212t1412r1397b1448],

1	e1	NN	O	e1	_	0	SENT_291	[p21l1212t1412r1397b1448],
2	—	CD	NUMBER	—	number	3	SENT_291	[p21l1212t1412r1397b1448],
3	9	CD	NUMBER	9	num	1	SENT_291	[p21l1212t1412r1397b1448],
4	.	.	O	.	_	0	SENT_291	[p21l1212t1412r1397b1448],

1	Collet	NNP	PERSON	Collet	nn	4	SENT_292	[p21l748t1473r867b1510],
2	I-P	NNP	O	I-P	nn	4	SENT_292	[p21l881t1477r950b1521],
3	,	,	O	,	_	0	SENT_292	[p21l881t1477r950b1521],
4	Hulot	NNP	PERSON	Hulot	_	0	SENT_292	[p21l968t1473r1086b1510],
5	]	SYM	O	]	dep	4	SENT_292	[p21l1101t1476r1168b1521],
6	-	:	O	-	_	0	SENT_292	[p21l1101t1476r1168b1521],
7	S	NN	O	s	dep	4	SENT_292	[p21l1101t1476r1168b1521],
8	,	,	O	,	_	0	SENT_292	[p21l1101t1476r1168b1521],
9	Pena	NNP	PERSON	Pena	nn	10	SENT_292	[p21l1186t1477r1284b1510],
10	A	NNP	O	A	appos	7	SENT_292	[p21l1298t1476r1340b1516],
11	,	,	O	,	_	0	SENT_292	[p21l1298t1476r1340b1516],
12	et	FW	O	et	dep	7	SENT_292	[p21l1357t1480r1393b1510],
13	al.	FW	O	al.	dep	7	SENT_292	[p21l1407t1473r1451b1510],
14	.	.	O	.	_	0	SENT_292	[p21l1407t1473r1451b1510],

1	Cytochrome	NN	O	cytochrome	nn	4	SENT_293	[p21l1468t1473r1717b1522],
2	P450	NN	O	p450	nn	4	SENT_293	[p21l1734t1475r1831b1510],
3	2C19	NN	O	2c19	nn	4	SENT_293	[p21l1847t1476r1946b1511],
4	polymorphism	NN	O	polymorphism	_	0	SENT_293	[p21l747t1530r1052b1579],
5	in	IN	O	in	_	0	SENT_293	[p21l1066t1532r1107b1567],
6	young	JJ	O	young	amod	7	SENT_293	[p21l1120t1543r1249b1579],
7	patients	NNS	O	patient	prep_in	4	SENT_293	[p21l1262t1532r1425b1579],
8	treated	VBN	O	treat	partmod	7	SENT_293	[p21l1440t1530r1582b1567],
9	with	IN	O	with	_	0	SENT_293	[p21l1594t1530r1686b1567],
10	clopidogrel	NN	O	clopidogrel	prep_with	8	SENT_293	[p21l1700t1530r1929b1579],
11	after	IN	O	after	_	0	SENT_293	[p21l1944t1530r2036b1567],
12	myocardial	JJ	O	myocardial	amod	13	SENT_293	[p21l747t1585r974b1634],
13	infarction	NN	O	infarction	prep_after	8	SENT_293	[p21l988t1585r1201b1623],
14	:	:	O	:	_	0	SENT_293	[p21l988t1585r1201b1623],
15	a	DT	O	a	det	16	SENT_293	[p21l1217t1599r1238b1623],
16	cohort	NN	O	cohort	dep	4	SENT_293	[p21l1252t1585r1384b1623],
17	study	NN	O	study	dep	16	SENT_293	[p21l1398t1585r1514b1634],
18	.	.	O	.	_	0	SENT_293	[p21l1398t1585r1514b1634],

1	Lancet	NNP	O	Lancet	_	0	SENT_294	[p21l1532t1589r1659b1623],
2	2009	CD	DATE	2009	num	1	SENT_294	[p21l1673t1589r1779b1628],
3	;	:	O	;	_	0	SENT_294	[p21l1673t1589r1779b1628],
4	373	CD	NUMBER	373	num	6	SENT_294	[p21l1797t1587r1878b1623],
5	:	:	O	:	_	0	SENT_294	[p21l1797t1587r1878b1623],
6	309-17	CD	NUMBER	309-17	dep	1	SENT_294	[p21l1897t1588r2035b1624],
7	.	.	O	.	_	0	SENT_294	[p21l1897t1588r2035b1624],

1	Hulot	NNP	PERSON	Hulot	nn	3	SENT_295	[p21l749t1649r867b1686],
2	]	CD	NUMBER	]	num	3	SENT_295	[p21l881t1652r935b1697],
3	S	NN	O	s	_	0	SENT_295	[p21l881t1652r935b1697],
4	,	,	O	,	_	0	SENT_295	[p21l881t1652r935b1697],
5	Collet	NNP	PERSON	Collet	nn	6	SENT_295	[p21l952t1649r1071b1686],
6	IP	NNP	O	IP	appos	3	SENT_295	[p21l1085t1653r1140b1697],
7	,	,	O	,	_	0	SENT_295	[p21l1085t1653r1140b1697],
8	Silvain	NNP	O	Silvain	appos	3	SENT_295	[p21l1159t1649r1296b1686],
9	I	PRP	O	I	dep	8	SENT_295	[p21l1311t1653r1337b1697],
10	,	,	O	,	_	0	SENT_295	[p21l1311t1653r1337b1697],
11	et	FW	O	et	nn	12	SENT_295	[p21l1353t1656r1389b1686],
12	al.	FW	O	al.	appos	3	SENT_295	[p21l1403t1649r1447b1686],
13	.	.	O	.	_	0	SENT_295	[p21l1403t1649r1447b1686],

1	Cardiovascular	NNP	O	Cardiovascular	nn	2	SENT_296	[p21l1464t1649r1770b1686],
2	risk	NN	O	risk	_	0	SENT_296	[p21l1783t1649r1861b1686],
3	in	IN	O	in	_	0	SENT_296	[p21l1874t1651r1915b1686],
4	clopidogrel-treated	JJ	O	clopidogrel-treated	amod	5	SENT_296	[p21l747t1705r1133b1754],
5	patients	NNS	O	patient	prep_in	2	SENT_296	[p21l1146t1707r1309b1753],
6	according	VBG	O	accord	_	0	SENT_296	[p21l1325t1705r1526b1754],
7	to	TO	O	to	prepc_according_to	2	SENT_296	[p21l1539t1712r1577b1742],
8	cytochrome	NN	O	cytochrome	nn	11	SENT_296	[p21l1592t1705r1832b1754],
9	P450	NN	O	p450	nn	11	SENT_296	[p21l1848t1707r1946b1742],
10	2C19	NN	O	2c19	nn	11	SENT_296	[p21l1961t1707r2109b1742],
11	*	NN	O	*	pobj	2	SENT_296	[p21l1961t1707r2109b1742],
12	2	CD	NUMBER	2	num	14	SENT_296	[p21l1961t1707r2109b1742],
13	loss-of-function	JJ	O	loss-of-function	amod	14	SENT_296	[p21l746t1760r1069b1797],
14	allele	NN	O	allele	dep	11	SENT_296	[p21l1083t1760r1188b1797],
15	or	CC	O	or	prep	14	SENT_296	[p21l1203t1773r1246b1797],
16	proton	NN	O	proton	nn	17	SENT_296	[p21l1259t1768r1396b1809],
17	pump	NN	O	pump	dep	15	SENT_296	[p21l1410t1773r1533b1809],
18	inhibitor	NN	O	inhibitor	nn	19	SENT_296	[p21l1547t1760r1730b1797],
19	coadministration	NN	O	coadministration	dep	17	SENT_296	[p21l1743t1760r2106b1797],
20	:	:	O	:	_	0	SENT_296	[p21l1743t1760r2106b1797],
21	a	DT	O	a	det	23	SENT_296	[p21l2123t1773r2144b1797],
22	systematic	JJ	O	systematic	amod	23	SENT_296	[p21l748t1819r963b1866],
23	meta-analysis	NN	O	meta-analysis	dep	19	SENT_296	[p21l976t1817r1267b1866],
24	.	.	O	.	_	0	SENT_296	[p21l976t1817r1267b1866],
25	]	SYM	O	]	dep	14	SENT_296	[p21l1278t1821r1303b1866],

1	Am	VBP	O	be	dep	3	SENT_297	[p21l1314t1820r1387b1854],
2	Coll	NNP	O	Coll	nn	3	SENT_297	[p21l1404t1817r1478b1854],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_297	[p21l1495t1817r1637b1854],
4	2010	CD	DATE	2010	num	3	SENT_297	[p21l1651t1820r1752b1860],
5	;	:	O	;	_	0	SENT_297	[p21l1651t1820r1752b1860],
6	56	CD	NUMBER	56	dep	3	SENT_297	[p21l1770t1819r1827b1854],
7	:	:	O	:	_	0	SENT_297	[p21l1770t1819r1827b1854],
8	134-43	CD	NUMBER	134-43	dep	6	SENT_297	[p21l1844t1820r1990b1854],
9	.	.	O	.	_	0	SENT_297	[p21l1844t1820r1990b1854],

1	Sibbing	VBG	O	sibb	_	0	SENT_298	[p21l750t1879r906b1929],
2	D	NN	O	d	dobj	1	SENT_298	[p21l922t1883r965b1922],
3	,	,	O	,	_	0	SENT_298	[p21l922t1883r965b1922],
4	Koch	NNP	PERSON	Koch	nn	5	SENT_298	[p21l983t1879r1085b1917],
5	W	NNP	O	W	appos	2	SENT_298	[p21l1098t1883r1149b1922],
6	,	,	O	,	_	0	SENT_298	[p21l1098t1883r1149b1922],
7	Gebhard	NNP	PERSON	Gebhard	nn	8	SENT_298	[p21l1166t1879r1344b1917],
8	D	NNP	O	D	appos	2	SENT_298	[p21l1360t1883r1403b1922],
9	,	,	O	,	_	0	SENT_298	[p21l1360t1883r1403b1922],
10	et	FW	O	et	nn	11	SENT_298	[p21l1419t1887r1455b1917],
11	al.	FW	O	al.	appos	2	SENT_298	[p21l1469t1879r1513b1917],
12	.	.	O	.	_	0	SENT_298	[p21l1469t1879r1513b1917],

1	Cytochrome	NN	O	cytochrome	nn	2	SENT_299	[p21l1531t1879r1780b1928],
2	2C19	NN	O	2c19	_	0	SENT_299	[p21l1796t1881r1962b1918],
3	*	CD	NUMBER	*	number	4	SENT_299	[p21l1796t1881r1962b1918],
4	17	CD	NUMBER	17	dep	2	SENT_299	[p21l1796t1881r1962b1918],
5	allelic	JJ	O	allelic	amod	2	SENT_299	[p21l1976t1879r2094b1917],
6	variant	NN	O	variant	tmod	5	SENT_299	[p21l746t1938r899b1979],
7	,	,	O	,	_	0	SENT_299	[p21l746t1938r899b1979],
8	platelet	NN	O	platelet	nn	9	SENT_299	[p21l914t1936r1065b1985],
9	aggregation	NN	O	aggregation	appos	6	SENT_299	[p21l1078t1938r1331b1985],
10	,	,	O	,	_	0	SENT_299	[p21l1078t1938r1331b1985],
11	bleeding	VBG	O	bleed	partmod	2	SENT_299	[p21l1346t1936r1525b1985],
12	events	NNS	O	event	dobj	11	SENT_299	[p21l1539t1943r1679b1979],
13	,	,	O	,	_	0	SENT_299	[p21l1539t1943r1679b1979],
14	and	CC	O	and	_	0	SENT_299	[p21l1696t1936r1772b1973],
15	stent	NN	O	stent	nn	16	SENT_299	[p21l1787t1943r1886b1973],
16	thrombosis	NN	O	thrombosis	conj_and	12	SENT_299	[p21l1899t1936r2133b1973],
17	in	IN	O	in	_	0	SENT_299	[p21l747t1994r788b2029],
18	clopidogrel-treated	JJ	O	clopidogrel-treated	amod	19	SENT_299	[p21l802t1992r1188b2041],
19	patients	NNS	O	patient	prep_in	16	SENT_299	[p21l1202t1994r1364b2041],
20	with	IN	O	with	_	0	SENT_299	[p21l1378t1992r1470b2029],
21	coronary	JJ	O	coronary	amod	23	SENT_299	[p21l1484t2005r1665b2041],
22	stent	NN	O	stent	nn	23	SENT_299	[p21l1679t1999r1779b2029],
23	placement	NN	O	placement	prep_with	2	SENT_299	[p21l1792t1992r2017b2041],
24	.	.	O	.	_	0	SENT_299	[p21l1792t1992r2017b2041],

1	Circulation	NN	O	circulation	_	0	SENT_300	[p21l751t2046r970b2084],
2	2010	CD	DATE	2010	num	1	SENT_300	[p21l984t2050r1086b2089],
3	;	:	O	;	_	0	SENT_300	[p21l984t2050r1086b2089],
4	121	CD	NUMBER	121	num	6	SENT_300	[p21l1103t2050r1178b2083],
5	:	:	O	:	_	0	SENT_300	[p21l1103t2050r1178b2083],
6	512-18	CD	NUMBER	512-18	dep	1	SENT_300	[p21l1196t2049r1341b2084],
7	.	.	O	.	_	0	SENT_300	[p21l1196t2049r1341b2084],

1	Taubert	NNP	PERSON	Taubert	nn	2	SENT_301	[p21l746t2110r904b2147],
2	D	NNP	O	D	_	0	SENT_301	[p21l919t2113r962b2153],
3	,	,	O	,	_	0	SENT_301	[p21l919t2113r962b2153],
4	Von	NNP	PERSON	Von	nn	6	SENT_301	[p21l977t2123r1052b2147],
5	Beckerath	NNP	PERSON	Beckerath	nn	6	SENT_301	[p21l1068t2110r1272b2147],
6	N	NNP	O	N	appos	2	SENT_301	[p21l1288t2113r1331b2153],
7	,	,	O	,	_	0	SENT_301	[p21l1288t2113r1331b2153],
8	Grimberg	NNP	PERSON	Grimberg	nn	9	SENT_301	[p21l1349t2110r1550b2159],
9	G	NNP	O	G	appos	2	SENT_301	[p21l1565t2112r1610b2153],
10	,	,	O	,	_	0	SENT_301	[p21l1565t2112r1610b2153],
11	et	FW	O	et	nn	12	SENT_301	[p21l1626t2117r1662b2147],
12	al.	FW	O	al.	appos	2	SENT_301	[p21l1676t2110r1720b2147],
13	.	.	O	.	_	0	SENT_301	[p21l1676t2110r1720b2147],

1	Impact	NN	O	impact	_	0	SENT_302	[p21l1738t2113r1883b2159],
2	of	IN	O	of	_	0	SENT_302	[p21l1897t2110r1942b2147],
3	P-glycoprotein	NN	O	p-glycoprotein	prep_of	1	SENT_302	[p21l749t2166r1046b2215],
4	on	IN	O	on	_	0	SENT_302	[p21l1060t2179r1112b2203],
5	clopidogrel	NN	O	clopidogrel	nn	6	SENT_302	[p21l1126t2166r1355b2215],
6	absorption	NN	O	absorption	prep_on	1	SENT_302	[p21l1370t2166r1600b2214],
7	.	.	O	.	_	0	SENT_302	[p21l1370t2166r1600b2214],

1	Clin	NN	PERSON	clin	nn	2	SENT_303	[p21l1620t2166r1701b2203],
2	Pl	NN	PERSON	pl	_	0	SENT_303	[p21l1717t2166r1928b2203],
3	’	CD	NUMBER	’	dep	2	SENT_303	[p21l1717t2166r1928b2203],
4	tdT	NN	O	tdt	dep	3	SENT_303	[p21l1717t2166r1928b2203],
5	'	''	O	'	_	0	SENT_303	[p21l1717t2166r1928b2203],
6	1	CD	NUMBER	1	number	7	SENT_303	[p21l1717t2166r1928b2203],
7	’	CD	NUMBER	’	dep	2	SENT_303	[p21l1717t2166r1928b2203],
8	l’t6lC0l	NN	O	l’t6lc0l	nn	9	SENT_303	[p21l1717t2166r1928b2203],
9	T1161	NN	O	t1161	dep	7	SENT_303	[p21l1945t2166r2034b2203],
10	’	CD	NUMBER	’	num	11	SENT_303	[p21l1945t2166r2034b2203],
11	2006	CD	DATE	2006	dep	2	SENT_303	[p21l2046t2169r2152b2209],
12	;	:	O	;	_	0	SENT_303	[p21l2046t2169r2152b2209],
13	80	CD	NUMBER	80	num	15	SENT_303	[p21l748t2224r805b2258],
14	:	:	O	:	_	0	SENT_303	[p21l748t2224r805b2258],
15	486-501	CD	NUMBER	486-501	dep	11	SENT_303	[p21l820t2223r995b2258],
16	.	.	O	.	_	0	SENT_303	[p21l820t2223r995b2258],

1	Simon	NNP	PERSON	Simon	nn	2	SENT_304	[p21l750t2287r883b2322],
2	T	NN	PERSON	t	_	0	SENT_304	[p21l896t2287r930b2328],
3	,	,	O	,	_	0	SENT_304	[p21l896t2287r930b2328],
4	Verstuyft	NNP	O	Verstuyft	nn	5	SENT_304	[p21l945t2284r1132b2334],
5	C	NNP	O	C	appos	2	SENT_304	[p21l1147t2287r1187b2328],
6	,	,	O	,	_	0	SENT_304	[p21l1147t2287r1187b2328],
7	Mary-Krause	NNP	O	Mary-Krause	nn	8	SENT_304	[p21l1205t2288r1467b2334],
8	M	NNP	O	M	appos	2	SENT_304	[p21l1483t2288r1535b2327],
9	,	,	O	,	_	0	SENT_304	[p21l1483t2288r1535b2327],
10	et	FW	O	et	nn	11	SENT_304	[p21l1551t2292r1587b2322],
11	al.	FW	O	al.	appos	2	SENT_304	[p21l1601t2285r1645b2322],
12	.	.	O	.	_	0	SENT_304	[p21l1601t2285r1645b2322],

1	Genetic	JJ	O	genetic	amod	2	SENT_305	[p21l1663t2287r1820b2322],
2	determinants	NNS	O	determinant	_	0	SENT_305	[p21l1834t2284r2109b2322],
3	of	IN	O	of	_	0	SENT_305	[p21l747t2340r793b2378],
4	response	NN	O	response	prep_of	2	SENT_305	[p21l800t2353r984b2389],
5	to	TO	O	to	_	0	SENT_305	[p21l998t2348r1036b2378],
6	clopidogrel	NN	O	clopidogrel	nn	9	SENT_305	[p21l1052t2340r1280b2390],
7	and	CC	O	and	_	0	SENT_305	[p21l1295t2340r1371b2378],
8	cardiovascular	JJ	O	cardiovascular	nn	9	SENT_305	[p21l1385t2340r1681b2378],
9	events	NNS	O	event	prep_to	2	SENT_305	[p21l1695t2348r1834b2378],
10	.	.	O	.	_	0	SENT_305	[p21l1695t2348r1834b2378],

1	N	NN	O	n	nn	3	SENT_306	[p21l1853t2344r1889b2378],
2	Engl	NNP	O	Engl	nn	3	SENT_306	[p21l1902t2340r1987b2390],
3	]	NNP	O	]	nsubj	4	SENT_306	[p21l1995t2344r2020b2390],
4	Med	VBD	O	med	_	0	SENT_306	[p21l2033t2340r2117b2378],
5	2009	CD	DATE	2009	dobj	4	SENT_306	[p21l748t2400r854b2440],
6	;	:	O	;	_	0	SENT_306	[p21l748t2400r854b2440],
7	360	CD	NUMBER	360	num	9	SENT_306	[p21l871t2400r954b2434],
8	:	:	O	:	_	0	SENT_306	[p21l871t2400r954b2434],
9	363-75	CD	NUMBER	363-75	dep	5	SENT_306	[p21l972t2399r1123b2435],
10	.	.	O	.	_	0	SENT_306	[p21l972t2399r1123b2435],

1	Husted	NNP	PERSON	Husted	nn	2	SENT_307	[p21l749t2459r899b2497],
2	S	NNP	O	S	_	0	SENT_307	[p21l915t2462r949b2502],
3	,	,	O	,	_	0	SENT_307	[p21l915t2462r949b2502],
4	Emanuelsson	NNP	PERSON	Emanuelsson	nn	5	SENT_307	[p21l967t2459r1246b2497],
5	H	NNP	PERSON	H	conj_and	2	SENT_307	[p21l1262t2463r1311b2502],
6	,	,	O	,	_	0	SENT_307	[p21l1262t2463r1311b2502],
7	Heptinstall	NNP	O	Heptinstall	nn	8	SENT_307	[p21l1329t2459r1557b2508],
8	S	NNP	O	S	conj_and	2	SENT_307	[p21l1574t2462r1607b2502],
9	,	,	O	,	_	0	SENT_307	[p21l1574t2462r1607b2502],
10	Sandset	NNP	O	Sandset	nn	11	SENT_307	[p21l1626t2459r1785b2497],
11	PM	NNP	O	PM	conj_and	2	SENT_307	[p21l1801t2463r1882b2502],
12	,	,	O	,	_	0	SENT_307	[p21l1801t2463r1882b2502],
13	Wickens	NNP	PERSON	Wickens	nn	14	SENT_307	[p21l1897t2459r2072b2497],
14	M	NNP	PERSON	M	conj_and	2	SENT_307	[p21l2089t2463r2140b2502],
15	,	,	O	,	_	0	SENT_307	[p21l2089t2463r2140b2502],
16	Peters	NNP	PERSON	Peters	nn	18	SENT_307	[p21l749t2519r872b2552],
17	G.	NNP	PERSON	G.	nn	18	SENT_307	[p21l888t2518r933b2552],
18	Pharmacodynamics	NNP	PERSON	Pharmacodynamics	conj_and	2	SENT_307	[p21l951t2515r1369b2564],
19	,	,	O	,	_	0	SENT_307	[p21l951t2515r1369b2564],
20	pharrnacokinetics	NNS	O	pharrnacokinetic	conj_and	2	SENT_307	[p21l1384t2515r1763b2564],
21	,	,	O	,	_	0	SENT_307	[p21l1384t2515r1763b2564],
22	and	CC	O	and	_	0	SENT_307	[p21l1780t2515r1856b2552],
23	safety	NN	O	safety	conj_and	2	SENT_307	[p21l1871t2515r1988b2564],
24	of	IN	O	of	_	0	SENT_307	[p21l2001t2515r2047b2552],
25	the	DT	O	the	det	31	SENT_307	[p21l2053t2515r2118b2552],
26	oral	JJ	O	oral	amod	31	SENT_307	[p21l747t2572r825b2609],
27	reversible	JJ	O	reversible	amod	31	SENT_307	[p21l839t2572r1038b2609],
28	P2Y12	NN	O	p2y12	nn	31	SENT_307	[p21l1055t2575r1179b2609],
29	antagonist	NN	O	antagonist	nn	31	SENT_307	[p21l1195t2574r1411b2621],
30	AZ	NNP	MISC	AZ	nn	31	SENT_307	[p21l1423t2574r1487b2609],
31	D6140	NN	MISC	d6140	prep_of	23	SENT_307	[p21l1493t2575r1617b2609],
32	with	IN	O	with	_	0	SENT_307	[p21l1630t2572r1721b2609],
33	aspirin	NN	O	aspirin	prep_with	31	SENT_307	[p21l1736t2574r1879b2621],
34	in	IN	O	in	_	0	SENT_307	[p21l1893t2574r1934b2609],
35	patients	NNS	O	patient	prep_in	33	SENT_307	[p21l1948t2574r2110b2621],
36	with	IN	O	with	_	0	SENT_307	[p21l746t2628r837b2665],
37	atherosclerosis	NN	O	atherosclerosis	prep_with	35	SENT_307	[p21l852t2628r1169b2665],
38	:	:	O	:	_	0	SENT_307	[p21l852t2628r1169b2665],
39	a	DT	O	a	det	41	SENT_307	[p21l1186t2641r1206b2665],
40	double-blind	JJ	O	double-blind	amod	41	SENT_307	[p21l1221t2628r1482b2665],
41	comparison	NN	O	comparison	dep	2	SENT_307	[p21l1496t2630r1741b2676],
42	to	TO	O	to	_	0	SENT_307	[p21l1754t2635r1792b2665],
43	clopidogrel	NN	O	clopidogrel	prep_to	41	SENT_307	[p21l1807t2628r2036b2677],
44	with	IN	O	with	_	0	SENT_307	[p21l2049t2628r2140b2665],
45	aspirin	NN	O	aspirin	prep_with	43	SENT_307	[p21l747t2685r901b2732],
46	.	.	O	.	_	0	SENT_307	[p21l747t2685r901b2732],

1	Ear	NN	O	ear	nn	2	SENT_308	[p21l920t2685r992b2720],
2	Heart	NNP	O	Heart	_	0	SENT_308	[p21l1005t2686r1150b2732],
3	]	CD	NUMBER	]	num	4	SENT_308	[p21l1005t2686r1150b2732],
4	2006	CD	DATE	2006	dep	2	SENT_308	[p21l1163t2686r1269b2726],
5	;	:	O	;	_	0	SENT_308	[p21l1163t2686r1269b2726],
6	27	CD	NUMBER	27	num	8	SENT_308	[p21l1287t2685r1344b2721],
7	:	:	O	:	_	0	SENT_308	[p21l1287t2685r1344b2721],
8	1038-47	CD	NUMBER	1038-47	dep	2	SENT_308	[p21l1361t2685r1522b2722],
9	.	.	O	.	_	0	SENT_308	[p21l1361t2685r1522b2722],

1	Gurbel	NNP	ORGANIZATION	Gurbel	nn	2	SENT_309	[p21l748t2747r889b2784],
2	PA	NN	ORGANIZATION	pa	_	0	SENT_309	[p21l906t2749r975b2789],
3	,	,	O	,	_	0	SENT_309	[p21l906t2749r975b2789],
4	Bliden	NNP	PERSON	Bliden	nn	5	SENT_309	[p21l993t2747r1125b2784],
5	KP	NNP	O	KP	appos	2	SENT_309	[p21l1141t2750r1210b2789],
6	,	,	O	,	_	0	SENT_309	[p21l1141t2750r1210b2789],
7	Butler	NNP	PERSON	Butler	nn	8	SENT_309	[p21l1228t2747r1353b2784],
8	K	NNP	PERSON	K	appos	2	SENT_309	[p21l1368t2750r1407b2789],
9	,	,	O	,	_	0	SENT_309	[p21l1368t2750r1407b2789],
10	et	FW	O	et	nn	11	SENT_309	[p21l1423t2754r1460b2784],
11	al.	FW	O	al.	appos	2	SENT_309	[p21l1473t2747r1517b2784],
12	.	.	O	.	_	0	SENT_309	[p21l1473t2747r1517b2784],

1	Randomized	VBN	O	randomize	_	0	SENT_310	[p21l1536t2747r1796b2784],
2	double-blind	JJ	O	double-blind	amod	3	SENT_310	[p21l1810t2747r2072b2784],
3	assessment	NN	O	assessment	dobj	1	SENT_310	[p21l747t2810r985b2840],
4	of	IN	O	of	_	0	SENT_310	[p21l998t2802r1044b2840],
5	the	DT	O	the	det	6	SENT_310	[p21l1051t2802r1115b2840],
6	ONSET	NNP	O	ONSET	prep_of	3	SENT_310	[p21l1131t2804r1288b2840],
7	and	CC	O	and	_	0	SENT_310	[p21l1302t2802r1378b2840],
8	OFFSET	NNP	O	OFFSET	prep_of	3	SENT_310	[p21l1393t2804r1570b2840],
9	of	IN	O	of	_	0	SENT_310	[p21l1584t2802r1629b2840],
10	the	DT	O	the	det	12	SENT_310	[p21l1636t2802r1700b2840],
11	antiplatelet	JJ	O	antiplatelet	amod	12	SENT_310	[p21l1715t2802r1945b2851],
12	effects	NNS	O	effect	prep_of	3	SENT_310	[p21l1959t2803r2089b2840],
13	of	IN	O	of	_	0	SENT_310	[p21l2104t2802r2150b2840],
14	ticagrelor	NN	O	ticagrelor	prep_of	12	SENT_310	[p21l746t2859r942b2908],
15	versus	CC	O	versus	_	0	SENT_310	[p21l954t2872r1085b2896],
16	clopidogrel	NN	O	clopidogrel	dobj	1	SENT_310	[p21l1101t2859r1330b2908],
17	in	IN	O	in	_	0	SENT_310	[p21l1344t2861r1386b2896],
18	patients	NNS	O	patient	prep_in	16	SENT_310	[p21l1399t2861r1561b2908],
19	with	IN	O	with	_	0	SENT_310	[p21l1576t2859r1667b2896],
20	stable	JJ	O	stable	amod	23	SENT_310	[p21l1682t2859r1799b2896],
21	coronary	JJ	O	coronary	amod	23	SENT_310	[p21l1814t2872r1995b2908],
22	artery	NN	O	artery	nn	23	SENT_310	[p21l2008t2866r2127b2908],
23	disease	NN	O	disease	prep_with	1	SENT_310	[p21l747t2916r905b2953],
24	:	:	O	:	_	0	SENT_310	[p21l747t2916r905b2953],
25	the	DT	O	the	det	29	SENT_310	[p21l921t2916r985b2953],
26	ONSET	NNP	O	ONSET	nn	29	SENT_310	[p21l1001t2918r1170b2964],
27	/	:	O	/	punct	28	SENT_310	[p21l1001t2918r1170b2964],
28	OFFSET	NNP	O	OFFSET	dep	29	SENT_310	[p21l1175t2918r1352b2953],
29	study	NN	O	study	dep	23	SENT_310	[p21l1367t2916r1482b2965],
30	.	.	O	.	_	0	SENT_310	[p21l1367t2916r1482b2965],

1	Circulation	NN	O	circulation	_	0	SENT_311	[p21l1502t2916r1721b2953],
2	2009	CD	DATE	2009	num	1	SENT_311	[p21l1736t2919r1842b2959],
3	;	:	O	;	_	0	SENT_311	[p21l1736t2919r1842b2959],
4	120	CD	NUMBER	120	num	6	SENT_311	[p21l1859t2919r1938b2953],
5	:	:	O	:	_	0	SENT_311	[p21l1859t2919r1938b2953],
6	2577-85	CD	NUMBER	2577-85	dep	1	SENT_311	[p21l1955t2918r2128b2954],
7	.	.	O	.	_	0	SENT_311	[p21l1955t2918r2128b2954],

1	20	CD	NUMBER	20	num	7	SENT_312	[p21l6t3320r71b3368],
2	Storey	NNP	O	Storey	nn	7	SENT_312	[p21l151t3319r332b3385],
3	RF	NNP	O	RF	nn	7	SENT_312	[p21l353t3318r449b3376],
4	,	,	O	,	_	0	SENT_312	[p21l353t3318r449b3376],
5	Melissa	NNP	PERSON	Melissa	appos	7	SENT_312	[p21l474t3315r694b3368],
6	Thornton	NNP	PERSON	Thornton	nn	7	SENT_312	[p21l712t3315r994b3368],
7	S	NN	O	s	_	0	SENT_312	[p21l1018t3319r1066b3377],
8	,	,	O	,	_	0	SENT_312	[p21l1018t3319r1066b3377],
9	Lawrance	NN	PERSON	lawrance	nn	10	SENT_312	[p21l1092t3321r1367b3368],
10	R	NN	PERSON	r	appos	7	SENT_312	[p21l1391t3321r1446b3377],
11	,	,	O	,	_	0	SENT_312	[p21l1391t3321r1446b3377],
12	et	FW	O	et	nn	13	SENT_312	[p21l1470t3326r1521b3368],
13	al.	FW	O	al.	appos	10	SENT_312	[p21l1541t3315r1603b3368],
14	.	.	O	.	_	0	SENT_312	[p21l1541t3315r1603b3368],

1	Ticagrelor	NNP	O	Ticagrelor	nn	2	SENT_313	[p21l1625t3315r1923b3386],
2	yields	NNS	O	yield	_	0	SENT_313	[p21l1940t3315r2107b3385],
3	consistent	JJ	O	consistent	amod	5	SENT_313	[p21l147t3399r446b3449],
4	dose-dependent	JJ	O	dose-dependent	amod	5	SENT_313	[p21l466t3396r931b3465],
5	inhibition	NN	O	inhibition	dep	2	SENT_313	[p21l950t3396r1243b3449],
6	of	IN	O	of	_	0	SENT_313	[p21l1263t3396r1328b3449],
7	AD	NN	O	ad	prep_of	5	SENT_313	[p21l1337t3399r1433b3448],
8	P-induced	JJ	O	p-induced	amod	10	SENT_313	[p21l1441t3396r1736b3449],
9	platelet	NN	O	platelet	nn	10	SENT_313	[p21l1755t3396r1968b3465],
10	aggregation	NN	O	aggregation	dep	2	SENT_313	[p21l147t3479r491b3546],
11	in	IN	O	in	_	0	SENT_313	[p21l511t3479r570b3528],
12	patients	NNS	O	patient	prep_in	10	SENT_313	[p21l590t3479r821b3545],
13	with	IN	O	with	_	0	SENT_313	[p21l841t3476r970b3529],
14	atherosclerotic	JJ	O	atherosclerotic	amod	15	SENT_313	[p21l991t3476r1420b3529],
15	disease	NN	O	disease	prep_with	12	SENT_313	[p21l1441t3476r1651b3529],
16	regardless	RB	O	regardless	_	0	SENT_313	[p21l1671t3476r1968b3546],
17	of	IN	O	of	_	0	SENT_313	[p21l1991t3476r2056b3529],
18	genotypic	JJ	O	genotypic	amod	19	SENT_313	[p21l147t3559r429b3625],
19	variations	NNS	O	variation	prep_regardless_of	12	SENT_313	[p21l447t3559r733b3608],
20	in	IN	O	in	_	0	SENT_313	[p21l755t3559r813b3608],
21	P2RY12	NN	O	p2ry12	prep_in	19	SENT_313	[p21l836t3560r1076b3617],
22	,	,	O	,	_	0	SENT_313	[p21l836t3560r1076b3617],
23	PZRY1	NN	O	pzry1	conj_and	21	SENT_313	[p21l1102t3560r1306b3616],
24	,	,	O	,	_	0	SENT_313	[p21l1102t3560r1306b3616],
25	and	CC	O	and	_	0	SENT_313	[p21l1330t3555r1438b3608],
26	ITGB3	NN	O	itgb3	conj_and	21	SENT_313	[p21l1460t3558r1670b3608],
27	.	.	O	.	_	0	SENT_313	[p21l1460t3558r1670b3608],

1	Platelets	NNS	O	platelet	_	0	SENT_314	[p21l1698t3555r1921b3608],
2	2009	CD	DATE	2009	num	1	SENT_314	[p21l1942t3560r2093b3617],
3	;	:	O	;	_	0	SENT_314	[p21l1942t3560r2093b3617],
4	20	CD	NUMBER	20	num	6	SENT_314	[p21l148t3640r229b3688],
5	:	:	O	:	_	0	SENT_314	[p21l148t3640r229b3688],
6	341-48	CD	NUMBER	341-48	dep	1	SENT_314	[p21l255t3640r461b3688],
7	.	.	O	.	_	0	SENT_314	[p21l255t3640r461b3688],

1	Wallentin	NNP	PERSON	Wallentin	nn	2	SENT_315	[p22l145t25r430b79],
2	L	NNP	PERSON	L	_	0	SENT_315	[p22l453t31r500b87],
3	,	,	O	,	_	0	SENT_315	[p22l453t31r500b87],
4	Becker	NNP	PERSON	Becker	nn	5	SENT_315	[p22l526t25r724b79],
5	RC	NNP	O	RC	appos	2	SENT_315	[p22l746t30r847b87],
6	,	,	O	,	_	0	SENT_315	[p22l746t30r847b87],
7	Budaj	NNP	PERSON	Budaj	nn	8	SENT_315	[p22l874t25r1036b95],
8	A	NNP	O	A	appos	2	SENT_315	[p22l1059t30r1120b87],
9	,	,	O	,	_	0	SENT_315	[p22l1059t30r1120b87],
10	et	FW	O	et	nn	11	SENT_315	[p22l1144t36r1195b79],
11	al.	FW	O	al.	appos	2	SENT_315	[p22l1215t25r1277b79],
12	.	.	O	.	_	0	SENT_315	[p22l1215t25r1277b79],

1	Ticagrelor	NNP	O	Ticagrelor	_	0	SENT_316	[p22l1299t25r1597b96],
2	versus	CC	O	versus	prep	1	SENT_316	[p22l1614t44r1801b79],
3	clopidogrel	NN	O	clopidogrel	dep	2	SENT_316	[p22l1823t25r2149b96],
4	in	IN	O	in	_	0	SENT_316	[p22l146t109r205b158],
5	patients	NNS	O	patient	prep_in	1	SENT_316	[p22l224t109r455b176],
6	with	IN	O	with	_	0	SENT_316	[p22l475t106r606b159],
7	acute	JJ	O	acute	amod	9	SENT_316	[p22l626t117r778b159],
8	coronary	JJ	O	coronary	amod	9	SENT_316	[p22l800t125r1057b176],
9	syndromes	NNS	O	syndrome	prep_with	5	SENT_316	[p22l1077t106r1413b176],
10	.	.	O	.	_	0	SENT_316	[p22l1077t106r1413b176],

1	N	NN	O	n	nn	3	SENT_317	[p22l1439t111r1490b159],
2	Engl	NNP	O	Engl	nn	3	SENT_317	[p22l1509t106r1630b176],
3	]	NNP	O	]	nsubj	4	SENT_317	[p22l1641t111r1676b176],
4	Med	VBD	O	med	_	0	SENT_317	[p22l1695t106r1815b159],
5	2009	CD	DATE	2009	dobj	4	SENT_317	[p22l1835t111r1986b168],
6	;	:	O	;	_	0	SENT_317	[p22l1835t111r1986b168],
7	361	CD	NUMBER	361	num	9	SENT_317	[p22l147t191r259b240],
8	:	:	O	:	_	0	SENT_317	[p22l147t191r259b240],
9	1045-57	CD	NUMBER	1045-57	dep	5	SENT_317	[p22l284t189r513b241],
10	.	.	O	.	_	0	SENT_317	[p22l284t189r513b241],

1	Iames	NNS	MISC	iame	nn	2	SENT_318	[p22l148t281r322b344],
2	S	NN	O	s	_	0	SENT_318	[p22l349t279r396b336],
3	,	,	O	,	_	0	SENT_318	[p22l349t279r396b336],
4	Akerblom	NNP	PERSON	Akerblom	nn	5	SENT_318	[p22l418t275r712b328],
5	A	NNP	O	A	appos	2	SENT_318	[p22l731t279r792b337],
6	,	,	O	,	_	0	SENT_318	[p22l731t279r792b337],
7	Cannon	NNP	O	Cannon	nn	8	SENT_318	[p22l817t279r1048b328],
8	CP	NNP	O	CP	appos	2	SENT_318	[p22l1069t279r1169b337],
9	,	,	O	,	_	0	SENT_318	[p22l1069t279r1169b337],
10	et	FW	O	et	nn	11	SENT_318	[p22l1192t286r1244b328],
11	al.	FW	O	al.	appos	2	SENT_318	[p22l1264t275r1326b328],
12	.	.	O	.	_	0	SENT_318	[p22l1264t275r1326b328],

1	Comparison	NN	O	comparison	nsubj	37	SENT_319	[p22l1351t279r1712b345],
2	of	IN	O	of	_	0	SENT_319	[p22l1733t275r1798b328],
3	ticagrelor	NN	O	ticagrelor	prep_of	1	SENT_319	[p22l1807t275r2094b346],
4	,	,	O	,	_	0	SENT_319	[p22l1807t275r2094b346],
5	the	DT	O	the	det	6	SENT_319	[p22l146t356r237b409],
6	ﬁrst	NN	O	ﬁrst	npadvmod	7	SENT_319	[p22l257t356r374b409],
7	reversible	JJ	O	reversible	amod	9	SENT_319	[p22l393t356r677b409],
8	oral	JJ	O	oral	amod	9	SENT_319	[p22l698t356r809b409],
9	P2Y1	NN	O	p2y1	appos	1	SENT_319	[p22l831t361r978b422],
10	,	,	O	,	_	0	SENT_319	[p22l831t361r978b422],
11	receptor	NN	O	receptor	nn	12	SENT_319	[p22l998t367r1239b425],
12	antagonist	NN	O	antagonist	appos	1	SENT_319	[p22l1259t359r1580b426],
13	,	,	O	,	_	0	SENT_319	[p22l1259t359r1580b426],
14	with	IN	O	with	_	0	SENT_319	[p22l1601t356r1731b409],
15	clopidogrel	NN	O	clopidogrel	prep_with	1	SENT_319	[p22l1751t356r2077b426],
16	in	IN	O	in	_	0	SENT_319	[p22l146t439r204b488],
17	patients	NNS	O	patient	prep_in	15	SENT_319	[p22l224t439r455b505],
18	with	IN	O	with	_	0	SENT_319	[p22l475t435r606b489],
19	acute	JJ	O	acute	amod	21	SENT_319	[p22l626t446r778b489],
20	coronary	JJ	O	coronary	amod	21	SENT_319	[p22l800t454r1057b505],
21	syndromes	NNS	O	syndrome	prep_with	17	SENT_319	[p22l1077t435r1412b505],
22	:	:	O	:	_	0	SENT_319	[p22l1077t435r1412b505],
23	rationale	NN	O	rationale	nsubj	37	SENT_319	[p22l1436t435r1708b497],
24	,	,	O	,	_	0	SENT_319	[p22l1436t435r1708b497],
25	design	NN	O	design	appos	23	SENT_319	[p22l1731t435r1939b506],
26	,	,	O	,	_	0	SENT_319	[p22l1731t435r1939b506],
27	and	CC	O	and	_	0	SENT_319	[p22l1962t435r2071b489],
28	baseline	NN	O	baseline	nn	29	SENT_319	[p22l145t516r386b569],
29	characteristics	NNS	O	characteristic	conj_and	1	SENT_319	[p22l408t516r824b569],
30	of	IN	O	of	_	0	SENT_319	[p22l847t516r912b569],
31	the	DT	O	the	det	33	SENT_319	[p22l921t516r1013b569],
32	PLATelet	NN	O	platelet	nn	33	SENT_319	[p22l1036t516r1294b569],
33	inhibition	NN	O	inhibition	prep_of	29	SENT_319	[p22l1313t516r1605b569],
34	and	CC	O	and	_	0	SENT_319	[p22l1626t516r1734b569],
35	patient	NN	O	patient	nn	36	SENT_319	[p22l1753t519r1957b586],
36	Outcomes	NNS	O	outcome	prep_of	29	SENT_319	[p22l148t601r445b649],
37	(	VBP	O	(	_	0	SENT_319	[p22l472t599r720b666],
38	PLATO	NNP	ORGANIZATION	PLATO	nsubj	40	SENT_319	[p22l472t599r720b666],
39	)	CD	NUMBER	)	num	40	SENT_319	[p22l472t599r720b666],
40	trial	NN	O	trial	xcomp	37	SENT_319	[p22l744t596r875b649],
41	.	.	O	.	_	0	SENT_319	[p22l744t596r875b649],

1	Am	VBP	O	be	dep	2	SENT_320	[p22l898t599r1001b648],
2	Heart	NNP	O	Heart	_	0	SENT_320	[p22l1023t601r1229b666],
3	]	CD	NUMBER	]	num	2	SENT_320	[p22l1023t601r1229b666],
4	2009	CD	DATE	2009	dep	2	SENT_320	[p22l1248t601r1399b657],
5	;	:	O	;	_	0	SENT_320	[p22l1248t601r1399b657],
6	157	CD	NUMBER	157	dep	4	SENT_320	[p22l1424t598r1535b650],
7	:	:	O	:	_	0	SENT_320	[p22l1424t598r1535b650],
8	599-605	CD	NUMBER	599-605	dep	6	SENT_320	[p22l1561t599r1816b649],
9	.	.	O	.	_	0	SENT_320	[p22l1561t599r1816b649],

1	Soﬁ	NN	O	soﬁ	nn	2	SENT_321	[p22l151t686r258b740],
2	F	NN	O	f	_	0	SENT_321	[p22l281t689r331b748],
3	,	,	O	,	_	0	SENT_321	[p22l281t689r331b748],
4	Giusti	NNP	PERSON	Giusti	nn	5	SENT_321	[p22l356t690r532b740],
5	B	NNP	PERSON	B	appos	2	SENT_321	[p22l555t692r609b748],
6	,	,	O	,	_	0	SENT_321	[p22l555t692r609b748],
7	Marcucci	NNP	PERSON	Marcucci	nn	8	SENT_321	[p22l634t690r901b740],
8	R	NNP	PERSON	R	appos	5	SENT_321	[p22l924t692r979b748],
9	,	,	O	,	_	0	SENT_321	[p22l924t692r979b748],
10	Gori	NNP	ORGANIZATION	Gori	nn	11	SENT_321	[p22l1004t690r1132b740],
11	AM	NNP	ORGANIZATION	AM	appos	5	SENT_321	[p22l1151t690r1276b748],
12	,	,	O	,	_	0	SENT_321	[p22l1151t690r1276b748],
13	Abbate	NNP	ORGANIZATION	Abbate	nn	14	SENT_321	[p22l1297t686r1499b740],
14	R	NNP	ORGANIZATION	R	appos	5	SENT_321	[p22l1523t692r1578b748],
15	,	,	O	,	_	0	SENT_321	[p22l1523t692r1578b748],
16	Gensini	NNP	O	Gensini	nn	17	SENT_321	[p22l1603t690r1833b740],
17	GF	NN	O	gf	appos	5	SENT_321	[p22l1855t689r1958b740],
18	.	.	O	.	_	0	SENT_321	[p22l1855t689r1958b740],

1	Cytochrome	NN	O	cytochrome	nn	4	SENT_322	[p22l148t767r502b837],
2	P450	NN	O	p450	nn	4	SENT_322	[p22l526t770r665b820],
3	2C19	NN	O	2c19	nn	4	SENT_322	[p22l687t770r897b820],
4	*	NN	O	*	_	0	SENT_322	[p22l687t770r897b820],
5	2	CD	NUMBER	2	num	6	SENT_322	[p22l687t770r897b820],
6	polymorphism	NN	O	polymorphism	dep	4	SENT_322	[p22l918t767r1354b837],
7	and	CC	O	and	_	0	SENT_322	[p22l1374t767r1483b820],
8	cardiovascular	JJ	O	cardiovascular	amod	9	SENT_322	[p22l1502t767r1924b820],
9	recurrences	NNS	O	recurrence	conj_and	4	SENT_322	[p22l146t866r490b901],
10	in	IN	O	in	_	0	SENT_322	[p22l512t851r570b900],
11	patients	NNS	O	patient	prep_in	9	SENT_322	[p22l590t851r821b917],
12	taking	VBG	O	take	partmod	4	SENT_322	[p22l842t848r1026b918],
13	clopidogrel	NN	O	clopidogrel	dobj	12	SENT_322	[p22l1046t848r1387b918],
14	:	:	O	:	_	0	SENT_322	[p22l1046t848r1387b918],
15	a	DT	O	a	det	16	SENT_322	[p22l1410t866r1440b901],
16	meta-analysis	NN	O	meta-analysis	dep	13	SENT_322	[p22l1460t848r1873b918],
17	.	.	O	.	_	0	SENT_322	[p22l1460t848r1873b918],

1	Pharmacogenomics	NNS	MISC	pharmacogenomic	nsubj	2	SENT_323	[p22l150t927r684b997],
2	]	VBP	O	]	_	0	SENT_323	[p22l695t933r731b997],
3	2010	CD	DATE	2010	dobj	2	SENT_323	[p22l749t932r893b988],
4	;	:	O	;	_	0	SENT_323	[p22l749t932r893b988],
5	published	VBN	O	publish	partmod	3	SENT_323	[p22l916t927r1208b997],
6	online	NN	O	online	prep	5	SENT_323	[p22l1228t927r1413b980],
7	March	NNP	DATE	March	tmod	5	SENT_323	[p22l1436t927r1622b980],
8	30	CD	DATE	30	num	7	SENT_323	[p22l1645t932r1724b980],
9	.	.	O	.	_	0	SENT_323	[p22l1645t932r1724b980],

1	DOI	NNP	O	DOI	_	0	SENT_324	[p22l1751t932r2136b997],
2	:10.1038	CD	NUMBER	:10.1038	num	1	SENT_324	[p22l1751t932r2136b997],
3	/	:	O	/	punct	4	SENT_324	[p22l1751t932r2136b997],
4	tpj	NN	O	tpj	dep	1	SENT_324	[p22l145t1011r469b1077],
5	.2010.21	CD	NUMBER	.2010.21	num	4	SENT_324	[p22l145t1011r469b1077],
6	.	.	O	.	_	0	SENT_324	[p22l145t1011r469b1077],

1	Xie	NNP	O	Xie	nn	2	SENT_325	[p22l145t1101r242b1151],
2	HG	NNP	O	HG	_	0	SENT_325	[p22l265t1102r386b1159],
3	,	,	O	,	_	0	SENT_325	[p22l265t1102r386b1159],
4	Kim	NNP	PERSON	Kim	nn	5	SENT_325	[p22l412t1101r535b1150],
5	RB	NN	O	rb	appos	2	SENT_325	[p22l557t1103r658b1159],
6	,	,	O	,	_	0	SENT_325	[p22l557t1103r658b1159],
7	Wood	NNP	O	Wood	nn	9	SENT_325	[p22l679t1097r850b1152],
8	A	NNP	O	A	nn	9	SENT_325	[p22l868t1102r954b1166],
9	]	NN	O	]	appos	2	SENT_325	[p22l868t1102r954b1166],
10	,	,	O	,	_	0	SENT_325	[p22l868t1102r954b1166],
11	Stein	NNP	PERSON	Stein	nn	12	SENT_325	[p22l981t1101r1128b1151],
12	CM	NN	O	cm	appos	2	SENT_325	[p22l1150t1102r1271b1151],
13	.	.	O	.	_	0	SENT_325	[p22l1150t1102r1271b1151],

1	Molecular	JJ	MISC	molecular	amod	2	SENT_326	[p22l1296t1097r1589b1151],
2	basis	NN	O	basis	_	0	SENT_326	[p22l1607t1097r1752b1151],
3	of	IN	O	of	_	0	SENT_326	[p22l1775t1097r1839b1151],
4	ethnic	JJ	O	ethnic	amod	5	SENT_326	[p22l1851t1097r2032b1151],
5	differences	NNS	O	difference	prep_of	2	SENT_326	[p22l147t1202r468b1255],
6	in	IN	O	in	_	0	SENT_326	[p22l490t1205r549b1254],
7	drug	NN	O	drug	nn	8	SENT_326	[p22l569t1202r706b1272],
8	disposition	NN	O	disposition	prep_in	2	SENT_326	[p22l727t1202r1051b1272],
9	and	CC	O	and	_	0	SENT_326	[p22l1071t1202r1179b1255],
10	response	NN	O	response	prep_in	2	SENT_326	[p22l1198t1221r1476b1272],
11	.	.	O	.	_	0	SENT_326	[p22l1198t1221r1476b1272],

1	Annu	NNP	O	Annu	nn	4	SENT_327	[p22l145t1287r307b1337],
2	Rev	NN	O	rev	nn	4	SENT_327	[p22l329t1288r427b1336],
3	Pharmacol	NNP	O	Pharmacol	nn	4	SENT_327	[p22l449t1283r750b1337],
4	Toxicol	NNP	O	Toxicol	_	0	SENT_327	[p22l773t1283r965b1337],
5	2001	CD	DATE	2001	num	4	SENT_327	[p22l985t1288r1130b1345],
6	;	:	O	;	_	0	SENT_327	[p22l985t1288r1130b1345],
7	41	CD	NUMBER	41	num	9	SENT_327	[p22l1152t1288r1230b1337],
8	:	:	O	:	_	0	SENT_327	[p22l1152t1288r1230b1337],
9	815-50	CD	NUMBER	815-50	dep	4	SENT_327	[p22l1254t1286r1470b1337],
10	.	.	O	.	_	0	SENT_327	[p22l1254t1286r1470b1337],

1	Ragia	NN	O	ragium	nn	2	SENT_328	[p22l149t1376r308b1443],
2	G	NN	O	g	_	0	SENT_328	[p22l330t1376r393b1433],
3	,	,	O	,	_	0	SENT_328	[p22l330t1376r393b1433],
4	Arvanitidis	NNP	PERSON	Arvanitidis	nn	5	SENT_328	[p22l415t1372r737b1425],
5	KI	NNP	PERSON	KI	appos	2	SENT_328	[p22l762t1378r844b1434],
6	,	,	O	,	_	0	SENT_328	[p22l762t1378r844b1434],
7	Tavridou	NNP	O	Tavridou	nn	8	SENT_328	[p22l865t1372r1122b1425],
8	A	NNP	O	A	appos	2	SENT_328	[p22l1141t1376r1202b1433],
9	,	,	O	,	_	0	SENT_328	[p22l1141t1376r1202b1433],
10	Manolopoulos	NNP	O	Manolopoulos	nn	11	SENT_328	[p22l1227t1372r1642b1442],
11	VG	NNP	O	VG	appos	2	SENT_328	[p22l1663t1376r1775b1426],
12	.	.	O	.	_	0	SENT_328	[p22l1663t1376r1775b1426],

1	Need	VBN	O	need	_	0	SENT_329	[p22l1800t1372r1949b1425],
2	for	IN	O	for	_	0	SENT_329	[p22l1968t1372r2052b1425],
3	reassessment	NN	O	reassessment	prep_for	1	SENT_329	[p22l146t1464r543b1506],
4	of	IN	O	of	_	0	SENT_329	[p22l563t1453r629b1506],
5	reported	VBN	O	report	amod	8	SENT_329	[p22l638t1453r887b1522],
6	CYPZC19	NN	O	cypzc19	nn	8	SENT_329	[p22l908t1456r1180b1506],
7	allele	NN	O	allele	nn	8	SENT_329	[p22l1203t1453r1352b1506],
8	frequencies	NNS	O	frequency	prep_of	3	SENT_329	[p22l1372t1453r1712b1522],
9	in	IN	O	in	_	0	SENT_329	[p22l1734t1456r1793b1505],
10	various	JJ	O	various	amod	11	SENT_329	[p22l1811t1456r2023b1506],
11	populations	NNS	O	population	prep_in	8	SENT_329	[p22l146t1533r491b1602],
12	in	IN	O	in	_	0	SENT_329	[p22l513t1536r572b1585],
13	view	NN	O	view	prep_in	11	SENT_329	[p22l590t1536r724b1586],
14	of	IN	O	of	_	0	SENT_329	[p22l743t1533r808b1586],
15	CYP2C19	NN	O	cyp2c19	nn	17	SENT_329	[p22l820t1536r1189b1588],
16	’	CD	NUMBER	’	num	17	SENT_329	[p22l820t1536r1189b1588],
17	~	NN	O	~	prep_of	13	SENT_329	[p22l820t1536r1189b1588],
18	‘	CD	NUMBER	‘	number	19	SENT_329	[p22l820t1536r1189b1588],
19	17	CD	NUMBER	17	num	20	SENT_329	[p22l820t1536r1189b1588],
20	discovery	NN	O	discovery	dep	17	SENT_329	[p22l1209t1533r1493b1603],
21	:	:	O	:	_	0	SENT_329	[p22l1209t1533r1493b1603],
22	the	DT	O	the	det	23	SENT_329	[p22l1514t1533r1606b1586],
23	case	NN	O	case	dep	17	SENT_329	[p22l1628t1551r1748b1586],
24	of	IN	O	of	_	0	SENT_329	[p22l1770t1532r1835b1586],
25	Greece	NNP	LOCATION	Greece	prep_of	23	SENT_329	[p22l1847t1537r2061b1586],
26	.	.	O	.	_	0	SENT_329	[p22l1847t1537r2061b1586],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_330	[p22l150t1612r684b1683],
2	2009	CD	DATE	2009	num	1	SENT_330	[p22l705t1617r856b1674],
3	;	:	O	;	_	0	SENT_330	[p22l705t1617r856b1674],
4	10	CD	NUMBER	10	num	6	SENT_330	[p22l880t1617r957b1665],
5	:	:	O	:	_	0	SENT_330	[p22l880t1617r957b1665],
6	43-49	CD	NUMBER	43-49	dep	1	SENT_330	[p22l978t1617r1160b1666],
7	.	.	O	.	_	0	SENT_330	[p22l978t1617r1160b1666],

1	Ameyaw	NNP	O	Ameyaw	nn	2	SENT_331	[p22l145t1707r400b1774],
2	MM	NN	O	mm	_	0	SENT_331	[p22l421t1709r558b1765],
3	,	,	O	,	_	0	SENT_331	[p22l421t1709r558b1765],
4	Regateiro	NN	O	regateiro	nn	5	SENT_331	[p22l584t1707r858b1774],
5	F	NN	O	f	appos	2	SENT_331	[p22l882t1707r931b1765],
6	,	,	O	,	_	0	SENT_331	[p22l882t1707r931b1765],
7	Li	NNP	PERSON	Li	nn	8	SENT_331	[p22l957t1707r1009b1756],
8	T	NN	PERSON	t	appos	2	SENT_331	[p22l1028t1707r1075b1765],
9	,	,	O	,	_	0	SENT_331	[p22l1028t1707r1075b1765],
10	et	FW	O	et	nn	11	SENT_331	[p22l1099t1714r1150b1757],
11	al.	FW	O	al.	appos	2	SENT_331	[p22l1170t1704r1232b1757],
12	.	.	O	.	_	0	SENT_331	[p22l1170t1704r1232b1757],

1	MDR1	NN	O	mdr1	nn	2	SENT_332	[p22l1258t1709r1443b1756],
2	pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_332	[p22l1463t1704r2014b1774],
3	:	:	O	:	_	0	SENT_332	[p22l1463t1704r2014b1774],
4	frequency	NN	O	frequency	nsubjpass	15	SENT_332	[p22l146t1783r438b1853],
5	of	IN	O	of	_	0	SENT_332	[p22l458t1783r523b1837],
6	the	DT	O	the	det	9	SENT_332	[p22l532t1783r623b1837],
7	C343	NN	O	c343	nn	9	SENT_332	[p22l646t1788r787b1837],
8	5T	NN	O	5t	nn	9	SENT_332	[p22l796t1787r869b1836],
9	mutation	NN	O	mutation	prep_of	4	SENT_332	[p22l888t1787r1159b1837],
10	in	IN	O	in	_	0	SENT_332	[p22l1178t1787r1237b1836],
11	exon	NN	O	exon	prep_in	9	SENT_332	[p22l1257t1802r1394b1837],
12	26	CD	NUMBER	26	num	11	SENT_332	[p22l1416t1788r1481b1837],
13	is	VBZ	O	be	auxpass	15	SENT_332	[p22l1502t1787r1547b1837],
14	signiﬁcantly	RB	O	signiﬁcantly	advmod	15	SENT_332	[p22l1571t1783r1930b1854],
15	inﬂuenced	VBN	O	inﬂuenced	dep	2	SENT_332	[p22l146t1864r460b1917],
16	by	IN	O	by	_	0	SENT_332	[p22l478t1864r547b1934],
17	ethnicity	NN	O	ethnicity	agent	15	SENT_332	[p22l566t1864r828b1934],
18	.	.	O	.	_	0	SENT_332	[p22l566t1864r828b1934],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_333	[p22l855t1864r1349b1934],
2	2001	CD	DATE	2001	num	1	SENT_333	[p22l1369t1869r1514b1926],
3	;	:	O	;	_	0	SENT_333	[p22l1369t1869r1514b1926],
4	11	CD	NUMBER	11	num	6	SENT_333	[p22l1538t1869r1610b1917],
5	:	:	O	:	_	0	SENT_333	[p22l1538t1869r1610b1917],
6	217-21	CD	NUMBER	217-21	dep	1	SENT_333	[p22l1634t1867r1837b1919],
7	.	.	O	.	_	0	SENT_333	[p22l1634t1867r1837b1919],

1	Mega	JJ	O	mega	amod	2	SENT_334	[p22l148t1959r306b2024],
2	IL	NN	O	il	_	0	SENT_334	[p22l327t1959r401b2022],
3	,	,	O	,	_	0	SENT_334	[p22l327t1959r401b2022],
4	Close	NNP	O	Close	nn	5	SENT_334	[p22l426t1953r584b2007],
5	SL	NNP	O	SL	appos	2	SENT_334	[p22l609t1958r694b2015],
6	,	,	O	,	_	0	SENT_334	[p22l609t1958r694b2015],
7	Wiviott	NNP	PERSON	Wiviott	nn	8	SENT_334	[p22l716t1957r928b2007],
8	SD	NN	O	sd	appos	2	SENT_334	[p22l951t1958r1050b2015],
9	,	,	O	,	_	0	SENT_334	[p22l951t1958r1050b2015],
10	et	FW	O	et	nn	11	SENT_334	[p22l1074t1964r1126b2007],
11	al.	FW	O	al.	appos	2	SENT_334	[p22l1145t1953r1207b2007],
12	.	.	O	.	_	0	SENT_334	[p22l1145t1953r1207b2007],

1	Cytochrome	NN	O	cytochrome	nn	2	SENT_335	[p22l1233t1953r1587b2023],
2	P450	NN	O	p450	_	0	SENT_335	[p22l1611t1957r1749b2007],
3	genetic	JJ	O	genetic	amod	4	SENT_335	[p22l1770t1957r1980b2024],
4	polymorphisms	NNS	O	polymorphism	dep	2	SENT_335	[p22l146t2033r608b2103],
5	and	CC	O	and	_	0	SENT_335	[p22l631t2033r740b2086],
6	the	DT	O	the	det	7	SENT_335	[p22l758t2033r849b2086],
7	response	NN	O	response	conj_and	2	SENT_335	[p22l870t2052r1132b2103],
8	to	TO	O	to	_	0	SENT_335	[p22l1151t2044r1206b2086],
9	prasugrel	NN	O	prasugrel	prep_to	7	SENT_335	[p22l1226t2033r1518b2104],
10	:	:	O	:	_	0	SENT_335	[p22l1226t2033r1518b2104],
11	relationship	NN	O	relationship	dep	2	SENT_335	[p22l1541t2033r1893b2103],
12	to	TO	O	to	_	0	SENT_335	[p22l1913t2044r1967b2086],
13	pharmacolcinetic	JJ	O	pharmacolcinetic	prep_to	11	SENT_335	[p22l146t2114r655b2183],
14	,	,	O	,	_	0	SENT_335	[p22l146t2114r655b2183],
15	pharmacodynamic	JJ	O	pharmacodynamic	prep_to	11	SENT_335	[p22l678t2114r1242b2184],
16	,	,	O	,	_	0	SENT_335	[p22l678t2114r1242b2184],
17	and	CC	O	and	_	0	SENT_335	[p22l1265t2114r1373b2167],
18	clinical	JJ	O	clinical	amod	19	SENT_335	[p22l1393t2114r1600b2167],
19	outcomes	NNS	O	outcome	conj_and	13	SENT_335	[p22l1622t2125r1919b2167],
20	.	.	O	.	_	0	SENT_335	[p22l1622t2125r1919b2167],

1	Circulation	NN	O	circulation	_	0	SENT_336	[p22l152t2194r464b2247],
2	2009	CD	DATE	2009	num	1	SENT_336	[p22l484t2198r635b2254],
3	;	:	O	;	_	0	SENT_336	[p22l484t2198r635b2254],
4	119	CD	NUMBER	119	num	6	SENT_336	[p22l660t2198r766b2247],
5	:	:	O	:	_	0	SENT_336	[p22l660t2198r766b2247],
6	2553-60	CD	NUMBER	2553-60	dep	1	SENT_336	[p22l790t2197r1047b2247],
7	.	.	O	.	_	0	SENT_336	[p22l790t2197r1047b2247],

1	Giusti	NNP	PERSON	Giusti	nn	2	SENT_337	[p22l148t2287r325b2337],
2	B	NNP	PERSON	B	_	0	SENT_337	[p22l347t2289r402b2345],
3	,	,	O	,	_	0	SENT_337	[p22l347t2289r402b2345],
4	Gori	NNP	ORGANIZATION	Gori	nn	5	SENT_337	[p22l426t2287r555b2337],
5	AM	NNP	ORGANIZATION	AM	appos	2	SENT_337	[p22l573t2288r698b2346],
6	,	,	O	,	_	0	SENT_337	[p22l573t2288r698b2346],
7	Marcucci	NNP	PERSON	Marcucci	nn	8	SENT_337	[p22l723t2287r990b2337],
8	R	NNP	PERSON	R	appos	2	SENT_337	[p22l1012t2289r1068b2346],
9	,	,	O	,	_	0	SENT_337	[p22l1012t2289r1068b2346],
10	et	FW	O	et	nn	11	SENT_337	[p22l1092t2295r1143b2337],
11	al.	FW	O	al.	appos	2	SENT_337	[p22l1163t2284r1225b2337],
12	.	.	O	.	_	0	SENT_337	[p22l1163t2284r1225b2337],

1	Relation	NN	O	relation	_	0	SENT_338	[p22l1251t2284r1491b2337],
2	of	IN	O	of	_	0	SENT_338	[p22l1512t2284r1576b2337],
3	cytochrome	NN	O	cytochrome	nn	7	SENT_338	[p22l1587t2284r1928b2354],
4	P450	NN	O	p450	nn	7	SENT_338	[p22l1952t2287r2090b2337],
5	2C19	NN	O	2c19	nn	7	SENT_338	[p22l148t2368r288b2417],
6	loss-of-function	NN	O	loss-of-function	nn	7	SENT_338	[p22l309t2364r768b2417],
7	polymorphism	NN	O	polymorphism	prep_of	1	SENT_338	[p22l787t2364r1222b2434],
8	to	TO	O	to	_	0	SENT_338	[p22l1241t2375r1295b2417],
9	occurrence	NN	O	occurrence	prep_to	7	SENT_338	[p22l1317t2383r1639b2417],
10	of	IN	O	of	_	0	SENT_338	[p22l1660t2363r1725b2417],
11	drug-eluting	JJ	O	drug-eluting	amod	14	SENT_338	[p22l1736t2364r2101b2434],
12	coronary	JJ	O	coronary	amod	14	SENT_338	[p22l147t2462r404b2514],
13	stent	NN	O	stent	nn	14	SENT_338	[p22l425t2454r566b2497],
14	thrombosis	NN	O	thrombosis	prep_of	1	SENT_338	[p22l584t2443r934b2497],
15	.	.	O	.	_	0	SENT_338	[p22l584t2443r934b2497],

1	Am	VBP	O	be	dep	3	SENT_339	[p22l956t2448r1060b2496],
2	]	CD	NUMBER	]	num	3	SENT_339	[p22l1070t2449r1106b2513],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_339	[p22l1128t2443r1329b2497],
4	2009	CD	DATE	2009	num	3	SENT_339	[p22l1350t2448r1500b2505],
5	;	:	O	;	_	0	SENT_339	[p22l1350t2448r1500b2505],
6	103	CD	NUMBER	103	dep	3	SENT_339	[p22l1525t2448r1637b2497],
7	:	:	O	:	_	0	SENT_339	[p22l1525t2448r1637b2497],
8	806-11	CD	NUMBER	806-11	dep	6	SENT_339	[p22l1660t2448r1869b2497],
9	.	.	O	.	_	0	SENT_339	[p22l1660t2448r1869b2497],

1	Sibbing	VBG	O	sibb	_	0	SENT_340	[p22l151t2535r372b2605],
2	D	NN	O	d	dobj	1	SENT_340	[p22l395t2540r456b2596],
3	,	,	O	,	_	0	SENT_340	[p22l395t2540r456b2596],
4	Stegherr	NN	O	stegherr	nn	5	SENT_340	[p22l484t2535r732b2605],
5	I	NN	O	i	appos	2	SENT_340	[p22l753t2540r789b2603],
6	,	,	O	,	_	0	SENT_340	[p22l753t2540r789b2603],
7	Latz	NNP	PERSON	Latz	nn	8	SENT_340	[p22l815t2540r932b2588],
8	W	NNP	O	W	appos	2	SENT_340	[p22l952t2540r1024b2596],
9	,	,	O	,	_	0	SENT_340	[p22l952t2540r1024b2596],
10	et	FW	O	et	nn	11	SENT_340	[p22l1048t2546r1099b2588],
11	al.	FW	O	al.	appos	2	SENT_340	[p22l1119t2535r1181b2588],
12	.	.	O	.	_	0	SENT_340	[p22l1119t2535r1181b2588],

1	Cytochrome	NN	O	cytochrome	nn	5	SENT_341	[p22l1206t2535r1561b2605],
2	P450	NN	O	p450	nn	5	SENT_341	[p22l1584t2538r1722b2588],
3	2C19	NN	O	2c19	nn	5	SENT_341	[p22l1745t2539r1885b2588],
4	loss-of-function	NN	O	loss-of-function	nn	5	SENT_341	[p22l145t2614r604b2668],
5	polymorphism	NN	O	polymorphism	_	0	SENT_341	[p22l624t2614r1058b2684],
6	and	CC	O	and	_	0	SENT_341	[p22l1080t2614r1188b2668],
7	stent	NN	O	stent	nn	8	SENT_341	[p22l1209t2625r1351b2668],
8	thrombosis	NN	O	thrombosis	conj_and	5	SENT_341	[p22l1368t2614r1702b2668],
9	following	VBG	O	follow	_	0	SENT_341	[p22l1724t2614r1999b2685],
10	percutaneous	JJ	O	percutaneous	amod	12	SENT_341	[p22l146t2704r541b2763],
11	coronary	JJ	O	coronary	amod	12	SENT_341	[p22l563t2712r821b2763],
12	intervention	NN	O	intervention	prep_following	5	SENT_341	[p22l839t2697r1214b2747],
13	.	.	O	.	_	0	SENT_341	[p22l839t2697r1214b2747],

1	Eur	NNP	O	Eur	nn	2	SENT_342	[p22l1241t2697r1343b2746],
2	Heart	NNP	O	Heart	_	0	SENT_342	[p22l1362t2699r1569b2763],
3	]	CD	NUMBER	]	num	4	SENT_342	[p22l1362t2699r1569b2763],
4	2009	CD	DATE	2009	dep	2	SENT_342	[p22l1587t2698r1738b2755],
5	;	:	O	;	_	0	SENT_342	[p22l1587t2698r1738b2755],
6	30	CD	NUMBER	30	num	8	SENT_342	[p22l1763t2698r1844b2747],
7	:	:	O	:	_	0	SENT_342	[p22l1763t2698r1844b2747],
8	916-22	CD	NUMBER	916-22	dep	2	SENT_342	[p22l1868t2698r2083b2747],
9	.	.	O	.	_	0	SENT_342	[p22l1868t2698r2083b2747],

1	Trenl	NN	O	trenl	_	0	SENT_343	[p22l145t2785r316b2838],
2	<	JJR	O	<	amod	3	SENT_343	[p22l145t2785r316b2838],
3	D	NN	O	d	dep	1	SENT_343	[p22l338t2790r399b2846],
4	,	,	O	,	_	0	SENT_343	[p22l338t2790r399b2846],
5	Hochholzer	NNP	PERSON	Hochholzer	nn	6	SENT_343	[p22l425t2785r770b2838],
6	W	NNP	PERSON	W	appos	3	SENT_343	[p22l788t2790r860b2846],
7	,	,	O	,	_	0	SENT_343	[p22l788t2790r860b2846],
8	Fromm	NNP	PERSON	Fromm	nn	9	SENT_343	[p22l886t2788r1103b2838],
9	MF	NN	O	mf	appos	3	SENT_343	[p22l1125t2788r1239b2846],
10	,	,	O	,	_	0	SENT_343	[p22l1125t2788r1239b2846],
11	et	FW	O	et	nn	12	SENT_343	[p22l1262t2795r1314b2838],
12	al.	FW	O	al.	appos	3	SENT_343	[p22l1333t2785r1395b2838],
13	.	.	O	.	_	0	SENT_343	[p22l1333t2785r1395b2838],

1	Cytochrome	NN	O	cytochrome	nn	4	SENT_344	[p22l1421t2785r1775b2855],
2	P450	NN	O	p450	nn	4	SENT_344	[p22l1799t2788r1937b2838],
3	2C19	NN	O	2c19	nn	4	SENT_344	[p22l1960t2788r2100b2838],
4	681G	NN	O	681g	_	0	SENT_344	[p22l147t2868r382b2917],
5	>	JJR	O	>	dep	4	SENT_344	[p22l147t2868r382b2917],
6	A	DT	O	a	det	7	SENT_344	[p22l147t2868r382b2917],
7	polymorphism	NN	O	polymorphism	nsubj	13	SENT_344	[p22l400t2864r836b2934],
8	and	CC	O	and	_	0	SENT_344	[p22l857t2864r965b2917],
9	high	JJ	O	high	amod	12	SENT_344	[p22l983t2864r1117b2934],
10	on-clopidogrel	JJ	O	on-clopidogrel	amod	12	SENT_344	[p22l1138t2864r1559b2935],
11	platelet	NN	O	platelet	nn	12	SENT_344	[p22l1579t2864r1793b2934],
12	reactivity	NN	O	reactivity	conj_and	7	SENT_344	[p22l1811t2868r2076b2934],
13	associated	VBN	O	associate	ccomp	5	SENT_344	[p22l147t2945r445b2998],
14	with	IN	O	with	_	0	SENT_344	[p22l462t2945r593b2998],
15	adverse	JJ	O	adverse	amod	18	SENT_344	[p22l613t2945r831b2998],
16	1-year	JJ	DURATION	1-year	amod	18	SENT_344	[p22l853t2950r1021b3015],
17	clinical	JJ	O	clinical	amod	18	SENT_344	[p22l1040t2945r1248b2998],
18	outcome	NN	O	outcome	prep_with	13	SENT_344	[p22l1268t2956r1522b2998],
19	of	IN	O	of	_	0	SENT_344	[p22l1543t2945r1609b2998],
20	elective	JJ	O	elective	amod	23	SENT_344	[p22l1619t2945r1834b2998],
21	percutaneous	JJ	O	percutaneous	amod	23	SENT_344	[p22l146t3035r541b3094],
22	coronary	JJ	O	coronary	amod	23	SENT_344	[p22l563t3044r821b3095],
23	intervention	NN	O	intervention	prep_of	18	SENT_344	[p22l839t3028r1200b3078],
24	with	IN	O	with	prep	5	SENT_344	[p22l1218t3025r1348b3078],
25	drug-eluting	NN	O	drug-eluting	dep	24	SENT_344	[p22l1368t3025r1733b3095],
26	or	CC	O	or	_	0	SENT_344	[p22l1754t3044r1814b3078],
27	bare-metal	JJ	O	bare-metal	amod	28	SENT_344	[p22l1832t3025r2145b3078],
28	stents	NNS	O	stent	dep	24	SENT_344	[p22l148t3115r333b3157],
29	.	.	O	.	_	0	SENT_344	[p22l148t3115r333b3157],
30	]	SYM	O	]	dep	4	SENT_344	[p22l348t3110r384b3174],

1	Am	VBP	O	be	dep	3	SENT_345	[p22l399t3108r503b3157],
2	Coll	NNP	O	Coll	nn	3	SENT_345	[p22l527t3104r633b3157],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_345	[p22l657t3104r858b3157],
4	2008	CD	DATE	2008	num	3	SENT_345	[p22l878t3109r1030b3166],
5	;	:	O	;	_	0	SENT_345	[p22l878t3109r1030b3166],
6	51	CD	NUMBER	51	dep	3	SENT_345	[p22l1055t3107r1131b3157],
7	:	:	O	:	_	0	SENT_345	[p22l1055t3107r1131b3157],
8	1925-34	CD	NUMBER	1925-34	dep	6	SENT_345	[p22l1155t3107r1401b3158],
9	.	.	O	.	_	0	SENT_345	[p22l1155t3107r1401b3158],

1	Owen	NNP	PERSON	Owen	nn	2	SENT_346	[p22l148t3201r319b3249],
2	A	NNP	O	A	_	0	SENT_346	[p22l338t3199r399b3257],
3	,	,	O	,	_	0	SENT_346	[p22l338t3199r399b3257],
4	Goldring	NNP	PERSON	Goldring	nn	5	SENT_346	[p22l423t3196r685b3266],
5	C	NNP	O	C	conj_and	2	SENT_346	[p22l707t3200r764b3257],
6	,	,	O	,	_	0	SENT_346	[p22l707t3200r764b3257],
7	Morgan	NNP	ORGANIZATION	Morgan	nn	8	SENT_346	[p22l789t3201r1017b3266],
8	P	NN	ORGANIZATION	p	conj_and	2	SENT_346	[p22l1040t3201r1092b3257],
9	,	,	O	,	_	0	SENT_346	[p22l1040t3201r1092b3257],
10	Chadwick	NN	ORGANIZATION	chadwick	nn	11	SENT_346	[p22l1116t3196r1406b3249],
11	D	NN	ORGANIZATION	d	conj_and	2	SENT_346	[p22l1427t3201r1489b3257],
12	,	,	O	,	_	0	SENT_346	[p22l1427t3201r1489b3257],
13	Park	NNP	O	Park	nn	14	SENT_346	[p22l1514t3196r1645b3249],
14	BK	NNP	O	BK	conj_and	2	SENT_346	[p22l1666t3201r1767b3257],
15	,	,	O	,	_	0	SENT_346	[p22l1666t3201r1767b3257],
16	Pirmohamed	NNP	O	Pirmohamed	nn	18	SENT_346	[p22l149t3275r534b3329],
17	M.	NNP	O	M.	nn	18	SENT_346	[p22l555t3281r628b3328],
18	Relationship	NN	O	relationship	conj_and	2	SENT_346	[p22l654t3275r1021b3345],
19	between	IN	O	between	_	0	SENT_346	[p22l1040t3275r1285b3329],
20	the	DT	O	the	det	22	SENT_346	[p22l1304t3275r1395b3329],
21	C343	NN	O	c343	nn	22	SENT_346	[p22l1418t3280r1559b3329],
22	5T	NN	O	5t	prep_between	18	SENT_346	[p22l1568t3279r1641b3328],
23	and	CC	O	and	_	0	SENT_346	[p22l1661t3275r1769b3329],
24	G2677T	NN	O	g2677t	conj_and	2	SENT_346	[p22l1790t3279r2097b3346],
25	(	CD	NUMBER	(	num	24	SENT_346	[p22l1790t3279r2097b3346],
26	A	DT	O	a	det	28	SENT_346	[p22l1790t3279r2097b3346],
27	)	NN	O	)	nn	28	SENT_346	[p22l1790t3279r2097b3346],
28	polymorphisms	NNS	O	polymorphism	dep	2	SENT_346	[p22l146t3356r608b3426],
29	in	IN	O	in	_	0	SENT_346	[p22l630t3359r689b3408],
30	the	DT	O	the	det	32	SENT_346	[p22l708t3356r799b3409],
31	ABCB1	NN	O	abcb1	nn	32	SENT_346	[p22l819t3360r1030b3409],
32	gene	NN	O	gene	prep_in	28	SENT_346	[p22l1051t3375r1188b3426],
33	and	CC	O	and	_	0	SENT_346	[p22l1210t3356r1318b3409],
34	P-glycoprotein	NN	O	p-glycoprotein	nn	35	SENT_346	[p22l1340t3356r1762b3426],
35	expression	NN	O	expression	conj_and	32	SENT_346	[p22l1782t3359r2095b3426],
36	in	IN	O	in	_	0	SENT_346	[p22l146t3439r205b3488],
37	human	JJ	O	human	amod	38	SENT_346	[p22l223t3436r438b3489],
38	liver	NN	O	liver	prep_in	32	SENT_346	[p22l456t3436r593b3489],
39	.	.	O	.	_	0	SENT_346	[p22l456t3436r593b3489],

1	Br	NN	O	br	nn	4	SENT_347	[p22l620t3441r688b3488],
2	]	CD	NUMBER	]	num	4	SENT_347	[p22l695t3441r730b3506],
3	Clin	NNP	O	Clin	nn	4	SENT_347	[p22l753t3436r868b3489],
4	Pharmacol	NNP	O	Pharmacol	_	0	SENT_347	[p22l891t3436r1191b3489],
5	2005	CD	DATE	2005	dep	4	SENT_347	[p22l1211t3439r1363b3498],
6	;	:	O	;	_	0	SENT_347	[p22l1211t3439r1363b3498],
7	59	CD	NUMBER	59	num	9	SENT_347	[p22l1389t3438r1469b3489],
8	:	:	O	:	_	0	SENT_347	[p22l1389t3438r1469b3489],
9	365-70	CD	NUMBER	365-70	dep	4	SENT_347	[p22l1494t3439r1709b3491],
10	.	.	O	.	_	0	SENT_347	[p22l1494t3439r1709b3491],

1	Hoffmeyer	NNP	PERSON	Hoffmeyer	nn	2	SENT_348	[p22l149t3526r467b3596],
2	S	NNP	O	S	_	0	SENT_348	[p22l490t3530r538b3588],
3	,	,	O	,	_	0	SENT_348	[p22l490t3530r538b3588],
4	Burk	NNP	PERSON	Burk	nn	5	SENT_348	[p22l563t3526r705b3579],
5	o	NN	O	o	appos	2	SENT_348	[p22l725t3531r788b3588],
6	,	,	O	,	_	0	SENT_348	[p22l725t3531r788b3588],
7	von	NN	PERSON	von	nn	9	SENT_348	[p22l809t3545r916b3579],
8	Richter	NNP	PERSON	Richter	nn	9	SENT_348	[p22l939t3526r1151b3579],
9	O	NNP	PERSON	O	appos	2	SENT_348	[p22l1172t3531r1235b3588],
10	,	,	O	,	_	0	SENT_348	[p22l1172t3531r1235b3588],
11	et	FW	O	et	nn	12	SENT_348	[p22l1258t3537r1310b3579],
12	al.	FW	O	al.	appos	2	SENT_348	[p22l1330t3526r1392b3579],
13	.	.	O	.	_	0	SENT_348	[p22l1330t3526r1392b3579],

1	Functional	JJ	O	functional	amod	2	SENT_349	[p22l1418t3526r1729b3579],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_349	[p23l146t24r608b94],
3	of	IN	O	of	_	0	SENT_349	[p23l631t24r696b77],
4	the	DT	O	the	det	7	SENT_349	[p23l706t24r797b77],
5	human	JJ	O	human	amod	7	SENT_349	[p23l817t24r1031b77],
6	multidrug-resistance	JJ	O	multidrug-resistance	amod	7	SENT_349	[p23l1050t24r1663b94],
7	gene	NN	O	gene	prep_of	2	SENT_349	[p23l1685t43r1838b94],
8	:	:	O	:	_	0	SENT_349	[p23l1685t43r1838b94],
9	multiple	JJ	O	multiple	amod	11	SENT_349	[p23l1861t24r2109b94],
10	sequence	NN	O	sequence	nn	11	SENT_349	[p23l148t122r418b173],
11	variations	NNS	O	variation	dep	2	SENT_349	[p23l437t107r723b157],
12	and	CC	O	and	_	0	SENT_349	[p23l745t104r853b157],
13	correlation	NN	O	correlation	conj_and	11	SENT_349	[p23l872t104r1189b157],
14	of	IN	O	of	_	0	SENT_349	[p23l1209t104r1274b157],
15	one	CD	NUMBER	one	num	16	SENT_349	[p23l1285t123r1390b157],
16	allele	NN	O	allele	prep_of	13	SENT_349	[p23l1411t104r1560b157],
17	with	IN	O	with	_	0	SENT_349	[p23l1579t104r1709b157],
18	P-glycoprotein	NN	MISC	p-glycoprotein	nn	19	SENT_349	[p23l1732t104r2154b174],
19	expression	NN	O	expression	prep_with	16	SENT_349	[p23l147t187r460b253],
20	and	CC	O	and	_	0	SENT_349	[p23l480t183r588b236],
21	activity	NN	O	activity	conj_and	19	SENT_349	[p23l608t187r813b253],
22	in	FW	O	in	prep	13	SENT_349	[p23l831t187r890b236],
23	vivo	FW	O	vivo	pobj	22	SENT_349	[p23l908t187r1039b237],
24	.	.	O	.	_	0	SENT_349	[p23l908t187r1039b237],

1	Proc	NNP	ORGANIZATION	Proc	nn	5	SENT_350	[p23l1067t189r1188b236],
2	Natl	NNP	ORGANIZATION	Natl	nn	5	SENT_350	[p23l1209t183r1329b236],
3	Acad	NNP	ORGANIZATION	Acad	nn	5	SENT_350	[p23l1347t183r1489b236],
4	Sci	NNP	ORGANIZATION	Sci	nn	5	SENT_350	[p23l1512t185r1592b236],
5	USA	NNP	ORGANIZATION	USA	_	0	SENT_350	[p23l1622t187r1751b236],
6	2000	CD	DATE	2000	num	5	SENT_350	[p23l1771t188r1923b245],
7	;	:	O	;	_	0	SENT_350	[p23l1771t188r1923b245],
8	97	CD	NUMBER	97	num	10	SENT_350	[p23l147t268r229b319],
9	:	:	O	:	_	0	SENT_350	[p23l147t268r229b319],
10	3473-78	CD	NUMBER	3473-78	dep	5	SENT_350	[p23l255t268r496b320],
11	.	.	O	.	_	0	SENT_350	[p23l255t268r496b320],

1	Marin	NNP	O	Marin	nn	2	SENT_351	[p23l148t358r325b408],
2	F	NN	O	f	_	0	SENT_351	[p23l348t358r397b416],
3	,	,	O	,	_	0	SENT_351	[p23l348t358r397b416],
4	Gonzalez-Conejero	NNP	PERSON	Gonzalez-Conejero	nn	5	SENT_351	[p23l422t354r981b424],
5	R	NNP	PERSON	R	appos	2	SENT_351	[p23l1005t360r1060b416],
6	,	,	O	,	_	0	SENT_351	[p23l1005t360r1060b416],
7	Capranzano	NNP	O	Capranzano	nn	8	SENT_351	[p23l1085t359r1436b424],
8	P	NN	O	p	appos	2	SENT_351	[p23l1460t360r1512b416],
9	,	,	O	,	_	0	SENT_351	[p23l1460t360r1512b416],
10	Bass	NNP	ORGANIZATION	Bass	nn	11	SENT_351	[p23l1537t360r1666b408],
11	TA	NNP	ORGANIZATION	TA	appos	2	SENT_351	[p23l1687t358r1785b416],
12	,	,	O	,	_	0	SENT_351	[p23l1687t358r1785b416],
13	Roldan	NNP	PERSON	Roldan	nn	14	SENT_351	[p23l1811t354r2015b408],
14	V	NNP	PERSON	V	appos	2	SENT_351	[p23l2034t360r2086b416],
15	,	,	O	,	_	0	SENT_351	[p23l2034t360r2086b416],
16	Angiolillo	NNP	O	Angiolillo	nn	17	SENT_351	[p23l145t435r434b505],
17	D	NNP	O	D	appos	2	SENT_351	[p23l458t440r544b503],
18	]	NN	O	]	dep	17	SENT_351	[p23l458t440r544b503],
19	.	.	O	.	_	0	SENT_351	[p23l458t440r544b503],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_352	[p23l571t435r1107b505],
2	in	IN	O	in	_	0	SENT_352	[p23l1128t438r1187b487],
3	cardiovascular	JJ	O	cardiovascular	amod	5	SENT_352	[p23l1208t435r1628b488],
4	antithrombotic	JJ	O	antithrombotic	amod	5	SENT_352	[p23l1648t435r2088b488],
5	therapy	NN	O	therapy	prep_in	1	SENT_352	[p23l145t515r374b585],
6	.	.	O	.	_	0	SENT_352	[p23l145t515r374b585],
7	]	SYM	O	]	dep	1	SENT_352	[p23l390t520r425b585],

1	Am	VBP	O	be	dep	3	SENT_353	[p23l440t519r544b568],
2	Coll	NNP	O	Coll	nn	3	SENT_353	[p23l568t515r674b568],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_353	[p23l698t515r899b568],
4	2009	CD	DATE	2009	num	3	SENT_353	[p23l919t520r1070b577],
5	;	:	O	;	_	0	SENT_353	[p23l919t520r1070b577],
6	54	CD	NUMBER	54	dep	3	SENT_353	[p23l1097t517r1177b568],
7	:	:	O	:	_	0	SENT_353	[p23l1097t517r1177b568],
8	1041-57	CD	NUMBER	1041-57	dep	6	SENT_353	[p23l1201t518r1423b570],
9	.	.	O	.	_	0	SENT_353	[p23l1201t518r1423b570],

1	wvvw	NN	O	wvvw	_	0	SENT_354	[p23l796t767r1333b818],
2	.	.	O	.	_	0	SENT_354	[p23l796t767r1333b818],

1	the	DT	O	the	det	2	SENT_355	[p23l796t767r1333b818],
2	|	NN	O	|	_	0	SENT_355	[p23l796t767r1333b818],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_355	[p23l796t767r1333b818],
4	Vol	NNP	O	Vol	dep	2	SENT_355	[p23l1377t767r1464b818],
5	376	CD	NUMBER	376	num	6	SENT_355	[p23l1484t766r1588b826],
6	October	NNP	DATE	October	dep	2	SENT_355	[p23l1635t767r1861b818],
7	16,2010	CD	DATE	16,2010	num	6	SENT_355	[p23l1877t766r2124b828],

